
(IN-PACKAGE :SP)
(DEFPARAMETER SPARSER::*NS-RD-PHASE3-7801-8100*
  '(".3" ".5266dupC" ".91+2T" "4eBP1" "A-0.483" "A-BRCA2" "A-pretreatment"
    "A-rich" "A-to-G" "A-type" "A1" "A1046A" "A1065T" "A138S" "A14" "A1789T"
    "A1789TvsWT-contrast" "A1C" "A279T" "A2V6-GFP" "A2V6-GFP-expressing"
    "A2V6-GFP-transfected" "A2WT-GFP" "A2WT-GFP-expressing"
    "A2WT-GFP-transfected" "A36" "A4" "A431-D3" "A431-V" "A47" "A5" "A6" "A7"
    "A72V" "A750EGFR" "A8" "AA280988" "AACAUC" "AACC" "AACR" "AAHRPP" "AAV"
    "AB7-263" "ABCG" "ABCG+2hox" "ABCG+2nox" "ABCG2+hox" "ABCG2+nox"
    "ABL-positive" "ACAAC" "ACIS" "ACM" "AD395-423" "AFB" "AFC" "AG+GG"
    "AG1487" "AGC" "AGE-BSA" "AGITG" "AGTCAG" "AGU" "AH-23848" "AH2-ABM"
    "AH2-MBM" "AH2N" "AHO" "AHO-like" "AIO" "AITL" "AKK" "AKKFF"
    "AKT-dependent" "AKT-targeted" "AKs" "ALDH3A" "AML-2" "AMPKα" "AMSH-MUT"
    "ANJ" "AOCS" "AOR" "AOR " "AOR " "AP-MS" "AP1-membrane" "APB-regulatory"
    "APDC" "APO-BRDU" "APPL1-K280E" "ARHGAP" "ARM7" "ARMS-Scorpion" "ARMS-like"
    "AR_CAG" "AS10" "AS15" "AS17" "ASCO" "ASCO-CAP" "ASK" "ASLV" "ASR" "ASR "
    "AT-0.467" "ATCC" "ATI-like" "ATM-Chk2-dependent" "ATM-dependent"
    "ATM-mediated" "ATM-proficient" "ATMi" "ATM–RASSF1A–MST2" "ATP-competitive"
    "ATR-Seckel" "ATR-catalyzed" "ATR-dependent" "ATR-mediated" "AUCUG" "AUDs"
    "AUTS2" "AVSD" "AXXAXR" "Ab-2" "Abate-Shen" "Abbott" "Abeln" "Abelson"
    "Abp1-SH3" "Ac-IEPD-pNA" "Ac-K382-p53" "Ac-K68K71-Skp2" "Ac-K83-p53"
    "Ac-p300" "AceView" "Acetylation-mimetic" "Achilles" "Actb"
    "Actin-cytoskeleton" "Ad-Cav-1" "Ad-Tat" "Ad-cav-1" "AdCa" "AdCas" "AdGFP"
    "AdNrf2" "Afftymetrix" "Affymetrix" "AffymetrixGeneChip" "Africa" "African"
    "African-American" "Africans" "Ag" "AgeI" "Ago-RISC" "Ago2-PAZ10"
    "Ago2-interaction" "Ahd1" "Akt-SRPK-SR" "Akt-dependent" "Ala-substitution"
    "Ala71Thr" "Aladdin" "Albright" "Albright's" "Alexa" "AlexaFluor488"
    "Algeria" "Alignment" "Alix" "Alsterpaullone" "Alu-Sb" "Alu-Sb2" "Alu-Sc"
    "Alu-Sj" "Alu-Sp" "Alu-Sq" "Alu-Sx" "Alzheimer" "Alzheimer's" "Alzheimer’s"
    "Amaxa" "Ambros" "Ambrosius" "Amemiya" "America" "American" "Americans"
    "Amerindians" "Amersham" "Amino-acids" "Aminoactinomycin" "Ammons"
    "Anchorage-independence" "Anderson" "Angelman" "Antonio" "Antony" "Apert"
    "Apo" "Arab" "Arabia" "Arabs" "Araki" "Arg15-Trp16" "Arg15-Trp16-Thr17"
    "Argentina" "Arizona" "Armitage" "Armstrong" "Array-CGH" "ArrayExpress"
    "Artemi" "Artemis" "Ashkenazi" "Asian" "Asians" "Asp98-Arg94"
    "Asp98-Ser184" "AssayID" "AssayIDs" "Asxl" "Asxl1-deficient" "Atg1p"
    "Atg5-12" "Atg7p" "Atlanta" "Atria" "Auboeuf" "AuroraA" "Australia" "Ave"
    "Avellino" "AvgP" "Aβ" "Aβ40" "Aβ42" "Aβ43" "A–4C" "B-3501A"
    "B-Cell-Non-Hodgkin-Lymphomas" "B-RafV600E" "B-RafV600E-positive"
    "B-Rafoncogenes" "B-boxes" "B-catenin" "B-lineage" "B-lymphoid" "B-mode"
    "B-subunit" "B-type" "B1" "B1-Cdk1" "B1-FRB-YFP" "B1-YFP" "B10"
    "B16-F10-shRab27a" "B16-F10mCherry" "B16-F10shMet" "B16-F10shScramble" "B2"
    "B2-1" "B2-Ahd1" "B3" "B4" "B5" "B55α" "B6" "B9" "BADGE" "BAEC" "BAPTA-AM"
    "BARCA1" "BBC1" "BBC2" "BBECs" "BCBL" "BCCIPα" "BCO13712"
    "BCPAP-HA-β-TRCP1" "BCPAP-HA–β-TRCP1" "BCR-like" "BD" "BGLF" "BGO1" "BH1-3"
    "BH3-domain" "BH3-mimetic" "BH3-mimetics" "BH3-only" "BH3-proapoptotic"
    "BH3m" "BHQ" "BIRB" "BJ" "BJ-E6E7" "BJ-SV40" "BJ-SV40LT" "BJ-p53dn" "BJE6"
    "BLOSUM62" "BMH1" "BMH2" "BMI" "BMIs" "BMP-RIA" "BMP-RIB" "BMP-RII" "BMPII"
    "BMPR-I" "BMPRs" "BMRF1" "BMS" "BMS-536924" "BPD1" "BRAF-inhibitor-induced"
    "BRAFT" "BRAFeither" "BRC5" "BRCA-interaction" "BRCA1-A"
    "BRCA1-KD-dependent" "BRCA1-KD-induced" "BRCA1-SKOV3" "BRCA1-defective"
    "BRCA1-interaction" "BRCA1-proficient" "BRCA2-F2" "BRCA2-F8"
    "BRCA2-defective" "BRCAPRO" "BT474M1" "BTAM" "BTG-1" "BUB1β" "BUZ" "BV"
    "BWH" "BWS" "BX-1" "Baan" "Backert" "Background" "Bak-dependence"
    "Bak-dependent" "Bak-mediated" "Baluk" "Bam" "Bangkok"
    "Bannayan–Riley–Ruvalcaba" "Barbareschi" "Barcelona" "Barford" "Barrientes"
    "Barrier-protective" "Bax" "Bax-derived" "Bax-like" "Bax-α1" "Bax-α6"
    "Bax-α9" "Bay-11-7085" "Bay11-7085" "Bazooka" "Bcl" "Bcl-2-family" "Bcl-XL"
    "Bcl-Xl" "Bcl-xl" "Bcl2a1c" "Bcl2a1d" "Bec126" "Beckman" "Beckwith"
    "Beckwith-Wiedemann" "Becton" "Bedford" "Begg" "Begg’s" "Beige-SCID"
    "Bel7704" "Benjamini" "Benjamini–Hochberg" "Berger" "Beta-PV" "Beta-PVs"
    "Betweenness" "Beuren" "Beyotime" "Bfl-1" "Bfl-1-derived" "Bfl-1-α1"
    "Bfl-1-α5" "Bfl-1-α6" "Bfl-1-α9" "Bfl-1DD" "Bfl-1SD" "Bh113" "Bh133"
    "BiNGS" "Biacore" "Bild" "Bim-S" "Bim-SAHB" "Bim-SAHB-induced"
    "Bim1-reverse" "BimEE" "BimEL-EE" "BimEL-EE-Beclin-1" "BimL-EE" "BimS-EE"
    "BimT" "BimT116E" "Bio" "Bio-Rad" "Biomeda" "Biosoft" "Biosystems"
    "Biotech" "Biotin-Capture" "Bioview" "Birukov" "Bis" "Blackfan"
    "Blue-labelled" "Bmh1p" "Bmx-binding" "Boltzmann" "Bonferroni" "Bonn"
    "Bordoni" "Borgne" "Borrmann" "Bouwmeester" "Bowen" "Boyden" "Bp65"
    "Brazil" "Brd" "Broad" "Bruni" "Bruton" "Bruton's" "Buckley" "Burk"
    "Burkitt" "Burkitt’s" "Buttita" "B–Cdk1" "B–EGFP" "B–containing"
    "B–expressing" "B–mediated" "C-0.408" "C-0.971" "C-0.985" "C-F12" "C-G2"
    "C-GTTC" "C-domain" "C-domain-BH-groove" "C-elegans" "C-lobe"
    "C-proteinase" "C-ter" "C-terminally" "C1" "C1Q1" "C2" "C2-domain"
    "C2-mediated" "C3" "C3-3P" "C4" "C42" "C5" "C57" "C57Bl" "C6" "C7"
    "C8orf13" "CA+AA" "CA-Rac1" "CA15.3" "CAACAA" "CAAX" "CABIT" "CACC"
    "CAIRO2" "CAL-101" "CAP" "CAPB" "CATCTG" "CAU" "CAUCUG" "CCAAT" "CCFR1"
    "CCGD" "CCNB" "CCR6+CCR4" "CCSP-rtta" "CCU" "CD138-positive" "CD20-antigen"
    "CD3+anti-CD4" "CD44v6" "CD74-ROS-WT" "CD74-ROS-triggered" "CD8SP" "CDCA2"
    "CDDO-Imidazolide" "CDE" "CEACAM1-N" "CEACAM1-NA1" "CEACAM1-NA1B"
    "CEACAM1-mKate" "CEACAM3-mKate" "CEACAM5" "CEACAMs" "CEN17" "CEN17 " "CEN8"
    "CEP17" "CEP2A" "CEP5A" "CEU" "CEs" "CFP-Sam68-ΔPxxP"
    "CFP-YFP-fusion-protein" "CGC" "CGG" "CGNP" "CGNPs" "CGPS" "CHC" "CHDs"
    "CHPKs" "CHRPE" "CHiP-qPCR" "CHiP-qtPCR" "CIHP" "CIHPs" "CIMBA" "CIN–54%"
    "CIdU" "CJ" "CJ179" "CJs" "CKIδ" "CKI–mediated" "CL10" "CL13" "CL61" "CLL3"
    "CLL4" "CLSM" "CMFDA" "CMGC" "CMML" "CMV-Gag-GFP" "CNGPs" "CNVs" "COBRA"
    "COGS" "COINNBS" "COP" "COS-1" "COSM28026" "CP91149" "CPT-sensitivity"
    "CRL-substrate" "CRYS" "CRYS-TAL" "CT-0.452" "CTCs" "CTD110.6" "CTFα"
    "CTFβ" "CTG" "CTL-MI" "CTL-mean" "CU" "CUGC" "CUP" "CY" "Ca(2+)-permeable"
    "Ca-calmodulin-dependent" "CaCl" "CaMPDB" "Cag-A" "Cal12T" "Calbiochem"
    "Calcein-AM" "Calcineurine" "CalcuSyn" "Calderwood" "Calistoga" "Calmette"
    "Calmette-Guerin" "Cambridge" "Carey" "Caribbean" "Carna" "Carolinas"
    "Carpinteria" "Carracedo" "CaspACE" "Castleman" "Catasus" "CateGOrizer"
    "Cath" "Caucasian" "Caucasians" "Cbl" "Cd4Cre" "Cdc28-4" "Cdc42h" "Cdc7"
    "Cdh1-interaction" "Cdk-consensus" "Cdk-like" "Cdk1-like" "Cdk1AF-mCherry"
    "Cdk1WT" "Cdk2-like" "Cdt1-cerulean" "Cecener" "Cenp" "Cenp-F"
    "Cenp-F-positive" "Central-South" "ChIP-QPCR" "ChIP-on-chip" "ChIP-qPCR"
    "ChIP-quantitative" "Chae" "Chandarlapaty" "Charcot-Marie-Tooth" "Che"
    "Cherry" "Cheung" "Chi-square" "Chiang" "Chiari" "Chilean" "Chip-QPCR"
    "Chk1" "Chk1-pS317" "Chk2-independent" "Chlamydomonas" "Choi"
    "Cholecystokinin" "Chou" "Chou-Talalay" "Chx10Cre" "Cia2" "Cif" "Cip"
    "Clara" "Clark" "Clarke" "Class-I" "CldU" "ClinSeq"
    "Clinical–Translational" "Clone2" "Clornorchis" "ClustalW2" "CoCa" "CoLaus"
    "Cochran" "Cochran-Armitage" "Coiled-Coil" "Collins" "Colorado" "Columbia"
    "Complete" "Concha" "Conclusion" "Conclusions" "Congo" "Consite"
    "Constitutively-expressed" "Control-mean" "Conway" "Coomassie" "Copenhagen"
    "Copy-Number-Variation" "Coremine" "Corp" "Costello" "Cowden" "CpG-A"
    "CpG-A–induced" "CreER" "Crick" "Crip1" "Cristofano" "Croatia" "Crohn"
    "Crohn’s" "Crouzon" "Cruz" "CsA-pretreatment" "Ct" "CtIP-mediated" "Ctsw"
    "Cullin-RING" "Cullin–Ring" "Cullin–Roc1" "Cut1-206-GFP" "Cut14"
    "Cut1–Cut2" "Cut1–securin" "Cut2" "Cy2" "CyPet" "CypD-mediated" "CytoC"
    "Cytoplasmic" "Cytoscape" "Cβ" "C–1E" "C–6E" "D-box" "D-cyclins" "D-loop"
    "D-loops" "D-overexpressing" "D-type" "D0" "D2" "D3" "DABSYL" "DAH" "DC101"
    "DEAH-family" "DED-DED" "DED-Only" "DED-only" "DED1" "DED1-DED2" "DED2"
    "DEVD" "DEVD-AMC" "DFG-out" "DG" "DGGE" "DISP3" "DLD1" "DMAT" "DMEM"
    "DMNT1" "DMR" "DMR1" "DMRs" "DN-to-DP" "DNA-Pokemon-antibody"
    "DNA-binding-domain" "DNAaseI" "DNAs" "DNP-DAB" "DO1" "DOTAP" "DOX"
    "DP-to-SP" "DQC" "DRESS" "DSBs" "DSG-T" "DSG-like" "DUSP18" "DW" "DXA"
    "Daikoku" "Dana" "Dana-Farber" "Danese" "Danvers" "Darby" "David" "Davids"
    "Davis" "Dbs" "DeNicola" "Decock" "Deep-seated" "Dejana" "Del-3" "Delaware"
    "Denghai" "Deniaud" "Denmark" "Denver" "Depakine" "Dex" "Dh404"
    "Dhandapany" "Dharmacon" "Dhh" "Di-Ras2" "DiaSorin" "Diagnòstica" "Diana"
    "Dickinson" "Dickson" "DiffK" "Discussion" "Diskin" "Dlg" "Dnmt3a-null"
    "Dohuk" "Dominant-negative" "Double-strand" "Down-stream" "Downs-Kelly"
    "Doxy" "Dp110" "DpnI" "Drebber" "DsRed-BGLF4-transfected" "Dscr1l2" "Du"
    "Dual-fluorescence" "Dublin" "Dulbecco" "Dulbecco’s" "Dvl2" "Dynabeads"
    "Dβ-Jβ" "Dβ-to-Jβ" "Dβ1-Jβ1" "Dβ2-Jβ2" "DβJβ" "D–activated" "D–containing"
    "D–enhanced" "D–expressing" "D–induced" "D–inducible" "D–mediated"
    "D–overexpressing" "D–positive" "D–specific" "E-MTAB-761" "E-Syt" "E-Syt3"
    "E-X-S" "E-box" "E-boxes" "E1-E2" "E1-E4" "E1308X" "E1A" "E1B" "E1∧E4"
    "E2A-PBX1" "E2F1through" "E2~Ub" "E3-Ubiquitin" "E3-ligases" "E3-like"
    "E3002D" "E3002K" "E3F3" "E3Histone" "E430004N04Rik" "E542K" "E545K" "E7"
    "E746-A750" "E746–A750Del" "E8.5–9.5" "E9.0" "E9.5" "EABR" "EACs" "EAIV"
    "EAhy926" "EB3-GFP3-positive" "EBV-GCs" "EC-like" "ECHDC1" "ECM-detachment"
    "ECV" "ECV-GFPeNOS-CAAX" "ECV-GFPeNOS-G2A" "ECV-GFPeNOSG2A" "ECV-MVB-like"
    "ECV-eNOSGFP" "ECVeNOSGFP" "ED" "EF-1δ" "EFGR" "EGFP" "EGFR+EGF"
    "EGFR-Stat3-mediated" "EGFR-overexpression-specific" "EGFRand" "EGFRcancer"
    "EGFRdNLS" "EGFRtk" "EGH2" "EGR" "EH" "EHEC" "EHTLLD" "EIC" "EIIA" "EJ28"
    "ELISAs" "ELISPOT" "EMBRACE" "EMMA" "EMS" "EMT-like" "ENT" "ENaC" "EPEC"
    "EPS-1-225" "ER+" "ER-Exit-Sites" "ER-Golgi" "ER-resident"
    "ER-stress-induced" "ER-to-Golgi" "ER-to-nucleus" "ER1-3" "ER2" "ERB-041"
    "ERE-Luc" "ERE-like" "ERK-dependent" "ERK-regulated" "ERK-responsive"
    "ERK1-2" "ERα-null" "ER + " "ESCRT-0" "ESCRT-1" "ESCRT-I"
    "ESCRT-recruitment-competent" "ESCRTs" "ESE" "ESEs" "ESP-Cohort" "ESR1_TA"
    "ESR2_CA" "ESRa1" "ET-like" "EULAR" "EVER8" "Early-onset" "Ebi2" "Eckardt"
    "Eckardt-Michel" "Ecoli" "Ectopic" "EdU-negative" "Edinburgh" "Edman"
    "Edod1" "Edwin" "Eeles" "Egger" "Egger’s" "Egr1" "Egypt" "Egyptians"
    "Ehrlich" "Eighty-five" "Eighty-two" "Elias" "Ellenson" "Elliott" "Elston"
    "EmGD" "Emp1" "Empty" "Enamine" "End-Results" "Endothelial-specific"
    "English" "Ep" "EpiTYPER" "Epithelial-Mesenchymal" "Epithelial-mesenchymal"
    "ErbB" "ErbB2-amplification" "ErbB2-amplified" "ErbB2-siRNA"
    "ErbB2-signaling" "Erbil" "Erk2-dependence" "Eto" "Euclidean" "Europe"
    "European" "European-descent" "Europeans" "Evans" "Ex3" "Exiqon"
    "Exocyst-association" "ExonA" "Exosomes" "Expt" "Expt "
    "Extra-mitochondrial" "Extract-induced" "Extract-treated" "EÎE4" "E–S5G"
    "F-SRC-1-M" "F-SRC-1M" "F-sensitive" "F122" "F122G" "F2" "F25" "F71"
    "F71–N72" "F8" "FA-AJ" "FA-J" "FA-defective" "FA-like" "FAAP20-UBZ"
    "FACScan" "FADD-DN" "FAF" "FAF-10" "FAK-CT" "FAK-FERM" "FAK-FERM–enhanced"
    "FAK-FERM–mediated" "FAK-I" "FAK-Is" "FAK-I–induced" "FAK-I–treated"
    "FAK-I–triggered" "FAK-mediated" "FANCA-defective" "FANCA-proficient"
    "FANCD1-defective" "FANCD2-defective" "FANCJ-null" "FANCM-MHF" "FASAY"
    "FDC6" "FDG-PET" "FEV1" "FFPETs" "FGAs" "FGFR1-chimeric" "FGFR1s"
    "FIG-ROS-WT" "FIGO" "FITC-VAD-FMK" "FK2" "FK2-aggresome"
    "FK2-ubiquitin-containing" "FKBP-rapamycin" "FKBP-rapamycin-FRB"
    "FKBP-rapamycin-binding" "FKBP12-like" "FKBPx2-YFP-H-Ras" "FLAG"
    "FLAG-HA-tagged" "FLAG-JNK2α2" "FLAG-Kif26b" "FLAG-TRIM50#3" "FLAG-tagged"
    "FLAG–STAT3α" "FLAG–STAT3β" "FLAG–Tor1-D" "FLAG–Tor2-S" "FM19G11" "FMC7"
    "FNA" "FO2-385" "FO2-385 " "FOLFIRI" "FOP2-FGFR1" "FOPFlash" "FOX" "FOXO4a"
    "FR1" "FRB-YFP" "FRB-cyclin" "FRB-mRFP-FT" "FRGY1" "FRGY2" "FSRC"
    "FSRC-1-M" "FTI277" "FTIR" "FTRs" "FUCCI" "FVC" "Fadare" "Fagonia" "Farber"
    "Fas-mediated" "Fauceglia" "Fbw7α" "Fbw7γ" "Fbxol" "Fbxw11a" "Fbxw11b"
    "Fc-receptors" "FcgRIIa" "FcyRII" "Fcγ" "FcγRI" "FcεR1γ" "FcεRI" "Fe"
    "Feng" "Feret" "Fgfr" "Fifty-four" "Fifty-one" "Fifty-six" "Fig2B"
    "FigureFigure" "Filamin" "Fine-mapping" "Finnish" "Fiorcari" "First-Line"
    "Five-year" "Fkh1-dependent" "Flag" "Flag-FAAP20-D164A" "Flag-Tat"
    "Flag-immunoprecipitation" "Flag-tagged-HDAC3" "Flash" "FlexPepDock"
    "Flinn" "Fluorodeoxyglucose" "FnBP-mediated" "Follow-up" "Forty-eight"
    "Forty-three" "Foundation" "France" "Francis" "Francisco" "Fraumeni"
    "French" "Frew" "Friedreich" "Friedreich’s" "Fritzsche" "Fru-2,6-P" "Fu"
    "FuGENE" "Fudan" "Fugu" "Fujiwara" "Fungoides" "Furman" "Fusco" "Fwd" "Fyn"
    "Fynomer-phage" "F–1H" "G-0.000" "G-0.015" "G-C-C-T" "G-E" "G-actin"
    "G-coupled" "G-loop" "G-rich" "G0" "G1" "G1-S" "G1-arrest" "G1-checkpoint"
    "G1-like" "G1-to-S" "G12" "G1–S" "G2" "G2-M" "G2-arrest" "G2-checkpoint"
    "G2-regulatory" "G2–M" "G3003A" "G319R" "GA-3" "GABPα" "GAC"
    "GAL4–ERt2–VP16" "GAP1" "GATCATTTGGAACAGTCTGCAAGGGAAAGTGGCATGGT" "GAU"
    "GBD" "GBM12" "GBM12TMZ" "GBM12TMZ#0461" "GBM12TMZ+SAHA" "GBM14" "GBM14TMZ"
    "GBM22" "GBM22TMZ" "GBM28" "GBM28TMZ" "GBM43" "GBP-1-7" "GC-content" "GCCG"
    "GCGTG" "GCNs" "GCS" "GCU" "GDS3099" "GEF-catalyzed" "GEF-exchange"
    "GEF-inducible" "GEF-stimulated" "GEMOX" "GENABEL" "GEO-shPdcd4" "GESBC"
    "GF-2" "GFP-2xFYVE" "GFP-APIM" "GFP-BGLF4" "GFP-BGLF4-expressing"
    "GFP-FAAP20-D164A" "GFP-FYVE-1" "GFP-Pokemon-labeled"
    "GFP-Rac1-L61-expressing" "GFP-RhoA-43I" "GFP-RhoA-43T" "GFP-RhoC-43T"
    "GFP-RhoC-43V" "GFP-VIA" "GFP-VIVIT" "GFP-VIVIT-transfected" "GFP-fusion"
    "GFP-reporter" "GFPV" "GFPeNOS-CAAX" "GFPeNOS-G2A" "GFPeNOSCAAX"
    "GFPeNOSG2A" "GG" "GGTCAnnnTGACC" "GGTIs" "GGU" "GLMN-RBX1-CUL1" "GRCh37"
    "GRβ" "GS-1011" "GSE-22" "GSE15852" "GSE22" "GSE36584"
    "GSG-domain-dependent" "GSH-Sepharose" "GSH-paxillin" "GSPx" "GST-Fyn-SH3"
    "GST-Kif26b-C" "GST-Nck1#2-SH3" "GST-Nef" "GST-Pac" "GST-Px-peptides"
    "GST-RasGAP-SH3" "GST-RhoA" "GST-RhoA-43I" "GST-RhoA-43T" "GST-RhoB-43I"
    "GST-RhoB-V43I" "GST-RhoC-43T" "GST-RhoC-43V" "GST-SH3-fusion"
    "GST-SH3-pull-down-assays" "GST-Spartan-C" "GST-TSAd-SH2" "GST-U2AF-35"
    "GST-U2AF65" "GST-UBZ-C147A" "GST-UBZ-WT" "GST-c-Src-SH2" "GST-c-Src-SH3"
    "GST-fusion" "GST-fusions" "GST-pull" "GST-pull-down"
    "GST-pull-down-assays" "GSTp65" "GST–MD-N" "GTAAA" "GTATA" "GTC"
    "GTGGGACAAAGAATTGGATCTGTATCATTTGGAACA" "GTL16R1" "GTL16R3" "GTL16S5" "GTTC"
    "GU" "GUC" "GWASs" "Gag-Akt" "Gag-ESCRT" "Gag-GFP" "Gag-PI" "Gag-Tsg101"
    "Gain-of-function" "Gal4-AD" "Gal4-BD" "GalCer" "GalGalCer" "GalNAc"
    "GalNAcα1-O-Ser" "Galβ1-3GalNAcα1-O-Ser" "Gambia" "Gastrin-mediated"
    "Gavathiotis" "Gavet" "GelMount" "Geminin-cerulean" "GenBank" "GeneChip"
    "GeneSplicer" "Genentech" "Genepop" "Genome-wide" "Genotype-phenotype"
    "Genotypes" "George" "Georgia" "German" "Germany" "Germyan" "Gharbiah"
    "Ghilardi" "Giovanni" "Gjerstad" "GlaxoSmithKline" "Gleason" "Glendale"
    "Globocan" "Glostrup" "Glu-tubulin" "Glu453del" "Gn" "GoDARTS" "GoldenGate"
    "Goldmann" "Golgi-like" "Golsteyn" "Goltsov" "Gould-Rothberg" "Governate"
    "Governates" "Gozgit" "Gram-negative" "Graphpad" "Gravalos" "Grd19p"
    "Greek" "Greeks" "Grose" "Group-1" "Group-2" "Group-3" "Grunhage" "Grus"
    "Gs" "Gsalpha" "Gtt-3" "Guatelli" "Guerin" "Guidugli" "Gumerlock" "Gy"
    "G→T" "H&E" "H&E-stained" "H+E" "H-score" "H1" "H1047L" "H133W" "H187→Y"
    "H19" "H1975" "H1993" "H2-Ld-HuIL-6" "H2009" "H3" "H3255s" "H3K14" "H3K18"
    "H3K27" "H3K56Ac" "H3K9" "H3K9-ac" "H3K9Ac" "H4" "H9" "H9-derived"
    "HA-FLAG-MMS19" "HA-Tag" "HA-WT" "HA-YAP" "HA-tag" "HAH" "HARP-like"
    "HBECs" "HBGF" "HBMEC-CEACAM1-GFP" "HBUS" "HC2a" "HC2b" "HC3a" "HC3b"
    "HC3c" "HCC827ER1" "HCT" "HDCA6" "HDMECs" "HDRSRT" "HEAT" "HECT~ubiquitin"
    "HEK-293A" "HEK293-hCD1d" "HEKn" "HEM-LP" "HER-VIA" "HER2-VIA"
    "HER2-VIA-containing" "HER2-VIA-induced" "HER2-VIA-treated" "HER2-mediated"
    "HER2-positive" "HER2-soluble" "HER2-subtype" "HER2over-activationare"
    "HESCs" "HFF" "HFFs" "HFKs" "HIER" "HIPR" "HIV-Tat" "HJ" "HL-P" "HL7702"
    "HLA-DR4" "HMBCS" "HMCLs" "HME-1563" "HME-1564" "HME-1565" "HME-1573"
    "HME-1855" "HME-1916" "HME-like" "HMEpC" "HMS" "HMS-97" "HMVEC" "HMVECs"
    "HN" "HND+LCA" "HND+LCAf" "HND+LCAx" "HO16" "HOFs" "HP-virus" "HP1-γ"
    "HPI-gamma" "HPLC-ESI-MS" "HPV16-status" "HPV16E7" "HR-defective" "HR=0.86"
    "HR=1.30" "HR=1.33" "HR=1.37" "HR=1.43" "HR=1.44" "HR=1.86" "HR=2.00"
    "HR=2.08" "HR=2.21" "HR=2.42" "HR=2.49" "HR=2.51" "HR=2.62" "HR=2.67"
    "HR=3.28" "HR=3.39" "HR=4.06" "HR=4.22" "HRMC" "HRMCs" "HSF1and"
    "HSF1regulation" "HSQC" "HSV-1" "HT-12" "HT1080" "HT29-shPdcd4" "HTB-178"
    "HTB-182" "HTERT" "HTS-amenable" "HUH7" "Hacohen" "Hahn" "Hammond" "Hans"
    "Hanyu" "Hap300" "Hap370" "HapMap" "HapMap3" "Haploview" "Harbin" "Harbord"
    "Hardy-Weinberg" "Hardy–Weinberg" "Hartmuth" "Hashimoto" "Hashimoto’s"
    "Hatley" "Hayashi" "Hayes" "HbA1c" "Hck-SH3" "Hck-SH3-GST" "Hck-SH3-domain"
    "Hck-SH3-phage" "Hck-SH3–ALIX" "Heka" "Helsinki" "Hematology" "Hemminki"
    "Henle" "HepA" "Hercep" "HercepTest" "Hervouet" "Hewa" "Hifα"
    "High-Resolution" "High-affinity" "High-level" "High-risk" "Hilden"
    "Hill-coefficients" "Hill-transformed" "HindIII" "Hinoda" "Hippo-YAP"
    "His-C" "His-CSD" "His-Rad6B" "His-Sam68" "His-YB-1" "His-tones" "Hispanic"
    "Hochberg" "Hodgkin" "Hodgkin's" "Hodgkin’s" "Hoechst" "Hoeflich" "Hoek"
    "Hoellenrigel" "Hoffman" "Hofmann" "Hogdkin" "Hogdkin’s" "Holliday"
    "Host-mediated" "Hsp27-CAT" "Hsp27-depedent" "Hsp70" "Hsp90-containing"
    "Hsu" "HuCCT-1-parent" "Huang" "Human-1.2M-Duo" "HumanHap240S"
    "HumanHap300" "HumanHap550" "Humar" "Huntington" "Huntington’s" "Hurst"
    "Hygro" "Hyper-immunoglobulin" "Hz" "I-III" "I-SMAD" "I-binding"
    "I-mediated" "I-nicked" "IAPS" "IARC" "IC-FGFR1-MYC" "IC50" "ICD-10" "ICF"
    "ICI182790" "ICOGs" "IDs" "IEC" "IECs" "IETD-AFC" "IETD-CHO" "IFN-A"
    "IFN-A1" "IFN-A14" "IFN-A2" "IFN-A4" "IFN-A5" "IFN-a" "IFN-γ-stimulated"
    "IFN-λ1" "IFNγ+Fyn" "IFNγ+chloroquine" "IFNγ-treatment" "IGF-1-1kb-Luc"
    "IGF-1-EREL-Luc" "IGF-1–induced" "IGHV" "IGV" "IGVH" "IHEECs" "IHESCs"
    "II-2" "II-4" "II-5" "II-IV" "IIA" "III-IV" "III-V" "IIIA9" "IIIa" "IIIc"
    "III–IV" "IIumina" "IIα" "II–IV" "IKKi" "IKN4a" "IL-11R" "IL-6-ms" "IL2-R"
    "ILN" "IMR" "IMR90-SV40LT" "INKa" "INRG" "INR " "IOSE-592F" "IQ" "IREs"
    "ISGs" "ISH" "ISI" "ISRE" "ITC" "IU" "IUS" "IVKAs" "IVS" "IVS1" "IWCLL"
    "Iba-1" "Identity-by-descent" "Ig-like" "IgA" "IgECL" "IgIII" "IgIIIa"
    "IgIIIb" "Igf" "Ignatiadis" "Iida" "Illinois" "Illumina" "ImageJ"
    "Imatinib" "ImmunoFISH" "Immunodeficiency-Centromeric" "In-cell" "In-situ"
    "In-vitro" "InCell" "Inc" "Infinium" "Infinium-iSelect" "Inhibitor-KappaB"
    "Int" "Interferon-λ1" "Intermediate-length" "Intersectins"
    "Intra-glandular" "Invitrogen" "Iowa" "Iran" "Iraq" "Ireland"
    "Ischemia-reperfusion" "Ishida" "Isopropyl" "Italians" "Ito" "Iwamori"
    "IκBα-luc" "I–II" "I–III" "J1" "J82" "JAK2V615L" "JAK2V615LV617F"
    "JAK2V617F" "JAK2V67F" "JAP" "JBC" "JH1" "JH3-part" "JH4-JH7" "JHK" "JHS"
    "JJI" "JLF" "JLM" "JMD" "JMS" "JNK-reporter" "JNZ" "JQ1" "JQ354981" "JRM"
    "JSK" "JW" "JX" "JYT" "JZF" "Jackman" "Jackson" "Jackson-Weiss" "Janus"
    "Japanese" "Jarboe" "Jeghers" "Jemal" "Jewish" "Jews" "Jiang" "Jimenof"
    "JointSNVMix" "Jonkers" "Jordan" "Joshi" "Juan" "Juliusberg" "K-382-p53"
    "K-Means" "K122" "K14" "K14-HPV16" "K141" "K19" "K2-treated" "K312"
    "K354R-or" "K429A-K430A" "K48-and" "K49R" "K68L" "K68Q" "K68R" "K71L"
    "K71Q" "K71R" "K9" "KF" "KI-67" "KIF" "KIFs" "KIST301080" "KIT20" "KIT21"
    "KITD816V" "KJ" "KKAy" "KKCCFHCQACAITK" "KKCCFHCQVCFITK" "KKKQRW" "KLFs"
    "KLH" "KQ" "KRAS+PK3CA" "KRASallele" "KRASand" "KRAScancer" "KRASmutations"
    "KRK" "KRK-1014" "KRKR-Skp2" "KRRPR" "KRTAP5-6" "KU55933-inhibitor"
    "KUOO6379" "KVSR" "KXTQTX" "Kaen" "Kalinski" "Kallmann" "Kang" "Kaplan"
    "Kaplan-Meier" "Kaplan–Meier" "Kaposi" "Kaposi-Juliusberg" "Kaposi’s"
    "Karnofsky" "Karolina" "Kashani" "Kashani-Sabet" "Katsuragi" "Kawai"
    "Kawakami" "Kd-value" "Kd-values" "Kds" "Kelch" "Kemp" "Kennedy" "Khon"
    "Ki-67" "Ki67" "Kiernan" "Kiev" "Kif26" "Kif26b" "Kim" "Kinesin-11" "Kip"
    "Kirsten" "Kit-8" "Kit-ir" "Klemm" "Klipp" "Klippel" "Klippel-Trenaunay"
    "Klotman" "Knock-down" "Knock-in" "Knockin" "Knudson" "Knudson's" "Kolch"
    "Kolmogorov" "Kolmogorov-Smirnov" "Komatsu" "Konecny" "Konopka" "Korean"
    "Koreans" "Kounelis" "Kp21-4" "Kp27-5" "Kras" "Kratky" "Krishna" "Krüppel"
    "Krüppel-like" "Ksp" "Ksp1.3-Cre" "Kunjin" "Kurdish" "Kurds" "Kusano"
    "Kyoto" "Kärkkäinen" "K→L" "K→Q" "K→R" "L-CD1d" "L-CD1d-DR4" "L-N-methyl"
    "L-NMA" "L1" "L123" "L123G" "L2" "L26" "L2972W" "L2987A" "L3000A" "L319"
    "L5-S1" "L597R" "LA2" "LATS" "LC-2" "LC3-I" "LC3B-I" "LC3B-II" "LCL" "LCLs"
    "LD-1,2" "LD-3,4" "LD-4" "LDL-cholesterol" "LDR" "LE" "LEOPARD" "LHβ" "LIM"
    "LIM-2" "LIM-kinase1" "LIMKi" "LIMKs" "LIMMA" "LINE-1" "LIVE" "LLB"
    "LMTK-CD1d1" "LMW" "LOC100506504" "LOC199990" "LOD" "LOF" "LOGFC" "LOQ"
    "LPS" "LQ" "LR" "LR00-016a1" "LR06-220" "LR08-018" "LR09-006" "LR11-153"
    "LR11-230" "LR11-270" "LR11-354" "LR12-033" "LRIT3s" "LRs" "LSI" "LSKcells"
    "LTQ-Orbitrap" "LTR-GFP" "LW6" "LY29" "LY293646" "Labour-associated" "Lac"
    "LacZ-VIA" "Lafayette" "Lamp1-positive" "Lampang" "Laos" "Lap2β"
    "Large-scale" "Latin" "Lats1" "Lauren" "Lauren's" "Lauren’s" "Lawe" "Le"
    "Lebanon" "Lef" "Lehmann" "Lehmann-Che" "Leica" "Lekomsev" "Lekomtsev"
    "Lerma" "Lerner" "Leung" "Lgl" "Li" "Li-Fraumeni" "Li-Fraumeni-like"
    "Liang" "Lif" "Ligand-receptor" "Light-Electron" "Lin28-let-7" "Lineweaver"
    "Lineweaver-Burk" "Lipofectamine" "Liu" "Live-Dead" "Live-cell"
    "Li–Fraumeni" "Lockless" "Log-Rank" "Lohr" "London" "Loss-of-function"
    "Lp53" "Lu" "Lund" "Lupus-like" "Lwtp53" "Lyn-FKBP2-mCherry" "M-8" "M-C"
    "M-Mitf" "M10" "M13-specific" "M1775RvsWT-contrast" "M4-1" "M4-2" "M8"
    "MAAN" "MAGPHPVIVITGPHEE" "MALDI-TOF-TOF" "MALDI-TOF-TOF-based"
    "MALDI-TOF-TOF-driven" "MAPK-YT" "MAR" "MB-0110" "MB-020" "MB-030"
    "MBS-RFP" "MC159" "MC58" "MCF7-p53i" "MCF7-vector" "MCL-like" "MCM2-7"
    "MCM4-6-7" "MD-C" "MD-M" "MD-N" "MEK-DD" "MEK1-2" "MEKi" "MEM" "MEME"
    "MET-dependent" "MET-positive" "MFN" "MG-U87" "MGH" "MHC-I" "MIEG3"
    "MITF-M" "MITF-M-independent" "MKK" "MKN" "MLH1-interaction-defective"
    "MLNAF" "MNSC" "MOWSE" "MP-470" "MPLW515L" "MPYS" "MQN" "MRD" "MRDs" "MS"
    "MS-PCR" "MS2-fusion" "MSCV" "MSI-H" "MSKCC" "MST2" "MUT-USP2a" "MYPT1-CD"
    "MYPT1-MD" "MYPT1–PP1C-mediated" "Maas" "Maas-Szabowski" "MacCallum"
    "Macrobius" "Madin" "Madin–Darby" "Mai" "Mainz" "Mammen" "Mandard" "Maniwa"
    "Mantel-Cox" "Map" "Marapsin" "Martinez" "MassArray" "MassEXTEND"
    "Massachusetts" "Material" "Materials" "Mathelin" "MaxEntScan" "Maxi"
    "Mayo" "McKie" "McTN" "McTNs" "Mdm30" "MeSAMP" "Megalencephaly-capillary"
    "Mei-P26" "Meier" "Mekk2,3" "Melbourne" "Melke" "Mellinghoff" "Mendelian"
    "Mendez" "Menten" "Merck" "Met5-Met10" "Meta-regression" "Method"
    "Methodology" "Methods" "Mexican" "Mexican-mestizo" "Mfn2HA" "Mhawech"
    "Mhawech-Fauceglia" "MiR-191" "MiR-23a" "Michael" "Michaelis"
    "Michaelis-Menten" "Michel" "Micro-Checker" "Microsatellites" "Middle-East"
    "Mierke" "Miettinen" "Mikhail" "Millipore" "MitoTracker" "Mm00434225"
    "Mm00439671" "Mm00445231" "Mm00457691" "Mm00505670" "Mm00515466"
    "Mm00607939" "Mm00614433" "Mm01295719" "Mm01740674" "MoFloTM" "ModFit"
    "Mohammadi" "Morgentaler" "Morrison" "Moscati" "Mozes" "MudPIT" "Mule"
    "Mulholland" "Multi-cellular" "Multi-subunit" "Munich" "Musat" "Mut-4"
    "Mut-6" "MutvsWT" "MutvsWT-contrast" "MyPhoNE" "Myc-1" "Myc-RhoA-43I"
    "Myc-RhoA-43T" "Myc-RhoA-43T-63L" "Myc-RhoC-43T" "Myc-RhoC-43V"
    "Myc-epitope-tagged" "MycER" "Myo3" "Myp2" "MβCD" "N-EmGFP-DEST" "N-SH2"
    "N-SH2-binding" "N-acetyl" "N-aminoimidazole" "N-and" "N-diethylamino"
    "N-ethylcarbamide" "N-glycosidase" "N-glycosylation" "N-labeled"
    "N-labelled" "N-linked" "N-lobe" "N-methyl-nitrosourea" "N-nitrosamines"
    "N1-aryl-propane-1,3-diamine" "N17Rac1" "N19-RhoA" "N7" "N72" "N=5" "N=8"
    "N=93" "NA" "NASF" "NASPLK" "NATRWT" "NCBI" "NCI" "NCI-H1155" "NCI-H1755"
    "NCI-H1915" "NCP-TW01" "NCZ" "ND-1000" "NEP-ICD" "NESPAS" "NETO" "NF-κB1"
    "NFATS" "NFKB" "NFkBp65" "NFκBp50" "NFκBp65" "NHL-2" "NHLB1" "NHLBI"
    "NHS-S-S-biotin" "NHS-S-S-biotin-labelled" "NHTi" "NIA" "NIH-III" "NIOSH"
    "NK4a" "NLS-FKBP-mCherry" "NLS-FKBP2-mCherry" "NLS3-mCherry" "NLSs" "NMII"
    "NM_139323" "NOD-SCID" "NPHP-481-732" "NPHP1-1-205" "NPHP1-12"
    "NPHP1-237-670" "NPHPs" "NR-818" "NROB2" "NRTK" "NS-like" "NSC-M"
    "NSC27366" "NSdB" "NTHi" "NY-1" "NZFs" "Nacken" "Nagoya" "Nakajima" "Nano"
    "NanoPro" "NanoSight" "Nanogen" "Nanogen-Master" "Nck1#1" "Nck1#2" "Nck1#3"
    "Nedd4-MO" "Nef-SH3" "Nef-like" "Neoadjuvant" "NetPhosK" "Neu"
    "Neutrophilis" "Next-generation" "NextBio" "NheI" "Ni" "Ni-NTA" "Nick-End"
    "Nickel-nitrilotriacetic" "Niementowski" "Nigeria" "Nigerians" "Nijmegen"
    "NimbleGen" "Nishimura" "Nkx" "Nmethyl" "Nmethyl-nitrosourea" "No" "NoLS"
    "Nod" "Nofech" "Nofech-Mozes" "Nonidet" "Noonan" "Normal" "North-East"
    "Nottingham" "Nowell" "Nras" "Nrf2" "Nsp" "Nutlin-3+ATMi"
    "Nutlin-3-Crizotinib" "N = 4" "N≥300" "O-GalNAc" "O-GlcNAcylated"
    "O-GlcNAcylation" "O-GlcNAcylation-induced" "O-glycosidic" "O-glycosylated"
    "O-glycosylation" "O-linked" "O1" "O2" "O6-BG" "O6-MG" "O6-methylguanine"
    "O6-methylguanine-DNA-methytransferase" "OB2" "OH" "OHT" "OHdG" "OMIM"
    "OMVs" "OR=2.31" "OR=2.4" "OR=2.48" "OR=2.75" "ORs" "ORs " "OR = 2.4"
    "OSF-SH3" "OSF-Src-interaction" "OVCA" "OXPHOS" "Ohio" "OligofectAMINE"
    "Olympus" "OncoMap" "Oncology" "Oncology-College" "One-half"
    "One-hundred-and-sixty-eight" "One-hundred-and-twenty-two" "One-way"
    "One-week" "Opc" "Opti" "Opti-MEM" "Orbitrap" "Osteodystrophy" "Ostrovsky"
    "Over-activation" "Overexpression" "OxPAPC" "P0" "P1" "P1+P2" "P1–P4" "P2"
    "P47A" "P6" "P7" "P72A" "P72G" "P72R" "P75A" "P75G" "P78A" "P78G"
    "P790-M791" "P=0.003" "P=0.006" "P=0.01" "P=0.012" "P=0.019" "P=0.02"
    "P=0.06" "P=0.15" "P=0.80" "PAGE" "PAHS-020" "PAK4i" "PAK4r" "PALS"
    "PAX3-FOXO1-positive" "PBMNCs" "PBmiR-21" "PBmir" "PBmir-21" "PBmirVec"
    "PCNA-interaction" "PCR-LDR" "PCR-RFLP" "PD20" "PDFGR" "PDGF" "PDGFRα"
    "PDGFRα-immunoreactive" "PDGFRα-ir" "PDGRβ" "PDK" "PDR90" "PEC" "PEST"
    "PETACC-2" "PETACC-3" "PF-04217903" "PF-04880594" "PFD+FE" "PFTα" "PGI"
    "PHP-Ia" "PHP-Ib" "PHPIb" "PI3-kinase-like" "PI3-like" "PI3K-C2α"
    "PI3K-dependence" "PI3K-dependency" "PI3K-like" "PI3KC3" "PI3KCA" "PI5K"
    "PIK3CAalleles" "PIK3CAcancer" "PIK3CAmutants" "PIK3CAmutations"
    "PIK3CAoncogenes" "PIK3CAor" "PIKKs" "PISA" "PKAc" "PKC-ζ" "PLC-δ"
    "PLCγand" "PLINK" "PLK1-siRNA-treated" "PLK1was" "PML-I" "PML-III" "PML-IV"
    "PML-IV-specific" "PML-IV–tethered" "PML-VI" "PMP" "PMPs" "PNEC" "PNST"
    "PNSTs" "POT" "POT1a" "POT1a-tetOFF" "POT1a-tetOFF-19" "POT1a-tetOFF-26"
    "POT1atetOFF" "POT1atetOFF-19" "POT1b" "POZ" "PP1-cell" "PP1R" "PP1RB"
    "PP1cα" "PP1cβ" "PP1cγ1" "PP1cγ2" "PP1cδ" "PP1γD64N" "PP2A-B55δ" "PP2A-Bδ"
    "PP2B" "PPAR3" "PPARG-agonists" "PPBN" "PPI" "PPI-Pred" "PPP1R2A" "PPXY"
    "PPXY-WW" "PPlα" "PQVPLR" "PRKC-ζ" "PRKC-ι" "PRKC–β" "PRKC–ι" "PR + "
    "PSIC" "PTAP" "PTEN-null" "PTEN-proficient" "PTP-interacting" "PTPN14-YAP"
    "PTV" "PUMA-dependent" "PVD" "PVs" "PX-BAR" "PYKFPSSPL" "PYKFPSSPLR"
    "Pacific" "Paget" "Pakistan" "Palsamy" "Pan-European" "Par3" "Parkinson"
    "Parkinson's" "Pará" "Pawlik" "Pd" "Pearson" "Pen-Strep" "Penney"
    "Pentacam" "Petersen" "Petra" "Peutz" "Peutz-Jeghers" "PfSir2" "Ph"
    "Philadelphia" "Phosphoflow" "Phyre" "Piccirillo" "Pires" "Plk1-pT210"
    "Poernbacher" "Poisson-Boltzmann" "Pokemon-null" "Poland" "PolyGln"
    "PolyPhen2" "Polyphen" "Polyphen2" "Ponceau" "Pongidae" "Pop3" "Position-4"
    "Post-inductional" "Post-replication" "Post-transcriptional"
    "Post-translational" "Post-treatment" "Potente" "Powell" "Prader"
    "Prader-Willi" "Principal" "Prion-like" "Pro-inflammatory" "Pro-survival"
    "Processing-bodies" "Project" "Prolifigen" "Promega" "Prostin"
    "Przybylowska" "Puerto" "Pull-down" "Pulse-chase" "Purelink" "Purkinje"
    "PxQxS" "PxxP" "PxxP-ligand-motif" "PxxP-motif" "PxxP-motifs"
    "PxxP-peptide" "PxxP-peptides" "PxxPs" "PxxPxK" "PyMT" "Pyro" "P = 0.0001"
    "P = 0.006" "P = 0.02" "P = 0.03" "P≤0.05" "Q-FISH" "Q-test" "Q1756term"
    "Q318" "Q346" "Q442A" "Q51X" "QADRWT" "QMP" "QQ" "QQ-plot" "QRS" "QUASAR2"
    "QV" "QVCF" "QW" "Qiagen" "Qidong" "QuantityOne" "QuikChange" "Quincke"
    "R-Smad" "R-package" "R1" "R139H" "R172H" "R177" "R177A" "R178A" "R2"
    "R262Q" "R2973C" "R3005A" "R509H" "R52X" "R5H3" "RAD51-mediator"
    "RAD54L-ABM" "RAD54L-MBM" "RAD6" "RAERST" "RAFi" "RALS-seq" "RAP80-null"
    "RASL" "RASL-seq" "RASS" "RASSF1-10" "RASSF1-6" "RASSF1A–MST2–LATS1"
    "RASSF2A" "RASSF5A" "RASSF5B" "RASSF5C" "RASSF7-10" "RASSFIA" "RATA"
    "RBX1-CUL1-containing" "RBX1-CUL1~NEDD8" "RB–E2F1complex" "RDRPLRRDRRGKRQR"
    "RECI" "RECl" "RFLP" "RFLPs" "RIA" "RIG-I-like" "RII" "RING-E2"
    "RING-finger" "RIPA" "RL2" "RLHs" "RLW" "RMSD" "RNA" "RNA-protein" "RNAPII"
    "RNAi-1" "RNAi-2" "RNA–induced" "RNA–protein" "RNPC1-RNA" "RNPC1a" "RNPC1b"
    "RNR3" "RNaseP" "ROI" "ROSETTA" "RPA-ssDNA" "RQL" "RRB" "RRRCWWGYYY"
    "RRVSFA" "RS1-E" "RS2-E" "RSK-dependent" "RSK-regulated" "RUNX" "RVxF"
    "RWT" "RXRXXS" "RXS" "RXXS" "Rac-effectors" "Rac1" "Rac1-17" "Rac1-54"
    "Rac1-GTP" "Rac1b-induced" "Rac1b–associated" "Rac1b–induced" "RacGAP"
    "Rad18-like" "Rad3" "Rad6BshRNA" "Raf1L613V" "Rafoncogenes" "Ral-GTP"
    "Ramprasath" "Ran-GTP" "Ran-dependent" "Ranganathan" "Ras-Raf-Erk1"
    "Ras-association" "Ras-like" "RasGRF1-kd" "Rayleigh" "Rb-like"
    "Rb-mediated" "Rb-proficient" "Rbxl" "Re-establishment" "Re-expression"
    "Re-introduction" "Re-organisation" "RecD" "RecG" "RefSeq" "Regensburg"
    "Reid" "Reisenbichler" "Remmele" "Repo" "Repo-Man" "Repo-Man–deficient"
    "Results" "Reticulum" "Reticulum-Golgi" "Rex" "Rheb-GTP" "Rho-family"
    "Rho-like" "RhoA-ROCK-MLC-mediated" "RhoA-V43I" "RhoA-V43T" "RhoA-null"
    "RhoAGAP" "RhoG" "Rhodamine-phalloidin" "Rican" "Richard" "Rico" "Rif"
    "RmZm" "Roche" "Romanians" "Rorγ" "Roscovitine-treated" "Rosi" "Rothberg"
    "Rotin" "Rous" "Rs13306465" "Rs1801278" "Rubin" "Ruffer" "Rum1" "Russel"
    "Russell" "RxI" "RxL" "RxPxxP" "Rybak" "Rüschoff" "S-Cdk" "S-DISC" "S-L"
    "S-X" "S-checkpoint" "S-labeled" "S-nitrosated" "S-nitrosation" "S-pS"
    "S-phase-like" "S1" "S1046" "S1882X" "S1B-C" "S1C" "S1H" "S1I" "S1J" "S20A"
    "S217" "S2A" "S2B" "S2C" "S2D" "S3" "S3016A" "S3020C" "S303" "S307" "S314"
    "S317" "S320" "S326" "S33" "S345" "S37" "S3A-B" "S3C" "S3E" "S445–specific"
    "S46A" "S4A" "S4B" "S553fs" "S6" "S6-NEP" "S6-NEP-ICD" "S6-kinase"
    "S6A-NEP" "S6G" "S7" "S72D" "S75D" "S7KD" "S8" "S8A–C" "S8D–E" "S9"
    "SA-Biosciences" "SAR" "SARAH" "SAβGal" "SBCS" "SBI" "SCA2-length" "SCEs"
    "SCRT" "SELDI-TOF-based" "SF2Nef" "SF2NefP72G" "SF763-Si-BMPR-IB" "SFS"
    "SFV" "SFV-hNEP" "SFV-hNEP-infected" "SH-groups" "SH2-domain" "SH3-PxxP"
    "SH3-PxxP-pair" "SH3-domain" "SH3-domain-PxxP-interaction" "SH3-domains"
    "SH3-interactions" "SH3-ligand" "SH3-phages" "SH3–peptide" "SHBR"
    "SHP2-cardiomyocyte" "SHPG171A" "SHPK170N" "SHPK170R" "SHPK171A" "SHPWT"
    "SID-MRM" "SIFT" "SIOD" "SIRT" "SIRTs" "SIg" "SJD" "SK-Mel202" "SK-Mel28"
    "SK-N-DZ" "SK-N-FI" "SKMEL" "SKMEL-23" "SKP1-CUL1-F-box" "SLC45A-BRAF"
    "SLC7A" "SLN" "SLNs" "SMADS" "SMART-i" "SMARTpool" "SMIs" "SN50" "SN9"
    "SNARES" "SNP" "SNP-FASST2" "SNPTEST" "SNPs" "SNaPshot-based" "SOCCS"
    "SOCl" "SOS" "SOX" "SOX-families" "SP44" "SPRR2D" "SPRR2F" "SPSS" "SR16"
    "SRC-1isoform" "SRC-1to" "SRMs" "SRPK1-326D587D" "SRPKs" "SSCP" "SSH-1"
    "SSXS" "SSc" "ST-HSC" "STAT-DNA" "STAT1-B" "STAT1α" "STAT3-induced"
    "STAT3-mediated" "STAT3CA" "STAT5a1*6" "STAT5b1*6" "STE-20-like" "STKE"
    "STR-HI" "STR-LI" "STR-higher" "STRING" "STZ+Tudca"
    "SUMOylated-to-non-SUMOylated" "SUVmax" "SVCs" "SWISSPROT" "SXS" "SXSS"
    "SY" "SYBR" "Sabet" "Sagata" "Sagiv" "Saharan" "Salhia" "Salvaggi"
    "Salvesen" "Sam68-PxxP-motifs" "Sam68-SH3" "Sam68-SH3-interactions"
    "Sam68-binder" "Sam68-binders" "Sam68-interactions" "Sam68-ligands"
    "Sam68ΔP0" "Sam68ΔP0345" "Sampson" "Sampson's" "Sanger" "Santopietro"
    "Sarcoptes" "Sasano" "Saudi" "Sausville" "Scansite" "Scatchard" "Schiffer"
    "Schimke" "Schirmer" "Schizosaccharomyces" "Schmitz" "Schutze" "Schutze’s"
    "Schwann" "Scotland1" "Scotland2" "Scotland3" "Scottish" "Scrib" "Sec61β"
    "Seckel" "Self-Sufficiency" "Selleck" "Semi-quantitative" "Sendai"
    "Sequence-specific" "Sequenom" "Ser-1046" "Ser104" "Ser106" "Ser184-Asp98"
    "Ser197" "Ser201" "Ser217" "Ser235" "Ser240" "Ser2448-mTOR"
    "Ser267LysfsX19" "Ser27" "Ser33" "Ser37" "Ser428LKB1" "Ser473" "Ser473-AKT"
    "Ser612Pro613" "Ser65" "Ser893" "Ser894" "Ser9-GSK3β" "SerGln" "Serpina3f"
    "Seven-Marker" "Seventy-eight" "Seventy-four" "Seventy-one" "Seventy-three"
    "Shao" "Sharman" "Shb" "Shen" "Sherman" "Shibuya" "Shiga" "Shimada"
    "Shimida" "Si-Control-DU145" "Si-LEDGF" "Si-LEDGF-deficient"
    "Si-LEDGF-transfected" "Siglec" "Siglec-10" "Significance" "Silver-Russel"
    "Silver-Russell" "Silverberg" "Silver–Russell" "Simeone" "Simeone-Penney"
    "Sinai" "Single-locus" "Sirtuins" "Sisson" "Sisson-Ammons" "Sixty-one"
    "Sixty-three" "Sixty-two" "Ski" "Skoda" "Skp1-Cul1-F-box" "Skp2-KLKL"
    "Skpl" "Slingshot-1L" "Smad" "Smad1" "Smad2" "Smarta" "Smc5" "Smirnov"
    "Smits" "SmoA" "SmoA1" "SmoA1-driven" "Smy1p" "Soesanto" "Soloff"
    "Songkhla" "Soong" "Sos" "Sos1-E846K" "South-East" "Sox9" "SpCC" "SpCCs"
    "Spain" "Spearman" "Spearman’s" "Spectometry" "Spi6" "SpliceSiteFinder"
    "Sponge-induced" "Sponge-mediated" "SprT-like" "Spry1" "Sq" "Src" "Src-SH3"
    "Src-family" "Src-homology-2" "Src-kinase-family" "SspH1" "Stacey"
    "Staining" "Staph" "Stat3" "Stat3α" "StatXact" "Steady-state" "Stenberg"
    "Stenotrophomonas" "Stillman" "Stratagene" "Straver" "Strep" "Strep-tagged"
    "Stress-Induced" "Stress-induced" "Stressed-higher" "Sty" "Sub-Saharan"
    "Subbaiah" "Subclass" "Sudan" "Sudanese" "Sulaimaniyah" "Sundvold"
    "Sundvold-Gjerstad" "Superose" "Suppl" "Surveilance" "Sweden" "Swedish"
    "Swiss" "Sx" "Szabowski" "Szukala" "T-0.050" "T-0.140" "T-PLL" "T-PLLs"
    "T-cell" "T-lineage" "T-lymphomas" "T-lymphotropic" "T-φ-X-D" "T1" "T1-T5"
    "T11-NEP-ICDs" "T1859A" "T1–6" "T2" "T202" "T25A" "T2D" "T3" "T323" "T4"
    "T41" "T6" "T7" "T790M" "T8M" "TAP-tag" "TAT-Cre" "TATA" "TAW" "TAX2501"
    "TBK" "TBRII" "TBS" "TBST" "TCCG" "TCF-activity" "TCF-dependent"
    "TCF-regulated" "TCG" "TCGA" "TCR+CD28" "TCR+CD4" "TCRS" "TCRgamma" "TCRα"
    "TCRβ-proliferation" "TCRβ-selection" "TCRγ" "TCRδ" "TCT" "TD47" "TDL"
    "TEER" "TEFb" "TERT-NHUC" "TEV" "TFBS" "TGF-ßR1" "TGF-ßR3" "TGF-β-and"
    "TGF-β-receptor" "TGF-βRI" "TGFb" "TGFβRI" "TGFβRI-mediated" "TGFβRII"
    "TIF-regulatory" "TIGA" "TIGAR-RE" "TIL4ABS" "TK1-like" "TMZ-SAHA"
    "TNF+CHX" "TNF+CHX-induced" "TNFR-59-induced" "TNFR2-112" "TNFR2-150"
    "TNFR2-59" "TNFR2-84" "TNFR2-L319" "TNFR2-null" "TO" "TOP" "TOPFlash"
    "TOPIIIα" "TOPOIIIα" "TOPOIIa" "TP33" "TP53AIP" "TPG" "TRAF2-Rm"
    "TRAF2-RmZm" "TRAF2–TRAF3–cIAP1" "TRAF3-AKKFF" "TRAF3-TANK-TBK1" "TRAIL-R"
    "TRAIL-Rs" "TRAP-PAGE" "TRAP-polyacrylamide" "TRCP" "TRF1-So" "TRF1-gfp"
    "TRF1-interactive" "TRF1R6" "TRF1R6-So" "TRF1–PML-IV" "TROSY"
    "TSAd-dependent" "TSP4–TSP6" "TSP7–TSP9" "TSY" "TTA" "TTAA-OE19"
    "TTAA-OE33" "TTAA-transgenic" "TTCG" "TTFR" "TTTA" "TY" "Ta" "Takahashi"
    "Takao" "Takeuchi" "Takizawa" "Talalay" "Tam-10" "Tam-10-treated" "Tam-100"
    "Tantbirojn" "TaqMan" "TaqMans" "Taqman" "Targa" "TargetScan" "Tashiro"
    "Tat" "Tat-PP1" "Tat-activated" "Tat-enhanced" "Tat-expressing"
    "Tat-independent" "Tat-induced" "Tat-mediated" "Tateishi" "Taxus" "Tayside"
    "Tcf" "Tcf4" "Tcrα" "Tcrγ" "Tehran" "Tehran-Iran" "Temperature-sensitive"
    "Tet-On" "Tet-on" "Tet2-haploinsufficient" "Tet2-null" "Texas" "Tg" "Th10"
    "Th17" "Th5.5" "Thailand" "Thd" "TheFAAP20" "Themis1-GFP" "Themis1tg"
    "Themis2tg" "Themis3" "Theodosius" "Thep53" "Thermo" "Thi" "Thiamet-G"
    "Thirty-six" "Thirty-six-hours" "Thirty-two" "This" "Thr-kinase"
    "Thr-mutant" "Thr183" "Thr202" "Thr308" "Thr37" "Thr41" "Thr421" "Thr46"
    "ThrGln" "Tilvis" "Time-course" "Time-lapse" "Tirumalai" "TnfRII"
    "Tokumaru" "Tolgay" "Toll-like" "TopIIIα" "Tor1-D" "Tor2-S" "Traish"
    "Transcriptome" "Transfac" "Transgenes" "Transiently-expressed" "Transwell"
    "Trenaunay" "Trichophyton" "Trim-family" "Triple-negative"
    "Triple-transgenic" "Tris-Acetate" "Tris-HCl" "Tris–HCl" "TritonX"
    "TritonX-100" "Trotman" "Trouiller" "Trunk-expressing" "Truong" "Tsai"
    "Tschopp" "Tschopp’s" "Tsg101caused" "Tukey" "Tumor" "TurboRFP" "Tween"
    "Tween-20" "Twenty-eight" "Twenty-four" "Twenty-nine" "Twenty-one"
    "Twenty-three" "Twenty-two" "TwinsUK" "Tyr1248-ErbB2" "Tyr185-SAPK"
    "Tyr204" "Tyr204-ERK1" "Tyverb" "Tα" "U-rich" "U1" "U133" "U133A" "U138"
    "U2" "U251" "U251-AAV" "U251-AAV-IB" "U87" "U87-ΔEGFR-shSTAT5b" "UAS"
    "UAUAGGA" "UBP69" "UCA" "UCCC" "UCSC" "UCUG" "UF" "UFBs" "UG" "UGGC" "UGU"
    "UK1" "UK2" "UM-SCC" "UM-SCC-14A" "UMSCC" "UMSCC22A-46" "UMSCC46" "UMSCC6"
    "UPMC" "UPS" "UR" "USA" "USHBP1" "UTR-A" "UTR-B" "UTR-C" "UTR-D" "UTRhet"
    "UTRs" "UU" "UV-0" "UV-20" "UV-25" "UV-30" "UV-35" "UV-5" "UV-50" "UV-A"
    "UV-C" "UVB" "UVC" "UVC-irradiated" "UVs" "UW" "UW-426" "Ub-like" "Ubiprot"
    "Ubr1p" "Ukraine" "Ultra-Low" "Unc5h" "Under-expression" "Ungvari"
    "Uniprot" "Urick" "Utah" "Uzbekistan" "V$HTF" "V+PRR" "V-1" "V-6" "V-C8"
    "V14-RhoA" "V2-bead" "V4" "V463del" "V5" "V5-tagged" "V590fs" "V600"
    "V600E" "V615LV617F" "V637M---have" "VAC14" "VCF" "VDJ" "VEEASPGRPSSVDTLLS"
    "VEFG" "VEGF-treatedtsad" "VEGFKO-VEGF" "VEGFKO-shMET" "VEGFKO-shMET1"
    "VEGFKO-shMET2" "VEGFR2-Δ450C" "VEGFR2–DSG-T" "VIT7" "VJ" "VJ-B"
    "VKEEPPSPPQSPR" "VMCUB3" "VQ" "VQ58" "VR" "VRPQVPLRP" "VS28" "VSAD" "VSELs"
    "VSV-G" "VVO-deficient" "VVOs" "Valencia" "Vanderbilt" "Vanderwinden"
    "Vasioukhin" "Vdel463" "Vehicle-treated" "Velasco" "Veltman" "Venice"
    "Venn" "Ventana" "Vessel-associated" "Vietnam" "Vilar" "Vilar's"
    "Virus-infection" "Vmax" "Vo" "Voeller" "Vyses" "Vysis" "Vβ" "W2990A" "WAK"
    "WARTS" "WASP" "WB" "WBC" "WF" "WGS" "WHB-RBX1" "WIP" "WJ" "WJJ" "WM1361"
    "WM5" "WS-15" "WS-15-Rad6BshRNA" "WT-Akt" "WT-BRCA2" "WT-GBM"
    "WT-GBM-bearing" "WT-LacZ" "WT-MEFs" "WT-NEP" "WT-PP1a" "WT-RPA" "WT-RPA32"
    "WT-Rb" "WT-RhoA" "WT-SIRT3" "WT-Skp2" "WT-VEGFR2" "WT-VEGR2" "WT-p53"
    "WTp53C" "WYP" "Waal" "Waals" "Wacholder" "Wada" "Waldman" "Walsh"
    "Warburg" "Washington" "Wat1" "Watson" "Webb" "Weinberg" "Weinlich" "Weiss"
    "Weissman" "Wellcome" "Werner" "Western-blot" "Western-blotting" "White"
    "Whitehouse" "Whitney" "Whole-cell" "Wiedemann" "Wilcoxon" "Wilko" "Willi"
    "Williams" "Wilmington" "Wingless-Int" "Wingless-int" "Wnt-silent"
    "Wnt1p53" "Woodfin" "Wrana" "Wu" "X-1" "X-inactivated" "X-inactivation"
    "X-ray" "X63131" "XDP" "XF" "XL" "XL-880" "XRG" "XT" "XTT" "XZ" "Xi"
    "Xp22.2" "Xq13.1" "Xq23" "Xue" "Y-family" "Y-phosphorylation" "Y1057"
    "Y1068" "Y1173" "Y1853term" "Y204" "Y283C" "Y2H" "Y440" "Y472C" "Y694"
    "YB-1–CAUC" "YFP-SH3" "YFP-SH3s" "YFP-fluorescence" "YHR122w" "YIL128w"
    "YKH1" "YM" "YPet" "YRI" "YW" "YWHA" "YXXL" "YZ" "Yanagida" "Yang" "Yarden"
    "Yemelyanova" "Yes" "Yes-associated" "Yi" "Yoeli" "Yoeli-Lerner" "Yoh"
    "Yori" "York" "Yorkie" "Yoshimoto" "Yusufzai" "YxxW" "Z-DEVD-FMK"
    "Z-projections" "Z-test" "Z138" "ZM1" "ZO" "ZR" "ZR-75.1" "ZR75" "ZY"
    "Zac-1" "Zambia" "Zeke" "Zhang" "Zhang's" "Zhao" "Zheng" "Zi" "Zi-Li" "Zn"
    "ZnSO" "Zta" "Zwang" "a-actinin" "a-c" "aCGH" "aPKCs" "aStat3" "aa266-289"
    "aa289-338" "aa324-355" "aa338-355" "aa338-380" "aa355-380" "above-basal"
    "absorbance" "accumbens" "acetyl-lysine" "acetylation-mimetic"
    "acetylcholine" "acetylgalactosamine" "achorage" "acid-base" "acid-locked"
    "acridine" "actinin" "actinomycin" "activators" "activities"
    "activities-Nef" "acute-phase" "acyl" "ad-TGFβ–treated" "adapter-bound"
    "adaptors" "adenoine" "adenomas" "adenopathies" "adenopathy"
    "adenoviral-mediated" "adenylate" "adheren" "adherens" "adjustedR"
    "adnexae" "adriamycine" "adult-onset" "advanced-stage" "aeruginosa"
    "affinites" "agar" "age-associated" "age-dependant" "age-specific"
    "age-year" "aggregate-positive" "aggregation-inhibition" "agoinsts"
    "agonism" "agonist-like" "air–liquid" "ak" "alarmins" "albicans"
    "albumin-adduct" "alcohol-serotonergic" "algorithm" "algorithms" "alia"
    "all-or-none" "allantois" "allohemagglutinins" "allostery" "almond-like"
    "alpha-PV" "alpha-PVs" "alpha-helical" "alpha-human" "alpha-papillomavirus"
    "alterations" "altered-function" "alveoli" "amidines" "amines" "amino-acid"
    "amino-acid-rich" "amino-terminal" "amino-terminus" "aminoacids"
    "aminoethoxydiphenylborate" "aminoimidazole" "aminonicotinamide"
    "aminoquinolone" "ammonium" "amoeboid" "amplicon" "amplicons"
    "amplifications" "amygdala" "amygdaloid" "amyloid-like" "amyloids"
    "analyzedtsad" "anaplasia" "ancestry-informative" "anchorage-independence"
    "anconi" "andAtm" "andBclX" "andBlk" "andH2ax" "andKRAS" "andPten" "andSHP"
    "andStat3" "andTC45" "andand" "andbcl" "andbrca2" "andp16" "andp53"
    "androgen-deprivation" "andtsad" "aneuploid" "aneuploidy" "aneusomy"
    "annum" "anoikis-selection" "anomalies" "anosmia" "anoxia"
    "anoxic-reoxygenated" "ansamysin" "antagonise" "antenna-like" "anterograde"
    "anthracyclin" "antibodies" "antibody-Fab-fragments" "antibody-receptor"
    "antihormone" "antiparallel" "antiplatelet" "antitumour" "antracyclines"
    "apical-basal" "apoptosis-active" "apoptosis-inactive" "apoptotic-inducing"
    "apoptotic-like" "apoptotic-type" "apoptotis" "app" "apparentK"
    "apple-green" "appropriateness" "arachnoid" "arisen" "arylquinazolines"
    "as-yet-undiscovered" "asboth" "associated-NS" "astrocyte-like"
    "asymmetries" "atfor" "atleast" "atypia" "aureus" "autoinhibits"
    "autophagic-deficient" "autophagic-like" "autophagic-mediated"
    "autophagy-inhibitory" "autophagy-lysosome" "autophagy-permissive"
    "autoradiography" "autosomal-dominant" "autosomal-recessive" "auxotrophy"
    "avg" "axial" "a–c" "a–u" "b-catenin" "b-ion" "bFGF1" "back-fusion"
    "background-level" "bacmid" "bacteriocins" "band-shift" "bar-coded"
    "barely-proliferating" "basal-dominant" "basal-induced" "basal-like"
    "basal-myoepithelial" "basaloid" "base-line" "base-pair" "basepair"
    "base–extension" "basic-leucine" "baumannii" "beacon-based" "beaklike"
    "begun" "belly-spot" "beta-HPV" "beta-PVs" "beta-papillomaviridae"
    "beta-sandwich" "beta-strands" "beta-value" "beta-values" "between-study"
    "betweenp53" "bi" "bi-directionally" "bi-nucleate" "bi-partite" "bifida"
    "bilayer" "bilineage" "binding-defective" "binding-strength" "binucleate"
    "bio-morphogenesis" "biological-link" "biosamples" "biotin" "biotin-dUTP"
    "biotin-labeled" "biquitin" "birch-pollen" "birch-pollen-provocated"
    "bis-phosphate" "bisphosphate" "blocker" "blockers" "blood-brain"
    "blood-derived" "blue-cell" "blue-positive" "bmh1" "bmh2" "bnormalities"
    "bolus" "bona" "bona-fide" "bothBRAF" "bothcell" "bothp53" "bp" "bp-long"
    "brain-heart" "brain-predominant" "breakage-fusion-bridge" "breakpoint"
    "breakpoints" "breast-ovary" "brevifolia" "brighter" "brightfield"
    "broad-spectrum" "bronchodilators" "browser" "built-in" "by-products"
    "c-Jun-N-terminal-kinase" "c-Jun-amino" "c-Myb-shRNA-mir" "c-MycER"
    "c-MycT58A" "c-Rous" "c-Src-SH3" "c-Src-mediated" "c-Src–dependent"
    "c-Src–mediated" "c5c6" "cAMP→PKA" "cAMP→PKA→pCREB" "cAMP→protein" "cBio"
    "cIAP" "cIMT" "cPKC" "cPKCs" "cadmium-mediated" "cagPAI"
    "calcium-calmodulin-dependent" "calphostin" "cancer-dominant"
    "cancer-susceptibility" "cap-analogue" "cap-bound" "cap-independent"
    "capabilitites" "capsid" "carbocyanine" "carbonyl" "carboxoacteamide"
    "carboxyl" "carboxyl-terminal" "carboxyl-terminus" "carcinoma-centric"
    "carcinoma-like" "cardio-facio-cutaneous" "cargos" "carotid"
    "carrier-treated" "carriers" "carry-over" "carrying-oncogenes" "case-case"
    "case-control" "case-controlled" "case-only" "case-referent" "cases-61.9%"
    "cases-75.0%" "case–control" "case–controlled" "caspase-cascades"
    "caspofungin" "catabolites" "catabolizes" "catalyse" "catastrophies"
    "caudate" "caveleolin-1" "caveolin-1α" "cdc28" "ceca" "cecal" "cecome"
    "cecum" "cell-autonomous" "cell-cycle-dependent" "cell-cycle–independent"
    "cell-injection" "cell-intrinsic" "cell-of-origin" "cell-permeable"
    "cell-regulatory" "cell-substratum" "cell-to-cell" "cells"
    "cellular-activation" "cellulo" "centriole" "centromere" "cephalosporin"
    "cerebella" "cerebellum" "cerebriform" "cerebrum" "cerevisiae"
    "cerulean-positive" "cg02589695" "cg17558126" "change-in-spectrum"
    "change-of-spectrum" "chaperon-inhibitor" "chaperone-like"
    "chaperonin-like" "charcoal-stripped" "chemical-detoxification"
    "chemically-induced" "chemo" "chemo-radiotherapy" "chemo-sensitivity"
    "chemoattractant" "chemoradiotherapy" "chemoresistance" "chemoresistant"
    "chemotherapeutic-induced" "chi-square" "chlorodeoxyuridine" "choanae"
    "cholesterol-chelators" "cholesterol-depletion" "cholesterol-rich"
    "choroid" "choroids" "chosen" "chr22" "chromatid" "chromatids"
    "chromatin-IP" "chromatin-remodeling" "chromophobe" "chromosome-bridge"
    "chromosome-bridge-mediated" "chromosome-loss" "chromosome-negative"
    "chymase-Fynomer" "cip1" "circuitry" "cis-interaction" "cis-regulatory"
    "cistron" "cistrons" "class-I" "cleavage-defective" "clinic-pathological"
    "clinical-pathologic" "clinical-response" "clinicians" "clinico"
    "clinico-patholgical" "clinico-pathological" "clinicopathology" "clonogens"
    "coIP" "coaberrations" "cobas" "cocktail-induced" "codon" "codons"
    "coefficientR" "coiled-coil" "coiled-coils" "coimmunopreci"
    "coimmunopreci-pitation" "col-YFP" "cold-shock" "coli" "collagens"
    "colonic-epithelium" "colonoscopies" "colony-formation" "colony-forming"
    "commonest" "comorbidities" "compartment-specific" "complex-karyotype"
    "complex–1" "complicit" "concentration-dependently" "conductance"
    "conformers" "confounders" "congenita" "conjunctiva" "constitu"
    "constitu-tively" "constitutively-activate" "contact-inhibited"
    "contagiosum" "contig" "continuum" "contractility-modulating"
    "control-Cherry" "control-MO" "control-empty" "control-siRNA-transfected"
    "control-siRNA-treated" "controllers" "controls-75.0%" "copy-number"
    "core-cancers" "core-needle" "corectopia" "corneum" "cornu" "cost-benefit"
    "cost-effective" "cotrimoxazole" "counter-intuitive"
    "country-of-origin-matched" "covariate" "covariates" "coworkers"
    "coxsackie" "cremaster" "cretica" "cross-inhibition" "cross-linkers"
    "cross-regulate" "cross-regulates" "cross-regulation" "cross-regulatory"
    "cross-sectional" "cross-talking" "cross-validation" "cross-β" "crossover"
    "crossovers" "ctMHCI" "cular" "cullin-SR" "cut-off" "cut-offs"
    "cut1-206-GFP" "cut1-21" "cut1-693" "cut2-364" "cut2-447" "cut2-EA2"
    "cycles-phase" "cyclin-substrate" "cyclinD-CDK2" "cyclodextrins"
    "cyclohexamide" "cyoskeleton" "cystines" "cytoarchitecture"
    "cytofluorimeter" "cytokine-stimulated" "cytometer" "cytopathology"
    "cytoplasma" "cytotoxic-associated" "d-f" "dA" "dC80" "dHER2" "dHPL"
    "dHPLC" "dHPLF1" "dHPLF2" "dHPLF3" "dHPLF4" "dHWP" "dPIPB" "dT" "dT30mer"
    "dT90mer" "dUTP-biotin" "dVIN" "damage-associated" "damage-dependent"
    "damage-induced" "damage-specific" "damage–induced" "darkfield" "dataset"
    "datasets" "day3" "dbSNP" "dbSNP129" "de-activating" "de-conjugate"
    "de-differentiated" "de-identified" "de-polymerisation" "de-regulation"
    "de-repress" "de-repressed" "de-repression" "de-repressor" "de-tagged"
    "de-ubiquinating" "decamer" "decatenates" "decreasedp21" "deeper"
    "deferens" "deformations" "degron" "degrons" "dehy" "dehy-drogenase"
    "del20q" "del309F" "delE746-A750" "deleteH2ax" "deletions" "dendritc"
    "dendrite" "deoxynucleotidyl" "dependent-apoptosis" "dephosphorylaton"
    "depression-like" "der" "derepresses" "describedp53" "descriptors"
    "desmoglein" "desmoids" "detachment-induced" "detergent-like" "deviance"
    "deviationRMSD" "df" "df " "df " "dh404" "di-Gly" "di-Ub" "di-leucine"
    "di-methylation" "diabetes-decreased" "diabetes-induced" "diaminobenzidine"
    "dichloroisocouramin" "dichroism" "diet-induced" "diethylamino"
    "difference=0.0006" "differentp53" "diffuse-type" "difluoride" "digitorum"
    "dihydro-CDDO-trifluoroethyl" "dihydrothymine" "dihydroxybitamin"
    "dilution-multiple" "dilysine" "dimethylbenz" "dimorphism" "dinucleotides"
    "dipeptidyl" "diphenyltetrazolium" "diphosphate" "diplochromosomes"
    "diploid" "diploid-like" "discoidin" "discrepant" "disease-causative"
    "disease-onset" "disease-relevant" "disomy" "disorganises"
    "dithioerythritol" "dnTcf4" "dodecy1" "domain-1" "domain-only" "domains"
    "dominant-negative" "dominant-negatively" "dominants" "dominant–negative"
    "donor-derived" "dormancy" "dose-dense" "dose-dependence"
    "dose-dependently" "dose-independent" "dose-response" "dose-responses"
    "dose-responsive" "dose–response" "dot-blots" "double-check" "double-dose"
    "double-knockout" "double-strand" "doublesex" "doublings" "doubly-depleted"
    "down-expression" "down-regulatedRhoA" "down-slanting" "down-stream"
    "downstream–at" "downstrream" "doxycycline-repressible" "doǹt" "drawn"
    "drig" "drop-out" "drug-like" "dsDNA" "dsx" "dual-color"
    "dual-fluorescence" "dual-specific" "dupGlu37" "duplexes" "dxr"
    "dynamin-like" "dyscrasia" "dyscrasias" "dysfunction-induced"
    "dyslipidaemia" "dyslipidemia" "dysmorphia" "dysmorphism" "dysplasia" "d–f"
    "eChIP" "eI4F" "eNOSGFP" "eNOS–NO–permeability" "eafness" "early-late"
    "early-onset" "early-phase" "early-stage" "eart" "easily-pelleted" "eath"
    "eavy" "ectoderm" "ectodomain" "ectopia" "eczematiform" "edema" "ef"
    "ef-ficiently" "egion" "eightfold" "eighty-one" "eitherKras"
    "electron-dense" "electropherograms" "element-like" "eluate" "eluates"
    "embryoid" "embryonic-like" "emphasise" "end-stage" "end-to-end"
    "endocycles" "endocytosis-impaired" "endoderm" "endogenousp21" "endometria"
    "endometrioid" "endometrium" "endoscopy" "endosome-to-Golgi"
    "endosulfine-α" "endothelial-independent" "endpoint" "endpoints" "ene"
    "energy-depleted" "energy-generating" "enhancer" "enhancer-binding"
    "enhancer-like" "enterica" "enterobacteria" "entigines"
    "environmentally-sensitive" "enzymatically-related" "enzyme-linked" "eosin"
    "eosinophils" "epidermodysplasia" "epidermoid" "epididymis"
    "epigenetically-driven" "epigenome" "epigenotypes" "epileptiform"
    "episodes" "epithelia" "epithelial-cell" "epithelial-derived"
    "epithelial-mesenchymal" "epithelial-origin" "epithelial-predominant"
    "epithelial-to-mesenchymal" "epitheliotropism" "epithelium" "epitheliums"
    "epitope-tagged-BCL2L1" "epoxy-activated" "eptides" "eq"
    "equivalent-density" "erythroleukaemia" "et" "eta" "ethal"
    "ethnic-specific" "ethnicities" "ethylcarbamide" "ethynyl-2-deoxyuridine"
    "evaginates" "ex" "ex-smokers" "ex-vivo" "examinees" "exo" "exoenzyme"
    "exome" "exomes" "exon-intron" "exon1" "exon1–2" "exons" "exorbitism"
    "exosome" "expectance" "expressingKras" "expressingUSP37" "extra-axial"
    "extra-chromosomally" "extra-cranial" "extra-thyroidal"
    "extracellular-regulated" "extract-induced" "extract-treated" "exudate"
    "e–h" "fBAC" "facto" "factor-1" "factor-2" "factor-E2-related" "factor–κ"
    "familiy" "far-reaching" "fast-migrating" "female-associated"
    "female-related" "female-specific" "femtomoles" "fibroadipose"
    "fibroblast-like" "fibroblast–like" "fibrobloasts"
    "fibronectin-leucine-rich" "fide" "fine-scale" "fine-tune" "fine-tuning"
    "first-degree" "first-line" "first-order" "first-principle"
    "five-generation" "five-marker" "five-year" "flag-peptide" "flask-like"
    "flavus" "flexneri" "fli1a" "flip-flop" "floor-of-mouth" "fluid-attenuated"
    "fluoracil" "fluorescein-probe-based" "fluorescent-activated"
    "fluorescent-labeled" "fluorescent-protein-fusions" "fluorescently-labeled"
    "fluorophore" "fluorophors" "fluoroquinoline" "fluoruracil"
    "fold-increases" "folding-competent" "folic" "folium" "follicles"
    "folliculitis-like" "follow-up" "followed-up" "followup" "forStat3"
    "forTsc2" "force-induced" "formamido-pyrimidine-DNA-glycosylase"
    "forty-two" "fossa" "four-marker" "four-minute" "fourths" "frame-shift"
    "frameshift" "free-drug" "free-thiol" "freely-diffusing" "freeze-thaw"
    "fribroblasts" "fromAtm" "fromBlk" "fromStat3" "frombrca2"
    "fructose-2,6-biphosphate" "fructose-2,6-bisphosphate" "fully-enclosed"
    "functionalities" "fundus" "fusion-induced" "fusion-mediated"
    "fusion-negative" "fusion-positive" "g-i" "gDNA" "gain-of"
    "gain-of-function" "gallbladder" "gamma-3" "gamma-herpesviruses"
    "gamma–HPV" "gastrectomy" "gatekeeper" "gavage" "gel-filtration"
    "gender-specific" "gene-disease" "gene-environment" "gene-like"
    "gene-to-chromosome" "generatedTip30" "genes" "genetic-algorithm"
    "genetically-engineered" "genetically-modified" "genitalia" "genome"
    "genome-wide" "genomes" "genotype" "genotype-phenotype"
    "genotype–phenotype" "genotype–vascular" "genu" "genuses" "geranylgeranyl"
    "germ-line" "germline" "glia" "globalvegfr2" "glomeruli"
    "glomerulonephritis" "glomerulus" "glomus" "glossitis" "glucan"
    "glutamylcysteine" "glutathione-Sepharose" "glutathione-s-transferase"
    "glycans" "glycine-to-arginine" "glycochenodeoxycholate" "glycosaminglycan"
    "glycosyl-phosphoinositol-anchored" "goes" "gold-sol" "gonads" "gone"
    "gonococci" "goodness-of-fitχ" "gp61–80" "gp66–77" "gram-negative"
    "gram-positive" "grape-like" "greater" "greatest" "ground" "growth--factor"
    "growth-arrest" "growth-inhibitory" "guanidyl" "guanylyl" "hCD2" "hCD4"
    "hDlg1" "hESC" "hMon2" "hNEP" "hStat3α" "hTert-RPE1" "hVps" "hain"
    "half-life" "half-sites" "half-time" "haplo" "haplo-insufficiency"
    "haplotype" "haplotypes" "hapotype" "hard-filtering" "hardly-detectable"
    "head-and-neck" "healthy-matched" "heart-lung" "heart-to-body"
    "heat-inactivated" "heat-inactivation" "heat-shock" "heat-stable" "heatmap"
    "heat–acid" "hedgehog-driven" "helices" "helix" "hematocrit"
    "hematopoietic-selective" "hematoxylin-eosin" "hematuria" "hemianopsia"
    "hemispherectomy" "hepatotoxicants" "heptad" "heregulin-β" "hereon"
    "hetero-octameric" "hetero-oligomers" "hetero-tetramers" "heteroatoms"
    "heterocomplex" "heterocomplexes" "heteroplasia" "heterotetramers"
    "heterotopia" "heterotrimer" "heterozygote" "hexahistidine"
    "hexanucleotide" "hidden" "high-FIGO" "high-HIF-2α" "high-accuracy"
    "high-affinity" "high-confidence" "high-density" "high-dose" "high-grade"
    "high-level" "high-penetrance" "high-performance" "high-powered"
    "high-quality" "high-resolution" "high-resolution-melting-curve-analysis"
    "high-risk" "high-salt" "high-survival" "higher-abundance" "higher-grade"
    "higher-molecular-weight" "higher-order" "higher-risk" "higher-stage"
    "higher-titer" "highest-affinity" "highest-ranked" "highly-abundant"
    "highly-amplified" "highly-correlated" "highly-optimized" "highly-precise"
    "highly-specific" "hilus" "hindlimb" "hio" "hirsutism" "histidine-rich"
    "histo" "histo-pathological" "histologic-specific" "histologically-defined"
    "histologies" "histologu" "histology" "histomorphology" "histopathology"
    "histoscore" "histotype" "histotypes" "hoc" "holoenzymes" "homeodomain"
    "homogenates" "homolog" "homologies" "homologs" "homologue-1" "homology-2"
    "homozygote" "homozygotes" "homozygous_genotype" "host-derived"
    "host-mediated" "hot-spot" "hot-spots" "hotspot" "hotspots" "hr"
    "hsa-miR-337" "hsa-miRPlus" "htSNPs" "http" "hydro-lyzes" "hydroxy"
    "hydroxyl" "hydroxyprostaglandin" "hydroxytamoxifen" "hydroxytryptamine"
    "hypRPA" "hyper" "hyper-activation-mediated" "hyper-immunoglobulin"
    "hyper-pigmentation" "hyper-proliferation" "hyper-radiosensitivity"
    "hyper-recombination" "hyper-sensitivity" "hyper-tetraploid"
    "hyperchromatism" "hypereosinophilia" "hyperleptinemia" "hypermorphism"
    "hypermorphs" "hyperpermeabilty" "hypertriploid" "hyperuricemia"
    "hypo-fractionation" "hypo-fractionations" "hypo-phosphorylated"
    "hypo-phosphorylation" "hypoglycemia" "hyposmia" "hypothermia"
    "hypoxia-reoxygenation" "iBMK" "iMyc" "iMyc∆Eμ" "iSTAT3α" "iSTAT3β"
    "iSelect" "iTRAQ" "ibonucleotide" "ibroblasts" "ice-cold"
    "identical-by-descent" "ie" "ii" "iii" "ilimaquinon" "ill-defined"
    "imidazole" "immotile" "immublot" "immune-mediated" "immune-modulatory"
    "immune-stimulatory" "immuneprecipitates" "immuno" "immuno-complex"
    "immuno-fluorescence" "immuno-precipitated" "immuno-precipitation"
    "immunoFISH" "immunoassay" "immunoassays" "immunocomplex" "immunocomplexes"
    "immunocytochemistry" "immunodominant" "immunoglobulin"
    "immunoglobulin-like" "immunogold" "immunohistochemistry" "immunophenotype"
    "immunophenotypes" "immunoprofile" "immunoscores" "immunosurveillance"
    "immunotherapies" "immunotherapy" "impedance" "in-depth" "in-frame"
    "in-house" "in-house-developed" "in-house–developed" "in-situ" "in-vitro"
    "in-vivo" "inAtm" "inBraf" "inKras" "inNPM" "inNf1" "inSHP" "inStat3"
    "inTsc2" "inUSP37" "inases" "includingp53" "indocarbocyanine"
    "indole-derivative" "induced-apoptosis" "ine" "inertiae" "infarction-type"
    "inflammation-driven" "inflammation-induced" "inflammation-pathways"
    "inflammatory-associated" "infoldings" "infra-orbital" "inhibitor-3"
    "initio" "inoculum" "inositides" "inp21" "insertion-substitution"
    "instability-Facial" "insulin-activated" "insulin-bound"
    "insulin-independent" "insulin-induced" "insulin-like" "insulin-sensitive"
    "insulin-signaling" "insulin-stimulated" "insulin-treated" "integrants"
    "integrin-mediated" "integrin-null" "integrity–loss" "intention-to-treat"
    "inter-SH2" "inter-individual" "inter-membrane" "inter-observer"
    "inter-reader" "inter-strand" "interactome" "interdigitate" "interdomain"
    "intermediate-density" "intermediate-length" "intermediate-sized"
    "interquartile" "interspace" "interstitium" "interstrand" "interwoven"
    "intestinal-type" "intoLATS1" "intra-E3" "intra-S" "intra-S-phase"
    "intra-abdominal" "intra-chromosomal" "intra-protein" "intra-strand"
    "intra-thyroidal" "intra-tumoral" "intracardiac" "intracarotid"
    "intradomain" "intramembrane" "intron3" "intsad" "invaginations"
    "invariant" "invasion-mediating" "invasion-negative" "invasion-positive"
    "iododeoxyuridine" "ion-channel" "ionic" "irradiation-induced" "ischaemia"
    "ischemia-reperfusion" "iso" "isobutyramide" "isoenzymes" "isoforms"
    "isotype" "iv" "jirovecii" "junction-associated" "juxtacrine" "k-core"
    "kB-containing" "kConFab" "kainate" "kappa-B" "karyotype" "karyotypes"
    "kelch-like" "keratincoytes" "keto" "key-signaling" "kg" "kianse"
    "kinase-ATF4-derived" "kinase-defective" "kinasesERK1" "kinesin-like"
    "knock-down" "knock-in" "knocked-down" "knocked-in" "knocked-out"
    "knocking-down" "knocking-in" "knowkdown" "koff" "kook" "labour-associated"
    "labour-intensive" "lacz" "laevis" "lambda" "lambdas" "lamelliapodia"
    "lamellipoda" "lamello" "lamello-podia" "lamillapodia" "lamina" "lane-1,2"
    "lane-3" "lane-4" "lane-6" "lane1" "lanes-1" "lanes-5–8" "large-cell"
    "large-scale" "laser-activated" "laser-generated" "laser-induced"
    "late-acting" "late-proximal" "late-stage" "latency-associated"
    "later-stage" "latero" "latero-cervical" "lathrin" "latrunculin" "lcn1l1"
    "leakiness" "leave-one-out" "lectin-like" "lef" "left-hand" "left-handed"
    "leg-derived" "leg-specific" "lenti" "lenti-viruses" "leptin-cellular"
    "leptin-concentration" "leptomeninges" "let-7a" "let-7g" "let-7i"
    "let-7i+miR-211" "let-7i+miR-22" "let-7i+miR-22+miR-211" "let-7i+miR-92"
    "leucocitosi" "leuke" "leuke-mogenesis" "leukemias"
    "leukocyte-endothelial-cell" "leukoencephalopathy" "lgorithms" "life-long"
    "life-or-death" "lifecycle" "lifespan" "ligand-1" "ligand-competitive"
    "ligand-peptide" "ligand-receptor" "ligand–receptor" "light-chain-3"
    "lin-4" "lin-41" "lineage-characteristic" "lineage-depleted"
    "lineage-negative" "lineage-specific" "lipid-raft" "lipidic-peptidic"
    "lipoatrophy" "lipopolysaccharide" "lipopolysaccharides" "liposome"
    "lithospermate" "littermate" "littermate-derivedTsc1" "littermates"
    "live-cell" "live-or-die" "lix" "lo" "lobectomy" "locked-in"
    "loco-regional" "locus-specific" "locus–locus" "log-lank" "log2"
    "log2-coefficient" "logrank" "long-acting" "long-duration" "long-lasting"
    "long-lived" "long-range" "long-standing" "longer-term" "longus"
    "loop-length" "loss-of-Erk2" "loss-of-function" "low-FIGO" "low-affinity"
    "low-density" "low-dose" "low-frequency" "low-frequency-haplotype"
    "low-grade" "low-intensity" "low-level" "low-medium" "low-metastatic"
    "low-pass" "low-penetarnt" "low-penetrance" "low-penetrant" "low-risk"
    "low-salt" "low-stage" "low-throughput" "low-titer" "lower-affinity"
    "lower-stage" "lowk" "lowp53" "loxP" "lt" "luc-reporter" "lucifearse"
    "lumen-derived" "lymph-node" "lymph-nodes" "lymphadenectomy"
    "lymphadenopathy" "lymphoblastoid" "lymphoblasts" "lymphopenia"
    "lymphotoxin" "lysis" "lysosomal-like" "m-o" "m-pore" "mCherry-FKBP-iSH"
    "mCherry-SH3BP1" "mDia1-depleted" "mERα" "mGFAP" "mPT-regulatory" "mPrE"
    "mPrEC" "mPrECs" "mRFP-Kinase" "mRFP-PAK4" "mRFP-PAK4r"
    "mRFP-PAK4r-rescued" "mRFP-PAK4ΔKinase" "mRFP1-SNX12" "mStat3α" "mTLE"
    "mTOR2" "mTORpathway" "macherinery" "machine-learning" "macroadenomas"
    "macroautophagic-deficient" "macroregions" "magainin" "magnetic-activated"
    "make-up" "male-pattern" "male-to-female" "maltophilia" "mammography"
    "mammoplasties" "mammoplasty" "mammosphere" "mant" "markerp16" "mastectomy"
    "materials" "maternal-infantile" "maternally-imprinted"
    "mathematically-designed" "matrigrel" "matrix-adhesion"
    "matrix-capsid-nucleocapsid-p6" "matrix-resident" "means±S" "mean±1"
    "mean±SD" "mean ± SD" "mediated-canonical" "medulla" "medulloblatomas"
    "megalencephaly-associated"
    "megalencephaly-polymicrogyria-polydactyly-hydrocephalus" "melanin"
    "melanogaster" "mellitus" "memory-like" "memory-phenotype" "meninges"
    "meningitidis" "meningococci" "meningococcus" "meric"
    "mesenchymal-epithelial" "mesenchymal-to-epithelial" "mesenchyme"
    "mesentery" "mesh-like" "meshwork" "mesoderm" "mestizo" "mesylate"
    "meta-analytic" "meta-regression" "metabolise" "metal-dependent"
    "metallopeptidase-9" "metaphase–anaphase" "metastasise" "methanesulfonate"
    "methycellulose" "methyl-β-cyclodextrin" "methylome" "miR-100" "miR-101"
    "miR-105" "miR-124" "miR-135b" "miR-143" "miR-145" "miR-155" "miR-17"
    "miR-17+miR-22" "miR-17-92" "miR-17∼92" "miR-181b-1" "miR-191" "miR-191’s"
    "miR-192" "miR-19a" "miR-200" "miR-205" "miR-20a" "miR-21-Luc" "miR-211"
    "miR-22" "miR-23" "miR-24" "miR-26a" "miR-27a" "miR-290" "miR-291a"
    "miR-291b" "miR-292" "miR-293" "miR-294" "miR-295" "miR-30" "miR-300"
    "miR-302" "miR-302a" "miR-302c" "miR-302d" "miR-337" "miR-337-3p" "miR-34"
    "miR-367" "miR-605" "miR-9" "miR-92" "miR-96" "miR-99a" "miR-ZIP-21"
    "miR-ZIPVec" "miR23a" "miRANDA" "miRISC" "miRNA" "miRNA-143" "miRPath"
    "miRPlus" "miRgen" "micro-irradiation" "micro-nucleation" "microRNA-155"
    "microRNA-34b" "microT4.0" "microbial-driven" "microbiota"
    "microcarcinomas" "microclusters" "microcystin-sepharose" "microdomain"
    "microdomains" "microglia–neuron" "micrograph" "micrographs" "microneedles"
    "microparticles" "micropenis" "micropheres" "microphotographs" "microplate"
    "microsatellite" "microsatellites" "microspheres" "microtentacle"
    "microtentacles" "microvessel" "microvessels" "microwells" "mid-2011"
    "mid-embryogenesis" "mid-face" "mid-stage" "midline" "mids" "midzone"
    "mini-gene" "mini-kit" "mini-stacks" "minigene" "minigenes" "ministacks"
    "minute-2" "mir" "mir-125" "mis-expression" "mis-localization"
    "mis-segregation" "mis-sense" "miss-expressed" "miss-expression"
    "miss-regulated" "missense" "mitochondrial-induced"
    "mitochondrial-mediated" "mitofusins" "mitomycin" "mitoses" "mitosis-like"
    "mitotic-like" "mitoticbrca2" "mixed-cultures" "mixed-subtype" "mixed-type"
    "mixmers" "ml " "mmc" "mock-depleted" "mock-treated" "model-PNST"
    "module-mutation" "molecularly-defined" "molluscum" "molten"
    "molten-globule" "mono-SUMOylated" "mono-ubiqutination" "monoamine"
    "monoamino" "monocyte-derived" "monocytogenes" "monodisperse" "monolayer"
    "monotherapies" "monotherapy" "months" "morpholino" "morpholinosydnonimine"
    "mortem" "mosaïcism" "motifs" "motile" "mportant" "mreps" "mt" "mt-tk"
    "mtAco" "mtHSP60" "mu" "mucosa" "multi-BH" "multi-cellular" "multi-domain"
    "multi-drug" "multi-factorial" "multi-functional" "multi-institutional"
    "multi-layer" "multi-mediator" "multi-national" "multi-protein"
    "multi-span" "multi-step" "multicenter" "multidomain" "multilocus"
    "multimers" "multiorgan" "multiple-testing" "multiplegenes" "multiprotein"
    "multisite" "multistage" "multisubunit" "multisystem" "multivariate"
    "murinebrca2" "muscle-invasive" "musculature" "musculo" "musculo-skeletal"
    "mut1" "mut1-1" "mut2" "mut2+3" "mut2-1" "mut2 + 3" "mut3" "mut4"
    "mutant-like" "mutant-metastatic" "mutation-like" "mutations"
    "mutations---R382W" "myeloiod" "myocardium" "myofibroblast-associated"
    "myofibroblasts" "myometrium" "myosin-ADP-Pi" "myristate" "myristoyl"
    "n-src-loop" "n-src-loops" "n=10" "n=2" "n=22" "n=4" "n=41" "n=5" "n=73"
    "n=8" "nFGA" "nHH" "nPKC" "nPKCs" "nSrc" "nano-TiO2" "nanobodies"
    "nanocluster" "nanoclusters" "nanoimmunoassay" "nanoimmunoassays"
    "nanotoxicology" "naïve" "near-complete" "near-diploid" "nearest"
    "necropsy" "necroscopy" "negative-cases" "negative-feedback" "nemia"
    "neoadjuvant" "neocortex" "neoformans" "neoplasias" "nephrectomy"
    "nephrocystins" "nephron" "nephrons" "nephropathies" "nephropathy"
    "neurite" "neuro" "neuro-oncology" "neuroendocrine" "neuron-like"
    "neurosphere" "neurospheres" "neurosurgery" "never-smoker" "never-smokers"
    "newer" "newly-discovered" "next-generation" "nick-end" "nitro"
    "nitro-substituent" "nitrogen-source" "nitroguanosine"
    "nitrosation-induced" "nitrosourea" "nkLTR" "no-effect" "node-negative"
    "node-positive" "nonSOD1" "nonheat" "nonmalignant" "nonmuscle"
    "nonmuscle-invasive" "nonobese" "nonredundant" "nonsense-mediated"
    "nonsignificant" "nontarget" "norFN" "norethindrone" "normal-length"
    "normal-looking" "normal-range" "normalFN" "not-well-studied" "notbrca2"
    "notp53" "nottsad" "nt" "ntg" "ntigen" "ntrauterine" "nucleases" "nucleate"
    "nucleolus-nucleoplasm-cytoplasm" "nurse-like" "nutrient-replete"
    "nvestigators" "n = 4" "n = 5" "occludens" "occulta" "octamers" "octoploid"
    "odifiers" "oestrogen" "of1.2" "ofAtm" "ofBlk" "ofBraf" "ofFAAP20" "ofH2ax"
    "ofKras" "ofNf1" "ofSTAT3" "ofStat3" "ofTip30" "ofbrca2" "ofcaspase-3"
    "off-rate" "off-target" "offs" "ofp16" "ofp21" "oftsad" "oipA" "olecule"
    "oligo" "oligoadenylate" "oligodeoxynucleotide" "oligodeoxynucleotides"
    "oligoncleotides" "oligonuleotides" "oligopyrimidine" "oligos"
    "oligoucleotides" "omains" "omplexes" "on-bead" "on-going" "on-rate"
    "on-target" "on-treatment" "onco-gene" "onco-genes" "onco-miR"
    "oncologists" "one-ended" "one-half" "one-hit" "one-nucleotide" "one-third"
    "one-way" "one-week" "onfFN" "onlyp21" "onsortium" "ontogeny" "oocytes"
    "oophorectomy" "opcA" "operculum" "orBlk" "orBraf" "orCdkn1b" "orKras"
    "orUSP37" "orangutan" "orasphere" "oraspheres" "organelle" "organelles"
    "organotropism" "organs" "oriLyt" "oropharynx" "orp53" "ortholog"
    "orthologue" "orthologues" "orthotopically-implanted" "osf" "osteclasts"
    "osteitis" "osteoblasts" "osteology" "osteomyelitis" "osteopenia"
    "osteotomies" "osteotomy" "otifs" "otitis" "otorrhea" "ouse" "out-compete"
    "out-of" "out-with" "outs" "over-activated" "over-activation"
    "over-duplicates" "over-lying" "over-representation" "overridden"
    "overview" "oxadiazolo" "oxalyplatin" "oxidase-A" "oxygenase-1"
    "p190RhoAGAP" "p21-4" "p21-knockout" "p21KO" "p21WAF1" "p21in" "p27Kip1and"
    "p300-CH3" "p38MAPK" "p53-RE" "p53-RE-luc" "p53-Rb" "p53-TIGAR-RE"
    "p53-centric" "p53-dependent" "p53-hypRPA" "p53-mediated" "p53-null"
    "p53-proficient" "p53175H" "p53R172H" "p53RE" "p53activation" "p53dn"
    "p65-ser-536" "p65-stimulated" "p70S6K-GST" "p85α" "p85α-SH3" "p=0.0001"
    "p=0.0006" "p=0.0008" "p=0.001" "p=0.003" "p=0.004" "p=0.005" "p=0.006"
    "p=0.008" "p=0.009" "p=0.01" "p=0.012" "p=0.018" "p=0.024" "p=0.03"
    "p=0.04" "p=0.31" "p=0.35" "p=0.86" "p=0.99" "pA-RATA" "pBim" "pBim-800"
    "pCAGA" "pCMV" "pCMV-VSV-G" "pCMV-δR8.2" "pCMV6-Myc" "pCREB" "pCUT1"
    "pChk2" "pCofilin" "pDEST26" "pDR-GFP-based" "pEGFP-LEDGF" "pEGFP-vector"
    "pEGFR" "pET01" "pErbB3" "pF-5UAS-SV40-puroGEV16" "pGC" "pGL-4.10"
    "pGL3-basic" "pGex" "pGex2T-PAX3PD" "pGex2T-PAX3PDHD-WT" "pH-fusion"
    "pH2AX" "pH " "pIGF-1R" "pLIMK" "pLIMK-T508" "pLXSN" "pM" "pMACS" "pMAP4Kl"
    "pMEK-1" "pMET" "pMLC" "pMX" "pMX-DEL" "pN2-3" "pNL4-3" "pNLENG1" "pPDGFRα"
    "pPLCγ" "pRKIP" "pRT" "pRT-PCR" "pRb-Tat" "pRb-cdNIPP1" "pRelA" "pS"
    "pS126" "pS126-cyclin" "pS126-staining" "pS473" "pS536" "pS727-Stat3"
    "pSFK" "pSSH" "pSSH-1L-S978" "pSTAT3" "pSTAT5" "pSTAT5b" "pSer104"
    "pSer106" "pSer294" "pSmad2" "pT" "pT11-NEP" "pT15-NEP" "pT180" "pT2"
    "pT25-NEP" "pT3" "pT308" "pT4" "pTDP" "pTDP-43" "pTRIPZ" "pVIII-SH3"
    "pVIII-fusions" "pXJ" "pXJ40-FLAG" "pY1054" "pY1059" "pY1175" "pY1214"
    "pY182" "pY202" "pY204" "pY280" "pY290" "pY305" "pY397" "pY418"
    "pY418-reactive" "pY527" "pY527-modified" "pY576" "pY699-STAT5b"
    "pY705-STAT3" "pY951" "pY993" "pYB-1" "pair-wise" "pairwise" "pan-Sirtuin"
    "pan-acetyl" "pan-inhibitor" "pan-phospho-SR" "pan-specific" "pancytopenia"
    "papain-like" "papillae" "papillomaviridae" "paracrine" "paraimmunoblasts"
    "paralog" "paralogues" "parasiticus" "paratope" "parenchyma"
    "parent-proband" "paronychia" "partecipates" "partite" "parvum"
    "pathobiology" "pathogen-associated" "pathological-response"
    "pathophysiology" "pattern-recognition" "pb" "pcDNA" "pcDNA3"
    "pcDNA3-PAX3-HA" "pcDNA4" "pcDNA4-dnTcf4" "pcDNA™6.2" "pdsx" "pdsx-CATCTG"
    "penetarnt" "penetrance" "penetrant" "pentoxide" "pepsinogenIandII"
    "peptide-analysis" "peptide-ligands" "peptide-to-lipid" "peptidylimidate"
    "per-allele" "perfom" "peri-airway" "peri-junctional" "perimetry"
    "peritoneum" "phage-ELISA-analysis" "phage-display-based" "phage-particle"
    "pharmacophore" "phase-dense" "phaseAtm" "phenylethylene"
    "phenylmethylsulfonyl" "phenylquinazoline" "phenylquinazolines" "phopho"
    "phosphate-containing" "phosphatidylinositide"
    "phosphatidylinositol-3-phosphate"
    "phosphatidylinositol-3-phosphate-5-kinase" "phosphatidylinositol-4,5"
    "phosphatidylinositol-4,5-biphosphate"
    "phosphatidylinositol-4,5-trisphosphate" "phospho-CDK" "phospho-STAT3"
    "phospho-Ser1962" "phospho-Thr1859" "phospho-smad1" "phosphoamino"
    "phosphodegron" "phosphodegrons" "phosphoglycolates" "phosphoglycoprotein"
    "phosphohistone" "phosphoinosite" "phosphoinositides" "phosphoinositol"
    "phosphoinositol-3-kinase" "phosphoinositols" "phosphopeptide"
    "phosphopeptides" "phosphoproteome" "phosphoribosyl" "phosphorylated-eIF2α"
    "phosphorylation-defective" "phosphosites" "phosphotyrosines"
    "phosphotyrosyl" "photoproducts" "phyla" "pi-stacks" "pifithrin-α"
    "piscine" "pixel" "pixels" "placebo-treated" "plas-mids"
    "plasma-membrane-enriched" "plasmacytoid" "plasmamembrane" "plasmon"
    "plastic-grown" "pleiotropy" "pleomorphism" "plethysmography" "plexi"
    "plexiform" "ploidy" "plug-in" "plus-stranded" "pneumatocele"
    "pneumatoceles" "pneumatocyst" "pneumococcus" "pneumomediastinum" "podia"
    "podocytopenia" "point---eIF4F" "point-mutations" "polarity-promoting"
    "poleward" "polo-box" "pololike" "poly-L-lysine" "poly-lysine" "polyQ"
    "polymorphism" "polymorphisms" "polypeptone" "polyphosphoinositides"
    "polyploid" "polyprotein" "polypyrimidine" "polysomy" "polyvinylidene"
    "polδ" "polη" "pombe" "poorer" "poorest" "popultations" "porate"
    "pore-forming" "positive-cases" "positron" "post-Golgi" "post-HU" "post-SE"
    "post-activation" "post-bevacizumab" "post-hoc" "post-hypoxia"
    "post-induction" "post-inductional" "post-infection" "post-injection"
    "post-intracalvarial" "post-ischemic" "post-menopausal" "post-menopausally"
    "post-metaphase" "post-mitotic" "post-mortem" "post-natal" "post-operative"
    "post-progression" "post-reconstitution" "post-release" "post-replication"
    "post-replicative" "post-thymic" "post-transcriptional"
    "post-transcriptionally" "post-transfection" "post-transformation"
    "post-translation" "post-translational" "post-translationally"
    "post-transplantation" "post-treatment" "post-zygotic" "postmortem"
    "postpartum" "postprostatectomy" "postsurgery" "prechemotherapy"
    "precursor-B" "preinclusions" "premalignancy" "preosteoclast" "preterm"
    "pri-miR-21" "pri-mir-21" "primaquine" "primary-like" "primarytsad"
    "primer-linked" "prion-like" "prionoid" "priori" "pro-HGF" "pro-MMP-9"
    "pro-MMP9" "pro-angiogenic" "pro-caspase-8" "pro-differentiation"
    "pro-fibrotic" "pro-inflammation" "pro-inflammatory" "pro-invasive"
    "pro-lymphocytic" "pro-metastatic" "pro-migratory" "pro-mitogenic"
    "pro-motile" "pro-motility" "pro-neoplastic" "pro-or" "pro-proliferative"
    "pro-survival" "pro-tumorigenic" "pro-vasculogenic" "proband" "probands"
    "procapase-8" "procarcinogens" "procaspase-10" "procaspase-3" "procollagen"
    "prodeath" "products" "progeny" "progestin" "prognathism"
    "progression-free" "projectons" "prokaryote" "prokaryotes" "prolif"
    "prolif-eration" "proliferator-activated" "prolin" "prolonged-HER2-VIA"
    "prometapahse" "promoter-regulatable" "promoter-reporter"
    "proof-of-concept" "proof-of-principle" "properly-folded" "prophase-like"
    "proportional-hazards" "proprotein" "propulations" "prostaglandins"
    "prostatectomy" "protease-4" "protectAtm" "protein-1α"
    "protein-interaction" "protein-lipid" "protein-only" "protein-pair"
    "protein-poor" "protein-protein-interaction" "protein-structures"
    "protein-tyrosine" "protein-tyrosine-phosphatases" "proteinopathy"
    "proteins" "proteome" "proteome-wide" "proteomics-based" "proteosome"
    "prothymosin-α" "proto" "protomer" "protooncogene" "proven"
    "proximity-induced" "prurigo-like" "pseudo-allosteric" "pseudoEndometrioid"
    "pseudogene" "pseudogenes" "pseudokinase-domain"
    "pseudopseudohypoparathyroidism" "publicly-available" "pufferfish"
    "pull-down" "pull-downs" "pulse-chase" "punctae" "pxPppPxp" "pyodermatitis"
    "pyridine" "p = 0.001" "p = 0.03" "p = 0.04" "p = 0.04" "qRT" "qtPCR"
    "qual" "quantile-quantile" "quantitative-like" "quencher"
    "quinazolinediamines" "quinazolinols" "quinoxalin-1-one" "r" "rAAV-BMPR-IB"
    "rAAV-BMPR-IB-infected" "rRNA" "rWnt5a" "race-specific" "rad3"
    "radiation-induced" "radio-enzymatic" "radiobiology" "radiochemotherapy"
    "radioresistance" "radioresistant" "radiosensitiser" "radiosensitises"
    "raft-associated" "raft-independent" "raft-specific" "random-effect"
    "random-effects" "randomizations" "rank-sum" "ransport" "rapalogs"
    "rarely-growing" "rarer" "re-absorption" "re-adhere" "re-assessed"
    "re-blotting" "re-challenge" "re-confimed" "re-distributed"
    "re-distribution" "re-encounter" "re-encountered" "re-enter" "re-entry"
    "re-establish" "re-evaluate" "re-evaluated" "re-expansion" "re-expressed"
    "re-expressing" "re-expression" "re-form" "re-formation" "re-growth"
    "re-induction" "re-infection" "re-infections" "re-injected" "re-introduce"
    "re-introduction" "re-locate" "re-organisation" "re-organization"
    "re-overexpressed" "re-overexpression" "re-probed" "re-seeded"
    "re-sensitize" "re-sensitizes" "re-sequenced" "re-transplanted"
    "re-treatment" "reaction-restriction" "reader-to-reader" "readout"
    "readouts" "realtime" "receptor-1" "receptor-counterreceptor"
    "receptor-proximal" "receptors-1" "receptor–ligand" "recombination-based"
    "rectus" "recurrencies" "recurvatum" "redone" "refractoriness" "reg"
    "regranulate" "regulatedRhoA" "relatedness" "release21" "renilla"
    "reoxygenation-induced" "repair-independent" "repeat-length-dependent"
    "replication-associated" "replication-competent" "replication-independent"
    "replicon" "replicons" "reporter-selection" "reportk" "repressors"
    "requisites" "rescueSTAT3" "residents" "resorb" "resp" "responder"
    "responders" "restriction-enzyme" "resultsindicate"
    "retinoic-acid-inducible" "retrognathism" "retromer" "retrovirus"
    "reuptake" "rewound" "rhodamin" "ribbon-like" "ribose" "right-hand"
    "rigidifies" "risk-breast" "risk-conferring" "risk-individuals"
    "risk-reducing" "risk-stratify" "rogramme" "rotein" "rowth" "rp"
    "rs10429491" "rs10502861" "rs10758669" "rs10771399" "rs10995190"
    "rs11066320" "rs11066322" "rs11212617" "rs1144396" "rs11506105"
    "rs11549009" "rs12173570" "rs12185268" "rs121913279" "rs12229892"
    "rs12229892A" "rs12363280" "rs12371778" "rs12373124" "rs12423190"
    "rs12423190T" "rs12509517" "rs12565727" "rs12718945" "rs1321311"
    "rs13277113" "rs13277113-A" "rs1330645" "rs13306465" "rs1430583"
    "rs1468727" "rs1558902" "rs16260" "rs17625845" "rs1800547" "rs1801123"
    "rs1801278" "rs2031920" "rs20417" "rs2046210" "rs2071231" "rs2073963"
    "rs2075847" "rs2077647" "rs2180341" "rs2230723" "rs2234693" "rs2248932"
    "rs2255227" "rs2274649" "rs2301756" "rs2301756G" "rs230539" "rs2409780"
    "rs2497938" "rs2618444" "rs2736336" "rs2736337" "rs2736338" "rs2736340"
    "rs2942168" "rs35652124" "rs3752651" "rs3822214" "rs3824999" "rs3825075"
    "rs4645949" "rs4648037" "rs4648065" "rs4648068" "rs4648408" "rs470206"
    "rs470558" "rs4767860" "rs4767860A" "rs4802998" "rs4820792" "rs4849887"
    "rs491152" "rs4947492" "rs4987117" "rs5275" "rs5275-C" "rs55758736"
    "rs5934683" "rs5934683or" "rs6047844" "rs61280460" "rs61764370"
    "rs62314947" "rs6413432" "rs6413432-T" "rs6706649" "rs6721961" "rs6818140"
    "rs689466" "rs689466-G" "rs6945541" "rs7089814" "rs7109266" "rs7125062"
    "rs72977282" "rs730437" "rs7816345" "rs78378222" "rs7958372" "rs7958372T"
    "rs845552" "rs9287638" "rs9329246" "rs9397435" "rs9642393" "rs998683"
    "rubripes" "rubrum" "run-through" "sGIT2" "saline-injected" "salpingo"
    "salpingo-oophorectomy" "sapiens" "sarcoma-leukosis" "saturation-dependent"
    "sc-10800" "sc-216" "scDNA" "scabiei" "scaffolding-property" "sclerosus"
    "scr-siRNA" "scratch-wound" "second-degree" "second-line"
    "second-messengers" "secretome" "selection-by-function" "self-DNA"
    "self-administration" "self-assembly" "self-associate" "self-associates"
    "self-association" "self-examination" "self-renew" "self-renewal"
    "self-sufficiency" "self-sustaining" "self-ubiquitylation" "semi"
    "semi-confluent" "semi-permissive" "semi-quantitative"
    "semi-quantitatively" "semi-restrictive" "semi-solid" "senesce"
    "senescence-associated-β-galactosidase" "sense5" "sensitizer" "sensors"
    "seq" "sequelae" "sequence-specific" "ser235" "serial-deletion" "serine-3"
    "serology" "serosa" "serotype" "serpin-cysteine" "sessile"
    "seven-amino-acid" "seven-marker" "sex-specific" "sh-NSC" "shGFP" "shHuwe1"
    "shLacZ" "shLuc" "shOGT" "shRNA1" "shRNAi" "shRNAmir" "shRb" "shRb#2"
    "shVEGFR2" "shYB-1" "sham-treat" "sharpest" "sheet-like" "sheetlike"
    "shiga-like" "shock-inducible" "short-acting" "short-circuits"
    "short-hairpin" "short-range" "short-term" "shβ-TRCP" "shβ-TRCP1"
    "shβ-TRCP1+2" "shβ-TRCP2" "si-P1" "si-control-transfected"
    "si-control-treated" "siBMPR" "siBMPR-IB" "siCSK" "siControl" "siExo84"
    "siFAAP20-2" "siGENOME" "siPAX3" "siPTEN" "siRNA-2" "siRNA-LEDGF-and"
    "siRNA1" "siRNF" "siRNF168-treated" "siRac1" "siSRPK1" "siScramble"
    "siSec5" "side-by-side" "side-effects" "silico" "silver-based"
    "single-base" "single-cell" "single-gene" "single-locus" "single-molecule"
    "single-mutant" "single-nucleotide" "single-nucleotide-polymorphism"
    "single-nucleus" "single-strand" "single–nucleotide" "sirtuin" "sirtuin-3"
    "sites" "situ" "six-marker" "six-well" "size-exclusion" "size-shortening"
    "skein-like" "skin-specific" "slippage-mediated" "slit-diaphragm"
    "slit-lamp" "slow-migrating" "slower-migrating" "sma-RFP" "small-cell"
    "small-conductance" "small-medium" "small-molecule" "small-scale"
    "small-study" "smokers" "snap-frozen" "snoRNA142" "so-far" "socio"
    "socio-economic" "soft-agar" "soft-tissue" "sol" "solenoid" "soleus"
    "solute" "solutes" "somite" "somites" "spacer" "spacers" "spatial-temporal"
    "spatially-distinct" "spatio" "spatio-temporal" "sphere-to-cylinder"
    "sphincter" "spina" "spindle-forming" "spindle-like" "spindlin"
    "spiral-shaped" "spirometry" "splice-blocking" "splice-site" "spliceform"
    "spliceforms" "spondylodiscitis" "squamous-like" "ssDNA-to-protein"
    "stab-injury" "stably-associated" "standard-of-care" "starvedp53"
    "stathmin-like" "status-positivity" "steady-state" "steady-states"
    "steeper" "stellate" "stem-cells" "stem-like" "stem-loop" "stemness"
    "stengths" "step-wise" "stepwise" "sterile-filtration"
    "stimulated-exchange" "store-operated-calcium-entry" "strain-specific"
    "streptavidin-binding" "stress-accumulated" "stress-activated"
    "stress-associated" "stress-fibres" "stress-induce" "stress-induced"
    "stress-inducible" "stress-mediated" "stress-response" "stress-responsive"
    "stressful" "stressors" "stress–specific" "stretch-induced"
    "stringently-defined" "stromal-associated" "stromal-vascular"
    "strongly-associated" "structure-activity" "structure-based"
    "structure-function" "structure–function" "sub-G0" "sub-G1" "sub-band"
    "sub-bands" "sub-cellular" "sub-clone" "sub-clones" "sub-divided"
    "sub-family" "sub-fraction" "sub-genomic" "sub-group" "sub-groups"
    "sub-lethally" "sub-line" "sub-membranous" "sub-nanomolar" "sub-optimal"
    "sub-picomolar" "sub-pocket" "sub-population" "sub-set" "sub-sites"
    "sub-studies" "sub-tetraploid" "sub-toxic" "sub-types" "subG1"
    "subarachnoid" "subcategories" "subclasses" "subclassifications"
    "subcomplex" "subcomplexes" "subcutis" "subfamilies" "subfields" "sublines"
    "submotifs" "submucosa" "subpocket" "subpolysome" "subpopulations" "subset"
    "subset-characteristic" "subsets" "subsitutions" "substrate-binding"
    "substrate-recognition" "substrate-specificity" "subtetraploid"
    "subvariants" "succinate" "sulfamethoxazole" "sulfapyridine"
    "sulfate-polyacrylamide" "sulfite" "sulfonate" "sun-protected"
    "sun-related" "super-family" "super-high" "supercomplex" "supernatant"
    "supernatants" "superset" "suppresser" "suppressers" "survival-death"
    "suspension-induced" "switch-like" "switchlike" "synaptotagmin-like"
    "syndrome-associated" "synergism" "synthsse" "syringomyelia" "systems-wide"
    "tBid-mediated" "tFN" "tGFP" "tSNP" "tSNPs" "tail-vein" "take-off"
    "tamoxifen-treatment" "tandem-arranged" "target-genes" "tea-based"
    "telengiectasia" "telomerase-deficient" "telomerase-negative"
    "telomerase-specific" "telomere-regulatory" "temperature-sensitive"
    "terminally-differentiated" "tet-OFF" "tetO-HA-MMP-3" "tetO-YFP-Rac1b"
    "tetOFF" "tetra-glutamate" "tetrahydroacridine" "tetranitrate" "tetraploid"
    "tetraploid-like" "tetraploidization-induced" "tetraploids" "tetrazolium"
    "thatAtm" "thatFAAP20" "thatVEGFR2" "theAtm" "theBraf" "theK" "theStat3"
    "theV43I" "thebrca2" "thedelE746" "therapy-independent" "therapy-naïve"
    "therapy-resistance" "therascreen" "thetsad" "thiamet" "thiamet-G"
    "thiamet-G–induced" "thiamine" "thioflavin" "third-degree" "thirty-two"
    "thirtyfold" "three-dimensional" "three-fourths" "three-independent"
    "three-marker" "three-step" "threonine-kinases" "threonine-rich"
    "thrombocythemia" "thrombus" "thymocyes" "thymocytes" "tiling-resolution"
    "time-course" "time-delay" "time-dependently" "time-efficient" "time-frame"
    "time-lapse" "time-of-flight" "time-period" "time-point" "time-points"
    "time-post" "timecourse" "timeframe" "timepoint" "timepoints"
    "tissue-distribution" "tissues" "tissure" "tk" "to-date" "to11-fold"
    "to150" "toAtm" "tobrca2" "top-binders" "topologies" "topology" "tor1"
    "tor1-D" "tor1-L2045S" "tor2-287" "torn" "toto" "trachomatis"
    "tract-specific" "trans-endothelial" "trans-gene" "trans-membrane"
    "trans-triepitopic" "trans-triepitopics" "trans-trispecific" "trans-well"
    "trans-wells" "transcription-factors" "transcriptome-wide" "transcriptomes"
    "transcytose" "transdifferentiate" "transducer" "transfectant"
    "transiently-expressed" "translocases" "translocon" "transplantedp53"
    "transposon" "transversions" "transwell" "treated-cells" "treatedtsad"
    "tresia" "trfc" "tri-HEAT-like" "triage" "trichostatin-A" "trichrome"
    "tricyclo" "tricyclo-DNAs" "trimethoxybenzoate" "triphenyl"
    "triphenyl-tetrazolium" "triphosphate" "triple-epitope" "triple-labeled"
    "triple-negative" "trisomy" "trisphosphate" "trophoblasts" "ts" "tubings"
    "tubule" "tubules" "tubulo" "tubulo-cisternal" "tubulo-cystic"
    "tumor-intrinsic" "tumor-normal" "tumor-suppressive" "tumorigeneis"
    "tumors" "tumour-suppressive" "tumour-suppressor" "turn-over" "two-centre"
    "two-factor" "two-hybrid" "two-independent" "two-level" "two-pronged"
    "two-sided" "two-site" "two-stage" "two-thirds" "two-way" "type-2" "type-I"
    "type1γ" "tyrosin" "uVIN" "uanine" "ub" "ubibiquitin" "ubiqitin"
    "ubiquinate" "ubiquitin-interface" "ubiquitin-proteasome-mediated"
    "ubiquitinproteasome" "ubiqutin" "ultra-deep" "ultrafine" "ultrastructure"
    "un" "und" "under-evaluate" "under-expressed" "undergone" "underpinnings"
    "undertaken" "units" "univariate" "unmet" "untangle" "untingtin"
    "untranslated-UTR" "up-regulator" "up-regulatory" "up-stream" "urea"
    "ureter" "uridylyl" "urothelium" "usingFAAP20" "utations" "uteri"
    "uterine-specific" "utlin-3" "v-Ki-ras2" "v-Myc-immortalized" "v-raf"
    "vSCC" "vaccine-induced" "vacuole" "vacuoles" "valgum" "value=1.555e-12"
    "values" "vanadium" "variable-like" "variants" "varum" "varus" "vas"
    "vascular-endothelial" "va–vy" "vector-only" "vehicle-treated" "venules"
    "vera" "verruciformis" "very-high-risk" "vesicles" "vesiculo"
    "vessel–associated" "viliform" "villi" "viral-induced" "virally-infected"
    "viremia" "virotherapy" "virus-infection" "virus-like" "vis-à-vis" "visal"
    "viscera" "vitamin-K-dependent" "vitro" "viverrini" "vivo" "voriconazole"
    "vs.control" "vulgaris" "vulvitis" "vy" "wZ" "water-soluble" "weakest"
    "web-based" "website" "well-annotated" "well-being" "well-characterised"
    "well-circumscribed" "well-conserved" "well-controlled" "well-coordinated"
    "well-defined" "well-designed" "well-developed" "well-differentiated"
    "well-distanced" "well-documented" "well-folded" "well-mixed"
    "well-preserved" "well-recognized" "well-studied" "well-tuned"
    "westernblot" "where-in" "whereasBcl" "whereasBcl-X" "whole-body"
    "whole-cell" "whole-chromosomal" "whole-exome" "whole-genome" "whole-lung"
    "whole-mounts" "wide-association" "wide-range" "widely-accepted"
    "widely-associated" "widely-used" "wih" "wild-type-Skp2" "wildtype-Sam68"
    "wildtype-like" "withBay11-7085" "withStat3" "within-the" "wk" "workers"
    "workflow" "wound-closure" "woven" "written" "wt-RPA" "wt-tk" "wtBRCA1"
    "wtLTR" "wtp53" "www" "x-axis" "x-ray" "xL" "xPxxP" "xanthoastrocytomas"
    "xenopus" "years" "yeast-based" "yet-to-be-characterized"
    "yet-to-be-identified" "yr" "yrosine" "z-plane" "zeocin" "zeolites"
    "zinc-inducible" "zymogen" "zymography" "»src-associated" "×10" "×100"
    "×71" "× 10" "× 10" "̀ed" "Δ2-7EGFR" "Δ266-289" "Δ289-338" "Δ338-355"
    "Δ355-380" "Δ46–110" "ΔB" "ΔBLISS" "ΔBΔM" "ΔC276" "ΔC542" "ΔCH3" "ΔCT"
    "ΔCt" "ΔDEP-Dvl2" "ΔEC" "ΔEGFR" "ΔEGFR-GFP" "ΔEGFR-NLS" "ΔEGFR-NLS-GFP"
    "ΔEGFR-STAT5b" "ΔEGFR-expressing" "ΔEGFR-ki" "ΔEGFR-mediated"
    "ΔEGFR-stimulated" "ΔEGFR-transport" "ΔEGFR’s" "ΔGTPase" "ΔKinase" "ΔM"
    "ΔMotor" "ΔN" "ΔN1-342" "ΔN147" "ΔN302" "ΔN412" "ΔN570" "ΔN69" "ΔNp63"
    "ΔNp63-specific" "ΔNp63a-miRNAs" "ΔP0" "ΔP0345" "ΔP3" "ΔP4" "ΔP5"
    "ΔPDZ-Dvl2" "ΔPIP" "ΔPten" "ΔPxxP" "ΔPxxP-constructs" "ΔQ" "ΔRNP1" "ΔRNP2"
    "ΔRNP2-deletion" "ΔRRM" "ΔSERAS" "ΔTk" "ΔUBZ" "Δplb1" "Δrac1" "Δtel" "ΔΨm"
    "ΦXXXXΦXXΦ" "ΦXΦXXXXΦ" "ΦXΦXXXXΦXXΦ" "Φ→A-Ku70" "α-Arp2" "α-FAK" "α-Flag"
    "α-GalCer" "α-GalGalCer" "α-PDGFR" "α-PDGFRs" "α-cortactin" "α-deletion"
    "α-dynamin" "α-galactosylceramide" "α-granule" "α-helical" "α-helices"
    "α-helix" "α-importin" "α-meningococcal" "α-p-Tyr-100" "α-p-tyr-100"
    "α-rabbit" "α1→2" "α4" "α4-integrin" "α4β1" "α5-α6" "α6-α7" "α7" "α8"
    "α8β1" "α9-containing" "α9-mediated" "αEF" "αF-loop" "αMHC" "αv" "αα1-323"
    "αβ-T" "αβTCR" "β-D-1-thiogalactopyranoside" "β-N-acetylglucosamine"
    "β-N-acetylglucosaminidase" "β-PDGFR" "β-PDGFRs" "β-PDGFR–associated"
    "β-Pix-SH3" "β-TRCP" "β-TRCP1" "β-TRCP1+2" "β-TRCP2" "β-TRCP2–MO-injected"
    "β-TRCP2–MO-treated" "β-TRCP–depleted" "β-TRCP–mediated"
    "β-TRCP–overexpressing" "β-TrCP-E3-ligase" "β-barrel" "β-deletion"
    "β-galactosdiase" "β-helical" "β-integrins" "β-mediated"
    "β-octyl-glucopyranoside" "β-pancreatic" "β-selection" "β-sheet"
    "β-sheet-rich" "β-strand" "β-strands" "β-subdomain"
    "β-transducin-repeat-containing" "β3" "β " "γ-chain" "γ-deletion"
    "γ-irradiation" "γc" "γcoactivator-1β" "κB" "λ-phosphatase" "μ1" "μL" "μg"
    "μg " "μl" "μmol" "π-π-interactions" "‘EX’" "‘MCAO’" "‘fibroadipose’"
    "‘hotspot’" "‘microclusters'" "‘o'" "‘therascreen'" "‘vq'"
    "”-accommodating" "”-binding" "”-mediated" "←3" "∆CT" "∆Eμ" "∆Xho" "∆∆CT"
    "−1.03%" "−1.12%" "−1.80%" "−10.15%" "−11.46%" "−11.83%" "−133.1%"
    "−138.3%" "−14.21%" "−16.03%" "−18.25%" "−3.47%" "−3.69%" "−4.05%" "−5.97%"
    "−6.23%" "−64.74%" "−73.6%" "−78%" "−8.10%" "−8.12%" "−8.50%" "−8.54%"
    "−85.5%" "−9.43%" "−91.5%" "∣D" "∧E4" "ﬁrst"))

(DEFPARAMETER SPARSER::*BIO-ENTITY-HEADS-PHASE3-7801-8100*
  '("ZM1" "Ser893/Ser894" "B55α" "late anaphase cells 42 h" "YPet" "CyPet"
    "poleward" "Repo" "-IRES-" "2 C" "pcDNA4" "dnTcf4" "pMACS" "mids" "pMAP4Kl"
    "pCMV6" "shLacZ" "premalignancy" "→MKK4→JNK" "DMBA/TPA" "/TPA"
    "dimethylbenz" "TPA" "Eto" "eath" "rogramme" "P≤0.05" "= C" "2×10"
    "β-catenin/Tcf" "aStat3" "the predominant STAT3 spliceform"
    "AffymetrixGeneChip" "basal non-cytokine" "theStat3" "≤−1"
    "basal non-cytokine-stimulated" "n/" "atfor" "Graphpad" "Actb" "AssayID"
    "Quantitative real-time TaqMan" "TaqMan" "AssayIDs" "CateGOrizer" "DAVID"
    "fromStat3" "LOGFC" "Benjamini" "LIMMA" "Australia" "Melbourne" "MacCallum"
    "Purelink" "iSTAT3β" "iSTAT3α" "Leica" "Biomeda" "GelMount" "/Cy3" "Cy2"
    "indocarbocyanine" "carbocyanine" "w/v" "Triton X-100/PBS" "CLSM"
    "Immunocomplex" "Nonidet" "Tris/HCl" "anti-phospho-STAT3" "pH "
    "penicillin/streptomycin" "pCMV" "pF-5UAS-SV40-puroGEV16" "pXJ" "HindIII"
    "ofSTAT3" "the mammary epithelium" "ofStat3" "spliceforms" "STAT3β"
    "STAT3α" "a shorter STAT3β spliceform" "spliceform" "S2C" "72 h"
    "confocal micrographs" "HEK293-hCD1d" "GalGalCer" "GalCer" "LMTK-CD1d1"
    "Ag" "logrank" "a publicly available dataset" "wildtype-like"
    "non-mutation-like" "Suppl" "E542K/L" "‘hotspot’" "p=0.009" "=0.35" "=0.99"
    "p=0.001" "=0.018" "p=0.004" "Twenty-one" "20/29" "=22" "tumor/normal"
    "Non-V600" "at least greater" "Vanderbilt" "G12/13" "_1790" "qual" "WGS"
    "28-day" "had similar viral titers" "ΔTk" "Tk" "+ /Mac-1" "LSKcells"
    "andBlk" "fromBlk" "ofBlk" "S+G2M phase" "hCD4" "MSCV-" "MSCV" "orBlk"
    "5 μg/mL" "CD34 +" "GFP +" "Takizawa" "X-1" "antitumour" "M4-2" "M4-1"
    "Strongest" "DOTAP" "B2-1" "EJ28" "5x10" "Sixty-one" "RSK1/2" "NimbleGen"
    "polysome/subpolysome" "WM1361" "rp" "MNK1/2" "oligopyrimidine" "nu/nu"
    "Ser235/236" "~70%" "association/dissociation" "S46A" "hypRPA" "CIAP"
    "dT90mer" "dT30mer" "Corp" "heterotrimer" "20A" "Vasioukhin"
    "keratincoytes" "N17Rac1" "retardation/defect" "triple immuno/fluorescent"
    "Darby" "Madin" "pixels" "RNAi-2" "RNAi-1" "co-localised" "disorganises"
    "vulgaris (PV)" "vulgaris" "desmoglein" "=6" "2 mg/ml" "1 h" "48 h"
    "reuptake" "monoamino" "non-alcoholics" "Hydroxytryptamine" "HATS"
    "hydroxytryptamine" "AUDs" "24-48 hrs" "cyclohexamide" "co-fractionation"
    "phyla" "4 C" "Nigeria" "longer AR_CAG" "racial/ethnic" "tag/capture"
    "Romanians" "Greeks" "1.36–2.54" "1.01–1.17"
    "The most significant single nucleotide polymorphism (SNP)" "nearest"
    "6q25.1" "Greek" "French" "the shortest AR_CAG" "Kennedy" "hirsutism"
    "PolyGln" "1.01–1.15" "1.10–1.74" "0.83–1.00" "Ave" "Genepop"
    "American (AA)" "Microsatellites" "AR_CAG" "ESR1_TA" "ESR2_CA" "_CA" "_CAG"
    "_TA" "microsatellites" "= 41" "P  = 0.04" "Fusco" "Ubiprot" "HDCA6"
    "FLAG-TRIM50#3" "CLEM" "WBS" "Beuren" "Williams" "BUZ" "Alexafluor 488"
    "p = 0.03" "FK2" "Uniprot" "0.5 mg/ml" "proto" "fibroblast–like" "Lgl"
    "a further 12 h" "Subbaiah" "Krishna" "hDlg 1" "0.5% soft agar" "achorage"
    "re-form" "hDlg1/hScrib" "hDlg1" "re-establish" "0.98–1.43" "Humar"
    "Q-test" "Grunhage" "Harbord" "adjustedR" "invasion/tumor suppressor gene"
    "Venice" "-160C" "= 0.93" "P  = 0.0001" "P  = 0.0008" "= 0.0005" "= 22"
    "= 0.0004" "= 0.90" "P  = 0.01" "= 0.86" "P = 0.03" "P  = 0.03" "= 19"
    "= 0.16" "P  = 0.15" "= 0.95" "= 0%" "= 1.14" "= 63" "= 45" "= 0.0003"
    "outs" "theK" "aK" "a phenotypic readout" "half-time" "H3/H4" "H133W/Y"
    "apparentK" "reportk" "ak" "lowk" "peptidylimidate" "app" "H3K9Ac" "Werner"
    "co-substrate" "ribose" "catalyse" "organismal lifespan" "16/60"
    "chromatin/DNA" "= 0.001" "RecD" "Ecoli" "K141/142A"
    "methanesulfonate (MMS)" "adenoine" "100 U/mL" "helicase/translocases"
    "polη" "Bouwmeester" "Gn" "Kunjin" "translocon" "COP" "TBK1-" "TBK" "ISRE"
    "Hec1B cells" "AKKFF" "dilysine" "duplexes" "dA:dT" "ministacks"
    "Y440/Q442A" "BFA" "punctae" "ER-to-Golgi" "≥0.7" "AP/MS" "MPYS"
    "Reticulum" "COPII" "anterograde" "-to-Golgi" "RLH" "ERGIC" "ERES"
    "non-Targeting" "≥0.5" "Anti-FLAG" "RIG-I-like" "non-infected" "postpartum"
    "RacGAP" "Penney" "Simeone" "nPKC" "cPKC" "aPKCs" "nPKCs" "cPKCs" "Stat3α"
    "hStat3α" "Calphostin" "co-precipitation" "mStat3α" "Biotech"
    "non-transcriptional" "co-precipitates" "20 p" "COS-1"
    "about specific ovarian cancer histology" "Endometrioid" "anaplasia"
    "pseudoEndometrioid" "serous histology" "Oncologists"
    "invasive ductal histology" "serous/undifferentiated" "14/42" "7/42"
    "a concurrent dominant mass and 2/42" "and 2/42" "p=0.06"
    "high grade serous histology" "7/43" "9/240" "42/325" "43/325" "240/325"
    "histomorphology" "salpingo" "mastectomy"
    "modified Nottingham grade 3 serous or undifferentiated histology"
    "giant/bizarre" "11/42" "267/283" "18/85" "231/240" "cornu"
    "325 ovarian tumors drawn" "Greater" "Nottingham" "sheet-like" "n=5"
    "GGTIs" "Smc5/6" "G-rich" "supercomplex" "kb/hr" "decatenates" "PD20"
    "Anti-Flag" "TopIIIα" "gallbladder"
    "at least two distinct VEGFR2/RTK heterocomplexes" "heterocomplexes"
    "shMET1" "shMET" "timeframe" "Δ450C" "significantly less motile" "DC101"
    "GBM43" "NSCG" "VEGFKO" "FLAIR" "heterocomplex" "8/9" "24-hour"
    "co-stimulated" "Co-stimulation" "shVEGFR2" "JSK" "histologu" "subfamilies"
    "the pathological histology" "pathological histology" "immunoscores"
    "p = 0.04" "p = 0.001" "p = 0.03" "TSY" "WYP" "JMS" "KF" "JZF" "serology"
    "other unidentified causative SNPs" "associated haplotypes"
    "an intronic enhancer" "Uzbekistan" "H. pylori -seropositive Japanese"
    "Koreans" "Utah" "0.93-1.83" "Hans" "GCGTG" "GTATA" "rs4767860" "rs7958372"
    "rs12229892" "examinees" "intron3" "rs11066322" "rs2301756" "rs12423190"
    "endoscopy" "pepsinogenIandII" "htSNPs" "/signal" "= 0.139" "= 0.90"
    "= 0.13" "P  = 0.03" "P  = 0.01" "P  = 0.02" "cAMP→PKA→pCREB" "E-box"
    "homologue-1" "pCREB" "PPRE" "E-boxes" ".3/II" "→cAMP→PKA" "cAMP→protein"
    "cAMP→PKA" "hydroxyprostaglandin" "Anti-human" "inKras" "LA2" "ntg"
    "NextBio" "trichrome" "tetO-HA-MMP-3" "homogenates" "tetO-YFP-Rac1b" "rtTA"
    "rtta" "Nonmalignant" "3b" "BMH2" "BMH1" "bmh2" "bmh1" "84.7±2.5%"
    "_139323" "Bh113-" "Bh113" "chaperone-like" "TOR1" "+ /" "14-3-3 β"
    "SUVmax" "ROI" "Fluorodeoxyglucose" "Salvaggi" "Kawai" "Group-1" "Group-2"
    "Group-3" "ERß" "non-nuclear" "clinicopathology" "mERα" "= 0.031"
    "P  = 0.003" "= 0.005" "P  = 0.019" "≥ 4" "Fifty-one" "Musat" "7/33"
    "phosphatidylinositol-4,5-biphosphate" "≥4" "macroadenomas" "OXPHOS"
    "ischaemia" "adenylate" "de-polymerisation" "RB–E2F1complex" "PAHS-020"
    "Valencia" "genotoxic/cellular" "TIGA" "UV-35" "Swiss" "UV-50" "UV-25"
    "D-type" "S/G2/M" "Fru-2,6-P" "p21 WAF1" "co-overexpressed" "4-days-on"
    "one-week" "oncogene/pathway" "Gozgit" "bilineage" "methycellulose" "GFP+"
    "retroviral supernatant" "MIEG3" "CD34+" "cytoarchitecture"
    "and 3-days-off" "/mouse" "Phosphoflow" "pPLCγ" "BBC2" "BBC1" "CEP5A"
    "CEP2A" "with/without" "leukemia/lymphoma (SCLL)" "MLNAF" "EMS" "3-days"
    "p = 0.0001" "pStat5" "50ng/ml" "anti-phosphotyrosine"
    "transduction/transplantation" "co-inhibition" "XTT" "1 hr" "18 hrs" "VEFG"
    "ethylcarbamide" "morpholinosydnonimine" "aminoacids" "S-nitrosated"
    "GFPeNOSG2A" "GFPeNOS" "quinoxalin-1-one (ODQ)" "oxadiazolo" "1H-"
    "guanylyl" "hyperpermeabilty" "ECVeNOSGFP" "postcapillary venules"
    "catabolites" "GFPeNOSCAAX" "EAhy926" "CVEC" "eNOSGFP" "S-nitrosation"
    "mg/Kg" "RQL" "homozygous_genotype" "_genotype"
    "the GG homozygous_genotype" "Broad/MGH" "browser" "Colorado" "Denver"
    "Nfkb" "orangutan" "A/G" "homozygous GG" "intronic SNPs"
    "only SNP rs4648068" "rs4648037" "rs4648065" "rs12509517" "rs230539"
    "Hapmap" "4q24" "Eastern Europe" "Homozygous rs4648068 GG" "AOR "
    "rs4648068" "Fudan" "P  = 0.004" "P  = 0.006" "P  = 0.001" "= 0.029"
    "95% CI " "JQ1" "38±9%" "FITC-VAD-FMK" "CaspACE" "−∆∆CT" "∆∆CT" "∆CT"
    "≥20%" "avidin/biotin" "intestinal villi" "subcategories" "iMyc∆Eμ"
    "IL-6-ms" "iMyc" "∆Eμ" "C/T" "HMCLs" "= 0.012" "= 19" "co-regulate"
    "van der Waal’s" "Waal" "Iwamori" "BRC5" "Lekomsev" "Lekomtsev"
    "egion (EABR)" "EABR" "egion" "lix" "SCRT-" "SCRT" "multipolar mitoses"
    "ofbrca2" "rubripes" "Fugu" "pufferfish" "website" "BCCIPα" "UFBs"
    "ultrafine" "tobrca2 +/+" "Lap2β" "p=0.03" "inbrca2" "Ahd1" "p=0.01"
    "thebrca2" "andbrca2 +/+" "frombrca2 +/+" "midzone" "=0.024" "p=0.006"
    "=0.03" "=0.004" "kinesin-like" "Written" "dyscrasias"
    "plasmacellular dyscrasia" "dyscrasia" "Fungoides" "CCNB"
    "all non-Hodgkin's" "oxalyplatin" "GEMOX" "Vyses" "XT" "LSI" "Vysis"
    "immunoprofile" "215bp" "Nanogen-" "TCRgamma" "VJ" "Diagnòstica" "Nanogen"
    "VDJ" "dendritc" "residual follicles" "parenchyma" "latero" "8500/mmc"
    "g/dl" "hematocrit" "Neutrophilis" "WBC" "leucocitosi" "hyperuricemia"
    "multiple superficial adenopathies" "Avellino" "Moscati" "adenopathies"
    "14q32" "other non-Hodgkin's" "leukemia/lymphoma (ATLL)" "AITL"
    "non-Hodgkin's" "G/A"
    "chronic lymphocytic leukemia/ small lymphocytic lymphoma" "http://www"
    "6XA" "ZR75" "α5/7" "K68R/K71R" "K68L/K71L" "KLKL" "KRKR" "KQ" "K→L" "D/S"
    "formamido-pyrimidine-DNA-glycosylase" "UV-induced DNA 6-4 photoproducts"
    "S-checkpoint" "active replicons"
    "human dermal fibroblasts in vitro using immunocytochemistry" "Trouiller"
    "UVB" "corneum" "NIOSH" "μg/L" "PNEC" "PEC" "sulfonate (MMS)" "sulfonate"
    "UVC-irradiated" "UVC" "replicons" "scored/chamber" "pChk2" "pH2AX"
    "histone 2AX" "nanotoxicology" "photoproducts" "telengiectasia" "/cm 2"
    "w/w" "0.5–1.5" "g/person" "Baan" "replicon" "nano" "± 9.3" "± 12.7" "= 54"
    "= 5" "= 41" "cells/μl" "~5%" "SHBR" "MQN" "DQC" "RRB" "TCRS" "Nmethyl"
    "3/5" "Pará" "aneusomy" "5/19" "Southeastern Brazil"
    "atrophic gastritis and 2/11" "and 2/11" "Targa" "df " "gastric neoplasias"
    "Northern Brazil" "N = 4" "1/8" "= 0.03" "OR = 2.4" "= 6" "= 0.010"
    "= 0.334" "= 41" "=  2" "= 0.024" "= 0.01" "= 0.001" "= 13" "= 19"
    "Francis" "Ranganathan" "Lockless" "CMGC" "heteroatoms" "pyridine"
    "phenylethylene" "SAR" "quinazolinediamines" "nitro"
    "the resultant quinazolinols" "amines" "SOCl" "quinazolinols" "amidines"
    "Niementowski" "arylquinazolines" "subpocket" "αEF/αF-loop" "αF-loop" "αEF"
    "phenylquinazoline" "phenylquinazolines" "2L14" "und" "1L14" "and 2L14"
    "Diskin" "specifically target non-catalytic" "–nitro-" "= 8" "-nitro-"
    "-Nitro-" "1 H" "20X" "non-catalytic" "IAPS" "bothcell" "PBMNCs" "PBMNC"
    "BCBL" "Bay 11-7085" "ofcaspase-3" "Xl" "non-Hodgkin’s"
    "multicentric Castleman’s" "multicentric Castleman" "Castleman" "NFKB-"
    "Bay11-7085" "non-toxic" "mucosal epithelia" "IgA" "P-specific" "CEACAM8/1"
    "CEACAM1-NA1B" "MβCD" "re-distribution" "non-lipid" "ΔCT"
    "mild detergent lysis" "Bruton's" "mKate" "Bruton" "re-locate"
    "non-glycosylated" "cholesterol-rich membrane microdomains" "gonococci"
    "CEACAMs" "ENaC" "dendrite" "anti-Kif26b" "anti-Kif26" "̀ed"
    "anti-phospho-Ser1962" "anti-phospho-Thr1859" "mesh-like" "KIF" "PPxY"
    "nonmuscle" "the undifferentiated metanephric mesenchyme" "deviance"
    "membranous organelles" "cargos" "distal tubule" "proximal tubule" "Henle"
    "glomerulus" "nephrons" "the metanephric mesenchyme" "mesenchyme" "KIFs"
    "2 mg/ml" "HSF1 and" "Calderwood" "approximately 1 hr" "#PTALIDSILR"
    "VKEEPPSPPQSPR" "Orbitrap" "with/requirement" "2B" "A β" "Egger’s" "Begg’s"
    "Egger" "Begg" "FASAY" "= 0.92" "= 1.32" "= 0.010" "= 54" "= 73"
    "lamellipoda" "parvum" "flexneri" "EHEC" "EPEC" "Backert"
    "the endocytotic macherinery" "macherinery" "familiy" "MitoTracker" "WIP"
    "α-p-Tyr-100" "cell-associated meningococci" "meningococci" "MC58"
    "non-kinase (FRNK)" "siaD" "rhodamin" "non-kinase" "type1γ" "RGD" "opcA"
    "Opc" "meningococcus" "meningitidis" "holoenzymes" "RNAPII" "RNA/HEXIM1"
    "inhibitor-3" "aminoimidazole" "N1-aryl-propane-1,3-diamine" "BRD"
    "-O-methyl" "guanidyl" "DNAs" "tricyclo" "mixmers" "WM5" "aminoquinolone"
    "fluoroquinoline" "carboxoacteamide" "tetrahydroacridine"
    "the inactive compound 1G3" "the global cellular proteome" "NL" "M 1H4"
    "Burk" "Lineweaver" "non-HIV-1" "Vmax" "KKCCFHCQACAITK" "QACA" "PYKFPSSPL"
    "·min −1" "RATA" "RVxF-" "KKCCFHCQVCFITK" "PYKFPSSPLR" "HIPR"
    "an inactive compound 1G3" "1G3" "Lac" "microplate" "Ukraine" "Kiev"
    "Enamine" "pharmacophore" "Barford" "David" "RRVSFA" "cdNIPP1" "pNL4-3"
    "TEFb" "MyPhoNE" "QVCF" "RVxF" "1H4" "VCF" "protein phosphatase-1" "TAR"
    "non-linear" "anti-HIV" "= 0.19 µ" "= 0.014 µ" "= 0.004 µ" "= 0.31 µ"
    "IC 50 s" "Ser612Pro613" "oriLyt" "immunocomplexes" "E2F1through" "KIT21"
    "VIT7" "B10" "REx" "octamers" "non-budded" "K102I-transformed cdc28-4"
    "BGLF4-" "BGLF" "non-permissive" "cdc28-4"
    "the temperature-sensitive (ts) yeast cdc28-13" "bacmid" "Maxi" "NA"
    "cdc28-13" "prophase-like" "Cdk-like" "1delta" "CHPKs" "S-phase-like" "Zta"
    "Burkitt’s" "Hodgkin’s" "phosphoamino" "BGLF4" "lamina" "2H" "20 as"
    "larger subset" "tumorigeneis" "EMBRACE" "PISA" "penetarnt" "histo"
    "larger datasets" "1.06–1.38" "ORs " "ICOGs" "CGPS" "Copenhagen" "GESBC"
    "kConFab" "SBCS" "0.90–1.16" "0.80–1.00" "±13.5" "1.00–1.11" "MSKCC"
    "HMBCS" "non-AJ" "Jewish (AJ)" "1.00–1.06" "BCAC" "rs2180341" "6q22.33"
    "= 0.006" "= 0.005" "= 0.19" "= 0.15" "p = 0.04" "p = 0.006" "= 0.80"
    "BRCA1 / 2" "ER+" "= 0.023" "receptor-1" "oligomeric Aβ"
    "activity/localization" "constitutive active T320A-PP1a transfectants"
    "KKKQRW" "S6A" "S4A-" "Biotin" "pT25-NEP"
    "the Aβ-degrading enzymes endothelin-converting enzyme-1"
    "endothelin-converting enzyme-1" "hNEP" "SFV" "MAPK/ERK kinase 1/2"
    "calphostin" "cortical/hippocampal neurons"
    "phosphorylation/dephosphorylation" "both soluble and fibrillary Aβ"
    "expression/activity" "Aβ40" "Aβ43" "Aβ42" "protein phosphatase-1a"
    "S6-NEP-ICD" "phosphorylation/dephosporylation" "co-treated" "-202"
    "1.0 × 10" "phosphorylation/" "point---eIF4F" "anti-UPS" "A36/A47" "≤0"
    "cell viability/growth" "ubiquitinproteasome" "P ≤0.05"
    "TTAA forms functional eI4F" "exogenous TTAA" "TTAA" "cistrons" "IRES"
    "cistron" "renilla" "adjacent normal esophageal mucosa" "EACs"
    "Thr202/Tyr 204" "≤0 .05" "immublot" "lucifearse" "oligoncleotides"
    "FOPFlash" "TOPFlash" "oligonuleotides" "Sox" "Yori" "KLFs" "TCF/LEF"
    "proteinopathy" "even SCA2-length (>34Q) polyQ-expanded ataxin" "Ataxin"
    "larger pTDP-43 preinclusions" "preinclusions" "postmortem" "neuron-like"
    "neurites" "27–29Q" "PolyQ" "31–32Q" "nonheat" "pTDP" "27–33Qs" "34Qs"
    "ataxin" "polyQ" "= 0.001" "22Q" "22Qs" "leuke" "6q22-24" "Doxo" "pTRIPZ"
    "DOXO" "Dex" "BALL" "TurboRFP" "shRNAmir" "Doxy" "neoplasias" "6q23.3"
    "E2A" "neurocognitive sequelae" "mature B and T-cell immunophenotypes"
    "immunophenotypes" "lymphoblasts" "immunophenotype" "~25%" "Lohr" "NWGC"
    "leukemia/lymphoma" "Hodgkin" "pJAK2+" "AACR" "C/C" "SNARES" "Joshi"
    "Powell" "Ehrlich" "bilayer" "microdomain" "hVps"
    "aminoethoxydiphenylborate" "store-operated-calcium-entry (SOCE)"
    "the intercellular bridge/midbody" "ESCRT-1" "PTAP" "LE/MVB" "LE" "EAIV"
    "acyl" "plasmamembrane" "LE/MVBs" "bis" "myristoyl" "capsid" "evaginates"
    "phospholipase-C-" "late endosome/multivesicular bodies" "polyprotein"
    "non-ESCRT" "factor-1" "0.5mg/ml" "/ml" "FOX" "non-oxidative"
    "Extract-treated MDA-MB-231 cells" "HMEpC" "2mg/ml" "cretica" "Fagonia"
    "sense 5" "MDA-MB-231cells" "which makes us" "Harbin" "1.21–1.79"
    "genotype  " "mutated homozygote" "Nigerians" "rs20417" "hepatotoxicants"
    "procarcinogens" "rs2031920" "rs689466" "rs6413432" "rs5275" "= 0.034"
    "= 5" "= 6" "= 0.016" "= 0.82" "P = 0.02" "P  = 0.003" "P  = 0.012"
    "P  = 0.019" "P  = 0.02" "= 0.037" "= 0.002" "mCherry-SH3BP1"
    "lamelliapodia" "siControl" "Non-Essential" "knowkdown" "cell-type-" "DEVD"
    "FOXO4a" "apoptotis" "5μg/ml" "= 10" "Non-HS" "neocortex"
    "tuberous sclerosis-1" "astrocyte-like" "non-HS" "hilus" "at least 2 h"
    "intractable mTLE" "spatio" "epileptiform" "cortical dysplasia"
    "mesial TLE" "mTLE" "distinct hippocampal subfields" "kainate" "subfields"
    "TLE" "n = 5" "= 13" "only 1 high scoring p53 RE" "initio" "transcriptomes"
    "Rb-like" "Consite" "mreps" "its two larger spacers" "spacers"
    "an unusual microsatellite" "TGYCC" "perfom" "FTRs" "Knudson's" "Knudson"
    "= C" "= A" "p107  −/−" "insertion/duplication" "24/25" "Buttita" "newer"
    "CEP17" "20/25" "23/25" "p=0.003" "HER2 -mutated" "=0.04" "20/24" "12bp"
    "utations" "YVMA" "HER2 -positive" "2/26" "non-small cell lung carcinomas"
    "1/3" "HER2-positive" "HER2 -" "senesce" "immortalized/transformed"
    "tetraploids" "re-seeded" "Roche" "FuGENE" "pBim" "Promega" "-TCG" "TCG"
    "Dynabeads" "Massachusetts" "Danvers" "Munich" "EQ" "Tween" "TBST" "Ohio"
    "Bedford" "Biosystems" "a Nano-drop ND-1000" "Delaware" "Wilmington" "Nano"
    "Georgia" "Beckman" "cytometer" "XDP" "MoFloTM" "TritonX" "Beyotime" "York"
    "OligofectAMINE" "Opti" "Gtt-3" "sense5" "GGU" "GAU" "-UCA" "UCA" "UGU"
    "CCU" "-GCU" "GCU" "GA-3" "CTG" "-TTA" "TTA" "CGG" "Arizona" "Glendale"
    "resultsindicate" "Aladdin" "HL7702" "Krüppel" "POZ" "clinicians" "ARHGAP"
    "≥300" "1.38–2.90" "=0.0003" "HR=2.00" "1.02–1.67" "HR=1.30" "GAC"
    "_36delinsCA" "CIMP" "LINE-1" "=93" "=0.014" "N=8" "≥30" "N=5" "=0.0007"
    "=0.037" "P =0.0001" "ilimaquinon"
    "mutated primitive mesodermal/mesenchymal stem cells (ARMS)" "SCID/beige"
    "toto" "activation/phosphorylation" "chemoattractants/growth factors"
    "chemoattractants" "DMR" "DMRs" "VSELs" "insulin-like growth factor-2"
    "immunodeficient SCID/beige" "ERMS" "non-dividing"
    "phosphorylated/activated" "catabolizes" "Pre-miR-23a" "KJ" "27a"
    "19p13.12" "Pre-miR-" "European (CEU)" "YRI" "comorbidities" "confounders"
    "≤7%" "ISI" "0.96–1.42" "UKPDS" "A1C" "GoDARTS" "Tayside" "rs11212617"
    "kg/m 2" "= 0.13" "96–1" "Polyphen2"
    "These heterozygous STAT3 mutations---R382W" "mutations---R382W" "V463del"
    "CD19+CD27+" "pneumatocyst" "DRESS" "Quincke" "sulfamethoxazole" "13/60"
    "adriamycine" "non-Hodgkin" "arachnoid" "fossa" "syringomyelia" "occulta"
    "bifida" "spina" "varus" "recurvatum" "varum" "valgum" "genu" "30/60"
    "retrognathism" "prognathism" "51/60" "Dysmorphia" "wk" "caspofungin"
    "voriconazole" "Cotrimoxazole" "cephalosporin" "cotrimoxazole" "Guerin"
    "Calmette" "spondylodiscitis" "osteomyelitis" "osteitis" "6/60"
    "external otitis" "otorrhea" "otitis" "44/60" "54/60" "ENT" "pneumatoceles"
    "lobectomy" "atleast" "pneumomediastinum" "sequelae" "jirovecii"
    "enterobacteria" "maltophilia" "Stenotrophomonas" "aeruginosa"
    "episodes/patient" "23/60" "scabiei" "Sarcoptes" "contagiosum" "molluscum"
    "a cutaneous Staph" "vulvitis" "Juliusberg" "rubrum" "Trichophyton"
    "glossitis" "42/60" "paronychia" "pyodermatitis" "subsequent Staph"
    "eczematiform" "lt" "years/patient" "allohemagglutinins" "pneumococcus"
    "IU/mL" "transitional CD19+IgM+CD38+B cells"
    "persistent global lymphopenia" "Hypereosinophilia" "Vdel463" "Pakistan"
    "Algeria" "France" "Lebanon" "lambdas" "Buckley" "Davis" "Hyper"
    "osteopenia" "pneumatocele" "Staph" "albicans" "aureus" "hypereosinophilia"
    "32/60" "n = 2" "n = 5" "25/82" "n = 4" "= 14" "n = 8" "= 6" "polyPhen2"
    "miR-17+miR-22" "106b" "miR-20a" "‘o'" "let-7i/7g" "miRanda" "miR-26a"
    "let-7i" "⩾1.5-fold" "Lafayette" "Thermo" "MKK1/2" "miR-17∼92" "∼60%"
    "∼75%" "co-regulated" "PyMT/ p21KO" "PyMT/P21KO" "PyMT/p21KO"
    "microneedles" "podia" "lamello" "transfectants" "TGFb" "p21KO" "PyMT"
    "stem cell-like" "~10-fold" "N = 5" "approximately 10 6 EGFR/cell"
    "EGFR/cell" "p21WAF1" "pCAGA" "the gastric epithelium" "Epidermoid"
    "Phospholipase Cγ" "=5" "7/35" "7/28" "2/10" "co-crystal" "ER2" "pIGF-1R"
    "sublines" "HCC827 ER1" "HCC827ER1" "pRelA" "pMET" "pEGFR" "8/15" "10/15"
    "8/17" "≥ 1" "15/17" "5/17" "≥1" "#13" "14/15" "25 mg/kg" "SIRT"
    "rs7109266" "rs1430583" "rs6818140" "rs12363280" "Columbia" "cIMT" "NOMAS"
    "SIRTs" "Sirtuins" "P = 0.006" "immunosurveillance" "HIV/PML"
    "co-operatively" "co-operative" "transfected/infected"
    "An optimal peptide MAGPHPVIVITGPHEE" "VIVIT" "MAGPHPVIVITGPHEE"
    "QuantityOne" "DpnI" "mt" "tk" "NFATS"
    "the circular polyomavirus DNA genome" "NCCR" "HIV-1/AIDS" "Concha"
    "Berger" "progressive multifocal leukoencephalopathy (PML)"
    "disease progressive multifocal leukoencephalopathy (PML)"
    "leukoencephalopathy" "6 hrs" "non-lymphoid" "Ub-like" "GLMN-RBX1-CUL1"
    "GLMN-RBX1-" "TROSY" "subsitutions" "Biacore"
    "competitive inhibition/relief" "conformers" "Kratky" "~NEDD8" "Kds"
    "rigidifies" "form superhelical solenoid" "solenoid" "untingtin-"
    "untingtin" "subdomains" "4HB" "glomus" "GVM"
    "the Gram-negative pathogenic bacterial effector Cif" "Cif" "autoinhibits"
    "WHB" "subdomain" "SRs" "E2~Ub" "HEAT-like" "C-terminally" "Mdm30"
    "Weissman" "Tsai" "E3Histone" "JNK2α2" "constitutively active JNK2α2"
    "*PXR/K" "NASPLK" "Mfn2HA" "dynamin-like" "Undergoes"
    "peroxisome proliferator-activated receptor γcoactivator-1β"
    "γcoactivator-1β" "interwoven" "mitofusins" "heptad" "/K" "-1β"
    "non-progression" "non-controllers" "anti-retroviral" "non-controller"
    "viremia" "Parkinson's" "Alzheimer's" "BTG-1" "HAART" "SN50" "K122/123"
    "122/123" "Kiernan" "pNLENG1" "nkLTR" "wtLTR" "cytopathology" "LTR"
    "cyclodextrins" "nuclear/cytoplasmic" "non-fat" "100U/ml" "p38 MAPK" "JHK"
    "HJ" "Dulbecco’s" "β-D-1-thiogalactopyranoside" "Isopropyl" "Dulbecco"
    "DMEM" "Lipopolysaccharide" "exudate" "embryonic fibroblast-1" "glucan"
    "ACM" "CMFDA" "cocultures" "nmol/l" "Ponceau" "secretome"
    "olfactory ensheathing glia" "Huntington’s" "Huntington" "5 μg/ml" "JYT"
    "UF" "DAH" "JLM" "AKK" "parathyroid hormone-like" "untangle" "rs10995190"
    "covariate" "rs1558902" "rs61280460" "chr22:40779964" "rs4820792"
    "rs10771399" "rs2046210" "rs9397435" "8p12" "·1" "rs62314947" "rs12371778"
    "rs7089814" "rs12173570" "rs4849887" "rs7816345" "Kusano" "rs17625845"
    "=0.035" "HumanHap550" "subvariants" "7q32" "Hoeflich" "pM" "ΔBLISS" "7q31"
    "GTL16S5" "breakpoint" "7q34" "GTL16R3" "GTL16R1" "squamous-like" "MEKi"
    "PF-04880594" "RAFi" "PF-04217903" "T202/Y204" "Φ→A" "fluoracil" "NRTK"
    "grape-like" "invaginations" "∼40%" "g/ ml" "Co-Immunoprecipitation"
    "6-Diamidino-2-Phenylindole" "non-degraded" "D-box" "A2V6/CDK2"
    "Cyclin A2V6" "Th5.5" "A2WT-GFP-transfected cells 5.5 h" "Anti-cyclin A2"
    "the biochemical underpinnings" "underpinnings" "Th10"
    "GTATGTATTACGGTCTTCACACACCTATCTTGTGAC" "A2WT" "A2V6" "/mL" "Exon 1"
    "B-type" "Conclusion/Significance" "Hogdkin’s" "Stenberg" "Hogdkin"
    "chemoresistant" "detergent- like" "magainin"
    "homologous membrane-active helices" "this latter helix" "Bax-like"
    "their homologous helices" "porate" "iBMK" "cellulo"
    "Bfl-1 or Bax membrane-active helices" "the membrane active helices"
    "the homologous helices" "Homologous Membrane-active Helices" "Helices"
    "the latter helix" "individual membrane-active helices" "Bax-α9"
    "homologous helices" "-calpain-mediated" "α9" "PFD+FE" "GFP-Bax-" "FE" "α4"
    "undergoes µ" "Bfl-1SD" "Bfl-1DD" "Edman" "CaMPDB" "sites/products"
    "bacteriocins" "α6" "α5" "BH1-3" "Anti-apoptotic" "Richard" "Zeke"
    "deformations" "osteclasts" "osf" "Intersectins" "stengths" "Mammen"
    "Sam68-SH3" "Sam68-SH3-interactions" "meric" "formally separable PxxPs"
    "PxxPs" "fluorophors" "affinites" "ΔP0" "OSF-SH3" "Sam68ΔP0345" "ΔPxxP"
    "ΔPxxP-constructs" "YFP-SH3s" "ΔP0345" "pxPppPxp" "xx" "woven"
    "CFP-YFP-fusion-protein" "GST-Nck1#2-SH3" "GST-pull-down-assays" "Nck1#1"
    "Nck1#2" "Scatchard" "SH3-domain-PxxP-interaction" "Lawe" "cfu/ml" "titers"
    "the near-complete human SH3 proteome" "Kärkkäinen" "Kd"
    "a left-handed poly-proline type II helix" "phosphotyrosines" "-SH3s"
    "Fyn-SH3" "Spi6" "15-week-old" "Cath" "re-expansion" "Naïve" "Serpina3f"
    "IHL" "15-weeks-old" "PBL" "re-infection" "ine" "subsequent re-encounter"
    "subsequent re-infections" "8 p" "= 0.03" "P = 0.02" "P = 0.0008" "μg / ml"
    "Shimida" "oocytes" "Sagata" "Katsuragi" "Hsu" "Carboxyl" "Kemp"
    "damage/replication" "to 2 mM" "Stillman" "Mendez" "Shimada" "Smits"
    "Chk1 following" "5 μg/ml" "bulky adducts" "Sausville" "mediator/adaptor"
    "9-1–1" "ischemic hindlimb" "postsurgery" "YxxW" "shiga-like"
    "de-ubiquinating" "ubibiquitin" "aa 338–380" "aa 289–338" "aa355-380"
    "L319/320A" "Δ289-338" "aa266-289" "the endocytic marker GFP-FYVE-1"
    "GFP-FYVE-1" "Δ355-380" "Δ338-355" "deletions/mutations" "SKEE" "BAEC"
    "hindlimb" "Tschopp’s" "Tschopp" "Schutze’s" "Schutze"
    "TNFR-associated factor-2" "di-leucine" "re-expressing" "S6G"
    "variants/isoforms" "KXTQTX" "BimT116E" "BimT" "HBSS" "BimEE" "Bec126" "xL"
    "multidomain" "subclasses" "1 × 10" "co-overexpression" "S1C" "TK1-like"
    "Thd" "Superose" "Menten" "Michaelis" "TEV" "dithioerythritol (DTE)" "DTE"
    "dithioerythritol" "DiaSorin" "Prolifigen" "diphosphate" "BMS-536924" "BMS"
    "Bam" "5677insA" "5382insC" "IGF-1-1kb-Luc" "IGF-1-EREL-Luc" "AGTCAG"
    "GGTCAnnnTGACC" "ERE-like" "control-siRNA-treated" "ERE" "EREs" "EREL"
    "μ g/ml" "100 U/ml" "non-Jewish" "non-genomic" "11 p" "-siRNA-treated"
    "almost entirely occupied 48 h" "CD44v6" "oligodeoxynucleotide" "Tcf/Lef"
    "casein kinase 1α" "7±" "Material/Methods" "andp53" "inSHP" "andSHP"
    "SHPWT" "SHPK170N" "SHPK170R" "SHPG171A" "Co-immunoprecipitation"
    "HCT116p53 +/+" "Giovanni" "immunotherapies" "further tumor histotypes"
    "HER-2 +" "HER-2+" "sheetlike" "leptomeninges" "subarachnoid" "cerebrum"
    "musculo" "intracarotid" "intracardiac" "abdominal viscera" "viscera"
    "recurrencies" "Multiorgan" "anti-Human" "TCGA-" "TCGA" "coaberrations"
    "=0.001" "P=0.06" "P=0.15" "=0.06" "P=0.019" "normal/low" "P=0.006"
    "=0.008" "=0.80" "co-amplifications" "race/ethnicity" "co-opted"
    "Phospholipase C γ" "=0.15" "Five-year" "=0.019" "PAZ10" "B-Boxes" "PTGS"
    "de-repressed" "oligoucleotides" "catalytically active miRISC" "ΔC276"
    "ΔN570" "Rybak" "eluate" "miR-302a" "snoRNA142" "Dox" "anti-let-7a"
    "let-7g" "embryoid" "NHL-2" "mir" "B-boxes" "uridylyl" "d" "miRISC"
    "Cip/Kip" "~60%" "ΔN" "urea" "R177A/R178A" "pY397" "E9.5"
    "EC-associated FAK pY576" "pY576" "knockin" "Knockin" "complex–1"
    "allantois" "α4β1" "E9.0" "Anti–human" "anti–human" "∼90%" "p38 MAPKs"
    "S2 B" "a previously published dataset" "BADJ" "Clara" "stem/progenitor"
    "cytological pleomorphism" "alveoli" "necroscopy" "B6/129SVJ"
    "bronchioalveolar stem/progenitor" "partite" "thymocyes" "Wt" "Fu"
    "anti-CD3+anti-CD4" "KRRPR" "motifs/domains" "memory-like" "lymphopenia"
    "Themis2 tg" "Themis1 tg" "lo" "tg" "promoter/enhancer" "RxPxxP" "PxxPxK"
    "BCO13712" "CABIT" "mportant" "olecule" "Themis1" "co-localize" "JW" "YZ"
    "difluoride" "polyvinylidene" "Choi" "Mierke" "the Burkitt’s"
    "erythroleukaemia" "siRNA-2" "tissure" "immuneprecipitates" "Petra"
    "Siglec" "Sagiv" "1.0 × 10" "μg/ml " "10 % FBS" "= 4" "95 % CI" "= 2"
    "= 0.020" "=14" "CO-IP" "YM" "HDAC1 siRNA not only increases Ac-K382-p53"
    "xPxxP" "imageJ" "activation/stabilization" "Ac-K382-p53/total"
    "acetylation/stabilization" "Ac-K382-p53" "ubiquinate" "non-coordinate"
    "glycochenodeoxycholate" "non-p300" "SPRR" "mean ± SD" "DO1"
    "Co-transfection" "co-activators" "suppresser" "ofAtm"
    "DNA replication-associated DSBs" "fromAtm" "non-selected" "Vβ"
    "essential non-redundant" "andAtm" "thatAtm" "phaseAtm"
    "heterologous chromatids" "protectAtm" "inAtm" "toAtm" "non-clonal" "UR"
    "un" "CEs" "CJs" "CE" "CJ" "pMX" "TCRα" "~2-fold" "F/+" "andH2ax" "+/F"
    "theAtm" "spontaneous replication-associated DSBs" "TCRδ" "TCRγ"
    "complexes around DSBs" "T-lineage" "Non-redundant" "F/F" "dyslipidemia"
    "7 ±" "dHWP" "HWP" "hyperleptinemia" "36 ± 3" "= 0.016" "p = 0.006"
    "= 0.01" "direct and indirect replication-associated DSBs"
    "replication-associated DSBs" "finally all unrejoined DSBs" "andand"
    "indirect DSBs" "FO2-385 " "CJ179" "pGC" "FO2-385" "Artemis" "Artemi"
    "foci/nucleus" "Cenp" "radiation-induced phosphoglycolates"
    "phosphoglycolates" "exo-" "exo" "radioresistant" "radiation-induced DSBs"
    "co-exist" "∼80%" "/nucleus" "G1/G0" "WJ" "Mu" "ESEs" "AACC" "AACAUC"
    "CAACAA" "CGC" "GU" "GUC" "UGGC" "AGU" "ΔRS" "B/A" "basic/acidic"
    "GST-U2AF65" "CATCTG" "pdsx" "minigenes" "shLuc" "mut2 + 3" "+3" "mut3-"
    "mut4" "an intronic splicing enhancer" "mut1-1" "mut2-1" "minigene"
    "a novel exonic splicing enhancer (ESE)" "enhancer (ESE)" "ESE" "UCUG" "UG"
    "CAU" "AUCUG" "CAUCUG" "a previously characterized enhancer" "ASLV"
    "doublesex" "mut3" "mut2" "mut1" "#27" "multimers" "#16" "U/C" "C/A-rich"
    "MEME" "dsx" "the Auboeuf's" "Auboeuf" "ACAAC" "A-rich" "CUGC" "domain-1"
    "polypyrimidine" "SELEX" "CACC" "CAUC" "7C" "B/" "A/P" "5 × 10"
    "non-related" "Co-IP" "Δ  Ct" "co-transcriptional" "pSTAT5b" "Iida" "*6"
    "ΔEGFR-expressing" "EGFR/ΔEGFR" "co-associated" "STAT5a/b" "ΔEGFR/EGFR+EGF"
    "EGFR+EGF" "ΔEGFR-GFP" "ΔEGFR-ki" "ΔEGFR-NLS-GFP" "pSTAT5" "Y694/9"
    "ΔEGFR’s" "ΔEGFR" "= 0.018" "Michael" "HR = 1.43" "rs13306465" "1.21–3.90"
    "95%CI:0.69–1.09" "=0.86" "HR=1.86" "1.28–2.70" "HR = 1.86" "1.39–3.52"
    "1.06–1.92" "p = 0.0008" "rs1801278" "RCA1/2 (CIMBA)" "odifiers"
    "nvestigators" "onsortium" "rs1330645" "rs1801123" "Rs1801278" "CIMBA"
    "= 0.009" "= 0.0008" "non-significant" "=0.0008"
    "cerebellar tonsillar ectopia" "Chiari" "ectopia"
    "these severe PIK3CA cancer mutation hotspots" "162-001P" "Alignment/Map"
    "IGV" "LR09-006" "LR00-016a1" "LR08-018"
    "a mild connective tissue dysplasia" "≥ 5" "= 3.3" "= 0.002" "HME-1855"
    "non-HME" "HME-1565" "operculum" "HME-1563" "HME-1573"
    "the recently developed JointSNVMix computational algorithm" "JointSNVMix"
    "CNVs" "neuronal heterotopia" "heterotopia" "Ito" "hemianopsia"
    "hemispherectomy" "co-occurrence"
    "The AKT2 mutation causes severe insulin-independent hypoglycemia" "2-4X"
    "ClinSeq" "exomes" "NHLBI" "USHBP1" "KTS" "Trenaunay" "Klippel"
    "cerebriform" "hypoglycemia" "lipoatrophy" "DXA" "kg" "‘fibroadipose’"
    "fibroadipose" "≥ 30" "1000 genomes" "Birukov" "HPAEC" "Pulldown" "LD-3,4"
    "-glycero-3-phosphocholine" "OxPAPC" "LD-1,2" "non-stimulated"
    "Non-transfected" "PP1R" "PP1cβ" "PP1cα" "PPP1R12A/PP1cδ" "HMS" "pT308"
    "pS473" "soleus" "longus" "digitorum" "pS/pT" "PP1cδ"
    "phosphatidylinositide" "protein phosphatase 2A" "·5" "·6" "*3"
    "histologies" "SRMs" "xanthoastrocytomas" "p=0.012" "~90%" "26/29" "CLIA"
    "BWH" "hematuria" "a percutaneous biopsy" "nephrectomy" "non-MA" "QIAGEN"
    "Pyro" "non-mutant" "associated SRPKs" "GRβ" "14-3-3β" "co-chaperone"
    "326D587D" "326A587A" "non-ATP" "RXRXXS/T" "HDRSRT" "Smirnov" "Kolmogorov"
    "RASL" "seq" "Clk/Sty" "exonic splicing enhancers" "SRPKs" "SR" "≥ 2"
    "progestins" "the levonorgestrel intrauterine system IUS" "IUS" "Progestin"
    "English" "0.02–1.0" "persisted/progressed" "norethindrone" "=41" "=73"
    "EH" "persistence/ progression" "PRB" "persistence/progression" "progestin"
    "mg/day" "n=4" "WAK" "HAH" "226.1/100,000" "ER+/HER2+" "Salhia" "Gharbiah"
    "40.5/100,000" "53.9/100,000" "ER+/PR+/HER2-" "HER2-" "ER+/PR+" "Atlanta"
    "Lund" "ER + " "Egyptians" "ER+/PR-" "ethnic/residence" "non-residents"
    "Germyan" "Dohuk" "Erbil" "Governate" "Hewa" "Southern Iraq" "Arab"
    "Jordan" "Arabia" "Saudi" "PR-" "Iraq" "antracyclines" "anthracyclin"
    "ER+/PR + " "Carolinas" "Surveilance" "ER+/HER2-" "Arabs" "6.3/100,000"
    "Kurds" "SEER" "Egypt" "Governates" "Sulaimaniyah" "Kurdish" "HER2 +"
    "= 0.12" "≤ 2" "HER2+" "PR+" "≥ 60 " "WZ" "YW" "ZY" "Wacholder" "BADGE"
    "enhancer-like" "= 0.0004" "Haplotypes" "=0.005" "IVS" "rs2234693"
    "rs2077647" "ESRa1" "multiplegenes" "This sexual dimorphism" "INR "
    "hapotype" "The sexual dimorphism" "dimorphism" "= 0.022" "= 8" "= 1" "= 8"
    "Aβ" "Alzheimer’s" "‘MCAO’" "=8" "TTC" "tetrazolium" "triphenyl" "MCAO"
    "Lp53" "anti-oxidation" "HCT116 p53+/+" "massive intracellular vacuoles"
    "TMRM" "immunogold" "wtp53" "rapidly release CytoC" "CytoC"
    "other vascular catastrophies" "catastrophies" "the rigid OMM" "H+" "ΔΨm"
    "OMM" "A-pretreatment" "2h" "re-sensitizes" "ischemia/reperfusion"
    "asymmetries" "Schmitz" "pS126-cyclin" "pS126" "pS126-staining" "Jackman"
    "JBC" "Borgne" "B1-FRB-YFP" "cyclin B1-5SA" "Lyn-FKBP2-mCherry" "Fucci"
    "NLS-FKBP2-mCherry" "binucleate" "Komatsu" "Cdk1WT" "Cdk1AF" "multisite"
    "Gavet" "-35" "DNA/" "IRM" "FA/cell" "Rayleigh" "chemoattractant"
    "Rac-driven lamellipodium extension/stability" "extension/stability" "β3"
    "geranylgeranyl" "Feret" "Anosmia" "anosmia" "choanae" "tresia" "eart"
    "heterozygotes" "#5" "_926delCTT" "del309F" "Proband" ".91+2T" "Q51X"
    "IU/L" "micropenis" "anosmia/hyposmia" "nHH" "Kallmann" "∼30%" "#4"
    "P  = 0.006" "/G 1" "H1993" "miRNA:target" "basepair" "GUAGGAA" "UAUAGGA"
    "17.81±5.31%" "HBECs" "14q32.2" "brevifolia" "Taxus" "miR-337-3p" "= 0.035"
    "= 0.013" "≥2" "pSTAT3" "Korean" "non-EBV-GCs" "FNA" "Lauren’s"
    "precise molecular subclassifications" "subclassifications" "OncoMap"
    "DFCI" "Farber" "Dana" "CCGD" "_v1" "n =  10" "=  1" "n =  2" "n =  4"
    "histotype" "Maniwa" "Fujiwara" "DABSYL" "quencher" "Taqman" "Ct"
    "Spearman’s" "hexanucleotide" "HTERT" "RPP" "basaloid" "TPG" "= 0.022"
    "P = 0.006" "mL/" "non-small" "P = 0.0001" "= 0.026" "= 0.092" "HT1080"
    "GABPα" "H3K18" "RefSeq" "H3K18Ac" "Ac" "Sirtuin" "glycosaminglycan"
    "podocytopenia" "streptozotocin-induced diabetic nephropathy" "actinin"
    "cyoskeleton" "regulatedRhoA" "RhoAGAP" "Nef /CIHPs" "EV/CIHPs"
    "microphotographs" "Klotman" "nephropathy (HIVAN)" "Nef/CIHPs" "Rif"
    "projectons" "Nef/CIHP" "=1" "6-Diamidino-2-phenylindole" "anti-Nef"
    "Hemminki" "oncolytic virotherapy" "LW6" "E1B" "immunocytochemistry"
    "coxsackie" "Oncolytic virotherapy" "virotherapy"
    "hypoxia-inducible factor-1α" "6-week" "an obvious ortholog" "A1/Bfl-1"
    "anti-human" "FcγRI" "andbcl-" "andbcl" "IgECL" "regranulate" "FcεRI" "Fcγ"
    "ECV-MVB-like" "Ultrastructure" "ECV/MVBs" "late endosomes/lysosomes"
    "AlexaFluor488" "ECV" "vacuole" "B-subunit" "Shiga" "Grd19p" "WASP"
    "retromer" "3-phosphorylated inositides" "inositides" "solutes" "Helix"
    "George" "descriptors" "RMSD" "IDs" "deviationRMSD" "avg" "coefficientR"
    "‘EX’" "EX" "zeolites" "EEM" "Gavathiotis" "SAHB" "de-repress" "allostery"
    "C-domain" "= 1" "de-repression" "drug-like"
    "the bacterial pathogen Listeria monocytogenes" "ZO" "occludens"
    "a more friable monolayer" "epitheliums" "E3-like"
    "IFNγ+Fyn siRNA-treated epithelia" "Hakai siRNA-treated T84 epithelia"
    "Fyn siRNA-treated epithelia" "monocytogenes" "4G10" "RIPA" "Lysis"
    "IFNγ-treated plastic-grown T84 cell monolayers"
    "the intestinal epithelial monolayer" "a more fragile T84 cell monolayer"
    "kook" "p65+/+" "p65−/−" "GSTp65" "supershift" "qRT" "kd" "PKAc" "–265"
    "non-phosphorylatable" "Antony" "prionoid" "heterotetramers"
    "co-aggregation" "anti-oligomer" "Elston" "Biopsies" "Amyloid-like"
    "circular dichroism (CD)" "dichroism" "soluble p53C" "molten" "Congo"
    "Parkinson" "Alzheimer" "paralogs" "prion-like" "amyloid-like" "p53C"
    "FTIR" "thioflavin" "amyloids" "= 1" "LIVE/DEAD" "co-authors"
    "appropriateness" "BV" "LQ" "/β" "·5 " "clonogens" "PTV" "/fraction" "TCP"
    "eq" "α/β" "radiobiology" "α/β " "histotypes" "= 10" "unmet"
    "exact two-sided P -value" "StatXact" "=39/48" "Cobas" "Workflow"
    "bidirectional Sanger" "Hilden" "workflow" "‘therascreen'" "therascreen"
    "Qiagen" "cobas" "non-responsive" "P -value"
    "targeting hypoxia-associated radioresistance" "radiosensitiser" "Hammond"
    "Pires" "⩽0.02% O" "severe hypoxia/anoxia" "growth/viability"
    "radiosensitises" "chemo/radioresistance" "Seckel" "phosphoinositol" "2 h"
    "1 h" "P -values" "=3" "rad3" "Rad 3" "TAW" "JHS" "JMD" "JAP" "TDL" "TBS"
    "Ammons" "Sisson" "myristate" "visal" "NHTi" "lysis" "immotile"
    "heat-inactivated NTHi" "heat-inactivated NTHi supernatants" "broth/50% "
    "Hz" "BBECs" "BBEC" "Supernatants" "the detrimental effect NTHi"
    "Non-typeable" "fresh NTHi culture supernatant" "NTHi" "48 hrs" "3 × 10"
    "DW" "follicles" "oropharynx" "Tokumaru" "Santopietro" "alia" "≥ 10%"
    "= 0.013" "= 0.023" "= 0.035" "= 0.008" "G 1 /S" "= 0.002" "KVSR" "UU"
    "goes" "ELISPOT" "Betweenness" "Calcineurine" "STKE" "TIL4ABS" "Overview"
    "$HTF" "_C" "_01" "TFBS" "TRANSFAC" "day 3" "doublings"
    "reinforcement/commitment" "An unbiased global transcriptome" "CD45RA +"
    "100 U/ml" "+1" "autocrine/paracrine" "24 h" "efficacy/sensitivity" "∼20%"
    "aggressive/metastatic" "squamous epithelium" "drawn" "activity/functions"
    "Very few HMVECs" "the β-TRCP1" "shβ -TRCP" "β-TRCP1/2" "shβ-TRCP" "somite"
    "trunk/tail" "fli1a:EGFP" "Fbxw11b" "Fbxw11a" "paralogues" "morpholino"
    "the β-TRCP–depleted HMVECs" "β-TRCP1+2" "shGFP-treated HMVECs"
    "β-TRCP–depleted HMVECs" "shGFP" "ScanSite" "degrons" "DDTD"
    "phosphodegrons" "CKIδ" "degron" "TRCP" "β-TRCP2" "β-TRCP1" "phosphodegron"
    "XX" "HMVECs" "PEST" "carboxyl" "and 3+" "H&E" "CLL4" "Sharman" "Flinn"
    "IWCLL" "lymphadenopathy" "Furman" "Hematology" "Davids" "Hoellenrigel"
    "Fiorcari" "IGVH" "GS" "Calistoga" "IGHV" "PDK" "phosphoinositides" "8/8"
    "non-redundant" "Δ46–110" "dupGlu37" "Costello" "intradomain" "A72V"
    "Phosphopeptide" "Boltzmann" "_186delTACinsGAG" "BTAM" "phosphotyrosyl-"
    "facial dysmorphism" "dysmorphism" "disease-causing weak hypermorphs" "= 2"
    "∼10%" "1 ps" "Thr 202 /Tyr 204" "CU" "ΔRNP2-deletion" "ΔRNP1-" "ΔRNP2"
    "ΔRNP1" "submotifs" "REMSA" "isotype" "lane1" "lane 1" "RNPC1b" "RNPC1a"
    "ribosomal stress-induced p53 activation" "minute-2" "U-rich" "5 × 10"
    "ESCRTs" "T/N" "Oligo" "anti-phospho-EGFR antibody" "ntigen" "ene"
    "hain (CHC)" "UBP69" "CHC" "hain" "eavy" "lathrin" "pidermal g rowth"
    "rowth" "ub" "ransport" "omplexes" "microdomains" "inases" "yrosine"
    "USP2a" "50 ng/ml" "Unc5h" "hypertrophic CGNPs" "SmoA1" "Bcl-2+" "4/4"
    "medulloblatomas" "hypertrophic Bax −/− CGNPs" "hypertrophic CNGPs" "CNGPs"
    "PCNA+" "NeuN+" "phosphohistone" "ND2:SmoA1" "the first cerebellar folium"
    "folium" "divided CGNPs" "EdU+" "SmoA" "Purkinje" "CGNP" "CGNPs"
    "the postnatal cerebellum" "de-identified" "=0.006" "7/16" "Melke" "SIM"
    "R-Smad/Co-Smad" "SXSS" "RECl" "RECI" "phosphorylation/dephosphorylaton"
    "EE" "Klipp" "Vilar's" "Vilar" "Wrana" "switchlike" "switch-like" "Clarke"
    "Zi" "transducers" "Hrs" "SSXS" "proprotein" "/Growth" "Smad2/3" "Burkitt"
    "significance/in situ" "MCL-like" "CLL/ SLL" "CLL/SLL" "CLL/"
    "Staining/ImmunoFISH" "ImmunoFISH" "usual SIg" "brighter" "UPMC" "SIg"
    "had identifiable paraimmunoblasts" "paraimmunoblasts" "immunoFISH"
    "adenopathy" "SOX11−" "SOX" "cyclin D1+" "Bioview"
    "57 extramedullary CLL/SLL biopsies"
    "chronic lymphocytic leukemia/small lymphocytic lymphoma" "Stacey"
    "the southeastern USA" "neuro" "neurosurgery" "rs78378222" "p=0.0001"
    "BDCA2/ FcεR1γ" "CD2AP/SHIP1" "CD2AP/" "lenti" "P-rich" "constitu"
    "coimmunopreci" "preosteoclast" "-bisphosphate" "lyzes" "dehy" "keto"
    "pg/ml" "pg/" "FcgRIIa" "realtime" "BDCA2/ Fcε R1γ" "CIN85/" "ILT7/FcεR1γ"
    "TLR7/9" "Plasmacytoid" "BDCA2/FcεR1γ" "FcεR1γ" "agonism" "mortem"
    "HND+LCAf" "Fc" "HND+LCAx" "nearly thirtyfold" "thirtyfold" "TCT" "Ab-Fn3-"
    "timecourse" "phosphosites" "HND+LCA" "mg/mL" "topologies"
    "Bispecific nanobodies" "nanobodies" "2 h" "Leung" "non-ubiquitinated"
    "ubiqitin" "laser-activated DSBs" "TheFAAP20" "siRNF" "non-replicating"
    "eChIP" "eta" "Zn" "subcomplex" "rotein" "nemia-" "nemia" "anconi"
    "LOC199990" "BRAFT" "MHF" "rewound" "CIdU-" "CIdU" "chlorodeoxyuridine"
    "iododeoxyuridine" "ABM" "MBM" "AH2N" "dHPL" "dC80" "~3%" "dPIPB" "-x-x-"
    "Q-x-x-" "F/Y" "HARP-like" "Yusufzai"
    "Schimke immunoosseous dysplasia (SIOD)" "Schimke" "HepA" "nucleases" "#6"
    "K19/K49R-" "K19/K49R" "*LN+" "LN+" "mammoplasties (RM)" "Rad6BshRNA"
    "nontarget" "WS-15" "+2" "imidazole" "ef" "mammoplasty" "cytoplasm/nuclei"
    "mammoplasties" "TOP/Flash" "co-upregulated" "adenomatous polyposis coli"
    "P =0.01" "n=10" "+186" "RecG" "orthologs"
    "the appropriate helicase/translocase" "helicases/translocases" "dsDNA"
    "D-loops" "scDNA" "crossovers" "D-loop" "CldU" "acridine" "ortholog"
    "co-localizing" "Rex" "NZFs" "TY/F" "PIKKs" "APIM" "BLM/TOPOIIIα" "SCEs"
    "crossover" "Holliday" "stalled/collapsed" "SIOD" "anti-FLAG" "metabolise"
    "Co-operate" "BIRB" "NHUC" "STAT3/5/6" "96-1" "J82" "FR1" "PLCγ and" "Ta"
    "non-motile" "metastasise" "5/6" "EMT-like" "miR-99a" "BRCA1/2-" "pre-miR-"
    "pb" "several bioinformatic target prediction algorithms" "miRANDA" "DIANA"
    "pRT" "miRPath" "Diana" "miR-125a/b" "miRPlus" "miR-30c" "Exiqon"
    "co-transfecting" "non-BRCA" "BRCA1/2" "the ciliary proteome" "NPHPs"
    "re-absorption" "sensory organelles" "phosphoproteome" "interactome"
    "Chlamydomonas" "ciliary gatekeeper" "nephrocystins" "gatekeeper"
    "non-ciliated" "hTERT-RPE1" "hrs" "NPHP1-1-205" "EHTLLD" "co-precipitated"
    "spindlin" "non-mitotic" "centriole" "microtubule-based sensory organelles"
    "NPH" "antenna-like sensory organelles" "re-entry" "24 hrs"
    "non-overlapping" "ng/µ" "re-enter" "doǹt" "tubings" "PMP"
    "hypothermic ECC ex vivo" "PMPs" "Microparticles" "GPIIb/IIIa" "ligand-1"
    "thrombus" "microparticles" "antiplatelet" "MeSAMP" "hypothermia" "n = 4"
    "in vitro/in vivo" "VPA/TMZ" "S-G2/M" "nitrosourea" "Depakine" "2-year"
    "monotherapies" "mg/kg" "light-chain-3" "U138" "β 1" "2 /2" "100 U/mL" "Gy"
    "mGFAP" "Semi" "generally low-grade PNSTs"
    "mice developed low-grade and high-grade PNSTs"
    "brachial and lumbar sacral plexi" "enlarged lumbar sacral plexi" "/Δ Pten"
    "Δ Nf1 /Δ Pten" "brachial plexi" "enlarged brachial plexi" "243-days"
    "included enlarged brachial plexi" "plexi" "Δ Pten" "Δ Nf1 /" "15-days"
    "flox/+" "transgenes" "Transgenes" "andPten" "Dhh" "transposon" "~10%"
    "benign plexiform" "plexiform" "PNST" "Schwann" "co-mutated" "PNSTs" "= 13"
    "P = 0.0001" "P = 0.0006" "deletion/mutation" "Waldman" "non-senescent"
    "Straver" "Carey" "Che" "Lehmann" "ZR" "mitotic arrest 24 hr"
    "underwent aberrant mitoses" "R172H/0" "R172H/+" "orp53"
    "clearly positive SAβGal" "SAβGal" "Pml" "Wnt1p53" "p53  R172H"
    "Thymocytes" "mitoses" "anti-BrdU" "non-functional" "p21 in" "5 p" "#1"
    "3/3" "p53/Rb" "nucleate" "cecome" "fribroblasts" "diploid-like"
    "tetraploid-like" "Hoechst" "tetOFF" "POT" "Rb/p16" "hr" "p53dn"
    "diplochromosomes" "chromatids" "S/G2" "DKO" "FUCCI" "POT1a" "octoploid"
    "GSE-22" "zeocin" "48RS-GSE22" "GSE22" "IMR" "BJ" "endocycles"
    "fibrobloasts" "the tumor suppressor Adenomatous Polyposis Coli (APC)"
    "Coli (APC)" "AuroraA" "Coli" "non-disjunction" "hypertriploid"
    "Aneuploidy" "tetraploid" "subtetraploid" "EULAR" "pentoxide" "vanadium"
    "multiorgan" "adnexae" "expression/activation" "spindle-like" "PDFGR" "SSc"
    "RTX" "mg/m 2" "= 0.013" "P = 0.012" "= 0.004" "the SLE-associated 71Thr"
    "the associated haplotype" "NFκBp50" "the same associated SNPs" "NFkBp65"
    "associated SNPs" "df" "Ala71Thr" "NFκBp65" "qtPCR" "rs2248932"
    "non-associated" "≈0" "rs55758736" "chr8:11443817" "chr8:11444706"
    "chr8:11446229" "rs2255227" "OR=2.48" "=1.57×10" "OR=2.75" "=5.16×10"
    "=1.32" "=1.61×10" "rs998683" "=1.05×10" "rs13277113" "8p23-p22" "71Thr"
    "OR=2.31" "two tightly linked associated haplotype" "GENABEL"
    "1000 Genomes" "8p" "HEK-293A" "plasmon" "liposomes" "liposome" "VAC14"
    "PI5K" "GFP-2xFYVE" "2xFYVE" "polyphosphoinositides" "PI3K-C2α" "1H"
    "a mature epithelium" "co-culture" "GDS3099" "Dataset" "o" "g" "Monolayers"
    "Monolayer" "Barrientes" "shRb" "#2" "IL1A/B" "HOFs" "HFKs" "HFF"
    "non-autonomous" "non-cell" "HFFs" "Szabowski" "Maas"
    "organotypic co-cultures" "JJI" "WF" "JX" "PR + " "Hochberg" "diploid"
    "aneuploid" "Re-expression" "≤ 2 " "=  0.012" "= 0.05" "= 0.016" "= 0.019"
    "= 0.012" "Decock" "centromeres" "SARAH" "4q13.3"
    "The shorter isoform RASSF5C" "RASSF5B" "6/9" "cg02589695" "cg17558126"
    "RASSF5C" "RASSF5A" "SK-N-DZ" "RASSF2A" "COBRA" "IIumina" "RASS" "11q"
    "the adrenal medulla" "medulla" "INRG" "non-enzymatic" "11p15"
    "re-expressed" "7.9×10" "a genome-wide significant SNP" "arisen" "1.0×10"
    "homozygotes" "rs12185268" "5×10" "1.06–1.55" "8.9×10" "superset" "1.4×10"
    "23andMe" "rs10502861" "18q21.1" "1.00×10" "AUTS2" "1.71×10" "7p21.1"
    "seven other genome-wide significant SNPs" "2q37"
    "the genome-wide significant SNPs"
    "the synonymous (His649His) SNP rs12373124" "rs12373124" "intramembrane"
    "20p11" "QQ" "gc  " "CEU" "Nijmegen" "TwinsUK" "CoLaus" "Bonn" "MAAN" "GWA"
    "≥0.4" "= 1.00" "= 0.99" "95%CI " "95% CI " "20p" "17q21" "= 2"
    "transfectant" "STAT3CA" "EGFRdNLS" "ErbBs" "epidermoid" "co-regulation"
    "48 hrs" "int" "alpha-helical" "ΔGTPase" "TCF/lef" "pixel" "6hrs"
    "westernblot" "48hrs" "normal colonic mucosa" "the colonic mucosa"
    "β-catenin/ T cell" "Int" "hetero" "an innate anti-bacterial"
    "Non-specific" "co-staining" "non-silencing" "=4" "co-incident"
    "the cervical epithelium" "Codon" "the anogenital tract epithelium" "RFLPs"
    "wih" "20/78" "the heterozygous P-value" "P-values" "heterozygote"
    "Genotype" "29/78" "34/78" "15/78" "19/78" "Histopathology" "Sudan"
    "genes/polymorphisms" "Sudanese" "=0.01" "=0.02" "=0.012" "UCSC" "CNV"
    "southern Brazil" "Italians" "Walsh" "proband" "Eeles" "_65577del36381"
    "Li-Fraumeni-like" "Jeghers" "Peutz" "Cowden" "Breakpoints" "LFS/LFL" "LFL"
    "Fraumeni" "Deniaud" "trimethoxybenzoate" "diethylamino"
    "lipopolysaccharide-" "receptors-1" "cytoplasma" "reestablishes"
    "lipopolysaccharide" "μ g/mL" "glycogen synthase kinase-3 β"
    "acetylcholine" "Shibuya" "fluorescent micropheres" "micropheres" "VVOs"
    "treatedtsad" "primarytsad" "nottsad" "adherens" "pY527" "lambda" "HDMECs"
    "pY418" "NanoPro" "venules" "fluorophore" "thetsad" "andtsad"
    "an intradermal bolus" "bolus" "analyzedtsad" "pY290" "pY305" "c-Src-SH2"
    "pY1214" "pY1175" "pY1059" "pY1054" "pY951" "consequent edema" "oftsad"
    "Younger" "Gjerstad" "Sundvold" "Shb" "phospholipase Cγ" "organelle"
    "vesiculo" "edema" "solute" "microspheres" "Evans" "intsad" "cremaster"
    "Rous" "6P" "∼50%" "overridden" "H9-derived ABCG2+hox"
    "Supporting Information Figure 7c" "7c" "apoptosis/differentiation"
    "FM19G11" "Calbiochem" "ABCG2+ nox" "Stemness" "ABCG2+ hox"
    "hypoxia/reperfusion" "ABCG2+hox-" "HIF-2α/low" "ABCG2+nox" "ABCG2+Hox"
    "ABCG2+hox" "hypoxia/reoxygenation" "hereon" "OHdG" "2b" "ABCG2−" "ABCG"
    "ABCG2+" "eightfold" "SSEA3+" "BGO1" "Hypoxia/Oxidative" "hESC" "GSPx"
    "subsequently trigger p53 activation" "SSEA3+/ABCG2+" "hypoxia/oxidative"
    "hESCs" "= 4" "D–mediated" "kinetics/affinity" "activation/shedding"
    "microvessel" "D–overexpressing" "D–enhanced" "migratory/invasive"
    "D/β-PDGFR" "Hygro" "D/" "D–containing" "B–containing" "mPrE" "mPrECs"
    "mPrEC" "matriptase/PDGF" "glomerulonephritis" "nonmalignant" "1 × 10"
    "Yorkie" "Poernbacher" "RUNX" "Webb" "re-sensitize" "Rotin" "co-IP"
    "YAP/TAZ" "PALS1-" "PALS" "adheren" "Lats1/2" "paralog" "erbB" "PPXY"
    "Anti-HA" "Co-expression" "BBC" "loss/mutation" "pSSH" "serine-3" "phopho"
    "pSSH-1L-S978" "pLIMK" "Slingshot-1L" "S3E" "pCofilin" "pMLC" "NMII"
    "electrical impedance" "microwells" "impedance" "microtentacle" "CTCs"
    "CTC" "dormancy" "PTEN−/−" "McTN" "McTNs" "microtentacles" "1h"
    "non-transfected" "non-tumorigenic" "PAK4i"
    "the competitive ATP inhibitor Imatinib/Gleevec" "Imatinib/Gleevec"
    "myeloiod" "G-loop" "A279T" "emphasises" "GID" "ΔKinase" "LIMKs" "LIMKi"
    "-isobutyramide" "isobutyramide" "PAK4r" "mRFP" "transwell" "μm/minute"
    "tGFP" "anti-metastatic" "re-assessed" "AD" "Soesanto"
    "phosphorylation/activities" "Thiamet" "shOGT" "RL2" "thiamet"
    "glycogen synthase kinase-3β" "O-linked" "actinomycin"
    "healthy non-smokers" "FEV 1 /FVC" "FEV 1"
    "inhaled short-acting bronchodilators" "bronchodilators" "BALF" "FEV1/FVC"
    "FEV1" "spirometry" "FVC" "xl" "Bcl" "× 10" "μg " "NLSs" "pcDNA"
    "N-EmGFP-DEST" "™6.2" "OMVs" "rectus" "trachomatis" "NUE" "enterica"
    "baumannii" "Hurst" "2q36.2" "8q22 ( YWHAZ )" "4p16.3" "17q12" "12q15"
    "3p25" "16q" "22q" "HC3c" "HC2a/HC3a" "urothelium" "Bild"
    "carried intra-chromosomal breakpoints" "fBAC" "nFGA" "10q" "13q14" "11p"
    "YWHA" "20q11" "1q21" "3p" "1q23" "8q22" "20q12" "FGAs" "11q13" "MRDs"
    "17p" "MRD" "6p" "13q" "5p" "UCs" "9p21" "Veltman" "6p22" "and 2q36" "UC"
    "non-synonymous" "10q23" "Ran-dependent"
    "HPV16 infected external epithelia" "external (cutaneous) epithelia"
    "external epithelia" "mucosal alpha-PVs" "the external vulval epithelium"
    "Whitney" "12/30" "4/5" "1/6" "the viral genome" "lifecycle" "E1∧E4" "∧E4"
    "HPV16 E7" "HPV16E7" "non-lesional" "2/14" "6/8" "11/14"
    "the upper cervical epithelium"
    "normal extragenital cutaneous, cervical and vulval epithelia"
    "non-genital" "cervical dysplasia" "HPV8" "sclerosus (LS)" "sclerosus"
    "dVIN" "uVIN" "alpha-PVs" "Cutaneous mu-" "genuses" "papillomaviridae"
    "verruciformis" "epidermodysplasia" "PVs" "alpha-papillomavirus" "alpha-PV"
    "epitheliotropism" "vSCC" "mu-" "mu" "= 0.003" "6/14" "VRE"
    "approximately 14 h" "H3K14" "A14" "Sendai" "ISGs" "plasmacytoid" "RLHs"
    "H3K9/K14" "TATA" "Mean ± SD" "= 4" "cells/100" "co-repressors"
    "Regensburg" "Mikhail" "B-Cell-Non-Hodgkin-Lymphomas" "SMIs" "IIa"
    "Algorithms" "expectance" "ICD-10" "Clark" "α4-integrin" "Sabet" "Kashani"
    "Rothberg" "coworkers" "Weinlich" "facto" "triage" "TBRII" "BMPII"
    "xenopus" "Polymorphism" "ovarian surface epithelium" "treated/untreated"
    "normal human ovarian surface epithelium" "GTAAA"
    "a single layer squamous epithelium" "ß2" "redone" "# 19" "#3" "wtBRCA1"
    "#19" "Atria" "gonads" "the ovarian surface epithelium (OSE)"
    "epithelium (OSE)" "IOSE" "pCDNA3" "Non-targeting" "rapalogs"
    "lamillapodia" "Hatley" "pri-miR-21" "phosphorylation/inactivation"
    "siPTEN" "chromophobe" "Ran-GTP" "Hifα" "Smad 2/3"
    "phosphorylation/activation" "3 H" "Elliott" "conjunctiva" "Soloff"
    "sulfapyridine" "+46" "Bp65" "Bp" "tissues/cell types" "preterm"
    "myometrium" "κ B" "cIAP1/2" "cIAP" "DLD1" "vacuoles" "RmZm" "lymphotoxin"
    "nonredundant" "NF-κB1" "κB" "1 h" "48 h" "non-small cell lung carcinoma"
    "inp21" "K562/Empty" "K562/p21" "NALM-6/SP-B/Empty" "NALM-6/SP-B/p21"
    "waf1/ cip1" "DOX" "HCT" "exogenous p21 waf1/cip1" "ofp21" "waf1/cip1"
    "NALM-6/SP-B" "non-treated" "pcDNA 3" "&6" "trophoblasts" "C/p" "G/p"
    "MaxEntScan" "SpliceSiteFinder" "GeneSplicer" "_799delTT/p"
    "The rare BRCA2 UV c" "PolyPhen2" "PSIC" "T/p" "A/p" "SSCP" "UVs"
    "breast/ovarian" "Mulholland" "Reid" "Yoshimoto" "endpoint"
    "nonsignificant" "H-score" "triphosphate" "phosphoinosite" "4-μm" "= 0.02"
    "≥10%" "‘microclusters'" "≥5" "/CEN8" "CEN8" "microclusters" "≥15"
    "Mohammadi" "Dickson" "Grose" "≥2.0" "=13" "non-tumor" "≥50%" "NASF"
    "agoinsts" "non-cytotoxic" "Tirumalai" "Kelch" "antioxidant/phase"
    "synthsse (FASN)" "Rosi-" "synthsse"
    "adenosquamous carcinoma cell line HTB-178" "HTB-182" "HTB-178" "Rosi"
    "DeNicola" "overactivated/overexpressed" "stem-like" "mean ± SD"
    "4,5-dimethylthiazol-2-yl" "G 0 /G 1" "Non-adherent" "Non-small-cell"
    "non-adherent" "8p11" "pathobiology" "gavage" "co-activation"
    "co-activated" "quantitative nanoimmunoassays" "nanoimmunoassays"
    "retroviruses"
    "capillary isoelectric focusing electrophoresis nanoimmunoassay (NIA)"
    "nanoimmunoassay (NIA)" "NIA" "nanoimmunoassay" "non-myeloid" "OCI/AML-2"
    "karyotype" "proliferating HEKn" "TargetScan" "CaCl" "HEKn" "UTRs" "24 h"
    "× 10" "non-coding" "TIRF" "FRET/CFP" "-FRB (LDR)" "LDR" "-FRB" "iSH"
    "nanocluster" "CAAX" "nanoclusters"
    "a recently developed technology called InCell SMART-i" "SMART-i" "InCell"
    "LY29" "RhoG" "inappropriate cell death/activation" "3/4" "F122/L123"
    "∼3:1" "DISC oligomeric structure/function" "TRAIL-R1/R2" "FAF" "AFC"
    "IETD" "F122G/L123G" "antiparallel" "topology" "nearly all DEDs" "DED1"
    "MC159" "Phyre" "DEDs" "subcomplexes" "LMW" "Expt " "1:1:1" "NSAF"
    "formation/function" "C–1E" "LC-MS/MS" "Expt" "Strep" "sensors/adaptors"
    "prodeath" "LRs" "dimerization/activation" "DED2" "DED-only" "DED"
    "re-evaluated" "4C" "and 3C" "stress/damage" "Blackfan" "non-FA" "γc"
    "co-transplanted" "re-injected" "mosaïcism" "non-detectable" "FA-like"
    "pancytopenia" "Rican" "gone" "socio" "Spain" "Chilean" "Texas" "Jews"
    "fourths" "Caribbean" "exon1–2" "=2" "6027del4" "BRCAPRO" "exon 1"
    "non-carriers" "Denghai" "Du" "Chae" "non-recurrent" "DiffK" "Kyoto"
    "Genomes" "U133"
    "the widely accepted Barcelona Clinic Liver Cancer (BCLC) algorithm" "BCLC"
    "Barcelona" "annum" "= 0.02" "= 0.076" "= 0.018" "Raf1L613V"
    "organs/tissues" "Dhandapany" "cell/tissue" "myocardium" "hypermorphs"
    "-3β" "Ishida" "craniofacial dysmorphia" "LS/+" "EIIA" "hypermorphism"
    "suppressers" "enhancers" "LOF" "capabilitites" "DORV" "AVSD"
    "facial dysmorphia" "dysmorphia" "sensorineural D eafness" "eafness"
    "genitalia" "bnormalities" "cular" "entigines" "Araki" "Ex"
    "phosphotyrosyl" "homology-2" "CHDs" "Noonan" "LEOPARD" "ssDNA" "otifs"
    "ΔPIP" "ΔUBZ" "cystines" "IRIF" "Rad18-like" "SprT-like" "inc" "omains"
    "biquitin-" "biquitin" "interdomain" "eptides" "CNA-" "CNA" "written" "UBZ"
    "lgorithms" "XZ" "refractoriness" "Hashimoto’s"
    "distant metastasis (including lung, bone and liver) Hashimoto’s"
    "Hashimoto" "Intra" "microcarcinomas" "followup" "H & E-stained" "& E"
    "PHPIb" "ICF" "epigenotypes" "multilocus" "Zac-1" "Some typical AHO"
    "Russel" "inertiae" "SGA" "Broader" "A/B" "32±6%" "23±6" "Z-test" "14±7%"
    "20±10" "DMR1" "hyper-" "29±3%" "36±3" "EpiTYPER" "Prostin"
    "some typical AHO" "ExonA/B" "uniparental disomy" "IGF2 / H19" "IGF2/H19"
    "also known as pleiomorphic adenoma gene-like" "gene-like" "Angelman"
    "Willi" "Prader" "Progressive Osseous Heteroplasia" "subcutis"
    "Heteroplasia" "pseudopseudohypoparathyroidism (PPHP)"
    "pseudopseudohypoparathyroidism" "Hereditary Osteodystrophy" "AHO-like"
    "Gs" "heteroplasia" "Albright's" "Hereditary Osteodystrophy (AHO)" "AHO"
    "Osteodystrophy" "Albright" "Gsalpha" "IC 50" "μg/ml" "4/6" "pcDNA3"
    "pcDNA3-PAX3-HA" "41.89%+/−8.10%" "52.83%+/−11.46%" "pGex2T-PAX3PDHD-WT"
    "ΔSERAS" "pGex" "homeodomain (HD)" "homeodomain" "-S/T" "79.90%+/−8.12%"
    "86.47%+/−6.23%" "siScramble" "SKMEL-23" "SKMEL" "S/T" "-3 α" "rarer"
    "Daikoku" "Tantbirojn" "Hayes" "non-p53" "invariant" "Yemelyanova"
    "Fauceglia" "Mhawech" "FIGO" "34 serous AdCas" "serous endometrial AdCas"
    "papillary AdCa" "serous or clear cell AdCa" "endometria" "papillary AdCas"
    "P-4E-BP1" "serous and clear cell AdCas" "non-tumourous"
    "One small glandular clear cell EIC" "Mozes" "Nofech" "Morrison" "Konecny"
    "several papillary AdCas" "the endometrial epithelium"
    "human endometrial serous AdCa" "concurrent serous AdCa" "Serous EIC"
    "serous AdCa" "Sherman" "Ambros" "Yi"
    "‘pure’ tubulo-cystic clear cell AdCa" "either serous AdCa" "tubulo"
    "Silverberg" "Human serous AdCas" "papillae"
    "both male and female Trp53 Δ/" "deferens" "vas" "ureter" "Δ/"
    "Ksp1.3-Cre/+" "epididymis" "fl/fl" "Jonkers" "Ksp1.3-Cre" "Shao" "Frew"
    "Ksp" "endometrial clear cell AdCas" "Szukala" "Soong" "Kounelis" "Liang"
    "Jarboe" "endometrial glandular dysplasia" "Endometrial serous AdCas" "EIC"
    "EmGD" "endometrial serous AdCa" "Fadare" "AdCa" "Wada" "Abeln"
    "approximately 1–3" "1–3" "serous AdCas" "oestrogen" "Velasco" "Urick"
    "Tashiro" "Salvesen" "Lu" "Konopka" "Cheung" "Catasus" "AdCas"
    "endometrioid" "Ellenson" "Cristofano" "Jemal" "Thr202/Tyr204" "–35"
    "Friedreich’s" "these endosymbiontic organelles" "organelles" "interstrand"
    "ISC-" "RNR3" "methanesulfonate" "S4B" "S4A" "succinate" "mtAco"
    "autoradiography" "-dihydrothymine" "dihydrothymine" "IREs"
    "the disease-relevant residue R112 destroyed Fe/S" "Cia2" "auxotrophy"
    "sulfite" "Fe" "YHR122w" "ISC" "Fe/S"
    "the neurodegenerative disorder Friedreich’s"
    "the neurodegenerative disorder Friedreich" "Friedreich" "co-purified"
    "S2B" "S2A" "MEM" "asboth" "ansamysin" "active immunotherapy" "antigens"
    "ammonium" "ELISAs" "AS15" "dHER2" "EGR" "pits/vesicles" "ºC"
    "immunotherapy" "HER2/neu" "co-internalizes" "1,221/1,222" "co-localizes"
    "Anti-tumor" "3-day" "10-week" "3B" "HER2/3" "tyrosin" "Osteoblasts"
    "prostaglandins" "dihydroxybitamin" "resorb" "phosphoglycoprotein" "1 h"
    "non-essential" "Conclusions/Significance" "Methodology/Principal"
    "Western Europe" "plasma R249S -mutated DNA concentrations ≥150 copies/mL"
    "R249S -mutated DNA plasma concentrations greater"
    "plasma R249S -mutated DNA concentrations greater" "HCC/no" "10/68"
    "Qidong" "Gambia" "CFDNA" "7/26" "ng/kg/day" "adduct" "adducts" "AFB"
    "parasiticus" "flavus" "Songkhla" "Kaen" "Khon" "Lampang" "Mai" "Chiang"
    "ASR" "ASR " "Vietnam" "Laos" "Clornorchis" "viverrini" "Africa" "Saharan"
    "CC" "≥150" "copies/mL" "Thailand" "9/10" "non-cancer" "G→T" "co-existing"
    "co-existence" "a shorter PFS" "shorter PFS" "one-half" "Subtypes" "≥6"
    "an essential signal transducer" "transducer" "Bcl2a1d" "whereasBcl"
    "andBclX" "Lif" "MFI" "Rorγ" "Dscr1l2" "3 h" "TnfRII" "Ctsw" "3h" "Venn"
    "pSmad2" "SXS" "Mekk2,3" "Smarta" "redirect" "Armstrong" "Th17"
    "co-stimulatory" "loxP" "f/f" "CreER" "reg" "3 × 10" "2 +" "1 +" "oncology"
    "re-organization" "re-treatment" "co-emerge" "#0461" "re-growth"
    "neurosphere/well" "#5485" "#5500" "GBM12TMZ+SAHA"
    "subsequent in vivo TMZ re-challenge" "re-challenge" "neurospheres/well"
    "#5920" "non-MGMT" "#3080" "neurospheres" "co-treatment" "H3K27" "H3K9"
    "neurosphere" "absorbance" "GBM22TMZ" "GBM22" "GBM28TMZ" "GBM14TMZ"
    "GBM12TMZ" "GBM28" "GBM14" "Mayo" "O6-MG"
    "O6-methylguanine-DNA-methytransferase (MGMT)" "re-expression" "GBM12"
    "H3K9-ac" "di-methylation" "ac" "20 mg/kg" "prechemotherapy"
    "postprostatectomy" "onco" "underwent radical prostatectomy" "hoc" "PFS"
    "KI-67" "TAX2501" "adjuvant/neoadjuvant" "caspase 3/7" "co-precipitating"
    "timepoint" "energy-depleted renal epithelia" "Renal ischemia/reperfusion"
    "proximal tubules" "nephron" "tubules" "tubule" "Protein A/G" "CALGB"
    "Multivariate" "KRK-1014" "KRK" "AIO" "FOLFIRI" "folic" "CRYS" "poorest"
    "PACCE" "mitomycin" "AGITG" "a 3-year" "endpoints" "v-Ki-ras2" "3-year"
    "the v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog ( KRAS )"
    "homolog ( KRAS )" "homolog" "Kirsten" "v" "radioresistance" "chemo-"
    "sirtuin" "mammosphere" "hyperchromatism" "cleaved/active" "orasphere"
    "oraspheres" "sirtuin-3" "≤ 0.05" "amoeboid" "OVCA" "GEF-exchange"
    "signaling/function" "GEF-inducible" "Waals" "der" "pulldown" "mant"
    "Myc-RhoA-43T-63L" "RhoA/B/C" "GEF-stimulated" "bulkier" "matrigrel"
    "GEF-catalyzed" "Dbs" "RhoA/B" "Washington" "Exome" "probands" "bFGF1"
    "F-sensitive" "simian and bovine LRIT3s" "human calvarial osteoblasts"
    "osteoblasts" "the previously known exon1" "exon1" "LRIT3s"
    "Simian and bovine LRIT3" "piscine" "LRIT3" "FNIII" "immunoglobulin" "IARC"
    "heatmap" "p53 activation" "p53i" "p53 is" "fluoruracil" "p53 REs" "p53 RE"
    "SYBR" "dxr" "p53RE" "shRNAi" "ubiqutin" "oligodeoxynucleotides" "alarmins"
    "Toll-like" "spacer" "=A" "decamer" "RRRCWWGYYY" "g/ml" "g/mL" "non-immune"
    "Truong" "3/18" "commonest" "antigen (PCNA)" "proliferating HPK" "and 3c"
    "HPK" "ΔNp63" "kinase/" "PVD" "a favorable genotype" "Martinez" "Karnofsky"
    "significantly younger" "Cecener" "Hervouet" "Elias" "≥60" "Univariate"
    "co-methylation" "dinucleotides" "epigenome" "methylome" "= 0.019"
    "= 0.040" "= 0.003" "= 0.035" "= 0.006" "= 0.031" "μ L" "accumbens"
    "caudate" "the basolateral amygdala (BLA)" "the medial amygdala"
    "amygdaloid" "collagens" "GeneChip" "monoamine" "stressful" "stressors"
    "LI" "Igf" "procollagen" "amygdala" "reagents/Materials" "WJJ"
    "-oligoadenylate" "oligoadenylate" "Michel" "Eckardt" "Bangkok" "AdGFP"
    "titer" "pfu/cell" "MFN" "transdifferentiate"
    "human primary alveolar type I-like" "RSV" "IFN-λ1" "AdNrf2" "ATI-like"
    "type I-like" "IAV" "ΔCt" "~80%" "ANJ" "complicit" "non-activating"
    "desmoids" "HIER" "Nagoya" "electropherograms" "COSM28026" "1/7"
    "Euclidean" "co-up" "2/7" "possible KIT expression/alterations"
    "expression/alterations" "anaplastic/malignant" "Abelson" "neuroendocrine"
    "meninges" "4q12" "3 + " "2 + " "1 + " "= 0%" "SY" "QW" "XF" "Wu" "APDC"
    "42/50" "32/50" "3/50" "2/50" "36/50" "37/50" "Yang" "± SD" "non-cancerous"
    "immunoassays" "our quantitative MRM/MS" "readouts" "pSer104/pSer106"
    "μmol/L" "NetPhosK" "Scansite" "nmol/L" "femtomoles" "LOQs" "LOQ" "MRM/MS"
    "readout" "immunoassay" "MRM" "co-stimulation" "= 3" "= 0.05" "60-mm"
    "vivo" "vitro" "C/ C" "A/A" "HMVEC" "=0.120" "=0.076" "mmHg/ml/100"
    "tissue/min" "ml/" "=0.020" "=0.003" "pairwise"
    "functionally relevant polymorphisms" "rs6721961" "rs6706649" "rs35652124"
    "carotid" "arterial pressure/FBF" "FVR"
    "strain-gauge venous occlusion plethysmography" "plethysmography" "653A/G"
    "651G/A" "617C/A" "=0.05" "Kelch-like" "/ C" "/C" "Bruni" "Antonio"
    "non-smoking" "Amerindians" "Africans" "macroregions" "Brazil" "≤45"
    "hundred sixty-one" "non-adenocarcinoma" "non-Asian" "ex" "Caucasians"
    "African" "Americans" "Europeans" "Asians" "non-smokers"
    "a considerable subset" "non-smoker" "+/" "Non-small cell lung carcinoma"
    "Smads" "broader" "two external datasets" "a external dataset" "CoCa"
    "940T cells" "ZIPVec" "PBmiRVec" "PBmiR" "histopathology" "PBmirVec"
    "PBmir" "miRgen" "b" "SpCC" "SpCCs" "ΔEC" "stemness" "co-transfection"
    "Southern Germany" "Germany" "15/30" "Poland" "4/30" ".5266dupC" "German"
    "Jewish" "basal-like" "5/30" "dyslipidaemia" "Tilvis" "Miettinen"
    "and 3T3-L1" "lipopolysaccharides (LPS)" "lipopolysaccharides" "SVCs"
    "HbA1c" "T2D" "mesoderm" "endoderm" "ectoderm" "-1c" "±SD" "= 0.02"
    "non-obese" "a quadrangular osteotomy" "midline" "exorbitism"
    "Quadrangular osteotomy" "osteotomy" "osteotomies" "Le" "corectopia" "ﬁrst"
    "codon (CCG)" "codon (GCG)" "A heterozygous missense mutation c" "choroids"
    "Axial" "II-2" "axial" "choroid" "MAR" "immunoglobulin-like"
    "just two exons" "IgIII" "IIIc" "IIIa" "Weiss" "Jackson" "Apert" "10q26"
    "IgIIIb" "IgIIIa" "iso" "beaklike" "osteology"
    "A heterozygous FGFR2 missense mutation c" "perimetry" "Goldmann"
    "Pentacam" "fundus" "Exons" "Crouzon" "KRTAP5-6" "Marapsin" "NESO" "OCs"
    "OC" "pcDNA4/TO" "VSAN" "FGFR1b (VSAD)" "VSAD" "FGFR1b"
    "the chromogenic substrate Ac-IEPD-pNA" "dichloroisocouramin" "Ac-IEPD-pNA"
    "≥48 h" "TOPOIIa" "kD" "DNA/protein" "n = 10" "Non-Targeting"
    "MDA-MB-231 cells" "KKAy"
    "cardiovascular diseases  xref  and diabetes mellitus"
    "phosphorylated protein kinase–like ER eukaryotic initiation factor 2α"
    "factor 2α" "mol/L" "STZ+Tudca" "mellitus" "EGFRtk" "non-neural" "inUSP37"
    "expressingUSP37" "orUSP37" "pDEST26" "H&E-stained" "&E" "cerebella" "CHX"
    "and 2C" "+/++/+++" "++++" "eosin" "IRB" "scr" "cerebellum"
    "neuronal specification derepresses" "derepresses" "HDAC1/2"
    "FLAG-HA-tagged" "=0.0006" "co-stained"
    "Such potential activator/repressor" "*/" "Tyr::Nras" "siCSK"
    "correlated/anti-correlated" "+0.5" "Hoek" "vga9/+" "littermate" "mm/day"
    "somites" "around E9.0" "melanin" "penetrant" "NLS" "m/h" "nls" "CMV::bcat"
    "CMV::EGFP" "Spearman" "1×10" "= 0.024" "−35" "OHT" "hydroxytamoxifen"
    "MycER" "c" "Perhaps" "the nucleolar Fbw7γ" "the nucleoplasmic Fbw7α"
    "Fbw7α" "nucleoplasmic Fbw7α" "either nucleolar Fbw7γ"
    "the nucleolar E3 ligase Fbw7γ" "the nucleolar ubiquitin ligase Fbw7γ"
    "inNPM" "proteosome" "the nucleolar E3 ubiquitin ligase Fbw7γ" "Fbw7γ"
    "I-mediated" "Nacken" "Grus" "Schirmer" "STRING" "trfc" "C1Q1" "ALDH3A"
    "the in-house-developed algorithm" "Cytoscape" "overview" "MOWSE"
    "SWISSPROT" "Mainz" "eluates" "SELDI-TOF-based" "nl"
    "the nipple aspirate fluid and ductal lavage" "lavage" "Pawlik" "Mathelin"
    "Proteome" "Mammography" "an in-house-developed algorithm"
    "desorption/ionization" "again strongest" "prophylactic oophorectomy"
    "oophorectomy" "15/66" "-variant-negative" "-variant-positive"
    "non-Hispanic" "rs61764370" "Germline" "= 0.05" "1/1" "=  3" "FASL"
    "Spectometry" "pY705" "oipA" "EV" "co-cultured" "MOI" "Bis" "MKN" "pRKIP"
    "cagPAI" "immunodominant" "pro-inflammatory cytokine gene polymorphisms"
    "non-phosphorylated" "CDE/CHR" "co-repressor" "CHR" "Afftymetrix" "≥2.3"
    "Kp27-5" "h" "polyploid" "ZnSO" "Kp21-4" "CDE"
    "a transcriptional co-repressor" "U133A" "co-activator"
    "congenital nephropathies" "nephropathies"
    "glomerular disease pathophysiology" "meshwork" "Glomeruli" "85±7.5%" "Luc"
    "NCK1/2" "NCK 1/2" "or/and 2" "IQ" "interdigitate" "WB" "96 h"
    "intron/exon" "EFGR" "Haplotype" "df " "tSNP" "1.05–1.66" "1.04–1.65"
    "rs730437" "rs1468727" "HWE" "MassEXTEND" "yrs" "SNP polymorphisms"
    "co-inheritance" "PLINK" "Xi" "tSNPs" "95% CIs" "= 0.004" "= 0.019"
    "= 0.024" "= 0.008" "a transcriptional co-activator"
    "a strong metabolic Achilles" "Achilles" "iv" "Warburg" "PIK3CAmutants"
    "steeper" "circuitry" "6AN" "aminonicotinamide" "EGFRcancer"
    "PIK3CAoncogenes" "PIK3CAmutations" "_cnt"
    "independently generated isogenic HME" "HME" "KRAScancer" "EGFRand"
    "PIK3CAcancer" "PIK3CAalleles" "PIK3CAor" "OH" "KRASmutations"
    "Rafoncogenes" "KRASand" "KRASallele" "delE746-A750"
    "the mature NK/T cell subsets" "ontogeny" "non-human" "more mature subsets"
    "Δtel" "Non-carrier" "non-carrier" "Tukey" "CD20+"
    "the memory T lymphocyte subset" "CD45RA−CD20−"
    "the CD45RA+CD57+ mature NK/T lymphocyte subset" "CD45RA+CD57+"
    "mature NK/T (CD45RA+CD57+) lymphocyte subsets" "NK/T" "sharpest" "CD45RA+"
    "yr" "age-year" "MTL" "age-specific breakpoints" "breakpoints" "= 3"
    "motile" "the parental and recombinant IHEECs" "parental IHEECs"
    "the endometriotic SRC-1 isoform" "the parental IHEECs" "SRC-1 to"
    "SRC-1 isoform" "The eutopic endometrium"
    "the eutopic and ectopic endometrium" "MMP2/9" "zymography"
    "Ectopic:W/F-SRC-1-M" "IHEECS" "FSRC" "IHESCs" "IHEECs"
    "the wild-type eutopic endometrium" "the SRC-1  −/− eutopic endometrium"
    "Tg" "eutopic endometrium" "the eutopic endometrium" "HESCs" "uteri"
    "endometriotic endometrium" "C57BL/6J" "SIE" "endometrium" "Sampson's"
    "Sampson" "ng/" "anti-Flag" "=10" "IC50" "chemo" "safer" "~50%"
    "anti-proliferative" "only one SLN" "pleiotropy"
    "the MET inhibitor displays strong synergism" "UTR" "MCTS" "synergism"
    "ATMi" "non-targeting" "wZ" "SLN" "BiNGS" "SBI" "utlin-3"
    "S ynthetic L ethal" "SLNs" "ethal" "14-3-3σ" "non-genotoxic"
    "anti-tumoral" "GRch37" "biosamples" "H2009" "Takeuchi" "priori"
    "clinically relevant molecular subsets" "NCI" "pY993" "≤0.05" "iTRAQ"
    "dataset" "the parietal peritoneum" "peritoneum" "KIST301080"
    "drastic anti-cancer" "perhaps" "pLXSN" "non-invasive" "downstrream"
    "anti-cancer" "anti-tumorigenic" "ie" "coli" "Tcf" "chemoradiotherapy"
    "GSK-3α/β" "rectal cancer epithelium" "immediately snap frozen" "frozen"
    "sphincter" "Wilcoxon" "-3α" "a unique molecular subtype" "prolif"
    "radiochemotherapy (RCT)" "western Europe" "responders" "Mandard"
    "neoadjuvant" "radiochemotherapy" "Neoadjuvant" "T47D:C42" "MCF-7/F"
    "MCF-7:2A" "MCF-7:5C" "SFS" "ATCC" "antihormone" "TNBC" "monotherapy"
    "rs1144396" "Ostrovsky" "rs2075847" "FFPET" "DHPLC" "TaqMans" "RFLP"
    "1G/2G" "Borrmann" "=0.023" "=0.573" "Bonferroni" "TTTA" "rs470558"
    "rs491152" "rs7125062" "rs2071231" "Weinberg" "FFPETs" "rs470206"
    "Ghilardi" "Hinoda" "Przybylowska" "Karolina" "TTCG" "GCCG" "TCCG" "GG"
    "Haploview" "SPSS" "Haplo" "Dvl2/Daam1/RhoA" "neurite" "GBD" "homologs"
    "enhancer" "polarise" "formation/maintenance" "ΔDEP-Dvl2" "ΔPDZ-Dvl2"
    "basal active RhoA" "60∼70%" "Boyden" "rWnt5a" "non-transforming"
    "Daam1/RhoA" "exoenzyme" "mmol/L" "ethnicities" "Ashkenazi" "VUS"
    "at least 20X" "amplicons" "amplicon" "HRMCA" "DGGE" "dHPLC" "nt" "HBOC"
    "mestizo" "Mexican" "_5117delTAAA" "_2640delTG" "_3133delAGCAATATTA"
    "_2808delAGAT" "Latin" "non-competitive" "paratope" "koff" "RAERST"
    "QADRWT" "NATRWT" "C-F12" "non-optimized" "carbonyl" "RWT"
    "co-crystallized" "dipeptidyl" "the inactive zymogen" "3C-D7" "and 3C-H2"
    "3C-B5" "4C-E4" "≈0.2" "the monomeric Fynomer" "monodisperse" "and 3C-B5"
    "mg/l" "hexahistidine" "randomizations" "soluble Fynomer" "interspace"
    "virtually any desired target antigen" "bio" "Fynomers" "Fynomer" "= 10"
    "JLF" "RLW" "SJD" "LLB" "replication/cytotoxicity" "thymocytes" "Collins"
    "Guatelli" "co-workers" "AXXAXR" "YXXL" "ionic" "Kaposi’s" "Kaposi" "PPI"
    "GFPV" "hydroxyl" "functionalities" "SF2Nef" "ctMHCI" "LR" "P78G" "P75A"
    "P72A" "IVKAs" "P75G" "P72G" "QV" "Nef-SH3" "VRPQVPLRP" "Nef/SH3 domain"
    "N- and" "μ1" "MHCI" "GFP/F" "Nef/activated" "PXXPXR" "non-motif" "PQVPLR"
    "VR" "JNZ" "XRG" "Foundation:30873029" "Foundation:81172384" "Schiffer"
    "BMP2/4" "Piccirillo" "1× 10" "microvessels" "pleomorphism" "3×10" "AAV"
    "soft agar" "agar" "siBMPR" "rAAV" "BMPs/BMPRs" "RII" "RIA" "subclass"
    "U251" "≤ 4 " "96 h" "Vanderwinden" "pathophysiology" "bi-" "bi" "Klemm"
    "musculature" "stellate" "submucosa" "DG" "ultrastructure" "glia"
    "Full thickness gastric body biopsies" "ir" "conductance" "GI"
    "Co-localization" "10-μm" "gDNA" "Anderson" "Amersham" "Bio" "aliquots"
    "phenylmethylsulfonyl" "immunocomplex" "GTC"
    "-GTGGGACAAAGAATTGGATCTGTATCATTTGGAACA"
    "GTGGGACAAAGAATTGGATCTGTATCATTTGGAACA"
    "-GATCATTTGGAACAGTCTGCAAGGGAAAGTGGCATGGT"
    "GATCATTTGGAACAGTCTGCAAGGGAAAGTGGCATGGT" "Y472C/R509H" "Stratagene" "XL"
    "QuikChange" "Dublin" "Conway" "Ireland" "Kolch" "Dharmacon" "SMARTpool"
    "siGENOME" "μL" "Amaxa" "Aminoactinomycin" "deoxynucleotidyl" "ModFit"
    "FACScan" "cytofluorimeter" "ImageJ" "IVKA" "Olympus" "Biosoft" "CalcuSyn"
    "Talalay" "Chou" "diphenyltetrazolium" "Selleck" "Alexa" "Millipore" "Cruz"
    "pSFK" "Sos" "/Rb" "protomer" "BRAFeither" "Rb" "Cal12T" "wt" "aCGH"
    "MassARRAY" "Sanger" "discoidin" "positron" "responder" "—popultations"
    "popultations" "subpopulations" "μg/mL" "histoscore" "Gumerlock" "Voeller"
    "CL10" "Chandarlapaty" "Carracedo" "Shen" "fl/+"
    "EGF-treated DU145 KD CL61" "CL61" "S1046/1047" "kianse" "Nishimura"
    "immuno" "primaquine" "their respective non-silencing" "poorer" "≤4"
    "Gleason" "Ep" "Nkx" "haplo" "Rubin" "Kawakami" "∼24%" "∼7%" "cBio"
    "Mellinghoff" "Edwin" "Bordoni" "Danese" "McKie" "orthologues" "Woodfin"
    "Hacohen" "Zwang" "Yarden" "Dejana" "Baluk" "Kim" "Goltsov" "Fritzsche"
    "Trotman" "Morgentaler" "Traish" "Potente" "ErbB" "± SD" "frameshift"
    "PI3KCA" "undergoes" "Fwd" "Pearson" "EMMA" "QMP" "presence/absence" "AS17"
    "karyotypes" "drig" "non-transformed" "Fgfr" "20mg/kg" "1–10mg/kg"
    "re-adhere" "2–3" "quantitate" "necropsy" "algorithms" "begun" "/Tyr204"
    "anti-tumor" "anti-apoptotic" "~30%" "the subsequent Transwell" "Takahashi"
    "PLK1 was" "49/56" "aneuploidy" "Takao" "Wilko" "Golsteyn" "39±14" "siRNA1"
    "Lipofectamine" "11/56" "31/56" "+++" "32/56" "2/56" "41/56" "Asian"
    "Kit-8" "72h" "48 h" "72 h" "non-small-cell" "fide" "bona"
    "re-overexpression" "re-overexpressed" "TUNEL" "biotin"
    "migration/proliferation" "Brd" "MTS" "Si" "pEGFP" "chosen"
    "6-diamidino-2-phenylindole" "48 h" "72 h" "JRM" "HN" "Brightfield"
    "HER2 IHC 2+" "darkfield" "blockers" "co-localization"
    "HER2 IHC and single color brightfield HER2 ISH" "or 2+" "Ignatiadis"
    "easier" "HER2 /CEN17" "the multiplex HER2 gene-protein assay co-localized"
    "co-localized" "bound non-specifically" "Reisenbichler" "Ni" "AP"
    "HER2 /CEN17 " "CEN17 " "single color chromogenic ISH (CISH)"
    "dual color fluorescence ISH (FISH)" "Invitrogen" "Illinois" "Abbott"
    "Denmark" "Glostrup" "Oncology (ASCO)" "Oncology" "GlaxoSmithKline" "USA"
    "Francisco" "Genentech" "CEN17" "-diaminobenzidine" "diaminobenzidine"
    "FFPE" "ISH (BISH)" "BISH" "brightfield" "US" "non-specific" "HER2 /"
    "chemoresistance" "NFKB" "protooncogene" "Coremine" "FigureFigure" "KEGG"
    "European" "ArrayExpress" "Guidugli" "partecipates" "A1789TvsWT-contrast"
    "MutvsWT" "A1789T" "non-homologous" "cyclin-dependent kinase inhibitor 1A"
    "Rad3" "phosphoinositols" "Δ rac1" "Europe" "serotype" "CNS" "non-brain"
    "Δ plb1" "Δplb1" "Δrac1" "transcytose" "monolayers" "TEER" "inoculum"
    "Ruffer" "monolayer" "Transwell" "Zambia" "neoformans" "10 % FBS"
    "dysplastic epithelium" "algorithm" "HER2/ neu IHC 3+" "ACIS" "Rüschoff"
    "Hoffman" "0/1+" "gastric cancer biopsies" "the IHC 3+" "the IHC 2+"
    "the IHC 0/1+" "esophageal/GEJ" "IIA" "Biopsy" "multicenter" "Carpinteria"
    "America" "Dako" "anti-HER2/" "GEJ" "IHC 3+" "HER2/ neu IHC 2+" "HER2/"
    "/International" "5-year" "torn" "Yanagida" "FRB" "FKBP12-like" "tor2  +"
    "non-suppressed" "This" "−Thi" "Thi" "thiamine" "pCUT1" "securin/"
    "separase/" "hyper" "cut1" "cut2" "Russell" "Rum1" "Myp2" "Myp2/Myo3"
    "latrunculin" "cut1-206" "micrographs" "NETO" "Hanyu" "semi-" "micrograph"
    "YPD" "polypeptone" "FACS" "Dickinson" "Becton" "PSTAIR" "Cut14"
    "Non-tagged" "non-tagged" "Whitehouse" "Merck" "p" "tor2-S" "Ts"
    "integrants"
    "the previously isolated temperature-sensitive (ts) TORC1 tor2-287"
    "tor2-287" "ts" "tor1" "°C" "Cut1" "Cut2" "separase/Cut1" "us" "Petersen"
    "Hartmuth" "co-precipitate" "Hayashi" "Pop3/Wat1" "cerevisiae" "pombe"
    "Schizosaccharomyces" "PIKK" "24 h" "2  +" "1  +"
    "preventing diabetes-induced oxidative stress/damage" "blocker" "nonobese"
    "Ramprasath" "tetranitrate" "the preventing diabetic nephropathy" "Dh404"
    "-GCS" "GCS" "Palsamy" "BHQ" "HRMC" "Zheng" "lithospermate" "Xue" "HFD"
    "Ungvari" "nitroguanosine" "Yoh" "diabetic nephropathy glomeruli" "biopsy"
    "glomeruli" "C57BL/6" "Jiang" "HRMCs" "anti-inflammation" "oxygenase-1"
    "-glutamylcysteine" "glutamylcysteine" "kelch-like" "diabetic nephropathy"
    "Diabetic nephropathy" "nephropathy" "24 h" "Zhang's" "Zhang" "Sasano"
    "Tateishi" "Jimenof" "Gravalos" "resp" "Lauren's" "2+/3+" "Hofmann"
    "Hercep" "Remmele" "HercepTest" "DAKO" "Ventana" "ISH (FISH)" "ISH"
    "univariate" "intestinal subtype" "Meier" "Kaplan"
    "the Lauren histologic subtype" "had IHC" "1+" "low IHC" "⩾15" "UCCC"
    "interquartile" "RNaseP" "GCNs" "non-amplified" "gene-to-chromosome"
    "-to-chromosome" "trisomy" "Lauren" "subtypes" "Liu" "antagonise" "MET IHC"
    "ASCO" "2+" "polysomy" "SISH" "situ" "GA" "GCN" "95% CI" "=0.31" "3+"
    "emphasise" "Pongidae" "sapiens" "DISP3" "CAPB" "1p36"
    "rare putative autosomal dominants" "dominants" "pseudogene" "pseudogenes"
    "PRKC-ζ  -a" "homologies" "Sx" "introns" "benign prostatic epithelia"
    "PRKC-ζ  -PrC" "PRKC-ζ  -" "#90" "Xq23" "LOC100506504" "1p" "GRCh37"
    "contig" "PANC" "supernatant" "5A6"
    "benign and malignant prostatic epithelium" "RDRPLRRDRRGKRQR"
    "prostatectomy" "T1–6" "si-" "si" "‘vq'" "GenBank" "transcriptome" "vq"
    "GTTC" "Immunohistochemistry" "prokaryote" "isoenzymes" "bp" "vy" "u"
    "AceView" "Transcriptome" "undergone" "NCBI" "μ g" "μg" "non-malignant"
    "μ g " "microbiota" "ofKras" "Feng" "orBraf" "eitherKras" "ofp16"
    "markerp16" "IEC" "andKRAS" "bothBRAF" "viliform" "non-receptor"
    "The intestinal epithelium" "theBraf" "orKras" "inBraf" "ceca"
    "mitotically active columnar epithelium" "the mature serrated epithelium"
    "The focal dysplasia" "cytological atypia" "atypia" "VS28" "cecum" "HBUS"
    "ELISA" "ectodomain" "INKa" "expressingKras" "the intestinal epithelium"
    "villi" "paracrine" "juxtacrine" "HBGF" "12/13" "phospho-ERK1/2" "biopsies"
    "IECs" "ofBraf" "SSA/P" "adenomas/polyps" "infoldings" "cecal"
    "the extracellular-regulated kinases (ERK)1/2" "1/2" "sessile" "Sinai"
    "colonoscopies" "= 0.0007" "co-transfected" "non-mutated" "ground"
    "rs10758669" "Crohn’s" "Crohn" "46/1" "haplotypes" "haplotype" "Skoda"
    "co-existent" "rs11549009" "MPLW515L" "JAK2V615LV617F" "V615LV617F"
    "mesylate" "pH" "20q" "DSB" "littermates" "DSBs" "centromere" "ploidy"
    "exome" "continuum" "wildtype" "9p" "acquired uniparental disomy" "disomy"
    "outcompete" "Asxl" "CMML" "JAK2V617F-" "JAK2V617F" "JH1"
    "polymorphism (SNP)" "Ph" "Philadelphia" "aliquot"
    "essential thrombocythemia (ET)" "vera (PV)" "thrombocythemia" "vera"
    "Nowell" "stepwise" "progeny" "Macrobius" "Theodosius" "Ambrosius" "AGC"
    "weakest" "pT210" "KO" "x" "oligo" "RhoA" "CD" "anti-HA" "Inc" "Carna"
    "PPBN" "phosphopeptides" "phosphopeptide" "proteome" "FERM" "LATS/WARTS"
    "MEN" "pololike" "/WARTS" "10% FBS" "G1/S" "lifespan" "orthologue"
    "chromatid" "CoIP" "VI" "PML" "TRF1R6" "coIP" "NoLS" "NSdB" "gfp" "ΔBΔM"
    "ΔM" "ΔB" "guanine nucleotide-binding protein-like 3-like" "MRN"
    "multiprotein" "et" "Hahn" "epithelia" "Subsets" "SMADS"
    "anti-inflammatory" "10%FBS" "luc" "timepoints" "IKKα/β" "48h" "24h"
    "TGFβRII" "Heka" "=0.0001" "5/9" "4/9" "UMSCC" "subsets" "++" "HNSCC"
    "non-canonical" "simpler" "`tertiary" "Hck-SH3" "-SH3" "proven" "ROSETTA"
    "FlexPepDock" "Y2H" "EOM" "`Nef-like" "nSrc" "HSQC" "a tertiary `Nef-like"
    "-SH3-GST" "Coomassie" "Nef-like" "IIIA9" "lacz" "V+PRR"
    "a three-dimensional `tertiary" "PXXP" "helices" "PxxP" "helix" "ESCRT"
    "prolin" "SAXS" "ITC" "mesenchymal/myofibroblasts" "O-glycosylated" "ED"
    "sol" "non-coated" "O-glycosylation" "supernatants" "HUH7/T6" "protein A/G"
    "YKH1" "KLH" "tFN" "-acetylgalactosamine" "acetylgalactosamine"
    "sequence-Val-Thr-His-Pro-Gly-Tyr-" "IIICS" "FDC6" "glycans" "β1" "norFN"
    "normalFN" "fetal cells/tissues" "onfFN" "GalNAc" "Amemiya" "Huang"
    "Nakajima" "lymphadenectomy" "serosa" "pT" "UICC" "AJCC" "American"
    "Drebber" "Tolgay" "offs" "Zhao" "semi" "intra" "greatest" "pT2" "pT4"
    "pT3" "undertaken" "discrepant" "immunohistochemistry (IHC)" "multistage"
    "deeper" "curative gastrectomy" "Iran" "Tehran" "gastrectomy" "mammography"
    "Lerner" "Yoeli" "Lerma" "Li" "Barbareschi" "10-year" "MassArray"
    "Sequenom" "Kalinski" "multivariate" "DFS" "subtype" "the last hotspot"
    "hotspot" "hotspots" "3q26" "trisphosphate" "bisphosphate" "zymogen"
    "Subclass" "hydroxy" "homozygote" "AKs" "BD" "MNSC" "Kang" "NMSC" "codon"
    "codons" "Polymorphisms" "DSBR" "oncologists" "AOR " "extramammary Paget’s"
    "extramammary Paget" "AOR" "polymorphism" "Bowen"
    "At least three common single nucleotide polymorphisms" "polymorphisms"
    "95 % CI" "demographic and clinical covariates" "covariates" "IHC" "BMIs"
    "histology" "Rico" "germline" "penetrance" "younger" "95%CI"
    "immunohistochemistry" "Puerto" "Juan" "BMI" "GF-2"
    "the low-metastatic B16-F1 exosomes" "organotropism" "Paget" "Pre" "shMet"
    "B16-F10shMet" "propulations" "mesentery" "B16-F10mCherry" "non-metastatic"
    "interstitium" "fluorescently-labeled B16-F10 exosomes" "naïve" "NanoSight"
    "Exosome" "low/+" "antigen" "exosomes" "Exosomes" "exosome"
    "vascular leakiness" "pre" "leakiness" "× 10" "Globocan" "PolyPhen" "SIFT"
    "Wellcome" "SNPTEST" "1000Genomes" "dbSNP" "X-inactivation" "HT-12" "LCLs"
    "silico" "LCL" "lymphoblastoid" "DNAaseI" "UW" "Transfac" "3,188bps"
    "release21" "HapMap" "genomes" "genotypes" "microsatellite" "clinico"
    "CHRPE" "Missense" "laevis" "epithelium" "=7.30" "CCFR1" "Scotland3" "UK1"
    "rs5934683" "Armitage" "Cochran" "Genotypes"
    "the two newly-discovered SNPs" "colonic mucosa" "mucosa" "WAF1/Cip1" "QRS"
    "multisubunit" "5.0×10" "=3.65" "=1.14" "Japanese" "Sweden" "Swedish"
    "Helsinki" "Finnish" "Croatia" "Cambridge" "Edinburgh" "rs3824999"
    "rs1321311" "ORs" "VQ" "COINNBS" "genotype" "relatedness" "hidden" "VQ58"
    "GoldenGate" "iSelect" "Infinium" "SNPs" "Scotland1" "UK2" "Scotland2"
    "NSCCG" "SOCCS" "London" "COGS" "Scottish" "datasets" "GWAS" "GWASs" "6p21"
    "11q13.4" "Xp22.2" "×10" "G0/G1" "subset" "strongest" "greater" "BWS" "UAS"
    "melanogaster" "Polyphen" "V-1" "Illumina" "Genome" "exons" "multisystem"
    "LOD" "Argentina" "SNP" "Affymetrix" "Nsp" "OMIM" "Wiedemann" "Beckwith"
    "missense" "congenita" "dysplasia" "ntrauterine" "HU" "ThrGln" "SerGln"
    "NCZ" "UV" "intron" "transversions" "uanine" "hio" "HPRT" "phosphoribosyl"
    "APC/C" "retrovirus" "prometapahse" "HA" "ibroblasts" "ouse" "oligos" "iii"
    "ii" "RxI/AxA" "LY293646" "DMAT" "Alsterpaullone" "RxI" "RxL" "CY" "MudPIT"
    "prokaryotes" "ibonucleotide" "Fbxol" "Skpl" "Rbxl" "RING" "multi"
    "genome"))

(DEFPARAMETER SPARSER::*BIO-CHEMICAL-HEADS-PHASE3-7801-8100*
  '(("a potentially carcinogenic state" . SPARSER::BIO-STATE)
    ("live HeLa cells stably expressing EGFP–CENP-A" . SPARSER::COLLECTION)
    ("EGFP–CENP-A" . SPARSER::COLLECTION) ("H2B-mCherry" . SPARSER::COLLECTION)
    ("the respective RNAi target proteins" . SPARSER::PROTEIN)
    ("phosphospecific antibodies" . SPARSER::ANTIBODY)
    ("INCENP" . SPARSER::PROTEIN)
    ("PP1 and its targeting subunits Repo-Man and Sds22" . SPARSER::COLLECTION)
    ("PP1α or PP1γ" . SPARSER::COLLECTION)
    ("Sds22 and Repo-Man" . SPARSER::COLLECTION)
    ("the different siRNA oligonucleotides delayed dephosphorylation"
     . SPARSER::MOLECULE)
    ("a heterotrimeric PP2A complex" . SPARSER::BIO-COMPLEX)
    ("PPP2CA, PPP2R1A, and PPP2R2A" . SPARSER::COLLECTION)
    ("CDCA" . SPARSER::MOLECULE)
    ("all respective siRNA oligonucleotides" . SPARSER::MOLECULE)
    ("subunits, Repo-Man and Sds22" . SPARSER::COLLECTION)
    ("Haspin-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Haspin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Glc" . SPARSER::MOLECULE)
    ("KNL-1, and Dsn1" . SPARSER::COLLECTION)
    ("NDC80/HEC1" . SPARSER::COLLECTION)
    ("Sds22 or Repo-Man" . SPARSER::COLLECTION)
    ("subunits, Sds22 and Repo-Man" . SPARSER::COLLECTION)
    ("Dsn1" . SPARSER::PROTEIN) ("RP23" . SPARSER::PROTEIN)
    ("histone 2B" . SPARSER::PROTEIN) ("H–K" . SPARSER::PROTEIN)
    ("CENP-A" . SPARSER::PROTEIN) ("E–G" . SPARSER::PROTEIN)
    ("Mklp2" . SPARSER::PROTEIN) ("M–R" . SPARSER::PROTEIN)
    ("G–L" . SPARSER::PROTEIN) ("PPP1R3C" . SPARSER::PROTEIN)
    ("PPP2R2A" . SPARSER::PROTEIN) ("PPP2R1A" . SPARSER::PROTEIN)
    ("PPP2CA" . SPARSER::PROTEIN) ("PPP1R7" . SPARSER::PROTEIN)
    ("p97" . SPARSER::PROTEIN) ("KNL-1" . SPARSER::PROTEIN)
    ("HEC1" . SPARSER::PROTEIN) ("NDC80" . SPARSER::PROTEIN)
    ("Sds22" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("JNK, and c-Jun" . SPARSER::COLLECTION)
    ("JNK/c-Jun" . SPARSER::COLLECTION)
    ("Tcf1, Tcf3, Tcf4, and LEF1" . SPARSER::COLLECTION)
    ("Tcf1" . SPARSER::PROTEIN) ("TAM" . SPARSER::PROTEIN)
    ("Jun or Fos" . SPARSER::COLLECTION)
    ("c-Jun and Fra-1" . SPARSER::COLLECTION)
    ("c-Fos, Fra-1, Fra-2, and FosB" . SPARSER::COLLECTION)
    ("FosB" . SPARSER::PROTEIN) ("c-Jun, JunB, and JunD" . SPARSER::COLLECTION)
    ("JunD" . SPARSER::PROTEIN) ("JunB" . SPARSER::PROTEIN)
    ("Jun-Jun homodimers or Jun-Fos heterodimers" . SPARSER::COLLECTION)
    ("Jun-Jun" . SPARSER::COLLECTION) ("c-Jun and AP-1" . SPARSER::COLLECTION)
    ("c-myc and map4k1" . SPARSER::COLLECTION)
    ("JNK, c-Jun, and AP-1" . SPARSER::COLLECTION)
    ("si-Myc" . SPARSER::COLLECTION) ("plas" . SPARSER::PROTEIN)
    ("-LUC" . SPARSER::COLLECTION) ("pCMV6" . SPARSER::PROTEIN)
    ("pCMV6-Myc" . SPARSER::COLLECTION) ("RNA and cell" . SPARSER::COLLECTION)
    ("phospho-JNK and phospho-c-Jun" . SPARSER::COLLECTION)
    ("JNK and c-Jun" . SPARSER::COLLECTION)
    ("cyclin D2 and cyclin-dependent kinase 4" . SPARSER::COLLECTION)
    ("activator or repressor" . SPARSER::COLLECTION)
    ("an essential protein" . SPARSER::PROTEIN) ("TAKl" . SPARSER::PROTEIN)
    ("c-Jun or c-Fos" . SPARSER::COLLECTION) ("TPA" . SPARSER::DRUG)
    ("DMBA" . SPARSER::MOLECULE) ("anthracene" . SPARSER::DRUG)
    ("c-Myc and MAP4K1" . SPARSER::COLLECTION) ("map4k1" . SPARSER::PROTEIN)
    ("ell" . SPARSER::PROTEIN) ("Tcf3" . SPARSER::PROTEIN)
    ("Fra-2" . SPARSER::PROTEIN) ("Fra-1" . SPARSER::PROTEIN)
    ("JNK protein" . SPARSER::PROTEIN) ("H-2K" . SPARSER::PROTEIN)
    ("phospho-JNK" . SPARSER::PROTEIN) ("STE-20" . SPARSER::PROTEIN)
    ("hematopoietic progenitor kinase" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase kinase kinase 1"
     . SPARSER::PROTEIN)
    ("12-O-tetradecanoylphorbol-13-acetate" . SPARSER::DRUG)
    ("pdcd4" . SPARSER::PROTEIN) ("Tcf4" . SPARSER::PROTEIN)
    ("k1" . SPARSER::PROTEIN) ("MAP4K1" . SPARSER::PROTEIN)
    ("MAP kinase kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Pdcd4" . SPARSER::PROTEIN)
    ("miR-21 and miR-181b-1" . SPARSER::COLLECTION)
    ("both active and inactive promoters" . SPARSER::PROMOTER)
    ("Necdin" . SPARSER::PROTEIN)
    ("repressor or negative regulator" . SPARSER::COLLECTION)
    ("α 1 -anti-chymotrypsin and α 2 -macroglobulin" . SPARSER::COLLECTION)
    ("-anti-chymotrypsin and α 2 -macroglobulin" . SPARSER::COLLECTION)
    ("-anti-chymotrypsin" . SPARSER::ANTIBODY)
    ("chymotrypsin" . SPARSER::PROTEIN) ("WAF/CIP1" . SPARSER::COLLECTION)
    ("WAF" . SPARSER::PROTEIN) ("STAT3α-" . SPARSER::PROTEIN)
    ("STAT3β–STAT3α" . SPARSER::COLLECTION) ("basal STAT3" . SPARSER::PROTEIN)
    ("STAT3α/STAT3β" . SPARSER::COLLECTION) ("Stat3 β" . SPARSER::PROTEIN)
    ("STAT3α and TC45" . SPARSER::COLLECTION)
    ("normally target STAT3α" . SPARSER::PROTEIN)
    ("Thbs1 , Fbln2 and Cyr61" . SPARSER::COLLECTION)
    ("Fbln2" . SPARSER::PROTEIN) ("Thbs1" . SPARSER::PROTEIN)
    ("Atp5d , Atp6v0b , Ipo9 and Tnpo2" . SPARSER::COLLECTION)
    ("Atp6v0b" . SPARSER::PROTEIN) ("Atp5d" . SPARSER::PROTEIN)
    ("≤−1" . SPARSER::COLLECTION) ("-STAT3β" . SPARSER::COLLECTION)
    ("the intense nuclear phospho-STAT3" . SPARSER::PROTEIN)
    ("STAT3α or STAT3β" . SPARSER::COLLECTION)
    ("S1B and S1C" . SPARSER::COLLECTION) ("FLAG–STAT3" . SPARSER::COLLECTION)
    ("PARP [poly(ADP-ribose) polymerase; nucleus] and α-tubulin (cytosol)"
     . SPARSER::COLLECTION)
    ("STAT3α and the shorter STAT3β isoform" . SPARSER::COLLECTION)
    ("Two STAT3 proteins, STAT3α and the shorter STAT3β isoform"
     . SPARSER::COLLECTION)
    ("the shorter STAT3β isoform" . SPARSER::ISOFORM)
    ("MEFs and iSTAT3α or iSTAT3β" . SPARSER::COLLECTION)
    ("Prism" . SPARSER::PROTEIN) ("Adamts9" . SPARSER::PROTEIN)
    ("Il18" . SPARSER::PROTEIN) ("Ifi44" . SPARSER::PROTEIN)
    ("Cxcl10" . SPARSER::PROTEIN) ("Aim2" . SPARSER::PROTEIN)
    ("Cy2 (carbocyanine)/Cy3 (indocarbocyanine)-conjugated secondary antibodies"
     . SPARSER::ANTIBODY)
    ("BSA/PBS" . SPARSER::COLLECTION) ("FBS/PBS" . SPARSER::COLLECTION)
    ("4% (w/v) paraformaldehyde and permeabilization" . SPARSER::COLLECTION)
    ("ice-cold methanol" . SPARSER::MOLECULE)
    ("ice-cold PBS" . SPARSER::PROTEIN) ("methanol" . SPARSER::MOLECULE)
    ("paraformaldehyde" . SPARSER::DRUG)
    ("Either mouse anti-FLAG M2 antibodies (Sigma) or rabbit anti-Myc antibodies (Santa Cruz Biotechnology)"
     . SPARSER::COLLECTION)
    ("-c-Myc" . SPARSER::COLLECTION) ("-FLAG" . SPARSER::COLLECTION)
    ("the anti-phospho-STAT3 (Tyr 705 ) (#9145) antibody" . SPARSER::PROTEIN)
    ("v/v" . SPARSER::COLLECTION) ("streptomycin" . SPARSER::DRUG)
    ("Puromycin" . SPARSER::DRUG) ("Polybrene" . SPARSER::MOLECULE)
    ("lentiviral structural components" . SPARSER::COMPONENT)
    ("-GCGCTAGCTTATTTCCAAACTGCATCAATGAA-3" . SPARSER::COLLECTION)
    ("-GCGCTAGCTCACATGGGGGAGGTAGCGCACTC-3" . SPARSER::COLLECTION)
    ("-GCACCGGTACCATGGACTACAAGGACGACGAT-3" . SPARSER::COLLECTION)
    ("-TTTGCTGCTTTCACTGAATAGTAGCAGGAAGGTGCCTGGA-3" . SPARSER::COLLECTION)
    ("-TCCAGGCACCTTCCTGCTACTATTCAGTGAAAGCAGCAAA-3" . SPARSER::COLLECTION)
    ("-GATAAACTTGGTCTTCAGGGCTGGGGCAGCGCTACCTGGGTC-3" . SPARSER::COLLECTION)
    ("GACCCAGGTAGCGCTGCCCCAGCCCTGAAGACCAAGTTTATC-3" . SPARSER::COLLECTION)
    ("phenylalanine (Y705F) and the critical Arg 609" . SPARSER::COLLECTION)
    ("STAT3α and STAT3β" . SPARSER::COLLECTION) ("STAT3β" . SPARSER::PROTEIN)
    ("STAT3α" . SPARSER::PROTEIN)
    ("-GCCTCGAGTTATTTCCAAACTGCATCAATGAA-3" . SPARSER::COLLECTION)
    ("FLAG–STAT3β" . SPARSER::COLLECTION)
    ("-GCCTCGAGTCACATGGGGGAGGTAGCGCACTC-3" . SPARSER::COLLECTION)
    ("-GCAAGCTTATGGCCCAATGGAATCAGCTACAG-3" . SPARSER::COLLECTION)
    ("FLAG–STAT3α" . SPARSER::COLLECTION) ("XhoI" . SPARSER::PROTEIN-FAMILY)
    ("monocytes and neutrophils" . SPARSER::COLLECTION)
    ("OSM (oncostatin M) and LIF (leukaemia inhibitory factor)"
     . SPARSER::COLLECTION)
    ("b-1" . SPARSER::PROTEIN) ("α 2 -macroglobulin" . SPARSER::PROTEIN)
    ("SHP1" . SPARSER::PROTEIN) ("TC45 " . SPARSER::PROTEIN)
    ("TC45" . SPARSER::PROTEIN) ("Tnpo2" . SPARSER::PROTEIN)
    ("Ipo9" . SPARSER::PROTEIN) ("Atp5" . SPARSER::PROTEIN)
    ("heat-shock protein" . SPARSER::PROTEIN) ("ERt2" . SPARSER::PROTEIN)
    ("VP16" . SPARSER::DRUG) ("Plce1" . SPARSER::PROTEIN)
    ("a 20 " . SPARSER::PROTEIN) ("COS1" . SPARSER::PROTEIN)
    ("granulocyte colony-stimulating factor" . SPARSER::PROTEIN)
    ("STAT3 " . SPARSER::PROTEIN) ("glycoprotein 130" . SPARSER::PROTEIN)
    ("acute-phase response factor" . SPARSER::PROTEIN)
    ("ROCK-LIMK-actin" . SPARSER::COLLECTION) ("Arl8b" . SPARSER::PROTEIN)
    ("CD1d ( xref ) as well as the lipid" . SPARSER::COLLECTION)
    ("other molecules that are critical for CD1d antigen loading or processing in endosomes"
     . SPARSER::COLLECTION)
    ("CD1d and ROCK" . SPARSER::COLLECTION)
    ("ROCK/actin" . SPARSER::COLLECTION) ("HSA" . SPARSER::PROTEIN)
    ("CD1d and MHC" . SPARSER::COLLECTION)
    ("ROCK and actin" . SPARSER::COLLECTION)
    ("CD1d- and MHC" . SPARSER::COLLECTION) ("CD1d-" . SPARSER::PROTEIN)
    ("ROCK, LIMK and actin" . SPARSER::COLLECTION)
    ("the exogenous ligand" . SPARSER::LIGAND)
    ("disaccharide" . SPARSER::MOLECULE)
    ("galactosylceramide" . SPARSER::MOLECULE)
    ("exogenous lipid antigens" . SPARSER::PROTEIN)
    ("CD1d and LAMP-1" . SPARSER::COLLECTION)
    ("ROCK/LIMK" . SPARSER::COLLECTION)
    ("the ROCK- or LIMK-specific shRNA" . SPARSER::COLLECTION)
    ("ROCK-" . SPARSER::PROTEIN-FAMILY) ("ROCK or LIMK" . SPARSER::COLLECTION)
    ("Rhodamine" . SPARSER::PROTEIN) ("ROCK and LIMK" . SPARSER::COLLECTION)
    ("LIMK1 ( xref ) and LIMK2 ( xref )" . SPARSER::COLLECTION)
    ("LIMK1 or LIMK2" . SPARSER::COLLECTION)
    ("LIMK2 or control (NC) shRNA" . SPARSER::COLLECTION)
    ("LIMK1, LIMK2 or control (NC) shRNA" . SPARSER::COLLECTION)
    ("control (NC) shRNA" . SPARSER::PROTEIN)
    ("kinases (LIMK)" . SPARSER::PROTEIN)
    ("ROCK and F-actin" . SPARSER::COLLECTION)
    ("LIMK1 and LIMK2" . SPARSER::COLLECTION)
    ("its filamentous form" . SPARSER::FORM)
    ("very efficient antigen" . SPARSER::PROTEIN)
    ("the Rho GTPase effector and serine/threonine kinase"
     . SPARSER::COLLECTION)
    ("ROCK/LIMK/actin" . SPARSER::COLLECTION) ("vis" . SPARSER::DRUG)
    ("ROCK or its downstream effector LIMK" . SPARSER::COLLECTION)
    ("kinase (LIMK)" . SPARSER::KINASE)
    ("Rho kinase (ROCK)" . SPARSER::PROTEIN)
    ("ROCK1 and ROCK2" . SPARSER::COLLECTION)
    ("kinases, ROCK1 and ROCK2" . SPARSER::COLLECTION)
    ("NKT" . SPARSER::PROTEIN) ("CD1d antigen" . SPARSER::PROTEIN)
    ("CD1c" . SPARSER::PROTEIN) ("CD1b" . SPARSER::PROTEIN)
    ("Rho kinase 2" . SPARSER::PROTEIN) ("P81" . SPARSER::PROTEIN)
    ("LIMK2" . SPARSER::PROTEIN) ("GM-CSF" . SPARSER::PROTEIN)
    ("PKCδ" . SPARSER::PROTEIN) ("CD1d" . SPARSER::PROTEIN)
    ("PI3K, BRAF, MEK or mTOR" . SPARSER::COLLECTION)
    ("a more comprehensive solution" . SPARSER::MOLECULE)
    ("MEK, AKT or PIK3CA" . SPARSER::COLLECTION)
    ("AREG and EREG" . SPARSER::COLLECTION)
    ("the further downstream-located BRAF" . SPARSER::PROTEIN)
    ("KRAS ( xref ) and PIK3CA" . SPARSER::COLLECTION)
    ("DUSP4 and DUSP6" . SPARSER::COLLECTION)
    ("AREG , EREG , DUSP6 and SLC26A3" . SPARSER::COLLECTION)
    ("DUSP6 and DUSP18" . SPARSER::COLLECTION)
    ("RAS, PI3K and mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("KIT, CDC42, MRAS, CRK, FCGR2A, LCK and JAK2" . SPARSER::COLLECTION)
    ("EGFR/ERK/MAPK" . SPARSER::COLLECTION)
    ("KRAS , BRAF or PIK3CA" . SPARSER::COLLECTION)
    ("AREG/EREG" . SPARSER::COLLECTION) ("Erbitux" . SPARSER::DRUG)
    ("amphiregulin ( AREG ) and epiregulin ( EREG )" . SPARSER::COLLECTION)
    ("EREG" . SPARSER::PROTEIN) ("epiregulin" . SPARSER::PROTEIN)
    ("RHEB" . SPARSER::PROTEIN)
    ("KIT, CDC42, MRAS, CRK, FCGR2A, JAK2 and LCK" . SPARSER::COLLECTION)
    ("LCK" . SPARSER::PROTEIN) ("CRK" . SPARSER::PROTEIN)
    ("MRAS" . SPARSER::PROTEIN) ("RAS, PI3K and MEK 1/2" . SPARSER::COLLECTION)
    ("BRAF , KRAS and PI3KCA" . SPARSER::COLLECTION)
    ("KRAS , BRAF and PI3KCA" . SPARSER::COLLECTION)
    ("BRAF and/or PIK3CA" . SPARSER::COLLECTION)
    ("KRAS/BRAF/PIK3CA" . SPARSER::COLLECTION)
    ("the minimal optimal gene" . SPARSER::GENE) ("MCC" . SPARSER::PROTEIN)
    ("KRAS and PI3KCA" . SPARSER::COLLECTION)
    ("BRAF , KRAS or PIK3CA" . SPARSER::COLLECTION)
    ("metastatic CRC" . SPARSER::PROTEIN)
    ("BRAF (11.0%) and PIK3CA (11.5%)" . SPARSER::COLLECTION)
    ("KRAS (30.2%), BRAF (11.0%) and PIK3CA (11.5%)" . SPARSER::COLLECTION)
    ("SLC26A3" . SPARSER::PROTEIN) ("PHLDA1" . SPARSER::PROTEIN)
    ("DKK1" . SPARSER::PROTEIN) ("DUSP6" . SPARSER::PROTEIN)
    ("FCGR2A" . SPARSER::PROTEIN) ("MEK 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PK3" . SPARSER::PROTEIN) ("phospholipase D" . SPARSER::PROTEIN)
    ("inositol 3-kinase" . SPARSER::PROTEIN)
    ("APC , BRCA2 , NOTCH1 , PTEN , and NF1" . SPARSER::COLLECTION)
    ("Trametinib" . SPARSER::DRUG) ("Dabrafenib" . SPARSER::DRUG)
    ("possibly K601E mutants" . SPARSER::MUTANT)
    ("MEK and BRAF" . SPARSER::COLLECTION)
    ("BRAF (V600E/K/M/R/D) as well as NRAS (G12/13, Q61)"
     . SPARSER::COLLECTION)
    ("dacarbazine" . SPARSER::DRUG) ("Vemurafenib" . SPARSER::DRUG)
    ("-ERK" . SPARSER::COLLECTION) ("BRAF and MEK" . SPARSER::COLLECTION)
    ("GNAQ (Q209) and GNA11 (Q209)" . SPARSER::COLLECTION)
    ("“BRAF-wildtype" . SPARSER::COLLECTION)
    ("KIT, NRAS, GNAQ, and GNA11" . SPARSER::COLLECTION)
    ("GNAQ" . SPARSER::PROTEIN) ("a highly aggressive BRAF" . SPARSER::PROTEIN)
    ("BRAF or KIT" . SPARSER::COLLECTION) ("NOTCH1" . SPARSER::PROTEIN)
    ("GRIN2A" . SPARSER::PROTEIN) ("glutamate receptor" . SPARSER::PROTEIN)
    ("GSK2118436" . SPARSER::DRUG) ("MEK inhibitor TAK-733" . SPARSER::DRUG)
    ("GSK1120212" . SPARSER::DRUG) ("TAK-733" . SPARSER::DRUG)
    ("GNA11" . SPARSER::PROTEIN) ("Blk and p27" . SPARSER::COLLECTION)
    ("Blk and Alox5" . SPARSER::COLLECTION)
    ("Pax5 and Cdkn1b" . SPARSER::COLLECTION)
    ("Blk and GFP" . SPARSER::COLLECTION)
    ("CFSE stained CD34 + CD38" . SPARSER::PROTEIN)
    ("Blk (ΔTk) or BCR-ABL" . SPARSER::COLLECTION)
    ("Cdk2 and Cyclin E" . SPARSER::COLLECTION)
    ("BCR-ABL-transducedCdkn1b" . SPARSER::COLLECTION)
    ("LT-" . SPARSER::PROTEIN) ("GFP or BCR-ABL" . SPARSER::COLLECTION)
    ("p21 and cyclin-dependent kinase 2" . SPARSER::COLLECTION)
    ("p27 and Blk" . SPARSER::COLLECTION) ("Cdkn1b" . SPARSER::PROTEIN)
    ("EBF1 and Pax5" . SPARSER::COLLECTION)
    ("Pax5 and Blk" . SPARSER::COLLECTION)
    ("c-Myc and EBF1" . SPARSER::COLLECTION)
    ("Pax5 and GFP or GFP" . SPARSER::COLLECTION)
    ("Pax5 or BCR-ABL" . SPARSER::COLLECTION)
    ("BCR-ABL and Pax5" . SPARSER::COLLECTION)
    ("GFP- or GFP" . SPARSER::COLLECTION) ("CD3e" . SPARSER::PROTEIN)
    ("Blk-GFP" . SPARSER::COLLECTION) ("GFP or GFP" . SPARSER::COLLECTION)
    ("donor-derived myeloid" . SPARSER::PROTEIN)
    ("ST-HSCs" . SPARSER::COLLECTION) ("MPPs" . SPARSER::PROTEIN)
    ("MEP, and GMP" . SPARSER::COLLECTION) ("Flt-3" . SPARSER::PROTEIN)
    ("ST-LSCs" . SPARSER::COLLECTION) ("LT-LSCs" . SPARSER::COLLECTION)
    ("MEP" . SPARSER::PROTEIN) ("CMP" . SPARSER::CMP)
    ("LSCs or ST" . SPARSER::COLLECTION)
    ("Blk or imatinib" . SPARSER::COLLECTION)
    ("BCR-ABL or BCR-ABL" . SPARSER::COLLECTION)
    ("BCR-ABL and Blk" . SPARSER::COLLECTION)
    ("normal HSCs" . SPARSER::PROTEIN) ("Alox5" . SPARSER::PROTEIN)
    ("LSCs" . SPARSER::PROTEIN) ("pLP2" . SPARSER::PROTEIN)
    ("granulocyte-colony-stimulating factor" . SPARSER::PROTEIN)
    ("interleukin-3" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 2" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor 1B" . SPARSER::PROTEIN)
    ("IRF8" . SPARSER::PROTEIN)
    ("interferon regulatory factor 8" . SPARSER::PROTEIN)
    ("EBF1" . SPARSER::PROTEIN) ("Gr-1" . SPARSER::PROTEIN)
    ("BCL2, XIAP and survivin" . SPARSER::COLLECTION)
    ("c-IAP2 and XIAP" . SPARSER::COLLECTION) ("c-IAP1" . SPARSER::COLLECTION)
    ("survivin and Bcl-xL" . SPARSER::COLLECTION)
    ("ligand (TRAIL)" . SPARSER::MOLECULE)
    ("BCL2 or XIAP" . SPARSER::COLLECTION)
    ("livin, XIAP and survivin" . SPARSER::COLLECTION)
    ("livin" . SPARSER::PROTEIN) ("the new siRNAs" . SPARSER::PROTEIN)
    ("the previously used siRNAs" . SPARSER::PROTEIN)
    ("new siRNAs" . SPARSER::PROTEIN)
    ("BCL2, Bcl-xL, XIAP or survivin" . SPARSER::COLLECTION)
    ("other prosurvival genes" . SPARSER::GENE)
    ("BCL2 and IAP" . SPARSER::COLLECTION) ("S-1 or S-2" . SPARSER::COLLECTION)
    ("S-2" . SPARSER::PROTEIN) ("BCL2, Bcl-xL or XIAP" . SPARSER::COLLECTION)
    ("BCL2 and XIAP" . SPARSER::COLLECTION)
    ("whereby 40 nM siRNA" . SPARSER::PROTEIN) ("BX-1" . SPARSER::COLLECTION)
    ("complex (RISC)" . SPARSER::BIO-COMPLEX)
    ("survivin-XIAP" . SPARSER::COLLECTION)
    ("nonmuscle-invasive BCa" . SPARSER::PROTEIN)
    ("Survivin and XIAP" . SPARSER::COLLECTION)
    ("IAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BCL2 and Bcl-xL" . SPARSER::COLLECTION)
    ("gemcitabine and cisplatin" . SPARSER::COLLECTION)
    ("antiapoptotic BCL2, Bcl-xL, XIAP and survivin" . SPARSER::COLLECTION)
    ("BCL2, Bcl-xL, XIAP and survivin" . SPARSER::COLLECTION)
    ("BCa" . SPARSER::PROTEIN) ("c-IAP2" . SPARSER::PROTEIN)
    ("IAP1" . SPARSER::PROTEIN) ("apoptosis-inducing" . SPARSER::PROTEIN)
    ("tumour necrosis factor" . SPARSER::PROTEIN)
    ("TATA box binding protein" . SPARSER::PROTEIN) ("S-1" . SPARSER::PROTEIN)
    ("ERK-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK and RSK" . SPARSER::COLLECTION)
    ("ERK1/2-activated protein kinase" . SPARSER::COLLECTION)
    ("S6K1 and 4E-BP1" . SPARSER::COLLECTION)
    ("eEF1b and Rpl12" . SPARSER::COLLECTION) ("Rpl12" . SPARSER::PROTEIN)
    ("Fifteen different ribosomal proteins" . SPARSER::PROTEIN)
    ("MAPK and mTORC1" . SPARSER::COLLECTION)
    ("mRNAs, and gene" . SPARSER::COLLECTION)
    ("MAPK and mTOR" . SPARSER::COLLECTION)
    ("polysomal mRNA" . SPARSER::PROTEIN)
    ("MAPK or mTORC1" . SPARSER::COLLECTION)
    ("the polysomal RNA fraction" . SPARSER::COMPONENT)
    ("total or polysomal mRNA" . SPARSER::PROTEIN)
    ("RSK (BI-D1870) or mTORC1 (KU-0063794 and rapamycin) inhibitors"
     . SPARSER::COLLECTION)
    ("Total and polysomal RNAs" . SPARSER::RNA)
    ("KU-0063794 and rapamycin" . SPARSER::COLLECTION)
    ("eIF4E, eIF4G and eIF4A" . SPARSER::COLLECTION)
    ("ribosomes" . SPARSER::BIO-COMPLEX)
    ("MEK1/2 or RSK" . SPARSER::COLLECTION)
    ("RSK1 and RSK2" . SPARSER::COLLECTION)
    ("BRAF and NRAS" . SPARSER::COLLECTION)
    ("NRAS (WM852 and WM1361) or BRAF (Colo829 and A375)"
     . SPARSER::COLLECTION)
    ("rapamycin and KU-0063794" . SPARSER::COLLECTION)
    ("MEK1/2 and RSK" . SPARSER::COLLECTION)
    ("MEK1/2 (U0126 or PD184352) or RSK (BI-D1870 or SL0101)"
     . SPARSER::COLLECTION)
    ("U0126 or PD184352" . SPARSER::COLLECTION)
    ("BI-D1870 or SL0101" . SPARSER::COLLECTION) ("rpS6" . SPARSER::PROTEIN)
    ("rpS" . SPARSER::PROTEIN)
    ("H-Ras (G12V) or B-Raf (V600E)" . SPARSER::COLLECTION)
    ("MEK1 (MEK-DD), H-Ras (G12V) or B-Raf (V600E)" . SPARSER::COLLECTION)
    ("the eukaryotic translation initiation factor 4E (eIF4E) and the p70 ribosomal S6 kinases (S6K1 and S6K2)"
     . SPARSER::COLLECTION)
    ("the p70 ribosomal S6 kinases" . SPARSER::PROTEIN-FAMILY)
    ("two main translational regulators" . SPARSER::REGULATOR)
    ("S6K1 and S6K2" . SPARSER::COLLECTION) ("mTORC" . SPARSER::PROTEIN)
    ("The p90 ribosomal S6 kinase (RSK) family" . SPARSER::PROTEIN-FAMILY)
    ("Ras or Raf" . SPARSER::COLLECTION)
    ("a valuable therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("complex and polysome" . SPARSER::COLLECTION)
    ("ERK/RSK" . SPARSER::COLLECTION)
    ("MAPK-activated protein kinase" . SPARSER::COLLECTION)
    ("RSK" . SPARSER::PROTEIN) ("Ras and Raf" . SPARSER::COLLECTION)
    ("Ras/mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("RasG12V" . SPARSER::PROTEIN) ("K 3" . SPARSER::PROTEIN)
    ("4EBP1" . SPARSER::PROTEIN) ("eEF1b" . SPARSER::PROTEIN)
    ("e-12" . SPARSER::PROTEIN) ("7-methylguanosine" . SPARSER::MOLECULE)
    ("RSK2" . SPARSER::PROTEIN) ("KU-0063794" . SPARSER::DRUG)
    ("SL0101" . SPARSER::DRUG) ("BI-D1870" . SPARSER::MOLECULE)
    ("PD184352" . SPARSER::DRUG)
    ("phosphoinositide-3 kinase" . SPARSER::PROTEIN)
    ("S6Ks" . SPARSER::PROTEIN) ("S6K2" . SPARSER::PROTEIN)
    ("S6 kinases" . SPARSER::PROTEIN-FAMILY) ("p70" . SPARSER::PROTEIN)
    ("p90" . SPARSER::PROTEIN) ("ATR/ATM" . SPARSER::COLLECTION)
    ("Rad9/Rad1/Hus1" . SPARSER::COLLECTION)
    ("DNA-PK/ATM/ATR" . SPARSER::COLLECTION)
    ("cellular p53 is" . SPARSER::PROTEIN)
    ("equimolar ssDNA" . SPARSER::PROTEIN) ("RPA-p53" . SPARSER::COLLECTION)
    ("Chk2 or Chk1" . SPARSER::COLLECTION)
    ("DDRs, DNA-PK, ATM and ATR" . SPARSER::COLLECTION)
    ("ATM/ATR/p53" . SPARSER::COLLECTION) ("Cellular DDRs" . SPARSER::PROTEIN)
    ("KU55933 and NU6027" . SPARSER::COLLECTION)
    ("ATM and ATM" . SPARSER::COLLECTION) ("pDR" . SPARSER::PROTEIN)
    ("cellular RPA" . SPARSER::PROTEIN)
    ("promoting Rad51 presynaptic filament" . SPARSER::PROTEIN-FAMILY)
    ("Rad51 and hyp-RPA" . SPARSER::COLLECTION)
    ("wt-RPA" . SPARSER::PROTEIN-PAIR)
    ("recombinant RPA and hyp-RPA proteins" . SPARSER::COLLECTION)
    ("only non-phosphorylated RPA32" . SPARSER::PROTEIN)
    ("ATR or ATM" . SPARSER::COLLECTION)
    ("ATR, ATM, or DNA-PK" . SPARSER::COLLECTION)
    ("Ku55933 and Nu6027" . SPARSER::COLLECTION)
    ("ATR, ATM or DNA-PK" . SPARSER::COLLECTION)
    ("ATM, ATR and DNA-PK" . SPARSER::COLLECTION)
    ("DNA-PK, ATR and ATM" . SPARSER::COLLECTION) ("CIAP" . SPARSER::PROTEIN)
    ("Intestinal Alkaline Phosphatase (CIAP)" . SPARSER::PROTEIN)
    ("p53-associated proteins" . SPARSER::PROTEIN)
    ("native RPA and hyp-RPA" . SPARSER::COLLECTION)
    ("RPA/hyp-RPA" . SPARSER::COLLECTION)
    ("an equimolar mixture" . SPARSER::MOLECULE)
    ("hyp-RPA" . SPARSER::COLLECTION)
    ("possible p53-associated proteins" . SPARSER::PROTEIN)
    ("p53 and the unphosphorylated RPA" . SPARSER::COLLECTION)
    ("hyp-RPA32" . SPARSER::COLLECTION) ("hyp" . SPARSER::PROTEIN)
    ("phosphorylation-deficient RPA32 (PD-RPA) and wild-type RPA32 ( xref )"
     . SPARSER::COLLECTION)
    ("p53, RPA, DNA-PK, ATM and ATR" . SPARSER::COLLECTION)
    ("RPA or p53" . SPARSER::COLLECTION) ("p53 or RPA" . SPARSER::COLLECTION)
    ("DNA-PK and ATM/ATR" . SPARSER::COLLECTION)
    ("RPA and p53" . SPARSER::COLLECTION) ("TET" . SPARSER::PROTEIN)
    ("RPA-protein" . SPARSER::COLLECTION)
    ("the major eukaryotic single-stranded DNA (ssDNA) binding protein"
     . SPARSER::PROTEIN)
    ("protein A (RPA)" . SPARSER::PROTEIN)
    ("RPA70, RPA32, and RPA14" . SPARSER::COLLECTION)
    ("DDRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a 615 kDa heterotrimeric complex" . SPARSER::BIO-COMPLEX)
    ("Ku70 and Ku80" . SPARSER::COLLECTION) ("genotoxins" . SPARSER::MOLECULE)
    ("DNA-PK, ATM and ATR" . SPARSER::COLLECTION)
    ("p53 and RPA" . SPARSER::COLLECTION) ("p53-RPA" . SPARSER::COLLECTION)
    ("DNA-damage checkpoint kinases ataxia telangiectasia mutated (ATM) and ATM-"
     . SPARSER::COLLECTION)
    ("ataxia telangiectasia mutated (ATM)" . SPARSER::PROTEIN)
    ("DNA-damage" . SPARSER::DNA) ("Rad1" . SPARSER::PROTEIN)
    ("Rad9" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Rad52" . SPARSER::PROTEIN)
    ("S46" . SPARSER::PROTEIN) ("S15A" . SPARSER::PROTEIN)
    ("Nu6027" . SPARSER::DRUG) ("Ku55933" . SPARSER::DRUG)
    ("Intestinal Alkaline Phosphatase" . SPARSER::PROTEIN)
    ("RPA14" . SPARSER::PROTEIN) ("XRCC5" . SPARSER::PROTEIN)
    ("XRCC6" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase-related kinase" . SPARSER::PROTEIN)
    ("RPA32" . SPARSER::PROTEIN) ("PAK-GST" . SPARSER::COLLECTION)
    ("E-cadherin and Dsg3" . SPARSER::COLLECTION)
    ("antibody and phalloidin-actin" . SPARSER::COLLECTION)
    ("phalloidin-actin" . SPARSER::PROTEIN)
    ("actin/Dsg3" . SPARSER::COLLECTION) ("Dsg3/actin" . SPARSER::COLLECTION)
    ("Rac1/Dsg3" . SPARSER::COLLECTION) ("Rac1/Cdc42" . SPARSER::COLLECTION)
    ("Dsg3 and Dsg1" . SPARSER::COLLECTION)
    ("Rac1, Cdc42 and actin" . SPARSER::COLLECTION)
    ("The immobile fraction" . SPARSER::COMPONENT)
    ("EosFP-actin" . SPARSER::COLLECTION)
    ("Dsg3 and ZO-1" . SPARSER::COLLECTION)
    ("Triton soluble fraction" . SPARSER::COMPONENT)
    ("Triton insoluble fraction" . SPARSER::COMPONENT)
    ("Triton soluble and insoluble fractions" . SPARSER::COMPONENT)
    ("the adjacent actin" . SPARSER::PROTEIN)
    ("more pronounced linear organised junctional actin" . SPARSER::PROTEIN)
    ("a weaker and more diffuse punctate E-cadherin and actin"
     . SPARSER::COLLECTION)
    ("E-cadherin and actin" . SPARSER::COLLECTION)
    ("E-cadherin–catenin" . SPARSER::COLLECTION)
    ("antibody and phalloidin–actin" . SPARSER::COLLECTION)
    ("phalloidin–actin" . SPARSER::PROTEIN)
    ("the Triton soluble fraction" . SPARSER::COMPONENT)
    ("subcellular fraction" . SPARSER::COMPONENT)
    ("Dsg3-actin" . SPARSER::COLLECTION)
    ("Dsg2 and actin" . SPARSER::COLLECTION) ("desmoplakin" . SPARSER::PROTEIN)
    ("the peripheral Dsg3 and F-actin" . SPARSER::COLLECTION)
    ("junctional actin" . SPARSER::PROTEIN)
    ("Dsg3 and F-actin" . SPARSER::COLLECTION) ("PV-IgG" . SPARSER::COLLECTION)
    ("a p120 related desmosomal plaque protein" . SPARSER::PROTEIN)
    ("plakophilin-1" . SPARSER::COLLECTION) ("plakophilin" . SPARSER::PROTEIN)
    ("the desmosomal components" . SPARSER::COMPONENT)
    ("cadherin–catenin" . SPARSER::COLLECTION)
    ("Rac, Cdc42 and RhoA" . SPARSER::COLLECTION)
    ("an alternate morphology state" . SPARSER::BIO-STATE)
    ("autoantigen" . SPARSER::DRUG) ("the junctional actin" . SPARSER::PROTEIN)
    ("Dsg3 and actin" . SPARSER::COLLECTION) ("Dsg1" . SPARSER::PROTEIN)
    ("C–E" . SPARSER::PROTEIN) ("Dsg2" . SPARSER::PROTEIN)
    ("3 h" . SPARSER::PROTEIN) ("18 h" . SPARSER::PROTEIN)
    ("H10" . SPARSER::PROTEIN) ("Myosin Light Chain 2" . SPARSER::PROTEIN)
    ("plakophilin-2" . SPARSER::PROTEIN) ("α-catenins" . SPARSER::PROTEIN)
    ("Dsg3" . SPARSER::PROTEIN) ("Desmoglein 3" . SPARSER::PROTEIN)
    ("GABA) ( xref ) and dopamine ( xref )" . SPARSER::COLLECTION)
    ("Two key neurotransmitters" . SPARSER::MOLECULE)
    ("serotonin and other neurotransmitters ( xref )" . SPARSER::COLLECTION)
    ("valproic acid and TSA" . SPARSER::COLLECTION)
    ("HAT-HDAC" . SPARSER::COLLECTION) ("HATs and HDACs" . SPARSER::COLLECTION)
    ("Sp1 and Sp3" . SPARSER::COLLECTION)
    ("HDAC and TSA" . SPARSER::COLLECTION)
    ("dopamine and serotonin" . SPARSER::COLLECTION)
    ("catechol-omethyltransferase" . SPARSER::COLLECTION)
    ("omethyltransferase" . SPARSER::PROTEIN) ("catechol" . SPARSER::PROTEIN)
    ("monoaminergic neurotransmission genes" . SPARSER::GENE)
    ("proteins and gene" . SPARSER::COLLECTION)
    ("serotonergic receptors" . SPARSER::PROTEIN)
    ("TSA and serotonin" . SPARSER::COLLECTION)
    ("receptors or complex" . SPARSER::COLLECTION)
    ("serotonin and other neurotransmitters" . SPARSER::COLLECTION)
    ("TSA and ondansetron" . SPARSER::COLLECTION)
    ("ondansetron and TSA" . SPARSER::COLLECTION)
    ("ondansetron" . SPARSER::DRUG)
    ("western blot and flow cytometry ( xref )" . SPARSER::COLLECTION)
    ("Alcohol and TSA" . SPARSER::COLLECTION) ("Alcohol" . SPARSER::DRUG)
    ("alcohol and TSA" . SPARSER::COLLECTION)
    ("TSA and TSA" . SPARSER::COLLECTION)
    ("a nonspecific inhibitor and the mechanisms of action"
     . SPARSER::COLLECTION)
    ("a nonspecific inhibitor" . SPARSER::INHIBITOR)
    ("a widely use HDACi" . SPARSER::MOLECULE) ("Ethanol" . SPARSER::PROTEIN)
    ("enzymes and transporters" . SPARSER::COLLECTION)
    ("serotonin and serotonin" . SPARSER::COLLECTION)
    ("histones and DNA" . SPARSER::COLLECTION) ("cocaine" . SPARSER::DRUG)
    ("ethanol, HDACs, and serotonin" . SPARSER::COLLECTION)
    ("receptor and transporter" . SPARSER::COLLECTION)
    ("drug and alcohol" . SPARSER::COLLECTION)
    ("the serotonin transporter (SERT) and the enzyme monoamine oxidase-A (MAO-A)"
     . SPARSER::COLLECTION)
    ("transporter (SERT)" . SPARSER::PROTEIN) ("SERT" . SPARSER::PROTEIN)
    ("5-HT3 and serotonin" . SPARSER::COLLECTION)
    ("HDACs and HATs" . SPARSER::COLLECTION) ("HATs" . SPARSER::PROTEIN)
    ("Serotonin" . SPARSER::MOLECULE)
    ("western blot and flow cytometry" . SPARSER::COLLECTION)
    ("serotonin and 5-HT3" . SPARSER::COLLECTION) ("alcohol-" . SPARSER::DRUG)
    ("HDACi" . SPARSER::MOLECULE) ("serotonin" . SPARSER::MOLECULE)
    ("neurotransmitter" . SPARSER::MOLECULE)
    ("neurotransmitters" . SPARSER::MOLECULE) ("GABA)" . SPARSER::PROTEIN)
    ("Sp3" . SPARSER::PROTEIN) ("ion channel" . SPARSER::PROTEIN-FAMILY)
    ("5-HT 3" . SPARSER::PROTEIN) ("HDAC 8" . SPARSER::PROTEIN)
    ("HDAC 3" . SPARSER::PROTEIN) ("HDAC 1" . SPARSER::PROTEIN)
    ("5-HT3A" . SPARSER::PROTEIN) ("HDAC 2" . SPARSER::PROTEIN)
    ("opioid receptor" . SPARSER::PROTEIN) ("MAO-A" . SPARSER::PROTEIN)
    ("5-HT3" . SPARSER::PROTEIN) ("5-HT" . SPARSER::PROTEIN)
    ("Rags and Rheb" . SPARSER::COLLECTION)
    ("cellular TSC2" . SPARSER::PROTEIN)
    ("the Rag GTPases and the scaffolding complex" . SPARSER::COLLECTION)
    ("the Rab or other small G-protein families" . SPARSER::COLLECTION)
    ("Rab17" . SPARSER::PROTEIN) ("Rabs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Unconventional TBC domains generally lack known targets"
     . SPARSER::TARGET-PROTEIN)
    ("TBC-domain" . SPARSER::BIO-COMPLEX)
    ("the stoichiometric complex and its downstream functions"
     . SPARSER::COLLECTION)
    ("the stoichiometric complex" . SPARSER::BIO-COMPLEX)
    ("previously forTsc2 −/− MEFs" . SPARSER::PROTEIN)
    ("growth factors and glucose" . SPARSER::COLLECTION)
    ("glucose and amino acids" . SPARSER::COLLECTION)
    ("the trimeric complex" . SPARSER::BIO-COMPLEX)
    ("mTORC2 and Akt" . SPARSER::COLLECTION)
    ("TBC1D7 or TSC1" . SPARSER::COLLECTION) ("TSC2-GAP" . SPARSER::COLLECTION)
    ("phenformin" . SPARSER::DRUG)
    ("the functional GAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TSC1 or TBC1D7" . SPARSER::COLLECTION)
    ("most commercially available TSC2 antibodies" . SPARSER::ANTIBODY)
    ("some TSC1 ( xref and xref ) and TSC2 ( xref and xref )"
     . SPARSER::COLLECTION)
    ("TBC1D7-TSC1" . SPARSER::COLLECTION)
    ("TBC1D7, TSC1, and TSC2" . SPARSER::COLLECTION)
    ("still bind TSC1" . SPARSER::PROTEIN)
    ("TBC1D7 and TSC1" . SPARSER::COLLECTION)
    ("TBC1D7 and TSC2" . SPARSER::COLLECTION)
    ("previously characterized TSC1- or TSC2-associated proteins"
     . SPARSER::COLLECTION)
    ("TSC2-associated proteins" . SPARSER::PROTEIN)
    ("previously characterized TSC1-" . SPARSER::PROTEIN)
    ("TSC1-" . SPARSER::PROTEIN) ("NaCl or SDS" . SPARSER::COLLECTION)
    ("detergents" . SPARSER::MOLECULE)
    ("TSC2 and TBC1D7" . SPARSER::COLLECTION)
    ("TSC1 (~130 kDa) and TSC2 (~200 kDa)" . SPARSER::COLLECTION)
    ("total cellular TBC1D7" . SPARSER::PROTEIN)
    ("six unique antibodies" . SPARSER::ANTIBODY)
    ("TSC1 or TSC2" . SPARSER::COLLECTION) ("Rab-GAP" . SPARSER::COLLECTION)
    ("Tre2-Bub2-Cdc16" . SPARSER::COLLECTION)
    ("growth factors and cytokines" . SPARSER::COLLECTION)
    ("Rheb, and complex" . SPARSER::COLLECTION)
    ("hamartin and tuberin" . SPARSER::COLLECTION)
    ("Rap1Gap" . SPARSER::PROTEIN) ("Gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hamartin" . SPARSER::PROTEIN) ("Rheb and mTORC1" . SPARSER::COLLECTION)
    ("protein and lipid" . SPARSER::COLLECTION)
    ("Rheb-GAP" . SPARSER::COLLECTION)
    ("TSC1-TSC2-TBC1D7" . SPARSER::COLLECTION) ("TBC" . SPARSER::BIO-COMPLEX)
    ("ubiquitous third core subunit" . SPARSER::FRAGMENT)
    ("TSC1-TSC2" . SPARSER::COLLECTION) ("RhebL1" . SPARSER::PROTEIN)
    ("Rheb2" . SPARSER::PROTEIN) ("LAMP2" . SPARSER::PROTEIN)
    ("Rab family" . SPARSER::PROTEIN) ("member 7" . SPARSER::PROTEIN)
    ("Cdc16" . SPARSER::PROTEIN) ("Bub2" . SPARSER::PROTEIN)
    ("Tre2" . SPARSER::PROTEIN) ("G-proteins" . SPARSER::PROTEIN)
    ("TBC1D7" . SPARSER::PROTEIN) ("lobes" . SPARSER::PROTEIN)
    ("our AA and NG cohorts" . SPARSER::COLLECTION)
    ("neither ESR2 nor AR genes" . SPARSER::COLLECTION)
    ("exact allele" . SPARSER::ALLELE) ("ESR1 and ESR2" . SPARSER::COLLECTION)
    ("SS and SL" . SPARSER::COLLECTION) ("AA or AA" . SPARSER::COLLECTION)
    ("AA and S" . SPARSER::COLLECTION) ("Alleles" . SPARSER::ALLELE)
    ("STRs" . SPARSER::PROTEIN)
    ("estrogens and androgens" . SPARSER::COLLECTION)
    ("estrogens and progesterone" . SPARSER::COLLECTION)
    ("the complex and comprehensive nature" . SPARSER::COLLECTION)
    ("hormonal receptor genes" . SPARSER::GENE)
    ("ESR1 , ESR2 and AR" . SPARSER::COLLECTION)
    ("the estrogen receptor ( ESR1 , ESR2) and androgen receptor ( AR ) genes"
     . SPARSER::COLLECTION)
    ("isoform 4" . SPARSER::PROTEIN) ("CCDC170" . SPARSER::PROTEIN)
    ("TRIM50 and LC3" . SPARSER::COLLECTION)
    ("microtubule-associated protein 1A/1B" . SPARSER::COLLECTION)
    ("TRIM50-p62" . SPARSER::COLLECTION) ("LIR" . SPARSER::PROTEIN)
    ("a multifunctional adapter protein" . SPARSER::PROTEIN)
    ("Serpin H1, HSP90B1, PPIB, and 14-3-3" . SPARSER::COLLECTION)
    ("PPIB" . SPARSER::PROTEIN)
    ("molecular chaperones and ubiquitin-proteasome system components"
     . SPARSER::COLLECTION)
    ("both soluble and insoluble fractions" . SPARSER::COMPONENT)
    ("HDAC6 and p62" . SPARSER::COLLECTION) ("Prof" . SPARSER::PROTEIN)
    ("the detergent insoluble fraction" . SPARSER::COMPONENT)
    ("p62 and TRIM50" . SPARSER::COLLECTION)
    ("p62 and HDAC6" . SPARSER::COLLECTION) ("Myc-p62" . SPARSER::COLLECTION)
    ("an anti-Myc" . SPARSER::ANTIBODY) ("FLAG-TRIM50" . SPARSER::COLLECTION)
    ("TRIM50 and p62" . SPARSER::COLLECTION)
    ("Sequestosome 1/p62" . SPARSER::COLLECTION)
    ("TRIM50-HDAC6" . SPARSER::COLLECTION) ("Tubb2b" . SPARSER::PROTEIN)
    ("Light" . SPARSER::PROTEIN) ("trans-" . SPARSER::PROTEIN-FAMILY)
    ("B-Box and Coiled-Coil" . SPARSER::COLLECTION)
    ("an insoluble protein aggregate fraction" . SPARSER::COMPONENT)
    ("interactors, HDAC6 and p62" . SPARSER::COLLECTION)
    ("p62 and HDCA6" . SPARSER::COLLECTION)
    ("28 hemizygous genes mapping" . SPARSER::PROTEIN)
    ("TRIM" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p62/SQSTM1" . SPARSER::COLLECTION)
    ("Microtubule-associated histone deacetylase 6" . SPARSER::PROTEIN)
    ("Trim50" . SPARSER::PROTEIN) ("Hdac6" . SPARSER::PROTEIN)
    ("B-box" . SPARSER::PROTEIN) ("light chain 3" . SPARSER::PROTEIN)
    ("microtubule-associated protein 1A" . SPARSER::PROTEIN)
    ("zeta)" . SPARSER::PROTEIN) ("HSP90B1" . SPARSER::PROTEIN)
    ("Serpin H1" . SPARSER::PROTEIN) ("Sequestosome 1" . SPARSER::PROTEIN)
    ("Tubulin beta 2B class IIb" . SPARSER::PROTEIN)
    ("B-Box" . SPARSER::PROTEIN) ("NBR1" . SPARSER::PROTEIN)
    ("SQSTM1" . SPARSER::PROTEIN) ("histone deacetylase 6" . SPARSER::PROTEIN)
    ("TRIM50" . SPARSER::PROTEIN) ("Ubiquitin ligase" . SPARSER::PROTEIN)
    ("the BRCA1-A complex and BRCA1-dependent DNA damage response"
     . SPARSER::COLLECTION)
    ("RAP80 and functional BRCA1-A complex" . SPARSER::COLLECTION)
    ("BRCA1, CCDC98 and NBA1" . SPARSER::COLLECTION)
    ("BRCA1 and other subunits" . SPARSER::COLLECTION)
    ("exogenous RAP80" . SPARSER::PROTEIN)
    ("CCDC98 and NBA1" . SPARSER::COLLECTION)
    ("BRCA1 and NBA1" . SPARSER::COLLECTION)
    ("BRCA1 and RAP80" . SPARSER::COLLECTION)
    ("CCDC98, BRCC36, NBA1 and BRE" . SPARSER::COLLECTION)
    ("radiation-induced foci (IRIF)" . SPARSER::PROTEIN)
    ("RAP80 and BRCA1" . SPARSER::COLLECTION) ("IRIF" . SPARSER::PROTEIN)
    ("AZA" . SPARSER::DRUG) ("BRIP1, PALB2 and Rad51" . SPARSER::COLLECTION)
    ("NBA1/MERIT40/HSPC142" . SPARSER::COLLECTION)
    ("BRCC45/BRE" . SPARSER::COLLECTION)
    ("ABRAXAS/CCDC98" . SPARSER::COLLECTION) ("ABRAXAS" . SPARSER::PROTEIN)
    ("correct abnormal DNA adducts" . SPARSER::PROTEIN)
    ("at least three different complexes" . SPARSER::BIO-COMPLEX)
    ("BRCA1, CCDC98, NBA1, BRCC36 and BRE" . SPARSER::COLLECTION)
    ("BRE" . SPARSER::PROTEIN)
    ("a subunit of the BRCA1-A complex and targets BRCA1"
     . SPARSER::COLLECTION)
    ("HSPC142" . SPARSER::PROTEIN) ("MERIT40" . SPARSER::PROTEIN)
    ("BRCC45" . SPARSER::PROTEIN) ("BRCC36" . SPARSER::PROTEIN)
    ("NBA1" . SPARSER::PROTEIN) ("CCDC98" . SPARSER::PROTEIN)
    ("RAP80" . SPARSER::PROTEIN)
    ("Receptor Associated Protein 80" . SPARSER::PROTEIN)
    ("sub-genomic DNA" . SPARSER::DNA)
    ("an exogenous oncogene" . SPARSER::ONCOGENE)
    ("their respective homologue" . SPARSER::PROTEIN)
    ("hDlg and hScrib" . SPARSER::COLLECTION)
    ("Scrib, Dlg and Lgl" . SPARSER::COLLECTION)
    ("the sub-genomic DNA" . SPARSER::DNA)
    ("propidium iodide staining and flow cytometry" . SPARSER::COLLECTION)
    ("HEMA" . SPARSER::PROTEIN)
    ("pro- or anti-apoptotic" . SPARSER::COLLECTION)
    ("Ras or Myc" . SPARSER::COLLECTION) ("Scribble" . SPARSER::PROTEIN)
    ("collagen or fibronectin" . SPARSER::COLLECTION)
    ("cytoskeletal fractions" . SPARSER::COMPONENT)
    ("β-catenin and E-cadherin" . SPARSER::COLLECTION)
    ("E-cadherin and β-catenin" . SPARSER::COLLECTION)
    ("commercial shRNA" . SPARSER::PROTEIN)
    ("Dlg and Scrib" . SPARSER::COLLECTION)
    ("hScrib or hDlg1" . SPARSER::COLLECTION)
    ("JNK and ERK" . SPARSER::COLLECTION) ("Ras and Myc" . SPARSER::COLLECTION)
    ("Scrib or Dlg" . SPARSER::COLLECTION) ("discs" . SPARSER::BIO-COMPLEX)
    ("proteins, hScrib, hDlg1 and Hugl-1" . SPARSER::COLLECTION)
    ("the Par complex and the Scrib complex xref" . SPARSER::COLLECTION)
    ("hScrib and hDlg1" . SPARSER::COLLECTION)
    ("hScrib and hDlg" . SPARSER::COLLECTION) ("hDlg" . SPARSER::PROTEIN)
    ("hScrib" . SPARSER::PROTEIN) ("Dlg" . SPARSER::PROTEIN)
    ("Scrib" . SPARSER::DRUG) ("p84" . SPARSER::PROTEIN)
    ("E4-ORF1" . SPARSER::PROTEIN) ("Hugl-1" . SPARSER::PROTEIN)
    ("allele and lung" . SPARSER::COLLECTION) ("the exact type" . TYPE)
    ("a special histological form" . SPARSER::FORM)
    ("type, ethnicity and source" . SPARSER::COLLECTION)
    ("inhibitor or activator" . SPARSER::COLLECTION)
    ("wild type or dominant negative SIRT6 and knock outs"
     . SPARSER::COLLECTION)
    ("which controls genes" . SPARSER::GENE) ("Gli" . SPARSER::PROTEIN)
    ("a surprisingly low deacetylase activity" . SPARSER::PROTEIN)
    ("−1 and aK" . SPARSER::COLLECTION)
    ("transcription factors GLI (p value 0.0163; genes NHLH1, GLI1, OLIG2, VEGFA and CD24) and GLI3 ( p value 0.0207; GLI1)"
     . SPARSER::COLLECTION)
    ("NHLH1, GLI1, OLIG2, VEGFA and CD24" . SPARSER::COLLECTION)
    ("VEGFA" . SPARSER::PROTEIN) ("GLI" . SPARSER::PROTEIN)
    ("SIRT6 and the H133W mutant" . SPARSER::COLLECTION)
    ("153 upregulated genes and 45 downregulated genes" . SPARSER::COLLECTION)
    ("FC" . SPARSER::PROTEIN)
    ("the SIRT6 or H133W proteins" . SPARSER::COLLECTION)
    ("wild type SIRT6 or the H133W mutant" . SPARSER::COLLECTION)
    ("an inflammatory cytokine" . SPARSER::PROTEIN)
    ("SIRT6 or the H133W catalytically dead mutant" . SPARSER::COLLECTION)
    ("YFP-p65" . SPARSER::COLLECTION)
    ("Yellow Fluorescent Protein-p65" . SPARSER::COLLECTION)
    ("wild type SIRT6 nor the H133W mutant" . SPARSER::COLLECTION)
    ("target genes and occupancy" . SPARSER::COLLECTION)
    ("min −1 , and 0.32s" . SPARSER::COLLECTION)
    ("H3K56Ac peptides and in vivo  xref" . SPARSER::COLLECTION)
    ("activators or inhibitors" . SPARSER::COLLECTION)
    ("RECQL2/WRN" . SPARSER::COLLECTION)
    ("a macromolecular complex" . SPARSER::BIO-COMPLEX)
    ("SIRT6 and SIRT7" . SPARSER::COLLECTION)
    ("deacetylase activity and SIRT4 and SIRT6" . SPARSER::COLLECTION)
    ("SIRT4 and SIRT6" . SPARSER::COLLECTION)
    ("-O-acetyl-ADP-ribose" . SPARSER::MOLECULE) ("Ac" . SPARSER::PROTEIN)
    ("a valid drug target" . SPARSER::TARGET-PROTEIN)
    ("activators and inhibitors" . SPARSER::COLLECTION)
    ("NFκB and HIF1α" . SPARSER::COLLECTION) ("MCP-1" . SPARSER::PROTEIN)
    ("M −1" . SPARSER::PROTEIN) ("GLI3" . SPARSER::PROTEIN)
    ("OLIG2" . SPARSER::PROTEIN) ("GLI1" . SPARSER::PROTEIN)
    ("NHLH1" . SPARSER::PROTEIN) ("CXCL10" . SPARSER::PROTEIN)
    ("MCP1" . SPARSER::PROTEIN)
    ("Yellow Fluorescent Protein" . SPARSER::PROTEIN)
    ("K56" . SPARSER::PROTEIN) ("Deacetylase Activity" . SPARSER::PROTEIN)
    ("RECQL2" . SPARSER::PROTEIN) ("PARP1" . SPARSER::PROTEIN)
    ("DNA-dependent protein kinase" . SPARSER::PROTEIN)
    ("ADP-ribosyl" . SPARSER::MOLECULE)
    ("O-acetyl-ADP-ribose" . SPARSER::MOLECULE)
    ("HDAC or HAT" . SPARSER::COLLECTION)
    ("histone and non-histone" . SPARSER::COLLECTION)
    ("state, HDACIII, SIRT1, and CBP" . SPARSER::COLLECTION)
    ("HDACIII" . SPARSER::PROTEIN-FAMILY)
    ("BRCA1, RPA and BLM" . SPARSER::COLLECTION)
    ("BRCA1 as well as FANCJ" . SPARSER::COLLECTION)
    ("CPT or zeocin" . SPARSER::COLLECTION)
    ("This more robust DDR" . SPARSER::PROTEIN)
    ("HR and DNA" . SPARSER::COLLECTION) ("BRCA-FA" . SPARSER::COLLECTION)
    ("FANCJ K1249R or FANCJ K1249Q" . SPARSER::COLLECTION)
    ("RPA and Rad51" . SPARSER::COLLECTION)
    ("FANCJ K1249Q or FANCJ" . SPARSER::COLLECTION)
    ("the CPT-treated FANCJ" . SPARSER::PROTEIN)
    ("Chk2 and γ-H2AX" . SPARSER::COLLECTION)
    ("Rad54 or polη" . SPARSER::COLLECTION)
    ("Rad18 or the translesion polymerase polη" . SPARSER::COLLECTION)
    ("ICLs and intra-strand" . SPARSER::COLLECTION)
    ("FANCJ K1249R and FANCJ K1249Q" . SPARSER::COLLECTION)
    ("FANCJ S990A and FANCJ K141/142A" . SPARSER::COLLECTION)
    ("BRCA1 and MLH1" . SPARSER::COLLECTION)
    ("BRCA1- and MLH1-interaction-defective" . SPARSER::COLLECTION)
    ("BRCA1-" . SPARSER::PROTEIN) ("exogenous FANCJ" . SPARSER::PROTEIN)
    ("the very last amino acid of FANCJ" . SPARSER::PROTEIN)
    ("the very last amino acid" . SPARSER::AMINO-ACID)
    ("overlapping peptides" . SPARSER::PEPTIDE)
    ("HDAC1, HDAC2, or SIRT6" . SPARSER::COLLECTION)
    ("class 1 and class II HDACs" . SPARSER::COLLECTION)
    ("various Flag- or HA-tagged histone acetyltransferases"
     . SPARSER::COLLECTION)
    ("Flag-" . SPARSER::PROTEIN-FAMILY)
    ("acetyltransferases" . SPARSER::PROTEIN)
    ("proteins, CtIP and FANCJ" . SPARSER::COLLECTION)
    ("a robust DDR" . SPARSER::PROTEIN)
    ("cisplatin, melphalan, or mitomycin C" . SPARSER::COLLECTION)
    ("melphalan" . SPARSER::DRUG) ("DEAH" . SPARSER::PROTEIN-FAMILY)
    ("Abraxas, CtIP and FANCJ" . SPARSER::COLLECTION)
    ("BRIP1 or BACH1" . SPARSER::COLLECTION)
    ("Abraxas" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an essential tumor suppressor" . SPARSER::SUPPRESSOR)
    ("Rad54 and greater" . SPARSER::COLLECTION)
    ("HDAC3 or SIRT1" . SPARSER::COLLECTION) ("BRCA–FA" . SPARSER::COLLECTION)
    ("BRCA1–Fanconi anemia" . SPARSER::COLLECTION)
    ("CtIP and FANCJ" . SPARSER::COLLECTION)
    ("BRIP1/BACH1" . SPARSER::COLLECTION) ("Not1" . SPARSER::PROTEIN)
    ("NaVO 3" . SPARSER::MOLECULE) ("Dog-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P47" . SPARSER::PROTEIN) ("SIRT6" . SPARSER::PROTEIN)
    ("an exhaustive study mapping" . SPARSER::PROTEIN)
    ("NF-κB 2/p100" . SPARSER::COLLECTION) ("TRAF3-TBK1" . SPARSER::COLLECTION)
    ("TRAF3 and TRADD" . SPARSER::COLLECTION)
    ("MAVS and STING" . SPARSER::COLLECTION)
    ("TLR3 and TLR4" . SPARSER::COLLECTION)
    ("proteins, Sec16A and p115" . SPARSER::COLLECTION)
    ("dsRNA- and dsDNA-transfected cells" . SPARSER::COLLECTION)
    ("TRAF2 or TRAF6" . SPARSER::COLLECTION)
    ("TRAF3, Sec16A, p115 and TBK1" . SPARSER::COLLECTION)
    ("COPI and COP" . SPARSER::COLLECTION) ("polydA:dT" . SPARSER::BIO-COMPLEX)
    ("SeV-" . SPARSER::PROTEIN) ("dsRNA-" . SPARSER::RNA)
    ("TLR3, TLR4, TLR7, TLR8 and TLR9" . SPARSER::COLLECTION)
    ("p115 ( xref ) and Sec16A ( xref )" . SPARSER::COLLECTION)
    ("the phosphorylation state of IRF-3 and the induction of ISG54 in HeLa cells"
     . SPARSER::COLLECTION)
    ("oas1" . SPARSER::PROTEIN) ("ifit1" . SPARSER::PROTEIN)
    ("Ifnb" . SPARSER::PROTEIN)
    ("Sec16A, p115 and TRAF3" . SPARSER::COLLECTION)
    ("RIG-I-" . SPARSER::PROTEIN) ("TRIF-" . SPARSER::PROTEIN)
    ("Sec16 or p115" . SPARSER::COLLECTION) ("Sec16" . SPARSER::PROTEIN)
    ("the ISG56 promoter and the NF-κB-dependent promoter ( xref )"
     . SPARSER::COLLECTION)
    ("the TLR3 essential effector TRIF" . SPARSER::PROTEIN)
    ("NF-κB and IRF-3" . SPARSER::COLLECTION)
    ("COPI and COPII" . SPARSER::COLLECTION)
    ("COPI" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p115- and Sec16A-containing complexes" . SPARSER::COLLECTION)
    ("p115-" . SPARSER::PROTEIN) ("PAMP" . SPARSER::PROTEIN)
    ("dT" . SPARSER::HUMAN-PROTEIN-FAMILY) ("dA" . SPARSER::MOLECULE)
    ("TFG" . SPARSER::PROTEIN) ("TIM" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ring and Zinc finger" . SPARSER::COLLECTION) ("Ring" . SPARSER::PROTEIN)
    ("BFA" . SPARSER::MOLECULE)
    ("endogenous Sec16A ( xref ) or Myc-p115 ( xref )" . SPARSER::COLLECTION)
    ("FLAG-TRAF6" . SPARSER::COLLECTION) ("FLAG-TRAF2" . SPARSER::COLLECTION)
    ("TRAF3 and the ER marker calnexin ( xref , panel 6)"
     . SPARSER::COLLECTION)
    ("calnexin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TRAF2, TRAF3 or TRAF6" . SPARSER::COLLECTION)
    ("TRADD and RIP1" . SPARSER::COLLECTION)
    ("TRAF1, TRAF2 and TRAF3" . SPARSER::COLLECTION)
    ("TRAF2, TRAF3 and TRAF6" . SPARSER::COLLECTION)
    ("Myc-TRAF3" . SPARSER::COLLECTION)
    ("TRAF3, Sec16A and p115" . SPARSER::COLLECTION)
    ("FLAG-p115" . SPARSER::COLLECTION) ("EGFP-Sec16A" . SPARSER::COLLECTION)
    ("Myc-p115" . SPARSER::COLLECTION) ("FLAG-TRAF3" . SPARSER::COLLECTION)
    ("the antiviral state" . SPARSER::BIO-STATE)
    ("p115 or Sec16A" . SPARSER::COLLECTION)
    ("p115 and Sec16A" . SPARSER::COLLECTION)
    ("novel essential mediators" . SPARSER::PROTEIN)
    ("MITA, ERIS, and MPYS" . SPARSER::COLLECTION) ("ERIS" . SPARSER::PROTEIN)
    ("MITA" . SPARSER::PROTEIN) ("STING" . SPARSER::PROTEIN)
    ("giantin" . SPARSER::PROTEIN)
    ("Sec16A (also known as KIAA0310) and p115 (also known as USO1)"
     . SPARSER::COLLECTION)
    ("TRAF3-" . SPARSER::PROTEIN) ("FADD-" . SPARSER::PROTEIN)
    ("FADD and RIP1" . SPARSER::COLLECTION)
    ("MAVS and TRADD" . SPARSER::COLLECTION)
    ("TBK1 and IKKi" . SPARSER::COLLECTION) ("IKKi" . SPARSER::PROTEIN)
    ("TRAF2-cIAP1-cIAP2" . SPARSER::COLLECTION)
    ("BAFFR, CD40, LTβR, RANK, CD30, and Fn14" . SPARSER::COLLECTION)
    ("BAFFR" . SPARSER::PROTEIN)
    ("receptors or signalling proteins" . SPARSER::COLLECTION)
    ("TRAF" . SPARSER::PROTEIN-FAMILY)
    ("TNFR, IL1R, and TLRs" . SPARSER::COLLECTION)
    ("IPS-1, Cardif and VISA" . SPARSER::COLLECTION)
    ("IRF-3 and NF-κB" . SPARSER::COLLECTION) ("VISA" . SPARSER::PROTEIN)
    ("Cardif" . SPARSER::PROTEIN) ("RIG-I and MDA5" . SPARSER::COLLECTION)
    ("helicases (RLH)" . SPARSER::PROTEIN) ("kinase (PKR)" . SPARSER::KINASE)
    ("DAI" . SPARSER::PROTEIN) ("IRFs" . SPARSER::PROTEIN)
    ("retinoic" . SPARSER::PROTEIN) ("RLH" . SPARSER::PROTEIN)
    ("PRRs" . SPARSER::PROTEIN) ("p115, Sec16A and TBK1" . SPARSER::COLLECTION)
    ("MAVS and Tank-binding kinase-1 (TBK1)" . SPARSER::COLLECTION)
    ("Sec16A or p115" . SPARSER::COLLECTION)
    ("IFNβ, ISG56 and NF-κB" . SPARSER::COLLECTION)
    ("dsRNA and dsDNA" . SPARSER::COLLECTION) ("Helicase" . SPARSER::PROTEIN)
    ("MAVS" . SPARSER::PROTEIN) ("Sec16A and p115" . SPARSER::COLLECTION)
    ("Sec16A" . SPARSER::PROTEIN)
    ("Tumor Necrosis Factor receptor-associated factor-3" . SPARSER::PROTEIN)
    ("dsRNA" . SPARSER::RNA) ("P115" . SPARSER::PROTEIN)
    ("Poly I:C" . SPARSER::MOLECULE) ("pRK5" . SPARSER::PROTEIN)
    ("NF-κB 2" . SPARSER::PROTEIN) ("GD3" . SPARSER::MOLECULE)
    ("MIP-T3" . SPARSER::PROTEIN) ("ISG54" . SPARSER::PROTEIN)
    ("signal peptide" . SPARSER::PROTEIN) ("poly I:C" . SPARSER::MOLECULE)
    ("Zinc finger" . SPARSER::PROTEIN) ("brefeldin A" . SPARSER::MOLECULE)
    ("ERGIC53" . SPARSER::PROTEIN) ("Rab1" . SPARSER::PROTEIN)
    ("GOLGA2" . SPARSER::PROTEIN) ("Sec61" . SPARSER::PROTEIN)
    ("USO1" . SPARSER::PROTEIN) ("KIAA0310" . SPARSER::PROTEIN)
    ("Fn14" . SPARSER::PROTEIN) ("CD40" . SPARSER::PROTEIN)
    ("TRAF4" . SPARSER::PROTEIN) ("TRAF7" . SPARSER::PROTEIN)
    ("IL1R" . SPARSER::PROTEIN) ("IRF-3" . SPARSER::PROTEIN)
    ("IPS-1" . SPARSER::PROTEIN)
    ("nucleotide-binding oligomerization domain" . SPARSER::PROTEIN)
    ("IFI16" . SPARSER::PROTEIN) ("AIM2" . SPARSER::PROTEIN)
    ("Absent In Melanoma 2" . SPARSER::PROTEIN)
    ("HIN-200 family" . SPARSER::PROTEIN-FAMILY) ("LGP2" . SPARSER::PROTEIN)
    ("MDA5" . SPARSER::PROTEIN) ("beta)" . SPARSER::PROTEIN)
    ("ISG56" . SPARSER::PROTEIN) ("IFNβ" . SPARSER::PROTEIN)
    ("Hec1" . SPARSER::PROTEIN) ("p115" . SPARSER::PROTEIN)
    ("16A" . SPARSER::PROTEIN) ("factor-3" . SPARSER::PROTEIN)
    ("Tumor Necrosis Factor" . SPARSER::PROTEIN)
    ("GTP-bound Cdc42 and the tyrosine kinase" . SPARSER::COLLECTION)
    ("GTPase and protein" . SPARSER::COLLECTION)
    ("Mitochondrial Stat3" . SPARSER::PROTEIN)
    ("Akt, ERK2, and GSK3β" . SPARSER::COLLECTION)
    ("kinases and PKC" . SPARSER::COLLECTION)
    ("Rac1 and MgcRacGAP" . SPARSER::COLLECTION)
    ("individual kinases" . SPARSER::KINASE) ("DAG" . SPARSER::DAG)
    ("aPKC" . SPARSER::PROTEIN) ("PKC and Rac1" . SPARSER::COLLECTION)
    ("Rac1-Stat3" . SPARSER::COLLECTION)
    ("the first 17 amino acids of Rac1 that are involved in Stat3 binding"
     . SPARSER::PROTEIN)
    ("Stat3 and CA Rac1" . SPARSER::COLLECTION)
    ("Rac1 and isoforms" . SPARSER::COLLECTION)
    ("JAK-Stat3" . SPARSER::COLLECTION)
    ("the NH 2 -terminal 54 amino acids of Rac1" . SPARSER::PROTEIN)
    ("AAs" . SPARSER::MOLECULE) ("GST/Rac1" . SPARSER::COLLECTION)
    ("Rac1 and Stat3α" . SPARSER::COLLECTION) ("Gal4" . SPARSER::PROTEIN)
    ("Stat3 and the NH 2 -terminal 54 amino acids" . SPARSER::COLLECTION)
    ("Stat3/Rac1" . SPARSER::COLLECTION)
    ("Stat3 and PKCζ" . SPARSER::COLLECTION)
    ("PKCζ siRNA or negative control siRNA" . SPARSER::COLLECTION)
    ("chelerythrine" . SPARSER::DRUG) ("Stat3/PKC" . SPARSER::COLLECTION)
    ("Rac1 and H/R" . SPARSER::COLLECTION)
    ("Stat3 and Rac1" . SPARSER::COLLECTION)
    ("Rac1 and PKC, and Stat3" . SPARSER::COLLECTION)
    ("PKC, and Stat3" . SPARSER::COLLECTION)
    ("cysteine (NAC)" . SPARSER::MOLECULE)
    ("both during normoxia and following H/R" . SPARSER::COLLECTION)
    ("I/R or hypoxia/reoxygenation" . SPARSER::COLLECTION)
    ("JAK-Stat" . SPARSER::COLLECTION)
    ("tyrosine and serine" . SPARSER::COLLECTION)
    ("growth factors or cytokines" . SPARSER::COLLECTION)
    ("JAKs" . SPARSER::PROTEIN) ("pro-inflammatory genes" . SPARSER::GENE)
    ("Stats" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transducers and activators" . SPARSER::COLLECTION)
    ("Rac1 and Stat3" . SPARSER::COLLECTION)
    ("Rac1 and PKC" . SPARSER::COLLECTION) ("p67 phox" . SPARSER::PROTEIN)
    ("PKCζ" . SPARSER::PROTEIN) ("p-S" . SPARSER::PROTEIN)
    ("R-T" . SPARSER::PROTEIN) ("NADPH-oxidase" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule-1" . SPARSER::PROTEIN)
    ("three other histologic subtypes" . SPARSER::PROTEIN)
    ("SET" . SPARSER::PROTEIN) ("contiguous hyaline" . SPARSER::PROTEIN)
    ("hyaline" . SPARSER::PROTEIN) ("lax" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("high grade ductal histologic type" . TYPE)
    ("isoform-selective pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("additionally two Ral GTPase activating proteins" . SPARSER::PROTEIN)
    ("Ras-driven PDAC tumor cells RalA" . SPARSER::PROTEIN)
    ("Ral or RalB" . SPARSER::COLLECTION)
    ("inhibitor (GGTI)" . SPARSER::INHIBITOR) ("GGTI" . SPARSER::PROTEIN)
    ("Therapeutics" . SPARSER::THERAPEUTICS)
    ("RalBP1 or even unknown effector proteins" . SPARSER::COLLECTION)
    ("even unknown effector proteins" . SPARSER::PROTEIN)
    ("RalB and Sec5" . SPARSER::COLLECTION)
    ("this octomeric complex" . SPARSER::BIO-COMPLEX)
    ("RalBP1/RLIP76" . SPARSER::COLLECTION) ("exocyst" . SPARSER::BIO-COMPLEX)
    ("Common and Distinct Effectors" . SPARSER::EFFECTOR)
    ("Effectors" . SPARSER::EFFECTOR) ("K-Ras-RalGEF" . SPARSER::COLLECTION)
    ("RalA or RalB" . SPARSER::COLLECTION)
    ("PDAC and CRC" . SPARSER::COLLECTION)
    ("GEFs and GAPs" . SPARSER::COLLECTION) ("RalGEFs" . SPARSER::PROTEIN)
    ("HRAS , KRAS and NRAS" . SPARSER::COLLECTION)
    ("distinct Ral" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RalGEF-Ral" . SPARSER::COLLECTION) ("PDAC" . SPARSER::MOLECULE)
    ("Raf and phosphoinositol" . SPARSER::COLLECTION)
    ("RalGEF" . SPARSER::PROTEIN) ("TBK1" . SPARSER::PROTEIN)
    ("RLIP76" . SPARSER::PROTEIN)
    ("Ral guanine nucleotide exchange factor" . SPARSER::PROTEIN)
    ("the major hereditary breast cancer suppressors" . SPARSER::SUPPRESSOR)
    ("the sporadic breast cancer cell line MCF7" . SPARSER::PROTEIN)
    ("BRCA and FA" . SPARSER::COLLECTION) ("endonucleases" . SPARSER::PROTEIN)
    ("PCNA and RAD51" . SPARSER::COLLECTION)
    ("BRCA and RAD51" . SPARSER::COLLECTION)
    ("BRCA2/RAD51" . SPARSER::COLLECTION)
    ("ICL and other DNA" . SPARSER::COLLECTION)
    ("FANCD2-Ub" . SPARSER::COLLECTION)
    ("FANCD2 and RAD51" . SPARSER::COLLECTION)
    ("even wild-type RAD51" . SPARSER::PROTEIN)
    ("forms hyperstable filaments" . SPARSER::PROTEIN-FAMILY)
    ("RAD51 and BRCA2" . SPARSER::COLLECTION)
    ("FANCD2-complemented" . SPARSER::COLLECTION)
    ("FA and RAD51" . SPARSER::COLLECTION) ("mirin" . SPARSER::DRUG)
    ("BRCA2 or RAD51" . SPARSER::COLLECTION)
    ("-complemented" . SPARSER::COLLECTION)
    ("BRCA and FANC" . SPARSER::COLLECTION) ("tet/tet" . SPARSER::COLLECTION)
    ("Blm" . SPARSER::PROTEIN) ("FA and BRCA" . SPARSER::COLLECTION)
    ("BRCA1 and BRCA2—the" . SPARSER::COLLECTION)
    ("a functional BRCA1" . SPARSER::PROTEIN)
    ("FANCD2 and BRCA2" . SPARSER::COLLECTION)
    ("FA-Associated Proteins" . SPARSER::PROTEIN)
    ("the chemotherapeutic gemcitabine" . SPARSER::DRUG)
    ("elongation, or camptothecin" . SPARSER::COLLECTION)
    ("poison" . SPARSER::MOLECULE) ("FANCA-complemented" . SPARSER::COLLECTION)
    ("FANCD2/FANCI" . SPARSER::COLLECTION) ("complemented" . SPARSER::PROTEIN)
    ("BRCA2 and RAD51" . SPARSER::COLLECTION)
    ("FANCD2 and HR" . SPARSER::COLLECTION) ("FA and HR" . SPARSER::COLLECTION)
    ("poisons" . SPARSER::MOLECULE)
    ("homologous recombination (HR) proteins" . SPARSER::PROTEIN)
    ("BRCA2/FANCD1" . SPARSER::COLLECTION)
    ("FANCD2-FANCI" . SPARSER::COLLECTION)
    ("camptothecin and cisplatin" . SPARSER::COLLECTION)
    ("gemcitabine and 5-fluorouracil" . SPARSER::COLLECTION)
    ("FA, RAD51, and BRCA1/2" . SPARSER::COLLECTION)
    ("RAD51 and the BRCA1 / 2 breast cancer suppressors" . SPARSER::COLLECTION)
    ("FANCD2 , and BRCA1" . SPARSER::COLLECTION) ("Smc5" . SPARSER::PROTEIN)
    ("mitomycin-C" . SPARSER::DRUG) ("VEGF and MET" . SPARSER::COLLECTION)
    ("VEGFKO-shMET" . SPARSER::PROTEIN-PAIR)
    ("glycosylphosphatidylinositol" . SPARSER::MOLECULE)
    ("the classical E-cadherin" . SPARSER::PROTEIN)
    ("Snail and N-Cadherin" . SPARSER::COLLECTION)
    ("Traits" . SPARSER::PROTEIN)
    ("MET, VEGFR2, EGFR, insulin receptor, and PDGFR" . SPARSER::COLLECTION)
    ("inadequate oxygen or nutrient" . SPARSER::COLLECTION)
    ("oxygen or nutrient" . SPARSER::COLLECTION)
    ("VEGFR2/RTK" . SPARSER::COLLECTION)
    ("semaphorins" . SPARSER::PROTEIN-FAMILY)
    ("other co-receptors and surface molecules" . SPARSER::COLLECTION)
    ("VEGFR2 or MET" . SPARSER::COLLECTION)
    ("VEGF or VEGFR2" . SPARSER::COLLECTION)
    ("key mesenchymal genes and markers" . SPARSER::COLLECTION)
    ("genes and markers" . SPARSER::COLLECTION)
    ("vimentin, CD44, and YKL-40" . SPARSER::COLLECTION)
    ("the mesenchymal subtype" . SPARSER::PROTEIN)
    ("Bevacizumab" . SPARSER::DRUG)
    ("Snail and N-cadherin" . SPARSER::COLLECTION)
    ("a more mesenchymal and aggressive state" . SPARSER::BIO-STATE)
    ("anti-VEGF and anti-MET" . SPARSER::COLLECTION)
    ("shMET1" . SPARSER::PROTEIN) ("VEGFKO-shMET1" . SPARSER::COLLECTION)
    ("the late endosome marker Rab7" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rab5 and Rab4" . SPARSER::COLLECTION) ("MET/EEA-1" . SPARSER::COLLECTION)
    ("PTP1B/MET" . SPARSER::COLLECTION) ("PTP1B and MET" . SPARSER::COLLECTION)
    ("orthovanadate" . SPARSER::MOLECULE)
    ("MET and WT-VEGFR2" . SPARSER::COLLECTION) ("PLA" . SPARSER::PROTEIN)
    ("Δ450C" . SPARSER::PROTEIN) ("VEGFR2-Δ450C" . SPARSER::COLLECTION)
    ("VEGFKO and GBM43" . SPARSER::COLLECTION)
    ("kinase and effector" . SPARSER::COLLECTION)
    ("VEGFR2-" . SPARSER::PROTEIN) ("-VEGFR2" . SPARSER::COLLECTION)
    ("VEGFR2 and MET" . SPARSER::COLLECTION)
    ("MET and VEGFR2" . SPARSER::COLLECTION)
    ("VEGF/VEGFR2" . SPARSER::COLLECTION) ("VEGFR2/MET" . SPARSER::COLLECTION)
    ("VEGFR1 (MF1) and VEGFR2 (DC101)" . SPARSER::COLLECTION)
    ("MF1" . SPARSER::PROTEIN) ("VEGF and HGF" . SPARSER::COLLECTION)
    ("MET and FAK" . SPARSER::COLLECTION)
    ("hypoxia-regulated pro-invasive genes" . SPARSER::GENE)
    ("intratumoral hypoxia" . SPARSER::PROTEIN) ("VEGFKO" . SPARSER::PROTEIN)
    ("exogenous VEGF" . SPARSER::PROTEIN)
    ("large T-antigen and H-ras" . SPARSER::COLLECTION)
    ("VEGFKO-VEGF" . SPARSER::COLLECTION)
    ("HGF and VEGF" . SPARSER::COLLECTION)
    ("fluid-attenuated inversion recovery (FLAIR) MRI" . SPARSER::PROTEIN)
    ("MET/VEGFR2" . SPARSER::COLLECTION) ("Zeb-1" . SPARSER::PROTEIN)
    ("N-Cadherin" . SPARSER::PROTEIN) ("HIF1α" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor" . SPARSER::PROTEIN)
    ("Anti-VEGF" . SPARSER::DRUG) ("YKL-40" . SPARSER::PROTEIN)
    ("EEA-1" . SPARSER::PROTEIN) ("VEGF 121" . SPARSER::PROTEIN)
    ("NRP-1" . SPARSER::PROTEIN) ("large T-antigen" . SPARSER::PROTEIN)
    ("anti-VEGF" . SPARSER::DRUG) ("T-cadherin" . SPARSER::PROTEIN)
    ("PTP1B" . SPARSER::PROTEIN) ("MH" . SPARSER::MOLECULE)
    ("IK" . SPARSER::PROTEIN) ("EK" . SPARSER::PROTEIN)
    ("JK" . SPARSER::PROTEIN) ("MAPK, or p53" . SPARSER::COLLECTION)
    ("Bim and Puma" . SPARSER::COLLECTION)
    ("EGFR-TKI (tyrosine kinase inhibitor) and pemetrexed [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("pemetrexed" . SPARSER::DRUG)
    ("proteins, Bad, Bid and Bim" . SPARSER::COLLECTION)
    ("Noxa or Puma" . SPARSER::COLLECTION)
    ("proteins, Bim, Noxa and Puma" . SPARSER::COLLECTION)
    ("pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("protein and BH3-only" . SPARSER::COLLECTION)
    ("Puma or Noxa" . SPARSER::COLLECTION)
    ("p27, Ki67 and cyclin E" . SPARSER::COLLECTION)
    ("Bim, Noxa, or Puma" . SPARSER::COLLECTION)
    ("the antibodies observed within the cytoplasm" . SPARSER::ANTIBODY)
    ("blot and immunohistochemistry" . SPARSER::COLLECTION)
    ("Bim and Noxa" . SPARSER::COLLECTION)
    ("Bim, Noxa and Puma" . SPARSER::COLLECTION)
    ("Noxa and Puma" . SPARSER::COLLECTION) ("Akt/PI3K" . SPARSER::COLLECTION)
    ("Bik, Bid, Bim, Bmf, Hrk, Bad, Noxa, and Puma" . SPARSER::COLLECTION)
    ("Bim, Noxa, and Puma" . SPARSER::COLLECTION)
    ("CX" . SPARSER::PROTEIN-FAMILY) ("MAPKs and NF-κB" . SPARSER::COLLECTION)
    ("JNKs" . SPARSER::PROTEIN) ("IL-6/STAT3" . SPARSER::COLLECTION)
    ("CTLA-4/PD-1" . SPARSER::COLLECTION)
    ("PTP and N-SH2 domain" . SPARSER::COLLECTION)
    ("a complete LDs" . SPARSER::PROTEIN) ("LDs" . SPARSER::PROTEIN)
    ("PG" . SPARSER::PROTEIN) ("apoB" . SPARSER::PROTEIN)
    ("cagA/SHP-2" . SPARSER::COLLECTION) ("Src and Abl" . SPARSER::COLLECTION)
    ("HDL-C" . SPARSER::PROTEIN) ("LDL-C" . SPARSER::PROTEIN)
    ("nonreceptor-type 11" . SPARSER::PROTEIN)
    ("traditional thiazolidinediones" . SPARSER::PROTEIN)
    ("thiazolidinediones" . SPARSER::PROTEIN)
    ("BRCA1 and p300" . SPARSER::COLLECTION)
    ("their receptors and CBP/p300 ( xref ) reducing" . SPARSER::COLLECTION)
    ("receptors and CBP/p300 ( xref ) reducing" . SPARSER::COLLECTION)
    ("p300 and the CYP19 promoter" . SPARSER::COLLECTION)
    ("active CREB or its coactivator p300" . SPARSER::COLLECTION)
    ("PGE 2 , cAMP, and PKA" . SPARSER::COLLECTION)
    ("EP 2 and EP 4" . SPARSER::COLLECTION)
    ("a prototypic PPARγ target gene" . SPARSER::GENE)
    ("aromatase activity and mRNA" . SPARSER::COLLECTION)
    ("PPARγ and p300" . SPARSER::COLLECTION)
    ("pioglitazone, p300, BRCA1, and PPARγ" . SPARSER::COLLECTION)
    ("BRCA1, pCREB, and p300" . SPARSER::COLLECTION)
    ("BRCA1, p300, and pCREB" . SPARSER::COLLECTION)
    ("CREB or p300" . SPARSER::COLLECTION) ("PPRE" . SPARSER::PROTEIN)
    ("mRNA and promoter" . SPARSER::COLLECTION)
    ("PGE 2 and aromatase" . SPARSER::COLLECTION)
    ("Egr-1 and Snail" . SPARSER::COLLECTION)
    ("pioglitazone-treated preadipocytes" . SPARSER::PROTEIN)
    ("cAMP and PKA" . SPARSER::COLLECTION) ("exogenous PGE 2" . SPARSER::DRUG)
    ("primary human visceral preadipocytes" . SPARSER::PROTEIN)
    ("BRCA1, p300, and aromatase" . SPARSER::COLLECTION)
    ("CREB" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("prototypic inhibitors" . SPARSER::INHIBITOR)
    ("COX-2 and PGE 2" . SPARSER::COLLECTION)
    ("COX and aromatase" . SPARSER::COLLECTION) ("COX" . SPARSER::PROTEIN)
    ("15-PGDH and BRCA1" . SPARSER::COLLECTION)
    ("protein, p300, and CYP19" . SPARSER::COLLECTION)
    ("Pioglitazone" . SPARSER::DRUG)
    ("a repressive transcription factor" . SPARSER::PROTEIN)
    ("catabolism" . SPARSER::PROTEIN)
    ("histone acetyl-transferase" . SPARSER::PROTEIN)
    ("EP 4" . SPARSER::PROTEIN) ("EP 2" . SPARSER::PROTEIN)
    ("Aromatase activity" . SPARSER::PROTEIN) ("βgal" . SPARSER::PROTEIN)
    ("glucose-6-phosphate" . SPARSER::MOLECULE) ("Egr-1" . SPARSER::PROTEIN)
    ("Cytochrome P450" . SPARSER::PROTEIN-FAMILY)
    ("15-PGDH" . SPARSER::PROTEIN) ("Prostaglandin E 2" . SPARSER::MOLECULE)
    ("aromatase activity" . SPARSER::PROTEIN) ("CYP19" . SPARSER::PROTEIN)
    ("pathological inducers" . SPARSER::MOLECULE)
    ("nearly every tumor type" . TYPE) ("orntg/Kras" . SPARSER::COLLECTION)
    ("CCSP-rtta/Kras" . SPARSER::COLLECTION)
    ("p16/INK4A" . SPARSER::COLLECTION)
    ("expressed both the YFP" . SPARSER::PROTEIN) ("MMP-3–" . SPARSER::PROTEIN)
    ("ad-LacZ, ad-MMP-3, or ad-TGFβ" . SPARSER::COLLECTION)
    ("exogenous MMP-3" . SPARSER::PROTEIN)
    ("actin and vimentin" . SPARSER::COLLECTION)
    ("three-dimensional Matrigel" . SPARSER::PROTEIN)
    ("red fluorescent protein (RFP)" . SPARSER::PROTEIN)
    ("yellow fluorescent protein (YFP)" . SPARSER::PROTEIN)
    ("MMP-3/Rac1b" . SPARSER::COLLECTION)
    ("mesenchymal marker mRNA" . SPARSER::PROTEIN)
    ("myofibroblast-associated smooth muscle actin"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MMP-3 and Rac1b" . SPARSER::COLLECTION)
    ("MMP-3 and MMP-9" . SPARSER::COLLECTION)
    ("the mesenchymal marker vimentin" . SPARSER::PROTEIN)
    ("mesenchymal cell components" . SPARSER::COMPONENT)
    ("urethane" . SPARSER::MOLECULE) ("carbamate" . SPARSER::MOLECULE)
    ("collagen, vimentin, and α-smooth muscle" . SPARSER::COLLECTION)
    ("rtta" . SPARSER::PROTEIN) ("CCSP-rtta" . SPARSER::PROTEIN-PAIR)
    ("the Clara cell secretory protein (CCSP) promoter" . SPARSER::PROMOTER)
    ("tetO-YFP-Rac1b" . SPARSER::COLLECTION) ("CCSP" . SPARSER::PROTEIN)
    ("tetO" . SPARSER::PROTEIN) ("emphysema" . SPARSER::PROTEIN)
    ("malignant LAC" . SPARSER::PROTEIN)
    ("−p53/p16 Ink4a" . SPARSER::COLLECTION)
    ("MMP-3, MMP-7, and MMP-28" . SPARSER::COLLECTION)
    ("LAC" . SPARSER::PROTEIN)
    ("cytokines, growth factors, and proteases" . SPARSER::COLLECTION)
    ("triphosphatase" . SPARSER::PROTEIN)
    ("an attractive molecular target" . SPARSER::TARGET-PROTEIN)
    ("matrix metalloproteinase (MMP)" . SPARSER::PROTEIN)
    ("a tumor-associated protein" . SPARSER::PROTEIN)
    ("DCR2" . SPARSER::PROTEIN)
    ("tumor necrosis factor receptor superfamily" . SPARSER::PROTEIN)
    ("INK4B" . SPARSER::PROTEIN) ("hnRNP A1" . SPARSER::PROTEIN)
    ("heterogeneous nuclear ribonucleoprotein A1" . SPARSER::PROTEIN)
    ("1A1" . SPARSER::PROTEIN) ("p16 Ink4a" . SPARSER::PROTEIN)
    ("p19 Arf" . SPARSER::PROTEIN) ("MMP-28" . SPARSER::PROTEIN)
    ("Rac1b" . SPARSER::PROTEIN)
    ("the autophagic genes atg1 or atg7" . SPARSER::COLLECTION)
    ("atg1 or atg7" . SPARSER::COLLECTION)
    ("functional Bcl-2" . SPARSER::PROTEIN)
    ("Bmh1 or Bmh2" . SPARSER::COLLECTION)
    ("almost identical 14-3-3 genes" . SPARSER::GENE)
    ("chaperonin" . SPARSER::PROTEIN) ("BMH" . SPARSER::PROTEIN)
    ("the autophagic mutants" . SPARSER::MUTANT)
    ("The autophagic-deficient atg1" . SPARSER::PROTEIN)
    ("Atg7" . SPARSER::PROTEIN) ("Atg1" . SPARSER::PROTEIN)
    ("the nuclear vital dye propidium iodide (PI) and fluorescently labeled AnnexinV"
     . SPARSER::COLLECTION)
    ("the nuclear vital dye propidium iodide (PI)" . SPARSER::PROTEIN)
    ("AnnexinV" . SPARSER::PROTEIN) ("DHE" . SPARSER::DRUG)
    ("Cycloheximide" . SPARSER::PROTEIN)
    ("a previously characterized Bax suppressor" . SPARSER::SUPPRESSOR)
    ("the galactose inductive media" . SPARSER::PROTEIN)
    ("glucose or galactose" . SPARSER::COLLECTION)
    ("galactose" . SPARSER::MOLECULE) ("ceramide" . SPARSER::MOLECULE)
    ("dUTPase" . SPARSER::PROTEIN) ("phosphatidylserine" . SPARSER::PROTEIN)
    ("these autophagic-deficient mutants" . SPARSER::MUTANT)
    ("the macroautophagic-deficient atg1" . SPARSER::PROTEIN)
    ("atg7" . SPARSER::PROTEIN) ("atg1" . SPARSER::PROTEIN)
    ("atg" . SPARSER::DRUG) ("whose paralogs" . SPARSER::PROTEIN)
    ("a cardinal regulator" . SPARSER::REGULATOR) ("GAL1" . SPARSER::PROTEIN)
    ("ura3" . SPARSER::PROTEIN) ("leu2" . SPARSER::PROTEIN)
    ("Bmh2" . SPARSER::PROTEIN) ("atg11" . SPARSER::PROTEIN-FAMILY)
    ("Bmh1" . SPARSER::PROTEIN) ("yeast homolog" . SPARSER::PROTEIN)
    ("PNA-LNA" . SPARSER::COLLECTION) ("PNA" . SPARSER::PROTEIN)
    ("ER and VEGF or Ki-67" . SPARSER::COLLECTION)
    ("VEGF or Ki-67" . SPARSER::COLLECTION)
    ("ER and EGFR" . SPARSER::COLLECTION) ("EGFR and ER" . SPARSER::COLLECTION)
    ("ERα or ERß" . SPARSER::COLLECTION)
    ("VEGF and Ki-67" . SPARSER::COLLECTION) ("FDG" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor (VEGF) and Ki-67"
     . SPARSER::COLLECTION)
    ("the other histological subtypes" . SPARSER::PROTEIN)
    ("mER" . SPARSER::PROTEIN) ("MIB-1" . SPARSER::PROTEIN)
    ("PRL" . SPARSER::PROTEIN) ("GH" . SPARSER::PROTEIN)
    ("ACTH" . SPARSER::PROTEIN) ("homologue (PTEN)" . SPARSER::PROTEIN)
    ("heterodimeric lipid kinases" . SPARSER::PROTEIN)
    ("prolactin" . SPARSER::PROTEIN) ("COL7A1" . SPARSER::PROTEIN)
    ("phosphoinositide-dependent protein kinase-1" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("adrenocorticotropic hormone" . SPARSER::PROTEIN)
    ("p110-α" . SPARSER::PROTEIN)
    ("cyclins, CDKs and CDK-inhibitors" . SPARSER::COLLECTION)
    ("Myt-1 and Wee-1" . SPARSER::COLLECTION)
    ("increased Cyclin A and Cdk2-dependent kinases" . SPARSER::COLLECTION)
    ("p27–CDK2" . SPARSER::COLLECTION)
    ("the eukaryotic mRNA cap-binding protein elongation factor"
     . SPARSER::PROTEIN)
    ("Akt/mTOR" . SPARSER::COLLECTION) ("CDK4/cyclin-D1" . SPARSER::COLLECTION)
    ("CDK4/cyclin D1" . SPARSER::COLLECTION)
    ("CDK4/Cyclin D1" . SPARSER::COLLECTION)
    ("AMPK and p53" . SPARSER::COLLECTION) ("Va" . SPARSER::MOLECULE)
    ("cytochrome" . SPARSER::PROTEIN)
    ("Cyclin D, Cyclin E, Cdk2, Cdk4 and Cdk6" . SPARSER::COLLECTION)
    ("p21 and other cyclin–Cdk inhibitors" . SPARSER::COLLECTION)
    ("The pro-proliferative E2F1-responsive genes" . SPARSER::GENE)
    ("Cyclin E–CDK2" . SPARSER::COLLECTION)
    ("TIGAR and p21 WAF1/CIP1" . SPARSER::COLLECTION)
    ("cyclin–Cdk" . SPARSER::COLLECTION)
    ("Cyclin E–cdk2" . SPARSER::COLLECTION)
    ("Cyclin D–cdk4" . SPARSER::COLLECTION) ("PAHS" . SPARSER::MOLECULE)
    ("Cyclin D, CDK2, CDK4, CDK6, E2F1, RB and Cyclin E" . SPARSER::COLLECTION)
    ("its regulatory cyclins (Cyclins D and E) and the CDKs (CDK2, CDK4 and CDK5)"
     . SPARSER::COLLECTION)
    ("its regulatory cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDK2, CDK4 and CDK5" . SPARSER::COLLECTION)
    ("p53 and TIGAR" . SPARSER::COLLECTION)
    ("p21, p53, p27, p57, p16, ATM, ATR, BARCA1, CHEK2 and CDKN2A"
     . SPARSER::COLLECTION)
    ("p53 and p53-TIGAR-RE" . SPARSER::COLLECTION) ("Tam" . SPARSER::PROTEIN)
    ("CDK4/6-Cyclin D" . SPARSER::COLLECTION)
    ("its actively growth-suppressing hypo-phosphorylated state"
     . SPARSER::BIO-STATE)
    ("specifically target Rb/p105" . SPARSER::COLLECTION)
    ("Rb/p105" . SPARSER::COLLECTION) ("Rb" . SPARSER::PROTEIN)
    ("cdk4 or cdk6" . SPARSER::COLLECTION) ("Rb2/p130" . SPARSER::COLLECTION)
    ("cyclin/CDK" . SPARSER::COLLECTION)
    ("at least 16 cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mitotic cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin/cdk" . SPARSER::COLLECTION)
    ("cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("at least nine different CDKs (CDK1–CDK9) and many more cyclins (cyclin A through T)"
     . SPARSER::COLLECTION)
    ("at least nine different CDKs" . SPARSER::PROTEIN)
    ("CDK1–CDK9" . SPARSER::COLLECTION) ("cyclins/CDKs" . SPARSER::COLLECTION)
    ("fructose" . SPARSER::PROTEIN)
    ("6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase"
     . SPARSER::COLLECTION)
    ("Fru" . SPARSER::PROTEIN) ("RB–E2F1" . SPARSER::COLLECTION)
    ("IPP" . SPARSER::PROTEIN)
    ("blot, luciferase and chromatin" . SPARSER::COLLECTION)
    ("TIGAR-" . SPARSER::PROTEIN) ("Wee-1" . SPARSER::PROTEIN)
    ("Myt-1" . SPARSER::PROTEIN)
    ("Alternative Reading Frame" . SPARSER::PROTEIN)
    ("phospho-inositide" . SPARSER::MOLECULE)
    ("mRNA cap-binding protein" . SPARSER::PROTEIN) ("MNK1" . SPARSER::PROTEIN)
    ("cyclin-D1" . SPARSER::PROTEIN) ("UFD1" . SPARSER::PROTEIN)
    ("SCO2" . SPARSER::PROTEIN) ("BS2" . SPARSER::PROTEIN)
    ("BS1" . SPARSER::PROTEIN) ("CDK4/6" . SPARSER::PROTEIN)
    ("Rb2" . SPARSER::PROTEIN) ("cdk6" . SPARSER::PROTEIN)
    ("cdk4" . SPARSER::PROTEIN) ("Cyclin D3" . SPARSER::PROTEIN)
    ("fructose-1,6-bisphosphate" . SPARSER::PROTEIN)
    ("fructose-2,6-bisphosphatase" . SPARSER::PROTEIN)
    ("6-phosphofructo-2-kinase" . SPARSER::PROTEIN)
    ("PFK-2/FBPase-2" . SPARSER::PROTEIN)
    ("TP53-induced glycolysis and apoptosis regulator" . SPARSER::PROTEIN)
    ("RB protein" . SPARSER::PROTEIN) ("Cyclin D" . SPARSER::PROTEIN)
    ("CDK-6" . SPARSER::PROTEIN) ("CDK-4" . SPARSER::PROTEIN)
    ("CDK-2" . SPARSER::PROTEIN) ("ZNF112 or CEP2A" . SPARSER::COLLECTION)
    ("GSIs" . SPARSER::PROTEIN) ("ZMYM2–FGFR1" . SPARSER::COLLECTION)
    ("MPD" . SPARSER::PROTEIN)
    ("that PKC412 (midostaurin) and TKI258 (dovitinib) increases growth inhibition of FGFR1-transformed BaF3 cells"
     . SPARSER::COLLECTION)
    ("dovitinib" . SPARSER::DRUG) ("midostaurin" . SPARSER::DRUG)
    ("Ponatinib or DMSO" . SPARSER::COLLECTION)
    ("the chimeric FGFR1, PLCγ or pSrc" . SPARSER::COLLECTION)
    ("FGFR1, PLCγ or pSrc" . SPARSER::COLLECTION)
    ("TKI258 and Ponatinib" . SPARSER::COLLECTION)
    ("ZNF112 and CEP2A" . SPARSER::COLLECTION) ("pSrc" . SPARSER::PROTEIN)
    ("pPLC" . SPARSER::PROTEIN)
    ("Dasatinib and Ponatinib" . SPARSER::COLLECTION)
    ("ZNF112, CEP2A and CEP5A" . SPARSER::COLLECTION)
    ("ZMYM-FGFR1" . SPARSER::COLLECTION) ("Titre-Glo" . SPARSER::COLLECTION)
    ("Glo" . SPARSER::PROTEIN) ("chimeric FGFR1" . SPARSER::PROTEIN)
    ("CUX1-FGFR1" . SPARSER::COLLECTION) ("FOP-FGFR1" . SPARSER::COLLECTION)
    ("BCR-FGFR1" . SPARSER::COLLECTION) ("exogenous genes" . SPARSER::GENE)
    ("kinases, and perhaps" . SPARSER::COLLECTION)
    ("CEP110-FGFR1" . SPARSER::COLLECTION)
    ("several different FGFR1 fusion kinases and their downstream effectors"
     . SPARSER::COLLECTION)
    ("Bcr-Abl kinase and its mutants" . SPARSER::COLLECTION)
    ("FGFR1OP2-FGFR1" . SPARSER::COLLECTION) ("Dovitinib" . SPARSER::DRUG)
    ("Midostaurin" . SPARSER::DRUG)
    ("overt acute myelogenous leukemia" . SPARSER::PROTEIN)
    ("ZMYM2-FGFR" . SPARSER::COLLECTION)
    ("Bcl2 and Il2r" . SPARSER::COLLECTION) ("Il2r" . SPARSER::PROTEIN)
    ("Tcra" . SPARSER::PROTEIN) ("ZMYM2-FGFR1" . SPARSER::COLLECTION)
    ("which fuses ZMYM2" . SPARSER::PROTEIN)
    ("downstream signaling effects involving classical FGFR1"
     . SPARSER::PROTEIN)
    ("SCLL and perhaps" . SPARSER::COLLECTION)
    ("the fusion kinases and their downstream effectors" . SPARSER::COLLECTION)
    ("activated chimeric FGFR1" . SPARSER::PROTEIN)
    ("PLCγ, Stat5 and Src" . SPARSER::COLLECTION) ("Ponatinib" . SPARSER::DRUG)
    ("SCLL" . SPARSER::PROTEIN) ("Myeloid and lymphoid" . SPARSER::COLLECTION)
    ("Myeloid" . SPARSER::PROTEIN) ("CEP5" . SPARSER::PROTEIN)
    ("CEP2" . SPARSER::PROTEIN) ("ZNF112" . SPARSER::PROTEIN)
    ("IL3" . SPARSER::PROTEIN) ("CUX1" . SPARSER::PROTEIN)
    ("CEP110" . SPARSER::PROTEIN) ("FGFR1OP2" . SPARSER::PROTEIN)
    ("TKI258" . SPARSER::DRUG) ("PKC412" . SPARSER::DRUG)
    ("gamma secretase" . SPARSER::PROTEIN) ("Notch1" . SPARSER::PROTEIN)
    ("ZNF198" . SPARSER::PROTEIN) ("ZMYM2" . SPARSER::PROTEIN)
    ("SHP2/EGFR" . SPARSER::COLLECTION) ("EGFR and SHP2" . SPARSER::COLLECTION)
    ("at least some SHP2" . SPARSER::PROTEIN)
    ("SHP2 and GAB1" . SPARSER::COLLECTION) ("SHP2-GAB1" . SPARSER::COLLECTION)
    ("SHP2 D61A or SHP2 E76A" . SPARSER::COLLECTION)
    ("constitutively active SHP2 D61A or SHP2 E76A" . SPARSER::COLLECTION)
    ("ERK and AKT" . SPARSER::COLLECTION)
    ("the crude membrane fraction" . SPARSER::COMPONENT)
    ("crude membrane fractions" . SPARSER::COMPONENT)
    ("AKT and STAT3" . SPARSER::COLLECTION)
    ("GAB1 and EGFR" . SPARSER::COLLECTION)
    ("dominant-negative dynamin" . SPARSER::PROTEIN)
    ("SHP2 and ERK" . SPARSER::COLLECTION)
    ("ERBB3, and MET" . SPARSER::COLLECTION)
    ("GAB1 and EGFR, and SHP2" . SPARSER::COLLECTION)
    ("EGFR, and SHP2" . SPARSER::COLLECTION)
    ("ERK and SHP2" . SPARSER::COLLECTION)
    ("6,8-difluoro-4-methylumbelliferyl phosphate" . SPARSER::DRUG)
    ("GAB2" . SPARSER::PROTEIN) ("juncional proteins" . SPARSER::PROTEIN)
    ("PAF and TNF-α" . SPARSER::COLLECTION)
    ("E-cadherin and VE-cadherin" . SPARSER::COLLECTION)
    ("p120-VE-cadherin" . SPARSER::COLLECTION)
    ("pro-inflammatory agonists" . SPARSER::AGONIST)
    ("key junctional proteins" . SPARSER::PROTEIN)
    ("sGC/PKG" . SPARSER::COLLECTION) ("phosphodiesterases" . SPARSER::PROTEIN)
    ("the adherens junctional complex" . SPARSER::BIO-COMPLEX)
    ("particular β-catenin and p120" . SPARSER::COLLECTION)
    ("S-nitrosoglutathione (GSNO)" . SPARSER::MOLECULE)
    ("GSNO" . SPARSER::MOLECULE) ("NAC and L-NMA" . SPARSER::COLLECTION)
    ("NMA" . SPARSER::PROTEIN)
    ("the junctional complex" . SPARSER::BIO-COMPLEX)
    ("GFPeNOS" . SPARSER::PROTEIN) ("GFPeNOS-G2A" . SPARSER::PROTEIN-PAIR)
    ("ODQ" . SPARSER::MOLECULE) ("ACh" . SPARSER::PROTEIN)
    ("endothelial junctional proteins" . SPARSER::PROTEIN)
    ("junctional proteins" . SPARSER::PROTEIN)
    ("eNOS and the target proteins" . SPARSER::COLLECTION)
    ("sGC" . SPARSER::PROTEIN)
    ("α-catenin, β-catenin, plakoglobin, and p120-catenin"
     . SPARSER::COLLECTION)
    ("junctional membrane protein" . SPARSER::PROTEIN)
    ("cytosolic eNOS (GFPeNOSG2A) and plasma membrane eNOS (GFPeNOSCAAX)"
     . SPARSER::COLLECTION)
    ("β-catenin and p120" . SPARSER::COLLECTION)
    ("β-catenin and p120-catenin" . SPARSER::COLLECTION)
    ("PAF" . SPARSER::PROTEIN-FAMILY) ("SIN-1" . SPARSER::PROTEIN)
    ("superoxide anion" . SPARSER::MOLECULE)
    ("S-nitrosoglutathione" . SPARSER::MOLECULE) ("L-N" . SPARSER::PROTEIN)
    ("tumor necrosis factor-alpha" . SPARSER::PROTEIN)
    ("streptavidin–agarose" . SPARSER::DRUG) ("S-NO" . SPARSER::PROTEIN)
    ("G2A" . SPARSER::PROTEIN)
    ("Tumor necrosis factor-alpha" . SPARSER::PROTEIN)
    ("L-arginine" . SPARSER::MOLECULE) ("N-ethylmaleimide" . SPARSER::MOLECULE)
    ("activating factor" . SPARSER::PROTEIN) ("JN" . SPARSER::PROTEIN)
    ("SCG" . SPARSER::PROTEIN) ("PAL" . SPARSER::PROTEIN)
    ("The predominant nucleotide" . SPARSER::NUCLEOTIDE)
    ("Gao" . SPARSER::PROTEIN) ("the homozygous GG alleles" . SPARSER::ALLELE)
    ("VCAM1 and LDL" . SPARSER::COLLECTION)
    ("a proinflammatory transcription factor" . SPARSER::PROTEIN)
    ("intron or exon" . SPARSER::COLLECTION) ("p65/p50" . SPARSER::COLLECTION)
    ("c-Rel, and RELB" . SPARSER::COLLECTION) ("RELB" . SPARSER::PROTEIN)
    ("AA, AG, and GG" . SPARSER::COLLECTION) ("TIMP-1" . SPARSER::PROTEIN)
    ("VCAM1" . SPARSER::PROTEIN) ("N-myc" . SPARSER::PROTEIN)
    ("Rel-B" . SPARSER::PROTEIN) ("NFKB2" . SPARSER::PROTEIN)
    ("factor-κB" . SPARSER::PROTEIN) ("YB-1 and YB-1" . SPARSER::COLLECTION)
    ("YB-1 or MYC protein" . SPARSER::COLLECTION)
    ("MYC or YB-1" . SPARSER::COLLECTION)
    ("YB-1 , MYC and TCTP" . SPARSER::COLLECTION)
    ("PCs and HMCLs" . SPARSER::COLLECTION) ("MYC/CD138" . SPARSER::COLLECTION)
    ("a switchable 4-OHT-dependent variant" . SPARSER::VARIANT)
    ("MER" . SPARSER::PROTEIN) ("mRNA, and YB-1" . SPARSER::COLLECTION)
    ("AMO-1 and 27±12%" . SPARSER::COLLECTION)
    ("subpolysomal and polysomal fractions" . SPARSER::COMPONENT)
    ("polysome" . SPARSER::BIO-COMPLEX) ("TCTP and MYC" . SPARSER::COLLECTION)
    ("the YB-1 protein as well as MYC" . SPARSER::COLLECTION)
    ("YB-1 and MYC protein" . SPARSER::COLLECTION)
    ("AMO-1-tet" . SPARSER::COLLECTION) ("MYC and TCTP" . SPARSER::COLLECTION)
    ("protein 1 ( TCTP )" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TCTP" . SPARSER::PROTEIN) ("YB-1 and MYC" . SPARSER::COLLECTION)
    ("the detected YB-1 bound mRNAs" . SPARSER::PROTEIN)
    ("α - tubulin , EEF2 and UBC" . SPARSER::COLLECTION)
    ("MYC/CD138-positive malignant PCs" . SPARSER::PROTEIN)
    ("both MYC ( xref ) and YB-1 ( xref )" . SPARSER::COLLECTION)
    ("YB-1 and CD138" . SPARSER::COLLECTION) ("normal PCs" . SPARSER::PROTEIN)
    ("YB-1/CD138" . SPARSER::COLLECTION) ("pristane" . SPARSER::DRUG)
    ("both YB-1 and the PTB-1 (polypyrimidine tract-binding protein-1)"
     . SPARSER::COLLECTION)
    ("polypyrimidine tract-binding protein-1" . SPARSER::COLLECTION)
    ("MYC and YB-1" . SPARSER::COLLECTION) ("malignant PCs" . SPARSER::PROTEIN)
    ("bromodomain" . SPARSER::PROTEIN) ("BET" . SPARSER::PROTEIN)
    ("normal and malignant PCs" . SPARSER::PROTEIN)
    ("YB-1/mRNA" . SPARSER::COLLECTION) ("MYC/YB-1" . SPARSER::COLLECTION)
    ("the polysomal fraction" . SPARSER::COMPONENT)
    ("YB-1/MYC" . SPARSER::COLLECTION)
    ("a translational regulator" . SPARSER::REGULATOR)
    ("EEF2" . SPARSER::PROTEIN) ("α - tubulin" . SPARSER::PROTEIN)
    ("polypyrimidine tract-binding protein" . SPARSER::PROTEIN)
    ("PTB-1" . SPARSER::PROTEIN) ("MAS5" . SPARSER::PROTEIN)
    ("FL-1" . SPARSER::PROTEIN) ("CD138" . SPARSER::PROTEIN)
    ("AMO-1" . SPARSER::PROTEIN) ("4-Hydroxytamoxifen" . SPARSER::DRUG)
    ("Y-box binding protein 1" . SPARSER::PROTEIN)
    ("OB1 and OB2" . SPARSER::COLLECTION) ("OB" . SPARSER::PROTEIN)
    ("Alix and CEP55" . SPARSER::COLLECTION)
    ("Alix-BRCA2" . SPARSER::COLLECTION)
    ("BRCA2 and Alix" . SPARSER::COLLECTION) ("Tex14" . SPARSER::PROTEIN)
    ("CEP55-BRCA2" . SPARSER::COLLECTION)
    ("CEP55 or BRCA2" . SPARSER::COLLECTION)
    ("BRCA2-CEP55" . SPARSER::COLLECTION) ("Dimeric CEP55" . SPARSER::PROTEIN)
    ("SNARE" . SPARSER::PROTEIN) ("MKLP2, and CEP55" . SPARSER::COLLECTION)
    ("kinesins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MgcRacGAP and MKLP1" . SPARSER::COLLECTION)
    ("MgcRacGAP or MKLP1" . SPARSER::COLLECTION)
    ("MKLP1 and MgcRacGAP" . SPARSER::COLLECTION)
    ("centralspindlin" . SPARSER::PROTEIN)
    ("PRC1, MKLP1 and MKLP2" . SPARSER::COLLECTION)
    ("BRCA2-Rad51" . SPARSER::COLLECTION) ("BRC" . SPARSER::PROTEIN)
    ("antibodies and siRNAs" . SPARSER::COLLECTION)
    ("essential structural components" . SPARSER::COMPONENT)
    ("MKLP1 or CEP55" . SPARSER::COLLECTION)
    ("CEP55 or the downstream components Alix and Tsg101"
     . SPARSER::COLLECTION)
    ("wildtype and the E3002K mutant" . SPARSER::COLLECTION)
    ("Myosin" . SPARSER::PROTEIN-FAMILY)
    ("CEP55, Alix and Tsg101caused" . SPARSER::COLLECTION)
    ("Alix or Tsg101" . SPARSER::COLLECTION)
    ("CEP55 and Tsg101" . SPARSER::COLLECTION)
    ("BRCA2 ( xref ) or Plk1, MKLP1 or PRC1" . SPARSER::COLLECTION)
    ("Plk1, MKLP1 or PRC1" . SPARSER::COLLECTION)
    ("CEP55, Alix, and Tsg101" . SPARSER::COLLECTION)
    ("CEP55 or Tsg101" . SPARSER::COLLECTION)
    ("BRCA2-Tsg101" . SPARSER::COLLECTION) ("BRCA2-Alix" . SPARSER::COLLECTION)
    ("BRCA2, CEP55 and Tsg101" . SPARSER::COLLECTION)
    ("Del-2 and Del-3" . SPARSER::COLLECTION)
    ("Alix-CEP55" . SPARSER::COLLECTION)
    ("CEP55 and BRCA2" . SPARSER::COLLECTION)
    ("CEP55 and Alix" . SPARSER::COLLECTION) ("BRCA2-F3" . SPARSER::COLLECTION)
    ("BRCA2 and CEP55" . SPARSER::COLLECTION) ("inbrca2" . SPARSER::PROTEIN)
    ("Plk1 and CEP55" . SPARSER::COLLECTION)
    ("BRCA2-Filamin" . SPARSER::COLLECTION)
    ("BRCA2 and Endobrevin" . SPARSER::COLLECTION)
    ("MgcRacGAP and Plk1" . SPARSER::COLLECTION)
    ("BRCA2, PRC1, Endobrevin, MgcRacGAP and Plk1" . SPARSER::COLLECTION)
    ("FLNA" . SPARSER::PROTEIN) ("A lentiviral shRNAs" . SPARSER::RNA)
    ("both full-length BRCA2 ( xref and xref ) and BRCA2-F8 ( xref )"
     . SPARSER::COLLECTION)
    ("cytoskeletal and cytokinetic proteins" . SPARSER::PROTEIN)
    ("BCCIP" . SPARSER::PROTEIN)
    ("overlapping FLAG-tagged BRCA2" . SPARSER::PROTEIN)
    ("functional BRCA2 protein" . SPARSER::PROTEIN)
    ("Alix, Tsg101, and Endobrevin" . SPARSER::COLLECTION)
    ("Tsg101 and Endobrevin" . SPARSER::COLLECTION)
    ("Endobrevin" . SPARSER::PROTEIN)
    ("both Alix (p<0.001) and Tsg101 (p<0.001)" . SPARSER::COLLECTION)
    ("Alix and Tsg101" . SPARSER::COLLECTION)
    ("MKLP1, MKLP2 and PRC1" . SPARSER::COLLECTION)
    ("MKLP1 and MKLP2" . SPARSER::COLLECTION)
    ("protein (BLM)" . SPARSER::PROTEIN)
    ("Lap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CEP55 and Filamin" . SPARSER::COLLECTION) ("Brca2" . SPARSER::PROTEIN)
    ("H2B-mRFP" . SPARSER::COLLECTION) ("PEO1" . SPARSER::PROTEIN)
    ("brca2" . SPARSER::PROTEIN) ("BRCA2 and Anillin" . SPARSER::COLLECTION)
    ("Anillin" . SPARSER::PROTEIN)
    ("BRCA2 and components" . SPARSER::COLLECTION)
    ("PRC1 ( xref ) and CEP55 ( xref )" . SPARSER::COLLECTION)
    ("BRCA2 and central spindle and midbody proteins" . SPARSER::COLLECTION)
    ("α-tubulin identified BRCA2 at centrosomes, the spindle midzone, and the midbody"
     . SPARSER::COLLECTION)
    ("centrosomes, the spindle midzone, and the midbody" . SPARSER::COLLECTION)
    ("EGFP-tagged BRCA2 (WT-BRCA2) and mCherry" . SPARSER::COLLECTION)
    ("α-tubulin identified BRCA2" . SPARSER::PROTEIN)
    ("two individual BRCA2 siRNAs (Qiagen) and a BRCA2 siRNA"
     . SPARSER::COLLECTION)
    ("MgcRacGAP" . SPARSER::PROTEIN)
    ("CEP55, Alix and Tsg101" . SPARSER::COLLECTION)
    ("BRCA2 and Filamin" . SPARSER::COLLECTION)
    ("BRCA2 and HMG20b" . SPARSER::COLLECTION)
    ("proteins, Alix and Tsg101" . SPARSER::COLLECTION)
    ("CEP55-Tsg101" . SPARSER::COLLECTION) ("CEP55-Alix" . SPARSER::COLLECTION)
    ("DSS1" . SPARSER::PROTEIN) ("OB1" . SPARSER::PROTEIN)
    ("Del-2" . SPARSER::PROTEIN) ("Mut-7" . SPARSER::PROTEIN)
    ("BRCA2 protein" . SPARSER::PROTEIN)
    ("v-SNARE" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MKLP2" . SPARSER::PROTEIN)
    ("CENP-E" . SPARSER::PROTEIN) ("MKLP1" . SPARSER::PROTEIN)
    ("PRC1" . SPARSER::PROTEIN) ("HMG20b" . SPARSER::PROTEIN)
    ("CEP55" . SPARSER::PROTEIN) ("AV" . SPARSER::MOLECULE)
    ("PCNA and other cell-cycle regulatory proteins" . SPARSER::COLLECTION)
    ("protein, and bcl-2" . SPARSER::COLLECTION) ("10 C-" . SPARSER::PROTEIN)
    ("CCNA, CCNB, TOP2A, and PCNA" . SPARSER::COLLECTION)
    ("locus-specific fluorophore-labelled DNA" . SPARSER::DNA)
    ("IGH/CCND1" . SPARSER::COLLECTION) ("cyclin D1/IGH" . SPARSER::COLLECTION)
    ("IGH" . SPARSER::PROTEIN) ("a cospicous part" . SPARSER::COMPONENT)
    ("Unexpectedly cyclin D1 antibody" . SPARSER::ANTIBODY)
    ("CD10, CD8, CD56, CD57, CD1a, CD34, CD99 and ALK1" . SPARSER::COLLECTION)
    ("finely dispersed chromatin and inconspicuous nucleoli"
     . SPARSER::COLLECTION)
    ("MIB1 and cyclin D1" . SPARSER::COLLECTION)
    ("BSAP/Pax5" . SPARSER::COLLECTION) ("BSAP" . SPARSER::PROTEIN)
    ("10% neutral buffered formalin" . SPARSER::MOLECULE)
    ("PLT" . SPARSER::PROTEIN) ("dl" . SPARSER::MOLECULE)
    ("Haemoglobin" . SPARSER::MOLECULE) ("Monocytes" . SPARSER::PROTEIN)
    ("Leukocytes" . SPARSER::PROTEIN) ("IgH" . SPARSER::PROTEIN)
    ("only two subtypes" . SPARSER::PROTEIN) ("10 C" . SPARSER::PROTEIN)
    ("TOP2A" . SPARSER::PROTEIN) ("Green fluorescent" . SPARSER::PROTEIN)
    ("MIB1" . SPARSER::PROTEIN) ("CD79a" . SPARSER::PROTEIN)
    ("CD30" . SPARSER::PROTEIN) ("CD99" . SPARSER::PROTEIN)
    ("CD1a" . SPARSER::PROTEIN) ("bcl6" . SPARSER::PROTEIN)
    ("bcl2" . SPARSER::PROTEIN) ("CD43" . SPARSER::PROTEIN)
    ("p23" . SPARSER::PROTEIN)
    ("an acetylation-mimetic mutant (KLKL) forms dimers" . SPARSER::DIMER)
    ("p21 and FOXO1" . SPARSER::COLLECTION)
    ("Skp2 as well as its various downstream ubiquitin substrates"
     . SPARSER::COLLECTION)
    ("FOXO1 and Skp2" . SPARSER::COLLECTION)
    ("p300 and Akt" . SPARSER::COLLECTION)
    ("Acetylation-mimetic mutants" . SPARSER::MUTANT)
    ("Akt and p300" . SPARSER::COLLECTION) ("Skp2/p300" . SPARSER::COLLECTION)
    ("Skp2 ( xref ; xref ) and Fbx4 ( xref )" . SPARSER::COLLECTION)
    ("Skp2/p27" . SPARSER::COLLECTION)
    ("Skp2 and E-cadherin" . SPARSER::COLLECTION)
    ("SIRT3/Skp2" . SPARSER::COLLECTION) ("KRKR" . SPARSER::PROTEIN)
    ("the KLKL acetylationmimetic Skp2 mutant" . SPARSER::MUTANT)
    ("KRKR-Skp2" . SPARSER::COLLECTION)
    ("the acetylation-mimetic Skp2 mutant" . SPARSER::MUTANT)
    ("the acetylation-mimetic KLKL-Skp2" . SPARSER::COLLECTION)
    ("KLKL-Skp2" . SPARSER::COLLECTION) ("KLKL" . SPARSER::PROTEIN)
    ("α5 and α7" . SPARSER::COLLECTION)
    ("all acetylation-mimetic mutants" . SPARSER::MUTANT)
    ("Skp2-KLKL" . SPARSER::PROTEIN-PAIR) ("bromodeoxyuridine" . SPARSER::DRUG)
    ("the acetylation-mimetic mutant" . SPARSER::MUTANT)
    ("acetylation-mimetic (K68L/K71L, denoted as KLKL) mutants"
     . SPARSER::MUTANT)
    ("both KQ and KL acetylation-mimetic mutants" . SPARSER::MUTANT)
    ("KR" . SPARSER::PROTEIN-FAMILY) ("KL" . SPARSER::PROTEIN)
    ("Cdh1 and Skp2" . SPARSER::COLLECTION)
    ("acetylation-mimetic amino acids" . SPARSER::AMINO-ACID)
    ("Skp2 and Cdh1" . SPARSER::COLLECTION)
    ("acetylation-mimetic mutants" . SPARSER::MUTANT)
    ("the phosphomimetic mutant" . SPARSER::MUTANT)
    ("N-acetyl-L-cysteine (NAC)" . SPARSER::MOLECULE)
    ("nicotinamide (NAM)" . SPARSER::PROTEIN) ("NAM" . SPARSER::PROTEIN-FAMILY)
    ("Skp2 and SIRT3" . SPARSER::COLLECTION)
    ("SIRT3 and SIRT4" . SPARSER::COLLECTION) ("Garcinol" . SPARSER::MOLECULE)
    ("CBP and GCN5" . SPARSER::COLLECTION)
    ("p300 and Skp2" . SPARSER::COLLECTION) ("/Akt" . SPARSER::COLLECTION)
    ("APC/Cdh1" . SPARSER::COLLECTION) ("p53 or PTEN" . SPARSER::COLLECTION)
    ("p27, p21, p57, p130, and FOXO1" . SPARSER::COLLECTION)
    ("Cullin-1, Skp1, and Rbx1" . SPARSER::COLLECTION)
    ("more aggressive forms" . SPARSER::FORM) ("BCR-Abl" . SPARSER::PROTEIN)
    ("acetyl-transferase" . SPARSER::PROTEIN) ("Fbx4" . SPARSER::PROTEIN)
    ("N-acetyl-L-cysteine" . SPARSER::MOLECULE) ("SIRT4" . SPARSER::PROTEIN)
    ("Akt2" . SPARSER::PROTEIN) ("ROS and radical" . SPARSER::COLLECTION)
    ("spin" . SPARSER::PROTEIN) ("Fpg" . SPARSER::PROTEIN-FAMILY)
    ("Chk2 and pChk2" . SPARSER::COLLECTION)
    ("p21 and Bax" . SPARSER::COLLECTION) ("NCCT" . SPARSER::PROTEIN)
    ("water and aerosols" . SPARSER::COLLECTION)
    ("ATM, Chk2 and Chk1" . SPARSER::COLLECTION)
    ("IR and UV-C" . SPARSER::COLLECTION) ("p-Chk1" . SPARSER::COLLECTION)
    ("ATM, Chk1, and H2AX" . SPARSER::COLLECTION) ("pATM" . SPARSER::PROTEIN)
    ("Dynamic light" . SPARSER::PROTEIN) ("ATM and Chk1" . SPARSER::COLLECTION)
    ("Ultraviolet light" . SPARSER::PROTEIN)
    ("ultraviolet light (UV)" . SPARSER::PROTEIN)
    ("ATR-Chk1" . SPARSER::COLLECTION) ("ATM-Chk2" . SPARSER::COLLECTION)
    ("sunscreen" . SPARSER::DRUG) ("EPA" . SPARSER::PROTEIN)
    ("Food and Drug Administration (FDA)" . SPARSER::COLLECTION)
    ("absorptive" . SPARSER::PROTEIN) ("sunscreens" . SPARSER::DRUG)
    ("H2AX, ATM, and Chk2" . SPARSER::COLLECTION)
    ("ATM/Chk2" . SPARSER::COLLECTION) ("TiO2" . SPARSER::MOLECULE)
    ("histone 2" . SPARSER::PROTEIN) ("Titanium dioxide" . SPARSER::MOLECULE)
    ("TiO 2" . SPARSER::MOLECULE) ("titanium dioxide" . SPARSER::MOLECULE)
    ("CRT" . SPARSER::PROTEIN) ("MFL" . SPARSER::PROTEIN)
    ("MNU" . SPARSER::DRUG) ("p53-Rb" . SPARSER::PROTEIN-PAIR)
    ("transcriptional activator and p53 is" . SPARSER::COLLECTION)
    ("hTERT and MYC" . SPARSER::COLLECTION)
    ("MYC and TP53" . SPARSER::COLLECTION)
    ("MYC and p53" . SPARSER::COLLECTION)
    ("a key tumor suppressor gene" . SPARSER::PROTEIN)
    ("hTERT as well as TP53 [ xref ]" . SPARSER::COLLECTION)
    ("hTERT, MYC, and TP53" . SPARSER::COLLECTION)
    ("hTERT, MYC, and p53" . SPARSER::COLLECTION)
    ("hTERT , MYC, and TP53" . SPARSER::COLLECTION) ("TP" . SPARSER::PROTEIN)
    ("tightly binding molecules" . SPARSER::MOLECULE)
    ("p38α and its MAPK" . SPARSER::COLLECTION)
    ("interdependent amino acids" . SPARSER::AMINO-ACID)
    ("favorable water- or ion-mediated interactions with Asp residues 292 and 294"
     . SPARSER::COLLECTION)
    ("favorable water-" . SPARSER::MOLECULE) ("8b" . SPARSER::PROTEIN)
    ("formate" . SPARSER::MOLECULE)
    ("SB203580 and BIRB-796" . SPARSER::COLLECTION)
    ("the environmentally-sensitive fluorophore acrylodan" . SPARSER::DRUG)
    ("acrylodan" . SPARSER::DRUG) ("the secondary amine" . SPARSER::MOLECULE)
    ("cyclopropyl" . SPARSER::MOLECULE) ("quinazoline" . SPARSER::MOLECULE)
    ("amine" . SPARSER::MOLECULE) ("HTS" . SPARSER::PROTEIN)
    ("EF" . SPARSER::PROTEIN)
    ("cyclin dependant kinases (CDKs) and glycogen synthase kinase"
     . SPARSER::COLLECTION)
    ("several MAP kinases, cyclin dependant kinases (CDKs) and glycogen synthase kinase"
     . SPARSER::COLLECTION)
    ("PDK1, Akt, Mek or Bcr-Abl" . SPARSER::COLLECTION)
    ("a tight binding ligand" . SPARSER::MOLECULE) ("DFG" . SPARSER::PROTEIN)
    ("FLiK" . SPARSER::PROTEIN)
    ("the highly conserved ATP-pocket" . SPARSER::ATP)
    ("highly conserved ATP-pocket" . SPARSER::ATP)
    ("ATP-pocket" . SPARSER::ATP) ("C 20" . SPARSER::PROTEIN)
    ("N 5" . SPARSER::PROTEIN) ("18 H" . SPARSER::PROTEIN)
    ("N 3" . SPARSER::PROTEIN) ("H 10" . SPARSER::PROTEIN)
    ("3H" . SPARSER::PROTEIN) ("CD 3" . SPARSER::PROTEIN)
    ("BIRB-796" . SPARSER::DRUG) ("L14" . SPARSER::PROTEIN)
    ("p38α" . SPARSER::PROTEIN)
    ("Cyclophosphamide, Doxorubicin, Prednisolone and Vincristine"
     . SPARSER::COLLECTION)
    ("Vincristine" . SPARSER::DRUG) ("Prednisolone" . SPARSER::DRUG)
    ("Cyclophosphamide" . SPARSER::DRUG) ("Methotrexate" . SPARSER::DRUG)
    ("NFkB and AKT" . SPARSER::COLLECTION)
    ("AKT and NFkB" . SPARSER::COLLECTION)
    ("caspase-3 and cleavage PARP" . SPARSER::COLLECTION)
    ("caspase-9, caspase-3 and cleavage PARP" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-Xl protein and inactivated Bad protein"
     . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-Xl" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-Xl, XIAP and Survivin" . SPARSER::COLLECTION)
    ("IκBα, XIAP, Bcl-Xl and Survivin" . SPARSER::COLLECTION)
    ("annexin V/PI" . SPARSER::COLLECTION)
    ("NFkB and PI3-kinase/AKT inhibitors" . SPARSER::COLLECTION)
    ("Inhibitor and Bay11-7085" . SPARSER::COLLECTION)
    ("caspase-9, caspase-3, caspase-8 and Bid" . SPARSER::COLLECTION)
    ("either 80 µM caspase-8 inhibitor (IETD-CHO) or 80 µM caspase-9 inhibitor (LEHD-CHO)"
     . SPARSER::COLLECTION)
    ("LEHD-CHO" . SPARSER::COLLECTION) ("IETD-CHO" . SPARSER::PROTEIN-PAIR)
    ("a universal inhibitor" . SPARSER::INHIBITOR)
    ("a BH3-proapoptotic protein" . SPARSER::PROTEIN)
    ("caspase-8 and Bid" . SPARSER::COLLECTION)
    ("caspase-9 and caspase-3" . SPARSER::COLLECTION)
    ("caspase-3 and PARP" . SPARSER::COLLECTION)
    ("Caspases" . SPARSER::PROTEIN) ("XIAP and Survivin" . SPARSER::COLLECTION)
    ("cIAP1 and cIAP2" . SPARSER::COLLECTION)
    ("caspases-9 and -3" . SPARSER::COLLECTION) ("IAPs" . SPARSER::PROTEIN)
    ("the polymeric form" . SPARSER::FORM)
    ("the monomeric form" . SPARSER::FORM) ("Apo" . SPARSER::PROTEIN)
    ("calcein and ethidium" . SPARSER::COLLECTION)
    ("FOXO1, GSK3 and Bad" . SPARSER::COLLECTION)
    ("Foxo1, GSK3 and Bad" . SPARSER::COLLECTION)
    ("p-Bad" . SPARSER::COLLECTION) ("p-GSK3" . SPARSER::COLLECTION)
    ("p-Foxo1" . SPARSER::COLLECTION)
    ("AKT and its Down-stream" . SPARSER::COLLECTION)
    ("IκBα, Bcl-2, Bcl-xL and XIAP" . SPARSER::COLLECTION)
    ("IκBα, Bcl-2, Bcl-Xl and XIAP" . SPARSER::COLLECTION)
    ("IκBα, Bcl-2, Bcl-Xl, XIAP and Survivin" . SPARSER::COLLECTION)
    ("Survivin" . SPARSER::PROTEIN) ("RelB and c-Rel" . SPARSER::COLLECTION)
    ("RHD" . SPARSER::PROTEIN) ("REL" . SPARSER::PROTEIN)
    ("XIAP, Bcl-2, Bcl-Xl, IκB-α, cIAP1, cIAP-2 and survivin"
     . SPARSER::COLLECTION)
    ("PEL cells use viral IL-6 and IL-10" . SPARSER::COLLECTION)
    ("IL-6 and IL-10" . SPARSER::COLLECTION)
    ("AKT-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AKT and its downstream targets" . SPARSER::COLLECTION)
    ("PI3-kinase/AKT" . SPARSER::COLLECTION) ("PI3/AKT" . SPARSER::COLLECTION)
    ("Cytochrome c" . SPARSER::PROTEIN) ("z-VAD-fmk" . SPARSER::DRUG)
    ("caspases-8" . SPARSER::PROTEIN) ("caspases-9" . SPARSER::PROTEIN)
    ("JC1" . SPARSER::MOLECULE) ("annexin-V" . SPARSER::PROTEIN)
    ("3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide"
     . SPARSER::MOLECULE)
    ("A-8" . SPARSER::PROTEIN) ("PARP-1" . SPARSER::PROTEIN)
    ("GSK3α" . SPARSER::PROTEIN) ("zVAD-fmk" . SPARSER::DRUG)
    ("Dimethyl Sulfoxide" . SPARSER::MOLECULE) ("Rel-A" . SPARSER::PROTEIN)
    ("cIAP-2" . SPARSER::PROTEIN)
    ("these bacterial target molecules" . SPARSER::MOLECULE)
    ("intact pIgR" . SPARSER::PROTEIN) ("pIgR" . SPARSER::PROTEIN)
    ("multiple eukaryotic surface receptors" . SPARSER::RECEPTOR)
    ("integrins and Toll-like" . SPARSER::COLLECTION)
    ("GRP94 or HSP90b1" . SPARSER::COLLECTION) ("HSP90b1" . SPARSER::PROTEIN)
    ("OmpA" . SPARSER::PROTEIN-FAMILY)
    ("dominant-negative variants" . SPARSER::VARIANT)
    ("rat CEACAM1 and the insulin receptor (IR)" . SPARSER::COLLECTION)
    ("cadherin or discoidin" . SPARSER::COLLECTION)
    ("CEA as well as CEACAM6" . SPARSER::COLLECTION)
    ("a fully-enclosed state" . SPARSER::BIO-STATE)
    ("the major phosphoinositide" . SPARSER::PROTEIN)
    ("Rho and Arf" . SPARSER::COLLECTION)
    ("CEACAM1, CEA, and CEACAM6" . SPARSER::COLLECTION)
    ("PI3K- and PI" . SPARSER::COLLECTION) ("BTK" . SPARSER::PROTEIN)
    ("CEACAM3 and the chimeric receptor" . SPARSER::COLLECTION)
    ("CEACAM1, CEACAM3 and the chimeric receptor" . SPARSER::COLLECTION)
    ("CEACAM1/CEACAM3-TM" . SPARSER::COLLECTION)
    ("TfR and flotillin2" . SPARSER::COLLECTION)
    ("the non-lipid raft-associated transferrin receptor" . SPARSER::PROTEIN)
    ("mKate" . SPARSER::PROTEIN) ("CEACAM1 and CEACAM1" . SPARSER::COLLECTION)
    ("PI3K or SHIP" . SPARSER::COLLECTION)
    ("wildtype or phosphatase-inactive" . SPARSER::COLLECTION)
    ("wildtype SHIP or an enzymatically inactive form" . SPARSER::COLLECTION)
    ("either HA-tagged CEACAM1 or HA-tagged CEACAM3" . SPARSER::COLLECTION)
    ("HBMEC-GFP or HBMEC-CEACAM1-GFP" . SPARSER::COLLECTION)
    ("CEACAM1-GFP" . SPARSER::COLLECTION)
    ("CEACAM1- or CEACAM3" . SPARSER::COLLECTION)
    ("CEACAM1 or CEACAM3" . SPARSER::COLLECTION)
    ("CEACAM1-mKate or CEACAM3-mKate" . SPARSER::COLLECTION)
    ("CEACAM3-mKate" . SPARSER::PROTEIN-PAIR)
    ("CEACAM1-mKate" . SPARSER::COLLECTION)
    ("CEACAM3 as well as CEACAM1" . SPARSER::COLLECTION)
    ("either mKate-tagged CEACAM1 or mKate-tagged CEACAM3"
     . SPARSER::COLLECTION)
    ("Btk" . SPARSER::PROTEIN) ("Phosphatidylinositol" . SPARSER::PROTEIN)
    ("CEACAM1 and other epithelial CEACAMs" . SPARSER::COLLECTION)
    ("PI3K and PIPs" . SPARSER::COLLECTION)
    ("PIPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CEACAM1, CEA and CEACAM6" . SPARSER::COLLECTION)
    ("chelators" . SPARSER::MOLECULE) ("sphingolipid" . SPARSER::MOLECULE)
    ("the guanine nucleotide exchange factor (GEF) Vav and the adaptor molecule Nck"
     . SPARSER::COLLECTION)
    ("the small GTPase Rac (the GEF Vav) and a downstream effector"
     . SPARSER::COLLECTION)
    ("WAVE" . SPARSER::PROTEIN)
    ("CEACAM1, CEA, or CEACAM6" . SPARSER::COLLECTION)
    ("CEA (the product of the CEACAM5 gene) and CEACAM6" . SPARSER::COLLECTION)
    ("CEACAM1 and CEACAM3" . SPARSER::COLLECTION)
    ("12 genes and a number" . SPARSER::COLLECTION)
    ("CEA and CEACAM6" . SPARSER::COLLECTION) ("CEACAM1-" . SPARSER::PROTEIN)
    ("CEACAM1, CEA or CEACAM6" . SPARSER::COLLECTION)
    ("CEACAM" . SPARSER::PROTEIN) ("secretory component" . SPARSER::PROTEIN)
    ("polymeric immunoglobulin receptor" . SPARSER::PROTEIN)
    ("GRP94" . SPARSER::PROTEIN) ("Gp96" . SPARSER::PROTEIN)
    ("gp96" . SPARSER::PROTEIN) ("co-receptors" . SPARSER::PROTEIN)
    ("transmembrane domain (TM)" . SPARSER::PROTEIN)
    ("flotillin2" . SPARSER::PROTEIN) ("Flotillin2" . SPARSER::PROTEIN)
    ("HD11" . SPARSER::PROTEIN) ("anti -" . SPARSER::ANTIBODY)
    ("cd-" . SPARSER::PROTEIN) ("CEACAM8" . SPARSER::PROTEIN)
    ("type2" . SPARSER::PROTEIN)
    ("Carcinoembryonic antigen-related cell adhesion molecule 1"
     . SPARSER::PROTEIN)
    ("CEACAM3" . SPARSER::PROTEIN) ("CEACAM6" . SPARSER::PROTEIN)
    ("CEACAM1" . SPARSER::PROTEIN)
    ("oligonucleotides (MO)" . SPARSER::MOLECULE)
    ("canonical Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CNrasGEF" . SPARSER::PROTEIN) ("Nedd4 and Nedd4-2" . SPARSER::COLLECTION)
    ("p35 and CDK5" . SPARSER::COLLECTION) ("CDK5/p35" . SPARSER::COLLECTION)
    ("p35 or p39" . SPARSER::COLLECTION)
    ("microtubule-associated proteins" . SPARSER::PROTEIN)
    ("Tau, MAP2 and stathmin-like" . SPARSER::COLLECTION)
    ("Tau" . SPARSER::PROTEIN) ("Kif26b and CDK5" . SPARSER::COLLECTION)
    ("Kif26b-Nedd4" . SPARSER::COLLECTION)
    ("CDKs and polyubiquitination" . SPARSER::COLLECTION)
    ("the lysosomotropic drug chloroquine" . SPARSER::PROTEIN)
    ("DMSO or nocodazole" . SPARSER::COLLECTION)
    ("Kif26b or anti-phospho-Ser1962" . SPARSER::COLLECTION)
    ("HEK" . SPARSER::PROTEIN) ("GAKIN/KIF13B" . SPARSER::COLLECTION)
    ("KIF26B and Kif26b" . SPARSER::COLLECTION)
    ("Polyubiquitination" . SPARSER::PROTEIN)
    ("GST-Nedd4" . SPARSER::COLLECTION)
    ("associated proteins" . SPARSER::PROTEIN)
    ("Kif26b and other proteins ( xref  )" . SPARSER::COLLECTION)
    ("Myc-Ub" . SPARSER::COLLECTION) ("MG132 and Kif26b" . SPARSER::COLLECTION)
    ("(Ub) in HEK293 cells" . SPARSER::COLLECTION)
    ("Myc-Ubiquitin" . SPARSER::COLLECTION)
    ("Polyubiquitinated" . SPARSER::PROTEIN)
    ("Kif26b and anti-phospho-Ser1962" . SPARSER::COLLECTION)
    ("Roscovitine or AP" . SPARSER::COLLECTION) ("Ser-" . SPARSER::AMINO-ACID)
    ("AP" . SPARSER::PROTEIN-FAMILY) ("FLAG-Kif26b" . SPARSER::PROTEIN-PAIR)
    ("CDK2 and CDK5" . SPARSER::COLLECTION)
    ("GST-Kif26b" . SPARSER::COLLECTION) ("-Pro" . SPARSER::COLLECTION)
    ("phosphoserine/phosphothreonine" . SPARSER::COLLECTION)
    ("Myc-Nedd4" . SPARSER::COLLECTION)
    ("Myc-tagged Nedd4 and FLAG-tagged full-length or partial Kif26b"
     . SPARSER::COLLECTION)
    ("full-length or partial" . SPARSER::COLLECTION)
    ("Kif26b and wild type (WT) Nedd4 ( xref )" . SPARSER::COLLECTION)
    ("Kif26b and Nedd4" . SPARSER::COLLECTION)
    ("an approximately 120 kDa protein" . SPARSER::PROTEIN)
    ("IIB" . SPARSER::PROTEIN) ("Gdnf" . SPARSER::PROTEIN)
    ("an unconventional kinesin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Kif26a" . SPARSER::PROTEIN) ("Wnt9b" . SPARSER::PROTEIN)
    ("GDNF" . SPARSER::PROTEIN) ("water and salt" . SPARSER::COLLECTION)
    ("Nocodazole" . SPARSER::DRUG)
    ("subsequent polyubiquitination" . SPARSER::PROTEIN)
    ("Sall1" . SPARSER::PROTEIN) ("Liddle syndrome" . SPARSER::PROTEIN)
    ("Nedd4-2" . SPARSER::PROTEIN) ("Wnt3a" . SPARSER::PROTEIN)
    ("p39" . SPARSER::PROTEIN) ("p35" . SPARSER::PROTEIN)
    ("KIF26B" . SPARSER::PROTEIN) ("UBE1" . SPARSER::PROTEIN)
    ("cyclin D3" . SPARSER::PROTEIN) ("AMP-PNP" . SPARSER::MOLECULE)
    ("KIF13B" . SPARSER::PROTEIN) ("CDK5" . SPARSER::PROTEIN)
    ("KIF26A" . SPARSER::PROTEIN) ("Kif26" . SPARSER::PROTEIN-FAMILY)
    ("glial cell line-derived neurotrophic factor" . SPARSER::PROTEIN)
    ("neural precursor cell expressed developmentally down-regulated protein 4"
     . SPARSER::PROTEIN)
    ("Kif26b" . SPARSER::PROTEIN)
    ("a highly pleiotropic kinase" . SPARSER::KINASE)
    ("pTEF-b" . SPARSER::COLLECTION) ("acetylase" . SPARSER::PROTEIN)
    ("HSF" . SPARSER::PROTEIN)
    ("the heat shock-inducible hsp70.1 gene" . SPARSER::GENE)
    ("a powerful inducer" . SPARSER::PROTEIN)
    ("MG132 or sodium arsenite" . SPARSER::COLLECTION)
    ("ribosomal S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("Electron" . SPARSER::MOLECULE) ("LTQ" . SPARSER::MOLECULE)
    ("mTOR and ATP" . SPARSER::COLLECTION) ("GST-HSF1" . SPARSER::COLLECTION)
    ("threonine or serine" . SPARSER::COLLECTION)
    ("GAPDH (Fig2B) and β-actin (not shown)" . SPARSER::COLLECTION)
    ("RICTOR" . SPARSER::PROTEIN) ("immunophilin" . SPARSER::PROTEIN)
    ("mTOR and the adapter protein RAPTOR" . SPARSER::COLLECTION)
    ("Indeed mTORC1 inhibitor rapamycin" . SPARSER::DRUG)
    ("mTORC1 and mTOR2" . SPARSER::COLLECTION)
    ("proteins (HSP)" . SPARSER::PROTEIN)
    ("Hsp70, Hsp90 and Hsp110" . SPARSER::COLLECTION)
    ("Hsp110" . SPARSER::PROTEIN)
    ("mitogens and variations" . SPARSER::COLLECTION)
    ("eIF2 alpha" . SPARSER::HUMAN-PROTEIN-FAMILY) ("hsp70" . SPARSER::PROTEIN)
    ("TORC1 complex" . SPARSER::BIO-COMPLEX)
    ("phospho-Serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("Sodium Arsenite" . SPARSER::DRUG) ("KU0063794" . SPARSER::DRUG)
    ("Mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("sodium arsenite" . SPARSER::DRUG) ("HSF1" . SPARSER::PROTEIN)
    ("heat shock transcription factor 1" . SPARSER::PROTEIN)
    ("RRs" . SPARSER::MOLECULE)
    ("total CR (RR = 1.46; 95% CI = 1.22–1.75; p<0.001) and pathological CR (RR = 1.49; 95% CI = 1.24–1.79; p<0.001)"
     . SPARSER::COLLECTION)
    ("protein and gene" . SPARSER::COLLECTION)
    ("protein or gene" . SPARSER::COLLECTION)
    ("pathological CR" . SPARSER::PROTEIN) ("Allele" . SPARSER::ALLELE)
    ("RR " . SPARSER::MOLECULE)
    ("these focal contact proteins" . SPARSER::PROTEIN)
    ("FAK, zyxin and tensin" . SPARSER::COLLECTION)
    ("integrins, vinculin, talin, paxillin, α-actinin, FAK, zyxin and tensin"
     . SPARSER::COLLECTION)
    ("GTPases and RhoA" . SPARSER::COLLECTION)
    ("cortactin-dynamin" . SPARSER::COLLECTION)
    ("an actin filament-binding protein and a major substrate"
     . SPARSER::COLLECTION)
    ("tensin, filamin, talin, plectin and α-actinin" . SPARSER::COLLECTION)
    ("plectin" . SPARSER::PROTEIN)
    ("at least 12 different adaptor proteins" . SPARSER::PROTEIN)
    ("a dual kinase complex" . SPARSER::BIO-COMPLEX)
    ("p130Cas and paxillin" . SPARSER::COLLECTION)
    ("FAK and Src kinase" . SPARSER::COLLECTION)
    ("FAK and Src" . SPARSER::COLLECTION) ("spp" . SPARSER::PROTEIN)
    ("invasin" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase (PI-3 kinase) and Grb2"
     . SPARSER::COLLECTION)
    ("genistein" . SPARSER::PROTEIN)
    ("the mutant form cortactin W22A or cortactin W525K" . SPARSER::COLLECTION)
    ("Arp2/3 or dynamin" . SPARSER::COLLECTION)
    ("cortactin, and FAK" . SPARSER::COLLECTION) ("tyr" . SPARSER::AMINO-ACID)
    ("antibody or α-cortactin" . SPARSER::COLLECTION)
    ("cortactin/FAK" . SPARSER::COLLECTION)
    ("cortactin and FAK" . SPARSER::COLLECTION) ("siaD" . SPARSER::PROTEIN)
    ("FAK K454M or FAK Y397F" . SPARSER::COLLECTION)
    ("strain MC58 siaD" . SPARSER::PROTEIN) ("gentamicin" . SPARSER::DRUG)
    ("unspecific control siRNA" . SPARSER::PROTEIN)
    ("a commercial siRNA" . SPARSER::PROTEIN)
    ("the GFP (actin stain) and rhodamin" . SPARSER::COLLECTION)
    ("secondary TRITC-labelled goat α-rabbit IgG"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("goat" . SPARSER::PROTEIN) ("TRITC" . SPARSER::MOLECULE)
    ("latrunculin B and jasplakinolide" . SPARSER::COLLECTION)
    ("jasplakinolide" . SPARSER::DRUG)
    ("Src, cortactin and FAK" . SPARSER::COLLECTION)
    ("an actin-binding protein and a key regulator" . SPARSER::COLLECTION)
    ("Cortactin" . SPARSER::PROTEIN) ("FAK/Src" . SPARSER::COLLECTION)
    ("a receptor-proximal regulator" . SPARSER::REGULATOR)
    ("integrin-associated proteins" . SPARSER::PROTEIN)
    ("the cytoskeletal proteins paxillin and talin" . SPARSER::COLLECTION)
    ("paxillin and talin" . SPARSER::COLLECTION) ("FAT" . SPARSER::PROTEIN)
    ("kDA" . SPARSER::PROTEIN) ("protein and Src" . SPARSER::COLLECTION)
    ("relatively large heterodimeric transmembrane proteins"
     . SPARSER::PROTEIN)
    ("Integrins" . SPARSER::PROTEIN) ("α5β1-integrin" . SPARSER::COLLECTION)
    ("vitronectin and fibronectin" . SPARSER::COLLECTION)
    ("ST" . SPARSER::PROTEIN) ("Opa and Opc" . SPARSER::COLLECTION)
    ("The primary meningococcal invasins" . SPARSER::PROTEIN)
    ("invasins" . SPARSER::PROTEIN) ("Opa" . SPARSER::MOLECULE)
    ("adhesin" . SPARSER::PROTEIN)
    ("FAK, Src and cortactin" . SPARSER::COLLECTION)
    ("FAK (FRNK)" . SPARSER::PROTEIN) ("FRNK" . SPARSER::PROTEIN)
    ("the respective integrins" . SPARSER::PROTEIN)
    ("fibronectin or vitronectin" . SPARSER::COLLECTION)
    ("p80" . SPARSER::PROTEIN) ("α-HA" . SPARSER::MOLECULE)
    ("D11" . SPARSER::PROTEIN) ("CA5" . SPARSER::PROTEIN)
    ("B15" . SPARSER::PROTEIN) ("PR3" . SPARSER::PROTEIN)
    ("p130Cas" . SPARSER::PROTEIN) ("dynamin-2" . SPARSER::PROTEIN)
    ("β1" . SPARSER::PROTEIN) ("PF 573228" . SPARSER::DRUG)
    ("latrunculin B" . SPARSER::DRUG) ("cytochalasin D" . SPARSER::DRUG)
    ("type1" . SPARSER::PROTEIN) ("fibronectin receptor" . SPARSER::PROTEIN)
    ("α5β1" . SPARSER::PROTEIN) ("Arp2/3" . SPARSER::PROTEIN)
    ("surface protein" . SPARSER::PROTEIN)
    ("novel antiretroviral therapeutics" . SPARSER::THERAPEUTICS)
    ("cdNIPP1" . SPARSER::PROTEIN)
    ("PP1α and protein phosphatase 2B" . SPARSER::COLLECTION)
    ("GST-PCAF" . SPARSER::COLLECTION) ("diamine" . SPARSER::MOLECULE)
    ("propane" . SPARSER::MOLECULE) ("aryl" . SPARSER::PROTEIN)
    ("RNA and Tat" . SPARSER::COLLECTION)
    ("amino disaccharides" . SPARSER::MOLECULE)
    ("isoquinoline" . SPARSER::DRUG) ("disaccharides" . SPARSER::MOLECULE)
    ("RNA-" . SPARSER::RNA)
    ("Previously reported inhibitors" . SPARSER::INHIBITOR)
    ("RNA, Tat and host" . SPARSER::COLLECTION)
    ("guanidine" . SPARSER::MOLECULE) ("QACA" . SPARSER::PROTEIN)
    ("Tat 35 QACA" . SPARSER::PROTEIN)
    ("sds22 and inhibitor-3" . SPARSER::COLLECTION)
    ("PNUTS or NIPP1" . SPARSER::COLLECTION)
    ("PNUTS and NIPP1" . SPARSER::COLLECTION)
    ("microcystin" . SPARSER::MOLECULE) ("PP1α-EGFP" . SPARSER::COLLECTION)
    ("PPl" . SPARSER::PROTEIN)
    ("recombinant PP1α and a generic substrate" . SPARSER::COLLECTION)
    ("a generic substrate" . SPARSER::SUBSTRATE)
    ("PP1 and PP2A" . SPARSER::COLLECTION) ("IRR" . SPARSER::PROTEIN)
    ("Vo" . SPARSER::MOLECULE) ("pRb-cdNIPP1" . SPARSER::PROTEIN-PAIR)
    ("pRb-NIPP1" . SPARSER::COLLECTION) ("Vo " . SPARSER::MOLECULE)
    ("NL4-3" . SPARSER::COLLECTION) ("LTR-" . SPARSER::PROTEIN)
    ("valine and phenylalanine" . SPARSER::COLLECTION)
    ("Molecule" . SPARSER::MOLECULE) ("pNL" . SPARSER::PROTEIN)
    ("MePCE" . SPARSER::PROTEIN)
    ("NIPP1 (Nuclear Inhibitor of PP1) or PNUTS (Phosphatase Nuclear Targeting Subunit)"
     . SPARSER::COLLECTION)
    ("Subunit" . SPARSER::FRAGMENT)
    ("PP1α, PP1β/δ or PP1γ" . SPARSER::COLLECTION) ("RNAP" . SPARSER::PROTEIN)
    ("the viral LTR" . SPARSER::PROTEIN)
    ("the viral Tat protein" . SPARSER::PROTEIN)
    ("HIV-1 viral proteins" . SPARSER::PROTEIN)
    ("novel antiviral drugs" . SPARSER::DRUG)
    ("NIPP1 and PNUTS" . SPARSER::COLLECTION) ("PNUTS" . SPARSER::PROTEIN)
    ("CDK9/cyclin T1" . SPARSER::COLLECTION) ("MS-MS" . SPARSER::PROTEIN)
    ("R - E" . SPARSER::PROTEIN) ("protein phosphatase 2B" . SPARSER::PROTEIN)
    ("hexamethylene bisacetamide" . SPARSER::DRUG) ("nuc-1" . SPARSER::PROTEIN)
    ("CREB binding protein" . SPARSER::PROTEIN)
    ("transcriptional coactivator" . SPARSER::PROTEIN)
    ("transcriptional activators" . SPARSER::PROTEIN-FAMILY)
    ("sds22" . SPARSER::HUMAN-PROTEIN-FAMILY) ("M 1" . SPARSER::MOLECULE)
    ("min -1" . SPARSER::PROTEIN) ("NL4" . SPARSER::PROTEIN)
    ("MT4" . SPARSER::PROTEIN) ("LARP7" . SPARSER::PROTEIN)
    ("HEXIM1" . SPARSER::PROTEIN) ("7SK" . SPARSER::RNA)
    ("PP1γ" . SPARSER::PROTEIN) ("PP1β" . SPARSER::PROTEIN)
    ("NIPP1" . SPARSER::PROTEIN) ("cyclin T1" . SPARSER::PROTEIN)
    ("lamin" . SPARSER::PROTEIN) ("MLL" . SPARSER::PROTEIN)
    ("a ubiquitous enzyme" . SPARSER::ENZYME) ("GIN" . SPARSER::PROTEIN)
    ("p-CCND-luc" . SPARSER::COLLECTION)
    ("anti-RB antibody and the immunocomplexes" . SPARSER::COLLECTION)
    ("anti-RB and anti-E2F1" . SPARSER::COLLECTION)
    ("BGLF4 and other CHPKs" . SPARSER::COLLECTION)
    ("RB and E2F1" . SPARSER::COLLECTION) ("cyclin-Cdks" . SPARSER::COLLECTION)
    ("Regulator" . SPARSER::REGULATOR) ("MN" . SPARSER::PROTEIN)
    ("KIT2 and KIT21" . SPARSER::COLLECTION) ("VIT" . SPARSER::PROTEIN)
    ("at least 120 hpi" . SPARSER::PROTEIN)
    ("B20 and B22" . SPARSER::COLLECTION)
    ("loose condensation" . SPARSER::PROTEIN-FAMILY)
    ("the Hoechst 33258-stained DNA" . SPARSER::DNA)
    ("DsRed-BGLF4" . SPARSER::COLLECTION) ("DsRed" . SPARSER::PROTEIN)
    ("the basic subunits" . SPARSER::PROTEIN) ("GFP-H2B" . SPARSER::COLLECTION)
    ("Cdc2-" . SPARSER::PROTEIN) ("hydroxyurea (HU)" . SPARSER::DRUG)
    ("BGLF4 and UL97" . SPARSER::COLLECTION) ("BGLF4-" . SPARSER::PROTEIN)
    ("cdc28-4" . SPARSER::PROTEIN) ("yeast strain cdc28-4" . SPARSER::PROTEIN)
    ("Both BGLF4 and its homolog HCMV UL97" . SPARSER::COLLECTION)
    ("cdc28-13" . SPARSER::PROTEIN)
    ("BGLF4-induced premature chromosome condensation"
     . SPARSER::PROTEIN-FAMILY)
    ("MCM-helicase" . SPARSER::COLLECTION)
    ("MCM4-MCM6-MCM7" . SPARSER::COLLECTION) ("BGLF4" . SPARSER::PROTEIN)
    ("GFP-BGLF4" . SPARSER::COLLECTION)
    ("a temperature-sensitive mutant yeast cdc28-13" . SPARSER::PROTEIN)
    ("yeast cdc28-13" . SPARSER::PROTEIN)
    ("other viral proteins" . SPARSER::PROTEIN)
    ("Cdk4 and Cdk2" . SPARSER::COLLECTION)
    ("Cdk1/cyclin" . SPARSER::COLLECTION) ("Topoisomerase" . SPARSER::PROTEIN)
    ("the MCM4-6-7 complex-associated DNA helicase" . SPARSER::PROTEIN)
    ("KIP" . SPARSER::PROTEIN) ("Topo" . SPARSER::PROTEIN)
    ("delta" . SPARSER::PROTEIN) ("Cdks" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("immediate early and early genes" . SPARSER::COLLECTION)
    ("cyclins, cyclin E and cyclin" . SPARSER::COLLECTION)
    ("Rta" . SPARSER::PROTEIN) ("cyclin D1 and ZBRK1" . SPARSER::COLLECTION)
    ("RB-E2F1" . SPARSER::COLLECTION) ("NCP" . SPARSER::PROTEIN)
    ("premature chromosome condensation" . SPARSER::PROTEIN-FAMILY)
    ("condensin and topoisomerase" . SPARSER::COLLECTION)
    ("BHLF1" . SPARSER::PROTEIN) ("KIT2" . SPARSER::PROTEIN)
    ("B20" . SPARSER::PROTEIN) ("B17" . SPARSER::PROTEIN)
    ("T-REx" . SPARSER::PROTEIN-FAMILY) ("Cdk-1" . SPARSER::PROTEIN)
    ("Cdc28" . SPARSER::PROTEIN) ("MCM7" . SPARSER::PROTEIN)
    ("MCM6" . SPARSER::PROTEIN) ("B22" . SPARSER::PROTEIN)
    ("TIP60" . SPARSER::PROTEIN) ("Cdk-2" . SPARSER::PROTEIN)
    ("MCM4" . SPARSER::PROTEIN) ("ORF36" . SPARSER::PROTEIN)
    ("U69" . SPARSER::PROTEIN) ("UL97" . SPARSER::PROTEIN-FAMILY)
    ("UL13" . SPARSER::PROTEIN) ("immediate early" . SPARSER::PROTEIN)
    ("these common variants and other as-yet-undiscovered rare variants"
     . SPARSER::COLLECTION)
    ("other as-yet-undiscovered rare variants" . SPARSER::VARIANT)
    ("ubiquitin-ligases" . SPARSER::COLLECTION)
    ("allele OR = 0.99" . SPARSER::COLLECTION)
    ("principal components" . SPARSER::COMPONENT)
    ("allele OR = 1" . SPARSER::COLLECTION) ("HR " . SPARSER::PROTEIN)
    ("allele and breast" . SPARSER::COLLECTION) ("RNF146" . SPARSER::PROTEIN)
    ("SSTR" . SPARSER::PROTEIN-FAMILY) ("neuropeptides" . SPARSER::PROTEIN)
    ("neprilysin and PP1a" . SPARSER::COLLECTION)
    ("S4- and T11-NEP-ICDs" . SPARSER::COLLECTION)
    ("S4-" . SPARSER::PROTEIN-FAMILY)
    ("cyclosporin A and FK-506" . SPARSER::COLLECTION)
    ("fostriecin" . SPARSER::DRUG) ("S6A" . SPARSER::PROTEIN)
    ("S6A-NEP" . SPARSER::COLLECTION)
    ("serines/threonines" . SPARSER::COLLECTION)
    ("threonines" . SPARSER::AMINO-ACID)
    ("NT-3 and U0126" . SPARSER::COLLECTION)
    ("the phosphoserine- and phosphothreonine-specific antibodies pS4-NEP"
     . SPARSER::COLLECTION)
    ("threonine and serine" . SPARSER::COLLECTION)
    ("pS6-NEP" . SPARSER::COLLECTION) ("pS4-NEP" . SPARSER::COLLECTION)
    ("phosphoserine-" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("phosphothreonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("phosphoserine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("plasma membrane-associated proteins" . SPARSER::PROTEIN)
    ("avidin and anti-neprilysin" . SPARSER::COLLECTION)
    ("avidin" . SPARSER::PROTEIN)
    ("APP, CTFα, CTFβ, and APP" . SPARSER::COLLECTION)
    ("CTF" . SPARSER::PROTEIN) ("neuronal Trk receptors" . SPARSER::RECEPTOR)
    ("NT-3 and calphostin" . SPARSER::COLLECTION)
    ("kinase, and protein" . SPARSER::COLLECTION)
    ("BDNF, NGF, NT-3, or NT-4" . SPARSER::COLLECTION)
    ("Trk" . SPARSER::PROTEIN) ("BDNF, NT-3, and NT-4" . SPARSER::COLLECTION)
    ("the neurotrophic factors BDNF, NGF, NT-3, and NT-4"
     . SPARSER::COLLECTION)
    ("BDNF, NGF, NT-3, and NT-4" . SPARSER::COLLECTION)
    ("possible drug" . SPARSER::DRUG)
    ("the neurotrophic factors brain-derived neurotrophic factor (BDNF)"
     . SPARSER::PROTEIN)
    ("brain-derived neurotrophic factor (BDNF)" . SPARSER::PROTEIN)
    ("somatostatin" . SPARSER::PROTEIN)
    ("amyloid precursor protein (APP) and presenilins" . SPARSER::COLLECTION)
    ("causative genes" . SPARSER::GENE)
    ("presenilins" . SPARSER::PROTEIN-FAMILY) ("APP" . SPARSER::PROTEIN)
    ("tautomycetin" . SPARSER::DRUG) ("NEP" . SPARSER::PROTEIN)
    ("the neurotrophic factors brain-derived neurotrophic factor"
     . SPARSER::PROTEIN)
    ("growth factor, and neurotrophins" . SPARSER::COLLECTION)
    ("neurotrophins" . SPARSER::PROTEIN) ("neprilysin" . SPARSER::PROTEIN)
    ("Neprilysin" . SPARSER::PROTEIN) ("SSTR5" . SPARSER::PROTEIN)
    ("SSTR1" . SPARSER::PROTEIN) ("DARPP32" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("D–G" . SPARSER::PROTEIN) ("casein kinase 2" . SPARSER::PROTEIN)
    ("neurotrophic factor" . SPARSER::PROTEIN) ("i.e. S" . SPARSER::MOLECULE)
    ("insulin-degrading enzyme" . SPARSER::PROTEIN)
    ("converting enzyme" . SPARSER::PROTEIN)
    ("MAPK/ERK kinase 1" . SPARSER::PROTEIN)
    ("Membrane-bound" . SPARSER::PROTEIN) ("PP1α" . SPARSER::PROTEIN)
    ("PP1A" . SPARSER::PROTEIN) ("L4–1" . SPARSER::PROTEIN)
    ("PP1a" . SPARSER::PROTEIN) ("pS4" . SPARSER::PROTEIN)
    ("FK-506" . SPARSER::DRUG) ("NT-4" . SPARSER::PROTEIN)
    ("NT-3" . SPARSER::PROTEIN)
    ("amyloid precursor protein" . SPARSER::PROTEIN)
    ("serine 6" . SPARSER::PROTEIN)
    ("brain-derived neurotrophic factor" . SPARSER::PROTEIN)
    ("ERBB2/PI3K/AKT" . SPARSER::COLLECTION)
    ("the translational repressor" . SPARSER::REPRESSOR)
    ("apex" . SPARSER::PROTEIN)
    ("novel eIF4F inhibitors or upstream mTORC1 inhibitors"
     . SPARSER::COLLECTION)
    ("rapamycin and bortezomib" . SPARSER::COLLECTION)
    ("eIF4E and eIF4G1" . SPARSER::COLLECTION)
    ("bortezomib and rapamycin" . SPARSER::COLLECTION)
    ("Bortezomib" . SPARSER::DRUG)
    ("highly-amplified ErbB2" . SPARSER::PROTEIN)
    ("eIF4E, Src, or Ras" . SPARSER::COLLECTION)
    ("an effective translational repressor" . SPARSER::REPRESSOR)
    ("functionally active eIF4F complex" . SPARSER::BIO-COMPLEX)
    ("exogenous BP1 proteins" . SPARSER::PROTEIN)
    ("4E-BP1 and eIF4G1" . SPARSER::COLLECTION)
    ("exogenous BP1" . SPARSER::PROTEIN) ("4E-BP1 (WT)" . SPARSER::PROTEIN)
    ("the translationally active eIF4F complex" . SPARSER::BIO-COMPLEX)
    ("cap-bound eIF4G1" . SPARSER::PROTEIN)
    ("eIF4E, eIF4G1 and 4E-BP1" . SPARSER::COLLECTION)
    ("4E-BP1 and eIF" . SPARSER::COLLECTION) ("eIF4G1" . SPARSER::PROTEIN)
    ("osteopontin, cyclin D1 and p16" . SPARSER::COLLECTION)
    ("p16, Src and Cyclin D1" . SPARSER::COLLECTION)
    ("herceptin and LY294002" . SPARSER::COLLECTION)
    ("p-P70S6K" . SPARSER::COLLECTION) ("p-MAPK" . SPARSER::COLLECTION)
    ("two major mTOR" . SPARSER::PROTEIN)
    ("therapeutic monoclonal antibody" . SPARSER::DRUG)
    ("p70S6K and 4E-BP1" . SPARSER::COLLECTION) ("herceptin" . SPARSER::DRUG)
    ("the eukaryotic translation initiation complex eIF4F" . SPARSER::PROTEIN)
    ("BPs" . SPARSER::PROTEIN) ("RAS/MAP kinase" . SPARSER::COLLECTION)
    ("directly target eIF4F" . SPARSER::PROTEIN)
    ("the m-TOR inhibitor rapamycin and the proteasome inhibitor bortezomib"
     . SPARSER::COLLECTION)
    ("bortezomib" . SPARSER::DRUG) ("Mnk-1" . SPARSER::PROTEIN)
    ("anti-ERBB2" . SPARSER::DRUG) ("P70S6K" . SPARSER::PROTEIN)
    ("E-1" . SPARSER::PROTEIN) ("A37" . SPARSER::PROTEIN)
    ("kip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ERBB-2" . SPARSER::PROTEIN)
    ("PS341" . SPARSER::DRUG) ("BP3" . SPARSER::PROTEIN)
    ("BP2" . SPARSER::PROTEIN) ("cap-binding protein" . SPARSER::PROTEIN)
    ("eukaryotic initiation factor 4E" . SPARSER::PROTEIN-FAMILY)
    ("c-erb-B2" . SPARSER::PROTEIN) ("m-TOR" . SPARSER::PROTEIN)
    ("β-catenin and KLF4" . SPARSER::COLLECTION)
    ("neither Sox9 nor KLF4" . SPARSER::COLLECTION)
    ("β-catenin or TCF" . SPARSER::COLLECTION)
    ("Sox9 and β-catenin" . SPARSER::COLLECTION)
    ("β-catenin as well as TCF4 [ xref ]" . SPARSER::COLLECTION)
    ("β-catenin/TCF4" . SPARSER::COLLECTION)
    ("TCF and Sox9 or KLF4" . SPARSER::COLLECTION)
    ("transcriptional activator, oncogene, or tumor" . SPARSER::COLLECTION)
    ("β-catenin and TCF4" . SPARSER::COLLECTION)
    ("Sox9 (2, 3) and KLF4 (2, 3)" . SPARSER::COLLECTION)
    ("β-catenin and Sox9 or KLF4" . SPARSER::COLLECTION)
    ("anti-Sox9 or anti-KLF4" . SPARSER::COLLECTION)
    ("Sox9, KLF4, or β-catenin" . SPARSER::COLLECTION)
    ("Sox9/KLF4" . SPARSER::COLLECTION)
    ("β-catenin/Sox9/KLF4" . SPARSER::COLLECTION)
    ("β-catenin/KLF4" . SPARSER::COLLECTION)
    ("β-catenin/Sox9" . SPARSER::COLLECTION)
    ("KLF4 and Sox9" . SPARSER::COLLECTION)
    ("asterix" . SPARSER::PROTEIN-FAMILY)
    ("anti-β-catenin" . SPARSER::COLLECTION)
    ("KLF4 as well as TCF" . SPARSER::COLLECTION)
    ("Sox9, KLF4 as well as TCF" . SPARSER::COLLECTION)
    ("TCF DNA-sites" . SPARSER::DNA)
    ("Sox9 or KLF4 and TCF" . SPARSER::COLLECTION)
    ("KLF4 and TCF" . SPARSER::COLLECTION) ("DNA-sites" . SPARSER::DNA)
    ("TCF or KLF4" . SPARSER::COLLECTION) ("Sox9-" . SPARSER::PROTEIN)
    ("Sox9 or KLF4" . SPARSER::COLLECTION) ("SRF" . SPARSER::PROTEIN)
    ("Sox17, Sox3, Sox7, and Sox9" . SPARSER::COLLECTION)
    ("Sox3" . SPARSER::PROTEIN) ("chondrocytes" . SPARSER::PROTEIN)
    ("an effector and a target" . SPARSER::COLLECTION)
    ("TCF4 and Sox9" . SPARSER::COLLECTION)
    ("KLF4 and β-catenin" . SPARSER::COLLECTION)
    ("β-catenin and TCF" . SPARSER::COLLECTION)
    ("TCF-luciferase" . SPARSER::COLLECTION)
    ("Sox9 and KLF4" . SPARSER::COLLECTION)
    ("serum response factor" . SPARSER::PROTEIN)
    ("anti-Histone" . SPARSER::PROTEIN) ("OCT-1" . SPARSER::PROTEIN)
    ("OCT1" . SPARSER::PROTEIN) ("Colon cancer" . SPARSER::PROTEIN)
    ("Sox7" . SPARSER::PROTEIN) ("Sox17" . SPARSER::PROTEIN)
    ("Sox9" . SPARSER::PROTEIN) ("normal ataxin" . SPARSER::PROTEIN)
    ("ataxin" . SPARSER::PROTEIN)
    ("neurodegenerative disease, and perhaps more specific inhibitors"
     . SPARSER::INHIBITOR)
    ("minocycline" . SPARSER::DRUG)
    ("the toxic disease protein TDP-43" . SPARSER::PROTEIN)
    ("FUS" . SPARSER::PROTEIN)
    ("insoluble phosphorylated TDP-43" . SPARSER::PROTEIN)
    ("caspase 3 and pTDP-43" . SPARSER::COLLECTION)
    ("ALS or SCA2" . SPARSER::COLLECTION)
    ("ALS and SCA2" . SPARSER::COLLECTION)
    ("pathological forms" . SPARSER::FORM)
    ("some insoluble pTDP-43 fragment" . SPARSER::FRAGMENT)
    ("perhaps" . SPARSER::PROTEIN)
    ("the insoluble pTDP-43 fragment" . SPARSER::FRAGMENT)
    ("FMK" . SPARSER::PROTEIN)
    ("an insoluble pTDP-43 fragment" . SPARSER::FRAGMENT)
    ("cellular caspases" . SPARSER::PROTEIN)
    ("ataxin 3 and ataxin 7" . SPARSER::COLLECTION)
    ("SCA3 and SCA7" . SPARSER::COLLECTION) ("SCA3" . SPARSER::PROTEIN)
    ("the insoluble pTDP-43 C-terminal fragment" . SPARSER::FRAGMENT)
    ("the insoluble fraction" . SPARSER::COMPONENT)
    ("insoluble TDP-43" . SPARSER::PROTEIN)
    ("soluble and insoluble protein fractions" . SPARSER::COMPONENT)
    ("enzymes, kinases, phosphatases, and proteases" . SPARSER::COLLECTION)
    ("SCA2 and ALS" . SPARSER::COLLECTION)
    ("an autosomal dominant hereditary ataxia" . SPARSER::PROTEIN)
    ("the highly insoluble C-terminal fragments" . SPARSER::FRAGMENT)
    ("Pathological TDP-43" . SPARSER::PROTEIN) ("Caspase" . SPARSER::PROTEIN)
    ("polyglutamine" . SPARSER::MOLECULE) ("ALS" . SPARSER::PROTEIN)
    ("SCA7" . SPARSER::PROTEIN) ("ataxin 7" . SPARSER::PROTEIN)
    ("ataxin 3" . SPARSER::PROTEIN) ("caspase 7" . SPARSER::PROTEIN)
    ("ataxin-2" . SPARSER::PROTEIN) ("retinoic acid" . SPARSER::MOLECULE)
    ("l -glutamine" . SPARSER::MOLECULE) ("SCA2" . SPARSER::PROTEIN)
    ("Spinocerebellar ataxia" . SPARSER::PROTEIN)
    ("spinocerebellar ataxia" . SPARSER::PROTEIN) ("TDP-43" . SPARSER::PROTEIN)
    ("E2A and PBX1" . SPARSER::COLLECTION)
    ("acute myelogenous leukemia" . SPARSER::PROTEIN)
    ("a controllable shRNA" . SPARSER::PROTEIN)
    ("pre-BALL" . SPARSER::PROTEIN-PAIR) ("NOD" . SPARSER::PROTEIN)
    ("DOXO" . SPARSER::PROTEIN) ("Bcl-2 and c-Myc" . SPARSER::COLLECTION)
    ("The antiapoptotic protein Bcl-2 and the proto-oncogene c-Myc"
     . SPARSER::COLLECTION)
    ("the chemotherapeutic drugs" . SPARSER::DRUG)
    ("sh-Myb" . SPARSER::COLLECTION)
    ("c-Myb, PARP, and GAPDH" . SPARSER::COLLECTION)
    ("mercaptopurine" . SPARSER::DRUG)
    ("YO-PRO1 and propidium" . SPARSER::COLLECTION)
    ("sh-c-Myb" . SPARSER::COLLECTION)
    ("a controllable lentiviral based shRNA" . SPARSER::PROTEIN)
    ("E2A" . SPARSER::PROTEIN) ("pediatric B-ALL" . SPARSER::PROTEIN)
    ("E2A-PBX1" . SPARSER::COLLECTION) ("pre-B-ALL" . SPARSER::COLLECTION)
    ("Acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("Bmi1" . SPARSER::PROTEIN) ("proto-oncogene c-Myb" . SPARSER::PROTEIN)
    ("VP-16" . SPARSER::PROTEIN) ("YO-PRO1" . SPARSER::MOLECULE)
    ("c-Myb protein" . SPARSER::PROTEIN) ("v-Myb" . SPARSER::PROTEIN)
    ("PBX1" . SPARSER::PROTEIN) ("B-ALL" . SPARSER::PROTEIN)
    ("c-Myb" . SPARSER::PROTEIN)
    ("ruxolitinib and TG101348" . SPARSER::COLLECTION)
    ("SARS" . SPARSER::PROTEIN)
    ("MYD88, EGH2, CARD11 and CREBBP" . SPARSER::COLLECTION)
    ("CREBBP" . SPARSER::PROTEIN) ("JG" . SPARSER::PROTEIN)
    ("ESP" . SPARSER::PROTEIN)
    ("a heterozygous cytosine" . SPARSER::NUCLEOBASE)
    ("Leucine" . SPARSER::AMINO-ACID) ("Histidine" . SPARSER::AMINO-ACID)
    ("PMF" . SPARSER::PROTEIN) ("Ras-ERK" . SPARSER::COLLECTION)
    ("JAK2-STAT3" . SPARSER::COLLECTION) ("ruxolitinib" . SPARSER::DRUG)
    ("JAK2 and STAT3" . SPARSER::COLLECTION)
    ("JAK2 inhibitor TG101348" . SPARSER::DRUG) ("TG101348" . SPARSER::DRUG)
    ("CARD11" . SPARSER::PROTEIN) ("MYD88" . SPARSER::PROTEIN)
    ("B-RAF" . SPARSER::PROTEIN) ("Tsg101 and Alix" . SPARSER::COLLECTION)
    ("Rab9 and other small GTPases" . SPARSER::COLLECTION)
    ("NPC-1 and POSH" . SPARSER::COLLECTION)
    ("kinase, AP-1, and Filamin" . SPARSER::COLLECTION)
    ("Rab9 [ xref ] and other GTPases [ xref ]" . SPARSER::COLLECTION)
    ("Rab9" . SPARSER::PROTEIN) ("Filamin" . SPARSER::PROTEIN-FAMILY)
    ("POSH" . SPARSER::PROTEIN) ("citron" . SPARSER::PROTEIN)
    ("Ca 2+ , Sprouty and ARF1" . SPARSER::COLLECTION)
    ("Spry2 and ADP-ribosylation factor-1 (ARF1)" . SPARSER::COLLECTION)
    ("The non-ESCRT proteins, Spry2 and ADP-ribosylation factor-1 (ARF1)"
     . SPARSER::COLLECTION)
    ("Perhaps" . SPARSER::PROTEIN)
    ("the internal Ca 2+" . SPARSER::CALCIUM-ION)
    ("Kinesin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Kinesins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kinesin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Nedd4 or Alix" . SPARSER::COLLECTION)
    ("basic proteins" . SPARSER::PROTEIN) ("NMDA" . SPARSER::MOLECULE)
    ("MARCKS" . SPARSER::PROTEIN) ("Tsg101 or Alix" . SPARSER::COLLECTION)
    ("AP-1, AP-3, and Arf1" . SPARSER::COLLECTION) ("Arf1" . SPARSER::PROTEIN)
    ("at least one protein" . SPARSER::PROTEIN)
    ("the human vacuolar protein" . SPARSER::PROTEIN)
    ("SNAREs" . SPARSER::PROTEIN)
    ("proteins and organelles" . SPARSER::COLLECTION)
    ("Tsg101 and/or Alix" . SPARSER::COLLECTION)
    ("IP3R and PLC" . SPARSER::COLLECTION) ("Components" . SPARSER::COMPONENT)
    ("ROCE" . SPARSER::PROTEIN) ("ESCRT-III and Vps4" . SPARSER::COLLECTION)
    ("Tsg101" . SPARSER::PROTEIN) ("COS" . SPARSER::MOLECULE)
    ("VLPs" . SPARSER::PROTEIN) ("KE" . SPARSER::MOLECULE)
    ("basic amino acid" . SPARSER::AMINO-ACID) ("ring" . SPARSER::PROTEIN)
    ("bis" . SPARSER::PROTEIN) ("soluble polysomes" . SPARSER::BIO-COMPLEX)
    ("polysomes" . SPARSER::BIO-COMPLEX) ("mature proteins" . SPARSER::PROTEIN)
    ("viral RNA and nonspecific RNAs" . SPARSER::COLLECTION)
    ("nonspecific RNAs" . SPARSER::RNA) ("viral RNA" . SPARSER::RNA)
    ("recruiting other viral components" . SPARSER::COMPONENT)
    ("PM" . SPARSER::PROTEIN) ("IP3R and Spry2" . SPARSER::COLLECTION)
    ("PLC-" . SPARSER::PROTEIN) ("phospholipase" . SPARSER::PROTEIN)
    ("NPC-1" . SPARSER::PROTEIN) ("P 5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ARF-1" . SPARSER::PROTEIN) ("ARF1" . SPARSER::PROTEIN)
    ("KIF3" . SPARSER::PROTEIN) ("KIF4" . SPARSER::PROTEIN)
    ("growth-associated protein" . SPARSER::PROTEIN)
    ("TEX14" . SPARSER::PROTEIN) ("AP-3" . SPARSER::PROTEIN)
    ("Mon2" . SPARSER::PROTEIN) ("class C" . SPARSER::PROTEIN)
    ("Cep55" . SPARSER::PROTEIN) ("2-APB" . SPARSER::MOLECULE)
    ("Vps4" . SPARSER::PROTEIN) ("ESCRT-III" . SPARSER::PROTEIN-FAMILY)
    ("Nedd4" . SPARSER::PROTEIN) ("p2b" . SPARSER::PROTEIN)
    ("IP3" . SPARSER::IP3) ("inositol 1,4,5-triphosphate" . SPARSER::IP3)
    ("IP3R" . SPARSER::PROTEIN)
    ("inositol 1,4,5-triphosphate receptor" . SPARSER::PROTEIN)
    ("cellular NAD+ and ATP" . SPARSER::COLLECTION)
    ("cellular NAD+" . SPARSER::MOLECULE)
    ("MDA-MB-231cells" . SPARSER::PROTEIN)
    ("Bim, p27 and Fas-L" . SPARSER::COLLECTION)
    ("particular FOXO3a" . SPARSER::PROTEIN)
    ("a phamacological inhibitor" . SPARSER::INHIBITOR)
    ("the CDK-inhibitor p21 and pro-apoptotic BAX" . SPARSER::COLLECTION)
    ("pro-apoptotic BAX" . SPARSER::PROTEIN)
    ("MDA-MB-231 cells" . SPARSER::PROTEIN)
    ("p53 MDA-MB-231 cells" . SPARSER::PROTEIN)
    ("substance" . SPARSER::SUBSTANCE)
    ("p21 ( xref ) and BAX ( xref )" . SPARSER::COLLECTION)
    ("FPG" . SPARSER::PROTEIN-FAMILY) ("p53 and FOXO3a" . SPARSER::COLLECTION)
    ("local medicine" . SPARSER::DRUG) ("Akt and AMPk" . SPARSER::COLLECTION)
    ("AMPk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bim and Fas ligand" . SPARSER::COLLECTION)
    ("cyclinD-CDK2" . SPARSER::PROTEIN-PAIR)
    ("p21 (WAF1/CIP1), 14-3-3σ and cyclin G, and pro-apoptotic genes"
     . SPARSER::COLLECTION)
    ("WAF1/CIP1" . SPARSER::COLLECTION)
    ("FOXO3a and p53" . SPARSER::COLLECTION)
    ("p21 and BAX" . SPARSER::COLLECTION) ("type VII" . SPARSER::PROTEIN)
    ("NAD+" . SPARSER::MOLECULE) ("Fas-L" . SPARSER::PROTEIN)
    ("N-acetyl-cysteine" . SPARSER::DRUG) ("FOXO3" . SPARSER::PROTEIN)
    ("A-T-T-A" . SPARSER::COLLECTION) ("A-T-C-T" . SPARSER::COLLECTION)
    ("allele or genotype" . SPARSER::COLLECTION)
    ("allele and genotype" . SPARSER::COLLECTION)
    ("allele  " . SPARSER::ALLELE) ("nitrosamines" . SPARSER::MOLECULE)
    ("an ethanol- and drug-metabolizing enzyme" . SPARSER::COLLECTION)
    ("ethanol-" . SPARSER::PROTEIN)
    ("oncogenes and chemical carcinogens xref" . SPARSER::COLLECTION)
    ("this study prostaglandin-endoperoxide synthase 2 (PTGS2) and cytochrome P450"
     . SPARSER::COLLECTION)
    ("previously identified genes" . SPARSER::GENE)
    ("PTGS2 and CYP2E1" . SPARSER::COLLECTION)
    ("A-T-T-T" . SPARSER::COLLECTION) ("stats" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTGS2 (rs689466, rs5275, rs20417) and CYP2E1 (rs2031920, rs6413432) genes"
     . SPARSER::COLLECTION)
    ("T-A" . SPARSER::PROTEIN) ("C-T" . SPARSER::PROTEIN)
    ("dominant and recessive" . SPARSER::PROTEIN)
    ("carboxy-fluorescein" . SPARSER::DRUG)
    ("polypeptide 1" . SPARSER::PROTEIN) ("subfamily E" . SPARSER::PROTEIN)
    ("family 2" . SPARSER::PROTEIN)
    ("cytochrome P450" . SPARSER::PROTEIN-FAMILY)
    ("prostaglandin-endoperoxide synthase 2" . SPARSER::PROTEIN)
    ("T-T" . SPARSER::PROTEIN) ("A-T" . SPARSER::PROTEIN)
    ("C-C-T" . SPARSER::PROTEIN) ("CYP2E1" . SPARSER::PROTEIN)
    ("PTGS2" . SPARSER::PROTEIN) ("-Exo84" . SPARSER::COLLECTION)
    ("mCherry-fused" . SPARSER::COLLECTION) ("spindly" . SPARSER::PROTEIN)
    ("Sec5 or Exo84" . SPARSER::COLLECTION)
    ("either RalA 38R or RalA 47E" . SPARSER::COLLECTION)
    ("RalA 38R and RalA 47E" . SPARSER::COLLECTION)
    ("Exo84 and Sec5" . SPARSER::COLLECTION)
    ("RalA-Exo84" . SPARSER::COLLECTION) ("RalA-Sec5" . SPARSER::COLLECTION)
    ("a compensatory Sec5 point mutation" . SPARSER::PROTEIN)
    ("RalA and both Sec5 and Exo84" . SPARSER::COLLECTION)
    ("Only four Ral effectors" . SPARSER::EFFECTOR)
    ("Sec5 and Exo84" . SPARSER::COLLECTION) ("Sec5" . SPARSER::PROTEIN)
    ("RalA and RalB" . SPARSER::COLLECTION) ("RalGDS" . SPARSER::PROTEIN)
    ("RalB" . SPARSER::PROTEIN) ("Ras, Rho, Rab and Arf" . SPARSER::COLLECTION)
    ("hetero" . SPARSER::PROTEIN) ("nearby vasculature" . SPARSER::PROTEIN)
    ("RalA and its effectors" . SPARSER::COLLECTION)
    ("Exocyst" . SPARSER::BIO-COMPLEX) ("CO3" . SPARSER::PROTEIN)
    ("Fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("L38" . SPARSER::PROTEIN) ("Amino Acids" . SPARSER::AMINO-ACID)
    ("Sec15" . SPARSER::PROTEIN-FAMILY) ("RalBP1" . SPARSER::PROTEIN)
    ("Exo84" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("downstream pro-apoptotic genes Puma and Bim" . SPARSER::COLLECTION)
    ("AKT and FOXO3a" . SPARSER::COLLECTION)
    ("AKT/FOXO3a" . SPARSER::COLLECTION)
    ("PUMA protein and Puma" . SPARSER::COLLECTION) ("EBP" . SPARSER::PROTEIN)
    ("bZIP" . SPARSER::PROTEIN-FAMILY)
    ("One such key transcription factor" . SPARSER::PROTEIN)
    ("BIM and BID" . SPARSER::COLLECTION)
    ("death receptor-5 (DR5; TRAIL-R2) and Tribbles-related protein 3 (TRB3)"
     . SPARSER::COLLECTION)
    ("Tribbles" . SPARSER::PROTEIN-FAMILY)
    ("ATF6 and PERK" . SPARSER::COLLECTION)
    ("CHOP/GADD153" . SPARSER::COLLECTION) ("bZiP" . SPARSER::PROTEIN-FAMILY)
    ("key pro-apoptotic molecules PUMA and BIM" . SPARSER::COLLECTION)
    ("CHOP and total FOXO3a" . SPARSER::COLLECTION)
    ("CHOP and FOXO3a" . SPARSER::COLLECTION)
    ("the pro-apoptotic transcription factor CHOP" . SPARSER::PROTEIN)
    ("Akt and FOXO3a" . SPARSER::COLLECTION)
    ("pro-apoptotic proteins BIM and PUMA" . SPARSER::COLLECTION)
    ("BIM and PUMA" . SPARSER::COLLECTION)
    ("AKT or FOXO3a" . SPARSER::COLLECTION)
    ("phosphorylated AKT (serine 473) and its downstream target"
     . SPARSER::COLLECTION)
    ("tunicamycin-" . SPARSER::MOLECULE)
    ("Bim  −/− and p53  −/− E14.5 mice" . SPARSER::COLLECTION)
    ("PUMA, BIM and p53" . SPARSER::COLLECTION)
    ("tunicamycin or AraC" . SPARSER::COLLECTION)
    ("Puma and Bim" . SPARSER::COLLECTION) ("AraC" . SPARSER::DRUG)
    ("BIP/GRP78" . SPARSER::COLLECTION) ("SH-SH5Y" . SPARSER::COLLECTION)
    ("hypoxia-ischemia" . SPARSER::COLLECTION)
    ("AKT-FOXO3a" . SPARSER::COLLECTION) ("AFX" . SPARSER::PROTEIN)
    ("PUMA as well as NOXA" . SPARSER::COLLECTION) ("NOXA" . SPARSER::PROTEIN)
    ("the pro-apoptotic BH3-only proteins" . SPARSER::PROTEIN)
    ("BAX and BAK" . SPARSER::COLLECTION) ("BAK" . SPARSER::PROTEIN)
    ("PERK" . SPARSER::PROTEIN)
    ("a combined nuclease and kinase called IRE1" . SPARSER::PROTEIN)
    ("nuclease and kinase" . SPARSER::COLLECTION)
    ("multiple pro-apoptotic BH3-only molecules" . SPARSER::MOLECULE)
    ("/FOXO3a" . SPARSER::COLLECTION) ("Ddit3" . SPARSER::PROTEIN)
    ("PUMA and BIM" . SPARSER::COLLECTION)
    ("PUMA ( p 53 u pregulated m odulator of a poptosis) and BIM ( B CL2 i nteracting m ediator of cell death)"
     . SPARSER::COLLECTION)
    ("TRB3" . SPARSER::PROTEIN) ("DR5" . SPARSER::PROTEIN)
    ("death receptor-5" . SPARSER::PROTEIN)
    ("transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("PUMA protein" . SPARSER::PROTEIN)
    ("Glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("cytosine arabinoside" . SPARSER::DRUG) ("FOXO1a" . SPARSER::PROTEIN)
    ("FKHRL1" . SPARSER::PROTEIN) ("IRE1" . SPARSER::PROTEIN)
    ("class O" . SPARSER::PROTEIN) ("FOXO3a" . SPARSER::PROTEIN)
    ("GADD153" . SPARSER::PROTEIN)
    ("C/EBP homologous protein" . SPARSER::PROTEIN) ("CL2" . SPARSER::PROTEIN)
    ("p 53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the recurrent seizures" . SPARSER::PROTEIN)
    ("relatively recent TLE" . SPARSER::PROTEIN)
    ("pilocarpine" . SPARSER::MOLECULE)
    ("Widespread Reactive Astrocytes" . SPARSER::PROTEIN)
    ("pS6/NeuN" . SPARSER::COLLECTION) ("strong pS6 IR" . SPARSER::PROTEIN)
    ("Reactive astrocytes" . SPARSER::PROTEIN)
    ("the dentate gyrus and both CA subfields ( xref , e–h)"
     . SPARSER::COLLECTION)
    ("weak pS6 IR" . SPARSER::PROTEIN) ("CA1 and CA3" . SPARSER::COLLECTION)
    ("GFAP/pS6" . SPARSER::COLLECTION) ("gyrus and CA3" . SPARSER::COLLECTION)
    ("gyrus, CA1 and CA3" . SPARSER::COLLECTION) ("gyrus" . SPARSER::PROTEIN)
    ("dentate" . SPARSER::PROTEIN) ("CA1" . SPARSER::PROTEIN)
    ("seizures, and rapamycin" . SPARSER::COLLECTION)
    ("classical anticonvulsant drugs" . SPARSER::DRUG)
    ("anticonvulsant" . SPARSER::DRUG)
    ("widespread reactive astrocytes" . SPARSER::PROTEIN)
    ("reactive astrocytes" . SPARSER::PROTEIN) ("TLE" . SPARSER::PROTEIN)
    ("TSC-1" . SPARSER::PROTEIN) ("IR 5" . SPARSER::PROTEIN)
    ("CA3" . SPARSER::PROTEIN) ("p107 and p130" . SPARSER::COLLECTION)
    ("/p107" . SPARSER::COLLECTION) ("Rbl1" . SPARSER::PROTEIN)
    ("Rbl2 , Ncoa1 and Klhl26" . SPARSER::COLLECTION)
    ("p21 and Klhl26" . SPARSER::COLLECTION)
    ("p21, p130, Ncoa1 and Klhl26" . SPARSER::COLLECTION)
    ("doxorubicin or Nutlin" . SPARSER::COLLECTION) ("REFs" . SPARSER::PROTEIN)
    ("Rbl2 , Ncoa1 , and Klhl26" . SPARSER::COLLECTION)
    ("Klhl26 and 500+" . SPARSER::COLLECTION)
    ("573 stress-induced genes" . SPARSER::GENE)
    ("PFM and Consite" . SPARSER::COLLECTION)
    ("Only one candidate gene" . SPARSER::GENE)
    ("doxorubicin ( xref ) or Nutlin (not shown)" . SPARSER::COLLECTION)
    ("/p21" . SPARSER::COLLECTION) ("Oct4 and Nanog" . SPARSER::COLLECTION)
    ("p53–p21" . SPARSER::COLLECTION)
    ("a positional frequency matrix (PFM)" . SPARSER::PROTEIN-FAMILY)
    ("matrix (PFM)" . SPARSER::PROTEIN-FAMILY) ("PFM" . SPARSER::PROTEIN)
    ("MDM2-p53" . SPARSER::COLLECTION) ("lox/lox" . SPARSER::COLLECTION)
    ("p107/p130" . SPARSER::COLLECTION) ("Lox" . SPARSER::PROTEIN)
    ("the prototypical tumor suppressor gene" . SPARSER::PROTEIN)
    ("an unilateral or bilateral form" . SPARSER::FORM)
    ("/p130" . SPARSER::COLLECTION) ("Ncoa1 and Klhl26" . SPARSER::COLLECTION)
    ("Ncoa1" . SPARSER::PROTEIN)
    ("containing perfect p53 response elements"
     . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Rbl2" . SPARSER::PROTEIN) ("a classic example" . SPARSER::EXAMPLE)
    ("MEF2" . SPARSER::PROTEIN) ("BLAST 2" . SPARSER::PROTEIN)
    ("C-14" . SPARSER::PROTEIN) ("Nutlin 3a" . SPARSER::DRUG)
    ("SRC1" . SPARSER::PROTEIN) ("PIG3" . SPARSER::PROTEIN)
    ("Chx10" . SPARSER::PROTEIN) ("Klhl26" . SPARSER::PROTEIN)
    ("Retinoblastoma-like 2" . SPARSER::PROTEIN)
    ("other molecularly-defined cohorts" . SPARSER::MOLECULE)
    ("the HER2 and both the BRAF and ALK subsets" . SPARSER::COLLECTION)
    ("BRAF and ALK" . SPARSER::COLLECTION) ("EGFR/KRAS" . SPARSER::COLLECTION)
    ("major EGFR and KRAS" . SPARSER::COLLECTION)
    ("dacomitinib and afatinib" . SPARSER::COLLECTION)
    ("dacomitinib" . SPARSER::DRUG) ("HER2 and CEP17" . SPARSER::COLLECTION)
    ("A bronchoalveolar component" . SPARSER::COMPONENT)
    ("a mucinous component" . SPARSER::COMPONENT) ("IIIb" . SPARSER::DRUG)
    ("VC" . SPARSER::MOLECULE) ("amino acids (YVMA)" . SPARSER::AMINO-ACID)
    ("EGFR, KRAS, and ALK" . SPARSER::COLLECTION)
    ("both HER2 inhibitors and dual EGFR/HER2 inhibitors ( xref – xref )"
     . SPARSER::COLLECTION)
    ("dual EGFR/HER2 inhibitors" . SPARSER::INHIBITOR)
    ("some biologically aggressive forms" . SPARSER::FORM)
    ("extensive structural homology" . SPARSER::PROTEIN)
    ("EGFR, HER3 and HER4" . SPARSER::COLLECTION)
    ("HER3 (ERBB3) and HER4 (ERBB4)" . SPARSER::COLLECTION)
    ("EGFR (HER1/ERBB1), HER3 (ERBB3) and HER4 (ERBB4)" . SPARSER::COLLECTION)
    ("HER1/ERBB1" . SPARSER::COLLECTION)
    ("EGFR/KRAS/ALK" . SPARSER::COLLECTION)
    ("EGFR, KRAS, BRAF, NRAS, PIK3CA, MEK1 and AKT" . SPARSER::COLLECTION)
    ("EGFR (exons 19 and 21) and KRAS (exon 2)" . SPARSER::COLLECTION)
    ("ADC" . SPARSER::PROTEIN) ("ADCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("T - 3" . SPARSER::PROTEIN) ("ERBB1" . SPARSER::PROTEIN)
    ("the quiescent state and the risk" . SPARSER::COLLECTION)
    ("Arf and p53" . SPARSER::COLLECTION)
    ("barely-proliferating normal MEFs" . SPARSER::PROTEIN)
    ("normal MEFs" . SPARSER::PROTEIN) ("Arf or p53" . SPARSER::COLLECTION)
    ("senescent MEFs" . SPARSER::PROTEIN)
    ("the in vivo precancerous states" . SPARSER::BIO-STATE)
    ("MIN" . SPARSER::PROTEIN) ("Arf/p53" . SPARSER::COLLECTION)
    ("NK4" . SPARSER::PROTEIN) ("Five percent matrigel" . SPARSER::PROTEIN)
    ("Parts" . SPARSER::COMPONENT) ("pRL-TK" . SPARSER::COLLECTION)
    ("pGL" . SPARSER::PROTEIN) ("pRL" . SPARSER::PROTEIN)
    ("TC-3" . SPARSER::COLLECTION) ("CTA" . SPARSER::PROTEIN)
    ("CGA" . SPARSER::PROTEIN) ("EDTA and proteinase" . SPARSER::COLLECTION)
    ("chloroform" . SPARSER::MOLECULE)
    ("antibody or IgG" . SPARSER::COLLECTION)
    ("deoxycholate" . SPARSER::MOLECULE)
    ("included anti-human Pokemon (Sigma, USA), anti-human BIM, anti-caspase3 and anti-cleaved caspase-3 (Cell Signaling Technology, Danvers, Massachusetts, USA), and anti-human beta-actin (Beyotime, DaLian, China)"
     . SPARSER::COLLECTION)
    ("BIM, anti-caspase3 and anti-cleaved" . SPARSER::COLLECTION)
    ("BIM" . SPARSER::PROTEIN) ("Doc" . SPARSER::DRUG)
    ("HRP-conjugated secondary antibodies" . SPARSER::ANTIBODY)
    ("Trizol" . SPARSER::DRUG) ("ethanol" . SPARSER::PROTEIN)
    ("fresh media containing 20% FBS" . SPARSER::PROTEIN)
    ("siRNA and OligofectAMINE" . SPARSER::COLLECTION)
    ("-GCA" . SPARSER::COLLECTION) ("si-P3" . SPARSER::COLLECTION)
    ("Att-3" . SPARSER::COLLECTION) ("ACG" . SPARSER::PROTEIN)
    ("Att" . SPARSER::PROTEIN) ("GGA" . SPARSER::MOLECULE)
    ("ACC-3" . SPARSER::COLLECTION) ("-ATA" . SPARSER::MOLECULE)
    ("Bim-p" . SPARSER::COLLECTION) ("AAC" . SPARSER::PROTEIN)
    ("TCC" . SPARSER::PROTEIN) ("TTG" . SPARSER::PROTEIN)
    ("GAG" . SPARSER::PROTEIN) ("GCC" . SPARSER::PROTEIN)
    ("ATG" . SPARSER::DRUG) ("ATA" . SPARSER::MOLECULE)
    ("-bim800" . SPARSER::COLLECTION) ("bim" . SPARSER::PROTEIN)
    ("pGFP-POK" . SPARSER::COLLECTION) ("-POK" . SPARSER::COLLECTION)
    ("pEGFP-N3" . SPARSER::COLLECTION)
    ("the Bcl-2 family pro-apoptotic protein Bim" . SPARSER::PROTEIN)
    ("p53, p21 and Rb" . SPARSER::COLLECTION)
    ("exogenous Pokemon" . SPARSER::PROTEIN)
    ("GFP-Pokemon" . SPARSER::COLLECTION)
    ("Pokemon-Bim-anoikis" . SPARSER::COLLECTION)
    ("cyclin-cdk2" . SPARSER::COLLECTION) ("p21 and Rb" . SPARSER::COLLECTION)
    ("ARF-MDM2-p53" . SPARSER::COLLECTION)
    ("p53 and Bim" . SPARSER::COLLECTION) ("POK" . SPARSER::PROTEIN)
    ("Pokemon-Bim" . SPARSER::COLLECTION)
    ("cytometry and caspase-3" . SPARSER::COLLECTION)
    ("Pokemon" . SPARSER::PROTEIN) ("AC-3" . SPARSER::PROTEIN)
    ("Bim1" . SPARSER::PROTEIN) ("caspase3" . SPARSER::PROTEIN)
    ("p4" . SPARSER::HUMAN-PROTEIN-FAMILY) ("N3" . SPARSER::PROTEIN)
    ("si-P2" . SPARSER::PROTEIN) ("si-RNAs" . SPARSER::RNA)
    ("GATA1" . SPARSER::PROTEIN) ("cdk2" . SPARSER::PROTEIN)
    ("a predictive biomarker" . SPARSER::MOLECULE)
    ("Rho-GTPase activating" . SPARSER::COLLECTION)
    ("RAPGEF" . SPARSER::PROTEIN-FAMILY) ("RAF-MAPK" . SPARSER::COLLECTION)
    ("a more aggressive subtype" . SPARSER::PROTEIN)
    ("MSI, CIMP, PIK3CA , and LINE-1" . SPARSER::COLLECTION)
    ("A–B" . SPARSER::PROTEIN) ("TGC" . SPARSER::PROTEIN)
    ("GCA" . SPARSER::PROTEIN) ("CGT" . SPARSER::PROTEIN)
    ("BRAF and PIK3CA" . SPARSER::COLLECTION)
    ("almost all BRAF mutants" . SPARSER::MUTANT)
    ("RAS-GTP" . SPARSER::PROTEIN)
    ("nucleotide exchange factors" . SPARSER::NUCLEOTIDE-EXCHANGE-FACTOR)
    ("GTPase activating" . SPARSER::PROTEIN) ("C–D" . SPARSER::PROTEIN)
    ("SOCS1" . SPARSER::PROTEIN) ("RUNX3" . SPARSER::PROTEIN)
    ("NEUROG1" . SPARSER::PROTEIN) ("CRABP1" . SPARSER::PROTEIN)
    ("CACNA1G" . SPARSER::PROTEIN) ("D5S346" . SPARSER::PROTEIN)
    ("CXCR4, c-met, Igf-1R, and Ins-R" . SPARSER::COLLECTION)
    ("RasGRF1-scr" . SPARSER::COLLECTION)
    ("Igf-1R and Ins-R" . SPARSER::COLLECTION)
    ("CXCR4 and c-met" . SPARSER::COLLECTION)
    ("normal skeletal muscles" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-Myc-" . SPARSER::PROTEIN) ("DBL" . SPARSER::PROTEIN)
    ("KCNQ1 and RasGRF1" . SPARSER::COLLECTION)
    ("skeletal muscles" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tructural proteins and regulators" . SPARSER::COLLECTION)
    ("proteins and regulators" . SPARSER::COLLECTION)
    ("SDF-1 and Igf-2" . SPARSER::COLLECTION)
    ("the Igf-2 receptor (IGF-2R) and the Ins receptor (INS-R)"
     . SPARSER::COLLECTION)
    ("the SDF-1 receptor (CXCR4), the HGF receptor (c-met), the Igf-2 receptor (IGF-2R) and the Ins receptor (INS-R)"
     . SPARSER::COLLECTION)
    ("SF, Igf-2, and Ins" . SPARSER::COLLECTION)
    ("p42/44 MAPK and/or AKT" . SPARSER::COLLECTION)
    ("SDF-1 and HGF/SF" . SPARSER::COLLECTION)
    ("Igf-2, and Ins" . SPARSER::COLLECTION)
    ("pro-metastatic chemoattractants" . SPARSER::PROTEIN)
    ("Igf-2 or Ins" . SPARSER::COLLECTION) ("FTI" . SPARSER::DRUG)
    ("Igf-2 and Ins" . SPARSER::COLLECTION)
    ("several pro-metastatic chemoattractants" . SPARSER::PROTEIN)
    ("chemoattractants" . SPARSER::PROTEIN)
    ("normal skeletal muscle" . SPARSER::PROTEIN)
    ("further 2 ARMS" . SPARSER::PROTEIN)
    ("Igf-1, and Ins" . SPARSER::COLLECTION)
    ("Igf2 and KCNQ1" . SPARSER::COLLECTION)
    ("dominant-negative p53 or SV40 early region proteins and PAX-FOXO1"
     . SPARSER::COLLECTION)
    ("dominant-negative p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteins and PAX-FOXO1" . SPARSER::COLLECTION)
    ("proteins, and GTPase-activating" . SPARSER::COLLECTION)
    ("triphosphatases" . SPARSER::PROTEIN) ("guanosine" . SPARSER::MOLECULE)
    ("/p14 ARF" . SPARSER::COLLECTION) ("Ins" . SPARSER::PROTEIN)
    ("hepatocyte growth factor/scatter factor" . SPARSER::COLLECTION)
    ("ARMS and ERMS" . SPARSER::COLLECTION)
    ("PAX7-FOXO1" . SPARSER::COLLECTION)
    ("histologic subtype" . SPARSER::PROTEIN)
    ("two major subtypes" . SPARSER::PROTEIN) ("kd" . SPARSER::PROTEIN)
    ("RasGRF1-kd" . SPARSER::COLLECTION) ("MAPK and AKT" . SPARSER::COLLECTION)
    ("Igf-2" . SPARSER::PROTEIN) ("HGF/SF" . SPARSER::COLLECTION)
    ("SF" . SPARSER::PROTEIN) ("Ins-R" . SPARSER::PROTEIN)
    ("Igf-1R" . SPARSER::PROTEIN) ("p75" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("INS-R" . SPARSER::PROTEIN) ("IGF-2R" . SPARSER::PROTEIN)
    ("c-met" . SPARSER::PROTEIN) ("HGF receptor" . SPARSER::PROTEIN)
    ("SDF-1 receptor" . SPARSER::PROTEIN) ("CXCR7" . SPARSER::PROTEIN)
    ("HEMA 3" . SPARSER::PROTEIN) ("Ras-GTP" . SPARSER::PROTEIN)
    ("Raf-1" . SPARSER::PROTEIN)
    ("farnesyl transferase inhibitor" . SPARSER::DRUG)
    ("IGF-II" . SPARSER::PROTEIN) ("RASGRF1" . SPARSER::PROTEIN)
    ("KCNQ1" . SPARSER::PROTEIN) ("guanosine triphosphate" . SPARSER::MOLECULE)
    ("insulin-like growth factor-1" . SPARSER::PROTEIN)
    ("scatter factor" . SPARSER::PROTEIN) ("I-TAC" . SPARSER::PROTEIN)
    ("interferon-inducible T-cell alpha chemoattractant" . SPARSER::PROTEIN)
    ("derived factor-1" . SPARSER::PROTEIN) ("PAX7" . SPARSER::PROTEIN)
    ("p42/44" . SPARSER::PROTEIN) ("SDF-1" . SPARSER::PROTEIN)
    ("RasGRF1" . SPARSER::PROTEIN) ("EGFR-TKIs" . SPARSER::COLLECTION)
    ("tumor repressive miRNA" . SPARSER::PROTEIN)
    ("lactate" . SPARSER::LACTATE) ("glutaminase" . SPARSER::PROTEIN)
    ("β-catenin, and VEGF" . SPARSER::COLLECTION)
    ("MYC/MYCN" . SPARSER::COLLECTION)
    ("E-cadherin, ZEB1 and ZEB2" . SPARSER::COLLECTION)
    ("TGF-β1 and gefitinib" . SPARSER::COLLECTION)
    ("TGF-β1 or Pre-miR-23a" . SPARSER::COLLECTION)
    ("Mature miR-23a" . SPARSER::MOLECULE) ("miR-ctl" . SPARSER::COLLECTION)
    ("ctl" . SPARSER::PROTEIN) ("TGF-β1/Smad" . SPARSER::COLLECTION)
    ("over-expressed miR-23a and Smad2/3" . SPARSER::COLLECTION)
    ("PC1" . SPARSER::PROTEIN) ("these mature miRNAs" . SPARSER::PROTEIN)
    ("27a" . SPARSER::PROTEIN) ("miR-27a" . SPARSER::COLLECTION)
    ("mature miR-23a" . SPARSER::MOLECULE)
    ("diagnostic, prognostic and therapeutic biomarkers" . SPARSER::MOLECULE)
    ("MiRNAs" . SPARSER::PROTEIN)
    ("approximately 18–24 nucleotides" . SPARSER::NUCLEOTIDE)
    ("kinase, and Rho-like" . SPARSER::COLLECTION)
    ("receptor and form" . SPARSER::COLLECTION)
    ("transforming growth factor-β1" . SPARSER::PROTEIN-PAIR)
    ("vimentin and fibronectin" . SPARSER::COLLECTION)
    ("interleukin-6 receptor" . SPARSER::PROTEIN) ("ZEB2" . SPARSER::PROTEIN)
    ("EGFR-TKI" . SPARSER::PROTEIN) ("miR-23a" . SPARSER::MOLECULE)
    ("MiR-23a" . SPARSER::MOLECULE)
    ("Transforming growth factor" . SPARSER::PROTEIN)
    ("the DPP multiethnic cohort" . SPARSER::MOLECULE)
    ("a prediabetic cohort" . SPARSER::MOLECULE)
    ("relevant glycemic traits" . SPARSER::PROTEIN)
    ("allele and BMI or waist" . SPARSER::COLLECTION)
    ("relevant quantitative glycemic traits" . SPARSER::PROTEIN)
    ("DIo" . SPARSER::MOLECULE) ("Metformin" . SPARSER::DRUG)
    ("hemoglobin" . SPARSER::MOLECULE) ("related traits" . SPARSER::PROTEIN)
    ("DPP" . SPARSER::MOLECULE) ("metformin" . SPARSER::DRUG)
    ("LIFR" . SPARSER::PROTEIN)
    ("methotrexate and cytarabine" . SPARSER::COLLECTION)
    ("cytarabine" . SPARSER::MOLECULE) ("methotrexate" . SPARSER::DRUG)
    ("cyclophosphamide" . SPARSER::DRUG) ("prednisone" . SPARSER::DRUG)
    ("anaplastic lymphoma kinase (ALK)" . SPARSER::PROTEIN)
    ("itraconazole" . SPARSER::DRUG) ("Azithromycin" . SPARSER::MOLECULE)
    ("cloxacillin" . SPARSER::DRUG) ("macrolides" . SPARSER::MOLECULE)
    ("filamentous fungi" . SPARSER::PROTEIN)
    ("recurrent otitis media" . SPARSER::PROTEIN)
    ("EORTC/MSG" . SPARSER::COLLECTION) ("MSG" . SPARSER::PROTEIN)
    ("IgE and IgD" . SPARSER::COLLECTION) ("IgD" . SPARSER::PROTEIN)
    ("-CD4" . SPARSER::COLLECTION)
    ("IL-6, IL-10, and IL-21" . SPARSER::COLLECTION)
    ("pY705-STAT3" . SPARSER::PROTEIN-PAIR)
    ("IL-6, IL-10, IL-21, or IFN-" . SPARSER::COLLECTION)
    ("IFN-" . SPARSER::DRUG)
    ("the largest national cohort" . SPARSER::MOLECULE)
    ("IL-12 and IL-23" . SPARSER::COLLECTION)
    ("Flt3 ligand, M-CSF, G-CSF, leptin, and growth hormone"
     . SPARSER::COLLECTION)
    ("Antibiotic" . SPARSER::DRUG) ("IL" . SPARSER::PROTEIN)
    ("IL11R" . SPARSER::PROTEIN) ("IL-27" . SPARSER::PROTEIN)
    ("IL-17F" . SPARSER::PROTEIN) ("IL-17RA" . SPARSER::PROTEIN)
    ("IgG2" . SPARSER::BIO-COMPLEX) ("CD27" . SPARSER::PROTEIN)
    ("CCR4" . SPARSER::PROTEIN) ("CCR6" . SPARSER::PROTEIN)
    ("SOCS3" . SPARSER::PROTEIN) ("IL-22" . SPARSER::PROTEIN)
    ("growth hormone" . SPARSER::PROTEIN) ("G-CSF" . SPARSER::PROTEIN)
    ("M-CSF" . SPARSER::PROTEIN) ("Flt3 ligand" . SPARSER::PROTEIN)
    ("IL-23" . SPARSER::PROTEIN) ("IL-12R" . SPARSER::PROTEIN)
    ("leukemia inhibitory factor" . SPARSER::PROTEIN)
    ("oncostatin M" . SPARSER::PROTEIN)
    ("suppressor of cytokine signaling" . SPARSER::PROTEIN)
    ("IL-17A" . SPARSER::PROTEIN) ("Autosomal dominant" . SPARSER::PROTEIN)
    ("miRNAs and proteins" . SPARSER::COLLECTION)
    ("p21 and LEF1" . SPARSER::COLLECTION)
    ("miR-221 and miR" . SPARSER::COLLECTION) ("miRs" . SPARSER::PROTEIN)
    ("cancer-associated proteins" . SPARSER::PROTEIN)
    ("ITGB3 and FOSL1" . SPARSER::COLLECTION)
    ("FOSL1 and ITGB3" . SPARSER::COLLECTION)
    ("LEF1 or FOSL1" . SPARSER::COLLECTION)
    ("LEF1 and FOSL1" . SPARSER::COLLECTION)
    ("ITGB3, p21, LEF1 and FOSL1" . SPARSER::COLLECTION)
    ("CCND1, CCNE2 and ITGB3" . SPARSER::COLLECTION)
    ("CCND1, p21, ITGB3, LEF1 and FOSL1" . SPARSER::COLLECTION)
    ("B-Raf/MKK/ERK-responsive genes" . SPARSER::GENE)
    ("genes and cases" . SPARSER::COLLECTION)
    ("miR-34a and miR-22" . SPARSER::COLLECTION)
    ("U0126 and CI-1040" . SPARSER::COLLECTION)
    ("U0126 as well as CI-1040" . SPARSER::COLLECTION)
    ("HEM" . SPARSER::MOLECULE) ("MicroRNA" . SPARSER::RNA)
    ("many cancer-associated genes" . SPARSER::GENE)
    ("cancer-associated miRNAs" . SPARSER::PROTEIN)
    ("B-Raf/MKK/ERK" . SPARSER::COLLECTION) ("MKK" . SPARSER::PROTEIN-FAMILY)
    ("DUSP4" . SPARSER::PROTEIN) ("collagen-I" . SPARSER::PROTEIN)
    ("small nucleolar RNA" . SPARSER::RNA) ("miR-106a" . SPARSER::MOLECULE)
    ("miR-92a" . SPARSER::MOLECULE) ("LEF-1" . SPARSER::PROTEIN)
    ("gene 3" . SPARSER::PROTEIN) ("FOSL1" . SPARSER::PROTEIN)
    ("CI-1040" . SPARSER::DRUG) ("miR-221" . SPARSER::PROTEIN)
    ("miR-34a" . SPARSER::MOLECULE) ("MKK1" . SPARSER::PROTEIN)
    ("CDKIs" . SPARSER::DRUG) ("inhibitor or promoter" . SPARSER::COLLECTION)
    ("MMTV-Ras" . SPARSER::COLLECTION) ("Apc" . SPARSER::PROTEIN)
    ("motogenic growth factors" . SPARSER::GROWTH-FACTOR)
    ("FGF-2 or TGFb" . SPARSER::COLLECTION) ("tilt" . SPARSER::DRUG)
    ("p21CIP1 or anti" . SPARSER::COLLECTION)
    ("only ~2–6 lung foci" . SPARSER::PROTEIN)
    ("EGF and Matrigel" . SPARSER::COLLECTION)
    ("mammary fat" . SPARSER::PROTEIN)
    ("cytoskeletal states" . SPARSER::BIO-STATE)
    ("aberrant ECM" . SPARSER::PROTEIN)
    ("p21CIP1 in the malignant breast cancer MDA-MB-231 (MDA-231) cell line and its lung metastatic subline"
     . SPARSER::COLLECTION)
    ("its lung metastatic subline" . SPARSER::PROTEIN)
    ("anti-p21CIP1 or anti-BrdU" . SPARSER::COLLECTION)
    ("the mammary fat" . SPARSER::PROTEIN)
    ("cortical actin" . SPARSER::PROTEIN)
    ("cytokeratins" . SPARSER::PROTEIN-FAMILY)
    ("associated tumor suppressors" . SPARSER::SUPPRESSOR)
    ("p21CIP1/WAF1" . SPARSER::COLLECTION) ("pG1" . SPARSER::PROTEIN)
    ("CT 1" . SPARSER::PROTEIN) ("anti-mitotic" . SPARSER::MOLECULE)
    ("MMP-3" . SPARSER::PROTEIN) ("Cyclin E" . SPARSER::PROTEIN)
    ("p27KIP1" . SPARSER::PROTEIN) ("N-cad" . SPARSER::PROTEIN)
    ("Rho kinase" . SPARSER::PROTEIN) ("cyclin D2" . SPARSER::PROTEIN)
    ("p21CIP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Stat3, Smad7 and TGF-β" . SPARSER::COLLECTION)
    ("Stat3 and/or Smad7" . SPARSER::COLLECTION)
    ("Imidazolide" . SPARSER::MOLECULE)
    ("Stat3 and Smad7" . SPARSER::COLLECTION)
    ("EGFR-Stat3-Smad7-TGF-β" . SPARSER::COLLECTION)
    ("either TGF-β receptors or downstream signaling molecules"
     . SPARSER::COLLECTION)
    ("the tumor-associated overexpressed EGFR" . SPARSER::PROTEIN)
    ("IL-6 and IL-11" . SPARSER::COLLECTION)
    ("Erk1/2 and Akt" . SPARSER::COLLECTION)
    ("Erk1/2 or Akt" . SPARSER::COLLECTION) ("Ras/MAPK" . SPARSER::COLLECTION)
    ("BALB/c" . SPARSER::COLLECTION)
    ("S2 and S3 cells also displayed reduced EGF-mediated Stat3 transcriptional activity ( xref )"
     . SPARSER::COLLECTION)
    ("EGFR or phospho-Erk1/2" . SPARSER::COLLECTION)
    ("A-S1 and A-S2" . SPARSER::COLLECTION) ("pAPRE-luc" . SPARSER::COLLECTION)
    ("phospho-EGFR, phospho-Erk1/2 and phospho-Akt" . SPARSER::COLLECTION)
    ("MEK and PI3K" . SPARSER::COLLECTION) ("PI3-K/Akt" . SPARSER::COLLECTION)
    ("Ras-MAPKs" . SPARSER::COLLECTION)
    ("MEKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3-K and MEK" . SPARSER::COLLECTION)
    ("-thymidine" . SPARSER::COLLECTION)
    ("an inhibitor of cyclin-dependent kinases and mediator"
     . SPARSER::COLLECTION)
    ("-luc" . SPARSER::COLLECTION) ("U87MG-EGFR" . SPARSER::COLLECTION)
    ("IL-6/gp130" . SPARSER::COLLECTION)
    ("EGFR–Stat3–Smad7–TGF-β" . SPARSER::COLLECTION)
    ("cytokine and growth factor" . SPARSER::COLLECTION)
    ("Src and Signal transducer" . SPARSER::COLLECTION)
    ("-Akt-mTOR" . SPARSER::COLLECTION)
    ("Growth factor and cytokine" . SPARSER::COLLECTION)
    ("EGFR/Stat3/Smad7/TGF-β" . SPARSER::COLLECTION)
    ("Stat3 or Smad7" . SPARSER::COLLECTION) ("Tween20" . SPARSER::MOLECULE)
    ("IL-11" . SPARSER::PROTEIN) ("A-S2" . SPARSER::PROTEIN)
    ("A-S1" . SPARSER::PROTEIN) ("Akt-mTOR" . SPARSER::PROTEIN)
    ("PI3-K" . SPARSER::PROTEIN) ("Raf-Erk" . SPARSER::PROTEIN)
    ("DPC4" . SPARSER::PROTEIN) ("Growth factor" . SPARSER::GROWTH-FACTOR)
    ("Transforming Growth Factor" . SPARSER::PROTEIN)
    ("EGFR inhibitors and other molecularly targeted therapies"
     . SPARSER::COLLECTION)
    ("a general prognostic biomarker" . SPARSER::MOLECULE)
    ("MET and its ligand HGF" . SPARSER::COLLECTION)
    ("erlotinib or gefitinib and MET" . SPARSER::COLLECTION)
    ("gefitinib and MET" . SPARSER::COLLECTION)
    ("GAS6 and vimentin" . SPARSER::COLLECTION)
    ("erlotinib or gefitinib" . SPARSER::COLLECTION)
    ("p AXL and the IC 50" . SPARSER::COLLECTION)
    ("either wild type (WT) AXL or a kinase-impaired mutant"
     . SPARSER::COLLECTION)
    ("AXL and EGFR" . SPARSER::COLLECTION)
    ("pERK, pAKT and pRelA" . SPARSER::COLLECTION)
    ("MAPK, AKT and NF-kB" . SPARSER::COLLECTION)
    ("MP470 or XL880" . SPARSER::COLLECTION)
    ("2 commercially available small molecule inhibitors" . SPARSER::INHIBITOR)
    ("AXL and its ligand GAS6" . SPARSER::COLLECTION)
    ("K-Ras or BRAF" . SPARSER::COLLECTION)
    ("EGFR , MET , IGF-1R , pIGF-1R and Ras" . SPARSER::COLLECTION)
    ("AXL or other genes" . SPARSER::COLLECTION)
    ("a non-targeting shRNA or an shRNA" . SPARSER::COLLECTION)
    ("subline" . SPARSER::PROTEIN)
    ("currently available AXL inhibitors" . SPARSER::INHIBITOR)
    ("NSCLCs perhaps" . SPARSER::PROTEIN)
    ("AKT, MAPK or NF-kB" . SPARSER::COLLECTION)
    ("pAKT, pERK, and pRelA" . SPARSER::COLLECTION) ("Parp" . SPARSER::PROTEIN)
    ("IGF-1R , pIGF-1R, or Ras" . SPARSER::COLLECTION)
    ("pIGF" . SPARSER::PROTEIN) ("HMGA1 and HMGA2" . SPARSER::COLLECTION)
    ("AXL or GAS6" . SPARSER::COLLECTION)
    ("AXL and GAS6" . SPARSER::COLLECTION)
    ("AXL and MET" . SPARSER::COLLECTION) ("MET or GAS6" . SPARSER::COLLECTION)
    ("IGF-1R, Ras, or EGFR" . SPARSER::COLLECTION)
    ("Erlotinib" . SPARSER::DRUG) ("AXL" . SPARSER::PROTEIN)
    ("B-Raf" . SPARSER::PROTEIN) ("GSK1363089" . SPARSER::DRUG)
    ("PHA665752" . SPARSER::MOLECULE) ("XL880" . SPARSER::DRUG)
    ("MP470" . SPARSER::DRUG) ("BIBW2992" . SPARSER::DRUG)
    ("KRT5" . SPARSER::PROTEIN) ("KRT14" . SPARSER::PROTEIN)
    ("HMGA2" . SPARSER::PROTEIN) ("HMGA1" . SPARSER::PROTEIN)
    ("type IV collagen" . SPARSER::PROTEIN) ("COL6A1" . SPARSER::PROTEIN)
    ("GAS6" . SPARSER::PROTEIN)
    ("the UCP and SIRT genes and cIMT" . SPARSER::COLLECTION)
    ("UCP and SIRT" . SPARSER::COLLECTION) ("the brown fat" . SPARSER::PROTEIN)
    ("UCP1 , UCP2 , and SIRT2" . SPARSER::COLLECTION)
    ("UCP1 and SIRT3" . SPARSER::COLLECTION)
    ("UCP2 , or rs4802998" . SPARSER::COLLECTION)
    ("the top 2 principal components" . SPARSER::COMPONENT)
    ("intima-media" . SPARSER::COLLECTION) ("UCP" . SPARSER::PROTEIN)
    ("UCPs" . SPARSER::PROTEIN) ("SIRT2" . SPARSER::PROTEIN)
    ("UCP2" . SPARSER::PROTEIN) ("UCP1" . SPARSER::PROTEIN)
    ("extracellular cytokines" . SPARSER::PROTEIN)
    ("cyclosporine or VIVIT or NF-κB" . SPARSER::COLLECTION)
    ("VIVIT or NF-κB" . SPARSER::COLLECTION)
    ("TNF-α, and perhaps" . SPARSER::COLLECTION)
    ("TNF-α/NF-κB" . SPARSER::COLLECTION)
    ("TNF-α and TNFR1" . SPARSER::COLLECTION)
    ("NF-κB and NFAT" . SPARSER::COLLECTION)
    ("PML-type viral DNA" . SPARSER::DNA)
    ("the archetypal form" . SPARSER::FORM)
    ("pathogenic forms" . SPARSER::FORM)
    ("1 of the ICAM-1 gene ( xref ) and the C3-3P NF-κB site"
     . SPARSER::COLLECTION)
    ("NFAT and NF-κB" . SPARSER::COLLECTION)
    ("GFP and GFP-VIVIT-transfected" . SPARSER::COLLECTION)
    ("p65 and LIP" . SPARSER::COLLECTION)
    ("either NFAT4 (lane 3) or p65 (lane 9)" . SPARSER::COLLECTION)
    ("NFAT4, p65 and C/EBPβ" . SPARSER::COLLECTION)
    ("p65 and C/EBPβ" . SPARSER::COLLECTION) ("VIVIT" . SPARSER::PROTEIN)
    ("NFAT4, p65 and GFP-VIVIT" . SPARSER::COLLECTION)
    ("GFP-VIVIT" . SPARSER::COLLECTION) ("agnoprotein" . SPARSER::PROTEIN)
    ("the calcium-calmodulin-dependent protein serine phosphatase calcineurin"
     . SPARSER::PROTEIN)
    ("NFATs" . SPARSER::PROTEIN) ("cyclosporine" . SPARSER::DRUG)
    ("NFAT4 and p65" . SPARSER::COLLECTION)
    ("LIP and NFAT4" . SPARSER::COLLECTION)
    ("full-length, LIP and LAP" . SPARSER::COLLECTION)
    ("NFAT4/NF-κB" . SPARSER::COLLECTION) ("ionophore" . SPARSER::MOLECULE)
    ("a heterologous constitutive promoter" . SPARSER::PROMOTER)
    ("LUC" . SPARSER::PROTEIN) ("m1 or m2" . SPARSER::COLLECTION)
    ("m1 and m2" . SPARSER::COLLECTION) ("p65 and NFAT4" . SPARSER::COLLECTION)
    ("PMA or TNF-α" . SPARSER::COLLECTION)
    ("NFAT and p65" . SPARSER::COLLECTION)
    ("NF-κB and NFAT4" . SPARSER::COLLECTION)
    ("Constitutively-expressed NFAT proteins" . SPARSER::PROTEIN)
    ("NFAT4 (NFATc3/NFATx) and NFAT5 ( xref )" . SPARSER::COLLECTION)
    ("NFAT1 (NFATp), NFAT2 (NFATc), NFAT3 (NFATc4), NFAT4 (NFATc3/NFATx) and NFAT5 ( xref )"
     . SPARSER::COLLECTION)
    ("NFATc3/NFATx" . SPARSER::COLLECTION) ("NFATx" . SPARSER::PROTEIN)
    ("NFATc" . SPARSER::PROTEIN) ("NFATp" . SPARSER::PROTEIN)
    ("a heterologous promoter" . SPARSER::PROMOTER)
    ("a ternary complex" . SPARSER::BIO-COMPLEX)
    ("C/EBPβ-LIP" . SPARSER::COLLECTION) ("NF-κB/p65" . SPARSER::COLLECTION)
    ("LIP" . SPARSER::PROTEIN)
    ("growth factors and immunomodulators" . SPARSER::COLLECTION)
    ("immunomodulators" . SPARSER::DRUG)
    ("viral early and late genes" . SPARSER::GENE)
    ("This bidirectional promoter" . SPARSER::PROMOTER)
    ("a bidirectional promoter" . SPARSER::PROMOTER)
    ("viral genes" . SPARSER::GENE) ("immunotherapeutic drugs" . SPARSER::DRUG)
    ("Efalizumab" . SPARSER::DRUG) ("Natalizumab" . SPARSER::DRUG)
    ("myelin" . SPARSER::PROTEIN) ("calcineurin/NFAT" . SPARSER::COLLECTION)
    ("NFAT4 and NF-κB" . SPARSER::COLLECTION)
    ("NF-κB and C/EBPβ" . SPARSER::COLLECTION)
    ("capsid protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("lamin A/C" . SPARSER::PROTEIN) ("T-antigen" . SPARSER::PROTEIN)
    ("m2" . SPARSER::MOLECULE) ("cyclosporin A" . SPARSER::MOLECULE)
    ("NFAT5" . SPARSER::PROTEIN) ("NFATc3" . SPARSER::PROTEIN)
    ("NFAT3" . SPARSER::PROTEIN) ("NFAT2" . SPARSER::PROTEIN)
    ("NFAT1" . SPARSER::PROTEIN) ("Mad-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NFAT4" . SPARSER::PROTEIN) ("C/EBPβ" . SPARSER::PROTEIN)
    ("RING or HECT" . SPARSER::COLLECTION)
    ("masking" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CRLs and other E3s" . SPARSER::COLLECTION)
    ("RING-HECT" . SPARSER::COLLECTION) ("parkin" . SPARSER::PROTEIN)
    ("cIAP1 and c-CBL" . SPARSER::COLLECTION)
    ("cellular RBX1 and CUL1" . SPARSER::COLLECTION)
    ("RBX1 and CUL1" . SPARSER::COLLECTION)
    ("CAND1 or GLMN" . SPARSER::COLLECTION)
    ("1–4 and RBX1" . SPARSER::COLLECTION)
    ("multiple RBX1-associated cullins" . SPARSER::PROTEIN-FAMILY)
    ("CAND1 and GLMN" . SPARSER::COLLECTION) ("SR" . SPARSER::PROTEIN)
    ("the adjacent HEAT-like" . SPARSER::PROTEIN)
    ("HEAT-like" . SPARSER::PROTEIN) ("RBX1 and RBX2" . SPARSER::COLLECTION)
    ("RBX2 or the more distal relative APC11 ( xref )" . SPARSER::COLLECTION)
    ("the more distal relative APC11" . SPARSER::PROTEIN)
    ("the nearly 50% identical RBX2 protein or its associated CUL5"
     . SPARSER::COLLECTION)
    ("its associated CUL5" . SPARSER::PROTEIN)
    ("the nearly 50% identical RBX2 protein" . SPARSER::PROTEIN)
    ("its associated CUL1-CUL4" . SPARSER::COLLECTION)
    ("CUL1-CUL4" . SPARSER::COLLECTION) ("RINGs" . SPARSER::PROTEIN)
    ("CUL1-RBX1" . SPARSER::COLLECTION)
    ("uniquely binds GLMN" . SPARSER::PROTEIN)
    ("GLMN and CDC34" . SPARSER::COLLECTION) (":CDC34" . SPARSER::BIO-COMPLEX)
    ("stoichiometric GLMN" . SPARSER::PROTEIN) ("-GLMN" . SPARSER::COLLECTION)
    ("RBX1-GLMN" . SPARSER::COLLECTION) ("csp" . SPARSER::PROTEIN)
    ("RBX1-CDC34" . SPARSER::COLLECTION)
    ("endogenous RBX1 and its associated CUL1" . SPARSER::COLLECTION)
    ("its associated CUL1" . SPARSER::PROTEIN)
    ("oxygen and nitrogen" . SPARSER::COLLECTION)
    ("tri-HEAT-like" . SPARSER::PROTEIN-PAIR)
    ("RBX1-RING" . SPARSER::COLLECTION)
    ("the GLMN complex with RBX1’s" . SPARSER::BIO-COMPLEX)
    ("complex with RBX1’s" . SPARSER::BIO-COMPLEX)
    ("RBX1-cullin" . SPARSER::COLLECTION) ("CFP-RBX1" . SPARSER::COLLECTION)
    ("CFP-RBX1-CUL1" . SPARSER::COLLECTION) ("GLMN-YFP" . SPARSER::COLLECTION)
    ("GLMN and RBX1" . SPARSER::COLLECTION) ("SCFs" . SPARSER::PROTEIN)
    ("GLMN:SCF" . SPARSER::BIO-COMPLEX)
    ("a stoichiometric complex" . SPARSER::BIO-COMPLEX)
    ("GLMN-cullin" . SPARSER::COLLECTION)
    ("CAND1 rigidifies RBX1’s" . SPARSER::PROTEIN)
    ("RBX1-cullin~NEDD8" . SPARSER::COLLECTION)
    ("RBX1-CUL1-CAND1" . SPARSER::COLLECTION) ("WHB" . SPARSER::PROTEIN)
    ("that RBX1’s" . SPARSER::PROTEIN) ("larger SCF" . SPARSER::PROTEIN)
    ("GLMN not only contacts RBX1’s" . SPARSER::PROTEIN)
    ("GLMN not only contacts RBX1" . SPARSER::PROTEIN)
    ("GLMN-RBX1-CUL1" . SPARSER::COLLECTION) ("subdomain" . SPARSER::PROTEIN)
    ("CUL1[4HB-α/β] and RBX1" . SPARSER::COLLECTION)
    ("α/β-subdomain" . SPARSER::COLLECTION) ("4HB" . SPARSER::PROTEIN)
    ("subunit-" . SPARSER::FRAGMENT) ("4HB-α/β" . SPARSER::COLLECTION)
    ("subdomains" . SPARSER::PROTEIN) ("binding RBX1’s" . SPARSER::PROTEIN)
    ("masks" . SPARSER::PROTEIN) ("CyclinE and c-Myc" . SPARSER::COLLECTION)
    ("CRL-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RBX2-associated cullins" . SPARSER::PROTEIN-FAMILY)
    ("Glomulin (GLMN)" . SPARSER::PROTEIN)
    ("cullin-SR" . SPARSER::PROTEIN-PAIR) ("WHB-RBX1" . SPARSER::PROTEIN-PAIR)
    ("RBX1-CUL1" . SPARSER::COLLECTION)
    ("processive polyubiquitination" . SPARSER::PROTEIN)
    ("an associated Ub E2" . SPARSER::MOLECULE)
    ("the RBX protein’s" . SPARSER::PROTEIN) ("RBX" . SPARSER::PROTEIN)
    ("cullins" . SPARSER::PROTEIN-FAMILY)
    ("the highly divergent CRL" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the Mitotic Checkpoint Complex inhibitor" . SPARSER::INHIBITOR)
    ("CyclinE and p27" . SPARSER::COLLECTION)
    ("FBW7 and SCF" . SPARSER::COLLECTION)
    ("SKP2-CKSHS1" . SPARSER::COLLECTION) ("CyclinE" . SPARSER::PROTEIN-FAMILY)
    ("A cullin’s" . SPARSER::PROTEIN-FAMILY)
    ("cullin-RING" . SPARSER::COLLECTION) ("cullin" . SPARSER::PROTEIN-FAMILY)
    ("the E2’s" . SPARSER::MOLECULE) ("E1, E2, and E3" . SPARSER::COLLECTION)
    ("GLMN-RBX1" . SPARSER::COLLECTION) ("CRL" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("which binds RBX1’s" . SPARSER::PROTEIN)
    ("which binds RBX1" . SPARSER::PROTEIN) ("RING" . SPARSER::PROTEIN)
    ("GLMN" . SPARSER::PROTEIN) ("Glomulin" . SPARSER::PROTEIN)
    ("RBX1 or RBX2" . SPARSER::COLLECTION)
    ("Cullin-RING" . SPARSER::PROTEIN-PAIR) ("CRLs" . SPARSER::PROTEIN)
    ("UBA1" . SPARSER::PROTEIN) ("UbcH5B" . SPARSER::PROTEIN)
    ("c-CBL" . SPARSER::PROTEIN) ("LIN-23" . SPARSER::PROTEIN)
    ("APC11" . SPARSER::PROTEIN) ("CUL4" . SPARSER::PROTEIN)
    ("N- 1" . SPARSER::PROTEIN) ("CAND1" . SPARSER::PROTEIN)
    ("NEDD8" . SPARSER::PROTEIN) ("α/β" . SPARSER::PROTEIN)
    ("CUL5" . SPARSER::PROTEIN) ("CKSHS1" . SPARSER::PROTEIN)
    ("SKP2" . SPARSER::PROTEIN) ("CDC34" . SPARSER::PROTEIN)
    ("FBW7" . SPARSER::PROTEIN) ("CUL1" . SPARSER::PROTEIN)
    ("RBX2" . SPARSER::PROTEIN) ("RBX1" . SPARSER::PROTEIN)
    ("phosphatases and phospho-antibody" . SPARSER::COLLECTION)
    ("phospho-antibody" . SPARSER::PROTEIN)
    ("Mfn2 and Bcl-2" . SPARSER::COLLECTION)
    ("similarly targets Mcl-1" . SPARSER::PROTEIN)
    ("Mfn2 and DRP1" . SPARSER::COLLECTION)
    ("UBA or WWE" . SPARSER::COLLECTION)
    ("Mcl-1 and Mfn2" . SPARSER::COLLECTION)
    ("the stress-activated kinases" . SPARSER::KINASE)
    ("MyoD" . SPARSER::PROTEIN) ("obvious homology" . SPARSER::PROTEIN)
    ("Fzo1 and Mfn2" . SPARSER::COLLECTION) ("Fzo1" . SPARSER::PROTEIN)
    ("A major ubiquitin ligase" . SPARSER::PROTEIN) ("Mdm" . SPARSER::PROTEIN)
    ("Fzo" . SPARSER::PROTEIN) ("Mfn1-Mfn2" . SPARSER::COLLECTION)
    ("Huwe1-Mfn2" . SPARSER::COLLECTION) ("Doxycycline" . SPARSER::DRUG)
    ("Huwe1 and Mfn2" . SPARSER::COLLECTION)
    ("GST-Huwe1" . SPARSER::COLLECTION) ("Huwe1/Mule" . SPARSER::COLLECTION)
    ("pro-apoptotic proteins, Bax and Bak" . SPARSER::COLLECTION)
    ("proteins, Bax and Bak" . SPARSER::COLLECTION)
    ("Mfn2 and Huwe1" . SPARSER::COLLECTION)
    ("FLAG-Huwe1" . SPARSER::COLLECTION)
    ("HECT, UBA, and WWE" . SPARSER::COLLECTION)
    ("WWE" . SPARSER::PROTEIN-FAMILY) ("UBA" . SPARSER::PROTEIN)
    ("ubiquitin-protein" . SPARSER::COLLECTION)
    ("Bcl-2 and DRP1" . SPARSER::COLLECTION)
    ("Mfn2 and mutants" . SPARSER::COLLECTION)
    ("Mfn2 and its Ser27 mutants" . SPARSER::COLLECTION)
    ("lactacystin" . SPARSER::DRUG)
    ("Mfn2HA S27A and a Mfn2" . SPARSER::COLLECTION)
    ("Ubiquitin-" . SPARSER::PROTEIN) ("JNK2α2" . SPARSER::PROTEIN)
    ("FLAG-JNK2α2" . SPARSER::PROTEIN-PAIR)
    ("using distinct siRNAs" . SPARSER::PROTEIN)
    ("JNK1 and JNK2" . SPARSER::COLLECTION)
    ("ERKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("stress-activated kinases" . SPARSER::KINASE)
    ("JNK, ERK and p38" . SPARSER::COLLECTION)
    ("etoposide, 17-AAG, cis-platinum, tunicamycin and MG132"
     . SPARSER::COLLECTION)
    ("tunicamycin" . SPARSER::MOLECULE) ("AAG" . SPARSER::PROTEIN)
    ("PXR" . SPARSER::PROTEIN) ("MAP" . SPARSER::PROTEIN)
    ("exogenous Mfn2" . SPARSER::PROTEIN)
    ("the integral mitochondrial protein TOM40 nor the soluble dynamin-like component"
     . SPARSER::COLLECTION)
    ("the soluble dynamin-like component" . SPARSER::COMPONENT)
    ("the genotoxic chemotherapeutic agent doxorubicin" . SPARSER::PROTEIN)
    ("Undergoes" . SPARSER::PROTEIN) ("HECT" . SPARSER::PROTEIN)
    ("Adriamycin" . SPARSER::DRUG) ("DR" . SPARSER::MOLECULE)
    ("Parkin" . SPARSER::PROTEIN) ("hetero-oligomers" . SPARSER::PROTEIN-PAIR)
    ("mitofusin" . SPARSER::PROTEIN) ("Mfn1 and Mfn2" . SPARSER::COLLECTION)
    ("Lasu1" . SPARSER::PROTEIN) ("Huwe1" . SPARSER::PROTEIN)
    ("Mule" . SPARSER::PROTEIN) ("calyculin A" . SPARSER::MOLECULE)
    ("C-Myc" . SPARSER::PROTEIN) ("cis- platinum" . SPARSER::DRUG)
    ("ARF binding protein 1" . SPARSER::PROTEIN)
    ("Mcl-1 ubiquitin ligase E3" . SPARSER::PROTEIN)
    ("E2s" . SPARSER::MOLECULE) ("Ubiquitin Ligase" . SPARSER::PROTEIN)
    ("cis-platinum" . SPARSER::DRUG) ("S27A" . SPARSER::PROTEIN)
    ("DRP1" . SPARSER::PROTEIN) ("TOM40" . SPARSER::PROTEIN)
    ("PGC-1 β" . SPARSER::PROTEIN) ("p21Ras" . SPARSER::PROTEIN)
    ("CMT2A" . SPARSER::PROTEIN) ("Mfn2" . SPARSER::PROTEIN)
    ("Mfn1" . SPARSER::PROTEIN) ("mitofusin 1" . SPARSER::PROTEIN)
    ("HectH9" . SPARSER::PROTEIN) ("ARF-BP1" . SPARSER::PROTEIN)
    ("mitofusin 2" . SPARSER::PROTEIN) ("IL-4 and IL-21" . SPARSER::COLLECTION)
    ("PD-1, CD160 and CTLA-4" . SPARSER::COLLECTION)
    ("interferon and pro-inflammatory" . SPARSER::COLLECTION)
    ("IL-2 and IL-21" . SPARSER::COLLECTION)
    ("TRAIL and Bim" . SPARSER::COLLECTION)
    ("TGF-β1 and IFN-α" . SPARSER::COLLECTION)
    ("Foxo3a and its target gene TRAIL" . SPARSER::COLLECTION)
    ("TRAIL and FasL" . SPARSER::COLLECTION)
    ("IL-2 ( xref ) and IL-21 ( xref )" . SPARSER::COLLECTION)
    ("the Foxo3a pro-apoptotic target genes TRAIL" . SPARSER::PROTEIN)
    ("AKT and Foxo3a" . SPARSER::COLLECTION)
    ("monocyte-derived macrophages" . SPARSER::PROTEIN)
    ("Kino" . SPARSER::PROTEIN) ("Env" . SPARSER::PROTEIN)
    ("the viral proteins" . SPARSER::PROTEIN)
    ("hypoxia/ischemia" . SPARSER::COLLECTION)
    ("exogenous Foxo3a proteins" . SPARSER::PROTEIN)
    ("Bim, Puma and TRAIL" . SPARSER::COLLECTION)
    ("key pro-inflammatory molecules" . SPARSER::MOLECULE)
    ("IL-6 and TNF-α" . SPARSER::COLLECTION)
    ("Bcl-6 and Bim" . SPARSER::COLLECTION)
    ("AKT, ERK and IKK" . SPARSER::COLLECTION)
    ("AKT and IKK" . SPARSER::COLLECTION)
    ("ERK and serum glucose kinase (SGK)" . SPARSER::COLLECTION)
    ("kinase (SGK)" . SPARSER::KINASE) ("SGK" . SPARSER::PROTEIN)
    ("pro-apoptotic genes" . SPARSER::GENE)
    ("Bim, Noxa, Puma, FasL and TRAIL" . SPARSER::COLLECTION)
    ("p21, p27, p130, cyclin G2 and GADD45" . SPARSER::COLLECTION)
    ("Bcl-6 and BTG-1" . SPARSER::COLLECTION)
    ("IL-7 and IL-2" . SPARSER::COLLECTION)
    ("CTLA-4 and PD-1" . SPARSER::COLLECTION) ("DCs" . SPARSER::MOLECULE)
    ("CD160" . SPARSER::PROTEIN) ("IL-21" . SPARSER::PROTEIN)
    ("Insulin-like Growth Factor" . SPARSER::PROTEIN)
    ("Foxo3" . SPARSER::PROTEIN) ("retinoic acids" . SPARSER::MOLECULE)
    ("FoxP3" . SPARSER::PROTEIN) ("Bcl-6" . SPARSER::PROTEIN)
    ("glucose-6-phosphatase" . SPARSER::PROTEIN)
    ("cyclin G2" . SPARSER::PROTEIN) ("PD-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CTLA-4" . SPARSER::PROTEIN) ("Foxo3a" . SPARSER::PROTEIN)
    ("SIRT-1 or p300" . SPARSER::COLLECTION)
    ("that caveolin's" . SPARSER::PROTEIN) ("transporter" . SPARSER::PROTEIN)
    ("a pan-specific p65 antibody" . SPARSER::ANTIBODY)
    ("pan-specific anti-acetyl-lysine antibodies" . SPARSER::ANTIBODY)
    ("available reagents" . SPARSER::MOLECULE)
    ("transcriptionally inert p65" . SPARSER::PROTEIN)
    ("p65-myc" . SPARSER::COLLECTION)
    ("caveolin-1 and HIV-1 molecular clone pNLENG1" . SPARSER::COLLECTION)
    ("caveolin-1-RFP" . SPARSER::COLLECTION)
    ("NF-κB-GFP" . SPARSER::COLLECTION) ("LTR" . SPARSER::PROTEIN)
    ("LPS or TNF-alpha" . SPARSER::COLLECTION)
    ("LTR-GFP" . SPARSER::COLLECTION) ("VLP" . SPARSER::PROTEIN)
    ("TO-901317 or β-cyclodextrin" . SPARSER::COLLECTION)
    ("filipin" . SPARSER::MOLECULE) ("LXR" . SPARSER::PROTEIN)
    ("SR-BI and ABCA1" . SPARSER::COLLECTION) ("Caveolin" . SPARSER::PROTEIN)
    ("cell-associated viral proteins" . SPARSER::PROTEIN)
    ("cell-associated virus proteins" . SPARSER::PROTEIN)
    ("pYU-2" . SPARSER::COLLECTION) ("sphingolipids" . SPARSER::MOLECULE)
    ("Caveolins" . SPARSER::PROTEIN-FAMILY)
    ("cholesterol oxidase" . SPARSER::PROTEIN)
    ("Cholesterol Oxidase" . SPARSER::PROTEIN) ("RD1" . SPARSER::PROTEIN)
    ("CCR5" . SPARSER::PROTEIN) ("SIRT-1" . SPARSER::PROTEIN)
    ("gp41" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p 65" . SPARSER::PROTEIN)
    ("β-cyclodextrin" . SPARSER::MOLECULE) ("TO-901317" . SPARSER::DRUG)
    ("ABCA1" . SPARSER::PROTEIN) ("SR-BI" . SPARSER::PROTEIN)
    ("Low-density lipoprotein receptor-associated protein" . SPARSER::PROTEIN)
    ("Bovine serum albumin" . SPARSER::PROTEIN) ("Nickel" . SPARSER::MOLECULE)
    ("NTA" . SPARSER::MOLECULE) ("IPTG" . SPARSER::MOLECULE)
    ("Interferon-γ" . SPARSER::PROTEIN)
    ("LRP1/JAK/STAT1" . SPARSER::COLLECTION)
    ("ITGB3 or TLR2" . SPARSER::COLLECTION)
    ("vitronectin/ITGB3/TLR2" . SPARSER::COLLECTION)
    ("Vitronectin and integrin" . SPARSER::COLLECTION)
    ("PAI-1/vitronectin" . SPARSER::COLLECTION)
    ("LRP-1/JAK/STAT" . SPARSER::COLLECTION)
    ("Laminin, fibronectin, and collagen" . SPARSER::COLLECTION)
    ("Laminin" . SPARSER::PROTEIN) ("LRP/tPA/PAI-1" . SPARSER::COLLECTION)
    ("monocytes and macrophages" . SPARSER::COLLECTION)
    ("LRP or tPA" . SPARSER::COLLECTION) ("LRP1/PAI-1" . SPARSER::COLLECTION)
    ("WISH" . SPARSER::PROTEIN)
    ("vitronectin or uPA/uPAR" . SPARSER::COLLECTION)
    ("uPA/uPAR" . SPARSER::COLLECTION)
    ("uPA, tPA, LRP1, and vitronectin" . SPARSER::COLLECTION)
    ("Astrocytes" . SPARSER::PROTEIN) ("uPA and tPA" . SPARSER::COLLECTION)
    ("These soluble proteins" . SPARSER::PROTEIN)
    ("TLR2 and ITGB3" . SPARSER::COLLECTION)
    ("TLR2 or ITGB3" . SPARSER::COLLECTION)
    ("anti-TLR2 or anti-ITGB3" . SPARSER::COLLECTION)
    ("a multifunctional molecule" . SPARSER::MOLECULE)
    ("Vitronectin" . SPARSER::PROTEIN)
    ("vitronectin/ITGB3" . SPARSER::COLLECTION)
    ("The wild-type protein and the R346A mutant (unable to inhibit PA)"
     . SPARSER::COLLECTION)
    ("mRNA/protein" . SPARSER::COLLECTION) ("LTA" . SPARSER::PROTEIN)
    ("mRNA or TLR9" . SPARSER::COLLECTION)
    ("TLR2, TLR6 and glucan" . SPARSER::COLLECTION)
    ("Zymosan" . SPARSER::PROTEIN)
    ("exogenous PAI-1 protein" . SPARSER::PROTEIN)
    ("striatum" . SPARSER::PROTEIN)
    ("LRP1 siRNA and RAP protein" . SPARSER::COLLECTION)
    ("apolipoprotein E, lipoprotein lipase, uPA, tPA, and PAI-1"
     . SPARSER::COLLECTION)
    ("low-density lipoprotein receptor-related protein 1/Janus"
     . SPARSER::COLLECTION)
    ("activated microglia release NO and other neurotoxic mediators"
     . SPARSER::PROTEIN)
    ("MEF-1" . SPARSER::PROTEIN) ("Soluble proteins" . SPARSER::PROTEIN)
    ("acetone" . SPARSER::MOLECULE) ("LPS/IFN-γ" . SPARSER::COLLECTION)
    ("LPS and IFN-γ" . SPARSER::COLLECTION) ("JAK/STAT1" . SPARSER::COLLECTION)
    ("PAI-1/LRP1" . SPARSER::COLLECTION)
    ("low-density lipoprotein receptor-associated protein (RAP)"
     . SPARSER::PROTEIN)
    ("LRP1/tPA/PAI-1" . SPARSER::COLLECTION)
    ("PAI-1 and LRP1" . SPARSER::COLLECTION)
    ("PAI-1/uPA/uPAR" . SPARSER::COLLECTION) ("uPAR" . SPARSER::PROTEIN)
    ("Arg-Gly-Asp" . SPARSER::COLLECTION)
    ("PAI–vitronectin" . SPARSER::COLLECTION)
    ("protein (LRP)" . SPARSER::PROTEIN)
    ("both urokinase type plasminogen activators (uPA) and tissue type plasminogen activators (tPA)"
     . SPARSER::COLLECTION)
    ("plasmin" . SPARSER::PROTEIN)
    ("monocytes/macrophages" . SPARSER::COLLECTION)
    ("monocytes" . SPARSER::PROTEIN) ("Microglia" . SPARSER::PROTEIN)
    ("astrocytes [ xref - xref ] and microglia [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("vitronectin- and Toll-like" . SPARSER::COLLECTION)
    ("vitronectin-" . SPARSER::PROTEIN) ("PA" . SPARSER::PROTEIN)
    ("microglia" . SPARSER::PROTEIN) ("zymosan" . SPARSER::PROTEIN)
    ("urokinase type plasminogen activators (uPA) and tissue type plasminogen activators (tPA)"
     . SPARSER::COLLECTION)
    ("tPA" . SPARSER::PROTEIN) ("plasminogen" . SPARSER::PROTEIN)
    ("Urokinase type" . SPARSER::PROTEIN) ("Tissue type" . SPARSER::PROTEIN)
    ("Signal transducer and activator of transcription-1" . SPARSER::PROTEIN)
    ("Low-density lipoprotein receptor" . SPARSER::PROTEIN)
    ("Nitric oxide" . SPARSER::MOLECULE)
    ("Low-density lipoprotein receptor-related protein 1" . SPARSER::PROTEIN)
    ("Glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("LPR1" . SPARSER::PROTEIN) ("lipoprotein lipase" . SPARSER::PROTEIN)
    ("apolipoprotein E" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription-1" . SPARSER::PROTEIN)
    ("low-density lipoprotein receptor-related protein 1" . SPARSER::PROTEIN)
    ("ITGB3" . SPARSER::PROTEIN) ("dectin-1" . SPARSER::PROTEIN)
    ("LRP-1" . SPARSER::PROTEIN)
    ("microtubule-associated protein 2" . SPARSER::PROTEIN)
    ("Iba-1" . SPARSER::PROTEIN)
    ("glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("N-methyl-D-aspartate" . SPARSER::MOLECULE)
    ("amyloid-β" . SPARSER::MOLECULE) ("LRP1" . SPARSER::PROTEIN)
    ("low-density lipoprotein receptor" . SPARSER::PROTEIN)
    ("urokinase type" . SPARSER::PROTEIN)
    ("Plasminogen activator" . SPARSER::PROTEIN)
    ("ESR1 and rs12371778" . SPARSER::COLLECTION) ("FTO" . SPARSER::PROTEIN)
    ("PTHLH , and ZNF365" . SPARSER::COLLECTION) ("delC" . SPARSER::PROTEIN)
    ("epidermal growth factor and TGF" . SPARSER::COLLECTION)
    ("Amphiregulin" . SPARSER::PROTEIN) ("around ZNF365" . SPARSER::PROTEIN)
    ("both INHBA (inhibin, beta A) and INHBB" . SPARSER::COLLECTION)
    ("INHBA" . SPARSER::PROTEIN) ("inhibin and activin" . SPARSER::COLLECTION)
    ("ZNF703 , INHBB , and AREG" . SPARSER::COLLECTION)
    ("ESR1 and PTHLH" . SPARSER::COLLECTION)
    ("PTHLH , and rs62314947" . SPARSER::COLLECTION)
    ("PTHLH" . SPARSER::PROTEIN) ("INHBB" . SPARSER::PROTEIN)
    ("member 6" . SPARSER::PROTEIN) ("antitrypsin)" . SPARSER::PROTEIN)
    ("clade A (alpha-1 antiproteinase" . SPARSER::PROTEIN)
    ("serpin peptidase inhibitor" . SPARSER::PROTEIN)
    ("SERPINA6" . SPARSER::PROTEIN)
    ("megakaryoblastic leukemia (translocation) 1" . SPARSER::PROTEIN)
    ("MKL1" . SPARSER::PROTEIN)
    ("small G protein signaling modulator 3" . SPARSER::PROTEIN)
    ("SGSM3" . SPARSER::PROTEIN) ("checkpoint kinase 2" . SPARSER::PROTEIN)
    ("Activin A" . SPARSER::MOLECULE) ("beta A" . SPARSER::PROTEIN)
    ("zinc finger protein 365" . SPARSER::PROTEIN)
    ("estrogen receptor 1" . SPARSER::PROTEIN)
    ("zinc finger protein 703" . SPARSER::PROTEIN)
    ("ZNF365" . SPARSER::PROTEIN) ("ZNF703" . SPARSER::PROTEIN)
    ("the BRAF aggressive PTC" . SPARSER::PROTEIN)
    ("PDGFRbeta" . SPARSER::PROTEIN) ("COT" . SPARSER::PROTEIN)
    ("AKT/PI3K" . SPARSER::COLLECTION) ("c-Met and BRAF" . SPARSER::COLLECTION)
    ("Staphylococcal" . SPARSER::PROTEIN)
    ("previously described BRAF fusion proteins" . SPARSER::PROTEIN)
    ("GRB2 and GAB1" . SPARSER::COLLECTION)
    ("PI3K, SRC, and Ras" . SPARSER::COLLECTION)
    ("RAS-RAF-ERK" . SPARSER::COLLECTION)
    ("METi, RAFi, or MEKi" . SPARSER::COLLECTION)
    ("METi and RAFi" . SPARSER::COLLECTION) ("RBM" . SPARSER::PROTEIN)
    ("SND1 or BRAF" . SPARSER::COLLECTION)
    ("nuclease and tudor domain containing 1" . SPARSER::COLLECTION)
    ("staphylococcal" . SPARSER::PROTEIN) ("RACE" . SPARSER::PROTEIN)
    ("wildtype" . SPARSER::PROTEIN)
    ("EGFR, ERBB2, ERBB3, ERBB4, and SRC" . SPARSER::COLLECTION)
    ("total and phosphorylated proteins" . SPARSER::PROTEIN)
    ("RPPA" . SPARSER::PROTEIN)
    ("BRAF or the c-Met receptor" . SPARSER::COLLECTION)
    ("c-Met/ALK" . SPARSER::COLLECTION)
    ("a MEK inhibitor or the combination" . SPARSER::COLLECTION)
    ("c-Met and RAF" . SPARSER::COLLECTION)
    ("the resultant SND1-BRAF fusion protein" . SPARSER::PROTEIN)
    ("AGTRAP-BRAF" . SPARSER::COLLECTION) ("AKAP9-BRAF" . SPARSER::COLLECTION)
    ("FCHSD1-BRAF" . SPARSER::COLLECTION)
    ("KIAA1549-BRAF" . SPARSER::COLLECTION) ("ribonuclease" . SPARSER::PROTEIN)
    ("SND1 and BRAF" . SPARSER::COLLECTION)
    ("KRAS, BRAF, or AKT" . SPARSER::COLLECTION)
    ("EGFR/ERBB" . SPARSER::COLLECTION) ("c-Met/HGFR" . SPARSER::COLLECTION)
    ("sunitinib, erlotinib, gefitinib, and imatinib" . SPARSER::COLLECTION)
    ("sunitinib" . SPARSER::DRUG)
    ("a BRAF or a MEK inhibitor" . SPARSER::COLLECTION)
    ("METi and a RAF inhibitor" . SPARSER::COLLECTION)
    ("SND1-BRAF" . SPARSER::COLLECTION) ("METi" . SPARSER::PROTEIN)
    ("homo/heterodimers" . SPARSER::HOMO/HETERODIMER)
    ("tudor domain containing 1" . SPARSER::PROTEIN)
    ("ERBB3" . SPARSER::PROTEIN) ("GA2" . SPARSER::PROTEIN)
    ("BIS-TRIS" . SPARSER::MOLECULE) ("AKAP9" . SPARSER::PROTEIN)
    ("FCHSD1" . SPARSER::PROTEIN) ("KIAA1549" . SPARSER::PROTEIN)
    ("PD-0325901" . SPARSER::DRUG) ("SND1" . SPARSER::PROTEIN)
    ("caveolin-1/Ku70" . SPARSER::COLLECTION)
    ("Bax/Ku70" . SPARSER::COLLECTION) ("5-FU-" . SPARSER::PROTEIN)
    ("RNA and DNA" . SPARSER::COLLECTION)
    ("a chemotherapeutic drug" . SPARSER::DRUG)
    ("Ku70 and Bax" . SPARSER::COLLECTION) ("Φ→A" . SPARSER::PROTEIN)
    ("Φ→A-Ku70" . SPARSER::COLLECTION)
    ("caveolin-1 and Bax" . SPARSER::COLLECTION)
    ("caveolin-1, Ku70 and Bax" . SPARSER::COLLECTION)
    ("caveolin-1 or Bax" . SPARSER::COLLECTION)
    ("caveolin-1/Ku70/Bax" . SPARSER::COLLECTION)
    ("5-FU and etoposide" . SPARSER::COLLECTION)
    ("an anti-apoptotic protein ( xref and xref ) and chemotherapeutic drugs"
     . SPARSER::COLLECTION)
    ("etoposide and the interaction between caveolin-1 and Ku70"
     . SPARSER::COLLECTION)
    ("5-FU or etoposide" . SPARSER::COLLECTION)
    ("caveolin-1 and Ku70" . SPARSER::COLLECTION)
    ("Chemotherapeutic Drugs" . SPARSER::DRUG)
    ("Caveolin-1 and Ku70" . SPARSER::COLLECTION)
    ("a different chemotherapeutic drug" . SPARSER::DRUG)
    ("cleaved caspase 3 and Poly (ADP-ribose) polymerase (PARP) ( xref )"
     . SPARSER::COLLECTION)
    ("polymerase (PARP)" . SPARSER::PROTEIN)
    ("an apoptotic inducer" . SPARSER::PROTEIN)
    ("Ku70-Bax" . SPARSER::COLLECTION) ("Ku70/Ku80" . SPARSER::COLLECTION)
    ("caveolin-1 and signalling molecules" . SPARSER::COLLECTION)
    ("Nitric Oxide Synthase (NOS)" . SPARSER::PROTEIN)
    ("Kinases (NRTK)" . SPARSER::PROTEIN)
    ("Mdm2, Thioredoxin Reductase 1 and Protein Phosphatase"
     . SPARSER::COLLECTION)
    ("an essential protein component" . SPARSER::COMPONENT)
    ("Ku70/Bax" . SPARSER::COLLECTION) ("CBD" . SPARSER::DRUG)
    ("thymidylate synthase" . SPARSER::PROTEIN)
    ("ADP-ribose" . SPARSER::MOLECULE) ("LSM 5" . SPARSER::PROTEIN)
    ("alpha-tubulin" . SPARSER::PROTEIN)
    ("Glutathione S -transferase" . SPARSER::PROTEIN)
    ("s 5a" . SPARSER::PROTEIN) ("N-20" . SPARSER::PROTEIN)
    ("Ku80" . SPARSER::PROTEIN) ("Protein Phosphatase" . SPARSER::PROTEIN)
    ("Thioredoxin Reductase 1" . SPARSER::PROTEIN)
    ("Src-like" . SPARSER::PROTEIN) ("Ku70" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("scaffolding protein" . SPARSER::PROTEIN)
    ("Caveolin-1" . SPARSER::PROTEIN)
    ("A2V6-associated kinase" . SPARSER::KINASE)
    ("A2V6 and CDK2" . SPARSER::COLLECTION)
    ("anaphase-promoting complex (APC)" . SPARSER::PROTEIN)
    ("A2WT/CDK2" . SPARSER::COLLECTION)
    ("A2WT- and A2V6-GFP-transfected" . SPARSER::COLLECTION)
    ("A2WT-" . SPARSER::PROTEIN) ("an Inactive Complex" . SPARSER::BIO-COMPLEX)
    ("Inactive" . SPARSER::INACTIVE) ("Forms" . SPARSER::FORM)
    ("A2V6- and A2WT-GFP-expressing" . SPARSER::COLLECTION)
    ("A2V6-" . SPARSER::PROTEIN)
    ("cells studied displayed any nuclear endogenous cyclin A2"
     . SPARSER::PROTEIN)
    ("exogenous A2V6-GFP" . SPARSER::COLLECTION)
    ("exogenous A2WT-GFP" . SPARSER::COLLECTION) ("A2V6" . SPARSER::PROTEIN)
    ("A2WT" . SPARSER::PROTEIN) ("A2WT-GFP and A2V6-GFP" . SPARSER::COLLECTION)
    ("A2V6-GFP" . SPARSER::COLLECTION) ("A2WT-GFP" . SPARSER::COLLECTION)
    ("Introns" . SPARSER::PROTEIN)
    ("the mature cyclin A2 (A2WT) mRNA" . SPARSER::PROTEIN)
    ("sea" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin A2/CDK2" . SPARSER::COLLECTION)
    ("endoplasmic reticulum-associated non-degraded cyclin A2"
     . SPARSER::PROTEIN)
    ("Cyclin A/CDK2" . SPARSER::COLLECTION) ("Intron" . SPARSER::PROTEIN)
    ("exon–intron" . SPARSER::COLLECTION)
    ("mitotic cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S-E" . SPARSER::PROTEIN) ("8B" . SPARSER::PROTEIN)
    ("CCL-2" . SPARSER::PROTEIN)
    ("a pro-apoptotic fragment" . SPARSER::FRAGMENT)
    ("the other prosurvival Bcl-2 proteins" . SPARSER::PROTEIN)
    ("Bax or Bfl-1" . SPARSER::COLLECTION)
    ("larger molecules" . SPARSER::MOLECULE)
    ("MnSOD or Hsp70" . SPARSER::COLLECTION)
    ("an integral outer membrane protein" . SPARSER::PROTEIN)
    ("Hexokinase" . SPARSER::PROTEIN) ("HK1" . SPARSER::PROTEIN)
    ("the mitochondria and the supernatant fractions" . SPARSER::COLLECTION)
    ("Hsp70 and cytochrome c" . SPARSER::COLLECTION)
    ("endogenous Bax and/or Bak proteins ( xref , upper panels)"
     . SPARSER::COLLECTION)
    ("the mitochondrial matrix-resident protein Hsp70" . SPARSER::PROTEIN)
    ("MEF or iBMK" . SPARSER::COLLECTION)
    ("α5, α6 or α9" . SPARSER::COLLECTION) ("Peptides" . SPARSER::PEPTIDE)
    ("Bfl-1 or Bax" . SPARSER::COLLECTION)
    ("full length Bfl-1 as well as Bfl-1 helices" . SPARSER::COLLECTION)
    ("α5-α6-α9" . SPARSER::COLLECTION) ("α5-α6" . SPARSER::COLLECTION)
    ("larger GFP-fused" . SPARSER::COLLECTION)
    ("α5, α6 and α9" . SPARSER::COLLECTION) ("GFP-fused" . SPARSER::COLLECTION)
    ("homologous fragments" . SPARSER::FRAGMENT) ("α6" . SPARSER::PROTEIN)
    ("Bax-α5" . SPARSER::COLLECTION) ("MEF (WT)" . SPARSER::PROTEIN)
    ("bax/bak" . SPARSER::COLLECTION) ("bak" . SPARSER::PROTEIN)
    ("bax" . SPARSER::PROTEIN) ("α5 and α9" . SPARSER::COLLECTION)
    ("α9" . SPARSER::PROTEIN) ("α5" . SPARSER::PROTEIN)
    ("Bfl-1-α5" . SPARSER::COLLECTION) ("Bfl-1-α9" . SPARSER::COLLECTION)
    ("Bfl-1-α6" . SPARSER::COLLECTION) ("Bax-α6" . SPARSER::COLLECTION)
    ("GFP-Bax" . SPARSER::COLLECTION) ("the last exon" . SPARSER::PROTEIN)
    ("PFD" . SPARSER::PROTEIN) ("undergoes µ" . SPARSER::PROTEIN)
    ("TNFα and CHX or staurosporine" . SPARSER::COLLECTION)
    ("CHX or staurosporine" . SPARSER::COLLECTION)
    ("GFP-Bfl-1" . SPARSER::COLLECTION)
    ("trypsin and the resulting peptides" . SPARSER::COLLECTION)
    ("∼12,000 Da and 17,500 Da" . SPARSER::COLLECTION)
    ("Da" . SPARSER::MOLECULE) ("GST-Bfl-1" . SPARSER::COLLECTION)
    ("the subsequent cleaved fragments" . SPARSER::FRAGMENT)
    ("Bax and Bfl-1" . SPARSER::COLLECTION)
    ("prosurvival Bfl-1" . SPARSER::PROTEIN) ("calpains" . SPARSER::PROTEIN)
    ("the prosurvival factors Bcl-2, Bcl-xL and Mcl-1" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL and Mcl-1" . SPARSER::COLLECTION)
    ("Bax, Bcl-xL or Bid" . SPARSER::COLLECTION)
    ("Bax, Bcl-2 and Bcl-xL and α6-α7" . SPARSER::COLLECTION)
    ("Bcl-xL and α6-α7" . SPARSER::COLLECTION)
    ("their water-soluble state" . SPARSER::BIO-STATE)
    ("Bcl-2-like and Bax-like" . SPARSER::COLLECTION)
    ("Bax-" . SPARSER::PROTEIN)
    ("cytochrome c and other effectors" . SPARSER::COLLECTION)
    ("Bfl-1 and Bax" . SPARSER::COLLECTION)
    ("Bax or Bak" . SPARSER::COLLECTION) ("-calpain" . SPARSER::COLLECTION)
    ("calpain" . SPARSER::PROTEIN)
    ("protease µ" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Anti-apoptotic Bfl-1 and pro-apoptotic Bax" . SPARSER::COLLECTION)
    ("M +2" . SPARSER::MOLECULE) ("a 15 µ" . SPARSER::PROTEIN)
    ("CH 3" . SPARSER::MOLECULE)
    ("integral membrane protein" . SPARSER::PROTEIN)
    ("calpain inhibitor" . SPARSER::PROTEIN) ("μ -calpain" . SPARSER::PROTEIN)
    ("μ-calpain" . SPARSER::PROTEIN) ("BCL2L10" . SPARSER::PROTEIN)
    ("L21" . SPARSER::PROTEIN) ("diphtheria toxin" . SPARSER::PROTEIN)
    ("Bcl-2-like" . SPARSER::PROTEIN) ("BH4" . SPARSER::PROTEIN-FAMILY)
    ("a bona fide classical scaffold protein" . SPARSER::PROTEIN)
    ("a catalytically active protein and its corresponding target"
     . SPARSER::COLLECTION)
    ("Classical scaffold proteins" . SPARSER::PROTEIN)
    ("Src, OSF, and Sam68" . SPARSER::COLLECTION)
    ("scaffold-proteins" . SPARSER::COLLECTION)
    ("the basic aa" . SPARSER::MOLECULE)
    ("Grb-2 or Vav1" . SPARSER::COLLECTION)
    ("wildtype-Sam68" . SPARSER::PROTEIN-PAIR)
    ("OSF and p85" . SPARSER::COLLECTION)
    ("P3, P4 and P5" . SPARSER::COLLECTION) ("CFP-Sam68" . SPARSER::COLLECTION)
    ("CFP and YFP" . SPARSER::COLLECTION)
    ("CFP and YFP-fluorescence" . SPARSER::COLLECTION)
    ("GST-Fyn-SH3" . SPARSER::PROTEIN-PAIR)
    ("Sam68 and the SH3-phages" . SPARSER::COLLECTION)
    ("Nck1" . SPARSER::PROTEIN)
    ("osteoclast stimulating factor 1 (OSF)" . SPARSER::PROTEIN)
    ("RasGAP" . SPARSER::PROTEIN) ("pVIII" . SPARSER::PROTEIN)
    ("fine-mapping" . SPARSER::PROTEIN) ("lentiviral RNAs" . SPARSER::RNA)
    ("leptin-, EGF- or T-cell-receptor" . SPARSER::COLLECTION)
    ("EGF-" . SPARSER::PROTEIN) ("leptin-" . SPARSER::PROTEIN)
    ("GRP" . SPARSER::PROTEIN) ("GSG" . SPARSER::PROTEIN)
    ("KH" . SPARSER::MOLECULE)
    ("protein- and RNA-interactions" . SPARSER::COLLECTION)
    ("RNA-interactions" . SPARSER::RNA) ("protein-" . SPARSER::PROTEIN)
    ("a basic amino acid" . SPARSER::AMINO-ACID)
    ("a classical scaffold protein" . SPARSER::PROTEIN)
    ("Sam68 and OSF" . SPARSER::COLLECTION) ("OSF-Src" . SPARSER::COLLECTION)
    ("Sam68-Src" . SPARSER::COLLECTION)
    ("P3, P4, and P5" . SPARSER::COLLECTION) ("CFP-" . SPARSER::PROTEIN)
    ("OSF" . SPARSER::PROTEIN) ("PLCG1" . SPARSER::PROTEIN)
    ("MAP-kinase" . SPARSER::PROTEIN)
    ("Osteoclast stimulating factor 1" . SPARSER::PROTEIN)
    ("β-Pix" . SPARSER::PROTEIN) ("Pak2" . SPARSER::PROTEIN)
    ("osteoclast stimulating factor 1" . SPARSER::PROTEIN)
    ("Intersectin 2" . SPARSER::PROTEIN) ("coat protein" . SPARSER::PROTEIN)
    ("C20" . SPARSER::PROTEIN) ("MT-4" . SPARSER::PROTEIN)
    ("M15" . SPARSER::DRUG) ("sam68" . SPARSER::PROTEIN)
    ("T-cell-receptor" . SPARSER::PROTEIN) ("GLD-1" . SPARSER::PROTEIN)
    ("KH domain containing" . SPARSER::PROTEIN) ("KHDRBS1" . SPARSER::PROTEIN)
    ("poly-proline" . SPARSER::MOLECULE) ("src-homology" . SPARSER::PROTEIN)
    ("P5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("intersectin 2" . SPARSER::PROTEIN)
    ("Annexin V or YoPro1" . SPARSER::COLLECTION)
    ("Spi2A and Spi6" . SPARSER::COLLECTION)
    ("serpin-protease" . SPARSER::COLLECTION)
    ("distinct mRNAs" . SPARSER::PROTEIN)
    ("Other homologous Serpina3 family genes" . SPARSER::GENE)
    ("thioester" . SPARSER::MOLECULE) ("intact cathepsin B" . SPARSER::PROTEIN)
    ("papain" . SPARSER::PROTEIN) ("clearly fewer puncta" . SPARSER::PROTEIN)
    ("Lysotracker" . SPARSER::DRUG) ("LMP" . SPARSER::PROTEIN)
    ("naive CD45" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Spi2A and other serpins" . SPARSER::COLLECTION)
    ("serpins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Serpina3" . SPARSER::PROTEIN)
    ("Tetramer" . SPARSER::TETRAMER)
    ("environmental antigens" . SPARSER::PROTEIN)
    ("erythroid, myeloid, or lymphoid" . SPARSER::COLLECTION)
    ("Complementing" . SPARSER::PROTEIN)
    ("serpin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor-" . SPARSER::RECEPTOR) ("which releases ROS" . SPARSER::PROTEIN)
    ("Cathepsins" . SPARSER::PROTEIN) ("Oxygen" . SPARSER::MOLECULE)
    ("cathepsins" . SPARSER::PROTEIN) ("Lysosomal" . SPARSER::PROTEIN)
    ("L , and Mcl-1 in memory CD8 + T cells ( xref - xref )"
     . SPARSER::PROTEIN)
    ("IL-7 and IL-15" . SPARSER::COLLECTION) ("Antigen" . SPARSER::PROTEIN)
    ("IL-15 and IL-7" . SPARSER::COLLECTION) ("YoPro1" . SPARSER::MOLECULE)
    ("granzyme B" . SPARSER::PROTEIN) ("Cathepsin B" . SPARSER::PROTEIN)
    ("Cathepsin S" . SPARSER::PROTEIN) ("cm -1" . SPARSER::PROTEIN)
    ("M -1" . SPARSER::PROTEIN) ("cathepsin L" . SPARSER::PROTEIN)
    ("trypsin inhibitor" . SPARSER::PROTEIN)
    ("β2microglobulin" . SPARSER::PROTEIN) ("H-2" . SPARSER::PROTEIN)
    ("gp33" . SPARSER::PROTEIN) ("Thy1" . SPARSER::PROTEIN)
    ("Serpina3g" . SPARSER::PROTEIN)
    ("Serine Protease Inhibitor" . SPARSER::PROTEIN)
    ("KLRG1" . SPARSER::PROTEIN) ("IL-7R" . SPARSER::PROTEIN)
    ("cathepsin B" . SPARSER::PROTEIN) ("IL-7" . SPARSER::PROTEIN)
    ("IL-15" . SPARSER::PROTEIN) ("Spi2A" . SPARSER::PROTEIN)
    ("Serine protease inhibitor" . SPARSER::PROTEIN)
    ("complex and a cooperative mechanism" . SPARSER::COLLECTION)
    ("TQ" . SPARSER::DRUG) ("Chk1 and intra-S phase" . SPARSER::COLLECTION)
    ("Chk1 and G2/M" . SPARSER::COLLECTION)
    ("Timeless and Tipin" . SPARSER::COLLECTION) ("Tipin" . SPARSER::PROTEIN)
    ("Timeless" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the soluble and insoluble fractions" . SPARSER::COMPONENT)
    ("the soluble fraction" . SPARSER::COMPONENT)
    ("HU and IR" . SPARSER::COLLECTION)
    ("the insoluble chromatin fraction" . SPARSER::COMPONENT)
    ("IR or HU" . SPARSER::COLLECTION) ("Chk1 following" . SPARSER::PROTEIN)
    ("smaller foci" . SPARSER::PROTEIN)
    ("the distinct foci" . SPARSER::PROTEIN)
    ("GFP-Chk1S345A" . SPARSER::COLLECTION)
    ("GFP-Chk1 following" . SPARSER::PROTEIN-PAIR)
    ("GFP-Chk1" . SPARSER::COLLECTION)
    ("HU or cisplatin" . SPARSER::COLLECTION)
    ("BRCA1-shRNA" . SPARSER::COLLECTION) ("Cisplatin" . SPARSER::MOLECULE)
    ("its continued phosphorylation state" . SPARSER::BIO-STATE)
    ("HU and Chk1" . SPARSER::COLLECTION)
    ("Chk1 that is likely to promote Chk1’s" . SPARSER::PROTEIN)
    ("functional BRCA1" . SPARSER::PROTEIN)
    ("hydroxyurea (HU; a ribonucleotide reductase inhibitor) and cisplatin (a DNA cross-linking drug)"
     . SPARSER::COLLECTION)
    ("the Rad17 and the 9-1–1( xref , xref , xref , xref )"
     . SPARSER::COLLECTION)
    ("protein (ATRIP)" . SPARSER::PROTEIN) ("claspin" . SPARSER::PROTEIN)
    ("cisplatin or hydroxyurea" . SPARSER::COLLECTION)
    ("ovarian tumor suppressor" . SPARSER::SUPPRESSOR)
    ("rad17" . SPARSER::PROTEIN) ("Hus1" . SPARSER::PROTEIN)
    ("NaVO3" . SPARSER::MOLECULE) ("Rad17" . SPARSER::PROTEIN)
    ("TopBP1" . SPARSER::PROTEIN) ("PI-3" . SPARSER::PROTEIN)
    ("vascular cell adhesion molecule 1" . SPARSER::PROTEIN)
    ("TNFR2-L319/320A" . SPARSER::PROTEIN-PAIR) ("TRID" . SPARSER::PROTEIN)
    ("TRAF2/RIPK1" . SPARSER::COLLECTION)
    ("JNK and caspase" . SPARSER::COLLECTION) ("polymer" . SPARSER::MOLECULE)
    ("TRADD/RIPK1/TRAF2/FADD" . SPARSER::COLLECTION)
    ("FLICE" . SPARSER::PROTEIN) ("TRAF2 and Bmx" . SPARSER::COLLECTION)
    ("TRAF2-" . SPARSER::PROTEIN) ("primary vascular EC" . SPARSER::PROTEIN)
    ("iodide (PI)" . SPARSER::PROTEIN)
    ("a global inhibitor" . SPARSER::INHIBITOR)
    ("cycloheximide or shiga-like" . SPARSER::COLLECTION)
    ("TNFR2 and AIP1" . SPARSER::COLLECTION)
    ("the internal deletion mutants" . SPARSER::MUTANT)
    ("TRAF2/Bmx" . SPARSER::COLLECTION) ("TNFR2-TM" . SPARSER::COLLECTION)
    ("TNFR1 or TRAF2" . SPARSER::COLLECTION)
    ("NF-κB and JNK-reporter" . SPARSER::COLLECTION)
    ("NF-κB- and JNK-reporter" . SPARSER::COLLECTION)
    ("NF-κB-" . SPARSER::PROTEIN) ("EC (HUVEC)" . SPARSER::PROTEIN)
    ("TNFR1 and TNFR2" . SPARSER::COLLECTION)
    ("IκBα (an indication of NF-κB activation) and JNK" . SPARSER::COLLECTION)
    ("EC (MLEC)" . SPARSER::PROTEIN) ("MLEC" . SPARSER::PROTEIN)
    ("Only membrane-bound TNF" . SPARSER::PROTEIN) ("Bmx" . SPARSER::PROTEIN)
    ("TRAF2 and TRAF2-associated TRAF1, cIAP1 and cIAP2" . SPARSER::COLLECTION)
    ("TRAF2-associated TRAF1, cIAP1 and cIAP2" . SPARSER::COLLECTION)
    ("TRAF1, cIAP1 and cIAP2" . SPARSER::COLLECTION)
    ("vascular EC" . SPARSER::PROTEIN) ("AIP1-ASK1-JNK" . SPARSER::COLLECTION)
    ("complex I and complex" . SPARSER::COLLECTION)
    ("TNFR1, TRADD, RIPK1 and TRAF2" . SPARSER::COLLECTION)
    ("TRADD, TRAF2 and RIPK1" . SPARSER::COLLECTION)
    ("FADD and pro-caspase-8" . SPARSER::COLLECTION)
    ("TRADD" . SPARSER::PROTEIN)
    ("adaptor proteins and signaling molecules" . SPARSER::COLLECTION)
    ("a membrane distal part" . SPARSER::COMPONENT)
    ("TNFR1 or TNFR2" . SPARSER::COLLECTION)
    ("the type and growth state" . SPARSER::COLLECTION)
    ("the principal physiological targets" . SPARSER::TARGET-PROTEIN)
    ("NF-κB and JNK" . SPARSER::COLLECTION)
    ("The proinflammtory cytokine tumor necrosis factor (TNF)"
     . SPARSER::PROTEIN)
    ("tumor necrosis factor (TNF)" . SPARSER::PROTEIN)
    ("ICAM-1" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule 1" . SPARSER::PROTEIN)
    ("cell adhesion molecule 1" . SPARSER::PROTEIN)
    ("MAP3K" . SPARSER::PROTEIN) ("TRAF1" . SPARSER::PROTEIN)
    ("ASK1" . SPARSER::PROTEIN) ("complex I" . SPARSER::PROTEIN)
    ("RIPK1" . SPARSER::PROTEIN) ("protein kinase-1" . SPARSER::PROTEIN)
    ("AIP1" . SPARSER::PROTEIN) ("receptor 1" . SPARSER::PROTEIN)
    ("nonapoptotic Bim" . SPARSER::PROTEIN)
    ("LC8-Bim-Beclin 1" . SPARSER::COLLECTION)
    ("Beclin 1 and Bim" . SPARSER::COLLECTION)
    ("apoptosis-inactive LC8-associated Bim" . SPARSER::PROTEIN)
    ("LC8 and Bim" . SPARSER::COLLECTION) ("Nutrient" . SPARSER::MOLECULE)
    ("proteins, Bad and BNIP3" . SPARSER::COLLECTION)
    ("Bcl-2 and Beclin 1" . SPARSER::COLLECTION)
    ("Beclin 1-UVRAG" . SPARSER::COLLECTION)
    ("Beclin 1-Vps34" . SPARSER::COLLECTION)
    ("LC8 and the form" . SPARSER::COLLECTION)
    ("Bim or LC8" . SPARSER::COLLECTION) ("Bim-LC8" . SPARSER::COLLECTION)
    ("LC8 ( xref J and xref C–6E; see summary in xref D) and these forms"
     . SPARSER::COLLECTION)
    ("Beclin 1 and LC8" . SPARSER::COLLECTION) ("Ambra1" . SPARSER::PROTEIN)
    ("Bim and LC8" . SPARSER::COLLECTION) ("forms " . SPARSER::FORM)
    ("nonphosphorylatable (T116A) Bim mutants" . SPARSER::MUTANT)
    ("LC8-Bim" . SPARSER::COLLECTION) ("Bim (EL)" . SPARSER::PROTEIN)
    ("BimL and BimS" . SPARSER::COLLECTION) ("EL" . SPARSER::PROTEIN)
    ("Bim-L and Bim-S" . SPARSER::COLLECTION)
    ("BimS and Beclin 1" . SPARSER::COLLECTION)
    ("BimEL and BimL" . SPARSER::COLLECTION)
    ("BimS-Beclin 1" . SPARSER::COLLECTION) ("HBSS" . SPARSER::MOLECULE)
    ("siRNA- and Bim" . SPARSER::COLLECTION)
    ("Verapamil and calpastatin" . SPARSER::COLLECTION)
    ("calpastatin" . SPARSER::PROTEIN) ("Verapamil" . SPARSER::DRUG)
    ("Beclin 1-Bim" . SPARSER::COLLECTION)
    ("Bim and Bcl-2" . SPARSER::COLLECTION)
    ("Bim or Bcl-2" . SPARSER::COLLECTION)
    ("GFP-mRFP-LC3" . SPARSER::COLLECTION)
    ("UVRAG and Atg14" . SPARSER::COLLECTION)
    ("LC3-II and LC3" . SPARSER::COLLECTION)
    ("which binds Beclin 1" . SPARSER::PROTEIN) ("EE" . SPARSER::PROTEIN)
    ("Bim or BimEE" . SPARSER::COLLECTION)
    ("siRNA- or Bim" . SPARSER::COLLECTION) ("Bim-shRNA" . SPARSER::COLLECTION)
    ("htt" . SPARSER::PROTEIN) ("huntingtin" . SPARSER::PROTEIN)
    ("Bim -null MEFs" . SPARSER::PROTEIN)
    ("the autophagosome-associated protein LC3-II" . SPARSER::PROTEIN)
    ("actin/tubulin" . SPARSER::COLLECTION)
    ("the shortest isoform" . SPARSER::ISOFORM)
    ("BimEL-EE and BimL-EE" . SPARSER::COLLECTION)
    ("BimS and BimL" . SPARSER::COLLECTION) ("BimS-EE" . SPARSER::COLLECTION)
    ("BimL-EE" . SPARSER::COLLECTION) ("BimEL-EE" . SPARSER::COLLECTION)
    ("Bcl-2-Beclin 1" . SPARSER::COLLECTION)
    ("BimEL and greater" . SPARSER::COLLECTION)
    ("HA-tagged wild-type Bim and Flag-tagged Beclin 1" . SPARSER::COLLECTION)
    ("Bim-Beclin 1" . SPARSER::COLLECTION) ("Bec" . SPARSER::MOLECULE)
    ("Bim-Beclin 1" . SPARSER::COLLECTION)
    ("both BimEL and a BimL-sized protein" . SPARSER::COLLECTION)
    ("proteins, Puma, Noxa, and Bad" . SPARSER::COLLECTION)
    ("proteins or Bak" . SPARSER::COLLECTION)
    ("Bcl-xL-Beclin 1" . SPARSER::COLLECTION)
    ("Beclin 1-Bcl-2" . SPARSER::PROTEIN-PAIR)
    ("Beclin 1-Bcl-xL" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-xL" . SPARSER::COLLECTION)
    ("Bcl-2/Bcl-xL" . SPARSER::COLLECTION)
    ("Vps15, Beclin 1, and Atg14" . SPARSER::COLLECTION)
    ("UVRAG and Rubicon" . SPARSER::COLLECTION) ("Rubicon" . SPARSER::PROTEIN)
    ("UVRAG" . SPARSER::PROTEIN)
    ("an essential autophagy protein" . SPARSER::PROTEIN)
    ("the ancient Bcl-2 family" . SPARSER::PROTEIN-FAMILY)
    ("LC8 and the dynein motor complex ( xref )" . SPARSER::COLLECTION)
    ("BimL, and BimS" . SPARSER::COLLECTION) ("BimS" . SPARSER::PROTEIN)
    ("BimL" . SPARSER::PROTEIN) ("BimEL" . SPARSER::PROTEIN)
    ("Bim, Bid, Bad, Noxa, Puma, Bmf, Bik, Bnip3, and Hrk"
     . SPARSER::COLLECTION)
    ("Hrk" . SPARSER::PROTEIN) ("Bik" . SPARSER::PROTEIN)
    ("Bmf" . SPARSER::PROTEIN) ("Bim-Beclin1" . SPARSER::COLLECTION)
    ("Bim and Beclin 1" . SPARSER::COLLECTION)
    ("Beclin 1-LC8" . SPARSER::COLLECTION) ("DYNLL1/LC8" . SPARSER::COLLECTION)
    ("dynein light chain" . SPARSER::PROTEIN) ("BNIP3" . SPARSER::PROTEIN)
    ("C–6" . SPARSER::PROTEIN) ("LC8 " . SPARSER::PROTEIN)
    ("Beclin 1 " . SPARSER::PROTEIN) ("Bim-L" . SPARSER::PROTEIN)
    ("Atg12" . SPARSER::PROTEIN) ("DFCP1" . SPARSER::PROTEIN)
    ("p40phox" . SPARSER::PROTEIN) ("messenger RNA" . SPARSER::RNA)
    ("GFP-LC3" . SPARSER::PROTEIN) ("Bafilomycin A1" . SPARSER::DRUG)
    ("Beclin-1" . SPARSER::PROTEIN) ("F–1" . SPARSER::PROTEIN)
    ("Beclin 1" . SPARSER::PROTEIN) ("JNK1" . SPARSER::PROTEIN)
    ("Atg14" . SPARSER::PROTEIN) ("Vps15" . SPARSER::PROTEIN)
    ("PI-3 kinase" . SPARSER::PROTEIN) ("Complex I" . SPARSER::PROTEIN)
    ("Bnip3" . SPARSER::PROTEIN) ("BH1" . SPARSER::PROTEIN)
    ("Beclin1" . SPARSER::PROTEIN) ("Beclin 1" . SPARSER::PROTEIN)
    ("LC8" . SPARSER::PROTEIN) ("DYNLL1" . SPARSER::PROTEIN)
    ("dynein light chain 1" . SPARSER::PROTEIN)
    ("the oligomeric form" . SPARSER::FORM)
    ("oligomeric forms" . SPARSER::FORM)
    ("dimer or tetramer" . SPARSER::COLLECTION)
    ("tyrosine or methionine" . SPARSER::COLLECTION)
    ("monomers" . SPARSER::MONOMER) ("tetrameric forms" . SPARSER::FORM)
    ("DTT" . SPARSER::MOLECULE)
    ("11 cysteines and canine TK1" . SPARSER::COLLECTION)
    ("thiol" . SPARSER::MOLECULE) ("cysteines" . SPARSER::AMINO-ACID)
    ("active dimer and tetramer" . SPARSER::COLLECTION)
    ("Recombinant canine TK1" . SPARSER::PROTEIN)
    ("the canine TK1 enzyme" . SPARSER::ENZYME)
    ("the multimeric complex form" . SPARSER::FORM)
    ("apparently more active" . SPARSER::ACTIVE)
    ("multimeric forms" . SPARSER::FORM)
    ("the corresponding fractions and the major activity peak"
     . SPARSER::COLLECTION)
    ("acute lymphocytic leukemia" . SPARSER::PROTEIN)
    ("the canine TK1 protein" . SPARSER::PROTEIN) ("Sera" . SPARSER::PROTEIN)
    ("dimers and tetramers" . SPARSER::COLLECTION)
    ("40–100 kDa and 500–720 kDa (Figure xref D)" . SPARSER::COLLECTION)
    ("the native canine TK1" . SPARSER::PROTEIN)
    ("dimer and tetramer" . SPARSER::COLLECTION)
    ("the recombinant canine TK1" . SPARSER::PROTEIN)
    ("The canine TK1 protein" . SPARSER::PROTEIN)
    ("recombinant canine TK1" . SPARSER::PROTEIN)
    ("canine TK1 or a mouse monoclonal antibody" . SPARSER::COLLECTION)
    ("DTE" . SPARSER::MOLECULE) ("reducing agent (DTE)" . SPARSER::MOLECULE)
    ("KOH" . SPARSER::MOLECULE) ("HEPES" . SPARSER::MOLECULE)
    ("canine TK1, and ~40%" . SPARSER::COLLECTION)
    ("TK1, and ~40%" . SPARSER::COLLECTION) ("Thymidine" . SPARSER::PROTEIN)
    ("GTP, CTP, or UTP" . SPARSER::COLLECTION) ("UTP" . SPARSER::MOLECULE)
    ("CTP" . SPARSER::PROTEIN) ("canine TK1" . SPARSER::PROTEIN)
    ("dThd and AZT" . SPARSER::COLLECTION)
    ("an excess ATP and variable concentrations of dThd or AZT"
     . SPARSER::COLLECTION)
    ("dThd or AZT" . SPARSER::COLLECTION)
    ("purified recombinant canine TK1" . SPARSER::PROTEIN)
    ("full-length canine TK1" . SPARSER::PROTEIN)
    ("approximately 730 kDa" . SPARSER::PROTEIN)
    ("TK-REA" . SPARSER::COLLECTION) ("REA" . SPARSER::PROTEIN)
    ("dTDP" . SPARSER::MOLECULE) ("dTMP" . SPARSER::MOLECULE)
    ("veterinary medicine" . SPARSER::DRUG)
    ("26 kDa (dog) and 25 kDa (human)" . SPARSER::COLLECTION)
    ("dimeric and tetrameric forms" . SPARSER::FORM)
    ("Cellular TK1" . SPARSER::PROTEIN)
    ("the tetrameric and dimeric forms" . SPARSER::FORM)
    ("Oligomeric forms" . SPARSER::FORM) ("AZT" . SPARSER::DRUG)
    ("azido" . SPARSER::MOLECULE) ("dThd" . SPARSER::MOLECULE)
    ("Canine TK1" . SPARSER::PROTEIN) ("A polypeptide" . SPARSER::PROTEIN)
    ("α2-macroglobulin" . SPARSER::PROTEIN) ("- 3  " . SPARSER::PROTEIN)
    ("DE-" . SPARSER::MOLECULE) ("Thymidine kinase" . SPARSER::PROTEIN)
    ("a polypeptide" . SPARSER::PROTEIN) ("TK1" . SPARSER::PROTEIN)
    ("Thymidine kinase 1" . SPARSER::PROTEIN)
    ("ERE and AP1" . SPARSER::COLLECTION)
    ("IGF-1 and consensus ERE" . SPARSER::COLLECTION)
    ("tumor-associated BRCA1 mutants" . SPARSER::MUTANT)
    ("HDAC1 and HDAC2" . SPARSER::COLLECTION)
    ("p300 and cyclin D1" . SPARSER::COLLECTION)
    ("IGF-1R/PI3K/AKT/ER α" . SPARSER::COLLECTION)
    ("PI3K, ERK, and AKT" . SPARSER::COLLECTION)
    ("IGF-1R and ER α" . SPARSER::COLLECTION)
    ("MAPK or AKT" . SPARSER::COLLECTION)
    ("Igf-1, Irs-1, Igf-1r, and Igfbp2" . SPARSER::COLLECTION)
    ("IGF-1, IGF-2, IRS-1, and IGF-1R" . SPARSER::COLLECTION)
    ("Igf-1r" . SPARSER::PROTEIN) ("Perifosine" . SPARSER::PROTEIN)
    ("OSI-906, and AG 1024" . SPARSER::COLLECTION)
    ("OSI-906 and AG 1024" . SPARSER::COLLECTION) ("ATK" . SPARSER::PROTEIN)
    ("a neutralizing antibody or a small-molecule inhibitor"
     . SPARSER::COLLECTION)
    ("BRCA1–KD" . SPARSER::COLLECTION) ("insA" . SPARSER::PROTEIN)
    ("A tumor-associated BRCA1 mutant" . SPARSER::MUTANT)
    ("ERE" . SPARSER::PROTEIN) ("Carboxy" . SPARSER::MOLECULE)
    ("ERE-Luc" . SPARSER::COLLECTION) ("IGF-1-ELEL-Luc" . SPARSER::COLLECTION)
    ("EREL" . SPARSER::PROTEIN) ("ER α and BRCA1" . SPARSER::COLLECTION)
    ("BRCA1 and/or ER α" . SPARSER::COLLECTION)
    ("IGF-2, IGF-1R, and IRS-1" . SPARSER::COLLECTION)
    ("IGF-1R/PI3K/AKT" . SPARSER::COLLECTION)
    ("ER α , p53, STAT1, c-Myc, and ZBRK1" . SPARSER::COLLECTION)
    ("extracellular IGF-1" . SPARSER::PROTEIN)
    ("IGF-1 and IGF-2" . SPARSER::COLLECTION) ("IGFs" . SPARSER::PROTEIN)
    ("IGF-1/PI3K/AKT" . SPARSER::COLLECTION)
    ("IGF-1/IGF-1R/phosphoinositide 3-kinase" . SPARSER::COLLECTION)
    ("BRCA1 and ER α" . SPARSER::COLLECTION) ("BRCA1-KD" . SPARSER::COLLECTION)
    ("ER- α" . SPARSER::PROTEIN) ("β -galactosidase" . SPARSER::PROTEIN)
    ("pCR2" . SPARSER::PROTEIN) ("2–4 " . SPARSER::PROTEIN)
    ("BMS-754807" . SPARSER::DRUG) ("Jun D" . SPARSER::PROTEIN)
    ("HDAC2" . SPARSER::PROTEIN) ("Irs-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AG 1024" . SPARSER::DRUG) ("OSI-906" . SPARSER::DRUG)
    ("GSK3 β" . SPARSER::PROTEIN) ("activator protein 1" . SPARSER::PROTEIN)
    ("ICI182780" . SPARSER::DRUG) ("ZBRK1" . SPARSER::PROTEIN)
    ("Igf-1" . SPARSER::PROTEIN) ("IGF-2" . SPARSER::PROTEIN)
    ("IGF-1-" . SPARSER::PROTEIN) ("ER α" . SPARSER::PROTEIN)
    ("b" . SPARSER::PROTEIN) ("b-catenin" . SPARSER::COLLECTION)
    ("Proteases" . SPARSER::PROTEIN)
    ("E-cadherin, CD44v6 and MMP-7" . SPARSER::COLLECTION)
    ("MMP-7 and CD44" . SPARSER::COLLECTION)
    ("tumor cell-associated proteases" . SPARSER::PROTEIN)
    ("laminin and fibronectin" . SPARSER::COLLECTION)
    ("laminin" . SPARSER::PROTEIN)
    ("E-cadherin and CD44v6" . SPARSER::COLLECTION)
    ("E-cadherin-catenin" . SPARSER::COLLECTION)
    ("E-cadherin, MMP-7 and CD44v6" . SPARSER::COLLECTION)
    ("c-myc and cyclin D1" . SPARSER::COLLECTION)
    ("APC or β -catenin" . SPARSER::COLLECTION)
    ("the ultimate effector" . SPARSER::EFFECTOR)
    ("proteins and low-density lipoprotein receptor-related protein 5/6"
     . SPARSER::COLLECTION)
    ("transducin" . SPARSER::PROTEIN)
    ("adenomatous polyposis coli (APC) tumor suppressor protein"
     . SPARSER::PROTEIN)
    ("CK1α and GSK-3β" . SPARSER::COLLECTION) ("Axin" . SPARSER::PROTEIN)
    ("E-cadherin/catenin" . SPARSER::COLLECTION)
    ("MMP-7 and CD44v6" . SPARSER::COLLECTION)
    ("adhesion molecule" . SPARSER::PROTEIN) ("MMP7" . SPARSER::PROTEIN)
    ("low-density lipoprotein receptor-related protein 5" . SPARSER::PROTEIN)
    ("casein kinase 1" . SPARSER::PROTEIN)
    ("proteins, SHP, p53, and Mdm2" . SPARSER::COLLECTION)
    ("p53 or Mdm2" . SPARSER::COLLECTION)
    ("SHP, Mdm2 and p53" . SPARSER::COLLECTION) ("DXR" . SPARSER::PROTEIN)
    ("anti-SHP, anti-Mdm2 and anti-p53" . SPARSER::COLLECTION)
    ("Mdm2 and SHP" . SPARSER::COLLECTION)
    ("SHP and TR3" . SPARSER::COLLECTION) ("p53-Mdm2" . SPARSER::COLLECTION)
    ("p53, and Mdm2" . SPARSER::COLLECTION)
    ("p53 and nuclear receptor SHP" . SPARSER::COLLECTION)
    ("SHP or p53" . SPARSER::COLLECTION)
    ("likely affected p53's" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SHP (FL)" . SPARSER::PROTEIN) ("Rep" . SPARSER::PROTEIN)
    ("SHP and p53" . SPARSER::COLLECTION) ("GST-SHP" . SPARSER::COLLECTION)
    ("Mdm2 and p53" . SPARSER::COLLECTION)
    ("Mdm2, and SHP" . SPARSER::COLLECTION)
    ("SHP and Mdm2" . SPARSER::COLLECTION) ("ApoCIII" . SPARSER::PROTEIN)
    ("SHP and other tumor suppressors" . SPARSER::COLLECTION)
    ("BDL" . SPARSER::PROTEIN)
    ("tumor suppressor p53 and nuclear receptor SHP" . SPARSER::COLLECTION)
    ("p53 and SHP" . SPARSER::COLLECTION) ("SHP" . SPARSER::PROTEIN)
    ("s 5" . SPARSER::MOLECULE) ("Nur77" . SPARSER::PROTEIN)
    ("TR3" . SPARSER::PROTEIN) ("novel antimetastatic drugs" . SPARSER::DRUG)
    ("xenogeneic ( i.e. human and murine) molecules" . SPARSER::MOLECULE)
    ("new antimetastatic drugs" . SPARSER::DRUG) ("adrenals" . SPARSER::DRUG)
    ("different immunodeficient mutants" . SPARSER::MUTANT)
    ("Il2rg" . SPARSER::PROTEIN) ("anti –" . SPARSER::ANTIBODY)
    ("tween 20" . SPARSER::MOLECULE)
    ("Enhanced Green Fluorescent Protein" . SPARSER::PROTEIN)
    ("I-K" . SPARSER::PROTEIN) ("NVP-BKM120" . SPARSER::DRUG)
    ("Rag2" . SPARSER::PROTEIN) ("PI3K and MET" . SPARSER::COLLECTION)
    ("PTEN and INPP4B" . SPARSER::COLLECTION)
    ("MET and HGF" . SPARSER::COLLECTION) ("ir-HGF" . SPARSER::COLLECTION)
    ("PIK3CA and MET" . SPARSER::COLLECTION)
    ("suppressors, and data" . SPARSER::COLLECTION)
    ("MET, EGFR, HER2 and IGFR" . SPARSER::COLLECTION)
    ("The hepatocyte growth factor (HGF) and its receptor"
     . SPARSER::COLLECTION)
    ("RAS-MAPK" . SPARSER::COLLECTION) ("MET or PI3KCA" . SPARSER::COLLECTION)
    ("MET or PIK3CA" . SPARSER::COLLECTION)
    ("MET and PIK3CA" . SPARSER::COLLECTION) ("RFS" . SPARSER::PROTEIN)
    ("INPP4B" . SPARSER::PROTEIN) ("PLC γ" . SPARSER::PROTEIN-FAMILY)
    ("Ago2-PAZ10" . SPARSER::PROTEIN-PAIR) ("hunchback" . SPARSER::PROTEIN)
    ("miRNAs and Ago2" . SPARSER::COLLECTION)
    ("cyclin E-Cdk2" . SPARSER::COLLECTION)
    ("Trim71 and miRNAs" . SPARSER::COLLECTION)
    ("Trim71 and Cdkn1a" . SPARSER::COLLECTION)
    ("DGCR8-deficient ESCs lack mature miRNAs" . SPARSER::PROTEIN)
    ("propidium iodide and FITC-conjugated Annexin V" . SPARSER::COLLECTION)
    ("this posttranscriptional gene" . SPARSER::GENE)
    ("MS2-Rck" . SPARSER::COLLECTION) ("MS2-TNRC6B" . SPARSER::COLLECTION)
    ("MS2-Trim71" . SPARSER::COLLECTION) ("Rck" . SPARSER::PROTEIN)
    ("Sox2, Nanog, and Oct4" . SPARSER::COLLECTION)
    ("Cdkn1a/p21" . SPARSER::COLLECTION)
    ("mCherry::Trim71" . SPARSER::BIO-COMPLEX) ("DCP1a" . SPARSER::PROTEIN)
    ("ribonucleoprotein complexes containing catalytically active Ago2 and functional miR-295 and miR-302 in ESCs"
     . SPARSER::COLLECTION)
    ("‘slicer’" . SPARSER::PROTEIN) ("slicer" . SPARSER::PROTEIN)
    ("snoRNA" . SPARSER::RNA) ("the associated RNA" . SPARSER::RNA)
    ("miRNAs and catalytically active Ago2" . SPARSER::COLLECTION)
    ("Flag-Lin28" . SPARSER::COLLECTION)
    ("Ago2 and Trim71" . SPARSER::COLLECTION)
    ("Flag-Ago2" . SPARSER::COLLECTION)
    ("Trim71 and Ago2" . SPARSER::COLLECTION)
    ("mature miRNA" . SPARSER::PROTEIN) ("RNase" . SPARSER::PROTEIN)
    ("Flag-Trim71" . SPARSER::COLLECTION)
    ("Sox2, Nanog, or Oct4" . SPARSER::COLLECTION)
    ("Lin28 and Trim71" . SPARSER::COLLECTION)
    ("embryoid body (EB) formation assays Trim71 and the pluripotency factor Oct-4"
     . SPARSER::COLLECTION)
    ("EB" . SPARSER::PROTEIN-FAMILY) ("Trim32" . SPARSER::PROTEIN)
    ("Brat and Mei-P26" . SPARSER::COLLECTION) ("Mei" . SPARSER::MOLECULE)
    ("Brat" . SPARSER::PROTEIN) ("Trim" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mouse ESC-specific miR-290 family (miR-290, miR-291a, miR-291b, miR-292, miR-293, miR-294, miR-295) and miR-302 family (miR-302a, miR-302b, miR-302c, miR-302d, miR-367)"
     . SPARSER::COLLECTION)
    ("the Argonaute (Ago) and the GW182 families" . SPARSER::COLLECTION)
    ("essential components" . SPARSER::COMPONENT)
    ("Argonaute2 (Ago2) and microRNAs" . SPARSER::COLLECTION)
    ("1-8" . SPARSER::PROTEIN) ("TG-3" . SPARSER::PROTEIN)
    ("β-Tubulin" . SPARSER::PROTEIN) ("Pre-miRNAs" . SPARSER::RNA)
    ("β-Mercaptoethanol" . SPARSER::MOLECULE)
    ("ribonucleoprotein complex" . SPARSER::BIO-COMPLEX)
    ("TNRC6B" . SPARSER::PROTEIN) ("TNRC6A" . SPARSER::PROTEIN)
    ("DCP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("decapping enzyme" . SPARSER::PROTEIN) ("Ago1" . SPARSER::PROTEIN)
    ("ribonucleoprotein complexes" . SPARSER::BIO-COMPLEX)
    ("Sox2" . SPARSER::PROTEIN) ("P19" . SPARSER::PROTEIN)
    ("P26" . SPARSER::PROTEIN) ("DCR-1" . SPARSER::PROTEIN)
    ("LIN-41" . SPARSER::PROTEIN) ("TUT4" . SPARSER::PROTEIN)
    ("Zcchc11" . SPARSER::PROTEIN) ("Let-7" . SPARSER::RNA)
    ("miR-302b" . SPARSER::MOLECULE) ("GW182" . SPARSER::PROTEIN)
    ("Ago2" . SPARSER::PROTEIN) ("Argonaute2" . SPARSER::PROTEIN)
    ("mLin41" . SPARSER::PROTEIN) ("Trim71" . SPARSER::PROTEIN)
    ("Lin28" . SPARSER::HUMAN-PROTEIN-FAMILY) ("staurosporine" . SPARSER::DRUG)
    ("the major PTK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("integrins and cytokine" . SPARSER::COLLECTION)
    ("AP-1, NF-κB, and GATA" . SPARSER::COLLECTION)
    ("nickel" . SPARSER::MOLECULE)
    ("a complex with GATA4 and CHIP" . SPARSER::COLLECTION)
    ("p53 and Mdm2" . SPARSER::COLLECTION)
    ("MG132 and FAK-I" . SPARSER::COLLECTION)
    ("cochaperone/ubiquitin" . SPARSER::COLLECTION)
    ("FAK–p53" . SPARSER::COLLECTION)
    ("a cell-permeable proteasome inhibitor" . SPARSER::INHIBITOR)
    ("GATA4 and VCAM-1" . SPARSER::COLLECTION)
    ("FAK and GATA4" . SPARSER::COLLECTION)
    ("MEK1, MKK4, or MEKK1" . SPARSER::COLLECTION)
    ("TNF-α and FAK" . SPARSER::COLLECTION)
    ("integrin and cytokine" . SPARSER::COLLECTION)
    ("MEFs or FAK-I–treated" . SPARSER::COLLECTION)
    ("JNK/MAPK" . SPARSER::COLLECTION) ("Regulatory IkBα" . SPARSER::PROTEIN)
    ("MEFs and FAK-I–treated" . SPARSER::COLLECTION)
    ("MEFs or DMSO" . SPARSER::COLLECTION)
    ("extracellular-regulated kinase (ERK) MAPKs, JNK MAPKs, and p38 MAPKs as well as NF-κB"
     . SPARSER::COLLECTION)
    ("MAPKs, and p38 MAPKs" . SPARSER::COLLECTION)
    ("tight junction, integrin, and Rho" . SPARSER::COLLECTION)
    ("FAK-KD" . SPARSER::COLLECTION) ("FERM" . SPARSER::PROTEIN)
    ("integrin and FAK" . SPARSER::COLLECTION)
    ("PTK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Syk, and Src" . SPARSER::COLLECTION)
    ("MAPKs, and NF-κB" . SPARSER::COLLECTION)
    ("PTKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAPK and nuclear factor–κ light chain enhancer" . SPARSER::COLLECTION)
    ("VCAM-1 and integrin" . SPARSER::COLLECTION)
    ("FAK-FERM" . SPARSER::COLLECTION)
    ("integrin–matrix" . SPARSER::COLLECTION) ("WT/WT" . SPARSER::PROTEIN)
    ("B12)" . SPARSER::PROTEIN) ("D-2" . SPARSER::PROTEIN)
    ("G-4" . SPARSER::PROTEIN) ("C-21" . SPARSER::PROTEIN)
    ("Anti–β" . SPARSER::PROTEIN) ("Anti–" . SPARSER::ANTIBODY)
    ("K-2" . SPARSER::PROTEIN) ("E-selectin" . SPARSER::PROTEIN)
    ("MEKK1" . SPARSER::PROTEIN) ("IkBα" . SPARSER::PROTEIN)
    ("double minute 2" . SPARSER::PROTEIN) ("G protein" . SPARSER::PROTEIN)
    ("α4β7" . SPARSER::PROTEIN)
    ("immunoglobulin superfamily" . SPARSER::PROTEIN)
    ("band 4.1" . SPARSER::PROTEIN)
    ("Tumor necrosis factor" . SPARSER::PROTEIN)
    ("Vascular cell adhesion molecule–1" . SPARSER::PROTEIN)
    ("GATA4" . SPARSER::PROTEIN) ("CyclinD1 and PCNA" . SPARSER::COLLECTION)
    ("Rab5a and V-ATPases" . SPARSER::COLLECTION)
    ("EGF-EGFR" . SPARSER::COLLECTION) ("MMTV-Neu" . SPARSER::COLLECTION)
    ("c-Myc and osteopontin" . SPARSER::COLLECTION)
    ("papillar and solid subtype" . SPARSER::PROTEIN)
    ("EGFR and ERK" . SPARSER::COLLECTION)
    ("gefitinib and U0126" . SPARSER::COLLECTION)
    ("ERK1/2 and AKT" . SPARSER::COLLECTION)
    ("AKT (Ser473) and ERK1/2 (Thr202/Tyr204)" . SPARSER::COLLECTION)
    ("specifically target TIP30" . SPARSER::PROTEIN)
    ("p-Erk1/2" . SPARSER::COLLECTION) ("SP-C or CC10" . SPARSER::COLLECTION)
    ("antigen (PCNA)" . SPARSER::PROTEIN)
    ("SP-C and CC10" . SPARSER::COLLECTION)
    ("Tip30 +/− and Tip30  −/− Balb/c mice" . SPARSER::COLLECTION)
    ("Balb/c" . SPARSER::COLLECTION)
    ("a transcriptional cofactor" . SPARSER::MOLECULE)
    ("conditional bitransgenic inducible p53 /K- Ras genes" . SPARSER::GENE)
    ("/K- Ras" . SPARSER::COLLECTION)
    ("Proto-oncogenes and tumor suppressor genes" . SPARSER::COLLECTION)
    ("EGFR, k-Ras, c-Myc, p53 and DOK" . SPARSER::COLLECTION)
    ("DOK" . SPARSER::PROTEIN) ("pAKT and pERK1/2" . SPARSER::COLLECTION)
    ("Tip30" . SPARSER::PROTEIN) ("Tip" . SPARSER::PROTEIN)
    ("s 2" . SPARSER::MOLECULE) ("V-ATPases" . SPARSER::PROTEIN-FAMILY)
    ("Rab5a" . SPARSER::PROTEIN) ("CC10" . SPARSER::PROTEIN)
    ("SP-C" . SPARSER::PROTEIN) ("AT2" . SPARSER::PROTEIN)
    ("HTATIP2" . SPARSER::PROTEIN) ("K- Ras" . SPARSER::PROTEIN)
    ("k-Ras" . SPARSER::PROTEIN) ("Proto-oncogenes" . SPARSER::PROTO-ONCOGENE)
    ("TIP30" . SPARSER::PROTEIN) ("LAT and SLP76" . SPARSER::COLLECTION)
    ("LAT and SLP65" . SPARSER::COLLECTION)
    ("BLNK/SLP65" . SPARSER::COLLECTION) ("LAB/NTAL" . SPARSER::COLLECTION)
    ("BLNK" . SPARSER::PROTEIN) ("NTAL" . SPARSER::PROTEIN)
    ("JNK and P38" . SPARSER::COLLECTION)
    ("Themis1-Grb2-Vav1" . SPARSER::COLLECTION)
    ("CD4 or CD8" . SPARSER::COLLECTION) ("GTP/GDP" . SPARSER::PROTEIN-PAIR)
    ("CD5, CD69 and Gata-3" . SPARSER::COLLECTION)
    ("CD4/CD8" . SPARSER::COLLECTION)
    ("the exchange factor Ras-GRP1" . SPARSER::PROTEIN)
    ("Grb2-Sos1" . SPARSER::COLLECTION) ("DP or CD4" . SPARSER::COLLECTION)
    ("ERK, P38, and Vav1" . SPARSER::COLLECTION)
    ("LAT, Vav1, ERK and P38" . SPARSER::COLLECTION)
    ("the Themis1 or the Themis2 transgene" . SPARSER::COLLECTION)
    ("DP and CD4" . SPARSER::COLLECTION) ("Vav1 and P38" . SPARSER::COLLECTION)
    ("Vav1, P38 and LAT" . SPARSER::COLLECTION)
    ("P38 (pT180/pY182) and LAT (pY171)" . SPARSER::COLLECTION)
    ("Vav1 (pY160), P38 (pT180/pY182) and LAT (pY171)" . SPARSER::COLLECTION)
    ("Grb2 and Vav1" . SPARSER::COLLECTION)
    ("Themis1 or Themis2" . SPARSER::COLLECTION)
    ("Themis1/Grb2" . SPARSER::COLLECTION)
    ("Sos1 and Vav1" . SPARSER::COLLECTION)
    ("both Themis1 and transgenic Themis2" . SPARSER::COLLECTION)
    ("the adaptor protein Grb2 and the exchange factors Vav1 and Sos1 ( xref , xref )"
     . SPARSER::COLLECTION)
    ("Vav1 and Sos1" . SPARSER::COLLECTION)
    ("Themis1 and Themis2" . SPARSER::COLLECTION)
    ("Themis1" . SPARSER::PROTEIN)
    ("ZAP-70 kinase and the transmembrane adaptor protein LAT ( xref )"
     . SPARSER::COLLECTION)
    ("Themis1-GFP" . SPARSER::PROTEIN-PAIR) ("pervanadate" . SPARSER::PROTEIN)
    ("Lck or Fyn" . SPARSER::COLLECTION) ("VPR" . SPARSER::PROTEIN)
    ("transgene (AND)" . SPARSER::PROTEIN)
    ("the immature CD24" . SPARSER::PROTEIN)
    ("Vav1, ERK and P38" . SPARSER::COLLECTION)
    ("Vav1 and Lyn" . SPARSER::COLLECTION)
    ("Themis2 or Themis3" . SPARSER::COLLECTION)
    ("designated Themis3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("macrophages, and 9130404H23Rik" . SPARSER::COLLECTION)
    ("receptor (TCR)" . SPARSER::RECEPTOR)
    ("Grb2 and the exchange factors Vav 1 and/or Sos1 ( xref , xref )"
     . SPARSER::COLLECTION)
    ("the exchange factors Vav 1 and/or Sos1 ( xref , xref )"
     . SPARSER::COLLECTION)
    ("JNK/P38" . SPARSER::COLLECTION)
    ("the ubiquitous cytoplasmic adapter protein Grb2" . SPARSER::PROTEIN)
    ("bipartite" . SPARSER::PROTEIN) ("CD4- or CD8-" . SPARSER::COLLECTION)
    ("LAT and Grb2" . SPARSER::COLLECTION) ("LAT" . SPARSER::PROTEIN)
    ("mature CD4 + CD8" . SPARSER::PROTEIN)
    ("CD4- and CD8-" . SPARSER::COLLECTION) ("CD8-" . SPARSER::PROTEIN)
    ("CD4-" . SPARSER::PROTEIN) ("Themis" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SLP65" . SPARSER::PROTEIN) ("SLP76" . SPARSER::PROTEIN)
    ("Class-II" . SPARSER::PROTEIN) ("Ras-GRP" . SPARSER::PROTEIN)
    ("co-localize" . SPARSER::PROTEIN) ("ZAP-70" . SPARSER::PROTEIN)
    ("anti-IgM" . SPARSER::PROTEIN) ("GK1" . SPARSER::PROTEIN)
    ("C11" . SPARSER::PROTEIN) ("Na3VO4" . SPARSER::MOLECULE)
    ("pY160" . SPARSER::PROTEIN) ("pP38" . SPARSER::PROTEIN)
    ("ICB-1" . SPARSER::PROTEIN) ("Vav 1" . SPARSER::PROTEIN)
    ("cytoplasmic adapter protein" . SPARSER::PROTEIN)
    ("Themis family" . SPARSER::PROTEIN) ("Themis2" . SPARSER::PROTEIN)
    ("PVDF" . SPARSER::DRUG) ("Hao" . SPARSER::PROTEIN)
    ("CD24, Lyn and ERK1/2" . SPARSER::COLLECTION)
    ("Lyn-ERK" . SPARSER::COLLECTION) ("CD24-" . SPARSER::PROTEIN)
    ("P32/SH" . SPARSER::COLLECTION) ("ESb-MP" . SPARSER::COLLECTION)
    ("phospho-Src, phospho-Fyn or phospho-lck" . SPARSER::COLLECTION)
    ("GPI" . SPARSER::PROTEIN) ("RR " . SPARSER::MOLECULE)
    ("CD24 (=14.546, P = 0.000) or Lyn (=12.559, P = 0.000)"
     . SPARSER::COLLECTION)
    ("Lyn and ERK" . SPARSER::COLLECTION) ("siRNA-2" . SPARSER::COLLECTION)
    ("CD24 specific siRNA and PP2 synergistically inactivated ERK1/2"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("siRNA and PP2" . SPARSER::COLLECTION)
    ("Lyn, ERK1/2 and p38" . SPARSER::COLLECTION)
    ("Lyn, Erk1/2, and p38" . SPARSER::COLLECTION)
    ("ERK1/2 and p38" . SPARSER::COLLECTION)
    ("Lyn and CD24" . SPARSER::COLLECTION) ("-CD24" . SPARSER::COLLECTION)
    ("CD24-Lyn" . SPARSER::COLLECTION) ("VEC and SW480" . SPARSER::COLLECTION)
    ("VEC" . SPARSER::PROTEIN) ("Src, Fyn or lck" . SPARSER::COLLECTION)
    ("Src, Lyn, Fyn and lck" . SPARSER::COLLECTION) ("lck" . SPARSER::PROTEIN)
    ("at least nine highly homologous proteins" . SPARSER::PROTEIN)
    ("glycolipid" . SPARSER::MOLECULE)
    ("CD24 and MAP kinases" . SPARSER::COLLECTION)
    ("P-selectin
[ xref ] and Siglec-10
[ xref ]"
     . SPARSER::COLLECTION)
    ("CD24 or Lyn" . SPARSER::COLLECTION) ("Lyn-ERK1/2" . SPARSER::COLLECTION)
    ("Lyn and ERK1/2" . SPARSER::COLLECTION)
    ("CD24 and Lyn" . SPARSER::COLLECTION) ("P32" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mucin-like" . SPARSER::PROTEIN) ("CD24" . SPARSER::PROTEIN)
    ("protein and HDAC1" . SPARSER::COLLECTION)
    ("Cysteine and histidine-rich region" . SPARSER::COLLECTION)
    ("HDAC1/SPRR2A" . SPARSER::COLLECTION) ("p300-HDAC1" . SPARSER::COLLECTION)
    ("p53-p300" . SPARSER::COLLECTION)
    ("the cellular p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("both p300
[ xref ] and other cofactors"
     . SPARSER::COLLECTION)
    ("total cellular p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an attractive candidate molecule" . SPARSER::MOLECULE)
    ("MDM2 and mSin3a" . SPARSER::COLLECTION)
    ("p300 and p53" . SPARSER::COLLECTION)
    ("p300-SPRR2A" . SPARSER::COLLECTION) ("Ac-p300" . SPARSER::PROTEIN-PAIR)
    ("p53/p300" . SPARSER::COLLECTION) ("p21-luc" . SPARSER::COLLECTION)
    ("luc" . SPARSER::PROTEIN) ("sprr2A" . SPARSER::PROTEIN)
    ("p53/p300 " . SPARSER::COLLECTION) ("p53/SPRR2A" . SPARSER::COLLECTION)
    ("p300 or p53" . SPARSER::COLLECTION)
    ("SPRR2A (Additional file xref : Figure S1A ) and HepG2 endogenous p53 is"
     . SPARSER::COLLECTION)
    ("p53 and/or p300" . SPARSER::COLLECTION)
    ("SPRR2A, p300, and p53" . SPARSER::COLLECTION)
    ("p53 and p300" . SPARSER::COLLECTION)
    ("Ds-Red-SPRR2A" . SPARSER::COLLECTION)
    ("ubiquinate p53 and target" . SPARSER::COLLECTION)
    ("p53 and SPRR2A" . SPARSER::COLLECTION) ("SPRR" . SPARSER::PROTEIN)
    ("p300/CBP" . SPARSER::COLLECTION) ("Chk1/Chk2" . SPARSER::COLLECTION)
    ("ATM/ATR/DNAPK" . SPARSER::COLLECTION) ("DNAPK" . SPARSER::PROTEIN)
    ("MDM4 and MDM2" . SPARSER::COLLECTION)
    ("a sequence-specific transcription factor" . SPARSER::PROTEIN)
    ("response element (RE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("p21, GADD45, Bax, Puma, and Noxa" . SPARSER::COLLECTION)
    ("p53 and HDAC1" . SPARSER::COLLECTION) ("p300-p53" . SPARSER::COLLECTION)
    ("protein (SPRR)" . SPARSER::PROTEIN)
    ("Histone deacetylase 1" . SPARSER::PROTEIN) ("P21" . SPARSER::PROTEIN)
    ("streptavidin-agarose" . SPARSER::DRUG)
    ("sprr2" . SPARSER::PROTEIN-FAMILY) ("p300 " . SPARSER::PROTEIN)
    ("P53 " . SPARSER::HUMAN-PROTEIN-FAMILY) ("EP300" . SPARSER::PROTEIN)
    ("Ac-K" . SPARSER::PROTEIN) ("Ds-Red" . SPARSER::PROTEIN)
    ("MDM4" . SPARSER::PROTEIN) ("GADD45" . SPARSER::PROTEIN)
    ("histone deacetylase 1" . SPARSER::PROTEIN)
    ("human T-cell pro-lymphocytic leukemia" . SPARSER::PROTEIN)
    ("ATM and BCL11B" . SPARSER::COLLECTION)
    ("the Bcl11b haploinsufficient tumor suppresser gene" . SPARSER::GENE)
    ("Bcl11b" . SPARSER::PROTEIN) ("broken DNA" . SPARSER::DNA)
    ("H2AX and ATM" . SPARSER::COLLECTION)
    ("Atm and Xlf" . SPARSER::COLLECTION)
    ("H2ax and Xlf" . SPARSER::COLLECTION)
    ("Xlf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("XLF" . SPARSER::PROTEIN)
    ("Igh" . SPARSER::PROTEIN) ("Tcr" . SPARSER::PROTEIN)
    ("the other harbored clonal t" . SPARSER::PROTEIN)
    ("SKY" . SPARSER::PROTEIN)
    ("Atm  −/−  H2ax  −/− and Atm  −/− thymocytes" . SPARSER::COLLECTION)
    ("the pMX-DEL CJ retroviral V(D)J recombination substrate"
     . SPARSER::SUBSTRATE)
    ("abl" . SPARSER::PROTEIN) ("LAH and LA" . SPARSER::COLLECTION)
    ("LA and LAH" . SPARSER::COLLECTION)
    ("anti-CD4 and anti-CD8" . SPARSER::COLLECTION)
    ("controlLck-cre" . SPARSER::COLLECTION) ("LA" . SPARSER::PROTEIN)
    ("experimentalLck-cre" . SPARSER::COLLECTION) ("LAH" . SPARSER::PROTEIN)
    ("generateLck-cre" . SPARSER::COLLECTION)
    ("andLck-cre" . SPARSER::COLLECTION)
    ("analyzeLck-cre" . SPARSER::COLLECTION) ("Lck-cre" . SPARSER::COLLECTION)
    ("ATM and DNA-PKcs" . SPARSER::COLLECTION) ("DP" . SPARSER::PROTEIN)
    ("RAG1/RAG2" . SPARSER::COLLECTION)
    ("TCRβ, TCRγ, and TCRδ" . SPARSER::COLLECTION)
    ("DNA-PKcs and ATR" . SPARSER::COLLECTION)
    ("Atm or H2ax" . SPARSER::COLLECTION) ("Atm/H2ax" . SPARSER::COLLECTION)
    ("/CD8" . SPARSER::COLLECTION) ("Atm and H2ax" . SPARSER::COLLECTION)
    ("ATM and H2AX" . SPARSER::COLLECTION) ("H2ax" . SPARSER::PROTEIN)
    ("Atm" . SPARSER::PROTEIN) ("the predominant kinase" . SPARSER::KINASE)
    ("kinase and H2AX" . SPARSER::COLLECTION) ("BCL11B" . SPARSER::PROTEIN)
    ("Tcrβ" . SPARSER::PROTEIN) ("STI571" . SPARSER::DRUG)
    ("v-abl" . SPARSER::PROTEIN) ("RAG2" . SPARSER::PROTEIN)
    ("RAG1" . SPARSER::PROTEIN) ("T-cell receptor" . SPARSER::PROTEIN)
    ("DNA-PKcs" . SPARSER::PROTEIN) ("TCRβ" . SPARSER::PROTEIN)
    ("Ataxia Telangiectasia mutated" . SPARSER::PROTEIN)
    ("leptin-caveolin-1" . SPARSER::COLLECTION)
    ("STAT3 and ERK1/2" . SPARSER::COLLECTION)
    ("HWP and dHWP" . SPARSER::COLLECTION)
    ("fat, leptin, and caveolin-1" . SPARSER::COLLECTION)
    ("perilipin and FASN" . SPARSER::COLLECTION)
    ("FASN mRNA (p = 0.03) and protein (p = 0.016)" . SPARSER::COLLECTION)
    ("fatty acid synthase (FASN)" . SPARSER::PROTEIN)
    ("Perilipin" . SPARSER::PROTEIN)
    ("ERK1/2 (p < 0.0001) and STAT3 ( p < 0.0001)" . SPARSER::COLLECTION)
    ("both HWP (p = 0.05) and dHWP (p = 0.01, xref )" . SPARSER::COLLECTION)
    ("leptin and caveolin-1" . SPARSER::COLLECTION)
    ("Leptin" . SPARSER::PROTEIN)
    ("perilipin and fatty acid synthase" . SPARSER::COLLECTION)
    ("perilipin" . SPARSER::PROTEIN) ("HWP" . SPARSER::PROTEIN)
    ("preadipocytes (HWP)" . SPARSER::PROTEIN)
    ("preadipocytes" . SPARSER::PROTEIN) ("leptin" . SPARSER::PROTEIN)
    ("leptin-receptor" . SPARSER::PROTEIN) ("lipid droplet" . SPARSER::PROTEIN)
    ("cav-1" . SPARSER::PROTEIN) ("Cav-1" . SPARSER::PROTEIN)
    ("leptin receptor" . SPARSER::PROTEIN)
    ("Rad51 foci and a more prominent G2-arrest" . SPARSER::COLLECTION)
    ("at least XRCC3" . SPARSER::PROTEIN) ("functional ATM" . SPARSER::PROTEIN)
    ("visible foci" . SPARSER::PROTEIN)
    ("the principal kinase" . SPARSER::KINASE) ("ATRIP" . SPARSER::PROTEIN)
    ("the latter proteins" . SPARSER::PROTEIN)
    ("MRN complex" . SPARSER::BIO-COMPLEX)
    ("phosphorylation several essential components" . SPARSER::COMPONENT)
    ("CtIP, BRCA1, WRN, BLM and EXO1" . SPARSER::COLLECTION)
    ("CtIP" . SPARSER::PROTEIN) ("MRN" . SPARSER::BIO-COMPLEX)
    ("subsequent chromatin" . SPARSER::PROTEIN) ("-DNA" . SPARSER::DNA)
    ("ATR or Chk1" . SPARSER::COLLECTION)
    ("functional ATR and Chk1" . SPARSER::COLLECTION)
    ("ATR and Chk1" . SPARSER::COLLECTION)
    ("the S-phase ATR and its effector kinase Chk1" . SPARSER::COLLECTION)
    ("radiation-induced Rad51 foci" . SPARSER::PROTEIN)
    ("scr " . SPARSER::PROTEIN) ("CV-1" . SPARSER::PROTEIN)
    ("ATR and ATM" . SPARSER::COLLECTION) ("Caffeine" . SPARSER::MOLECULE)
    ("SSBs" . SPARSER::PROTEIN) ("functional ATR" . SPARSER::PROTEIN)
    ("Discrete foci" . SPARSER::PROTEIN) ("aphidicolin" . SPARSER::PROTEIN)
    ("additional ATM or control siRNA ( xref C, columns 6–7)"
     . SPARSER::COLLECTION)
    ("this major recombinase" . SPARSER::PROTEIN)
    ("Rad51 and γH2AX" . SPARSER::COLLECTION)
    ("residual γH2AX foci" . SPARSER::PROTEIN)
    ("particular HR" . SPARSER::PROTEIN)
    ("ATM- and Artemis-dependent HR" . SPARSER::COLLECTION)
    ("heterochromatic DNA" . SPARSER::DNA)
    ("ATM, Artemis, BRCA2 and Rad51" . SPARSER::COLLECTION)
    ("ATM and/or Artemis" . SPARSER::COLLECTION)
    ("complex (MRN)" . SPARSER::BIO-COMPLEX)
    ("Mre11/Nbs1/Rad50" . SPARSER::COLLECTION)
    ("ATM and Artemis" . SPARSER::COLLECTION)
    ("CyclinB/Cdk1" . SPARSER::COLLECTION)
    ("Chk2-p53-p21" . SPARSER::COLLECTION)
    ("NBS1, SMC1, Chk2, p53 and BRCA1" . SPARSER::COLLECTION)
    ("MDC1 and 53BP1" . SPARSER::COLLECTION) ("ATR/Chk1" . SPARSER::COLLECTION)
    ("incomplete HR" . SPARSER::PROTEIN) ("Artemis" . SPARSER::PROTEIN)
    ("endonuclease" . SPARSER::PROTEIN) ("XRCC2" . SPARSER::PROTEIN)
    ("RNF20" . SPARSER::PROTEIN) ("c-Abl" . SPARSER::PROTEIN)
    ("MCM2" . SPARSER::PROTEIN) ("EXO1" . SPARSER::PROTEIN)
    ("I-SceI" . SPARSER::PROTEIN) ("UCN-01" . SPARSER::DRUG)
    ("AT1BR" . SPARSER::PROTEIN) ("Kap1" . SPARSER::PROTEIN)
    ("Rad50" . SPARSER::PROTEIN) ("Nbs1" . SPARSER::PROTEIN)
    ("Mre11" . SPARSER::PROTEIN) ("SMC1" . SPARSER::PROTEIN)
    ("NBS1" . SPARSER::PROTEIN) ("MDC1" . SPARSER::PROTEIN)
    ("YB-1 and SF1" . SPARSER::COLLECTION) ("snRNP" . SPARSER::BIO-COMPLEX)
    ("SRp30c" . SPARSER::PROTEIN) ("cytidines" . SPARSER::MOLECULE)
    ("uridines" . SPARSER::DRUG)
    ("an essential splicing factor" . SPARSER::PROTEIN)
    ("snRNA" . SPARSER::RNA) ("PTB and Sxl" . SPARSER::COLLECTION)
    ("Sxl" . SPARSER::PROTEIN)
    ("both exon and the upstream intron" . SPARSER::COLLECTION)
    ("ACAA" . SPARSER::PROTEIN) ("AC" . SPARSER::PROTEIN)
    ("the HA-tagged U2AF proteins and the endogenous proteins"
     . SPARSER::COLLECTION)
    ("ΔRS" . SPARSER::PROTEIN) ("derivatives ΔRS" . SPARSER::PROTEIN)
    ("U2AF35 or their deletion mutants" . SPARSER::COLLECTION)
    ("HA-tagged U2AF65, U2AF35 or their deletion mutants"
     . SPARSER::COLLECTION)
    ("serine-arginine" . SPARSER::COLLECTION)
    ("the CSD and the C-terminal basic/acidic" . SPARSER::COLLECTION)
    ("alanine-proline" . SPARSER::COLLECTION)
    ("YB-1 and U2AF" . SPARSER::COLLECTION)
    ("U2AF65 and U2AF35" . SPARSER::COLLECTION)
    ("U2AF65 and YB-1" . SPARSER::COLLECTION) ("U2AF35" . SPARSER::PROTEIN)
    ("YB-1 protein under stringent washing conditions containing 600 mM salt and vice versa ( xref A, upper panels)"
     . SPARSER::COLLECTION)
    ("anti-YB-1 or anti-U2AF65" . SPARSER::COLLECTION)
    ("U2AF65 or YB-1" . SPARSER::COLLECTION) ("-1 " . SPARSER::PROTEIN)
    ("three consecutive pyrimidines" . SPARSER::DRUG)
    ("pyrimidines" . SPARSER::DRUG) ("exon v5" . SPARSER::PROTEIN)
    ("CAUC" . SPARSER::PROTEIN) ("variable exons v3" . SPARSER::PROTEIN)
    ("the constitutively spliced isoform and variable isoforms"
     . SPARSER::COLLECTION)
    ("stably knocked-down YB-1" . SPARSER::PROTEIN)
    ("transmembrane glycoproteins" . SPARSER::PROTEIN)
    ("YB-1–CAUC" . SPARSER::PROTEIN-PAIR)
    ("the previously characterized short RNAs ACE sel and ACE sel mut"
     . SPARSER::PROTEIN)
    ("sel and ACE" . SPARSER::COLLECTION) ("sel" . SPARSER::MOLECULE)
    ("ACE" . SPARSER::PROTEIN)
    ("Drosophila dsx female-specific exon" . SPARSER::PROTEIN)
    ("mut" . SPARSER::PROTEIN) ("GST-YB-1" . SPARSER::COLLECTION)
    ("exon and intron" . SPARSER::COLLECTION)
    ("the second adenosine (A2) and the fourth cytidine (C4)"
     . SPARSER::COLLECTION)
    ("cytidine" . SPARSER::MOLECULE)
    ("CD44 variable exon v4" . SPARSER::PROTEIN) ("Ray" . SPARSER::PROTEIN)
    ("ribonucleoprotein" . SPARSER::PROTEIN) ("alanine-" . SPARSER::AMINO-ACID)
    ("CSD" . SPARSER::PROTEIN) ("-type" . TYPE) ("hnRNP" . SPARSER::PROTEIN)
    ("introns" . SPARSER::PROTEIN) ("Trans" . SPARSER::PROTEIN-FAMILY)
    ("cis-" . SPARSER::PROTEIN) ("multi-exon" . SPARSER::COLLECTION)
    ("U2AF65" . SPARSER::PROTEIN) ("SF1" . SPARSER::PROTEIN)
    ("U1-70K" . SPARSER::PROTEIN) ("SR-related protein" . SPARSER::PROTEIN)
    ("SRp30" . SPARSER::PROTEIN) ("splicing factor" . SPARSER::PROTEIN)
    ("U2AFs" . SPARSER::BIO-COMPLEX) ("U1A" . SPARSER::PROTEIN)
    ("pre-mRNAs" . SPARSER::RNA) ("adenosine triphosphate" . SPARSER::MOLECULE)
    ("3 h" . SPARSER::PROTEIN) ("PP2Cγ" . SPARSER::PROTEIN)
    ("RNP-2" . SPARSER::PROTEIN) ("RNP-1" . SPARSER::PROTEIN)
    ("U2AF" . SPARSER::BIO-COMPLEX)
    ("spliceosome-associated protein" . SPARSER::PROTEIN)
    ("YB-1" . SPARSER::PROTEIN) ("CAM" . SPARSER::PROTEIN)
    ("Src, and EGFR" . SPARSER::COLLECTION)
    ("Src and STAT5" . SPARSER::COLLECTION)
    ("Src and Fyn" . SPARSER::COLLECTION)
    ("STAT5b and EGFR" . SPARSER::COLLECTION)
    ("STAT5a/STAT5b null MEFs" . SPARSER::PROTEIN)
    ("STAT5a/STAT5b" . SPARSER::COLLECTION)
    ("the chemotherapeutic drug cisplatin" . SPARSER::MOLECULE)
    ("receptor and Bcl-XL" . SPARSER::COLLECTION)
    ("STAT1 or STAT3" . SPARSER::COLLECTION)
    ("STAT5a/b null MEFs" . SPARSER::PROTEIN)
    ("EGFR or ΔEGFR" . SPARSER::COLLECTION)
    ("STAT5 and EGFR" . SPARSER::COLLECTION)
    ("STAT5b:STAT5b" . SPARSER::BIO-COMPLEX)
    ("Fyn and Src" . SPARSER::COLLECTION)
    ("Dasatinib and WP1066" . SPARSER::COLLECTION)
    ("PP2 or Dasatinib" . SPARSER::COLLECTION)
    ("PDGFR and BCR-ABL" . SPARSER::COLLECTION)
    ("Src inhibitor Dasatinib or the Jak2 inhibitor WP1066"
     . SPARSER::COLLECTION)
    ("growth factor receptors as well as JAK and Src kinases"
     . SPARSER::COLLECTION)
    ("JAK and Src" . SPARSER::COLLECTION)
    ("Src and Jak2" . SPARSER::COLLECTION)
    ("EGFR and STAT5" . SPARSER::COLLECTION)
    ("receptor and STAT5a/b" . SPARSER::COLLECTION) ("RRR" . SPARSER::PROTEIN)
    ("EGFR and ΔEGFR" . SPARSER::COLLECTION)
    ("the most predominant isoform" . SPARSER::ISOFORM)
    ("the predominant STAT5 isoform" . SPARSER::ISOFORM)
    ("the predominant isoform" . SPARSER::ISOFORM)
    ("STAT5a and STAT5b" . SPARSER::COLLECTION) ("STAT5a" . SPARSER::PROTEIN)
    ("ERα or ERβ" . SPARSER::COLLECTION)
    ("STAT5b and ΔEGFR" . SPARSER::COLLECTION)
    ("ΔEGFR/EGFRvIII" . SPARSER::COLLECTION) ("Cox-2" . SPARSER::PROTEIN)
    ("B-myb" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BcL-XL" . SPARSER::PROTEIN)
    ("AG490" . SPARSER::DRUG) ("Jak2" . SPARSER::PROTEIN)
    ("polynucleotide kinase" . SPARSER::PROTEIN)
    ("β-casein" . SPARSER::PROTEIN) ("Stat5b" . SPARSER::PROTEIN)
    ("Sp2" . SPARSER::PROTEIN) ("TOPRO3" . SPARSER::MOLECULE)
    ("- 3" . SPARSER::PROTEIN) ("NLS1" . SPARSER::PROTEIN)
    ("ERβ" . SPARSER::PROTEIN) ("STAT5b" . SPARSER::PROTEIN)
    ("STAT5" . SPARSER::PROTEIN) ("IRS1 and BRCA1" . SPARSER::COLLECTION)
    ("IGF and INS" . SPARSER::COLLECTION) ("INS" . SPARSER::PROTEIN)
    ("class 2 and BRCA2" . SPARSER::COLLECTION)
    ("RAS-ERK" . SPARSER::COLLECTION)
    ("extraceullar signal-regulated kinase (ERK)" . SPARSER::PROTEIN)
    ("jun" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K and Grb2" . SPARSER::COLLECTION)
    ("this larger cohort" . SPARSER::MOLECULE)
    ("variant and breast" . SPARSER::COLLECTION)
    ("at least one variant allele" . SPARSER::ALLELE)
    ("class 1 and class 2" . SPARSER::COLLECTION)
    ("class1 and class 2" . SPARSER::COLLECTION) ("p-" . SPARSER::PROTEIN)
    ("insulin receptor (IR)" . SPARSER::PROTEIN)
    ("Modifiers" . SPARSER::MOLECULE) ("regulated kinase" . SPARSER::PROTEIN)
    ("Class 1" . SPARSER::PROTEIN-FAMILY) ("HR 2" . SPARSER::PROTEIN)
    ("class2" . SPARSER::PROTEIN) ("class1" . SPARSER::PROTEIN-FAMILY)
    ("RCA1" . SPARSER::PROTEIN) ("IGF1R" . SPARSER::PROTEIN)
    ("insulin-like growth factor receptor" . SPARSER::PROTEIN)
    ("class 1" . SPARSER::PROTEIN-FAMILY)
    ("PTEN or the four other subunits" . SPARSER::COLLECTION)
    ("AKT3 , PIK3R2 or PIK3CA" . SPARSER::COLLECTION)
    ("PIK3R1 and PIK3R2" . SPARSER::COLLECTION)
    ("PIK3R2 and PIK3CA" . SPARSER::COLLECTION)
    ("microcephaly" . SPARSER::PROTEIN)
    ("the predominant downstream effector" . SPARSER::EFFECTOR)
    ("protein and 4E-BP1" . SPARSER::COLLECTION)
    ("PIK3R2 or PIK3CA" . SPARSER::COLLECTION)
    ("AKT3 , PIK3R2 and PIK3CA" . SPARSER::COLLECTION)
    ("AKT3 or PIK3R2" . SPARSER::COLLECTION) ("parental DNA" . SPARSER::DNA)
    ("the brain-predominant isoform" . SPARSER::ISOFORM)
    ("trio" . SPARSER::PROTEIN)
    ("lacks vascular malformations" . SPARSER::PROTEIN)
    ("vascular malformations" . SPARSER::PROTEIN)
    ("The patchy skin vascular malformations" . SPARSER::PROTEIN)
    ("MPPH" . SPARSER::PROTEIN) ("triton X-100" . SPARSER::MOLECULE)
    ("4E-BP" . SPARSER::PROTEIN) ("chr3" . SPARSER::PROTEIN)
    ("LR12" . SPARSER::DRUG) ("PI-103" . SPARSER::DRUG)
    ("eukaryotic translation initiation factor 4E" . SPARSER::PROTEIN)
    ("PI3K-AKT-mTOR" . SPARSER::PROTEIN)
    ("phosphatidylinositol-4,5-bisphosphate" . SPARSER::PIP2)
    ("BDP1" . SPARSER::PROTEIN) ("LR11" . SPARSER::PROTEIN)
    ("sirolimus" . SPARSER::DRUG)
    ("Hamartin and Tuberin" . SPARSER::COLLECTION)
    ("Tuberin" . SPARSER::PROTEIN) ("Hamartin" . SPARSER::PROTEIN)
    ("the neuronal marker MAP2" . SPARSER::PROTEIN)
    ("which uses ATP" . SPARSER::ATP) ("PIK3CA and MTOR" . SPARSER::COLLECTION)
    ("the possible variants" . SPARSER::VARIANT)
    ("a recurrent AKT1 c" . SPARSER::PROTEIN)
    ("TSC and mTOR" . SPARSER::COLLECTION)
    ("complex (TSC)" . SPARSER::BIO-COMPLEX)
    ("TSC1 and TSC2" . SPARSER::COLLECTION)
    ("Most affected individuals display progressive and catastrophic epilepsy"
     . SPARSER::PROTEIN)
    ("a clinically devastating pediatric MCD" . SPARSER::PROTEIN)
    ("MCD" . SPARSER::PROTEIN) ("Malformations" . SPARSER::PROTEIN)
    ("-AKT3-mTOR" . SPARSER::COLLECTION)
    ("A recurrent PIK3CA c" . SPARSER::PROTEIN)
    ("PIK3CA, AKT3 and MTOR" . SPARSER::COLLECTION) ("MTOR" . SPARSER::PROTEIN)
    ("The intractable epilepsy" . SPARSER::PROTEIN)
    ("epilepsy" . SPARSER::PROTEIN) ("6-carboxyfluorescein" . SPARSER::DRUG)
    ("Akt3" . SPARSER::PROTEIN) ("clinically available drugs" . SPARSER::DRUG)
    ("Pik3ca" . SPARSER::PROTEIN) ("Pik" . SPARSER::BIO-COMPLEX)
    ("PIK3CA and AKT" . SPARSER::COLLECTION)
    ("rac" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AKT2 and AKT3" . SPARSER::COLLECTION)
    ("AKT1, AKT2 and AKT3" . SPARSER::COLLECTION)
    ("AKT and p70 S6" . SPARSER::COLLECTION)
    ("The cancer-associated PIK3CA variant" . SPARSER::VARIANT)
    ("PI3K, and p" . SPARSER::COLLECTION) ("Usher" . SPARSER::PROTEIN-FAMILY)
    ("the heterozygous PIK3CA mutations c" . SPARSER::PROTEIN)
    ("these leg-specific genetic variants" . SPARSER::VARIANT)
    ("dermal fibroblast DNA" . SPARSER::DNA)
    ("the lateral venous anomaly or port wine" . SPARSER::MOLECULE)
    ("only capillary vascular malformations" . SPARSER::PROTEIN)
    ("cutaneous vascular malformations" . SPARSER::PROTEIN)
    ("malformations" . SPARSER::PROTEIN) ("rays" . SPARSER::PROTEIN)
    ("a somatic p" . SPARSER::PROTEIN) ("RTK/PI3K/AKT" . SPARSER::COLLECTION)
    ("receptor tyrosine kinase/phosphatidylinositol-3-kinase/AKT"
     . SPARSER::COLLECTION)
    ("a rational therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("the cancer-associated p" . SPARSER::PROTEIN)
    ("AKT1 , AKT2 , or AKT3" . SPARSER::COLLECTION)
    ("USH1C" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3,4,5-trisphosphate" . SPARSER::PIP3)
    ("AKT3" . SPARSER::PROTEIN) ("AKT2" . SPARSER::PROTEIN)
    ("PAK1 and cortactin" . SPARSER::COLLECTION)
    ("cortactin" . SPARSER::PROTEIN)
    ("full length GFP-tagged paxillin or a truncated paxillin mutant"
     . SPARSER::COLLECTION)
    ("β-catenin and full length paxillin" . SPARSER::COLLECTION)
    ("paxillin-β-catenin" . SPARSER::COLLECTION)
    ("paxillin or β-catenin" . SPARSER::COLLECTION)
    ("GSH-beads" . SPARSER::DRUG) ("GST-paxillin" . SPARSER::COLLECTION)
    ("paxillin or B-catenin" . SPARSER::COLLECTION)
    ("catenin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("growth factor (EGF)" . SPARSER::GROWTH-FACTOR)
    ("6-His-tagged full-length β-catenin and GST-fused full length paxillin ( xref )"
     . SPARSER::COLLECTION)
    ("6-His-tagged full-length β-catenin" . SPARSER::PROTEIN)
    ("AI" . SPARSER::PROTEIN) ("β-catenin and paxillin" . SPARSER::COLLECTION)
    ("bacterially expressed recombinant full length paxillin and its LIM-1"
     . SPARSER::COLLECTION)
    ("overexpressed 6-His-tagged β-catenin" . SPARSER::PROTEIN)
    ("paxillin and β-catenin" . SPARSER::COLLECTION)
    ("paxillin truncated mutants" . SPARSER::MUTANT)
    ("the structural focal adhesion-associated proteins vinculin, actopaxin, and tubulin"
     . SPARSER::COLLECTION)
    ("kinase (FAK)" . SPARSER::KINASE)
    ("vinculin, actopaxin, and tubulin" . SPARSER::COLLECTION)
    ("actopaxin" . SPARSER::PROTEIN) ("Csk" . SPARSER::PROTEIN)
    ("Crk" . SPARSER::PROTEIN)
    ("other FA-associated proteins" . SPARSER::PROTEIN)
    ("Paxillin" . SPARSER::PROTEIN) ("Barrier" . SPARSER::PROTEIN)
    ("βPIX" . SPARSER::PROTEIN) ("E.coli)" . SPARSER::PROTEIN)
    ("GIT2" . SPARSER::PROTEIN) ("p60Src" . SPARSER::PROTEIN)
    ("LIM-3" . SPARSER::PROTEIN) ("LIM-1" . SPARSER::PROTEIN)
    ("PP1c and PP1R" . SPARSER::COLLECTION)
    ("both PP1 and the protein phosphatase 2A (PP2A)" . SPARSER::COLLECTION)
    ("this important insulin-sensitive protein complex" . SPARSER::BIO-COMPLEX)
    ("IRS1/PI3K" . SPARSER::COLLECTION)
    ("wortmannin or OSU03012" . SPARSER::COLLECTION)
    ("only one kinase inhibitor" . SPARSER::INHIBITOR)
    ("PI3K and PDK1" . SPARSER::COLLECTION)
    ("wortmannin and OSU03012" . SPARSER::COLLECTION)
    ("insulin-activated serine/threonine kinases" . SPARSER::PROTEIN)
    ("mTORC1 and/or other downstream signaling molecules (e.g. S6K1)"
     . SPARSER::COLLECTION)
    ("Akt/PKB and mTORC1" . SPARSER::COLLECTION)
    ("phosphatase, PPP1R12A and PP1cδ" . SPARSER::COLLECTION)
    ("p85 and Grb2" . SPARSER::COLLECTION)
    ("Akt/PKB, mTOR, S6K1, GSK3, and MAPK" . SPARSER::COLLECTION)
    ("Akt and p70S6K" . SPARSER::COLLECTION)
    ("Akt and the mTOR substrate p70S6K" . SPARSER::COLLECTION)
    ("Akti and rapamycin" . SPARSER::COLLECTION)
    ("Akt and mTOR" . SPARSER::COLLECTION) ("p70S6K" . SPARSER::PROTEIN)
    ("Akti" . SPARSER::PROTEIN) ("phosphor-Akt and Akt" . SPARSER::COLLECTION)
    ("wortmannin or PD98059" . SPARSER::COLLECTION)
    ("Akt or MAPK" . SPARSER::COLLECTION)
    ("PPP1R12A/IRS1" . SPARSER::COLLECTION)
    ("anti-IRS1, PPP1R12A, and p85" . SPARSER::COLLECTION)
    ("wortmannin, a PI3K inhibitor ( xref , xref )," . SPARSER::DRUG)
    ("wortmannin, a PI3K inhibitor ( xref , xref ), or 50 μM PD98059"
     . SPARSER::COLLECTION)
    ("IRS1, PPP1R12A, or p85" . SPARSER::COLLECTION)
    ("PPP1R12A, IRS1, and p85" . SPARSER::COLLECTION)
    ("IRS1, PPP1R12A, and p85" . SPARSER::COLLECTION)
    ("IRS1 and p85" . SPARSER::COLLECTION)
    ("PI3K or MAPK" . SPARSER::COLLECTION)
    ("PPP1R12A and IRS1" . SPARSER::COLLECTION)
    ("polo-like kinase 1, interleukin-16, and telokin" . SPARSER::COLLECTION)
    ("telokin" . SPARSER::PROTEIN) ("EDL" . SPARSER::PROTEIN)
    ("the phosphatidylinositide 3 kinase (PI3K) and the MAPK-signaling pathways ( xref )"
     . SPARSER::COLLECTION)
    ("the insulin-stimulated IRS1 signaling complex" . SPARSER::BIO-COMPLEX)
    ("PPP1R12A and PP1cδ" . SPARSER::COLLECTION)
    ("Akt and mTOR/raptor" . SPARSER::COLLECTION)
    ("IRS1 and PPP1R12A" . SPARSER::COLLECTION)
    ("mTOR/raptor" . SPARSER::COLLECTION) ("raptor" . SPARSER::PROTEIN)
    ("p85 and PPP1R12A" . SPARSER::COLLECTION)
    ("IRS1/p85" . SPARSER::COLLECTION) ("Skeletal muscle" . SPARSER::PROTEIN)
    ("Akt/PKB" . SPARSER::PROTEIN) ("PPP1R2" . SPARSER::PROTEIN)
    ("beta-glycerophosphate" . SPARSER::DRUG) ("OSU03012" . SPARSER::DRUG)
    ("p-Thr" . SPARSER::PROTEIN) ("interleukin-16" . SPARSER::PROTEIN)
    ("myosin phosphatase target subunit 1" . SPARSER::PROTEIN)
    ("ribosomal protein S6 kinase beta-1" . SPARSER::PROTEIN)
    ("growth factor receptor binding protein" . SPARSER::PROTEIN)
    ("AS160" . SPARSER::PROTEIN) ("GLUT4" . SPARSER::PROTEIN)
    ("insulin receptor" . SPARSER::PROTEIN) ("PP1c" . SPARSER::PROTEIN)
    ("PPP1R12A" . SPARSER::PROTEIN)
    ("regulatory subunit 12A" . SPARSER::PROTEIN)
    ("protein phosphatase 1" . SPARSER::PROTEIN)
    ("Insulin receptor substrate-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IHC demonstrated p-MEK" . SPARSER::COLLECTION)
    ("radical or partial" . SPARSER::COLLECTION) ("MBE" . SPARSER::PROTEIN)
    ("BRAFV600E and MAPK" . SPARSER::COLLECTION) ("BRAFV" . SPARSER::PROTEIN)
    ("partial or radical" . SPARSER::COLLECTION)
    ("p-MEK" . SPARSER::COLLECTION) ("IGFBP7" . SPARSER::PROTEIN)
    ("INK4" . SPARSER::PROTEIN)
    ("oncogenes or tumor suppressors ( xref ; xref )" . SPARSER::COLLECTION)
    ("the regulatory p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SRPK1 and an allosteric kinase inhibitor" . SPARSER::COLLECTION)
    ("the SRPK and Clk families" . SPARSER::COLLECTION)
    ("SRPK1-326D587D" . SPARSER::PROTEIN-PAIR)
    ("p53 ( xref ) and the nuclear receptor GRβ ( xref )"
     . SPARSER::COLLECTION)
    ("GR" . SPARSER::PROTEIN)
    ("Hsp90 and its co-chaperone Aha1" . SPARSER::COLLECTION)
    ("Hsp70 and its co-chaperone Hsp40" . SPARSER::COLLECTION)
    ("their respective co-chaperones Hsp40 and Aha1" . SPARSER::COLLECTION)
    ("Hsp70 and Hsp90" . SPARSER::COLLECTION)
    ("Hsp40 and Aha1" . SPARSER::COLLECTION)
    ("kinase and phosphatase" . SPARSER::COLLECTION)
    ("the phosphorylation-defective mutant SRPK1" . SPARSER::PROTEIN)
    ("either Alanine (A) or Aspartic Acid (D)" . SPARSER::COLLECTION)
    ("Ser/Arg" . SPARSER::COLLECTION)
    ("even highly purified constitutively active Akt"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Akt and SR" . SPARSER::COLLECTION)
    ("a non-ATP competitive allosteric inhibitor" . SPARSER::INHIBITOR)
    ("SRPK1/K2" . SPARSER::COLLECTION) ("siRNA-" . SPARSER::PROTEIN)
    ("RALS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SRPK1 or SRPK2" . SPARSER::COLLECTION)
    ("Akt and SRPKs" . SPARSER::COLLECTION)
    ("Akt, SRPKs and SR" . SPARSER::COLLECTION)
    ("metazoans" . SPARSER::PROTEIN-FAMILY)
    ("SRPK1 and SRPK2" . SPARSER::COLLECTION)
    ("spliceosome" . SPARSER::BIO-COMPLEX)
    ("SRPK2 ( xref ) or Clk/Sty ( xref )" . SPARSER::COLLECTION)
    ("Sty" . SPARSER::PROTEIN) ("PSF" . SPARSER::PROTEIN)
    ("esters or cytokines" . SPARSER::COLLECTION)
    ("esters" . SPARSER::MOLECULE)
    ("particularly protein kinases and phosphatases" . SPARSER::COLLECTION)
    ("Hsp70-" . SPARSER::PROTEIN) ("SRPK" . SPARSER::PROTEIN)
    ("developmental and environmental cues" . SPARSER::PROTEIN-FAMILY)
    ("HSP40" . SPARSER::PROTEIN) ("α-Tubulin" . SPARSER::PROTEIN)
    ("WT1" . SPARSER::PROTEIN) ("Aha1" . SPARSER::PROTEIN)
    ("Hsp40" . SPARSER::PROTEIN) ("Aspartic Acid" . SPARSER::AMINO-ACID)
    ("SRSF1" . SPARSER::PROTEIN) ("Akt-induced" . SPARSER::PROTEIN)
    ("MK2206" . SPARSER::DRUG) ("GF109203X" . SPARSER::DRUG)
    ("WP1066" . SPARSER::DRUG) ("SRPK2" . SPARSER::PROTEIN)
    ("TRAP150" . SPARSER::PROTEIN) ("GSK3" . SPARSER::PROTEIN)
    ("Sam68" . SPARSER::PROTEIN) ("Pre-mRNA" . SPARSER::RNA)
    ("an easily evaluable biomarker" . SPARSER::MOLECULE)
    ("progestins" . SPARSER::DRUG)
    ("intrauterine levonorgestrel" . SPARSER::DRUG)
    ("Biomarkers" . SPARSER::MOLECULE) ("Pax-2 or Bcl-2" . SPARSER::COLLECTION)
    ("EAC" . SPARSER::PROTEIN) ("PR and progestin" . SPARSER::COLLECTION)
    ("levonorgestrel" . SPARSER::DRUG) ("estrone" . SPARSER::DRUG)
    ("The type and dose" . SPARSER::COLLECTION)
    ("medroxyprogesterone" . SPARSER::DRUG)
    ("IHC biomarkers" . SPARSER::MOLECULE)
    ("Various immunohistochemical (IHC) biomarkers" . SPARSER::MOLECULE)
    ("PTEN, Pax-2, and Bcl-2" . SPARSER::COLLECTION)
    ("PRA and PRB" . SPARSER::COLLECTION)
    ("PTEN, Pax-2 and Bcl-2" . SPARSER::COLLECTION) ("PRA" . SPARSER::PROTEIN)
    ("per 1" . SPARSER::PROTEIN) ("Pax-2" . SPARSER::PROTEIN)
    ("MDH" . SPARSER::PROTEIN) ("HAM" . SPARSER::PROTEIN)
    ("RAM" . SPARSER::PROTEIN)
    ("nearly all currently recommended generic drugs" . SPARSER::DRUG)
    ("HR or HER2" . SPARSER::COLLECTION)
    ("the second most common triple subtype" . SPARSER::PROTEIN)
    ("the most common triple subtype" . SPARSER::PROTEIN)
    ("the triple subtypes" . SPARSER::PROTEIN)
    ("The triple subtypes" . SPARSER::PROTEIN)
    ("ER/HER2" . SPARSER::COLLECTION)
    ("receptors and HER2" . SPARSER::COLLECTION)
    ("ductal carcinoma NOS" . SPARSER::PROTEIN) ("NOS" . SPARSER::PROTEIN)
    ("ER- and PR-" . SPARSER::COLLECTION) ("platinums" . SPARSER::MOLECULE)
    ("four major subtypes" . SPARSER::PROTEIN)
    ("HR- and HER2+" . SPARSER::COLLECTION) ("HR-" . SPARSER::PROTEIN)
    ("ER or HER2" . SPARSER::COLLECTION)
    ("PR-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ER-" . SPARSER::PROTEIN)
    ("HR/HER2" . SPARSER::COLLECTION) ("States (US)" . SPARSER::BIO-STATE)
    ("estrogen and progesterone receptors (ER and PR) and HER2"
     . SPARSER::COLLECTION)
    ("receptor (HR)" . SPARSER::RECEPTOR) ("Hormone" . SPARSER::MOLECULE)
    ("Progesterone receptor" . SPARSER::PROTEIN)
    ("anti-estrogenic" . SPARSER::DRUG)
    ("Estrogen receptor" . SPARSER::PROTEIN) ("anti-estrogen" . SPARSER::DRUG)
    ("FPRP" . SPARSER::PROTEIN) ("desirable components" . SPARSER::COMPONENT)
    ("ASC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("bearing at least one c" . SPARSER::PROTEIN) ("HBeAg" . SPARSER::PROTEIN)
    ("ASCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("another appropriated biological candidate susceptibility gene"
     . SPARSER::GENE)
    ("the -592 C allele and the -1082A-819 C-592 C haplotype"
     . SPARSER::COLLECTION)
    ("liver disease inducers or promoters [ xref ]" . SPARSER::COLLECTION)
    ("inducers or promoters [ xref ]" . SPARSER::COLLECTION)
    ("ESRs" . SPARSER::PROTEIN) ("estrogens" . SPARSER::MOLECULE)
    ("c-myb" . SPARSER::PROTEIN) ("ESR2" . SPARSER::PROTEIN)
    ("interleukin-6" . SPARSER::PROTEIN) ("ESR1" . SPARSER::PROTEIN)
    ("the destructive p53-CypD complex" . SPARSER::BIO-COMPLEX)
    ("CsA or non-immunosuppressive" . SPARSER::COLLECTION)
    ("sestrins, glutathione peroxidase and TIGAR" . SPARSER::COLLECTION)
    ("TIGAR" . SPARSER::PROTEIN) ("sestrins" . SPARSER::PROTEIN-FAMILY)
    ("a destructive p53-CypD complex" . SPARSER::BIO-COMPLEX)
    ("TNFR/RIP1" . SPARSER::COLLECTION)
    ("the type and dose" . SPARSER::COLLECTION)
    ("p53-cathepsin" . SPARSER::COLLECTION)
    ("DNA damage-induced ROS" . SPARSER::PROTEIN)
    ("cathepsin" . SPARSER::PROTEIN)
    ("PTP or ablating CypD" . SPARSER::COLLECTION)
    ("their cortical brain mitochondria" . SPARSER::PROTEIN)
    ("soluble intracellular form" . SPARSER::FORM)
    ("bind CypD and trigger pathologic PTP" . SPARSER::PROTEIN)
    ("very few extramitochondrial proteins" . SPARSER::PROTEIN)
    ("CypD and trigger" . SPARSER::COLLECTION)
    ("healthy Bax−/−Bak−/− mitochondria" . SPARSER::PROTEIN)
    ("MOMP-inducer" . SPARSER::COLLECTION)
    ("the pathologic p53-cypD complex" . SPARSER::BIO-COMPLEX)
    ("p53-cypD" . SPARSER::COLLECTION) ("cypD" . SPARSER::PROTEIN)
    ("a pathologic p53-CypD complex" . SPARSER::BIO-COMPLEX)
    ("intact mitochondrial dehydrogenase" . SPARSER::PROTEIN)
    ("mitochondrial p53 and CypD" . SPARSER::COLLECTION)
    ("Casp3 and PARP" . SPARSER::COLLECTION) ("Casp3" . SPARSER::PROTEIN)
    ("Casp" . SPARSER::PROTEIN) ("robust p53-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MEFs and HCT116 p53−/−" . SPARSER::COLLECTION)
    ("oxidative stress-induced PTP" . SPARSER::PROTEIN)
    ("transcriptional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Camptothecin" . SPARSER::DRUG) ("H 2 O 2-" . SPARSER::DRUG)
    ("cyclophilins" . SPARSER::PROTEIN) ("p53 and CypD" . SPARSER::COLLECTION)
    ("Calcein" . SPARSER::MOLECULE) ("healthy mitochondria" . SPARSER::PROTEIN)
    ("TMRM" . SPARSER::MOLECULE)
    ("The cationic fluorescent dye tetramethylrhodamine methyl ester (TMRM)"
     . SPARSER::MOLECULE)
    ("ester (TMRM)" . SPARSER::MOLECULE)
    ("tetramethylrhodamine" . SPARSER::MOLECULE)
    ("p53 and the major matrix" . SPARSER::COLLECTION)
    ("mtHSP70 and mtHSP60" . SPARSER::COLLECTION)
    ("H2O2-induced mitochondrial p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitochondrial p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tetrameric p53 is" . SPARSER::PROTEIN)
    ("monomer or tetramer" . SPARSER::COLLECTION)
    ("Bcl-xL/Bcl-2" . SPARSER::COLLECTION)
    ("endogenous mitochondrial p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GST-CypD" . SPARSER::COLLECTION)
    ("CypD, VDAC and ANT" . SPARSER::COLLECTION)
    ("p53 and the proposed structural components VDAC and ANT ( xref )"
     . SPARSER::COLLECTION)
    ("VDAC and ANT" . SPARSER::COLLECTION)
    ("p53 and the essential regulatory PTP component CypD ( xref )"
     . SPARSER::COLLECTION)
    ("the essential regulatory PTP component CypD" . SPARSER::PROTEIN)
    ("a prominent oxidative stress-induced endogenous complex"
     . SPARSER::BIO-COMPLEX)
    ("p53 and the PTP components CypD, ANT and VDAC" . SPARSER::COLLECTION)
    ("CypD, ANT and VDAC" . SPARSER::COLLECTION)
    ("the Essential Regulatory PTP Component CypD" . SPARSER::PROTEIN)
    ("the fluorescent dye calcein" . SPARSER::MOLECULE)
    ("Smac (soluble) and AIF (membrane tethered)" . SPARSER::COLLECTION)
    ("Smac" . SPARSER::PROTEIN) ("p53 and tBid" . SPARSER::COLLECTION)
    ("only soluble components" . SPARSER::COMPONENT)
    ("AIF and Endo" . SPARSER::COLLECTION) ("AIF" . SPARSER::PROTEIN)
    ("Lipid" . SPARSER::LIPID)
    ("stress-accumulated mitochondrial p53 protein" . SPARSER::PROTEIN)
    ("CsA" . SPARSER::PROTEIN)
    ("the only genetically proven indispensable PTP component"
     . SPARSER::COMPONENT)
    ("the essential regulator" . SPARSER::REGULATOR)
    ("isomerase" . SPARSER::ISOMERASE) ("prolyl" . SPARSER::PROTEIN)
    ("the actual pore-forming proteins" . SPARSER::PROTEIN)
    ("Anion" . SPARSER::MOLECULE) ("VDAC" . SPARSER::PROTEIN)
    ("a regulated non-selective water- and solute-passing protein channel spanning"
     . SPARSER::COLLECTION)
    ("water-" . SPARSER::MOLECULE) ("IMM" . SPARSER::PROTEIN)
    ("Ca 2+ and H 2 O 2 -induced cell death" . SPARSER::COLLECTION)
    ("HMGB1 and HDGF" . SPARSER::COLLECTION) ("HDGF" . SPARSER::PROTEIN)
    ("excess cytosolic Ca2+ and ROS levels" . SPARSER::COLLECTION)
    ("Mediators" . SPARSER::PROTEIN)
    ("DRAM, Bax and Puma" . SPARSER::COLLECTION) ("DRAM" . SPARSER::PROTEIN)
    ("AMPK and sestrin1/2" . SPARSER::COLLECTION) ("Mcl1" . SPARSER::PROTEIN)
    ("Bax/Bak" . SPARSER::COLLECTION) ("Mcl" . SPARSER::PROTEIN)
    ("p53-protein" . SPARSER::COLLECTION)
    ("components of the death receptor and mitochondrial pathways"
     . SPARSER::COLLECTION)
    ("Cyclosporine" . SPARSER::DRUG)
    ("a robust p53-CypD complex" . SPARSER::BIO-COMPLEX)
    ("p53-CypD" . SPARSER::COLLECTION) ("CypD" . SPARSER::PROTEIN)
    ("Cyclophilin" . SPARSER::PROTEIN)
    ("apoptotic and autophagic types" . TYPE) ("Ischemia" . SPARSER::PROTEIN)
    ("VDAC-1" . SPARSER::PROTEIN) ("ANT-2" . SPARSER::PROTEIN)
    ("pro-oxidant" . SPARSER::MOLECULE)
    ("RNA Polymerase II" . SPARSER::PROTEIN) ("α-Amanitin" . SPARSER::MOLECULE)
    ("ornithine transcarbamylase" . SPARSER::PROTEIN)
    ("High Mobility Group Box 1" . SPARSER::PROTEIN)
    ("mtHSP70" . SPARSER::PROTEIN) ("H2O2" . SPARSER::DRUG)
    ("Cytochrome C" . SPARSER::PROTEIN)
    ("Voltage Dependent" . SPARSER::PROTEIN)
    ("non-selective" . SPARSER::PROTEIN) ("HMGB1" . SPARSER::PROTEIN)
    ("Ca2+" . SPARSER::CALCIUM-ION) ("sestrin1" . SPARSER::PROTEIN)
    ("genes and proteins" . SPARSER::COLLECTION)
    ("Plk1 and Cdk1" . SPARSER::COLLECTION)
    ("cyclin A2-Cdk1" . SPARSER::COLLECTION)
    ("kinase and phosphatases" . SPARSER::COLLECTION)
    ("nuc" . SPARSER::PROTEIN) ("cyt" . SPARSER::MOLECULE)
    ("Cdk1/Cd25C/Wee1" . SPARSER::COLLECTION)
    ("the Mitotic Trigger" . SPARSER::PROTEIN) ("Trigger" . SPARSER::PROTEIN)
    ("phosphospecific cyclin B1 antibodies" . SPARSER::ANTIBODY)
    ("Cdk1-cyclin" . SPARSER::COLLECTION)
    ("another mitotic regulator" . SPARSER::REGULATOR)
    ("cyclin B1-5SA-CFP" . SPARSER::COLLECTION)
    ("cyclin B1-5SA" . SPARSER::PROTEIN)
    ("cyclin B1-5SA-YFP" . SPARSER::COLLECTION) ("SE" . SPARSER::PROTEIN)
    ("abrupt Cdk1-cyclin B1" . SPARSER::COLLECTION)
    ("a gradual cyclin B1" . SPARSER::PROTEIN)
    ("APC-Cdc20" . SPARSER::COLLECTION)
    ("Cdk1-Cyclin B1" . SPARSER::COLLECTION) ("Geminin" . SPARSER::PROTEIN)
    ("a second distinguishable cyclin B1 protein" . SPARSER::PROTEIN)
    ("iRap" . SPARSER::PROTEIN)
    ("Cdk1AF and cyclin B1-YFP" . SPARSER::COLLECTION)
    ("NEB and cyclin" . SPARSER::COLLECTION) ("pre-NEB" . SPARSER::COLLECTION)
    ("Cdk1AF-cyclin" . SPARSER::COLLECTION)
    ("Cdk1AF-cyclin B1" . SPARSER::COLLECTION)
    ("H2B underwent NEB" . SPARSER::PROTEIN)
    ("either histone H2B or NLS-cyclin B1-CFP underwent NEB"
     . SPARSER::PROTEIN)
    ("histone H2B or NLS-cyclin B1-CFP" . SPARSER::COLLECTION)
    ("Cdk1AF and NLS-cyclin B1" . SPARSER::COLLECTION)
    ("Cdk1AF" . SPARSER::PROTEIN) ("Wee1 or Myt1" . SPARSER::COLLECTION)
    ("Cdk1AF-mCherry" . SPARSER::PROTEIN-PAIR)
    ("Cdk1-mCherry" . SPARSER::COLLECTION)
    ("cyclin B1-CFP" . SPARSER::COLLECTION) ("Tet" . SPARSER::PROTEIN)
    ("Cyclin B1-YFP" . SPARSER::COLLECTION) ("AF" . SPARSER::PROTEIN)
    ("cyclin B1-YFP" . SPARSER::COLLECTION)
    ("the mitotic trigger" . SPARSER::PROTEIN)
    ("a bistable trigger" . SPARSER::PROTEIN)
    ("Wee1 and Myt1" . SPARSER::COLLECTION) ("lobe" . SPARSER::PROTEIN)
    ("approximately 1,600,000 Cdk1-cyclin B1" . SPARSER::COLLECTION)
    ("NEB" . SPARSER::PROTEIN) ("Cdk1-cyclin B1" . SPARSER::COLLECTION)
    ("Hog1" . SPARSER::PROTEIN) ("B55" . SPARSER::PROTEIN)
    ("cyclin A2" . SPARSER::PROTEIN) ("leptomycin B" . SPARSER::MOLECULE)
    ("Cdc25C" . SPARSER::PROTEIN) ("Cdc20" . SPARSER::PROTEIN)
    ("FK506 binding protein-12" . SPARSER::PROTEIN) ("Myt1" . SPARSER::PROTEIN)
    ("PP2C" . SPARSER::PROTEIN)
    ("receptors and signalling proteins" . SPARSER::COLLECTION)
    ("new FA" . SPARSER::PROTEIN) ("focal complex" . SPARSER::BIO-COMPLEX)
    ("smaller focal complexes" . SPARSER::BIO-COMPLEX)
    ("mDia1 or ROCKs" . SPARSER::COLLECTION)
    ("ROCKs" . SPARSER::PROTEIN-FAMILY)
    ("ROCK1 or ROCK2" . SPARSER::COLLECTION) ("formins" . SPARSER::PROTEIN)
    ("microtubules, and GEF-H1" . SPARSER::COLLECTION)
    ("Vega" . SPARSER::PROTEIN) ("RhoGEF" . SPARSER::PROTEIN)
    ("Integrin" . SPARSER::PROTEIN) ("RhoB and GEF-H1" . SPARSER::COLLECTION)
    ("randomly migrating LnCAP" . SPARSER::PROTEIN)
    ("β2 and β3" . SPARSER::COLLECTION)
    ("Matrigel or fibronectin" . SPARSER::COLLECTION)
    ("fibronectin or Matrigel" . SPARSER::COLLECTION)
    ("glass" . SPARSER::MOLECULE) ("LnCAP and DU145" . SPARSER::COLLECTION)
    ("LnCAP" . SPARSER::PROTEIN)
    ("receptor and vascular endothelial" . SPARSER::COLLECTION)
    ("isoprenoid" . SPARSER::MOLECULE)
    ("RhoA, RhoB and RhoC" . SPARSER::COLLECTION)
    ("integrin, and β1" . SPARSER::COLLECTION) ("1-1" . SPARSER::PROTEIN)
    ("Pak1" . SPARSER::PROTEIN) ("K-23" . SPARSER::PROTEIN)
    ("ARHGEF2" . SPARSER::PROTEIN) ("β2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S1 b" . SPARSER::PROTEIN)
    ("extracellular matrix protein" . SPARSER::PROTEIN)
    ("GHRHR" . SPARSER::PROTEIN) ("Gnrh1" . SPARSER::PROTEIN)
    ("Fgfr1" . SPARSER::PROTEIN) ("Chd7" . SPARSER::PROTEIN)
    ("Gnrh" . SPARSER::HUMAN-PROTEIN-FAMILY) ("deafness" . SPARSER::PROTEIN)
    ("ar" . SPARSER::HUMAN-PROTEIN-FAMILY) ("heterozygotes" . SPARSER::PROTEIN)
    ("CDP" . SPARSER::PROTEIN) ("FSH" . SPARSER::DRUG)
    ("KS and nHH" . SPARSER::COLLECTION) ("androgens" . SPARSER::DRUG)
    ("hormone and gonadotropin" . SPARSER::COLLECTION)
    ("hCG" . SPARSER::PROTEIN) ("Androgen" . SPARSER::PROTEIN)
    ("TAC3/TACR3" . SPARSER::COLLECTION) ("GnRH" . SPARSER::PROTEIN)
    ("TRT" . SPARSER::PROTEIN)
    ("KAL1 , FGFR1 , FGF8 , PROK2 , PROKR2 , CHD7 , WDR11 , GNRHR , GNRH1 , KISS1R , KISS1 , TAC3 , TACR3 , and LHβ"
     . SPARSER::COLLECTION)
    ("GNRHR" . SPARSER::PROTEIN) ("TACR3" . SPARSER::PROTEIN)
    ("TAC3" . SPARSER::PROTEIN) ("KISS1" . SPARSER::PROTEIN)
    ("KISS1R" . SPARSER::PROTEIN) ("GNRH1" . SPARSER::PROTEIN)
    ("WDR11" . SPARSER::PROTEIN) ("CHD7" . SPARSER::PROTEIN)
    ("PROKR2" . SPARSER::PROTEIN) ("PROK2" . SPARSER::PROTEIN)
    ("FGF8" . SPARSER::PROTEIN) ("KAL1" . SPARSER::PROTEIN)
    ("siRNA or miR-337-3p" . SPARSER::COLLECTION)
    ("RAP1A and STAT3" . SPARSER::COLLECTION)
    ("RAP1A or STAT3" . SPARSER::COLLECTION)
    ("stathmin, and RAP1A" . SPARSER::COLLECTION)
    ("MAP2 and MAP4" . SPARSER::COLLECTION)
    ("α/β-tubulin" . SPARSER::PROTEIN-PAIR) ("stathmin" . SPARSER::PROTEIN)
    ("p21 cip1 or Bcl-2" . SPARSER::COLLECTION)
    ("a dominant-negative form" . SPARSER::FORM)
    ("p21 cip1 and paclitaxel" . SPARSER::COLLECTION)
    ("cyclin D1, c-myc, Bcl-2, survivin and p21 cip1" . SPARSER::COLLECTION)
    ("a relatively universal therapeutic adjuvant" . SPARSER::DRUG)
    ("STAT3 and miR-337-3p" . SPARSER::COLLECTION)
    ("STAT3 and pSTAT3" . SPARSER::COLLECTION)
    ("STAT3 and phospho-STAT3" . SPARSER::COLLECTION)
    ("nucleoside" . SPARSER::MOLECULE) ("cucurbitacin" . SPARSER::MOLECULE)
    ("STAT3 or RAP1A" . SPARSER::COLLECTION)
    ("RAP1A and p " . SPARSER::COLLECTION) ("mers" . SPARSER::PROTEIN)
    ("Taxanes" . SPARSER::DRUG)
    ("the naturally occurring miRNA" . SPARSER::PROTEIN)
    ("a mature miRNA" . SPARSER::PROTEIN) ("Paclitaxel" . SPARSER::DRUG)
    ("taxanes, and STAT3 and RAP1A" . SPARSER::COLLECTION)
    ("taxanes" . SPARSER::DRUG) ("taxane" . SPARSER::DRUG)
    ("STAT3 and RAP1A" . SPARSER::COLLECTION) ("MAP4" . SPARSER::PROTEIN)
    ("MAP2" . SPARSER::PROTEIN) ("RAP1" . SPARSER::PROTEIN)
    ("p21 cip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("1–8" . SPARSER::PROTEIN)
    ("Qdot 655" . SPARSER::MOLECULE)
    ("recombinant human epidermal growth factor" . SPARSER::DRUG)
    ("single-stranded RNA" . SPARSER::RNA) ("RAP1A" . SPARSER::PROTEIN)
    ("personalized genomic medicine" . SPARSER::DRUG)
    ("BRAF, EGFR, ERBB2, PDGFRA, PTEN, and RET" . SPARSER::COLLECTION)
    ("PDGFRA" . SPARSER::PROTEIN)
    ("the largest gastric cancer cohort" . SPARSER::MOLECULE)
    ("KRAS, EGFR, HRAS and BRAF" . SPARSER::COLLECTION)
    ("KRAS, EGFR, PTEN, HRAS and BRAF" . SPARSER::COLLECTION)
    ("GCs" . SPARSER::PROTEIN) ("APC or CTNNB1" . SPARSER::COLLECTION)
    ("MSS" . SPARSER::PROTEIN) ("OncoMap v3" . SPARSER::PROTEIN)
    ("using OncoMap v4" . SPARSER::PROTEIN)
    ("ABL1, AKT, APC, BRAF, CDKN2A, CSF1R, CTNNB1, EGFR, ERBB2, FGFR, FLT3, FNA, HRAS, IDH, JAK, KIT, KRAS, MAP2K, MET, MLH1, MYC, NPM, NRAS, PDGFR, PIK3CA, PIK3R1, PTEN, RB1, RET, SRC, STK11, TP53, and VHL"
     . SPARSER::COLLECTION)
    ("RET" . SPARSER::PROTEIN) ("IDH" . SPARSER::PROTEIN)
    ("the known gastric cancer subtypes" . SPARSER::PROTEIN)
    ("OncoMap v4" . SPARSER::PROTEIN) ("termed OncoMap v4" . SPARSER::PROTEIN)
    ("v" . SPARSER::PROTEIN) ("MAP2K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CSF1R" . SPARSER::PROTEIN) ("STK11" . SPARSER::PROTEIN)
    ("ASV" . SPARSER::DRUG) ("determining histological type" . TYPE)
    ("four histological types" . TYPE) ("traditional TRAP" . SPARSER::PROTEIN)
    ("ON" . SPARSER::PROTEIN)
    ("Previous real-time quantitative TRAP" . SPARSER::PROTEIN)
    ("the traditional TRAP" . SPARSER::PROTEIN)
    ("histologic subtypes" . SPARSER::PROTEIN)
    ("telomerase activity and TNM" . SPARSER::COLLECTION)
    ("oligonucleotide (MTS)" . SPARSER::MOLECULE)
    ("Telomerase Activity and HTERT" . SPARSER::COLLECTION)
    ("TRAP" . SPARSER::PROTEIN) ("TC and coworkers" . SPARSER::COLLECTION)
    ("Adc" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("telomerase activity or hTERT" . SPARSER::COLLECTION)
    ("Telomerase activity and hTERT" . SPARSER::COLLECTION)
    ("telomerase activity and hTERT" . SPARSER::COLLECTION)
    ("ASVs" . SPARSER::DRUG) ("1 µL" . SPARSER::PROTEIN)
    ("Telomerase Activity" . SPARSER::PROTEIN)
    ("haploinsufficient tumor suppressors" . SPARSER::SUPPRESSOR)
    ("RPs" . SPARSER::PROTEIN)
    ("The adenoviral E1A oncoprotein" . SPARSER::PROTEIN)
    ("ELK4 and SIRT7" . SPARSER::COLLECTION)
    ("ELK1 or GABPα" . SPARSER::COLLECTION)
    ("considerable SIRT7 protein" . SPARSER::PROTEIN)
    ("proteins, ELK1 and GABPα" . SPARSER::COLLECTION)
    ("GABP" . SPARSER::PROTEIN) ("SIRT7 and ELK4" . SPARSER::COLLECTION)
    ("RPS20 or GAPDH" . SPARSER::COLLECTION)
    ("RPS20, RPS7, RPS14, NME1 , and COPS2" . SPARSER::COLLECTION)
    ("NME1 and COPS2" . SPARSER::COLLECTION) ("RP" . SPARSER::PROTEIN)
    ("macromolecule" . SPARSER::MOLECULE)
    ("a locus-specific enzyme" . SPARSER::ENZYME)
    ("H3K18Ac" . SPARSER::PROTEIN) ("nicotinamide" . SPARSER::PROTEIN)
    ("robust and specific NAD + -dependent H3K18Ac-deacetylase activity"
     . SPARSER::PROTEIN-PAIR)
    ("poly-nucleosomes" . SPARSER::PROTEIN)
    ("H3K18Ac-deacetylase activity" . SPARSER::PROTEIN-PAIR)
    ("nucleosomes" . SPARSER::PROTEIN)
    ("the cancer-associated ETS transcription factor ELK4" . SPARSER::PROTEIN)
    ("ETS" . SPARSER::PROTEIN) ("the transformed state" . SPARSER::BIO-STATE)
    ("AS-2" . SPARSER::PROTEIN) ("KD4" . SPARSER::PROTEIN)
    ("Sirt7" . SPARSER::PROTEIN) ("ELK1" . SPARSER::PROTEIN)
    ("RPS20" . SPARSER::PROTEIN) ("COPS2" . SPARSER::PROTEIN)
    ("NME1" . SPARSER::PROTEIN) ("deacetylase activity" . SPARSER::PROTEIN)
    ("Silent Information Regulator-2" . SPARSER::PROTEIN)
    ("ELK4" . SPARSER::PROTEIN) ("K18" . SPARSER::PROTEIN)
    ("NAD +" . SPARSER::MOLECULE) ("SIRT7" . SPARSER::PROTEIN)
    ("RIF" . SPARSER::PROTEIN) ("formin" . SPARSER::PROTEIN)
    ("Syndecan" . SPARSER::PROTEIN) ("proteoglycan" . SPARSER::PROTEIN)
    ("glycosaminoglycan" . SPARSER::MOLECULE)
    ("α-actinin and VASP" . SPARSER::COLLECTION) ("VASP" . SPARSER::PROTEIN)
    ("force-induced elongation" . SPARSER::PROTEIN)
    ("Zyxin" . SPARSER::PROTEIN) ("RAC1 and CDC42" . SPARSER::COLLECTION)
    ("the Arp 2/3 complex and N-WASP ( xref , xref )" . SPARSER::COLLECTION)
    ("various small Rho-family GTPases (e.g., Rac1) and actin capping/binding proteins (cofilin and profilin)"
     . SPARSER::COLLECTION)
    ("cofilin and profilin" . SPARSER::COLLECTION)
    ("actin-associated proteins" . SPARSER::PROTEIN)
    ("diaphanous interacting protein (DIP)" . SPARSER::PROTEIN)
    ("protein (DIP)" . SPARSER::PROTEIN) ("Rho and Rac" . SPARSER::COLLECTION)
    ("Rac1 and RhoA" . SPARSER::COLLECTION)
    ("Rac1, Rif, and CDC42" . SPARSER::COLLECTION)
    ("–actin" . SPARSER::COLLECTION) ("trypsinization" . SPARSER::PROTEIN)
    ("RAC and CDC42" . SPARSER::COLLECTION)
    ("RAC, Rif, and CDC42" . SPARSER::COLLECTION) ("RAC" . SPARSER::PROTEIN)
    ("Rac1 and CDC42" . SPARSER::COLLECTION) ("CHP" . SPARSER::PROTEIN)
    ("brightly fluorescent actin filaments" . SPARSER::PROTEIN-FAMILY)
    ("cortical F-actin" . SPARSER::BIO-COMPLEX)
    ("scanty actin filament" . SPARSER::PROTEIN-FAMILY)
    ("phalloidin and DAPI" . SPARSER::COLLECTION)
    ("most likely myosin 1C (132 kD) and actin (45 kD)" . SPARSER::COLLECTION)
    ("filamentous (F) actin" . SPARSER::PROTEIN)
    ("helical filaments" . SPARSER::PROTEIN-FAMILY)
    ("the accessory proteins" . SPARSER::PROTEIN)
    ("Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ASMase" . SPARSER::PROTEIN)
    ("sphingomyelinase" . SPARSER::PROTEIN)
    ("Rac1, syndecan-4, Rif, and CDC42" . SPARSER::COLLECTION)
    ("translational elongation factor" . SPARSER::PROTEIN)
    ("zyxin" . SPARSER::PROTEIN) ("syntaxin" . SPARSER::PROTEIN)
    ("filamin" . SPARSER::PROTEIN-FAMILY)
    ("syntrophin" . SPARSER::PROTEIN-FAMILY)
    ("The HIV-1 accessory protein Nef" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mDia2" . SPARSER::PROTEIN) ("Syndecan-4" . SPARSER::PROTEIN)
    ("Arp 2/3" . SPARSER::PROTEIN) ("p190" . SPARSER::PROTEIN)
    ("GAL-4" . SPARSER::PROTEIN) ("AH109" . SPARSER::DRUG)
    ("APOL1" . SPARSER::PROTEIN) ("syndecan-3" . SPARSER::PROTEIN)
    ("syndecan-4" . SPARSER::PROTEIN) ("elongation factor" . SPARSER::PROTEIN)
    ("45 kD" . SPARSER::PROTEIN)
    ("the hTERT promoter-regulated oncolytic adenovirus OBP-301"
     . SPARSER::DRUG)
    ("hTERT, cyclooxygenase-2 or multidrug" . SPARSER::COLLECTION)
    ("Pimonidazole" . SPARSER::DRUG)
    ("Various exogenous and endogenous hypoxia-related proteins"
     . SPARSER::PROTEIN)
    ("αvβ3 and αvβ5" . SPARSER::COLLECTION)
    ("the hTERT gene promoter-regulated oncolytic adenovirus OBP-301"
     . SPARSER::DRUG)
    ("the hTERT" . SPARSER::PROTEIN)
    ("the telomerase-specific oncolytic adenovirus OBP-301" . SPARSER::DRUG)
    ("hydrochloride" . SPARSER::MOLECULE) ("pimonidazole" . SPARSER::DRUG)
    ("viral E1A DNA" . SPARSER::DNA) ("OBP-301 or Ad5" . SPARSER::COLLECTION)
    ("the telomerase-dependent oncolytic adenovirus OBP-301" . SPARSER::DRUG)
    ("the adenoviral receptor CAR" . SPARSER::PROTEIN)
    ("exogenous hTERT gene promoter" . SPARSER::PROMOTER)
    ("hTERT and the adenovirus receptor" . SPARSER::COLLECTION)
    ("cobalt" . SPARSER::MOLECULE)
    ("5% CO 2 and 94% N 2" . SPARSER::COLLECTION)
    ("hTERT and the coxsackie and adenovirus receptor (CAR)"
     . SPARSER::COLLECTION)
    ("receptor (CAR)" . SPARSER::RECEPTOR) ("CAR" . SPARSER::PROTEIN)
    ("response element (HRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("subunits and HIF-1α" . SPARSER::COLLECTION)
    ("OBP-301 and Ad5" . SPARSER::COLLECTION) ("Telomelysin" . SPARSER::DRUG)
    ("type 5" . SPARSER::PROTEIN)
    ("porphobilinogen deaminase" . SPARSER::PROTEIN)
    ("αvβ5" . SPARSER::PROTEIN) ("αvβ3" . SPARSER::PROTEIN)
    ("CoCl 2" . SPARSER::MOLECULE)
    ("Hypoxia-inducible factor" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor-1" . SPARSER::PROTEIN)
    ("Ad5" . SPARSER::PROTEIN) ("OBP-301" . SPARSER::DRUG)
    ("adenosine" . SPARSER::MOLECULE) ("Fc" . SPARSER::PROTEIN)
    ("the BH3 mimetic compound ABT-737" . SPARSER::DRUG)
    ("PSO" . SPARSER::PROTEIN) ("tryptase and chymase" . SPARSER::COLLECTION)
    ("TC" . SPARSER::PROTEIN)
    ("BCL-2 , BCL-XL , or C-KIT" . SPARSER::COLLECTION)
    ("BFL-1 , MCL-1 or non-targeting" . SPARSER::COLLECTION)
    ("Bfl-1 and Bcl-B" . SPARSER::COLLECTION)
    ("ABT-737 and ABT-737/Roscovitine-treated" . SPARSER::COLLECTION)
    ("ABT-737 or ABT-737" . SPARSER::COLLECTION)
    ("0.5 μM ABT-737 and 5 μM roscovitine" . SPARSER::COLLECTION)
    ("ABT-737 and roscovitine" . SPARSER::COLLECTION)
    ("Mcl-1, Bcl-B or A1/Bfl-1" . SPARSER::COLLECTION)
    ("the BH3-only mimetic ABT-737" . SPARSER::DRUG)
    ("human IgE (1 μg/ml) and 0.2, 2 or 20 μg/ml" . SPARSER::COLLECTION)
    ("Fc-receptors" . SPARSER::PROTEIN-PAIR) ("member A1" . SPARSER::PROTEIN)
    ("a multivalent antigen" . SPARSER::PROTEIN) ("IgE" . SPARSER::PROTEIN)
    ("effectors and regulators" . SPARSER::COLLECTION)
    ("BFL-1 and MCL-1" . SPARSER::COLLECTION) ("mast cell" . SPARSER::PROTEIN)
    ("class 2" . SPARSER::PROTEIN) ("BCL2A1" . SPARSER::PROTEIN)
    ("MCL1" . SPARSER::PROTEIN) ("AG30" . SPARSER::DRUG)
    ("IgE-receptor" . SPARSER::PROTEIN) ("BCL-XL" . SPARSER::PROTEIN)
    ("BCL-2" . SPARSER::PROTEIN) ("Bcl-B" . SPARSER::PROTEIN)
    ("Bcl-W" . SPARSER::PROTEIN) ("mediator of activation" . SPARSER::PROTEIN)
    ("bcl-2" . SPARSER::PROTEIN) ("member A" . SPARSER::PROTEIN)
    ("Bcl-w" . SPARSER::PROTEIN) ("Bfl-1" . SPARSER::PROTEIN)
    ("MCL-1" . SPARSER::PROTEIN) ("BFL-1" . SPARSER::PROTEIN)
    ("ABT-737" . SPARSER::DRUG) ("viral proteins" . SPARSER::PROTEIN)
    ("the viral RNA" . SPARSER::RNA) ("VSV" . SPARSER::PROTEIN)
    ("fluorescent transferrin" . SPARSER::PROTEIN) ("Rab6" . SPARSER::PROTEIN)
    ("myc-SNX3" . SPARSER::COLLECTION) ("Myc-SNX12" . SPARSER::COLLECTION)
    ("Lamp1" . SPARSER::PROTEIN) ("SNX1, SNX3 or SNX12" . SPARSER::COLLECTION)
    ("SNX1 and SNX3" . SPARSER::COLLECTION)
    ("Vps35 and Vps26" . SPARSER::COLLECTION) ("Vps26" . SPARSER::PROTEIN)
    ("Vps35" . SPARSER::PROTEIN)
    ("the PtdIns3P binding-defective mutant SNX12 R71A" . SPARSER::PROTEIN)
    ("SNX3 and other PtdIns3P-binding proteins" . SPARSER::COLLECTION)
    ("the late endosomal marker LBPA" . SPARSER::MOLECULE)
    ("EEA1 and SNX3" . SPARSER::COLLECTION) ("GFP-SNX12" . SPARSER::COLLECTION)
    ("LBPA" . SPARSER::MOLECULE)
    ("only one common ancestor gene" . SPARSER::GENE)
    ("SNX3 and SNX12" . SPARSER::COLLECTION)
    ("SNX12 and SNX3" . SPARSER::COLLECTION)
    ("Wntless" . SPARSER::PROTEIN-FAMILY) ("TGN" . SPARSER::PROTEIN)
    ("SNX17 and SNX27" . SPARSER::COLLECTION) ("LRP" . SPARSER::PROTEIN)
    ("SNX13 and SNX25" . SPARSER::COLLECTION)
    ("TGFbeta" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SNX1, SNX2, SNX5 and SNX6" . SPARSER::COLLECTION)
    ("SNX" . SPARSER::PROTEIN) ("nexins" . SPARSER::PROTEIN)
    ("receptor (EGFR)" . SPARSER::RECEPTOR)
    ("growth factors as well as plasma membrane proteins and lipids"
     . SPARSER::COLLECTION)
    ("proteins and lipids" . SPARSER::COLLECTION) ("nexin" . SPARSER::PROTEIN)
    ("CD107a" . SPARSER::PROTEIN) ("LAMP1" . SPARSER::PROTEIN)
    ("co-localizes" . SPARSER::PROTEIN)
    ("PI 3-Kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PtdIns3P" . SPARSER::MOLECULE) ("S. cerevisiae)" . SPARSER::PROTEIN)
    ("SNX27" . SPARSER::PROTEIN) ("SNX17" . SPARSER::PROTEIN)
    ("SNX16" . SPARSER::PROTEIN) ("SNX15" . SPARSER::PROTEIN)
    ("SNX13" . SPARSER::PROTEIN) ("SNX33" . SPARSER::PROTEIN)
    ("SNX18" . SPARSER::PROTEIN) ("SNX9" . SPARSER::PROTEIN)
    ("SNX4" . SPARSER::PROTEIN) ("SNX6" . SPARSER::PROTEIN)
    ("SNX5" . SPARSER::PROTEIN) ("SNX2" . SPARSER::PROTEIN)
    ("SNX1" . SPARSER::PROTEIN) ("SNX3" . SPARSER::PROTEIN)
    ("SNX12" . SPARSER::PROTEIN) ("sorting nexin 12" . SPARSER::PROTEIN)
    ("excellent drug" . SPARSER::DRUG)
    ("triple alanine Bax mutants" . SPARSER::MUTANT)
    ("a triple alanine Bax mutant" . SPARSER::MUTANT)
    ("monomeric Bax" . SPARSER::PROTEIN) ("the protein's" . SPARSER::PROTEIN)
    ("VDAC2/Bak" . SPARSER::COLLECTION)
    ("pro-apoptotic Bcl-2 proteins" . SPARSER::PROTEIN)
    ("a triple alanine mutant" . SPARSER::MUTANT) ("intra" . SPARSER::PROTEIN)
    ("PDB" . SPARSER::MOLECULE) ("Bank" . SPARSER::PROTEIN)
    ("atomic partial" . SPARSER::PROTEIN)
    ("the original QM" . SPARSER::PROTEIN) ("QM" . SPARSER::PROTEIN)
    ("molecules and polypeptides" . SPARSER::COLLECTION)
    ("Partial" . SPARSER::PROTEIN) ("SAHB" . SPARSER::PROTEIN)
    ("Bim-SAHB" . SPARSER::COLLECTION) ("Bim and Bid" . SPARSER::COLLECTION)
    ("oligomerisation" . SPARSER::PROTEIN-FAMILY)
    ("Bak and Bax" . SPARSER::COLLECTION)
    ("cell death proteases which cleave the cell's"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MOMP" . SPARSER::PROTEIN) ("protein or protein" . SPARSER::COLLECTION)
    ("its natural activator protein" . SPARSER::PROTEIN)
    ("intra-protein" . SPARSER::PROTEIN-PAIR)
    ("The pro-apoptotic proteins Bax and Bak" . SPARSER::COLLECTION)
    ("BAK_HUMAN" . SPARSER::PROTEIN) ("Q16611" . SPARSER::PROTEIN)
    ("receptor proteins" . SPARSER::RECEPTOR-PROTEIN)
    ("ID 2" . SPARSER::PROTEIN) ("VDAC2" . SPARSER::PROTEIN)
    ("activator protein" . SPARSER::PROTEIN)
    ("IFNγ-Fyn-Hakai" . SPARSER::COLLECTION)
    ("E-cadherin, p120-catenin and beta-catenin" . SPARSER::COLLECTION)
    ("Bazooka" . SPARSER::PROTEIN)
    ("ZO-1 and the adherens junction proteins" . SPARSER::COLLECTION)
    ("claudins and occludin" . SPARSER::COLLECTION)
    ("zonula" . SPARSER::PROTEIN) ("claudins" . SPARSER::PROTEIN)
    ("the epithelial tight junction" . SPARSER::PROTEIN)
    ("an immune-stimulatory cytokine" . SPARSER::PROTEIN)
    ("kinase or Hakai" . SPARSER::COLLECTION) ("IFNγ-" . SPARSER::PROTEIN)
    ("Fyn nor Hakai siRNA" . SPARSER::COLLECTION)
    ("E-cadherin and occludin" . SPARSER::COLLECTION)
    ("soluble cytosolic E-cadherin" . SPARSER::PROTEIN)
    ("Fyn- and Hakai-specific siRNA" . SPARSER::COLLECTION)
    ("Fyn-" . SPARSER::PROTEIN)
    ("an approximately 85 kDa peptide fragment" . SPARSER::FRAGMENT)
    ("the soluble cytoplasmic fragments" . SPARSER::FRAGMENT)
    ("Ub-E-cadherin" . SPARSER::COLLECTION) ("chloroquine" . SPARSER::PROTEIN)
    ("Janus" . SPARSER::PROTEIN-FAMILY)
    ("E-cadherin and p120 Catenin" . SPARSER::COLLECTION)
    ("E-cadherin, p120 catenin or beta-catenin" . SPARSER::COLLECTION)
    ("E-cadherin/p120 catenin/beta-catenin" . SPARSER::COLLECTION)
    ("occludin" . SPARSER::PROTEIN) ("detergent" . SPARSER::MOLECULE)
    ("cytoskeletal components" . SPARSER::COMPONENT)
    ("a highly insoluble cellular fraction" . SPARSER::COMPONENT)
    ("intestinal tight junction form" . SPARSER::FORM)
    ("kinase and Hakai" . SPARSER::COLLECTION)
    ("beta-catenin and additional proteins" . SPARSER::COLLECTION)
    ("p120-catenin, beta-catenin and additional proteins"
     . SPARSER::COLLECTION)
    ("a critical intercellular junctional protein" . SPARSER::PROTEIN)
    ("macromolecules" . SPARSER::MOLECULE)
    ("a key inflammatory cytokine" . SPARSER::PROTEIN)
    ("PP1 and siRNA" . SPARSER::COLLECTION)
    ("Fyn or Hakai" . SPARSER::COLLECTION)
    ("Fyn and Hakai" . SPARSER::COLLECTION)
    ("Fyn and the E-cadherin-selective ubiquitin ligase" . SPARSER::COLLECTION)
    ("Hakai" . SPARSER::PROTEIN)
    ("E-cadherin and p120-catenin" . SPARSER::COLLECTION)
    ("p120-catenin and beta-catenin" . SPARSER::COLLECTION)
    ("an important regulatory cytokine" . SPARSER::PROTEIN)
    ("anti-microbial" . SPARSER::DRUG) ("v-Src" . SPARSER::PROTEIN)
    ("p120 Catenin" . SPARSER::PROTEIN) ("p120 catenin" . SPARSER::PROTEIN)
    ("Interferon-gamma" . SPARSER::PROTEIN) ("p120-catenin" . SPARSER::PROTEIN)
    ("Interferon gamma" . SPARSER::PROTEIN)
    ("global NF-κB inhibitors" . SPARSER::INHIBITOR)
    ("NF-κB and p53" . SPARSER::COLLECTION)
    ("TSA or promoter" . SPARSER::COLLECTION)
    ("S547A mutant p65 and endogenous p65" . SPARSER::COLLECTION)
    ("MEF" . SPARSER::PROTEIN) ("only few specific genes" . SPARSER::GENE)
    ("GSTp" . SPARSER::PROTEIN) ("p65 and ATR or DNA-PK" . SPARSER::COLLECTION)
    ("ATR or DNA-PK" . SPARSER::COLLECTION)
    ("p65 and HDAC" . SPARSER::COLLECTION) ("trichostatin" . SPARSER::MOLECULE)
    ("p50/p65" . SPARSER::COLLECTION) ("IL8 and IκBα" . SPARSER::COLLECTION)
    ("Etoposide" . SPARSER::PROTEIN) ("interleukin" . SPARSER::PROTEIN)
    ("around fifteen genes differentially" . SPARSER::PROTEIN)
    ("p50/p50" . SPARSER::COLLECTION) ("GST-p53" . SPARSER::COLLECTION)
    ("50 amino acids of p65 surrounding each candidate phosphorylation site ( xref )"
     . SPARSER::PROTEIN)
    ("GST-p65" . SPARSER::COLLECTION)
    ("p65 and GST-ATM (1–247)" . SPARSER::COLLECTION)
    ("p65 and GST" . SPARSER::COLLECTION) ("p65 and ATM" . SPARSER::COLLECTION)
    ("GST-ATM" . SPARSER::COLLECTION)
    ("proteins and substrates" . SPARSER::COLLECTION)
    ("ATM and p65" . SPARSER::COLLECTION)
    ("acetyltransferase (HAT)" . SPARSER::PROTEIN) ("PIASy" . SPARSER::PROTEIN)
    ("IKKγ or NEMO" . SPARSER::COLLECTION) ("p50–p65" . SPARSER::COLLECTION)
    ("Ataxia telangiectasia mutated (ATM)" . SPARSER::PROTEIN)
    ("genotoxic chemicals" . SPARSER::MOLECULE) ("SELE" . SPARSER::PROTEIN)
    ("CD83" . SPARSER::PROTEIN) ("CXCL1" . SPARSER::PROTEIN)
    ("i κ b α" . SPARSER::PROTEIN) ("TA1" . SPARSER::PROTEIN)
    ("Lys9" . SPARSER::PROTEIN) ("X-Gal" . SPARSER::MOLECULE)
    ("RSK1" . SPARSER::PROTEIN) ("MSK1" . SPARSER::PROTEIN)
    ("TNF receptor-associated factor 6" . SPARSER::PROTEIN)
    ("Ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("Lys 9" . SPARSER::PROTEIN) ("A20" . SPARSER::PROTEIN)
    ("glycosaminoglycans" . SPARSER::MOLECULE)
    ("the client conformation" . SPARSER::BIO-CONFORMATION)
    ("mutant p53 form heterogeneous mixtures" . SPARSER::MOLECULE)
    ("oligomers and amyloid" . SPARSER::COLLECTION)
    ("mixtures" . SPARSER::MOLECULE)
    ("prions and protein-only" . SPARSER::COLLECTION)
    ("Refs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD and FTIR" . SPARSER::COLLECTION) ("prions" . SPARSER::PROTEIN-FAMILY)
    ("anti-p53 and anti-oligomer" . SPARSER::COLLECTION)
    ("oligomer" . SPARSER::MOLECULE) ("A11 and anti-p53" . SPARSER::COLLECTION)
    ("p53 and Mutant" . SPARSER::COLLECTION) ("calcein" . SPARSER::MOLECULE)
    ("other amyloidogenic proteins" . SPARSER::PROTEIN)
    ("dot-blot" . SPARSER::PROTEIN)
    ("each identified secondary structure component" . SPARSER::COMPONENT)
    ("p53C and mutant" . SPARSER::COLLECTION)
    ("the secondary structure components" . SPARSER::COMPONENT)
    ("soluble and aggregated forms" . SPARSER::FORM)
    ("both soluble and aggregated wild-type proteins" . SPARSER::PROTEIN)
    ("its soluble and aggregated states" . SPARSER::BIO-STATE)
    ("p53C" . SPARSER::PROTEIN) ("Oligomers" . SPARSER::PROTEIN)
    ("Rh" . SPARSER::MOLECULE) ("PrP" . SPARSER::PROTEIN)
    ("typical amyloid" . SPARSER::PROTEIN) ("ThT" . SPARSER::MOLECULE)
    ("p53 and p53C" . SPARSER::COLLECTION)
    ("a mixture of amyloid oligomers and fibrils" . SPARSER::COLLECTION)
    ("wild-type p53 and its paralogs p63 and p73 ( xref )"
     . SPARSER::COLLECTION)
    ("p63 and p73" . SPARSER::COLLECTION)
    ("p53 co-localizes" . SPARSER::PROTEIN)
    ("a tetrameric flexible protein" . SPARSER::PROTEIN)
    ("co-localized" . SPARSER::PROTEIN)
    ("the typical conformation" . SPARSER::BIO-CONFORMATION)
    ("x" . SPARSER::PROTEIN) ("dynamic light" . SPARSER::PROTEIN)
    ("wild-type (WT) p53 and the hot-spot mutant R248Q" . SPARSER::COLLECTION)
    ("Prion" . SPARSER::PROTEIN-FAMILY) ("prion" . SPARSER::PROTEIN-FAMILY)
    ("oligomers" . SPARSER::PROTEIN) ("amyloid" . SPARSER::PROTEIN)
    ("ammonium chloride" . SPARSER::MOLECULE) ("MX1" . SPARSER::PROTEIN)
    ("cm −1" . SPARSER::PROTEIN) ("FB" . SPARSER::PROTEIN)
    ("DA" . SPARSER::MOLECULE) ("PP" . SPARSER::PROTEIN)
    ("a biological drug" . SPARSER::DRUG) ("Example" . SPARSER::EXAMPLE)
    ("biological drugs" . SPARSER::DRUG) ("-1 and α/β " . SPARSER::COLLECTION)
    ("EGFr" . SPARSER::PROTEIN) ("amplifiable DNA" . SPARSER::DNA)
    ("KRAS and EGFR" . SPARSER::COLLECTION)
    ("CRC as well as artificial DNA" . SPARSER::COLLECTION)
    ("artificial DNA" . SPARSER::DNA) ("ARMS" . SPARSER::PROTEIN)
    ("the anti-EGFR monoclonal antibodies, panitumumab and cetuximab"
     . SPARSER::COLLECTION)
    ("antibodies, panitumumab and cetuximab" . SPARSER::COLLECTION)
    ("anti-EGFR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("Medicines" . SPARSER::DRUG)
    ("the anti-epidermal growth factor receptor (EGFR) monoclonal antibodies, cetuximab and panitumumab"
     . SPARSER::COLLECTION)
    ("antibodies, cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("MPP" . SPARSER::PROTEIN) ("Site 2" . SPARSER::PROTEIN)
    ("Site 1" . SPARSER::PROTEIN) ("site 2" . SPARSER::PROTEIN)
    ("site 1" . SPARSER::PROTEIN)
    ("VE-821 and radiation" . SPARSER::COLLECTION)
    ("ATM and DNA-PK" . SPARSER::COLLECTION)
    ("DDR and HIF" . SPARSER::COLLECTION)
    ("GLUT-1 and LDH-A" . SPARSER::COLLECTION)
    ("a well-characterised HIF-1 target" . SPARSER::TARGET-PROTEIN)
    ("VE-821 or DMSO" . SPARSER::COLLECTION)
    ("hypoxia and ATR" . SPARSER::COLLECTION)
    ("normoxia or hypoxia" . SPARSER::COLLECTION)
    ("VE-821 and single-molecule DNA fibre analysis" . SPARSER::COLLECTION)
    ("Media" . SPARSER::PROTEIN)
    ("the inefficient tumour vasculature" . SPARSER::PROTEIN)
    ("antimetabolites and topoisomerase" . SPARSER::COLLECTION)
    ("antimetabolites" . SPARSER::DRUG)
    ("the phosphoinositol 3-kinase-like serine/threonine protein kinases (PIKK) ATM (Ataxia Telangiectasia Mutated) and ATR (Ataxia Telangiectasia and Rad 3 related)"
     . SPARSER::COLLECTION)
    ("kinases (PIKK)" . SPARSER::PROTEIN)
    ("ATR and the key regulator" . SPARSER::COLLECTION)
    ("H2AX and KAP1" . SPARSER::COLLECTION)
    ("severe hypoxia" . SPARSER::PROTEIN)
    ("the apical DDR kinase ATR" . SPARSER::PROTEIN)
    ("the most aggressive fraction" . SPARSER::COMPONENT)
    ("anti-angiogenic" . SPARSER::DRUG) ("LDH-A" . SPARSER::PROTEIN)
    ("18 h" . SPARSER::PROTEIN) ("β gal" . SPARSER::PROTEIN)
    ("ELK3" . SPARSER::PROTEIN) ("EF5" . SPARSER::PROTEIN)
    ("GLUT-1" . SPARSER::PROTEIN) ("γ H2AX" . SPARSER::PROTEIN)
    ("S15" . SPARSER::PROTEIN) ("β -mercaptoethanol" . SPARSER::MOLECULE)
    ("HIF-1 α" . SPARSER::PROTEIN)
    ("2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one" . SPARSER::DRUG)
    ("HIF–1" . SPARSER::PROTEIN)
    ("3-amino-6- (4-(methylsulfonyl) phenyl)- N -phenylpyrazine-2-carboxamide"
     . SPARSER::DRUG)
    ("NU6027" . SPARSER::DRUG) ("HIF-1" . SPARSER::PROTEIN)
    ("KAP1" . SPARSER::PROTEIN)
    ("Ataxia Telangiectasia Mutated" . SPARSER::PROTEIN)
    ("VE-821" . SPARSER::DRUG) ("KLB" . SPARSER::PROTEIN)
    ("Lactate" . SPARSER::LACTATE) ("Phorbol" . SPARSER::DRUG)
    ("Lipooligosaccharide (LOS)" . SPARSER::MOLECULE)
    ("Lipooligosaccharide" . SPARSER::MOLECULE)
    ("endotoxin" . SPARSER::MOLECULE) ("SAVA" . SPARSER::PROTEIN)
    ("Dynein" . SPARSER::PROTEIN)
    ("the ciliary protein 13S dynein" . SPARSER::PROTEIN)
    ("dynein" . SPARSER::PROTEIN) ("LDH" . SPARSER::PROTEIN)
    ("acetaldehyde" . SPARSER::MOLECULE) ("pneumolysin" . SPARSER::PROTEIN)
    ("phorbol" . SPARSER::DRUG) ("LOS" . SPARSER::MOLECULE)
    ("lipooligosaccharide" . SPARSER::MOLECULE)
    ("gram-negative rod" . SPARSER::PROTEIN) ("rod" . SPARSER::PROTEIN)
    ("CBF and PKC" . SPARSER::COLLECTION)
    ("CBF and motile" . SPARSER::COLLECTION) ("epsilon" . SPARSER::PROTEIN)
    ("CBF" . SPARSER::PROTEIN) ("PKCα" . SPARSER::PROTEIN)
    ("phosphatidyl-L-serine" . SPARSER::MOLECULE)
    ("nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("PKC δ" . SPARSER::PROTEIN) ("neuropeptide Y" . SPARSER::PROTEIN)
    ("MK" . SPARSER::PROTEIN) ("HP" . SPARSER::PROTEIN)
    ("p16 and p53" . SPARSER::COLLECTION)
    ("DCC and CDKN2A" . SPARSER::COLLECTION)
    ("the episomal form" . SPARSER::FORM)
    ("the physical state" . SPARSER::BIO-STATE)
    ("Cyclin A1 and p16" . SPARSER::COLLECTION)
    ("p16 (p = 0.00495) and p53 (p = 0.000228)" . SPARSER::COLLECTION)
    ("the associated protein" . SPARSER::PROTEIN)
    ("p16 or p53, and p53" . SPARSER::COLLECTION)
    ("p53, and p53" . SPARSER::COLLECTION)
    ("alcohol and nicotine" . SPARSER::COLLECTION)
    ("E2F-1 and Cyclin A" . SPARSER::COLLECTION)
    ("/Cyclin-dependent kinase 2" . SPARSER::COLLECTION)
    ("Cyclins, Cyclin A1 and Cyclin A2" . SPARSER::COLLECTION)
    ("Cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p27 and p57" . SPARSER::COLLECTION) ("-CDK" . SPARSER::COLLECTION)
    ("Activators and inhibitors" . SPARSER::COLLECTION)
    ("HPV16 DNA (p = 0.0014) and a lower recurrence rate"
     . SPARSER::COLLECTION)
    ("β-globin" . SPARSER::PROTEIN) ("Family 6" . SPARSER::PROTEIN)
    ("Beta-globin" . SPARSER::PROTEIN) ("CCNA1" . SPARSER::PROTEIN)
    ("F-18" . SPARSER::PROTEIN) ("CDC2" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase 2" . SPARSER::PROTEIN)
    ("E2F-1" . SPARSER::PROTEIN) ("Cyclin A2" . SPARSER::PROTEIN)
    ("p57" . SPARSER::PROTEIN) ("ARF family" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cyclin A1" . SPARSER::PROTEIN)
    ("Oncostatin M (OSM) and Prolactin" . SPARSER::COLLECTION)
    ("LIF and OSM" . SPARSER::COLLECTION) ("Prolactin" . SPARSER::PROTEIN)
    ("OSM" . SPARSER::PROTEIN) ("LIF and IL-4" . SPARSER::COLLECTION)
    ("LIF and IL-6" . SPARSER::COLLECTION)
    ("TCR + IL-4 + anti-IL-4" . SPARSER::ANTIBODY)
    ("LIF-IL-6-STAT3" . SPARSER::COLLECTION)
    ("STAT6 and not STAT3" . SPARSER::COLLECTION)
    ("evident PCNA, STAT3 and JUN" . SPARSER::COLLECTION)
    ("PCNA, STAT3 and JUN" . SPARSER::COLLECTION)
    ("STAT3 and JUN" . SPARSER::COLLECTION)
    ("JUN" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ALA" . SPARSER::AMINO-ACID)
    ("GLU" . SPARSER::AMINO-ACID) ("ASP" . SPARSER::PROTEIN)
    ("Folate" . SPARSER::MOLECULE) ("DUSP2 and DUSP9" . SPARSER::COLLECTION)
    ("DUSP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDC25C (triggers mitosis and suppresses growth arrest by p53) and CCNA (required both at the start and G2/M transition)"
     . SPARSER::COLLECTION)
    ("CCND2 (required for G1/S transition), CDC25C (triggers mitosis and suppresses growth arrest by p53) and CCNA (required both at the start and G2/M transition)"
     . SPARSER::COLLECTION)
    ("CCNA" . SPARSER::PROTEIN) ("Cytokine and cytokine" . SPARSER::COLLECTION)
    ("ABS" . SPARSER::PROTEIN) ("predefined biological gene" . SPARSER::GENE)
    ("MYOD" . SPARSER::PROTEIN) ("Xbp-1" . SPARSER::PROTEIN)
    ("Only two matrices" . SPARSER::PROTEIN-FAMILY)
    ("only two GO classes" . CLASS) ("BKL" . SPARSER::PROTEIN)
    ("Differentially" . SPARSER::PROTEIN)
    ("IL-4 and anti-IL-4R" . SPARSER::COLLECTION) ("CFSE" . SPARSER::DRUG)
    ("exogenous IL-4" . SPARSER::PROTEIN)
    ("IL-4 and IL-4R" . SPARSER::COLLECTION)
    ("a pleiotropic glycoprotein" . SPARSER::PROTEIN)
    ("the master regulator STAT3 and its upstream protein Leukemia inhibitory factor (LIF)"
     . SPARSER::COLLECTION)
    ("Leukemia inhibitory factor (LIF)" . SPARSER::PROTEIN)
    ("STAT6 and GATA3" . SPARSER::COLLECTION) ("LIF" . SPARSER::PROTEIN)
    ("SO 4" . SPARSER::PROTEIN) ("5–2" . SPARSER::PROTEIN)
    ("Oncostatin M" . SPARSER::PROTEIN) ("SHC-1" . SPARSER::PROTEIN)
    ("dual specificity phosphatase" . SPARSER::PROTEIN)
    ("DUSP9" . SPARSER::PROTEIN) ("CCND2" . SPARSER::PROTEIN)
    ("NF-AT" . SPARSER::PROTEIN) ("JAK-STAT" . SPARSER::PROTEIN)
    ("TIL4" . SPARSER::PROTEIN) ("IL-4 receptor" . SPARSER::PROTEIN)
    ("Leukemia inhibitory factor" . SPARSER::PROTEIN)
    ("IL4" . SPARSER::PROTEIN) ("GATA3" . SPARSER::PROTEIN)
    ("STAT6" . SPARSER::PROTEIN) ("IL-4R" . SPARSER::PROTEIN)
    ("VEGF-A–VEGFR2" . SPARSER::COLLECTION)
    ("more aggressive PTCs" . SPARSER::PROTEIN)
    ("PTC or FTCs" . SPARSER::COLLECTION) ("FTCs" . SPARSER::DRUG)
    ("the β-TRCP1–VEGFR2" . SPARSER::PROTEIN-PAIR) ("FTC" . SPARSER::DRUG)
    ("squamous metaplasia foci" . SPARSER::PROTEIN) ("ATC" . SPARSER::DRUG)
    ("axitinib and sorafenib" . SPARSER::COLLECTION)
    ("axitinib" . SPARSER::DRUG) ("BRAF and MAPK" . SPARSER::COLLECTION)
    ("SNAIL" . SPARSER::PROTEIN) ("Kdrl:EGFP" . SPARSER::BIO-COMPLEX)
    ("the entire vasculature" . SPARSER::PROTEIN)
    ("VEGF-A and VEGFR2" . SPARSER::COLLECTION)
    ("p-VEGFR2" . SPARSER::COLLECTION)
    ("pTyr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("other VEGF receptors (VEGFR1 and VEGFR3) or CCM3" . SPARSER::COLLECTION)
    ("VEGFR1 and VEGFR3" . SPARSER::COLLECTION) ("CCM3" . SPARSER::PROTEIN)
    ("GST-VEGFR2" . SPARSER::COLLECTION)
    ("a DSG triple mutant" . SPARSER::MUTANT)
    ("DSG1, DSG2, and DSG3" . SPARSER::COLLECTION)
    ("CKIα and CKIε" . SPARSER::COLLECTION)
    ("CKIα or CKIε" . SPARSER::COLLECTION) ("Casein" . SPARSER::PROTEIN)
    ("endogenous VEGFR2 and endogenous β-TRCP1" . SPARSER::COLLECTION)
    ("VEGFR2 and β-TRCP1" . SPARSER::COLLECTION) ("XX" . SPARSER::DRUG)
    ("DSG" . SPARSER::DRUG) ("Cullins" . SPARSER::PROTEIN-FAMILY)
    ("Cullin" . SPARSER::PROTEIN-FAMILY) ("Multi" . SPARSER::PROTEIN)
    ("lysosomal/proteasomal" . SPARSER::COLLECTION)
    ("EGFR, PDGFR, and CSFR1" . SPARSER::COLLECTION)
    ("CSFR" . SPARSER::PROTEIN) ("TKIs" . SPARSER::PROTEIN)
    ("new light" . SPARSER::PROTEIN) ("inhibitor (TKI)" . SPARSER::INHIBITOR)
    ("multi–tyrosine kinase" . SPARSER::COLLECTION)
    ("VEGFR2 and VEGF-A" . SPARSER::COLLECTION)
    ("the principal receptor" . SPARSER::RECEPTOR)
    ("a new biomarker" . SPARSER::MOLECULE) ("CKI" . SPARSER::PROTEIN)
    ("an aggressive subtype" . SPARSER::PROTEIN) ("UbcH5a" . SPARSER::PROTEIN)
    ("Cul-1" . SPARSER::PROTEIN) ("Cullin4" . SPARSER::PROTEIN)
    ("Cullin5" . SPARSER::PROTEIN) ("gag-pol" . SPARSER::PROTEIN)
    ("Cullin-4A" . SPARSER::PROTEIN) ("Cullin-1" . SPARSER::PROTEIN)
    ("Cullin 5" . SPARSER::PROTEIN) ("Cullin 3" . SPARSER::PROTEIN)
    ("Cullin 2" . SPARSER::PROTEIN) ("β -TRCP" . SPARSER::PROTEIN)
    ("fli1" . SPARSER::PROTEIN) ("VEGFR3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DSG3" . SPARSER::PROTEIN) ("DSG2" . SPARSER::PROTEIN)
    ("DSG1" . SPARSER::PROTEIN) ("CKIε" . SPARSER::PROTEIN)
    ("CKIα" . SPARSER::PROTEIN) ("Cullin 4" . SPARSER::PROTEIN)
    ("Cullin family" . SPARSER::PROTEIN-FAMILY) ("Cullin 1" . SPARSER::PROTEIN)
    ("Ring finger protein" . SPARSER::PROTEIN)
    ("prolactin receptor" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor receptor 2" . SPARSER::PROTEIN)
    ("β-TRCP" . SPARSER::PROTEIN)
    ("antibodies and bendamustine" . SPARSER::COLLECTION)
    ("rituximab and bendamustine" . SPARSER::COLLECTION)
    ("chemokines and cytokines" . SPARSER::COLLECTION)
    ("CCL3, CLL4, CXCL13 and TNF-alpha" . SPARSER::COLLECTION)
    ("rituximab, bendamustine, ofatumumab and fludarabine"
     . SPARSER::COLLECTION)
    ("ofatumumab" . SPARSER::DRUG) ("ASH" . SPARSER::PROTEIN)
    ("fludarabine and bendamustine" . SPARSER::COLLECTION)
    ("bendamustine" . SPARSER::DRUG) ("IL-6 and TNF" . SPARSER::COLLECTION)
    ("CXCL12 and CXCL13" . SPARSER::COLLECTION)
    ("an orally bioavailable, potent and selective inhibitor"
     . SPARSER::INHIBITOR)
    ("the hematopoietic-selective isoform p110δ" . SPARSER::PROTEIN)
    ("CAL" . SPARSER::PROTEIN)
    ("CD40L, BAFF, fibronectin, and BCR" . SPARSER::COLLECTION)
    ("BAFF" . SPARSER::PROTEIN) ("p110δ and p110δ" . SPARSER::COLLECTION)
    ("p110α and p110β" . SPARSER::COLLECTION)
    ("LY294002 and wortmannin" . SPARSER::COLLECTION)
    ("Bad/Bcl-X" . SPARSER::COLLECTION)
    ("PI3-Kinase/AKT" . SPARSER::COLLECTION) ("Akt1/2/3" . SPARSER::COLLECTION)
    ("kinases, PDK, Akt, ILK and Rac" . SPARSER::COLLECTION)
    ("ILK" . SPARSER::PROTEIN) ("Tec" . SPARSER::PROTEIN)
    ("PTEN and SHIP" . SPARSER::COLLECTION) ("SHIP" . SPARSER::PROTEIN)
    ("PtdIns" . SPARSER::PROTEIN)
    ("the receptor-associated JAK tyrosine kinases" . SPARSER::PROTEIN)
    ("Src family kinases (such as Lyn, Fyn and Blk) and spleen tyrosine kinase"
     . SPARSER::COLLECTION)
    ("CD19 and/or BCAP ( xref - xref )" . SPARSER::COLLECTION)
    ("Lyn, Fyn and Blk" . SPARSER::COLLECTION) ("BCAP" . SPARSER::PROTEIN)
    ("Igα-Igβ" . SPARSER::COLLECTION) ("Igα and Igβ" . SPARSER::COLLECTION)
    ("IgM" . SPARSER::PROTEIN) ("p110α, p110β and p110δ" . SPARSER::COLLECTION)
    ("p85, p50 or p55" . SPARSER::COLLECTION) ("Class" . CLASS)
    ("BCR, receptor tyrosine kinases and cytokine" . SPARSER::COLLECTION)
    ("receptor (BCR)" . SPARSER::RECEPTOR) ("CCL3" . SPARSER::PROTEIN)
    ("CXCL13" . SPARSER::PROTEIN) ("GS-1101" . SPARSER::DRUG)
    ("G-protein coupled" . SPARSER::PROTEIN) ("gp130" . SPARSER::PROTEIN)
    ("spleen tyrosine kinase" . SPARSER::PROTEIN) ("Igβ" . SPARSER::PROTEIN)
    ("Igα" . SPARSER::PROTEIN) ("etc." . SPARSER::PROTEIN)
    ("class 1A" . SPARSER::PROTEIN) ("p101" . SPARSER::PROTEIN)
    ("p55" . SPARSER::PROTEIN) ("PI3-Kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3-Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p110δ" . SPARSER::PROTEIN)
    ("MAPK and PI3K" . SPARSER::COLLECTION) ("RAF1-RAS" . SPARSER::COLLECTION)
    ("RALGDS" . SPARSER::PROTEIN)
    ("phosphatase and phosphopeptide" . SPARSER::COLLECTION)
    ("activated receptors or docking proteins" . SPARSER::COLLECTION)
    ("the N-SH2 domain-specific PTPNS1" . SPARSER::PROTEIN)
    ("−2, −1, +1, +2, and +3" . SPARSER::COLLECTION)
    ("6,057 pY-containing naturally occurring peptides" . SPARSER::PEPTIDE)
    ("guanidinium" . SPARSER::MOLECULE) ("solvent" . SPARSER::MOLECULE)
    ("even more radical" . SPARSER::MOLECULE)
    ("Both the pathogenetic mutants" . SPARSER::MUTANT)
    ("max" . SPARSER::PROTEIN) ("all possible mutants" . SPARSER::MUTANT)
    ("inactive and active" . SPARSER::COLLECTION)
    ("all possible amino acid" . SPARSER::AMINO-ACID)
    ("largely invariant amino acid" . SPARSER::AMINO-ACID)
    ("active and inactive" . SPARSER::COLLECTION)
    ("conformations" . SPARSER::BIO-CONFORMATION) ("pY-" . SPARSER::PROTEIN)
    ("its inactive state or increasing binding" . SPARSER::COLLECTION)
    ("GTPase-activating protein" . SPARSER::PROTEIN)
    ("GTPase-activating" . SPARSER::PROTEIN)
    ("aspartic acid" . SPARSER::AMINO-ACID) ("bar −1" . SPARSER::PROTEIN)
    ("PTPNS1" . SPARSER::PROTEIN) ("p- nitrophenyl" . SPARSER::MOLECULE)
    ("LT1" . SPARSER::PROTEIN) ("Gab1" . SPARSER::PROTEIN)
    ("glutamic acid" . SPARSER::AMINO-ACID) ("C-SH2" . SPARSER::PROTEIN)
    ("RNPC1 and MDM2" . SPARSER::COLLECTION)
    ("p53 and a negative regulator" . SPARSER::COLLECTION)
    ("p21, p73, and HuR" . SPARSER::COLLECTION)
    ("p63 and MDM2" . SPARSER::COLLECTION)
    ("p53, p63, p21, HuR, and MDM2" . SPARSER::COLLECTION)
    ("microRNAs and/or other RNA-binding proteins" . SPARSER::COLLECTION)
    ("RNPC1, MDM2, and p53" . SPARSER::COLLECTION)
    ("RNPC1, ΔRNP1, or ΔRNP2" . SPARSER::COLLECTION)
    ("RNP1 or RNP2" . SPARSER::COLLECTION) ("subfragments" . SPARSER::PROTEIN)
    ("the entire MDM2" . SPARSER::PROTEIN) ("RNA-chip" . SPARSER::RNA)
    ("the mature MDM2 mRNA" . SPARSER::PROTEIN)
    ("mature MDM2 mRNA" . SPARSER::PROTEIN)
    ("SW480 and p53" . SPARSER::COLLECTION)
    ("RNPC1 +/+ and p53 −/−" . SPARSER::COLLECTION) ("MDMX" . SPARSER::PROTEIN)
    ("RNPC1 and RNPC1a" . SPARSER::COLLECTION) ("tetracycline" . SPARSER::DRUG)
    ("p53 and p63" . SPARSER::COLLECTION)
    ("p53, p63, and p73" . SPARSER::COLLECTION)
    ("Musashi, HuR, and nucleolin" . SPARSER::COLLECTION)
    ("Musashi" . SPARSER::PROTEIN)
    ("RNA-binding protein (RBP)" . SPARSER::PROTEIN) ("RBP" . SPARSER::PROTEIN)
    ("RPL5, RPS7, RPL11, RPL23, and RPS27L" . SPARSER::COLLECTION)
    ("the hepatocyte growth factor (HGF) receptor (Met) and the insulin-like growth factor 1 (IGF-1) receptor (IGF-1R)"
     . SPARSER::COLLECTION)
    ("RB, Numb, and p21" . SPARSER::COLLECTION) ("Numb" . SPARSER::PROTEIN)
    ("MDM1, MDM2, and MDM3" . SPARSER::COLLECTION) ("MDM" . SPARSER::PROTEIN)
    ("exogenous MDM2" . SPARSER::PROTEIN)
    ("p53 family and forms" . SPARSER::COLLECTION)
    ("Dual-luciferase" . SPARSER::PROTEIN)
    ("A 3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TA 3" . SPARSER::PROTEIN)
    ("GC 3" . SPARSER::PROTEIN) ("AT 3" . SPARSER::PROTEIN)
    ("AGG 3" . SPARSER::PROTEIN) ("TG 3" . SPARSER::PROTEIN)
    ("TTC 3" . SPARSER::PROTEIN) ("RNase A" . SPARSER::PROTEIN)
    ("RNP2" . SPARSER::PROTEIN) ("RNP1" . SPARSER::PROTEIN)
    ("RNA binding" . SPARSER::PROTEIN) ("dual-luciferase" . SPARSER::PROTEIN)
    ("A3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("precursor mRNA" . SPARSER::RNA)
    ("RBM38" . SPARSER::PROTEIN) ("RPS27L" . SPARSER::PROTEIN)
    ("RPL23" . SPARSER::PROTEIN) ("RPL11" . SPARSER::PROTEIN)
    ("RPS7" . SPARSER::PROTEIN) ("RPL5" . SPARSER::PROTEIN)
    ("IGF-1R" . SPARSER::PROTEIN) ("MDM1" . SPARSER::PROTEIN)
    ("RNPC1" . SPARSER::PROTEIN) ("Tsg" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("STAM2 and Eps15" . SPARSER::COLLECTION)
    ("EGFR and USP2a" . SPARSER::COLLECTION) ("frozen" . SPARSER::PROTEIN)
    ("exogenous GFP-USP2a" . SPARSER::COLLECTION)
    ("a red fluorescent-labeled secondary antibody" . SPARSER::PROTEIN)
    ("phycoerythrin" . SPARSER::PROTEIN-FAMILY)
    ("internalized Alexa 488-labeled EGF" . SPARSER::PROTEIN)
    ("Alexa 488-labeled EGF" . SPARSER::PROTEIN)
    ("Rhod-EGF" . SPARSER::COLLECTION) ("Rhod" . SPARSER::PROTEIN)
    ("rhodamine-EGF" . SPARSER::COLLECTION) ("rhodamine" . SPARSER::PROTEIN)
    ("K63-Ub" . SPARSER::COLLECTION) ("-EGFR" . SPARSER::COLLECTION)
    ("USP2a (WT)" . SPARSER::PROTEIN)
    ("late endosomal-lysosomal marker LAMP-1" . SPARSER::PROTEIN)
    ("IF" . SPARSER::PROTEIN) ("EEA1, TfR and Rab5" . SPARSER::COLLECTION)
    ("TfR" . SPARSER::PROTEIN) ("TrR" . SPARSER::PROTEIN)
    ("Exogenous GFP-USP2a" . SPARSER::COLLECTION)
    ("GFP-USP2a" . SPARSER::COLLECTION)
    ("ErbB3, EEA1 and Rab" . SPARSER::COLLECTION) ("GSEA" . SPARSER::PROTEIN)
    ("Clathrin" . SPARSER::PROTEIN) ("MdmX" . SPARSER::PROTEIN)
    ("DUBs, AMSH and UBPY" . SPARSER::COLLECTION) ("UBPY" . SPARSER::PROTEIN)
    ("AMSH" . SPARSER::PROTEIN)
    ("proteins and ubiquitin" . SPARSER::COLLECTION)
    ("Receptors" . SPARSER::PROTEIN) ("USP2a and EGFR" . SPARSER::COLLECTION)
    ("USP2a" . SPARSER::PROTEIN) ("Texas-Red" . SPARSER::DRUG)
    ("pH 3" . SPARSER::MOLECULE) ("ESCRT-II" . SPARSER::PROTEIN-FAMILY)
    ("Eps15" . SPARSER::PROTEIN) ("STAM2" . SPARSER::PROTEIN)
    ("membrane protein" . SPARSER::PROTEIN) ("Rab11" . SPARSER::PROTEIN)
    ("LAMP-1" . SPARSER::PROTEIN) ("clathrin heavy chain" . SPARSER::PROTEIN)
    ("transferrin receptor" . SPARSER::PROTEIN) ("cyclin D" . SPARSER::PROTEIN)
    ("E3s" . SPARSER::MOLECULE) ("USP2" . SPARSER::PROTEIN)
    ("Bcl-2 and p27" . SPARSER::COLLECTION) ("Unc" . SPARSER::PROTEIN)
    ("Bax and Bak" . SPARSER::COLLECTION)
    ("Bax, p27 and Bcl-2" . SPARSER::COLLECTION)
    ("neuronal PCD" . SPARSER::PROTEIN)
    ("Bcl-2, and p27" . SPARSER::COLLECTION)
    ("robust nuclear p27" . SPARSER::PROTEIN)
    ("Bak, Bcl-XL, and p27" . SPARSER::COLLECTION) ("P22" . SPARSER::PROTEIN)
    ("Bax +/− and Bax −/− mice" . SPARSER::COLLECTION)
    ("intact Bax" . SPARSER::PROTEIN)
    ("at least 1 functional allele" . SPARSER::ALLELE)
    ("Rank" . SPARSER::PROTEIN) ("Math1-cre" . SPARSER::COLLECTION)
    ("cre" . SPARSER::PROTEIN)
    ("the neuronal marker NeuN and the proliferation marker Ki67"
     . SPARSER::COLLECTION)
    ("the neuronal marker NeuN" . SPARSER::PROTEIN) ("NeuN" . SPARSER::PROTEIN)
    ("Bcl-2 and Mcl-1" . SPARSER::COLLECTION)
    ("Dexamethasone" . SPARSER::PROTEIN)
    ("Bax +/+ and Bax −/− CGNPs demonstrated equivalent baseline expression of Cyclin D2"
     . SPARSER::COLLECTION)
    ("P11-P18" . SPARSER::COLLECTION) ("CGN" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor p27/Kip1" . SPARSER::COLLECTION)
    ("Jsap1" . SPARSER::PROTEIN) ("Ren" . SPARSER::PROTEIN)
    ("the rhombic lip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("lip" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CGNs" . SPARSER::PROTEIN)
    ("pro-apoptotic Bax" . SPARSER::PROTEIN) ("PCD" . SPARSER::PROTEIN)
    ("Bcl-XL" . SPARSER::PROTEIN) ("PH3" . SPARSER::PROTEIN)
    ("Math1" . SPARSER::PROTEIN) ("P17" . SPARSER::PROTEIN)
    ("Caspase 3" . SPARSER::PROTEIN) ("P18" . SPARSER::PROTEIN)
    ("P11" . SPARSER::PROTEIN) ("Cyclin D2" . SPARSER::PROTEIN)
    ("P16" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor p27" . SPARSER::PROTEIN)
    ("β-Arrestin" . SPARSER::PROTEIN) ("Gpr3" . SPARSER::PROTEIN)
    ("Sonic Hedgehog" . SPARSER::PROTEIN) ("ND2" . SPARSER::PROTEIN)
    ("ALK1 and ALK5" . SPARSER::COLLECTION)
    ("ALK-1 and ALK-5" . SPARSER::COLLECTION) ("mask" . SPARSER::PROTEIN)
    ("NF-κB, p53 and Erk" . SPARSER::COLLECTION)
    ("R-Smads and ubiquitin" . SPARSER::COLLECTION)
    ("Arkadia" . SPARSER::PROTEIN) ("Smad7 and TMEPAI" . SPARSER::COLLECTION)
    ("SnoN" . SPARSER::PROTEIN) ("receptors or Smad4" . SPARSER::COLLECTION)
    ("TMEPAI" . SPARSER::PROTEIN)
    ("receptors, PP1 phosphatase [ xref ]," . SPARSER::PROTEIN)
    ("receptors, PP1 phosphatase [ xref ], or the ubiquitination E3 ligase Smurf1 and Smurf2 [ xref ]"
     . SPARSER::COLLECTION)
    ("Smurf1 and Smurf2" . SPARSER::COLLECTION)
    ("ubiquitin-proteasomal" . SPARSER::COLLECTION)
    ("GFP-Smad2" . SPARSER::COLLECTION) ("FRAP" . SPARSER::PROTEIN)
    ("RO" . SPARSER::PROTEIN) ("R-Smad and Co-Smad" . SPARSER::COLLECTION)
    ("receptors and Smad" . SPARSER::COLLECTION) ("CIR" . SPARSER::PROTEIN)
    ("L17-TβRI" . SPARSER::COLLECTION)
    ("complex and R-Smad" . SPARSER::COLLECTION)
    ("TβRI and TβRII" . SPARSER::COLLECTION)
    ("growth factor (NGF)" . SPARSER::GROWTH-FACTOR) ("NGF" . SPARSER::PROTEIN)
    ("continuous TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGF or TGF-α" . SPARSER::COLLECTION)
    ("constitutively depleting extracellular TGF-β"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type, and medium" . SPARSER::COLLECTION)
    ("The principal molecular components" . SPARSER::COMPONENT)
    ("TGF-β/Smad" . SPARSER::COLLECTION) ("transducers" . SPARSER::PROTEIN)
    ("Phosphatase" . SPARSER::PHOSPHATASE)
    ("approximately 100-300 target genes" . SPARSER::GENE)
    ("lysosomal" . SPARSER::PROTEIN)
    ("TGF-β and the receptors" . SPARSER::COLLECTION)
    ("Ligand" . SPARSER::LIGAND) ("complex and scaffold" . SPARSER::COLLECTION)
    ("SARA and Hrs" . SPARSER::COLLECTION) ("SARA" . SPARSER::PROTEIN)
    ("the active receptor complex" . SPARSER::BIO-COMPLEX)
    ("a heterotetrameric complex" . SPARSER::BIO-COMPLEX)
    ("the active ligand-receptor complex" . SPARSER::BIO-COMPLEX)
    ("TGF-β and homodimers" . SPARSER::COLLECTION)
    ("TβRII and TβRI" . SPARSER::COLLECTION)
    ("TGF-β-TβRII" . SPARSER::COLLECTION)
    ("bioavailable TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bioactive TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("decorin, biglycan, and betaglycan" . SPARSER::COLLECTION)
    ("betaglycan" . SPARSER::PROTEIN) ("biglycan" . SPARSER::PROTEIN)
    ("decorin" . SPARSER::PROTEIN)
    ("the bioactive TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LAP and LTBP" . SPARSER::COLLECTION) ("LAP-TGF-β" . SPARSER::COLLECTION)
    ("Protein (LTBP)" . SPARSER::PROTEIN) ("LTBP" . SPARSER::PROTEIN-FAMILY)
    ("each monomeric peptide" . SPARSER::PEPTIDE)
    ("protein (LAP)" . SPARSER::PROTEIN)
    ("a noncovalently linked mature TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LAP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("morphogen" . SPARSER::PROTEIN)
    ("Mullerian Inhibitory Substance (MIS) ligands" . SPARSER::LIGAND)
    ("BMP/GDF" . SPARSER::COLLECTION) ("Substance" . SPARSER::SUBSTANCE)
    ("TGF-β, Activin, Inhibin, Nodal, and Lefty" . SPARSER::COLLECTION)
    ("Lefty" . SPARSER::PROTEIN) ("Nodal" . SPARSER::PROTEIN)
    ("TGF-β/Activin" . SPARSER::COLLECTION) ("GDF" . SPARSER::PROTEIN)
    ("the principal molecular components" . SPARSER::COMPONENT)
    ("ALK5" . SPARSER::PROTEIN) ("ALK1" . SPARSER::PROTEIN)
    ("ALK-1" . SPARSER::PROTEIN) ("ALK-5" . SPARSER::PROTEIN)
    ("Smurf2" . SPARSER::PROTEIN) ("Smurf1" . SPARSER::PROTEIN)
    ("Smad7" . SPARSER::PROTEIN) ("L17" . SPARSER::PROTEIN)
    ("TGF-α" . SPARSER::PROTEIN) ("PPM1A" . SPARSER::PROTEIN)
    ("R-Smad" . SPARSER::PROTEIN-FAMILY) ("R-Smads" . SPARSER::PROTEIN)
    ("target cell" . SPARSER::PROTEIN)
    ("Bone Morphogenetic Protein" . SPARSER::PROTEIN)
    ("cyclin D1−" . SPARSER::PROTEIN)
    ("the MCL-associated SOX11 transcription factor" . SPARSER::PROTEIN)
    ("only focal cyclin D1" . SPARSER::PROTEIN) ("PCMs" . SPARSER::PROTEIN)
    ("ATM or TP53" . SPARSER::COLLECTION) ("usual PCs" . SPARSER::PROTEIN)
    ("an overall more aggressive type" . TYPE) ("CD38−" . SPARSER::PROTEIN)
    ("about possible CCND1" . SPARSER::PROTEIN)
    ("even some foci" . SPARSER::PROTEIN)
    ("recognizable cyclin D1+ PC" . SPARSER::PROTEIN)
    ("the ATM tumor suppressor gene and a subset" . SPARSER::COLLECTION)
    ("dim" . SPARSER::PROTEIN-FAMILY) ("larger PCs" . SPARSER::PROTEIN)
    ("available cyclin D1" . SPARSER::PROTEIN)
    ("MCL or PCM" . SPARSER::COLLECTION) ("PCM" . SPARSER::PROTEIN)
    ("antigens" . SPARSER::PROTEIN) ("antigen" . SPARSER::PROTEIN)
    ("MCL" . SPARSER::PROTEIN) ("HLA-DR" . SPARSER::PROTEIN)
    ("MUM1" . SPARSER::PROTEIN) ("CD40L" . SPARSER::PROTEIN)
    ("CD38" . SPARSER::PROTEIN) ("CD10" . SPARSER::PROTEIN)
    ("Texas red" . SPARSER::DRUG) ("IGH@" . SPARSER::PROTEIN)
    ("CD23" . SPARSER::PROTEIN) ("proliferation-associated" . SPARSER::PROTEIN)
    ("SOX11" . SPARSER::PROTEIN) ("‘A’ allele" . SPARSER::PROTEIN)
    ("glioma histologic subtype" . SPARSER::PROTEIN)
    ("glioma histological subtype" . SPARSER::PROTEIN)
    ("A’" . SPARSER::PROTEIN) ("nephrin and podocin" . SPARSER::COLLECTION)
    ("types and cell types" . SPARSER::COLLECTION)
    ("the proximal signaling components" . SPARSER::COMPONENT)
    ("CD2AP, Cbl, and FcεR1γ" . SPARSER::COLLECTION)
    ("state, and CD2AP/SHIP1" . SPARSER::COLLECTION)
    ("CD2AP, SHIP1, and Cbl" . SPARSER::COLLECTION)
    ("SHIP1 and Cbl" . SPARSER::COLLECTION)
    ("Syk and Vav1" . SPARSER::COLLECTION) ("CD2AP-" . SPARSER::PROTEIN)
    ("CD2AP, SHIP1, FcεR1γ, and Syk" . SPARSER::COLLECTION)
    ("CD2AP, SHIP1, FcεR1γ and Syk" . SPARSER::COLLECTION)
    ("fresh isolated human pDCs" . SPARSER::PROTEIN)
    ("CD2AP and SHIP1" . SPARSER::COLLECTION)
    ("polypeptide, and tripartite motif containing 21" . SPARSER::COLLECTION)
    ("Several previously described CD2AP-interacting proteins"
     . SPARSER::PROTEIN)
    ("actin-capping protein, CIN85, and SH3BP1" . SPARSER::COLLECTION)
    ("pg" . SPARSER::MOLECULE)
    ("CD2AP and its family member CIN85" . SPARSER::COLLECTION)
    ("ILT7 and BDCA2" . SPARSER::COLLECTION)
    ("Syk and RTK" . SPARSER::COLLECTION)
    ("receptor tyrosine kinase (RTK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD2AP and CIN85" . SPARSER::COLLECTION)
    ("CIN85 and CD2AP" . SPARSER::COLLECTION)
    ("TRAF6–IRF7" . SPARSER::COLLECTION)
    ("microbial DNA and RNA" . SPARSER::COLLECTION)
    ("TLR9 and TLR7" . SPARSER::COLLECTION)
    ("DNA and RNA" . SPARSER::COLLECTION)
    ("CD2AP/SHIP1/Cbl" . SPARSER::COLLECTION)
    ("CD2AP/SHIP1" . SPARSER::COLLECTION)
    ("Syk and FcεR1γ" . SPARSER::COLLECTION) ("Cbl" . SPARSER::PROTEIN)
    ("Syk" . SPARSER::PROTEIN) ("CD2AP or SHIP1" . SPARSER::COLLECTION)
    ("CD2-associated adaptor protein" . SPARSER::PROTEIN)
    ("pDCs" . SPARSER::PROTEIN) ("pDC" . SPARSER::PROTEIN)
    ("BST2" . SPARSER::PROTEIN) ("glycoprotein VI" . SPARSER::PROTEIN)
    ("fibroblast growth factor-4" . SPARSER::PROTEIN)
    ("Vav1" . SPARSER::PROTEIN) ("DAP12" . SPARSER::PROTEIN)
    ("tripartite motif containing 21" . SPARSER::PROTEIN)
    ("branched chain" . SPARSER::PROTEIN) ("SH3BP1" . SPARSER::PROTEIN)
    ("actin-capping protein" . SPARSER::PROTEIN) ("CD11c" . SPARSER::PROTEIN)
    ("CD56" . SPARSER::PROTEIN) ("VAV1" . SPARSER::PROTEIN)
    ("FcγRIIa" . SPARSER::PROTEIN) ("CIN85" . SPARSER::PROTEIN)
    ("ILT7" . SPARSER::PROTEIN) ("TRAF6" . SPARSER::PROTEIN)
    ("IRAK1" . SPARSER::PROTEIN) ("IRAK4" . SPARSER::PROTEIN)
    ("SHIP1" . SPARSER::PROTEIN) ("CD2" . SPARSER::PROTEIN)
    ("BDCA2" . SPARSER::PROTEIN) ("toxins or siRNA" . SPARSER::COLLECTION)
    ("receptor-antibody" . SPARSER::COLLECTION)
    ("PBS- or HND+LCA" . SPARSER::COLLECTION) ("variant-" . SPARSER::VARIANT)
    ("PBS-" . SPARSER::PROTEIN) ("chimeric EGF" . SPARSER::PROTEIN)
    ("EGF and other EGFR ligands" . SPARSER::COLLECTION)
    ("ligand-competitive antibodies" . SPARSER::ANTIBODY)
    ("exogenous therapeutics" . SPARSER::THERAPEUTICS)
    ("a Ca-calmodulin-dependent kinase II target" . SPARSER::TARGET-PROTEIN)
    ("LCA" . SPARSER::PROTEIN) ("trans and tet" . SPARSER::COLLECTION)
    ("a representative dynamic light" . SPARSER::PROTEIN)
    ("cis and trans" . SPARSER::COLLECTION)
    ("the epidermal growth factor (EGF)-competitive 225 immunoglobulin (IgG) scaffold"
     . SPARSER::SCAFFOLD)
    ("domain 1 (clone A), domain 3 (clone B), and domains"
     . SPARSER::COLLECTION)
    ("soluble beta-sandwich protein" . SPARSER::PROTEIN)
    ("tri-" . SPARSER::PROTEIN) ("tri" . SPARSER::PROTEIN)
    ("MAPK and phosphoinositide 3 kinase" . SPARSER::COLLECTION)
    ("BRAF- and KRAS-mutant" . SPARSER::COLLECTION)
    ("BRAF-" . SPARSER::PROTEIN) ("antibody-fibronectin" . SPARSER::COLLECTION)
    ("raf and ras" . SPARSER::COLLECTION)
    ("cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("light chain" . SPARSER::PROTEIN) ("H11" . SPARSER::PROTEIN)
    ("domain 1" . SPARSER::PROTEIN)
    ("phosphoinositide 3 kinase" . SPARSER::PROTEIN)
    ("MRE11 and MLH1" . SPARSER::COLLECTION) ("Ali" . SPARSER::PROTEIN)
    ("psoralen and MMC" . SPARSER::COLLECTION)
    ("RNF8 or FAAP20" . SPARSER::COLLECTION)
    ("histone H2A and possibly other substrates" . SPARSER::COLLECTION)
    ("possibly other substrates" . SPARSER::SUBSTRATE)
    ("RNF8 and its partner UBC13" . SPARSER::COLLECTION)
    ("ATR and its downstream kinase CHK1" . SPARSER::COLLECTION)
    ("RNF-FAAP20" . SPARSER::COLLECTION)
    ("either FAAP20 ( xref ) or RNF8 ( xref )" . SPARSER::COLLECTION)
    ("RNF8 and FANCA" . SPARSER::COLLECTION)
    ("laser-activated psoralen ICLs" . SPARSER::PROTEIN)
    ("MHF" . SPARSER::PROTEIN)
    ("most FANCM and its DNA binding partner MHF (about 90%)"
     . SPARSER::COLLECTION)
    ("FANCA and other FANC proteins" . SPARSER::COLLECTION)
    ("FANCM-MHF" . SPARSER::COLLECTION)
    ("laser-activated ICLs" . SPARSER::PROTEIN)
    ("FANCA and FANCD2" . SPARSER::COLLECTION)
    ("GFP-FAAP20" . SPARSER::COLLECTION) ("Flag-FAAP20" . SPARSER::COLLECTION)
    ("laser-activated psoralen" . SPARSER::DRUG)
    ("FANCM and MHF1" . SPARSER::COLLECTION) ("psoralen" . SPARSER::DRUG)
    ("both K48-and K63 -linked polyubiquitin" . SPARSER::PROTEIN)
    ("monoubiquitin" . SPARSER::PROTEIN) ("ubiquitins" . SPARSER::PROTEIN)
    ("Nemo" . SPARSER::PROTEIN) ("FANCA or FANCG" . SPARSER::COLLECTION)
    ("FANCL or FANCC" . SPARSER::COLLECTION)
    ("exogenous FANCA" . SPARSER::PROTEIN)
    ("FANCA and FANCG" . SPARSER::COLLECTION)
    ("FAAP20-associated polypeptides" . SPARSER::PEPTIDE)
    ("anti-FANCA or FANCG" . SPARSER::COLLECTION)
    ("the FA core complex and BLM complex" . SPARSER::COLLECTION)
    ("BLM, TOPIIIα, and RPA70" . SPARSER::COLLECTION)
    ("either K63- or K48-linked ubiquitin" . SPARSER::COLLECTION)
    ("lysine 48 (K48)-linked polyubiquitins" . SPARSER::PROTEIN)
    ("polyubiquitins" . SPARSER::PROTEIN)
    ("FANCM, MHF and FAAP24" . SPARSER::COLLECTION)
    ("XPA and XPC" . SPARSER::COLLECTION) ("FANCP/SLX4" . SPARSER::COLLECTION)
    ("FANCP" . SPARSER::PROTEIN) ("FANCN/PALB2" . SPARSER::COLLECTION)
    ("FANCJ/BACH1/BRIP1" . SPARSER::COLLECTION)
    ("FANCD1/BRCA2" . SPARSER::COLLECTION) ("FANCN" . SPARSER::PROTEIN)
    ("proteins, FANCD2 and FANCI" . SPARSER::COLLECTION)
    ("ID" . SPARSER::PROTEIN)
    ("eight FANC proteins (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL and FANCM) and four FA-associated proteins (FAAP100, FAAP24, MHF1 and MHF2)"
     . SPARSER::COLLECTION)
    ("four FA-associated proteins" . SPARSER::PROTEIN)
    ("FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL and FANCM"
     . SPARSER::COLLECTION)
    ("FAAP100, FAAP24, MHF1 and MHF2" . SPARSER::COLLECTION)
    ("FANCL" . SPARSER::PROTEIN) ("FANCG" . SPARSER::PROTEIN)
    ("FANCF" . SPARSER::PROTEIN) ("FANCE" . SPARSER::PROTEIN)
    ("FANCC" . SPARSER::PROTEIN) ("FANCB" . SPARSER::PROTEIN)
    ("FANCA" . SPARSER::PROTEIN) ("Fanconi anemia (FA)" . SPARSER::PROTEIN)
    ("RNF8-FAAP20" . SPARSER::COLLECTION) ("RNF8 and FA" . SPARSER::COLLECTION)
    ("RNF8 and FAAP20" . SPARSER::COLLECTION)
    ("RNF8 and UBC13" . SPARSER::COLLECTION)
    ("RNF8-UBC13" . SPARSER::COLLECTION) ("MRE11" . SPARSER::PROTEIN)
    ("Rev1" . SPARSER::PROTEIN) ("RAD51 recombinase" . SPARSER::PROTEIN)
    ("C1ORF86" . SPARSER::PROTEIN) ("RPA70" . SPARSER::PROTEIN)
    ("ubiquitin conjugating enzymes" . SPARSER::PROTEIN-FAMILY)
    ("BRIP1" . SPARSER::PROTEIN) ("BACH1" . SPARSER::PROTEIN)
    ("FANCD1" . SPARSER::PROTEIN) ("MHF2" . SPARSER::PROTEIN)
    ("MHF1" . SPARSER::PROTEIN) ("FAAP100" . SPARSER::PROTEIN)
    ("FAAP20" . SPARSER::PROTEIN) ("a global activator" . SPARSER::ACTIVATOR)
    ("HARP, AH2, RAD54L and SMARCA1" . SPARSER::COLLECTION)
    ("bulky DNA adducts" . SPARSER::PROTEIN) ("adducts" . SPARSER::PROTEIN)
    ("HARP and HARP-like" . SPARSER::COLLECTION)
    ("RAD54L, RAD54L-MBM and RAD54L-ABM" . SPARSER::COLLECTION)
    ("RAD54L-ABM" . SPARSER::PROTEIN-PAIR)
    ("RAD54L-MBM" . SPARSER::PROTEIN-PAIR)
    ("AH2, RAD54L and SMARCA1" . SPARSER::COLLECTION)
    ("RAD54L or SMARCA1" . SPARSER::COLLECTION)
    ("at least two proteins, RAD54L and SMARCA1" . SPARSER::COLLECTION)
    ("proteins, RAD54L and SMARCA1" . SPARSER::COLLECTION)
    ("HARP and AH2" . SPARSER::COLLECTION)
    ("still more such proteins" . SPARSER::PROTEIN)
    ("AH2 or HARP" . SPARSER::COLLECTION)
    ("RPA and γH2AX" . SPARSER::COLLECTION)
    ("AH2 and HARP" . SPARSER::COLLECTION)
    ("HARP or HARP-like" . SPARSER::COLLECTION)
    ("wild-type AH2 as well as AH2 mutants ( xref )" . SPARSER::COLLECTION)
    ("four internal deletion mutants" . SPARSER::MUTANT)
    ("HARP and wild-type AH2" . SPARSER::COLLECTION)
    ("an internal deletion mutant" . SPARSER::MUTANT)
    ("exogenous AH2" . SPARSER::PROTEIN) ("HU or CPT" . SPARSER::COLLECTION)
    ("p21 or Cip1" . SPARSER::COLLECTION) ("Cip1" . SPARSER::PROTEIN)
    ("SMARCD1, SMARCA1, HELLS, RAD54L and HARP" . SPARSER::COLLECTION)
    ("HELLS" . SPARSER::PROTEIN) ("AH2 and PCNA" . SPARSER::COLLECTION)
    ("the major AH2-associated protein" . SPARSER::PROTEIN)
    ("SFB-AH2" . SPARSER::COLLECTION) ("TAP" . SPARSER::PROTEIN)
    ("CPT and MMC" . SPARSER::COLLECTION)
    ("inhibitor camptothecin (CPT) and the DNA cross-linking reagent mitomycin C (MMC) ( xref )"
     . SPARSER::COLLECTION)
    ("mitomycin C (MMC)" . SPARSER::DRUG)
    ("camptothecin (CPT)" . SPARSER::DRUG)
    ("Two lentiviral shRNAs" . SPARSER::RNA)
    ("discrete foci" . SPARSER::PROTEIN)
    ("RAD54L and SMARCA1" . SPARSER::COLLECTION)
    ("RPA-bound complementary ssDNA" . SPARSER::PROTEIN)
    ("complementary ssDNA" . SPARSER::PROTEIN)
    ("DNA polymerases and other replisome components" . SPARSER::COLLECTION)
    ("replisome" . SPARSER::PROTEIN)
    ("ultraviolet light-induced pyrimidine dimers" . SPARSER::DIMER)
    ("SMARCA1 and RAD54L" . SPARSER::COLLECTION) ("HPL" . SPARSER::PROTEIN)
    ("HARP" . SPARSER::PROTEIN) ("RAD54" . SPARSER::PROTEIN)
    ("pMD2" . SPARSER::MOLECULE) ("Anti-β" . SPARSER::PROTEIN)
    ("Rad54" . SPARSER::PROTEIN) ("BRG1" . SPARSER::PROTEIN)
    ("ATP dependent" . SPARSER::PROTEIN) ("SMARCD1" . SPARSER::PROTEIN)
    ("S-protein" . SPARSER::PROTEIN) ("autosomal recessive" . SPARSER::PROTEIN)
    ("RAD54L" . SPARSER::PROTEIN) ("SMARCA1" . SPARSER::PROTEIN)
    ("protein and cyclin D1" . SPARSER::COLLECTION)
    ("Lysines" . SPARSER::AMINO-ACID) ("ARM" . SPARSER::PROTEIN)
    ("βTrCP1" . SPARSER::PROTEIN)
    ("Rad6B and polyubiquitinated" . SPARSER::COLLECTION)
    ("Rad6B or histone" . SPARSER::COLLECTION)
    ("catalytically inert rad6B" . SPARSER::PROTEIN)
    ("H2A and H2B" . SPARSER::COLLECTION)
    ("ubiquitin or K63-linked ubiquitin chain antibody" . SPARSER::COLLECTION)
    ("RMs" . SPARSER::MOLECULE) ("nascent β-catenin" . SPARSER::PROTEIN)
    ("RM" . SPARSER::MOLECULE)
    ("Rad6B, cyclin D1, and c-Myc" . SPARSER::COLLECTION)
    ("Rad6B, cyclin D1 and c-Myc" . SPARSER::COLLECTION)
    ("shRNA or Rad6BshRNA, and myc-tagged" . SPARSER::COLLECTION)
    ("K394R-β-catenin and ubiquitin" . SPARSER::COLLECTION)
    ("ubiquitin or mutant" . SPARSER::COLLECTION)
    ("131–699 ( xref , arrow in b′) but not β-catenin 555–781 ( xref )"
     . SPARSER::PROTEIN)
    ("β-catenin–Rad6B" . SPARSER::COLLECTION) ("rad6B" . SPARSER::PROTEIN)
    ("-agarose" . SPARSER::MOLECULE) ("Sepharose" . SPARSER::MOLECULE)
    ("Rad6B/β-catenin" . SPARSER::COLLECTION)
    ("normal IgGs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rad6 or β-catenin" . SPARSER::COLLECTION)
    ("IgGs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rad6 and β-catenin" . SPARSER::COLLECTION)
    ("β-catenin and β-catenin" . SPARSER::COLLECTION)
    ("β-catenin and amino acids" . SPARSER::COLLECTION)
    ("polyubiquitinated-β-catenin" . SPARSER::COLLECTION)
    ("polyubiquitinated" . SPARSER::PROTEIN)
    ("β-catenin or its regulators" . SPARSER::COLLECTION)
    ("axin and adenomatous polyposis coli" . SPARSER::COLLECTION)
    ("β-TrCP/SCF" . SPARSER::COLLECTION)
    ("Rad6B and β-catenin" . SPARSER::COLLECTION)
    ("β-catenin/T-cell" . SPARSER::COLLECTION)
    ("HHR6A (UBE2A) and HHR6B (UBE2B)" . SPARSER::COLLECTION)
    ("rad6" . SPARSER::PROTEIN) ("Rad6A and Rad6B" . SPARSER::COLLECTION)
    ("Rad6A" . SPARSER::PROTEIN) ("Ser or Ala" . SPARSER::COLLECTION)
    ("protein and Rad6" . SPARSER::COLLECTION) ("Lysine" . SPARSER::AMINO-ACID)
    ("GST-β-catenin" . SPARSER::COLLECTION)
    ("β-catenin and Rad6B" . SPARSER::COLLECTION) ("TCF4" . SPARSER::PROTEIN)
    ("K19" . SPARSER::PROTEIN) ("βTrCP" . SPARSER::PROTEIN)
    ("CK1α" . SPARSER::PROTEIN) ("S33" . SPARSER::PROTEIN)
    ("TCF-4" . SPARSER::PROTEIN) ("P300" . SPARSER::PROTEIN)
    ("ubiquitin activating enzyme E1" . SPARSER::PROTEIN)
    ("cytokeratin-18" . SPARSER::PROTEIN)
    ("Glutathione S-transferase" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor" . SPARSER::PROTEIN) ("ARM1" . SPARSER::PROTEIN)
    ("GSK 3β" . SPARSER::PROTEIN)
    ("Glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("UBE2B" . SPARSER::PROTEIN) ("HHR6B" . SPARSER::PROTEIN)
    ("UBE2A" . SPARSER::PROTEIN) ("HHR6A" . SPARSER::PROTEIN)
    ("Rad6" . SPARSER::PROTEIN) ("Rad6B" . SPARSER::PROTEIN)
    ("RAD18 and WRNIP1" . SPARSER::COLLECTION) ("orthologs" . SPARSER::PROTEIN)
    ("ssDNA or dsDNA" . SPARSER::COLLECTION) ("ATPases" . SPARSER::PROTEIN)
    ("the recently described PARI anti-recombinase" . SPARSER::ANTIBODY)
    ("an anti-recombinase" . SPARSER::ANTIBODY)
    ("PCNA and RPA" . SPARSER::COLLECTION)
    ("FANCM and HLTF" . SPARSER::COLLECTION)
    ("BLM, WRN and RECQ5" . SPARSER::COLLECTION)
    ("preferentially binds K63-linked poly-ubiquitin" . SPARSER::PROTEIN)
    ("ZRANB3 or SMARCAL1" . SPARSER::COLLECTION)
    ("divalent ions" . SPARSER::MOLECULE) ("ions" . SPARSER::MOLECULE)
    ("FLAG-SMARCAL1" . SPARSER::COLLECTION)
    ("labeled duplex DNA" . SPARSER::DNA) ("a duplex DNA" . SPARSER::DNA)
    ("a previously developed plasmid based DNA substrate" . SPARSER::SUBSTRATE)
    ("homologous DNA" . SPARSER::DNA) ("Idu" . SPARSER::DRUG)
    ("IdU" . SPARSER::DRUG) ("MMC or camptothecin" . SPARSER::COLLECTION)
    ("camptothecin and milder sensitivity to hydroxyurea or cisplatin ( xref )"
     . SPARSER::COLLECTION)
    ("hydroxyurea or cisplatin" . SPARSER::COLLECTION)
    ("camptothecin, hydroxyurea or cisplatin" . SPARSER::COLLECTION)
    ("ZRANB3 and WRNIP1" . SPARSER::COLLECTION)
    ("a RAD18- and WRN-interacting ATPase" . SPARSER::COLLECTION)
    ("RAD18-" . SPARSER::PROTEIN) ("WRNIP1 and RAD18" . SPARSER::COLLECTION)
    ("RAD18 and UBC13" . SPARSER::COLLECTION)
    ("RAD18 or UBC13" . SPARSER::COLLECTION)
    ("ZRANB3 and PCNA" . SPARSER::COLLECTION)
    ("formaldehyde" . SPARSER::MOLECULE)
    ("ZRANB3 or ZRANB3" . SPARSER::COLLECTION)
    ("the double PIP and APIM mutant" . SPARSER::COLLECTION)
    ("ZRANB1, TAB2 and TAB3" . SPARSER::COLLECTION)
    ("TAB2, TAB3 and ZRANB1" . SPARSER::COLLECTION)
    ("deubiquitinase" . SPARSER::DEUBIQUITINASE)
    ("TAB2 and TAB3" . SPARSER::COLLECTION) ("UBM" . SPARSER::PROTEIN)
    ("the double PIP and APIM mutant ZRANB3" . SPARSER::COLLECTION)
    ("FLAG-ZRANB3" . SPARSER::COLLECTION)
    ("cisplatin and UV radiation ( xref and xref )" . SPARSER::COLLECTION)
    ("camptothecin" . SPARSER::DRUG)
    ("the PIP and APIM mutants ( xref )" . SPARSER::COLLECTION)
    ("both individual GFP-ZRANB3 PIP or APIM mutants" . SPARSER::COLLECTION)
    ("SiRNA" . SPARSER::PROTEIN) ("APIM" . SPARSER::PROTEIN)
    ("GFP-APIM" . SPARSER::PROTEIN-PAIR)
    ("the first 31 amino acids of SMARCAL1 ( xref ; xref ; xref ; xref ; xref )"
     . SPARSER::PROTEIN)
    ("GFP-SMARCAL1" . SPARSER::COLLECTION) ("GFP-ZRANB3" . SPARSER::COLLECTION)
    ("zinc finger (NZF)" . SPARSER::PROTEIN) ("HNH" . SPARSER::PROTEIN-FAMILY)
    ("NZF" . SPARSER::PROTEIN) ("ZRANB3 and SMARCAL1" . SPARSER::COLLECTION)
    ("PARI" . SPARSER::PROTEIN)
    ("RAD18 and the ATPase WRNIP1" . SPARSER::COLLECTION)
    ("SCE" . SPARSER::PROTEIN) ("ATPase" . SPARSER::PROTEIN)
    ("loss of heterozygosity (LOH)" . SPARSER::PROTEIN)
    ("HLTF and SHPRH" . SPARSER::COLLECTION)
    ("UBC13/MMS2" . SPARSER::COLLECTION) ("SHPRH" . SPARSER::PROTEIN)
    ("HLTF" . SPARSER::PROTEIN)
    ("WRN and the Fanconi Anemia FANCM/FAAP24 complex ( xref ; xref ; xref ; xref ; xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("FANCM/FAAP24" . SPARSER::COLLECTION) ("FANCM" . SPARSER::PROTEIN)
    ("WRN" . SPARSER::PROTEIN) ("BLM" . SPARSER::PROTEIN)
    ("RecQ" . SPARSER::PROTEIN-FAMILY) ("ssDNA" . SPARSER::PROTEIN)
    ("Ubi-1" . SPARSER::PROTEIN) ("RECQ5" . SPARSER::PROTEIN)
    ("hRAD51" . SPARSER::PROTEIN) ("poly-ubiquitin" . SPARSER::PROTEIN)
    ("RANBP2" . SPARSER::PROTEIN) ("ZRANB1" . SPARSER::PROTEIN)
    ("TAB3" . SPARSER::PROTEIN) ("TAB2" . SPARSER::PROTEIN)
    ("AlkB homolog 2" . SPARSER::PROTEIN) ("RPA2" . SPARSER::PROTEIN)
    ("nuclease activity" . SPARSER::PROTEIN) ("NPL4" . SPARSER::PROTEIN)
    ("AH2" . SPARSER::PROTEIN) ("Srs2" . SPARSER::PROTEIN)
    ("WRNIP1" . SPARSER::PROTEIN) ("Rad5" . SPARSER::PROTEIN)
    ("MMS2" . SPARSER::PROTEIN) ("UBC13" . SPARSER::PROTEIN)
    ("RAD18" . SPARSER::PROTEIN) ("FAAP24" . SPARSER::PROTEIN)
    ("Fanconi Anemia" . SPARSER::PROTEIN) ("SMARCAL1" . SPARSER::PROTEIN)
    ("SNF2" . SPARSER::PROTEIN) ("ZRANB3" . SPARSER::PROTEIN)
    ("invasive subtypes" . SPARSER::PROTEIN)
    ("invasive UC FGFR1" . SPARSER::PROTEIN)
    ("proteins and molecules" . SPARSER::COLLECTION)
    ("Activated FGFR1 increased intracellular PGE2" . SPARSER::DRUG)
    ("COX-2 and E-cadherin" . SPARSER::COLLECTION) ("CHO" . SPARSER::PROTEIN)
    ("regulating FGFR1-induced urothelial EMT" . SPARSER::PROTEIN)
    ("RAS-MEK-ERK" . SPARSER::COLLECTION) ("MEK-ERK" . SPARSER::COLLECTION)
    ("cAMP" . SPARSER::PROTEIN) ("FGF1, FGF7, and FGF10" . SPARSER::COLLECTION)
    ("FGFR1 and E-cadherin" . SPARSER::COLLECTION)
    ("FGFR1 and EMT" . SPARSER::COLLECTION)
    ("a partially de-differentiated state" . SPARSER::BIO-STATE)
    ("TGFβ and HGF" . SPARSER::COLLECTION)
    ("EP4 and phospholipase A2" . SPARSER::COLLECTION)
    ("AH" . SPARSER::MOLECULE)
    ("N-cadherin, vimentin and fibronectin" . SPARSER::COLLECTION)
    ("Both U0126 and BAPTA-AM significantly (p<0.05) reduced migration"
     . SPARSER::COLLECTION)
    ("U0126 or BIRB and FGF2" . SPARSER::COLLECTION)
    ("p38/STAT3" . SPARSER::COLLECTION) ("U0126 or BIRB" . SPARSER::COLLECTION)
    ("Urothelial EMT" . SPARSER::PROTEIN) ("BAPTA" . SPARSER::MOLECULE)
    ("chelator" . SPARSER::MOLECULE) ("p38 and STAT3" . SPARSER::COLLECTION)
    ("FGFR1-induced urothelial EMT" . SPARSER::PROTEIN)
    ("ERK, p38 and STATs" . SPARSER::COLLECTION)
    ("ERK and p38 MAPKs" . SPARSER::COLLECTION) ("Antibody" . SPARSER::PROTEIN)
    ("heparin or heparin and FGF2" . SPARSER::COLLECTION)
    ("heparin and FGF2" . SPARSER::COLLECTION) ("FR" . SPARSER::PROTEIN)
    ("a valid therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("growth factors and RAS" . SPARSER::COLLECTION)
    ("receptor tyrosine kinases and downstream effectors"
     . SPARSER::COLLECTION)
    ("the fibroblast growth factor (FGF) and transforming growth factor β (TGFβ) families"
     . SPARSER::COLLECTION)
    ("fibroblast growth factor (FGF)" . SPARSER::PROTEIN-FAMILY)
    ("PLCγand MAPK" . SPARSER::COLLECTION)
    ("mitogen activated protein kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("urothelial EMT" . SPARSER::PROTEIN) ("FGF10" . SPARSER::PROTEIN)
    ("FGF7" . SPARSER::PROTEIN) ("FGF1" . SPARSER::PROTEIN)
    ("PLA2" . SPARSER::PROTEIN) ("EP4" . SPARSER::PROTEIN)
    ("EP4 receptor" . SPARSER::PROTEIN) ("ZEB1" . SPARSER::PROTEIN)
    ("Cyclooxygenase-2" . SPARSER::PROTEIN) ("p38 MAPKs" . SPARSER::PROTEIN)
    ("NS-398" . SPARSER::DRUG) ("Prostaglandin E2" . SPARSER::MOLECULE)
    ("PGE 2" . SPARSER::DRUG) ("PGE2" . SPARSER::DRUG)
    ("prostaglandin E 2" . SPARSER::MOLECULE)
    ("mitogen activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("at least three KRAS" . SPARSER::PROTEIN)
    ("KRAS and Ras-responsive element-binding protein (RREB1)"
     . SPARSER::COLLECTION)
    ("KRAS and c-MYC" . SPARSER::COLLECTION)
    ("EGFR and ErbB2" . SPARSER::COLLECTION)
    ("growth-factor-receptor tyrosine kinases" . SPARSER::COLLECTION)
    ("KRAS/MAPK" . SPARSER::COLLECTION)
    ("miR-30c and KRAS" . SPARSER::COLLECTION) ("PITA" . SPARSER::PROTEIN)
    ("This miRNA potentially target important mediators" . SPARSER::PROTEIN)
    ("KRAS, RASA1, MAP3K1 and MAPK8" . SPARSER::COLLECTION)
    ("Almost all differentially" . SPARSER::PROTEIN)
    ("hsa-miR" . SPARSER::COLLECTION) ("hsa-miRNAs" . SPARSER::COLLECTION)
    ("hsa" . SPARSER::PROTEIN) ("LNA" . SPARSER::PROTEIN)
    ("genes and pathways" . SPARSER::COLLECTION)
    ("miRNA and mRNA" . SPARSER::COLLECTION)
    ("suppressors and oncogenes" . SPARSER::COLLECTION)
    ("five reproducible molecular subtypes" . SPARSER::PROTEIN)
    ("BRCAX" . SPARSER::PROTEIN)
    ("the currently known high risk-breast cancer genes" . SPARSER::GENE)
    ("miR-30c" . SPARSER::PROTEIN) ("pre-miR-30c" . SPARSER::COLLECTION)
    ("RAS3" . SPARSER::PROTEIN) ("Pre-miRNA" . SPARSER::RNA)
    ("Penicillin G" . SPARSER::MOLECULE) ("miR-125b" . SPARSER::MOLECULE)
    ("RREB1" . SPARSER::PROTEIN) ("ErbB-2" . SPARSER::PROTEIN)
    ("growth-factor" . SPARSER::HUMAN-PROTEIN-FAMILY) ("let-7" . SPARSER::RNA)
    ("MAPK8" . SPARSER::PROTEIN) ("MAP3K1" . SPARSER::PROTEIN)
    ("RASA1" . SPARSER::PROTEIN) ("miR-10b" . SPARSER::MOLECULE)
    ("miR-125a" . SPARSER::PROTEIN) ("the ciliary Plk1" . SPARSER::PROTEIN)
    ("ciliary substrates" . SPARSER::SUBSTRATE)
    ("the transition zone proteins or the ciliary proteome"
     . SPARSER::COLLECTION)
    ("no available phospho-specific antibody" . SPARSER::ANTIBODY)
    ("a possible larger functional complex" . SPARSER::BIO-COMPLEX)
    ("nephrocystin-4 (NPHP4) and the protein tyrosine kinase 2 (Pyk2)"
     . SPARSER::COLLECTION)
    ("NPHP1 and Plk1" . SPARSER::COLLECTION) ("pS" . SPARSER::PROTEIN)
    ("a mitotic inhibitor" . SPARSER::INHIBITOR)
    ("ciliary proteins" . SPARSER::PROTEIN)
    ("the ciliary fraction" . SPARSER::COMPONENT)
    ("Plk1 and Aurora-A" . SPARSER::COLLECTION)
    ("Aurora-A/HDAC-6" . SPARSER::COLLECTION)
    ("Aurora-A and Plk1" . SPARSER::COLLECTION)
    ("another mitotic kinase" . SPARSER::KINASE)
    ("the mitotic kinase Plk1" . SPARSER::PROTEIN)
    ("similarly localized active Plk1" . SPARSER::PROTEIN)
    ("ph-Plk1" . SPARSER::COLLECTION)
    ("the mitotic centrosomes" . SPARSER::PROTEIN)
    ("Plk1 or control siRNA (scr)" . SPARSER::COLLECTION)
    ("Plk1-pT210" . SPARSER::PROTEIN-PAIR)
    ("Plk1 and NPHP1" . SPARSER::COLLECTION) ("myc-Plk1" . SPARSER::COLLECTION)
    ("Plk1-NPHP1" . SPARSER::COLLECTION) ("Flag-Plk1" . SPARSER::COLLECTION)
    ("Plk1 or Flag" . SPARSER::COLLECTION) ("Nephrocystin" . SPARSER::PROTEIN)
    ("Component" . SPARSER::COMPONENT)
    ("the kinetochore-associated checkpoint kinase BUBR1 (also known as BUB1β) and the central spindlin complex protein"
     . SPARSER::COLLECTION)
    ("the kinetochore-associated checkpoint kinase BUBR1" . SPARSER::PROTEIN)
    ("kizuna" . SPARSER::PROTEIN-FAMILY) ("NINL" . SPARSER::PROTEIN)
    ("other mitotic regulators" . SPARSER::REGULATOR)
    ("a Ca(2+)-permeable nonselective cation channel" . SPARSER::PROTEIN)
    ("PKD" . SPARSER::PROTEIN) ("AURKA" . SPARSER::PROTEIN)
    ("NPHP1 and NPHP4" . SPARSER::COLLECTION) ("elegans" . SPARSER::PROTEIN)
    ("Lov" . SPARSER::PROTEIN) ("PKD1 and PKD2" . SPARSER::COLLECTION)
    ("polycystins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("almost all cystic disease-causing genes" . SPARSER::GENE)
    ("nephrocystin" . SPARSER::PROTEIN)
    ("a ciliary protein" . SPARSER::PROTEIN) ("Ataxin-10" . SPARSER::PROTEIN)
    ("Pyk2" . SPARSER::PROTEIN) ("tyrosine kinase 2" . SPARSER::PROTEIN)
    ("nephrocystin-4" . SPARSER::PROTEIN) ("pT-P" . SPARSER::PROTEIN)
    ("HDAC-6" . SPARSER::PROTEIN) ("HEF1" . SPARSER::PROTEIN)
    ("CH3" . SPARSER::MOLECULE) ("HCO3" . SPARSER::MOLECULE)
    ("32P" . SPARSER::|32P|) ("B-1" . SPARSER::PROTEIN)
    ("BI 2536" . SPARSER::DRUG) ("CYK4" . SPARSER::PROTEIN)
    ("BUBR1" . SPARSER::PROTEIN) ("ninein-like protein" . SPARSER::PROTEIN)
    ("cation channel" . SPARSER::PROTEIN) ("Ca(2+)" . SPARSER::CALCIUM-ION)
    ("polycystin-2" . SPARSER::PROTEIN) ("Aurora-A" . SPARSER::PROTEIN)
    ("NPHP4" . SPARSER::PROTEIN) ("polycystin-1" . SPARSER::PROTEIN)
    ("PKD2" . SPARSER::PROTEIN) ("PKD1" . SPARSER::PROTEIN)
    ("nephrocystin-1" . SPARSER::PROTEIN) ("NPHP1" . SPARSER::PROTEIN)
    ("Nephrocystin-1" . SPARSER::PROTEIN)
    ("cangrelor or drugs" . SPARSER::COLLECTION)
    ("platelets and other blood components" . SPARSER::COLLECTION)
    ("Such innovative substances" . SPARSER::SUBSTANCE)
    ("substances" . SPARSER::SUBSTANCE)
    ("the respective receptors" . SPARSER::PROTEIN)
    ("P 2 Y 12 , P 2 Y 1 or PI3K" . SPARSER::COLLECTION)
    ("p110α and p110γ" . SPARSER::COLLECTION)
    ("during ECC and hypothermia" . SPARSER::COLLECTION)
    ("normothermic ex vivo ECC" . SPARSER::MOLECULE)
    ("thienopyridine" . SPARSER::DRUG) ("cangrelor" . SPARSER::DRUG)
    ("clopidogrel and prasugrel" . SPARSER::COLLECTION)
    ("prasugrel" . SPARSER::DRUG) ("clopidogrel" . SPARSER::DRUG)
    ("thienopyridines" . SPARSER::DRUG)
    ("GPIbα and GPIIb/IIIa" . SPARSER::COLLECTION)
    ("leukocytes and platelets" . SPARSER::COLLECTION)
    ("Hypothermic ECC, P 2 Y Blockade and PI3K p110β Inhibition"
     . SPARSER::COLLECTION)
    ("receptor and PI3K" . SPARSER::COLLECTION)
    ("hypothermic ECC or antiplatelet agents (data not shown)"
     . SPARSER::COLLECTION)
    ("typical platelet surface receptors" . SPARSER::RECEPTOR)
    ("platelets and PMPs" . SPARSER::COLLECTION)
    ("ECC or P" . SPARSER::COLLECTION)
    ("fibrinogen and vWF" . SPARSER::COLLECTION)
    ("Hypothermic ECC" . SPARSER::MOLECULE) ("vWF" . SPARSER::PROTEIN)
    ("receptors and PI3K" . SPARSER::COLLECTION)
    ("fibrinogen" . SPARSER::PROTEIN)
    ("P-selectin-PSGL-1" . SPARSER::COLLECTION)
    ("CD11b/CD18" . SPARSER::COLLECTION)
    ("dysfunctional platelets" . SPARSER::PROTEIN) ("ECC-" . SPARSER::MOLECULE)
    ("P 2 Y 12 , P 2 Y 1 and PI3K" . SPARSER::COLLECTION)
    ("Mac-1" . SPARSER::PROTEIN)
    ("platelets and platelet-derived microparticles" . SPARSER::COLLECTION)
    ("GPIIb" . SPARSER::PROTEIN) ("hypothermic ECC" . SPARSER::MOLECULE)
    ("P 2 Y 12 and P 2 Y 1" . SPARSER::COLLECTION)
    ("ECC and hypothermia" . SPARSER::COLLECTION) ("ECC" . SPARSER::MOLECULE)
    ("CD15" . SPARSER::DRUG) ("PAC-1" . SPARSER::PROTEIN)
    ("p110γ" . SPARSER::PROTEIN) ("CD40 ligand" . SPARSER::PROTEIN)
    ("CD18" . SPARSER::PROTEIN) ("PSGL-1" . SPARSER::PROTEIN)
    ("P-selectin" . SPARSER::PROTEIN)
    ("von Willebrand factor" . SPARSER::PROTEIN) ("GPIbα" . SPARSER::PROTEIN)
    ("TGX-221" . SPARSER::DRUG) ("MRS2179" . SPARSER::DRUG)
    ("P 2 Y 1" . SPARSER::PROTEIN) ("P 2 Y 12" . SPARSER::PROTEIN)
    ("p110β" . SPARSER::PROTEIN)
    ("phosphoinositide-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BCNU" . SPARSER::DRUG) ("VPA and etoposide" . SPARSER::COLLECTION)
    ("U87, U251, and LN18" . SPARSER::COLLECTION)
    ("p21/WAF1" . SPARSER::COLLECTION) ("LN18" . SPARSER::PROTEIN)
    ("VPA and other anticancer drugs" . SPARSER::COLLECTION)
    ("valproic acid (VPA; Depakine) and suberoylanilide hydroxamic acid (SAHA; vorinostat)"
     . SPARSER::COLLECTION)
    ("-deoxycytidine" . SPARSER::COLLECTION) ("decitabine" . SPARSER::DRUG)
    ("deoxycytidine" . SPARSER::PROTEIN)
    ("4 mM VPA and/or 50  μ M TMZ" . SPARSER::COLLECTION)
    ("Bcl-2, Bak, and caspase-3" . SPARSER::COLLECTION)
    ("VPA (0–8 mM) and TMZ (50  μ M)" . SPARSER::COLLECTION)
    ("4 mM VPA and 50  μ M TMZ" . SPARSER::COLLECTION)
    ("VPA or TMZ" . SPARSER::COLLECTION) ("VPA or 0–1" . SPARSER::COLLECTION)
    ("inhibitor (HDACI)" . SPARSER::INHIBITOR) ("HDACI" . SPARSER::MOLECULE)
    ("chromatin-associated histones" . SPARSER::PROTEIN)
    ("epileptic seizures" . SPARSER::PROTEIN) ("migraine" . SPARSER::PROTEIN)
    ("seizures" . SPARSER::PROTEIN) ("carboxamide" . SPARSER::MOLECULE)
    ("tetrazine" . SPARSER::MOLECULE) ("VPA and TMZ" . SPARSER::COLLECTION)
    ("VPA" . SPARSER::PROTEIN) ("S-G2" . SPARSER::PROTEIN)
    ("Cyr61" . SPARSER::PROTEIN) ("LC3-II" . SPARSER::PROTEIN)
    ("LC3" . SPARSER::PROTEIN)
    ("microtubule-associated protein" . SPARSER::PROTEIN)
    ("Z-VAD-fmk" . SPARSER::DRUG)
    ("phenylmethanesulfonyl fluoride" . SPARSER::MOLECULE)
    ("LC3B" . SPARSER::PROTEIN) ("anti- β" . SPARSER::PROTEIN)
    ("valproic acid" . SPARSER::MOLECULE)
    ("short-chain fatty acid" . SPARSER::MOLECULE)
    ("gamma-aminobutyric acid" . SPARSER::MOLECULE)
    ("alkylating agent" . SPARSER::MOLECULE)
    ("O6-methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("Valproic acid" . SPARSER::MOLECULE) ("antisense" . SPARSER::PROTEIN)
    ("p53 or different cofactors" . SPARSER::COLLECTION)
    ("CDKN1A and PML" . SPARSER::COLLECTION)
    ("similar cumulative p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cumulative p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fresh growth media" . SPARSER::PROTEIN) ("β-gal" . SPARSER::PROTEIN)
    ("TP53AIP1" . SPARSER::PROTEIN) ("YPEL3" . SPARSER::PROTEIN)
    ("APAF1" . SPARSER::PROTEIN) ("PPM1D" . SPARSER::PROTEIN)
    ("GADD45A" . SPARSER::PROTEIN) ("tumor suppressor p53" . SPARSER::PROTEIN)
    ("het and Δ Nf1 /Δ Pten" . SPARSER::COLLECTION)
    ("Nf1 and Δ Pten" . SPARSER::COLLECTION)
    ("two potential mutational driver genes" . SPARSER::GENE)
    ("conditional Nf1 and Pten alleles" . SPARSER::ALLELE)
    ("PTEN and NF1" . SPARSER::COLLECTION)
    ("gene and indicator" . SPARSER::COLLECTION) ("mTor" . SPARSER::PROTEIN)
    ("Mapk/Erk" . SPARSER::COLLECTION)
    ("S100β and Olig2" . SPARSER::COLLECTION)
    ("both experimental cohorts" . SPARSER::MOLECULE)
    ("experimental cohorts" . SPARSER::MOLECULE)
    ("het and Nf1" . SPARSER::COLLECTION)
    ("Pten and Dhh" . SPARSER::COLLECTION)
    ("triple transgenic mice Dhh -Cre" . SPARSER::COLLECTION)
    ("recombination ofNf1 flox/flox ( xref ) andPten flox/flox ( xref ) alleles"
     . SPARSER::ALLELE)
    ("flox/flox" . SPARSER::COLLECTION) ("flox" . SPARSER::PROTEIN)
    ("Nf1 and Pten" . SPARSER::COLLECTION) ("Kras" . SPARSER::PROTEIN)
    ("the most frequently inactivated tumor suppressor gene"
     . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog ( Pten ) and neurofibromatosis 1 ( Nf1 ) genes"
     . SPARSER::COLLECTION)
    ("Pten and Nf1" . SPARSER::COLLECTION)
    ("the phosphatase and tensin homolog ( Pten ) and neurofibromatosis 1 ( Nf1 ) genes"
     . SPARSER::COLLECTION)
    ("Nf1" . SPARSER::PROTEIN) ("pS6" . SPARSER::PROTEIN)
    ("Pi3k" . SPARSER::PROTEIN) ("pErk1/2" . SPARSER::PROTEIN)
    ("Olig2" . SPARSER::PROTEIN) ("S100β" . SPARSER::PROTEIN)
    ("desert hedgehog" . SPARSER::PROTEIN) ("e-5" . SPARSER::PROTEIN)
    ("neurofibromin 1" . SPARSER::PROTEIN)
    ("anthracycline" . SPARSER::MOLECULE)
    ("isogenic variants" . SPARSER::VARIANT)
    ("expressed mitogenic cytokines" . SPARSER::PROTEIN)
    ("many potentially mitogenic cytokines" . SPARSER::PROTEIN)
    ("Ki67 and phospho-Stat3" . SPARSER::COLLECTION)
    ("MMTV-Wnt1" . SPARSER::COLLECTION)
    ("dose-dense doxorubicin" . SPARSER::PROTEIN)
    ("Functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the isogenic variants" . SPARSER::VARIANT)
    ("TP53 or p21" . SPARSER::COLLECTION) ("p53-p21" . SPARSER::COLLECTION)
    ("senescence associated cytokines" . SPARSER::PROTEIN)
    ("cytokines and chemokines" . SPARSER::COLLECTION)
    ("Cxcl5 and Rantes" . SPARSER::COLLECTION) ("Cxcl5" . SPARSER::PROTEIN)
    ("mitogens" . SPARSER::MITOGEN) ("Eotaxin" . SPARSER::PROTEIN)
    ("phospho-Stat3 and Ki67" . SPARSER::COLLECTION)
    ("intense nuclear phospho-Stat3" . SPARSER::PROTEIN)
    ("Rantes and Tnfα" . SPARSER::COLLECTION) ("Rantes" . SPARSER::PROTEIN)
    ("included ligands and receptors ( xref )" . SPARSER::COLLECTION)
    ("cytokines and their receptors and cofactors" . SPARSER::COLLECTION)
    ("receptors and cofactors" . SPARSER::COLLECTION)
    ("p21/p53" . SPARSER::COLLECTION)
    ("senescence associated β–galactosidase" . SPARSER::PROTEIN)
    ("p21 and Dcr2" . SPARSER::COLLECTION)
    ("Dec1 and Pml" . SPARSER::COLLECTION)
    ("Puma and Noxa" . SPARSER::COLLECTION) ("Noxa" . SPARSER::PROTEIN)
    ("p21 , Puma and Ccng1" . SPARSER::COLLECTION) ("Ccng1" . SPARSER::PROTEIN)
    ("Puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("homozygous null or heterozygous mutant" . SPARSER::MUTANT)
    ("a heterozygous p53 point mutation" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("senescence-associated cytokines" . SPARSER::PROTEIN)
    ("MMTV-" . SPARSER::PROTEIN) ("MMTV" . SPARSER::PROTEIN)
    ("Reverse transcriptase" . SPARSER::PROTEIN) ("mm 3" . SPARSER::PROTEIN)
    ("H/R" . SPARSER::PROTEIN) ("Tnfα" . SPARSER::DRUG)
    ("cyclin dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Stathmin1" . SPARSER::PROTEIN) ("βGal" . SPARSER::PROTEIN)
    ("β–galactosidase" . SPARSER::PROTEIN) ("Dec1" . SPARSER::PROTEIN)
    ("Dcr2" . SPARSER::PROTEIN) ("Wnt1" . SPARSER::PROTEIN)
    ("a fully transformed cancerous state" . SPARSER::BIO-STATE)
    ("supernumary centrosomes" . SPARSER::PROTEIN)
    ("histone H2B-GFP" . SPARSER::COLLECTION) ("tet" . SPARSER::PROTEIN)
    ("RPE and BJ" . SPARSER::COLLECTION) ("RPE" . SPARSER::PROTEIN)
    ("Cdt1 and geminin" . SPARSER::COLLECTION)
    ("E6 and E7" . SPARSER::COLLECTION) ("Chk1 and Chk2" . SPARSER::COLLECTION)
    ("p53-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LT" . SPARSER::PROTEIN)
    ("geminin and Cdt1" . SPARSER::COLLECTION)
    ("ATM and ATR" . SPARSER::COLLECTION) ("geminin" . SPARSER::PROTEIN)
    ("Cdk1/CyclinB" . SPARSER::COLLECTION) ("CyclinB" . SPARSER::PROTEIN)
    ("shelterin" . SPARSER::PROTEIN)
    ("Mad2, Emi1, LATS1, and AuroraA" . SPARSER::COLLECTION)
    ("Mad" . SPARSER::PROTEIN) ("p53 and Rb" . SPARSER::COLLECTION)
    ("I-19" . SPARSER::PROTEIN) ("P-S" . SPARSER::PROTEIN)
    ("centrin2" . SPARSER::PROTEIN) ("Foxn1" . SPARSER::PROTEIN)
    ("4-OHT" . SPARSER::DRUG) ("H2B" . SPARSER::PROTEIN)
    ("1–2 µ" . SPARSER::PROTEIN) ("2–4 µ" . SPARSER::PROTEIN)
    ("hCdt1" . SPARSER::PROTEIN)
    ("histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cdt1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("POT1" . SPARSER::PROTEIN)
    ("Emi1" . SPARSER::PROTEIN) ("broader" . SPARSER::PROTEIN)
    ("stimulatory autoantibodies" . SPARSER::PROTEIN)
    ("agonistic anti-PDGFR autoantibodies" . SPARSER::PROTEIN)
    ("bleomycin" . SPARSER::DRUG) ("PDGF-AA and PDGF-BB" . SPARSER::COLLECTION)
    ("actin and PDGFR" . SPARSER::COLLECTION)
    ("PDGFR and phospho-PDGFR" . SPARSER::COLLECTION)
    ("these stimulatory autoantibodies" . SPARSER::PROTEIN)
    ("agonistic autoantibodies" . SPARSER::PROTEIN)
    ("phospho-PDGFRα and phospho-PDGFRβ" . SPARSER::COLLECTION)
    ("PDGFRα and PDGFRβ" . SPARSER::COLLECTION) ("RTX" . SPARSER::DRUG)
    ("rituximab" . SPARSER::DRUG) ("PDGF-BB" . SPARSER::PROTEIN)
    ("FAM" . SPARSER::PROTEIN) ("orf" . SPARSER::PROTEIN)
    ("Blk" . SPARSER::PROTEIN) ("NFκB and IRF4" . SPARSER::COLLECTION)
    ("the heterozygous state" . SPARSER::BIO-STATE) ("IkBa" . SPARSER::PROTEIN)
    ("BcR" . SPARSER::PROTEIN) ("DNAse" . SPARSER::PROTEIN)
    ("a unique variant" . SPARSER::VARIANT)
    ("randomly chosen nucleotides" . SPARSER::NUCLEOTIDE)
    ("active promoters" . SPARSER::PROMOTER)
    ("NFkB and IRF4" . SPARSER::COLLECTION) ("CMH" . SPARSER::MOLECULE)
    ("BLK-" . SPARSER::PROTEIN) ("NFkBp50 and p65" . SPARSER::COLLECTION)
    ("whose risk alleles" . SPARSER::ALLELE) ("NFkB" . SPARSER::PROTEIN)
    ("cycloheximide and western blot" . SPARSER::COLLECTION)
    ("BLK" . SPARSER::PROTEIN) ("Pax5" . SPARSER::PROTEIN)
    ("H3K4" . SPARSER::PROTEIN) ("OR 1" . SPARSER::PROTEIN)
    ("HS polymerase" . SPARSER::PROTEIN) ("PAX5" . SPARSER::PROTEIN)
    ("IRF4" . SPARSER::PROTEIN) ("NFκ" . SPARSER::PROTEIN)
    ("chr8" . SPARSER::PROTEIN)
    ("protein kinase domains" . SPARSER::PROTEIN-FAMILY)
    ("NFkBp50" . SPARSER::PROTEIN) ("Rags" . SPARSER::PROTEIN)
    ("Lamp2 and mTOR" . SPARSER::COLLECTION)
    ("GST-PLCδ1" . SPARSER::COLLECTION) ("GST-Hrs" . SPARSER::COLLECTION)
    ("Hrs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GST-Atg18" . SPARSER::COLLECTION)
    ("liposomes" . SPARSER::PROTEIN) ("Atg18" . SPARSER::PROTEIN)
    ("Atg" . SPARSER::DRUG) ("Rheb and Rag" . SPARSER::COLLECTION)
    ("Rab5 and PI" . SPARSER::COLLECTION)
    ("PIKFYVE or PI3K-C2α" . SPARSER::COLLECTION)
    ("the former protein" . SPARSER::PROTEIN) ("Vps34" . SPARSER::PROTEIN)
    ("the heterotrimeric PIKFYVE complex" . SPARSER::BIO-COMPLEX)
    ("peripheral mTOR" . SPARSER::PROTEIN)
    ("discontinuous punctate" . SPARSER::PROTEIN)
    ("Akt–TSC–mTOR" . SPARSER::COLLECTION) ("TSC" . SPARSER::PROTEIN)
    ("both amino acids and insulin" . SPARSER::COLLECTION)
    ("Amino acids and insulin increase PI(3)P and PI(3,5)P 2"
     . SPARSER::COLLECTION)
    ("the adaptor proteins VAC14, VAC7, ATG18, and FIG4" . SPARSER::COLLECTION)
    ("a multimeric complex" . SPARSER::BIO-COMPLEX)
    ("VAC14, VAC7, ATG18, and FIG4" . SPARSER::COLLECTION)
    ("VAC" . SPARSER::PROTEIN) ("FAB1 or PIP5K3" . SPARSER::COLLECTION)
    ("polyphosphoinositide" . SPARSER::PROTEIN)
    ("the Rab5 guanine nucleotide exchange factor (GEF) Gapex-5 (also known as GAPVD1; xref ) and the class II phosphatidylinositol 3-kinase PI3K-C2α (also known as PIK3CA; xref )"
     . SPARSER::COLLECTION)
    ("an essential mTORC1 regulator" . SPARSER::REGULATOR)
    ("PIKFYVE and PI3K-C2α" . SPARSER::COLLECTION)
    ("the class III PI3K Vps34" . SPARSER::PROTEIN)
    ("PIKFYVE" . SPARSER::PROTEIN) ("Vps" . SPARSER::PROTEIN)
    ("caveolin 1" . SPARSER::PROTEIN) ("S6K1" . SPARSER::PROTEIN)
    ("Lamp2" . SPARSER::PROTEIN) ("PLCδ1" . SPARSER::PROTEIN)
    ("glutathione S -transferase" . SPARSER::PROTEIN)
    ("mTORC2" . SPARSER::PROTEIN) ("S6K" . SPARSER::PROTEIN)
    ("FIG4" . SPARSER::PROTEIN) ("ATG18" . SPARSER::PROTEIN)
    ("PIP5K3" . SPARSER::PROTEIN) ("FAB1" . SPARSER::PROTEIN)
    ("PI5" . SPARSER::PROTEIN) ("GAPVD1" . SPARSER::PROTEIN)
    ("Gapex-5" . SPARSER::PROTEIN) ("P 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatidylinositol 3-phosphate" . SPARSER::MOLECULE)
    ("mechanistic target of rapamycin" . SPARSER::PROTEIN)
    ("keratinocytes or their co-culture" . SPARSER::COLLECTION)
    ("GDS" . SPARSER::PROTEIN) ("Keratinocytes" . SPARSER::PROTEIN)
    ("an essential part" . SPARSER::COMPONENT)
    ("keratin-1 and filaggrin" . SPARSER::COLLECTION)
    ("involucrin and keratin-1" . SPARSER::COLLECTION)
    ("Monolayers" . SPARSER::PROTEIN)
    ("unphosphorylatable amino acids" . SPARSER::AMINO-ACID)
    ("keratinocytes as well as media" . SPARSER::COLLECTION)
    ("Brdu" . SPARSER::DRUG)
    ("the early differentiation marker keratin-1 and the late differentiation marker filaggrin"
     . SPARSER::COLLECTION)
    ("the late differentiation marker filaggrin" . SPARSER::PROTEIN)
    ("filaggrin" . SPARSER::PROTEIN)
    ("Haematoxylin and eosin (H+E) staining" . SPARSER::COLLECTION)
    ("Haematoxylin" . SPARSER::MOLECULE) ("p107 or p130" . SPARSER::COLLECTION)
    ("IL1A or IL1B" . SPARSER::COLLECTION)
    ("IL1A and IL1B" . SPARSER::COLLECTION) ("KGF" . SPARSER::PROTEIN)
    ("K13" . SPARSER::PROTEIN) ("K1" . SPARSER::PROTEIN)
    ("transglutaminase 1" . SPARSER::PROTEIN) ("pEF1" . SPARSER::PROTEIN)
    ("beta-mercaptoethanol" . SPARSER::MOLECULE)
    ("transglutaminase-1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 6" . SPARSER::PROTEIN)
    ("keratin-1" . SPARSER::PROTEIN) ("p130" . SPARSER::PROTEIN)
    ("IL1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Interleukin 1 alpha" . SPARSER::PROTEIN)
    ("Retinoblastoma protein" . SPARSER::PROTEIN)
    ("Keratinocyte Growth Factor" . SPARSER::PROTEIN)
    ("Interleukin-1beta" . SPARSER::PROTEIN) ("IL1A" . SPARSER::PROTEIN)
    ("Interleukin-1alpha" . SPARSER::PROTEIN)
    ("retinoblastoma protein" . SPARSER::PROTEIN)
    ("larger cohorts" . SPARSER::MOLECULE)
    ("RASSF1A/HIN-1" . SPARSER::COLLECTION) ("ER and PR" . SPARSER::COLLECTION)
    ("RASSF1A and HIN-1" . SPARSER::COLLECTION)
    ("RASSF1A, HIN-1, RIL and CDH13" . SPARSER::COLLECTION)
    ("ER, and PR" . SPARSER::COLLECTION) ("HR " . SPARSER::PROTEIN)
    ("HIN-1 ( p  = 0.002) and RASSF1A ( p  = 0.019)" . SPARSER::COLLECTION)
    ("ER " . SPARSER::PROTEIN) ("HIN-1/RASSF1A" . SPARSER::COLLECTION)
    ("HIN-1, RASSF1A, RIL and CDH13" . SPARSER::COLLECTION)
    ("estrogen receptor and progesterone receptor" . SPARSER::COLLECTION)
    ("RIL and CDH13" . SPARSER::COLLECTION)
    ("RIL, HIN-1, RASSF1A and CDH13" . SPARSER::COLLECTION)
    ("receptors (PR)" . SPARSER::RECEPTOR)
    ("receptors (ER)" . SPARSER::RECEPTOR) ("RIL/CDH13" . SPARSER::COLLECTION)
    ("RIL" . SPARSER::PROTEIN) ("PDLIM4" . SPARSER::PROTEIN)
    ("SCGB3A1" . SPARSER::PROTEIN) ("3  H" . SPARSER::PROTEIN)
    ("CDH13" . SPARSER::PROTEIN) ("HIN-1" . SPARSER::PROTEIN)
    ("HC" . SPARSER::PROTEIN)
    ("microtubules or centromeres" . SPARSER::COLLECTION)
    ("centromeres" . SPARSER::PROTEIN) ("ATRA" . SPARSER::DRUG)
    ("-promoter and the isoform RASSF5B" . SPARSER::COLLECTION)
    ("the longest isoform" . SPARSER::ISOFORM)
    ("-promoter" . SPARSER::PROMOTER)
    ("at least three different isoforms" . SPARSER::ISOFORM)
    ("Effector" . SPARSER::EFFECTOR) ("TSG" . SPARSER::PROTEIN)
    ("TSGs" . SPARSER::PROTEIN)
    ("RASSF6 , RASSF7 and RASSF10" . SPARSER::COLLECTION)
    ("RASSF5 (six to seven out of nine cell lines methylated depending on region analyzed) and RASSF6 (six out of nine cell lines methylated)"
     . SPARSER::COLLECTION)
    ("RASSF7 (eight out of nine cell lines methylated), RASSF5 (six to seven out of nine cell lines methylated depending on region analyzed) and RASSF6 (six out of nine cell lines methylated)"
     . SPARSER::COLLECTION)
    ("MSP or COBRA" . SPARSER::COLLECTION) ("Aza" . SPARSER::DRUG)
    ("dC" . SPARSER::MOLECULE) ("aza" . SPARSER::DRUG)
    ("MSP and COBRA" . SPARSER::COLLECTION) ("Bisulfite" . SPARSER::MOLECULE)
    ("BSP" . SPARSER::PROTEIN)
    ("RASSF2, RASSF4, RASSF5, RASSF6, RASSF7, RASSF8 and RASSF10"
     . SPARSER::COLLECTION)
    ("RASSF1A, RASSF2, RASSF3, RASSF4, RASSF5, RASSF6, RASSF7 and RASSF8"
     . SPARSER::COLLECTION)
    ("family (RASSF)" . SPARSER::PROTEIN-FAMILY) ("RA" . SPARSER::PROTEIN)
    ("NB and one example" . SPARSER::COLLECTION)
    ("the Ras-associated family member RASSF1A" . SPARSER::PROTEIN)
    ("NB" . SPARSER::PROTEIN)
    ("RASSF5 , RASSF6 and RASSF7" . SPARSER::COLLECTION)
    ("MYCN" . SPARSER::PROTEIN) ("RASSF5 and RASSF6" . SPARSER::COLLECTION)
    ("RASSF2 , RASSF4 , RASSF5 , RASSF6 , RASSF7 , and RASSF10"
     . SPARSER::COLLECTION)
    ("RASSF1A and RASSF5A" . SPARSER::COLLECTION)
    ("RASSF" . SPARSER::PROTEIN-FAMILY) ("HRAS1" . SPARSER::PROTEIN)
    ("HRC1" . SPARSER::PROTEIN) ("NORE1" . SPARSER::PROTEIN)
    ("Rassf1a" . SPARSER::PROTEIN) ("RASSF8" . SPARSER::PROTEIN)
    ("RASSF3" . SPARSER::PROTEIN) ("proto-oncogenes" . SPARSER::PROTO-ONCOGENE)
    ("RASSF10" . SPARSER::PROTEIN) ("RASSF7" . SPARSER::PROTEIN)
    ("RASSF6" . SPARSER::PROTEIN) ("RASSF4" . SPARSER::PROTEIN)
    ("RASSF2" . SPARSER::PROTEIN) ("RASSF5" . SPARSER::PROTEIN)
    ("AGA and rs12185268" . SPARSER::COLLECTION) ("traits" . SPARSER::PROTEIN)
    ("whose risk allele" . SPARSER::ALLELE) ("dopamine" . SPARSER::PROTEIN)
    ("AG and GG" . SPARSER::COLLECTION)
    ("identical genome-wide significant risk alleles" . SPARSER::ALLELE)
    ("AR gene and other AGA loci" . SPARSER::COLLECTION)
    ("spermidine" . SPARSER::MOLECULE) ("SRM" . SPARSER::PROTEIN)
    ("lectin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("mannan" . SPARSER::MOLECULE)
    ("TARDBP" . SPARSER::PROTEIN) ("ARR19 and CRIF1" . SPARSER::COLLECTION)
    ("transcriptional corepressors" . SPARSER::PROTEIN)
    ("HDAC4 and HDAC9" . SPARSER::COLLECTION)
    ("corepressors" . SPARSER::PROTEIN)
    ("HDAC9 and HDAC4" . SPARSER::COLLECTION) ("MAPT" . SPARSER::PROTEIN)
    ("the most proximal gene" . SPARSER::GENE) ("Foxa2" . SPARSER::PROTEIN)
    ("Androgens" . SPARSER::DRUG) ("AGA" . SPARSER::PROTEIN)
    ("SET binding protein 1" . SPARSER::PROTEIN) ("SETBP1" . SPARSER::PROTEIN)
    ("MASP2" . SPARSER::PROTEIN)
    ("peroxisomal biogenesis factor 14" . SPARSER::PROTEIN)
    ("PEX14" . SPARSER::PROTEIN) ("TAR DNA binding protein" . SPARSER::PROTEIN)
    ("candidate 2" . SPARSER::PROTEIN) ("ZNF652" . SPARSER::PROTEIN)
    ("CRIF1" . SPARSER::PROTEIN) ("ARR19" . SPARSER::PROTEIN)
    ("histone deacetylase 9" . SPARSER::PROTEIN) ("HDAC9" . SPARSER::PROTEIN)
    ("histone deacetylase 4" . SPARSER::PROTEIN) ("HDAC4" . SPARSER::PROTEIN)
    ("microtubule-associated protein tau" . SPARSER::PROTEIN)
    ("IMP5" . SPARSER::PROTEIN) ("forkhead box A2" . SPARSER::PROTEIN)
    ("FOXA2" . SPARSER::PROTEIN) ("STAT3-STAT1" . SPARSER::COLLECTION)
    ("EGFRvIII-STAT3" . SPARSER::COLLECTION)
    ("COX-2 [ xref ] and Myc [ xref ]" . SPARSER::COLLECTION)
    ("iNOS [ xref ], COX-2 [ xref ] and Myc [ xref ]" . SPARSER::COLLECTION)
    ("HER2-STAT3" . SPARSER::COLLECTION) ("STAT1:STAT3" . SPARSER::BIO-COMPLEX)
    ("pro-inflammatory cytokines and form homodimers and heterodimers"
     . SPARSER::COLLECTION)
    ("cytokines and form" . SPARSER::COLLECTION)
    ("homodimers and heterodimers" . SPARSER::COLLECTION)
    ("iNOS [ xref ] and COX-2 [ xref ]" . SPARSER::COLLECTION)
    ("iNOS" . SPARSER::PROTEIN) ("STAT1 and STAT3" . SPARSER::COLLECTION)
    ("STAT1 and its target genes" . SPARSER::COLLECTION)
    ("LMP1, Mcl-1 and vinculin" . SPARSER::COLLECTION)
    ("HER2 and STAT3" . SPARSER::COLLECTION)
    ("STAT1, EGFR and STAT3" . SPARSER::COLLECTION)
    ("STAT3 and STAT1" . SPARSER::COLLECTION) ("p-STAT1" . SPARSER::COLLECTION)
    ("EGFR/p-STAT3" . SPARSER::COLLECTION)
    ("the mutated nucleotides" . SPARSER::NUCLEOTIDE)
    ("-TT-N" . SPARSER::COLLECTION) ("EGFR-STAT3" . SPARSER::COLLECTION)
    ("EGFR and EGFRdNLS" . SPARSER::COLLECTION) ("STAT1-" . SPARSER::PROTEIN)
    ("EGFR/EGFRvIII/HER2" . SPARSER::COLLECTION)
    ("growth factor-" . SPARSER::GROWTH-FACTOR)
    ("EGFRvIII and HER2" . SPARSER::COLLECTION)
    ("nuclear HER2 [ xref ] and nuclear EGFRvIII [ xref ]"
     . SPARSER::COLLECTION)
    ("EGFR, HER2 and EGFRvIII" . SPARSER::COLLECTION)
    ("ErbBs" . SPARSER::PROTEIN)
    ("breast cancer resistance protein [ xref ] and cyclooxygenase-2 (COX-2)"
     . SPARSER::COLLECTION)
    ("c-Myc [ xref ], breast cancer resistance protein [ xref ] and cyclooxygenase-2 (COX-2)"
     . SPARSER::COLLECTION)
    ("HER3 or EGFR" . SPARSER::COLLECTION)
    ("ErbB3 (HER3) and ErbB4 (HER4)" . SPARSER::COLLECTION)
    ("ErbB1 (epidermal growth factor receptor; EGFR), ErbB2 (HER2), ErbB3 (HER3) and ErbB4 (HER4)"
     . SPARSER::COLLECTION)
    ("EGFR, EGFRvIII and HER2" . SPARSER::COLLECTION)
    ("HER2 and heregulin" . SPARSER::COLLECTION)
    ("p-STAT3" . SPARSER::COLLECTION) ("EGFRvIII" . SPARSER::PROTEIN)
    ("EGFR and STAT3" . SPARSER::COLLECTION) ("synergizes" . SPARSER::PROTEIN)
    ("LMP1" . SPARSER::PROTEIN) ("TT-N" . SPARSER::PROTEIN)
    ("thymidine kinase" . SPARSER::PROTEIN) ("1-C" . SPARSER::PROTEIN)
    ("1-B" . SPARSER::PROTEIN) ("GAG-3" . SPARSER::PROTEIN)
    ("Anti-EGFR" . SPARSER::PROTEIN) ("LMP2" . SPARSER::PROTEIN)
    ("L-15" . SPARSER::PROTEIN) ("U87MG" . SPARSER::PROTEIN)
    ("cancer resistance protein" . SPARSER::PROTEIN)
    ("B-Myb" . SPARSER::PROTEIN) ("ErbB3" . SPARSER::PROTEIN)
    ("ErbB1" . SPARSER::PROTEIN) ("STAT1" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 1" . SPARSER::PROTEIN)
    ("β-catenin 552-to-total β-catenin" . SPARSER::PROTEIN)
    ("GSK3-β and proteasomal" . SPARSER::COLLECTION)
    ("NF-κB/IRF" . SPARSER::COLLECTION)
    ("perijunctional GBP-1" . SPARSER::PROTEIN)
    ("inflammation-induced GBP-1" . SPARSER::PROTEIN)
    ("TNF-alpha and IFN-gamma" . SPARSER::COLLECTION)
    ("IFN-gamma" . SPARSER::PROTEIN) ("the mucosal barrier" . SPARSER::PROTEIN)
    ("GBP-1 and GBP-1" . SPARSER::COLLECTION)
    ("GBP-1 or GBP-1" . SPARSER::COLLECTION)
    ("either full length GBP-1 or a GBP-1 truncation mutant"
     . SPARSER::COLLECTION)
    ("either full-length GBP-1 (o/eGBP-1) or GTPase deficient GBP-1 (ΔGTPase GBP-1, D184N xref )"
     . SPARSER::COLLECTION)
    ("o/eGBP-1" . SPARSER::COLLECTION)
    ("cellular β-catenin" . SPARSER::PROTEIN)
    ("Either GBP-1 or a GTPase defective GBP-1 mutant (ΔGTPase GBP-1, D184N)"
     . SPARSER::COLLECTION)
    ("siRNA or siRNA" . SPARSER::COLLECTION)
    ("GBP-1 and β-catenin" . SPARSER::COLLECTION)
    ("GBP-1 and EdU" . SPARSER::COLLECTION) ("EdU" . SPARSER::DRUG)
    ("ethynyl" . SPARSER::MOLECULE) ("Frozen" . SPARSER::PROTEIN)
    ("exogenous TNF-α/IFN-γ" . SPARSER::COLLECTION)
    ("TNF-α and interferon gamma" . SPARSER::COLLECTION)
    ("TNF-α/IFN-γ" . SPARSER::COLLECTION)
    ("pro-mitogenic target genes" . SPARSER::GENE)
    ("Wnt-β-catenin" . SPARSER::COLLECTION) ("Wingless" . SPARSER::PROTEIN)
    ("GMP" . SPARSER::GMP) ("interferon-γ" . SPARSER::PROTEIN)
    ("β- catenin/TCF" . SPARSER::COLLECTION)
    ("proinflammatory cytokine" . SPARSER::PROTEIN)
    ("Proinflammatory cytokines" . SPARSER::PROTEIN)
    ("GPB-1" . SPARSER::PROTEIN)
    ("N-(4-Methoxybenzyl)-N’-(5-nitro-1,3-thiazol-2-yl)urea" . SPARSER::DRUG)
    ("AR-A014418" . SPARSER::DRUG) ("ToPro-3" . SPARSER::MOLECULE)
    ("1B" . SPARSER::PROTEIN) ("GBP1" . SPARSER::PROTEIN)
    ("GSK3- β" . SPARSER::PROTEIN)
    ("Glycogen Synthase Kinase 3 beta" . SPARSER::PROTEIN)
    ("Dkk1" . SPARSER::PROTEIN) ("TNF-alpha" . SPARSER::PROTEIN)
    ("GBP-5" . SPARSER::PROTEIN) ("beta catenin" . SPARSER::PROTEIN)
    ("Erk1/2" . SPARSER::PROTEIN) ("interferon gamma" . SPARSER::PROTEIN)
    ("Guanylate binding protein 1" . SPARSER::PROTEIN)
    ("β- catenin" . SPARSER::PROTEIN) ("GSK3-β" . SPARSER::PROTEIN)
    ("GBP-1" . SPARSER::PROTEIN)
    ("Guanylate Binding Protein 1" . SPARSER::PROTEIN)
    ("histological type" . TYPE) ("Pro/Pro" . SPARSER::COLLECTION)
    ("Arg/Pro" . SPARSER::COLLECTION) ("ADCA" . SPARSER::PROTEIN)
    ("Arg/Arg" . SPARSER::COLLECTION)
    ("tumor-suppressor protein" . SPARSER::PROTEIN)
    ("ddH 2" . SPARSER::PROTEIN) ("E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Loss of heterozygosity" . SPARSER::PROTEIN)
    ("Variants" . SPARSER::VARIANT) ("PAP and MT" . SPARSER::COLLECTION)
    ("PAP" . SPARSER::MOLECULE)
    ("TP53 , BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("TP53, or BRCA2" . SPARSER::COLLECTION)
    ("both classic LFS" . SPARSER::PROTEIN)
    ("BRCA1 , and BRCA2" . SPARSER::COLLECTION)
    ("highly penetrant Mendelian cancer-predisposing genes" . SPARSER::GENE)
    ("BRCA1/BRCA2" . SPARSER::COLLECTION)
    ("often some families" . SPARSER::PROTEIN-FAMILY)
    ("BRCA2 and TP53" . SPARSER::COLLECTION)
    ("BRCA1 , BRCA2 , and TP53" . SPARSER::COLLECTION)
    ("LFS" . SPARSER::PROTEIN)
    ("a multifunctional serine/threonine kinase" . SPARSER::KINASE)
    ("mitochondria and the ER" . SPARSER::COLLECTION)
    ("thapsigargin (TG)" . SPARSER::MOLECULE)
    ("thapsigargin" . SPARSER::MOLECULE)
    ("GRP78 and calcium" . SPARSER::COLLECTION)
    ("chaperones" . SPARSER::PROTEIN)
    ("ER-stress-related protein" . SPARSER::COLLECTION)
    ("-octyl-3" . SPARSER::COLLECTION) ("LPS-" . SPARSER::PROTEIN)
    ("EPCR" . SPARSER::PROTEIN)
    ("mitochondria or cytoplasma" . SPARSER::COLLECTION)
    ("a folding-competent state" . SPARSER::BIO-STATE)
    ("a classic molecular chaperone" . SPARSER::PROTEIN)
    ("APC and ER" . SPARSER::COLLECTION) ("anticoagulant" . SPARSER::DRUG)
    ("a vitamin-K-dependent serine protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein C (APC)" . SPARSER::PROTEIN) ("-siRNA" . SPARSER::COLLECTION)
    ("Calcium" . SPARSER::CALCIUM)
    ("stress-related protein" . SPARSER::PROTEIN) ("TMB-8" . SPARSER::DRUG)
    ("GRP78 protein" . SPARSER::PROTEIN) ("PAR-1" . SPARSER::PROTEIN)
    ("endothelial protein C receptor" . SPARSER::PROTEIN)
    ("Glucose-regulated protein" . SPARSER::PROTEIN)
    ("glucose-regulated protein" . SPARSER::PROTEIN)
    ("protein C" . SPARSER::PROTEIN)
    ("a dominant–negative C-terminal Src kinase (CSK)" . SPARSER::PROTEIN)
    ("Src kinase (CSK)" . SPARSER::PROTEIN)
    ("Akt and eNOS" . SPARSER::COLLECTION)
    ("serine, threonine, and tyrosine" . SPARSER::COLLECTION)
    ("PLCγ and PI3K/Akt in cells expressing a mutated Y951F VEGFR2"
     . SPARSER::COLLECTION)
    ("VEGF and histamine" . SPARSER::COLLECTION) ("PKB" . SPARSER::PROTEIN)
    ("TSAd–VE-cadherin" . SPARSER::COLLECTION)
    ("Vav and p21-activated kinase (PAK)" . SPARSER::COLLECTION)
    ("kinase (PAK)" . SPARSER::KINASE) ("Vav" . SPARSER::PROTEIN)
    ("VEGFR2 and VE-cadherin/β-catenin that lead" . SPARSER::COLLECTION)
    ("VE-cadherin/β-catenin" . SPARSER::COLLECTION)
    ("VE-cadherin and its binding partners β-catenin, plakoglobin, and p120"
     . SPARSER::COLLECTION)
    ("β-catenin, plakoglobin, and p120" . SPARSER::COLLECTION)
    ("plakoglobin" . SPARSER::PROTEIN) ("70-kD" . SPARSER::PROTEIN)
    ("VE-cadherin and TSAd" . SPARSER::COLLECTION)
    ("-citrulline" . SPARSER::MOLECULE) ("citrulline" . SPARSER::MOLECULE)
    ("VEGFR2 or the adherens and tight junction proteins VE-cadherin and ZO-1"
     . SPARSER::COLLECTION)
    ("VE-cadherin and ZO-1" . SPARSER::COLLECTION)
    ("VEGFR2 and c-Src in WT andtsad −/− mice" . SPARSER::COLLECTION)
    ("endothelial nitric oxide synthase" . SPARSER::PROTEIN)
    ("tsad" . SPARSER::PROTEIN)
    ("tyrosine, serine, or threonine" . SPARSER::COLLECTION)
    ("phosphatase-treated protein" . SPARSER::PROTEIN)
    ("P3 and P4" . SPARSER::COLLECTION)
    ("the tracheal vasculature" . SPARSER::PROTEIN)
    ("histamine" . SPARSER::PROTEIN) ("c" . SPARSER::PROTEIN)
    ("c-Src-SH2" . SPARSER::PROTEIN) ("VEGFR2 and TSAd" . SPARSER::COLLECTION)
    ("pY39, pY260, pY280, pY290, and pY305" . SPARSER::COLLECTION)
    ("GST-c-Src-SH2" . SPARSER::COLLECTION)
    ("TSAd and c-Src" . SPARSER::COLLECTION)
    ("TSAd and the Src kinase family member Lck ( xref )"
     . SPARSER::COLLECTION)
    ("a classical signal adapter molecule" . SPARSER::MOLECULE)
    ("VEGFR1 and VEGFR2" . SPARSER::COLLECTION)
    ("homophilic vascular-endothelial cadherin"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("caveolin" . SPARSER::PROTEIN)
    ("fibronectin and other extracellular matrix proteins"
     . SPARSER::COLLECTION)
    ("a provisional matrix" . SPARSER::PROTEIN-FAMILY)
    ("VEGF/VPF" . SPARSER::COLLECTION) ("VPF" . SPARSER::PROTEIN)
    ("Histamine" . SPARSER::PROTEIN)
    ("dextran, and microspheres" . SPARSER::COLLECTION)
    ("VE-cadherin, VEGFR2, and c-Src" . SPARSER::COLLECTION)
    ("endothelial nitric oxide" . SPARSER::MOLECULE)
    ("Tsad" . SPARSER::PROTEIN) ("TSAd" . SPARSER::PROTEIN)
    ("Na +" . SPARSER::MOLECULE) ("Nitric Oxide Synthase" . SPARSER::PROTEIN)
    ("HSP-70" . SPARSER::PROTEIN)
    ("VEGF receptor–associated protein" . SPARSER::PROTEIN)
    ("VEGF-A" . SPARSER::PROTEIN) ("anti–β" . SPARSER::PROTEIN)
    ("VE-Cadherin" . SPARSER::PROTEIN) ("NG2" . SPARSER::PROTEIN)
    ("β 2 microglobulin" . SPARSER::PROTEIN)
    ("hepatocyte-growth factor" . SPARSER::PROTEIN)
    ("GAB-1" . SPARSER::PROTEIN) ("AKT/protein" . SPARSER::PROTEIN)
    ("Pro-rich" . SPARSER::PROTEIN-FAMILY) ("c-Src–" . SPARSER::PROTEIN)
    ("p120" . SPARSER::PROTEIN) ("ZO-1" . SPARSER::PROTEIN)
    ("nitric oxide synthase" . SPARSER::PROTEIN)
    ("P3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("peak 1" . SPARSER::PROTEIN)
    ("Src kinase" . SPARSER::PROTEIN) ("Grb-2" . SPARSER::PROTEIN)
    ("PLCγ" . SPARSER::PROTEIN-FAMILY)
    ("vascular permeability factor" . SPARSER::PROTEIN)
    ("Vascular endothelial" . SPARSER::PROTEIN) ("c-Src-" . SPARSER::PROTEIN)
    ("VE–cadherin" . SPARSER::PROTEIN)
    ("extracellular regulated kinase" . SPARSER::PROTEIN)
    ("an extreme oxidative stress state" . SPARSER::BIO-STATE)
    ("functional ABCG2" . SPARSER::PROTEIN)
    ("high HIF-2α and low p53" . SPARSER::COLLECTION)
    ("low p53 and high MDM2 state" . SPARSER::COLLECTION)
    ("HIF-2α, Nanog, Oct4, and ABCG2" . SPARSER::COLLECTION)
    ("low p53 and high MDM2" . SPARSER::COLLECTION)
    ("p53 and MDM2 protein" . SPARSER::COLLECTION)
    ("Nanog, Oct-4, and ABCG2" . SPARSER::COLLECTION)
    ("Nutlin-3, an MDM2 inhibitor, and the survival as well as differentiation"
     . SPARSER::COLLECTION)
    ("high MDM2 and low p53 state [ xref ]" . SPARSER::COLLECTION)
    ("a high MDM2 and low p53 state" . SPARSER::COLLECTION)
    ("the HIF-2α inhibitor-treated ABCG2+hox fraction" . SPARSER::COMPONENT)
    ("p53 or pifithrin-α" . SPARSER::COLLECTION)
    ("Nanog and ABCG2" . SPARSER::COLLECTION)
    ("siRNA as well as FM19G11" . SPARSER::COLLECTION)
    ("6b" . SPARSER::PROTEIN) ("FM" . SPARSER::PROTEIN)
    ("HIF-2α and HIF-1α" . SPARSER::COLLECTION)
    ("a metastable state" . SPARSER::BIO-STATE)
    ("Nanog and Bcl-2" . SPARSER::COLLECTION)
    ("ROCK" . SPARSER::PROTEIN-FAMILY)
    ("FGF-2 and Bcl-2" . SPARSER::COLLECTION) ("MSC" . SPARSER::PROTEIN)
    ("MSCs" . SPARSER::PROTEIN) ("carboplatin" . SPARSER::DRUG)
    ("SH-SY5Y" . SPARSER::PROTEIN) ("ABCG2 and GSH" . SPARSER::COLLECTION)
    ("a potent cellular antioxidant" . SPARSER::PROTEIN)
    ("Nanog and Oct-4" . SPARSER::COLLECTION) ("normoxia" . SPARSER::PROTEIN)
    ("State" . SPARSER::BIO-STATE) ("hox" . SPARSER::PROTEIN)
    ("ROS, 8-OHdG, and caspase-3" . SPARSER::COLLECTION)
    ("ABCG2−" . SPARSER::PROTEIN) ("Fraction" . SPARSER::COMPONENT)
    ("p53 and HIF-2α" . SPARSER::COLLECTION)
    ("p53 as well as HIF-2α" . SPARSER::COLLECTION)
    ("ROS, p53, and HIFs" . SPARSER::COLLECTION) ("HIFs" . SPARSER::PROTEIN)
    ("P53 and HIF-2α" . SPARSER::COLLECTION)
    ("an even higher state" . SPARSER::BIO-STATE)
    ("vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF)-2 [ xref ]"
     . SPARSER::COLLECTION)
    ("antioxidant and component" . SPARSER::COLLECTION)
    ("HIF-1α and HIF-2α" . SPARSER::COLLECTION)
    ("growth factors and antioxidants" . SPARSER::COLLECTION)
    ("a highly cytoprotective and undifferentiated state" . SPARSER::BIO-STATE)
    ("HIF-2α and p53" . SPARSER::COLLECTION)
    ("enhanced stemness involved high Bcl-2" . SPARSER::PROTEIN)
    ("-2, and MDM2" . SPARSER::COLLECTION) ("p53/MDM2" . SPARSER::COLLECTION)
    ("Oct-4 and Nanog" . SPARSER::COLLECTION) ("Nanog" . SPARSER::PROTEIN)
    ("a low p53 and high hypoxia inducible factor (HIF)-2α state"
     . SPARSER::COLLECTION)
    ("HIF" . SPARSER::PROTEIN-FAMILY) ("Oct4" . SPARSER::PROTEIN)
    ("MDM2 protein" . SPARSER::PROTEIN) ("N -acetyl-cysteine" . SPARSER::DRUG)
    ("OH-" . SPARSER::MOLECULE) ("DCFH-DA" . SPARSER::DRUG)
    ("Y-27632" . SPARSER::MOLECULE) ("Mitomycin-C" . SPARSER::DRUG)
    ("FGF-2" . SPARSER::PROTEIN) ("HIF-1α" . SPARSER::PROTEIN)
    ("HIF-2α" . SPARSER::PROTEIN) ("Oct-4" . SPARSER::PROTEIN)
    ("SSEA3" . SPARSER::MOLECULE) ("VEGFR/PDGFR" . SPARSER::COLLECTION)
    ("cediranib" . SPARSER::DRUG) ("BPH-1 and mPrEC" . SPARSER::COLLECTION)
    ("a 2-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("testosterone" . SPARSER::MOLECULE) ("PI3K/Akt 2" . SPARSER::COLLECTION)
    ("HAI-1/matriptase" . SPARSER::COLLECTION)
    ("uPA, HGF, and ECM" . SPARSER::COLLECTION) ("uPA" . SPARSER::PROTEIN)
    ("CXCR4 and protease" . SPARSER::COLLECTION)
    ("VEGF and angiopoietin-1" . SPARSER::COLLECTION)
    ("a bona fide transformed state" . SPARSER::BIO-STATE)
    ("both human BPH-1 and normal mPrECs" . SPARSER::COLLECTION)
    ("MEK1 and MKK4" . SPARSER::COLLECTION) ("Nck" . SPARSER::PROTEIN)
    ("unique signaling molecules" . SPARSER::MOLECULE)
    ("cellular HAI-1" . SPARSER::PROTEIN)
    ("matriptase and HAI-1" . SPARSER::COLLECTION)
    ("matriptase-HAI-1" . SPARSER::COLLECTION)
    ("matriptas-HAI-1" . SPARSER::COLLECTION)
    ("a transmembrane serine protease and its active form"
     . SPARSER::COLLECTION)
    ("Matriptase" . SPARSER::PROTEIN)
    ("an active growth domain dimer" . SPARSER::DIMER)
    ("a pharmacologic JNK inhibitor" . SPARSER::INHIBITOR)
    ("PDGFRs" . SPARSER::PROTEIN)
    ("the upstream JNK activator MKK4 as well as downstream targets"
     . SPARSER::COLLECTION)
    ("JNK, c-Jun, and ATF-2" . SPARSER::COLLECTION)
    ("Erk and JNK" . SPARSER::COLLECTION) ("dimer" . SPARSER::DIMER)
    ("approximately 23 kDa" . SPARSER::PROTEIN)
    ("approximately 18 kDa" . SPARSER::PROTEIN) ("monomer" . SPARSER::MONOMER)
    ("phosphatase and tensin" . SPARSER::COLLECTION)
    ("BB and DD" . SPARSER::COLLECTION)
    ("biologically active growth factor domain dimers" . SPARSER::DIMER)
    ("the classic PDGF ligands" . SPARSER::LIGAND)
    ("heterodimeric growth factors" . SPARSER::GROWTH-FACTOR)
    ("AA, BB, AB, CC, and DD" . SPARSER::COLLECTION) ("BB" . SPARSER::MOLECULE)
    ("matriptase" . SPARSER::PROTEIN) ("PDGFD" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase and phosphoinositide 3-kinase"
     . SPARSER::COLLECTION)
    ("-kinase" . SPARSER::KINASE) ("-NH 2" . SPARSER::MOLECULE)
    ("Akt 2" . SPARSER::PROTEIN) ("HER 2" . SPARSER::PROTEIN)
    ("angiopoietin-1" . SPARSER::PROTEIN) ("B chain" . SPARSER::PROTEIN)
    ("SP600125" . SPARSER::PROTEIN) ("HAI-1" . SPARSER::PROTEIN)
    ("Glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("ATF-2" . SPARSER::PROTEIN) ("MKK4" . SPARSER::PROTEIN)
    ("BPH-1" . SPARSER::PROTEIN) ("CUB domain" . SPARSER::PROTEIN)
    ("c- jun" . SPARSER::PROTEIN) ("taxol" . SPARSER::DRUG)
    ("a potentially attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("Kibra and the PPXY" . SPARSER::COLLECTION)
    ("Kibra" . SPARSER::HUMAN-PROTEIN-FAMILY) ("drosophila" . SPARSER::PROTEIN)
    ("AMOT and the c-terminal fragment" . SPARSER::COLLECTION)
    ("the RUNX proteins, p73, PML, SMAD1, AMOT and the c-terminal fragment"
     . SPARSER::COLLECTION)
    ("erbB4" . SPARSER::PROTEIN) ("erlotinib or S12" . SPARSER::COLLECTION)
    ("ES-2" . SPARSER::PROTEIN)
    ("tryptophan and proline" . SPARSER::COLLECTION)
    ("the YAP homologous protein TAZ" . SPARSER::PROTEIN)
    ("FLAG-PTPN14" . SPARSER::COLLECTION)
    ("protein-Ezrin-Radixin-Moesin" . SPARSER::COLLECTION)
    ("Moesin" . SPARSER::PROTEIN) ("Radixin" . SPARSER::PROTEIN)
    ("Ezrin" . SPARSER::PROTEIN) ("YAP-associated proteins" . SPARSER::PROTEIN)
    ("PATJ, LIN7C and PALS1-" . SPARSER::COLLECTION)
    ("PTPN14 and MUPP1" . SPARSER::COLLECTION)
    ("AMOT/AMOTL2" . SPARSER::COLLECTION) ("PATJ" . SPARSER::PROTEIN)
    ("TEAD" . SPARSER::PROTEIN) ("AMOT" . SPARSER::PROTEIN)
    ("angiomotin" . SPARSER::PROTEIN) ("TAZ" . SPARSER::PROTEIN)
    ("connective tissue growth factor (CTGF)" . SPARSER::PROTEIN)
    ("cysteine-rich angiogenic inducer" . SPARSER::PROTEIN)
    ("cyclin E, E2F1, myc and survivin" . SPARSER::COLLECTION)
    ("CTGF" . SPARSER::PROTEIN) ("survivin" . SPARSER::PROTEIN)
    ("The Yes-associated protein (YAP)" . SPARSER::PROTEIN)
    ("R-Luc" . SPARSER::PROTEIN) ("pG5" . SPARSER::PROTEIN)
    ("N-term" . SPARSER::PROTEIN) ("YAP2" . SPARSER::PROTEIN)
    ("PTPN21" . SPARSER::PROTEIN) ("SMAD1" . SPARSER::PROTEIN)
    ("long form" . SPARSER::PROTEIN) ("TEAD4" . SPARSER::PROTEIN)
    ("MUPP1" . SPARSER::PROTEIN) ("PALS1" . SPARSER::PROTEIN)
    ("LIN7C" . SPARSER::PROTEIN) ("AMOTL2" . SPARSER::PROTEIN)
    ("Lats1" . SPARSER::PROTEIN) ("CYR61" . SPARSER::PROTEIN)
    ("connective tissue growth factor" . SPARSER::PROTEIN)
    ("PTPN14" . SPARSER::PROTEIN)
    ("cofilin, LIMK and SSH" . SPARSER::COLLECTION)
    ("parental MCF-10A or the PIK3CA" . SPARSER::COLLECTION)
    ("parental MCF-10A" . SPARSER::PROTEIN)
    ("the cytoskeletal proteins tensin and auxilin" . SPARSER::COLLECTION)
    ("tensin and auxilin" . SPARSER::COLLECTION) ("auxilin" . SPARSER::PROTEIN)
    ("tensin" . SPARSER::PROTEIN) ("PTPs" . SPARSER::PROTEIN)
    ("tyrosine-, serine-, and threonine-phosphorylated peptides ( xref )"
     . SPARSER::COLLECTION)
    ("PTEN and cofilin" . SPARSER::COLLECTION)
    ("serine-" . SPARSER::AMINO-ACID) ("tyrosine-" . SPARSER::AMINO-ACID)
    ("LIMK, SSH, cofilin, and McTNs" . SPARSER::COLLECTION)
    ("chronophin" . SPARSER::PROTEIN)
    ("T508 phosphorylated LIMK1 (pLIMK) and S978 phosphorylated SSH-1L (pSSH)"
     . SPARSER::COLLECTION)
    ("LIMK1 and Slingshot-1L" . SPARSER::COLLECTION)
    ("state, and growth factor" . SPARSER::COLLECTION)
    ("PTEN or GFP" . SPARSER::COLLECTION)
    ("LIMK and SSH-1L" . SPARSER::COLLECTION)
    ("LIM-kinase-1 (LIMK) and Slingshot-1L (SSH-1L)" . SPARSER::COLLECTION)
    ("LIMK and SSH" . SPARSER::COLLECTION)
    ("a broad-spectrum protein phosphatase or cytoskeletal docking protein"
     . SPARSER::COLLECTION)
    ("cytoskeletal docking protein" . SPARSER::PROTEIN)
    ("PI3K and MAPK" . SPARSER::COLLECTION) ("pAKT" . SPARSER::PROTEIN-FAMILY)
    ("PI3K or AKT" . SPARSER::COLLECTION)
    ("exogenous WT cofilin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IRES-GFP" . SPARSER::COLLECTION) ("phosphorylatable" . SPARSER::PROTEIN)
    ("actin and myosin" . SPARSER::COLLECTION) ("MLCK" . SPARSER::PROTEIN)
    ("blebbistatin" . SPARSER::DRUG) ("Blebbistatin" . SPARSER::DRUG)
    ("stable posttranslational modified forms" . SPARSER::FORM)
    ("live cells expressing membrane-targeted GFP" . SPARSER::PROTEIN)
    ("parental MCF-10A and PTEN−/−" . SPARSER::COLLECTION)
    ("MCF-10A and PTEN−/−" . SPARSER::COLLECTION)
    ("the reciprocal PI3K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K or Akt" . SPARSER::COLLECTION)
    ("virtually all actin-severing proteins" . SPARSER::PROTEIN)
    ("Guanine nucleotide Exchange Factors (GEFs) and GTPase Activating Proteins (GAPs)"
     . SPARSER::COLLECTION)
    ("GAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PIP 2 directly binds actin-associated proteins" . SPARSER::PROTEIN)
    ("vinculin, profilin, and α-actinin" . SPARSER::COLLECTION)
    ("profilin" . SPARSER::PROTEIN) ("vinculin" . SPARSER::PROTEIN)
    ("phosphoinositide" . SPARSER::PROTEIN)
    ("microtubules and actin" . SPARSER::COLLECTION)
    ("MECs" . SPARSER::PROTEIN)
    ("isogenic MCF-10A PTEN−/− and PIK3CA mutants" . SPARSER::MUTANT)
    ("cofilin, LIMK, and SSH" . SPARSER::COLLECTION)
    ("Slingshot" . SPARSER::PROTEIN) ("MgCl2" . SPARSER::MOLECULE)
    ("SSH3" . SPARSER::PROTEIN) ("SSH2" . SPARSER::PROTEIN)
    ("L-S" . SPARSER::PROTEIN) ("SSH-1L" . SPARSER::PROTEIN)
    ("kinase-1" . SPARSER::PROTEIN) ("ATPase activity" . SPARSER::PROTEIN)
    ("myosin light chain kinase" . SPARSER::PROTEIN)
    ("ML-7" . SPARSER::PROTEIN) ("non-muscle" . SPARSER::PROTEIN)
    ("intermediate filament protein" . SPARSER::PROTEIN)
    ("green fluorescent" . SPARSER::PROTEIN)
    ("GTPase Activating" . SPARSER::PROTEIN)
    ("Guanine nucleotide Exchange Factors" . SPARSER::GEF)
    ("α-actinin" . SPARSER::PROTEIN)
    ("phosphatidylinositol 4,5-bisphosphate" . SPARSER::PIP2)
    ("GST-PAK4" . SPARSER::COLLECTION) ("PAK4 and PAK4" . SPARSER::COLLECTION)
    ("Purvalanol" . SPARSER::MOLECULE)
    ("PAK E329K and its substrate (s)" . SPARSER::COLLECTION)
    ("PAK4 and PAK" . SPARSER::COLLECTION) ("Abl" . SPARSER::PROTEIN)
    ("Cdc42, Gab-1 and LIMK1" . SPARSER::COLLECTION)
    ("Cdc42/Gab-1" . SPARSER::COLLECTION) ("1b" . SPARSER::PROTEIN)
    ("Cdc42, Gab-1 or LIMK1" . SPARSER::COLLECTION)
    ("-PAK4" . SPARSER::COLLECTION)
    ("nucleophilic threonine" . SPARSER::AMINO-ACID)
    ("–Kinase" . SPARSER::KINASE) ("mRFP-" . SPARSER::PROTEIN)
    ("histidine" . SPARSER::AMINO-ACID) ("minimal PAK4" . SPARSER::PROTEIN)
    ("vitronectin" . SPARSER::PROTEIN) ("mRFP" . SPARSER::PROTEIN)
    ("mRFP-PAK4" . SPARSER::COLLECTION) ("PAK4:LIMK1" . SPARSER::BIO-COMPLEX)
    ("PAK4-LIMK-cofilin" . SPARSER::COLLECTION)
    ("matrices" . SPARSER::PROTEIN-FAMILY) ("Scott" . SPARSER::PROTEIN)
    ("LIMK" . SPARSER::PROTEIN) ("HGFR/c-Met" . SPARSER::COLLECTION)
    ("shRNA and tGFP" . SPARSER::COLLECTION)
    ("a PAK4-targeting competitive ATP inhibitor" . SPARSER::INHIBITOR)
    ("PAKs" . SPARSER::PROTEIN-FAMILY) ("Cofilin" . SPARSER::PROTEIN)
    ("β5 integrin ( xref ) and the ADF/cofilin regulators LIMK1 and slingshot homologue (SSH-1)"
     . SPARSER::COLLECTION)
    ("GEF-H1 ( xref ), paxillin ( xref ), β5 integrin ( xref ) and the ADF/cofilin regulators LIMK1 and slingshot homologue (SSH-1)"
     . SPARSER::COLLECTION)
    ("cytoskeletal protein" . SPARSER::PROTEIN)
    ("LIMK1 and slingshot" . SPARSER::COLLECTION)
    ("ADF/cofilin" . SPARSER::COLLECTION) ("SSH" . SPARSER::MOLECULE)
    ("slingshot" . SPARSER::PROTEIN) ("ADF" . SPARSER::PROTEIN)
    ("PAK" . SPARSER::PROTEIN-FAMILY)
    ("attractive therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("PAK4-specific competitive ATP inhibitors" . SPARSER::INHIBITOR)
    ("competitive ATP inhibitors" . SPARSER::INHIBITOR)
    ("a potential anti-metastatic therapeutic target"
     . SPARSER::TARGET-PROTEIN)
    ("Hepatocyte growth factor (HGF) and its receptor (c-Met)"
     . SPARSER::COLLECTION)
    ("Bcr-Abl" . SPARSER::PROTEIN) ("PAK6" . SPARSER::PROTEIN)
    ("PF3758309" . SPARSER::DRUG) ("β5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GEF-H1" . SPARSER::PROTEIN) ("LIMK1" . SPARSER::PROTEIN)
    ("PAK4" . SPARSER::PROTEIN) ("p21-activated kinase 4" . SPARSER::PROTEIN)
    ("OGT and OGA" . SPARSER::COLLECTION) ("glucosamine" . SPARSER::MOLECULE)
    ("tau" . SPARSER::PROTEIN) ("serine and threonine" . SPARSER::COLLECTION)
    ("AKT [ xref , xref ] and GSK-3β [ xref ]" . SPARSER::COLLECTION)
    ("AKT or GSK-3β" . SPARSER::COLLECTION) ("PUGNAc" . SPARSER::DRUG)
    ("AKT, and β-catenin" . SPARSER::COLLECTION)
    ("OGT or shOGT" . SPARSER::COLLECTION)
    ("other O-GlcNAcylated proteins" . SPARSER::PROTEIN)
    ("the O-GlcNAcylated proteins" . SPARSER::PROTEIN)
    ("O-GlcNAcylated AKT and GSK-3β" . SPARSER::COLLECTION)
    ("O-GlcNAcylated proteins" . SPARSER::PROTEIN)
    ("antibodies, RL2 and CTD110.6" . SPARSER::COLLECTION)
    ("All O-GlcNAcylated proteins" . SPARSER::PROTEIN)
    ("phosphoproteins" . SPARSER::PROTEIN) ("OGA" . SPARSER::PROTEIN)
    ("OGT" . SPARSER::PROTEIN) ("a unique type" . TYPE)
    ("UDP-GlcNAc" . SPARSER::MOLECULE) ("GlcNAc" . SPARSER::PROTEIN-FAMILY)
    ("Protein kinase B (AKT) and glycogen synthase kinase-3 (GSK-3β)"
     . SPARSER::COLLECTION)
    ("AKT and GSK-3β" . SPARSER::COLLECTION)
    ("Protein kinase B (AKT) and glycogen synthase kinase-3β (GSK-3β)"
     . SPARSER::COLLECTION)
    ("IGF-1–" . SPARSER::PROTEIN) ("FoxO1" . SPARSER::PROTEIN)
    ("Forkhead box protein O1" . SPARSER::PROTEIN) ("B-27" . SPARSER::PROTEIN)
    ("O-GlcNAcase" . SPARSER::PROTEIN)
    ("N-acetylglucosaminidase" . SPARSER::PROTEIN)
    ("O-GlcNAc" . SPARSER::PROTEIN) ("N-acetylglucosamine" . SPARSER::MOLECULE)
    ("glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("Protein kinase B" . SPARSER::PROTEIN)
    ("anti-apoptotic gene Bcl-xl and Mcl-1 mRNA’s" . SPARSER::PROTEIN)
    ("pro-apoptotic gene Bak mRNA" . SPARSER::PROTEIN)
    ("nicotine" . SPARSER::DRUG) ("normal neutrophils" . SPARSER::PROTEIN)
    ("genes and the environment [ xref , xref ]" . SPARSER::COLLECTION)
    ("a pro-apoptotic protein" . SPARSER::PROTEIN)
    ("the pro-apoptotic gene" . SPARSER::GENE)
    ("a pro-apoptotic gene" . SPARSER::GENE)
    ("Bcl-xl and Mcl-1 mRNA’s" . SPARSER::PROTEIN)
    ("Bak, Bcl-xl, and Mcl-1 mRNA’s" . SPARSER::PROTEIN)
    ("apoptotic neutrophils" . SPARSER::PROTEIN)
    ("the pro-apoptotic protein Bak and the anti-apoptotic proteins Bcl-xl and Mcl-1"
     . SPARSER::COLLECTION)
    ("the pro-apoptotic protein Bak" . SPARSER::PROTEIN)
    ("the pro-apoptotic proteins Bax, Bid, Bak, and Bad" . SPARSER::COLLECTION)
    ("Bax, Bid, Bak, and Bad" . SPARSER::COLLECTION)
    ("Ning" . SPARSER::PROTEIN-FAMILY)
    ("especially cigarette smoke" . SPARSER::MOLECULE)
    ("Bak, and anti-apoptotic" . SPARSER::COLLECTION)
    ("FEV" . SPARSER::PROTEIN) ("Bak, Bcl-xl, and Mcl-1" . SPARSER::COLLECTION)
    ("Neutrophil" . SPARSER::PROTEIN) ("Neutrophils" . SPARSER::PROTEIN)
    ("Bak and anti-aptototic" . SPARSER::COLLECTION) ("Bak" . SPARSER::PROTEIN)
    ("Mcl-2" . SPARSER::PROTEIN) ("CagA and VacA" . SPARSER::COLLECTION)
    ("junctional complexes" . SPARSER::BIO-COMPLEX)
    ("tumor-associated genes" . SPARSER::GENE)
    ("methyltransferases" . SPARSER::PROTEIN)
    ("transcriptional regulator, and DNA" . SPARSER::COLLECTION)
    ("specific bacterial molecules" . SPARSER::MOLECULE)
    ("Bacterial proteins" . SPARSER::PROTEIN)
    ("INK4A and hMLH1" . SPARSER::COLLECTION)
    ("INK4A , hMLH1 , and E-cadherin" . SPARSER::COLLECTION)
    ("green fluorescent protein (GFP)" . SPARSER::PROTEIN)
    ("dinucleotide" . SPARSER::MOLECULE) ("cytosine" . SPARSER::NUCLEOBASE)
    ("proteins and importins" . SPARSER::COLLECTION)
    ("NPC" . SPARSER::MOLECULE) ("importins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("effector (NUE)" . SPARSER::EFFECTOR)
    ("cytolethal distending toxins" . SPARSER::MOLECULE)
    ("very few bacterial proteins" . SPARSER::PROTEIN)
    ("IpaH9.8 and OspF" . SPARSER::COLLECTION) ("YopM" . SPARSER::PROTEIN)
    ("OspF" . SPARSER::PROTEIN) ("Tnp" . SPARSER::MOLECULE)
    ("a pathogenic mechanism whereby bacterial proteins" . SPARSER::PROTEIN)
    ("bacterial proteins" . SPARSER::PROTEIN)
    ("murine leukemia virus" . SPARSER::PROTEIN)
    ("sodium hydroxide" . SPARSER::MOLECULE) ("D-1" . SPARSER::PROTEIN)
    ("3 h" . SPARSER::PROTEIN) ("MgSO 4" . SPARSER::DRUG)
    ("T-3" . SPARSER::PROTEIN) ("AG-3" . SPARSER::PROTEIN)
    ("A-3" . SPARSER::PROTEIN) ("C-3" . SPARSER::PROTEIN)
    ("INK4A" . SPARSER::PROTEIN) ("nuclear pore" . SPARSER::BIO-COMPLEX)
    ("outer membrane protein" . SPARSER::PROTEIN)
    ("IpaH9.8" . SPARSER::PROTEIN) ("CDH1" . SPARSER::PROTEIN)
    ("FGFR3 or PIK3CA" . SPARSER::COLLECTION)
    ("no obvious 5p target genes" . SPARSER::GENE)
    ("pten and tp53" . SPARSER::COLLECTION) ("tp53" . SPARSER::PROTEIN)
    ("pten" . SPARSER::PROTEIN) ("PIK3CA and PTEN" . SPARSER::COLLECTION)
    ("RAF1 and RAS" . SPARSER::COLLECTION)
    ("CCND1 and E2F3" . SPARSER::COLLECTION)
    ("TP53 and RB1" . SPARSER::COLLECTION)
    ("potential target genes" . SPARSER::GENE)
    ("the DNA methyltransferase MGMT (10q23) and the CUL3 gene (2q36.2)"
     . SPARSER::COLLECTION)
    ("PTEN and RB1" . SPARSER::COLLECTION) ("paralogous genes" . SPARSER::GENE)
    ("several novel genes and chromosomal regions" . SPARSER::COLLECTION)
    ("KRT6A , KRT6B , KRT6C and KRT16" . SPARSER::COLLECTION)
    ("SPRR1B , SPRR2A , SPRR2D , and SPRR2F" . SPARSER::COLLECTION)
    ("RAS and 6p22/" . SPARSER::COLLECTION)
    ("FGFR3 , RB1 , and PTEN" . SPARSER::COLLECTION)
    ("E2F3/RB1" . SPARSER::COLLECTION) ("FGFR3/CCND1" . SPARSER::COLLECTION)
    ("CCND1 , RB1 , PTEN , CDKN2A , and RAF1" . SPARSER::COLLECTION)
    ("FGFR3, CCND1, p16, E2F3, and RB1" . SPARSER::COLLECTION)
    ("RAF1/RAS" . SPARSER::COLLECTION) ("/RB1" . SPARSER::COLLECTION)
    ("FGFR3 and CCND1" . SPARSER::COLLECTION) ("HDs" . SPARSER::PROTEIN)
    ("which targets TP53" . SPARSER::PROTEIN)
    ("subtypes (MS)" . SPARSER::PROTEIN)
    ("the two largest HCA" . SPARSER::PROTEIN) ("HCA" . SPARSER::PROTEIN)
    ("the paralogous genes CCND1 and CCNE1 , ID1 and ID2 , and YWHAZ , YWHAB , and YWHAQ"
     . SPARSER::COLLECTION)
    ("CCND1 and CCNE1 , ID1 and ID2 , and YWHAZ , YWHAB , and YWHAQ"
     . SPARSER::COLLECTION)
    ("CCNE1 , ID1 and ID2 , and YWHAZ , YWHAB , and YWHAQ"
     . SPARSER::COLLECTION)
    ("ID2 , and YWHAZ , YWHAB , and YWHAQ" . SPARSER::COLLECTION)
    ("YWHAZ , YWHAB , and YWHAQ" . SPARSER::COLLECTION)
    ("YWHAQ" . SPARSER::PROTEIN) ("YWHAB" . SPARSER::PROTEIN)
    ("YWHAZ" . SPARSER::PROTEIN)
    ("previously well-described oncogenes" . SPARSER::ONCOGENE)
    ("CUL3 (2q36.2) and MGMT (10q26)" . SPARSER::COLLECTION)
    ("FGA" . SPARSER::PROTEIN) ("FGFR3 and PIK3CA" . SPARSER::COLLECTION)
    ("TP53 and genes" . SPARSER::COLLECTION) ("DBC1" . SPARSER::PROTEIN)
    ("p22" . SPARSER::PROTEIN) ("RAS/RAF" . SPARSER::COLLECTION)
    ("TP53/MDM2" . SPARSER::COLLECTION)
    ("new candidate genes, such as SETDB1 (1q21), and BCL2L1 (20q11)"
     . SPARSER::COLLECTION)
    ("Several potential oncogenes" . SPARSER::ONCOGENE)
    ("E2F3 , CCND1 , and CCNE1" . SPARSER::COLLECTION)
    ("SP4" . SPARSER::PROTEIN) ("PTCH1" . SPARSER::PROTEIN)
    ("SPRR2" . SPARSER::PROTEIN-FAMILY) ("SPRR2A" . SPARSER::PROTEIN)
    ("SPRR1B" . SPARSER::PROTEIN) ("KRT16" . SPARSER::PROTEIN)
    ("KRT6C" . SPARSER::PROTEIN) ("KRT6B" . SPARSER::PROTEIN)
    ("KRT6A" . SPARSER::PROTEIN) ("p16 protein" . SPARSER::PROTEIN)
    ("MS2" . SPARSER::PROTEIN) ("HC5" . SPARSER::PROTEIN)
    ("HC3" . SPARSER::PROTEIN) ("HC2" . SPARSER::PROTEIN)
    ("ID2" . SPARSER::PROTEIN) ("p25" . SPARSER::PROTEIN)
    ("CUL3" . SPARSER::PROTEIN) ("p13" . SPARSER::PROTEIN)
    ("F3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("FGFR3" . SPARSER::PROTEIN)
    ("SETDB1" . SPARSER::PROTEIN) ("E2F3" . SPARSER::PROTEIN)
    ("a potential prognostic biomarker" . SPARSER::MOLECULE)
    ("cutaneous beta-PV" . SPARSER::PROTEIN)
    ("cutaneous HPV E7" . SPARSER::PROTEIN-FAMILY)
    ("external keratinocytes" . SPARSER::PROTEIN)
    ("K14-HPV8" . SPARSER::COLLECTION) ("HPV8" . SPARSER::PROTEIN)
    ("antitrypsin" . SPARSER::PROTEIN) ("alpha-1" . SPARSER::PROTEIN)
    ("E1 and E2" . SPARSER::COLLECTION)
    ("keratin 14-HPV8" . SPARSER::PROTEIN-PAIR) ("RHA" . SPARSER::PROTEIN)
    ("snap-frozen" . SPARSER::PROTEIN-PAIR)
    ("the squamous keratinising epithelial component" . SPARSER::COMPONENT)
    ("neither AKT1 nor loricrin" . SPARSER::COLLECTION)
    ("AKT1 and loricrin" . SPARSER::COLLECTION)
    ("a cutaneous beta-PV" . SPARSER::PROTEIN)
    ("the usual or undifferentiated type" . TYPE)
    ("UVR" . SPARSER::PROTEIN-FAMILY)
    ("both mucosal and cutaneous (beta" . SPARSER::PROTEIN)
    ("perinuclear region" . SPARSER::PROTEIN) ("keratin 14" . SPARSER::PROTEIN)
    ("Cytokeratin 1" . SPARSER::PROTEIN) ("CN2" . SPARSER::PROTEIN)
    ("keratin 1" . SPARSER::PROTEIN) ("co-factors" . SPARSER::MOLECULE)
    ("E7" . SPARSER::PROTEIN-FAMILY) ("(beta" . SPARSER::PROTEIN)
    ("CBP or p300" . SPARSER::COLLECTION)
    ("HAT and HDAC3" . SPARSER::COLLECTION)
    ("CBP-Pol II holoenzyme and TFIID" . SPARSER::COLLECTION)
    ("IRF3, IRF7, and NF-κB" . SPARSER::COLLECTION)
    ("holoenzyme and TFIID" . SPARSER::COLLECTION)
    ("CBP-Pol" . SPARSER::COLLECTION) ("SWI/SNF" . SPARSER::COLLECTION)
    ("SWI" . SPARSER::PROTEIN) ("IRF3 and/or IRF7" . SPARSER::COLLECTION)
    ("GCN5 and HDAC3" . SPARSER::COLLECTION)
    ("HDAC1 and HDAC8" . SPARSER::COLLECTION)
    ("IRF3 or IRF7" . SPARSER::COLLECTION)
    ("IKKε and IRF7" . SPARSER::COLLECTION)
    ("IRF7 and histone" . SPARSER::COLLECTION)
    ("PCAF and GCN5" . SPARSER::COLLECTION) ("PCAF" . SPARSER::PROTEIN)
    ("acetyltransferase" . SPARSER::PROTEIN)
    ("irrelevant antisera" . SPARSER::PROTEIN)
    ("nucleosome" . SPARSER::PROTEIN) ("Promoters" . SPARSER::PROMOTER)
    ("IRF7 and TBP" . SPARSER::COLLECTION)
    ("secondary response genes" . SPARSER::GENE) ("acetyl" . SPARSER::MOLECULE)
    ("target chromatin-associated histones" . SPARSER::PROTEIN)
    ("CBP/p300" . SPARSER::COLLECTION) ("IFNs" . SPARSER::DRUG)
    ("subtypes and IFN-β" . SPARSER::COLLECTION)
    ("ATF2/c-Jun" . SPARSER::COLLECTION)
    ("RIG-I-like helicases (RLHs) and Toll-like receptors (TLRs)"
     . SPARSER::COLLECTION)
    ("viral ligands" . SPARSER::LIGAND) ("IRF3 and IRF7" . SPARSER::COLLECTION)
    ("helicases" . SPARSER::PROTEIN) ("IRF7 and IRF3" . SPARSER::COLLECTION)
    ("IRF7 and TATA-binding protein (TBP)" . SPARSER::COLLECTION)
    ("protein (TBP)" . SPARSER::PROTEIN)
    ("chromatin-protein" . SPARSER::COLLECTION) ("TBP" . SPARSER::PROTEIN)
    ("IRF" . SPARSER::PROTEIN) ("SeV" . SPARSER::PROTEIN)
    ("HDAC6" . SPARSER::PROTEIN) ("HDAC8" . SPARSER::PROTEIN)
    ("Histone H3K" . SPARSER::PROTEIN) ("H3-K9" . SPARSER::PROTEIN)
    ("c-fos" . SPARSER::PROTEIN) ("GCN5" . SPARSER::PROTEIN)
    ("α-actin" . SPARSER::PROTEIN) ("IKKε" . SPARSER::PROTEIN)
    ("actinomycin D" . SPARSER::MOLECULE) ("Actinomycin D" . SPARSER::MOLECULE)
    ("small ubiquitin-related modifier" . SPARSER::PROTEIN)
    ("IRF2" . SPARSER::PROTEIN) ("PRDI-BF1" . SPARSER::PROTEIN)
    ("IFN-α" . SPARSER::PROTEIN) ("IFN-B" . SPARSER::PROTEIN)
    ("RIG-I" . SPARSER::PROTEIN) ("IRF3" . SPARSER::PROTEIN)
    ("K14" . SPARSER::PROTEIN) ("IRF7" . SPARSER::PROTEIN)
    ("histone deacetylase 3" . SPARSER::PROTEIN) ("HDAC3" . SPARSER::PROTEIN)
    ("the Adenomatous polyposis coli (APC) tumor suppressor"
     . SPARSER::SUPPRESSOR)
    ("Wnt/β-Catenin" . SPARSER::COLLECTION)
    ("phosphatase and tensin homolog (PTEN)" . SPARSER::PROTEIN)
    ("The monoclonal chimeric antibody Rituximab" . SPARSER::DRUG)
    ("Rituximab" . SPARSER::DRUG) ("CD20-antigen" . SPARSER::PROTEIN-PAIR)
    ("Bcl-2 or Bcl-X" . SPARSER::COLLECTION) ("PPARG" . SPARSER::PROTEIN)
    ("types and levels" . SPARSER::COLLECTION)
    ("Cyclooxygenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MTAP, COX-2 and Bcl-X" . SPARSER::COLLECTION)
    ("different histological subtypes" . SPARSER::PROTEIN)
    ("the various histological subtypes" . SPARSER::PROTEIN)
    ("Bcl-X and COX-2" . SPARSER::COLLECTION)
    ("CTNNB1 and Bax" . SPARSER::COLLECTION)
    ("MTAP and β-Catenin" . SPARSER::COLLECTION)
    ("metallothionein" . SPARSER::PROTEIN) ("MTAP" . SPARSER::PROTEIN)
    ("70 immunohistochemical (IHC) antibodies" . SPARSER::ANTIBODY)
    ("sentinel" . SPARSER::DRUG) ("Cyclooxygenase 2" . SPARSER::PROTEIN)
    ("interferon alpha" . SPARSER::PROTEIN) ("ITGA4" . SPARSER::PROTEIN)
    ("CD49d" . SPARSER::PROTEIN) ("S3B" . SPARSER::PROTEIN)
    ("pT1-2" . SPARSER::PROTEIN) ("β-Catenin" . SPARSER::PROTEIN)
    ("several other potential genes" . SPARSER::GENE)
    ("FOXL2 , BMP-2 , and Sp6" . SPARSER::COLLECTION)
    ("SMAD6 and FST" . SPARSER::COLLECTION)
    ("GDF-9, BMP-15, BMP-6, BMP-4, and BMP-7" . SPARSER::COLLECTION)
    ("bone morphogenetic proteins" . SPARSER::PROTEIN)
    ("SMAD2 or SMAD4" . SPARSER::COLLECTION)
    ("smad" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Sp6" . SPARSER::PROTEIN)
    ("BMP2, FOXL2 and Wnt4" . SPARSER::COLLECTION)
    ("forkhead" . SPARSER::PROTEIN)
    ("Activin, TGF-β1 and BMP-7" . SPARSER::COLLECTION)
    ("activin and its antagonist FST" . SPARSER::COLLECTION)
    ("BRCA1, FST, Activin, and SMAD6" . SPARSER::COLLECTION)
    ("activin, inhibin and FST" . SPARSER::COLLECTION)
    ("FST-siRNA" . SPARSER::COLLECTION)
    ("FST in all of the immortalized OSEs as well as BRCA1 overexpressing stable clone # 19 in SKOV3 cells"
     . SPARSER::COLLECTION)
    ("BRCA1 and FST" . SPARSER::COLLECTION)
    ("BRCA1-siRNA" . SPARSER::COLLECTION)
    ("BRCA1, FST, Activin and Actin" . SPARSER::COLLECTION)
    ("Activin and its receptors" . SPARSER::COLLECTION)
    ("Activin, Inhibin, and FST" . SPARSER::COLLECTION)
    ("approximately 2 fold higher secreted FST" . SPARSER::PROTEIN)
    ("Neo and BRCA1-SKOV3" . SPARSER::COLLECTION) ("Neo" . SPARSER::PROTEIN)
    ("FST and SMAD6" . SPARSER::COLLECTION) ("neo" . SPARSER::PROTEIN)
    ("Activin and SMAD" . SPARSER::COLLECTION)
    ("a strong homology" . SPARSER::PROTEIN)
    ("protein (FLRG)" . SPARSER::PROTEIN)
    ("-2, BMP-6, BMP-7, and GDF-8" . SPARSER::COLLECTION)
    ("FLRG" . SPARSER::PROTEIN) ("follistatin" . SPARSER::PROTEIN)
    ("ActRIIB" . SPARSER::PROTEIN) ("Inhibin" . SPARSER::PROTEIN)
    ("Inhibins" . SPARSER::PROTEIN)
    ("a functional antagonist" . SPARSER::MOLECULE)
    ("activin" . SPARSER::PROTEIN) ("inhibin" . SPARSER::PROTEIN)
    ("receptors or their intracellular signaling molecules"
     . SPARSER::COLLECTION)
    ("TGF-" . SPARSER::DRUG) ("cellular FST" . SPARSER::PROTEIN)
    ("Follistatin (FST)" . SPARSER::PROTEIN) ("OSE" . SPARSER::PROTEIN)
    ("cellular BRCA1" . SPARSER::PROTEIN) ("Activin" . SPARSER::PROTEIN)
    ("Follistatin" . SPARSER::PROTEIN)
    ("basic fibroblast growth factor" . SPARSER::PROTEIN)
    ("BMP-15" . SPARSER::PROTEIN) ("GDF-9" . SPARSER::PROTEIN)
    ("SBE1" . SPARSER::PROTEIN) ("Wnt4" . SPARSER::PROTEIN)
    ("FOXL2" . SPARSER::PROTEIN) ("BMP-2" . SPARSER::PROTEIN)
    ("bone morphogenetic protein 2" . SPARSER::PROTEIN)
    ("ALK2" . SPARSER::PROTEIN) ("BMP-4" . SPARSER::PROTEIN)
    ("ACVR2B" . SPARSER::PROTEIN) ("CA-125" . SPARSER::PROTEIN)
    ("K-19" . SPARSER::PROTEIN) ("C-20" . SPARSER::PROTEIN)
    ("polyvinylidene fluoride" . SPARSER::DRUG)
    ("L-Glutamine" . SPARSER::MOLECULE) ("NaHCO3" . SPARSER::DRUG)
    ("SMAD6" . SPARSER::PROTEIN) ("GDF-8" . SPARSER::PROTEIN)
    ("BMP-7" . SPARSER::PROTEIN) ("BMP-6" . SPARSER::PROTEIN)
    ("Bone morphogenetic protein" . SPARSER::PROTEIN)
    ("beta-glycan" . SPARSER::PROTEIN)
    ("gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("temsirolimus and everolimus" . SPARSER::COLLECTION)
    ("everolimus" . SPARSER::DRUG) ("temsirolimus" . SPARSER::DRUG)
    ("p130 CAS and focal adhesion kinase" . SPARSER::COLLECTION)
    ("paxillin" . SPARSER::PROTEIN)
    ("S6 kinase and mTOR" . SPARSER::COLLECTION)
    ("the translational repressors 4EBPs" . SPARSER::PROTEIN)
    ("both PTEN and the cell cycle inhibitor p27" . SPARSER::COLLECTION)
    ("kinase, c-Src and platelet-derived growth factor" . SPARSER::COLLECTION)
    ("miR-21 and PTEN" . SPARSER::COLLECTION)
    ("PI 3 kinase and Akt" . SPARSER::COLLECTION)
    ("a protein phosphatase as well as a lipid phosphatase"
     . SPARSER::COLLECTION)
    ("PI 3 kinase/Akt" . SPARSER::COLLECTION)
    ("regulators and growth factors" . SPARSER::COLLECTION)
    ("Medina" . SPARSER::MOLECULE)
    ("pre- and mature miR-21" . SPARSER::COLLECTION) ("3 H" . SPARSER::PROTEIN)
    ("PTEN/Akt" . SPARSER::COLLECTION) ("3 H-thymidine" . SPARSER::COLLECTION)
    ("onco-miR" . SPARSER::PROTEIN-PAIR) ("Luc" . SPARSER::PROTEIN)
    ("miR-21-Luc" . SPARSER::COLLECTION) ("pri-miR" . SPARSER::COLLECTION)
    ("pre-miR-21" . SPARSER::COLLECTION) ("only 2 miRNAs" . SPARSER::PROTEIN)
    ("only six miRNAs" . SPARSER::PROTEIN) ("RISC" . SPARSER::PROTEIN)
    ("Argonaute" . SPARSER::PROTEIN-FAMILY)
    ("Exportin-5 and its partner Ran-GTP" . SPARSER::COLLECTION)
    ("RNase III/TRBP" . SPARSER::COLLECTION) ("pre-miR" . SPARSER::COLLECTION)
    ("TRBP" . SPARSER::PROTEIN) ("dicer" . SPARSER::PROTEIN)
    ("which binds Drosha/DGCR8 complex" . SPARSER::BIO-COMPLEX)
    ("Drosha/DGCR8" . SPARSER::COLLECTION)
    ("Nearly 1000 miRNAs" . SPARSER::PROTEIN)
    ("growth factor (VEGF)" . SPARSER::GROWTH-FACTOR)
    ("Hif" . SPARSER::PROTEIN-FAMILY) ("VHL" . SPARSER::PROTEIN)
    ("Akt/TORC1" . SPARSER::COLLECTION) ("tuberin" . SPARSER::PROTEIN)
    ("mature miR-21" . SPARSER::PROTEIN) ("pri-miR-21" . SPARSER::COLLECTION)
    ("mature miRNAs" . SPARSER::PROTEIN) ("S16" . SPARSER::PROTEIN)
    ("IGF-1" . SPARSER::PROTEIN) ("p130 CAS" . SPARSER::PROTEIN)
    ("4EBPs" . SPARSER::PROTEIN) ("PI 3 kinase" . SPARSER::PROTEIN)
    ("p68" . SPARSER::PROTEIN) ("6B" . SPARSER::PROTEIN)
    ("p65 S" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NFκB" . SPARSER::PROTEIN)
    ("HK2" . SPARSER::PROTEIN) ("Exportin-5" . SPARSER::PROTEIN)
    ("pre-miRNA" . SPARSER::RNA) ("RNase III" . SPARSER::PROTEIN)
    ("RNA-binding protein" . SPARSER::PROTEIN) ("pri-miRNA" . SPARSER::RNA)
    ("von Hippel-Lindau" . SPARSER::PROTEIN)
    ("an attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("CEBP or AP-1" . SPARSER::COLLECTION)
    ("NF κ B and AP-1" . SPARSER::COLLECTION)
    ("AP1, CEBP, and NF κ B" . SPARSER::COLLECTION)
    ("tryptase" . SPARSER::PROTEIN) ("NF κ B and CEBP" . SPARSER::COLLECTION)
    ("Progesterone" . SPARSER::PROTEIN)
    ("dexamethasone or prednisolone" . SPARSER::COLLECTION)
    ("AP-1 and NF κ B" . SPARSER::COLLECTION) ("prednisolone" . SPARSER::DRUG)
    ("dexamethasone" . SPARSER::PROTEIN) ("Glucocorticoids" . SPARSER::PROTEIN)
    ("cyclopentenone" . SPARSER::DRUG) ("ASA" . SPARSER::PROTEIN)
    ("sulfasalazine" . SPARSER::DRUG) ("Drugs" . SPARSER::DRUG)
    ("Labour-associated genes" . SPARSER::GENE)
    ("PGHS-2, OTR, IL8, IL6, and TNF- α" . SPARSER::COLLECTION)
    ("OTR" . SPARSER::PROTEIN)
    ("the proinflammatory cytokine" . SPARSER::PROTEIN)
    ("c-Jun and c-Fos" . SPARSER::COLLECTION)
    ("NF κ B, CEBP, or AP-1" . SPARSER::COLLECTION)
    ("hrs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("cJun" . SPARSER::PROTEIN)
    ("cFos" . SPARSER::PROTEIN)
    ("IL8 and other chemokines" . SPARSER::COLLECTION)
    ("IL8, OXTR, and COX2" . SPARSER::COLLECTION) ("OXTR" . SPARSER::PROTEIN)
    ("enhanceosome" . SPARSER::PROTEIN)
    ("AP-1, CEBP, and NF κ B" . SPARSER::COLLECTION)
    ("the inflammatory cytokines" . SPARSER::PROTEIN)
    ("MAPK-" . SPARSER::PROTEIN) ("neutrophil" . SPARSER::PROTEIN)
    ("NF κ B, CEBP, and AP-1" . SPARSER::COLLECTION)
    ("protein (CEBP)" . SPARSER::PROTEIN) ("CEBP" . SPARSER::PROTEIN)
    ("CCAAT" . SPARSER::PROTEIN) ("prostaglandin J2" . SPARSER::MOLECULE)
    ("TNF- α" . SPARSER::PROTEIN) ("IL6" . SPARSER::PROTEIN)
    ("PGHS-2" . SPARSER::PROTEIN) ("phenol-red" . SPARSER::DRUG)
    ("c-Fos" . SPARSER::PROTEIN) ("NF κ" . SPARSER::PROTEIN)
    ("pGL2" . SPARSER::PROTEIN) ("COX2" . SPARSER::PROTEIN)
    ("IL1B" . SPARSER::PROTEIN) ("activator protein-1" . SPARSER::PROTEIN)
    ("NF κ B" . SPARSER::PROTEIN) ("the noncanonical NF-κB" . SPARSER::PROTEIN)
    ("TRAF2 and NIK" . SPARSER::COLLECTION)
    ("the TRAF2–TRAF3–cIAP1/2 degradative complex" . SPARSER::BIO-COMPLEX)
    ("IκB–NF-κB" . SPARSER::COLLECTION)
    ("Akt, LKB1 and AMPK" . SPARSER::COLLECTION)
    ("cytoplasmic APPL1 or binds endosomal APPL1" . SPARSER::COLLECTION)
    ("its soluble form" . SPARSER::FORM)
    ("endocytic proteins" . SPARSER::PROTEIN)
    ("IKK and NF-κB" . SPARSER::COLLECTION) ("IRAK" . SPARSER::PROTEIN)
    ("Tom1 (target of Myb1) and Tollip (Toll-interacting protein)"
     . SPARSER::COLLECTION)
    ("Tom1" . SPARSER::PROTEIN) ("Tollip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Myb" . SPARSER::PROTEIN)
    ("an endocytic protein APPL1" . SPARSER::PROTEIN)
    ("dominant-negative NIK" . SPARSER::PROTEIN)
    ("kinase-defective mutant" . SPARSER::MUTANT)
    ("NIK-KD" . SPARSER::COLLECTION)
    ("the NIK degradative complex" . SPARSER::BIO-COMPLEX)
    ("TRAF2, TRAF3, cIAP1 and NIK" . SPARSER::COLLECTION)
    ("TRAF2 and TRAF3" . SPARSER::COLLECTION)
    ("a key noncanonical kinase" . SPARSER::KINASE)
    ("IL-8 and TNF" . SPARSER::COLLECTION)
    ("TNFα and CCL2" . SPARSER::COLLECTION)
    ("APPL1 and IκBα" . SPARSER::COLLECTION) ("DLD" . SPARSER::PROTEIN)
    ("punctate" . SPARSER::PROTEIN) ("Rab5 or Rab21" . SPARSER::COLLECTION)
    ("Rab5 ( xref ) and Rab21 ( xref )" . SPARSER::COLLECTION)
    ("the kinase-defective mutant" . SPARSER::MUTANT)
    ("two quaternary point mutants" . SPARSER::MUTANT)
    ("Rm" . SPARSER::MOLECULE) ("dR" . SPARSER::MOLECULE)
    ("APPL1 and TRAF2" . SPARSER::COLLECTION)
    ("APPL1–TRAF2" . SPARSER::COLLECTION)
    ("APPL1 and vice versa" . SPARSER::COLLECTION)
    ("β-catenin/TCF" . SPARSER::COLLECTION)
    ("β-catenin–Reptin–HDAC" . SPARSER::COLLECTION)
    ("Reptin" . SPARSER::PROTEIN) ("HDACs" . SPARSER::PROTEIN)
    ("DCC and receptors" . SPARSER::COLLECTION)
    ("adiponectin and follicle stimulating hormone" . SPARSER::COLLECTION)
    ("adiponectin" . SPARSER::PROTEIN) ("DCC" . SPARSER::PROTEIN)
    ("TrkA" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase (PI3K) and inositol 5-phosphatase OCRL ( xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("Akt and LKB1" . SPARSER::COLLECTION) ("OCRL" . SPARSER::PROTEIN)
    ("such multifunctional endocytic proteins" . SPARSER::PROTEIN)
    ("NIK–IKK2" . SPARSER::COLLECTION)
    ("TRAF2 and cellular inhibitor" . SPARSER::COLLECTION)
    ("a degradative complex" . SPARSER::BIO-COMPLEX)
    ("polyubiquitination and proteasomal" . SPARSER::COLLECTION)
    ("kinase (NIK)" . SPARSER::KINASE) ("RelB–p52" . SPARSER::COLLECTION)
    ("NF-κB (RANK)" . SPARSER::PROTEIN) ("RANK" . SPARSER::PROTEIN)
    ("TRAFs" . SPARSER::PROTEIN) ("Cytokine" . SPARSER::PROTEIN)
    ("p100/p52" . SPARSER::COLLECTION) ("p105/p50" . SPARSER::COLLECTION)
    ("RelA/p65" . SPARSER::COLLECTION) ("RelB" . SPARSER::PROTEIN)
    ("RelA" . SPARSER::PROTEIN)
    ("the degradative complex" . SPARSER::BIO-COMPLEX)
    ("TRAF2, TRAF3 and cIAP1" . SPARSER::COLLECTION) ("NIK" . SPARSER::PROTEIN)
    ("APPL" . SPARSER::PROTEIN)
    ("a multifunctional adaptor protein" . SPARSER::PROTEIN)
    ("BAY 11–7082" . SPARSER::DRUG) ("P40" . SPARSER::PROTEIN)
    ("Protein-G" . SPARSER::PROTEIN) ("β-Gal" . SPARSER::PROTEIN)
    ("P-3" . SPARSER::PROTEIN) ("β-arrestins" . SPARSER::PROTEIN)
    ("IL-1R" . SPARSER::PROTEIN)
    ("Toll-interacting protein" . SPARSER::PROTEIN) ("A-K" . SPARSER::PROTEIN)
    ("transcriptionally active form" . SPARSER::PROTEIN)
    ("CCL2" . SPARSER::PROTEIN) ("interleukin-8" . SPARSER::PROTEIN)
    ("Rab21" . SPARSER::PROTEIN) ("Rab5" . SPARSER::PROTEIN)
    ("C49A" . SPARSER::PROTEIN) ("ligase activity" . SPARSER::PROTEIN)
    ("5–2 µ" . SPARSER::PROTEIN) ("BAY 11-7082" . SPARSER::DRUG)
    ("follicle stimulating hormone" . SPARSER::PROTEIN)
    ("netrin 1" . SPARSER::PROTEIN)
    ("nerve growth factor receptor" . SPARSER::PROTEIN)
    ("IKK2" . SPARSER::PROTEIN) ("cIAP2" . SPARSER::PROTEIN)
    ("IKK1" . SPARSER::PROTEIN) ("LTβR" . SPARSER::PROTEIN)
    ("BAFF-R" . SPARSER::PROTEIN)
    ("activating factor receptor" . SPARSER::PROTEIN)
    ("IL-1β" . SPARSER::PROTEIN) ("interleukin 1β" . SPARSER::PROTEIN)
    ("p52" . SPARSER::PROTEIN) ("p100" . SPARSER::PROTEIN)
    ("NF-κB2" . SPARSER::PROTEIN) ("p50" . SPARSER::PROTEIN)
    ("p105" . SPARSER::PROTEIN) ("c-Rel" . SPARSER::PROTEIN)
    ("cIAP1" . SPARSER::PROTEIN) ("TRAF3" . SPARSER::PROTEIN)
    ("TRAF2" . SPARSER::PROTEIN) ("APPL1" . SPARSER::PROTEIN)
    ("pro- and anti-apoptotic" . SPARSER::COLLECTION)
    ("Bax , Bcl-2 and Cas-3" . SPARSER::COLLECTION)
    ("p53 or c-Myc" . SPARSER::COLLECTION)
    ("the P-gp substrates doxorubicin (DOX) and vincristine (VCR)"
     . SPARSER::COLLECTION)
    ("doxorubicin (DOX)" . SPARSER::PROTEIN) ("VCR" . SPARSER::DRUG)
    ("Taxol" . SPARSER::DRUG) ("The ultimate aims" . SPARSER::PROTEIN)
    ("multidrug" . SPARSER::PROTEIN) ("vorinostat" . SPARSER::DRUG)
    ("HDI" . SPARSER::MOLECULE) ("HDIs" . SPARSER::MOLECULE)
    ("structurally similar bicyclic depsipeptide" . SPARSER::DRUG)
    ("depsipeptide" . SPARSER::DRUG) ("deacetylases" . SPARSER::PROTEIN)
    ("HDAC1 , p53 , Bax , Bcl-2 , Fas , caspase-3 , c-Myc and MDR1"
     . SPARSER::COLLECTION)
    ("doxorubicin and vincristine" . SPARSER::COLLECTION)
    ("paclitaxel" . SPARSER::DRUG) ("vincristine" . SPARSER::DRUG)
    ("spiruchostatin" . SPARSER::MOLECULE) ("FR901228" . SPARSER::DRUG)
    ("proto-oncogene c-Myc" . SPARSER::PROTEIN) ("Cas-3" . SPARSER::PROTEIN)
    ("Ara-C" . SPARSER::DRUG) ("P-glycoprotein" . SPARSER::PROTEIN)
    ("MDR1" . SPARSER::PROTEIN) ("P-gp" . SPARSER::PROTEIN)
    ("FK228" . SPARSER::DRUG) ("waf1" . SPARSER::PROTEIN)
    ("SP-B" . SPARSER::PROTEIN)
    ("Algerian breast/ovarian cancer families" . SPARSER::PROTEIN-FAMILY)
    ("10 new identified intronic variants" . SPARSER::VARIANT)
    ("Phe" . SPARSER::AMINO-ACID) ("Asn" . SPARSER::AMINO-ACID)
    ("HRM" . SPARSER::PROTEIN-FAMILY) ("Melting" . SPARSER::DRUG)
    ("PTEN and ERG" . SPARSER::COLLECTION) ("ERG/ETV1" . SPARSER::COLLECTION)
    ("TMPRSS2-ERG" . SPARSER::COLLECTION)
    ("PTEN or phos-AKT" . SPARSER::COLLECTION) ("ETV1" . SPARSER::PROTEIN)
    ("FGFR1 and CEN8" . SPARSER::COLLECTION)
    ("FGFs and FGFRs" . SPARSER::COLLECTION)
    ("FGFR-tyrosine kinase" . SPARSER::COLLECTION)
    ("a dual color FISH" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor-type 1" . SPARSER::COLLECTION)
    ("CDX2" . SPARSER::PROTEIN) ("cytokeratin 20" . SPARSER::PROTEIN)
    ("Napsin A" . SPARSER::PROTEIN) ("TTF1" . SPARSER::PROTEIN)
    ("cytokeratin 7" . SPARSER::PROTEIN) ("cytokeratin 5" . SPARSER::PROTEIN)
    ("fibroblast growth factors" . SPARSER::PROTEIN-FAMILY)
    ("type 4" . SPARSER::PROTEIN)
    ("Fibroblast Growth Factor Receptor 1" . SPARSER::PROTEIN)
    ("KEAP1, NRF2 and PPARγ" . SPARSER::COLLECTION) ("PPAR" . SPARSER::PROTEIN)
    ("KEAP1 or NRF2" . SPARSER::COLLECTION)
    ("ABCG2, WNT3 and OCT-4" . SPARSER::COLLECTION)
    ("cytotoxins" . SPARSER::PROTEIN) ("different histological types" . TYPE)
    ("both markedly increase NRF2" . SPARSER::PROTEIN)
    ("As 2 O 3 and tBHQ" . SPARSER::COLLECTION)
    ("classical anti-tumor drugs" . SPARSER::DRUG)
    ("particular acute promyelocytic leukemia" . SPARSER::PROTEIN)
    ("enzymes and antioxidants" . SPARSER::COLLECTION)
    ("GCLC and NQO1" . SPARSER::COLLECTION) ("acrolein" . SPARSER::MOLECULE)
    ("NRF2 and its target genes" . SPARSER::COLLECTION)
    ("many ARE-dependent antioxidant and detoxification enzymes"
     . SPARSER::COLLECTION)
    ("Cys" . SPARSER::AMINO-ACID)
    ("KEAP1 and/or NRF2 genes" . SPARSER::COLLECTION)
    ("lower KEAP1 and higher NRF2" . SPARSER::COLLECTION)
    ("NRF2 and KEAP1" . SPARSER::COLLECTION)
    ("enzyme and PPARγ" . SPARSER::COLLECTION)
    ("ROS and xenobiotics" . SPARSER::COLLECTION)
    ("xenobiotics" . SPARSER::MOLECULE)
    ("endogenous antioxidant and phase II enzyme expression"
     . SPARSER::COLLECTION)
    ("E-CAD and GSN" . SPARSER::COLLECTION)
    ("OCT-4, ABCG2 and WNT3" . SPARSER::COLLECTION)
    ("E-CAD and GELSOLIN" . SPARSER::COLLECTION) ("GSN" . SPARSER::PROTEIN)
    ("GELSOLIN" . SPARSER::PROTEIN) ("gene and protein" . SPARSER::COLLECTION)
    ("NRF2 and ARE-dependent genes" . SPARSER::COLLECTION)
    ("arsenite" . SPARSER::DRUG)
    ("NRF2 and some ARE-dependent genes" . SPARSER::COLLECTION)
    ("NQO1, GCLM and HO-1" . SPARSER::COLLECTION) ("SCR" . SPARSER::PROTEIN)
    ("As 2 O 3 , doxorubicin or etoposide" . SPARSER::COLLECTION)
    ("GCLM" . SPARSER::PROTEIN) ("GCLC" . SPARSER::PROTEIN)
    ("tBHQ" . SPARSER::DRUG) ("-KD" . SPARSER::COLLECTION)
    ("NRF2 or KEAP1" . SPARSER::COLLECTION)
    ("KEAP1-NRF2" . SPARSER::COLLECTION)
    ("chemotherapeutic drugs" . SPARSER::DRUG)
    ("As 2 O 3 , etoposide and doxorubicin" . SPARSER::COLLECTION)
    ("NRF2 or chemical inhibitors" . SPARSER::COLLECTION)
    ("Food and Drug Administration" . SPARSER::COLLECTION)
    ("acute promyleocytic leukemia" . SPARSER::PROTEIN)
    ("pioglitazone and rosiglitazone" . SPARSER::COLLECTION)
    ("rosiglitazone" . SPARSER::DRUG) ("pioglitazone" . SPARSER::DRUG)
    ("Tro" . SPARSER::PROTEIN) ("troglitazone" . SPARSER::DRUG)
    ("ciglitazone" . SPARSER::DRUG) ("Peroxisome" . SPARSER::PROTEIN)
    ("platinum" . SPARSER::MOLECULE)
    ("NRF2 and its downstream genes" . SPARSER::COLLECTION)
    ("target cytoprotective genes" . SPARSER::GENE)
    ("Maf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KEAP1-Cullin3" . SPARSER::COLLECTION)
    ("antioxidant and phase II detoxification enzymes [ xref ]"
     . SPARSER::COLLECTION)
    ("Nuclear factor-E2-related factor 2" . SPARSER::PROTEIN)
    ("PPARγ and detoxification enzymes" . SPARSER::COLLECTION)
    ("KEAP1 and NRF2" . SPARSER::COLLECTION)
    ("E-Cadherin and Gelsolin" . SPARSER::COLLECTION)
    ("Gelsolin" . SPARSER::PROTEIN) ("peroxisome" . SPARSER::PROTEIN)
    ("lentiviral shRNA" . SPARSER::PROTEIN)
    ("etoposide and doxorubicin" . SPARSER::COLLECTION) ("HTB" . SPARSER::DRUG)
    ("The nuclear factor-E2-related factor 2" . SPARSER::PROTEIN)
    ("promyelocytic leukemia" . SPARSER::PROTEIN) ("PPAR γ" . SPARSER::PROTEIN)
    ("ABCG2" . SPARSER::PROTEIN) ("CYCLIN D1" . SPARSER::PROTEIN)
    ("glutamate-cysteine ligase" . SPARSER::PROTEIN)
    ("β-ACTIN" . SPARSER::PROTEIN) ("WNT3" . SPARSER::PROTEIN)
    ("OCT-4" . SPARSER::PROTEIN) ("E-CAD" . SPARSER::PROTEIN)
    ("heme oxygenase 1" . SPARSER::PROTEIN)
    ("Arsenic trioxide" . SPARSER::MOLECULE) ("Cullin3" . SPARSER::PROTEIN)
    ("As 2 O 3" . SPARSER::DRUG) ("arsenic trioxide" . SPARSER::MOLECULE)
    ("Kelch-like ECH-associated protein 1" . SPARSER::PROTEIN)
    ("other leukemogenic receptor tyrosine kinases"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KIT and FLT3" . SPARSER::COLLECTION)
    ("EGFR, IGFR, PDGFR, FGFR, TRK, EPH, and TIE" . SPARSER::COLLECTION)
    ("TIE" . SPARSER::HUMAN-PROTEIN-FAMILY) ("EPH" . SPARSER::PROTEIN)
    ("TRK" . SPARSER::PROTEIN) ("IGFR" . SPARSER::PROTEIN)
    ("100 nM crizotinib and 20 nM PD173074(corresponding to their individualIC 50 values)"
     . SPARSER::COLLECTION)
    ("PD173074 and crizotinib" . SPARSER::COLLECTION)
    ("crizotinib and PD173074" . SPARSER::COLLECTION)
    ("FOP" . SPARSER::PROTEIN)
    ("CRKL, STAT3, and ERK1/2" . SPARSER::COLLECTION)
    ("CRKL" . SPARSER::PROTEIN) ("MET/ALK" . SPARSER::COLLECTION)
    ("PLZF-RARA" . SPARSER::COLLECTION) ("PLZF" . SPARSER::PROTEIN)
    ("AML1-ETO" . SPARSER::COLLECTION) ("PML-RARA" . SPARSER::COLLECTION)
    ("ETO" . SPARSER::PROTEIN) ("RARA" . SPARSER::PROTEIN)
    ("specific shRNAs and inhibiting MET kinase signaling using the kinase inhibitor SU11274 ( xref )"
     . SPARSER::COLLECTION)
    ("HGF and MET" . SPARSER::COLLECTION)
    ("HGF and downstream mediators" . SPARSER::COLLECTION)
    ("STAT3 and MAPK1" . SPARSER::COLLECTION)
    ("5,087 bar-coded shRNAs" . SPARSER::RNA) ("OCI" . SPARSER::PROTEIN)
    ("FGFR1 and MET" . SPARSER::COLLECTION) ("crizotinib" . SPARSER::DRUG)
    ("HGF or MET" . SPARSER::COLLECTION)
    ("hepatocyte growth factor (HGF)" . SPARSER::PROTEIN)
    ("FLT3" . SPARSER::PROTEIN) ("secreted growth factor" . SPARSER::PROTEIN)
    ("p11" . SPARSER::PROTEIN) ("AML1" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor 1" . SPARSER::PROTEIN)
    ("hepatocyte growth factor" . SPARSER::PROTEIN)
    ("CDK6 and SATB1" . SPARSER::COLLECTION) ("HAT" . SPARSER::PROTEIN)
    ("p16 and PML" . SPARSER::COLLECTION)
    ("SATB1 and CDK6–3" . SPARSER::COLLECTION) ("Thymine" . SPARSER::MOLECULE)
    ("Adenine" . SPARSER::NUCLEOBASE) ("CDK6–3" . SPARSER::COLLECTION)
    ("SATB1–3" . SPARSER::COLLECTION) ("MiR" . SPARSER::PROTEIN)
    ("the Special AT-rich Binding protein 1 (SATB1) and the Cyclin Dependent Kinase 6 (CDK6) mRNAs"
     . SPARSER::COLLECTION)
    ("the Special AT-rich Binding protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RB1/E2F" . SPARSER::COLLECTION) ("AGO-2/miRNAs" . SPARSER::COLLECTION)
    ("Dicer or DGCR8" . SPARSER::COLLECTION)
    ("classical oncogenes" . SPARSER::ONCOGENE)
    ("Cdk6 and Satb1" . SPARSER::COLLECTION)
    ("replicative senescence-associated miRNA" . SPARSER::PROTEIN)
    ("SATB1 and CDK6" . SPARSER::COLLECTION)
    ("se" . SPARSER::HUMAN-PROTEIN-FAMILY) ("B–D" . SPARSER::PROTEIN)
    ("ΔNp63α" . SPARSER::PROTEIN) ("P4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("K10" . SPARSER::PROTEIN) ("β-Actin" . SPARSER::PROTEIN)
    ("U18" . SPARSER::PROTEIN) ("pre-miRNAs" . SPARSER::RNA)
    ("Cyclin Dependent Kinase 6" . SPARSER::PROTEIN) ("RB1" . SPARSER::PROTEIN)
    ("AGO-2" . SPARSER::PROTEIN) ("messenger RNAs" . SPARSER::RNA)
    ("Satb1" . SPARSER::PROTEIN) ("Cdk6" . SPARSER::PROTEIN)
    ("CDK6" . SPARSER::PROTEIN) ("SATB1" . SPARSER::PROTEIN)
    ("these indirect regulators" . SPARSER::REGULATOR)
    ("Rac and Cdc42" . SPARSER::COLLECTION)
    ("both indirect and downstream activator small GTPases" . SPARSER::GTPASE)
    ("Tiam1, Fgd1, and SGEF" . SPARSER::COLLECTION)
    ("Rac, Cdc42, and RhoG" . SPARSER::COLLECTION)
    ("both PI3K and the PI3K activators" . SPARSER::COLLECTION)
    ("Tiam1 and Vav2" . SPARSER::COLLECTION) ("Rho-GEFs" . SPARSER::COLLECTION)
    ("Cdc42 and RhoG" . SPARSER::COLLECTION)
    ("Ras or Rho" . SPARSER::COLLECTION)
    ("Rac1, Cdc42, or RhoG" . SPARSER::COLLECTION)
    ("Rac2 and Rac3" . SPARSER::COLLECTION)
    ("Fgd1 and Vav2" . SPARSER::COLLECTION) ("only three GEFs" . SPARSER::GEF)
    ("SGEF, Tiam1, and Fgd1" . SPARSER::COLLECTION)
    ("Cdc42 or RhoG" . SPARSER::COLLECTION) ("Lyn-YFP" . SPARSER::COLLECTION)
    ("mCherry-PH" . SPARSER::COLLECTION)
    ("Fgd1, Tiam1, and SGEF" . SPARSER::COLLECTION)
    ("Cdc42, Rac1, and RhoG" . SPARSER::COLLECTION) ("SGEF" . SPARSER::PROTEIN)
    ("Actin" . SPARSER::PROTEIN) ("Ral" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rap1A or R-Ras" . SPARSER::COLLECTION)
    ("Rac1, Rap1A, or R-Ras" . SPARSER::COLLECTION)
    ("Rac1 or Rap1A and R-Ras" . SPARSER::COLLECTION)
    ("Rap1A and R-Ras" . SPARSER::COLLECTION)
    ("Cdc42/Rac" . SPARSER::COLLECTION) ("CRIB" . SPARSER::DRUG)
    ("Rac1 and Cdc42" . SPARSER::COLLECTION)
    ("Rap1A and RalA" . SPARSER::COLLECTION) ("Rac1-" . SPARSER::PROTEIN)
    ("Rap1A, RalA, Rac1, and Cdc42" . SPARSER::COLLECTION)
    ("Rap1A, Rap2B, and RalA" . SPARSER::COLLECTION)
    ("Rap1A" . SPARSER::PROTEIN) ("RalA" . SPARSER::PROTEIN)
    ("Dominant-negative Cdc42, RhoG, and Rac1" . SPARSER::COLLECTION)
    ("Cdc42, RhoG, and Rac1" . SPARSER::COLLECTION)
    ("dominant-negative mutants" . SPARSER::MUTANT)
    ("CFP-FKBP" . SPARSER::COLLECTION)
    ("a dominant-negative mutant" . SPARSER::MUTANT)
    ("the small GTPase Rac1 ( xref ) and possibly homologous small GTPases"
     . SPARSER::COLLECTION)
    ("possibly homologous small GTPases" . SPARSER::GTPASE)
    ("H-Ras, K-Ras4A, K-Ras4B, N-Ras, R-Ras, R-Ras2, and R-Ras3"
     . SPARSER::COLLECTION)
    ("the dominant-negative forms" . SPARSER::FORM)
    ("FKBP and FRB" . SPARSER::COLLECTION)
    ("small GTPases and RBD p110" . SPARSER::COLLECTION)
    ("reiterated FK506-binding protein (FKBP) and small GTPases"
     . SPARSER::COLLECTION)
    ("FK506-binding protein (FKBP)" . SPARSER::PROTEIN)
    ("NPs" . SPARSER::PROTEIN) ("nanoparticles" . SPARSER::MOLECULE)
    ("fluorescent proteins" . SPARSER::PROTEIN)
    ("prey" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nanoparticle" . SPARSER::MOLECULE) ("ferritin" . SPARSER::PROTEIN)
    ("trap" . SPARSER::PROTEIN) ("H-Ras, R-Ras, or Rheb" . SPARSER::COLLECTION)
    ("Rheb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ras and Rho" . SPARSER::COLLECTION) ("YFP-PH" . SPARSER::COLLECTION)
    ("CFP" . SPARSER::PROTEIN) ("PH" . SPARSER::PROTEIN)
    ("H-Ras or Rac1" . SPARSER::COLLECTION) ("Activators" . SPARSER::ACTIVATOR)
    ("GTPases and PI3K" . SPARSER::COLLECTION)
    ("H-Ras and K-Ras" . SPARSER::COLLECTION)
    ("neutrophils" . SPARSER::PROTEIN)
    ("PI3K as well as Ras family small GTPases" . SPARSER::COLLECTION)
    ("Rac, CDC42, and RhoG" . SPARSER::COLLECTION)
    ("Phosphoinositide 3-kinases (PI3Ks) and Ras and Rho family small GTPases"
     . SPARSER::COLLECTION)
    ("Ras and Rho family" . SPARSER::COLLECTION) ("k 2" . SPARSER::PROTEIN)
    ("G-3" . SPARSER::PROTEIN) ("p85β" . SPARSER::PROTEIN)
    ("Ras Family" . SPARSER::PROTEIN) ("Rac3" . SPARSER::PROTEIN)
    ("Rac2" . SPARSER::PROTEIN) ("Tiam1" . SPARSER::PROTEIN)
    ("Fgd1" . SPARSER::PROTEIN) ("Rap2B" . SPARSER::PROTEIN)
    ("Rap1" . SPARSER::PROTEIN) ("Rho Family" . SPARSER::PROTEIN)
    ("R-Ras3" . SPARSER::PROTEIN) ("FK506-binding protein" . SPARSER::PROTEIN)
    ("B-P" . SPARSER::PROTEIN) ("R-Ras" . SPARSER::PROTEIN)
    ("FGF2" . SPARSER::PROTEIN) ("N-Ras" . SPARSER::PROTEIN)
    ("Ras1" . SPARSER::PROTEIN) ("CDC42" . SPARSER::PROTEIN)
    ("Ras family" . SPARSER::PROTEIN) ("H-Ras" . SPARSER::PROTEIN)
    ("Phosphoinositide 3" . SPARSER::PROTEIN)
    ("soluble complexes" . SPARSER::BIO-COMPLEX)
    ("membrane-associated receptor" . SPARSER::RECEPTOR)
    ("CD95 and TRAIL-R1" . SPARSER::COLLECTION)
    ("CD95/TRAIL-R1" . SPARSER::COLLECTION)
    ("FADD ( xref ) or F122/L123" . SPARSER::COLLECTION)
    ("FADD-procaspase-8" . SPARSER::COLLECTION)
    ("receptor/FADD" . SPARSER::COLLECTION) ("mere" . SPARSER::PROTEIN-FAMILY)
    ("c-FLIP, caspase-8, and caspase-10" . SPARSER::COLLECTION)
    ("the next procaspase-8 molecule" . SPARSER::MOLECULE)
    ("caspase-8:FADD" . SPARSER::BIO-COMPLEX)
    ("the soluble form" . SPARSER::FORM)
    ("receptor:FADD" . SPARSER::BIO-COMPLEX)
    ("a LR-associated protein" . SPARSER::PROTEIN)
    ("CD95 and TRAIL-R1/R2" . SPARSER::COLLECTION)
    ("FADD, caspase-8, and TRAIL-Rs" . SPARSER::COLLECTION)
    ("DAXX, FLASH, FAP-1, DAP3, and FAF-10" . SPARSER::COLLECTION)
    ("FLASH" . SPARSER::PROTEIN) ("DAXX" . SPARSER::PROTEIN)
    ("c-FLIP and caspase-10" . SPARSER::COLLECTION)
    ("CD95 or TRAIL-R1" . SPARSER::COLLECTION)
    ("filament" . SPARSER::PROTEIN-FAMILY) ("active dimers" . SPARSER::DIMER)
    ("their respective DEDs" . SPARSER::PROTEIN) ("/p10" . SPARSER::COLLECTION)
    ("FADD and procaspase-8" . SPARSER::COLLECTION)
    ("procaspase-8 and MC159" . SPARSER::COLLECTION)
    ("phenylalanine/leucine (FL)" . SPARSER::COLLECTION)
    ("phenylalanine/leucine" . SPARSER::COLLECTION)
    ("the viral FLIP" . SPARSER::PROTEIN) ("FLIP" . SPARSER::PROTEIN)
    ("caspase-8, caspase-10, and c-FLIP" . SPARSER::COLLECTION)
    ("caspase-8 or FADD" . SPARSER::COLLECTION) ("DEDs" . SPARSER::PROTEIN)
    ("FADD and TRAIL-Rs or caspase-8" . SPARSER::COLLECTION)
    ("receptors and FADD" . SPARSER::COLLECTION)
    ("approximately 3-fold more TRAIL receptor" . SPARSER::RECEPTOR)
    ("TRAIL-R2:FADD" . SPARSER::BIO-COMPLEX)
    ("ligand, receptor, and FADD" . SPARSER::COLLECTION)
    ("complexes and high molecular weight (HMW) TRAIL DISC ( xref A, Expt B)"
     . SPARSER::COLLECTION)
    ("HMW" . SPARSER::PROTEIN) ("DISCs" . SPARSER::BIO-COMPLEX)
    ("two and five receptors and approximately four DED-only proteins ( xref D)"
     . SPARSER::COLLECTION)
    ("approximately four DED-only proteins" . SPARSER::PROTEIN)
    ("receptors, FADD, and caspase-8" . SPARSER::COLLECTION)
    ("a dual regulator" . SPARSER::REGULATOR)
    ("soluble TRAIL" . SPARSER::PROTEIN)
    ("the predominant signaling receptor" . SPARSER::RECEPTOR)
    ("the predominant receptor" . SPARSER::RECEPTOR)
    ("TRAIL-R1 and TRAIL-R2" . SPARSER::COLLECTION)
    ("cullin-3 and LRs" . SPARSER::COLLECTION)
    ("LR-associated cullin-3 and the hematopoetic DISC" . SPARSER::COLLECTION)
    ("the hematopoetic DISC" . SPARSER::BIO-COMPLEX)
    ("LR-associated cullin-3" . SPARSER::PROTEIN)
    ("Flotillin-1 and Lyn" . SPARSER::COLLECTION)
    ("soluble DISC (S-DISC) fractions" . SPARSER::COMPONENT)
    ("FADD, and caspase-8" . SPARSER::COLLECTION)
    ("polyubiquitination" . SPARSER::PROTEIN)
    ("CD95 or TRAIL" . SPARSER::COLLECTION)
    ("TRAIL-R4 and caspase-10" . SPARSER::COLLECTION)
    ("potential DISC components" . SPARSER::COMPONENT)
    ("approximately ten times less TRAIL DISC" . SPARSER::BIO-COMPLEX)
    ("FADD, and procaspase-8" . SPARSER::COLLECTION)
    ("DISC " . SPARSER::BIO-COMPLEX)
    ("receptor:FADD:caspase-8/caspase-10" . SPARSER::BIO-COMPLEX)
    ("proteins " . SPARSER::PROTEIN) ("CD95 and FADD" . SPARSER::COLLECTION)
    ("trimeric receptors" . SPARSER::PROTEIN)
    ("trimeric complexes" . SPARSER::BIO-COMPLEX)
    ("these trimeric complexes" . SPARSER::BIO-COMPLEX)
    ("caspase or c-FLIP" . SPARSER::COLLECTION)
    ("CD95:FADD:caspase-8" . SPARSER::BIO-COMPLEX)
    ("a 3:2:2" . SPARSER::COLLECTION) ("CD95-FADD" . SPARSER::COLLECTION)
    ("FADD and three molecules" . SPARSER::COLLECTION)
    ("trimer" . SPARSER::TRIMER) ("RIPK1 and RIPK3" . SPARSER::COLLECTION)
    ("caspase-8/caspase-10" . SPARSER::COLLECTION)
    ("an active DISC" . SPARSER::BIO-COMPLEX)
    ("receptor and FADD" . SPARSER::COLLECTION)
    ("the signaling competent TRAIL receptors" . SPARSER::RECEPTOR)
    ("TRAIL-R1/TRAIL-R2" . SPARSER::COLLECTION) ("TRAIL " . SPARSER::PROTEIN)
    ("TNF-related apoptosis-inducing ligand (TRAIL)" . SPARSER::PROTEIN)
    ("TRAIL/CD95" . SPARSER::COLLECTION)
    ("complex (DISC)" . SPARSER::BIO-COMPLEX) ("DISC" . SPARSER::BIO-COMPLEX)
    ("Q14790" . SPARSER::PROTEIN) ("Amino acids" . SPARSER::AMINO-ACID)
    ("Flotillin 1" . SPARSER::PROTEIN) ("DAP3" . SPARSER::PROTEIN)
    ("FAP-1" . SPARSER::PROTEIN) ("Procaspase-8" . SPARSER::PROTEIN)
    ("p10" . SPARSER::PROTEIN) ("p18" . SPARSER::PROTEIN)
    ("L26" . SPARSER::PROTEIN) ("DED1" . SPARSER::PROTEIN)
    ("A–4" . SPARSER::PROTEIN) ("A–3C" . SPARSER::PROTEIN)
    ("p43" . SPARSER::PROTEIN) ("A–3D" . SPARSER::PROTEIN)
    ("Flotillin-1" . SPARSER::PROTEIN) ("Cullin-3" . SPARSER::PROTEIN)
    ("p62" . SPARSER::PROTEIN) ("cullin-3" . SPARSER::PROTEIN)
    ("RIP1" . SPARSER::PROTEIN) ("TRAIL-R4" . SPARSER::PROTEIN)
    ("C–1" . SPARSER::PROTEIN) ("TNFR1" . SPARSER::PROTEIN)
    ("CD95 ligand" . SPARSER::PROTEIN) ("RIPK3" . SPARSER::PROTEIN)
    ("RIPK1 " . SPARSER::PROTEIN) ("caspase-10" . SPARSER::PROTEIN)
    ("c-FLIP" . SPARSER::PROTEIN) ("TRAIL-R2" . SPARSER::PROTEIN)
    ("TRAIL-R1" . SPARSER::PROTEIN) ("CD95L" . SPARSER::PROTEIN)
    ("TNF-related apoptosis-inducing ligand" . SPARSER::PROTEIN)
    ("procaspase-8" . SPARSER::PROTEIN) ("acute leukemia" . SPARSER::PROTEIN)
    ("a radical and curative therapy" . SPARSER::COLLECTION)
    ("endogeneous aldehydes" . SPARSER::MOLECULE)
    ("aldehydes" . SPARSER::MOLECULE) ("exogenous DNA" . SPARSER::DNA)
    ("ROS and TNFα" . SPARSER::COLLECTION) ("very young FA" . SPARSER::PROTEIN)
    ("an overt BMF" . SPARSER::PROTEIN) ("congenital BMF" . SPARSER::PROTEIN)
    ("CDKN2A/p16" . SPARSER::COLLECTION) ("CDKN1A/p21" . SPARSER::COLLECTION)
    ("embryonic and adult HSPCs" . SPARSER::PROTEIN)
    ("γH2AX and 53BP1" . SPARSER::COLLECTION)
    ("FANCD2 and p53" . SPARSER::COLLECTION)
    ("FANCD2-TP53" . SPARSER::COLLECTION) ("NSG" . SPARSER::PROTEIN-FAMILY)
    ("Nod" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 or p21" . SPARSER::COLLECTION) ("p53-GFP" . SPARSER::COLLECTION)
    ("spontaneous BMF" . SPARSER::PROTEIN)
    ("Fancg  -/- and Fancd2  -/-" . SPARSER::COLLECTION)
    ("p21 ( CDKN1A ) and GADD45a" . SPARSER::COLLECTION)
    ("p53 and p21" . SPARSER::COLLECTION) ("P53/p21" . SPARSER::COLLECTION)
    ("Fancd2" . SPARSER::PROTEIN) ("Fancg" . SPARSER::PROTEIN)
    ("MMC" . SPARSER::PROTEIN) ("The progressive BMF" . SPARSER::PROTEIN)
    ("overt BMF" . SPARSER::PROTEIN) ("Fanc" . SPARSER::PROTEIN-FAMILY)
    ("linker" . SPARSER::LINKER) ("IFN-γ and TNF-α" . SPARSER::COLLECTION)
    ("the fifteen FANC genes, the products" . SPARSER::GENE)
    ("FA/BRCA" . SPARSER::COLLECTION) ("FANC" . SPARSER::PROTEIN-FAMILY)
    ("CDKN1A/CIP1/WAF1" . SPARSER::COLLECTION)
    ("p53/p21" . SPARSER::COLLECTION) ("FA or FA-like" . SPARSER::COLLECTION)
    ("HSPC" . SPARSER::PROTEIN) ("HSPCs" . SPARSER::PROTEIN)
    ("BMF" . SPARSER::PROTEIN) ("FA" . SPARSER::PROTEIN)
    ("ABL1" . SPARSER::PROTEIN) ("(Beta" . SPARSER::PROTEIN)
    ("IL-3" . SPARSER::PROTEIN) ("U3" . SPARSER::PROTEIN)
    ("stem cell factor" . SPARSER::PROTEIN) ("IL2" . SPARSER::PROTEIN)
    ("VX-680" . SPARSER::DRUG) ("G2 accumulation" . SPARSER::PROTEIN)
    ("GADD45a" . SPARSER::PROTEIN) ("Mitomycin C" . SPARSER::DRUG)
    ("IFN-γ" . SPARSER::PROTEIN) ("CIP1" . SPARSER::PROTEIN)
    ("Fanconi anemia" . SPARSER::PROTEIN) ("NCCN" . SPARSER::MOLECULE)
    ("BRCA1 , BRCA2 and non-BRCA" . SPARSER::COLLECTION)
    ("BRCA1 , BRCA2 and non-carriers" . SPARSER::COLLECTION)
    ("MRI" . SPARSER::PROTEIN) ("BRCA 1" . SPARSER::PROTEIN)
    ("cancer 2" . SPARSER::PROTEIN) ("western-blot" . SPARSER::PROTEIN)
    ("Polymerase" . SPARSER::PROTEIN) ("RCR" . SPARSER::PROTEIN-FAMILY)
    ("HBV-associated HCC" . SPARSER::PROTEIN)
    ("Cyclin B1, Sec62, and Birc3" . SPARSER::COLLECTION)
    ("Birc2 and Birc3" . SPARSER::COLLECTION)
    ("the recurrent HCC" . SPARSER::PROTEIN)
    ("a potential target gene" . SPARSER::GENE)
    ("cyclin B1 or Sec62" . SPARSER::COLLECTION)
    ("cyclin B1/Sec62/Birc3" . SPARSER::COLLECTION)
    ("the 35 recurrent HCC" . SPARSER::PROTEIN)
    ("Genes and Genomes" . SPARSER::COLLECTION) ("Genes" . SPARSER::GENE)
    ("recurrence-associated genes" . SPARSER::GENE)
    ("the potential biomarkers" . SPARSER::MOLECULE)
    ("accurate predictive biomarkers" . SPARSER::MOLECULE)
    ("the carcinogenic cirrhosis" . SPARSER::PROTEIN)
    ("potential therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("cyclin B1 and Sec62" . SPARSER::COLLECTION)
    ("cyclin B1 (hazard ratio [HR], 4.762; p  = 0.002) and Sec62 (HR, 2.674; p  = 0.018)"
     . SPARSER::COLLECTION)
    ("p  " . SPARSER::PROTEIN) ("recurrent HCC" . SPARSER::PROTEIN)
    ("The tumor-associated proteins cyclin B1, Sec62, and Birc3"
     . SPARSER::COLLECTION)
    ("cyclin B1, Sec62, and Birc3" . SPARSER::COLLECTION)
    ("Birc3" . SPARSER::PROTEIN) ("Sec62" . SPARSER::PROTEIN)
    ("Glyceraldehyde-3-phosphate Dehydrogenase" . SPARSER::PROTEIN)
    ("Baculoviral IAP repeat-Containing3" . SPARSER::PROTEIN)
    ("SEC62 homolog(S.cerevisiae)" . SPARSER::PROTEIN)
    ("BH2" . SPARSER::MOLECULE) ("K  2" . SPARSER::PROTEIN)
    ("K  1" . SPARSER::PROTEIN) ("k  2" . SPARSER::PROTEIN)
    ("k  1" . SPARSER::PROTEIN) ("K2" . SPARSER::PROTEIN)
    ("Birc2" . SPARSER::PROTEIN) ("Cyclin B1" . SPARSER::PROTEIN)
    ("A-C" . SPARSER::PROTEIN) ("BIRC3" . SPARSER::PROTEIN)
    ("baculoviral IAP repeat-containing 3" . SPARSER::PROTEIN)
    ("SEC62" . SPARSER::PROTEIN)
    ("SEC62 homolog ( S. cerevisiae )" . SPARSER::PROTEIN)
    ("α-fetoprotein" . SPARSER::PROTEIN)
    ("mTOR ( xref ) or the regulator" . SPARSER::COLLECTION)
    ("RAPTOR" . SPARSER::PROTEIN) ("analog" . SPARSER::ANALOG)
    ("RAS/MAPK" . SPARSER::COLLECTION)
    ("MEK1/2 and/or ERK1/2" . SPARSER::COLLECTION) ("NFAT" . SPARSER::PROTEIN)
    ("Mek1/2 and ERK1/2" . SPARSER::COLLECTION)
    ("Mek1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the NS-associated Raf1L613V allele" . SPARSER::ALLELE)
    ("Sos1" . SPARSER::PROTEIN) ("-Cre" . SPARSER::COLLECTION)
    ("recombinase" . SPARSER::PROTEIN)
    ("AKT and its downstream effector" . SPARSER::COLLECTION)
    ("FAK, STAT3 and JNK1/2" . SPARSER::COLLECTION)
    ("AKT/mTOR" . SPARSER::COLLECTION)
    ("Gab-1 and IRS-1" . SPARSER::COLLECTION)
    ("deleter-Cre" . SPARSER::COLLECTION) ("enhancers" . SPARSER::PROTEIN)
    ("GOF and LOF" . SPARSER::COLLECTION) ("GOF" . SPARSER::PROTEIN)
    ("ASD" . SPARSER::PROTEIN) ("PS" . SPARSER::PROTEIN)
    ("the platelet-derived growth factor (PDGF) and insulin-like growth factor (IGF)"
     . SPARSER::COLLECTION)
    ("IGF" . SPARSER::PROTEIN) ("RHOA" . SPARSER::PROTEIN)
    ("Substrate" . SPARSER::SUBSTRATE) ("Shp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RASGap" . SPARSER::PROTEIN) ("kinases (SFK)" . SPARSER::PROTEIN)
    ("Ptpn11" . SPARSER::PROTEIN) ("scaffolds" . SPARSER::SCAFFOLD)
    ("receptors and integrins" . SPARSER::COLLECTION)
    ("integrins" . SPARSER::PROTEIN) ("PTP" . SPARSER::PROTEIN)
    ("KRAS , NRAS , SOS1 , RAF1 , BRAF , MEK1 , MEK2 , SHOC2 , and CBL"
     . SPARSER::COLLECTION)
    ("CBL" . SPARSER::PROTEIN) ("CHD" . SPARSER::PROTEIN)
    ("AKT-induced" . SPARSER::PROTEIN) ("PD325901" . SPARSER::DRUG)
    ("cyclosporine-A" . SPARSER::MOLECULE)
    ("calcineurin inhibitor" . SPARSER::PROTEIN) ("1L" . SPARSER::PROTEIN)
    ("JNK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Gab-1" . SPARSER::PROTEIN)
    ("shp2" . SPARSER::PROTEIN) ("IGF1" . SPARSER::PROTEIN)
    ("GRB2" . SPARSER::PROTEIN) ("SHPS-1" . SPARSER::PROTEIN)
    ("GAB1" . SPARSER::PROTEIN) ("GRB2-associated binder 1" . SPARSER::PROTEIN)
    ("IRS1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("insulin receptor substrate 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SHOC2" . SPARSER::PROTEIN) ("MEK2" . SPARSER::PROTEIN)
    ("RAF1" . SPARSER::PROTEIN) ("SOS1" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("PCNA and polyubiquitin" . SPARSER::COLLECTION)
    ("UV-induced PCNA nuclear foci" . SPARSER::PROTEIN)
    ("a trimeric complex" . SPARSER::BIO-COMPLEX)
    ("clamps" . SPARSER::PROTEIN-FAMILY) ("RPA-ssDNA" . SPARSER::COLLECTION)
    ("Part" . SPARSER::COMPONENT) ("FAN1 and SLX4" . SPARSER::COLLECTION)
    ("RNF8 and RNF168" . SPARSER::COLLECTION)
    ("polyubiquitin" . SPARSER::PROTEIN) ("DDR" . SPARSER::PROTEIN)
    ("soluble Rad18" . SPARSER::PROTEIN) ("GFP-Rad18" . SPARSER::COLLECTION)
    ("Spartan or Rad18" . SPARSER::COLLECTION) ("XPA" . SPARSER::PROTEIN)
    ("eGFP-Pol" . SPARSER::COLLECTION) ("eGFP" . SPARSER::PROTEIN)
    ("which targets only endogenous Spartan" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("which targets both endogenous Spartan and exogenous Spartan"
     . SPARSER::COLLECTION)
    ("exogenous Spartan" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("which targets both endogenous Spartan" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("both endogenous and exogenous Spartan or endogenous Spartan"
     . SPARSER::COLLECTION)
    ("siSpartan-2" . SPARSER::COLLECTION) ("siSpartan-1" . SPARSER::COLLECTION)
    ("Rad18 and Usp1" . SPARSER::COLLECTION)
    ("UV-induced Spartan WT foci" . SPARSER::PROTEIN)
    ("Usp1" . SPARSER::PROTEIN) ("SFB-Spartan" . SPARSER::COLLECTION)
    ("PCNA and ubiquitin" . SPARSER::COLLECTION) ("trimers" . SPARSER::TRIMER)
    ("fragment and PCNA" . SPARSER::COLLECTION)
    ("both K63- and K48-linked ubiquitin" . SPARSER::COLLECTION)
    ("neither GST nor GST-Spartan-C ΔUBZ" . SPARSER::COLLECTION)
    ("purified K63- or K48-linked ubiquitin" . SPARSER::COLLECTION)
    ("K63-" . SPARSER::PROTEIN) ("foci (IRIF)" . SPARSER::PROTEIN)
    ("the UV-induced Spartan foci" . SPARSER::PROTEIN)
    ("Triton" . SPARSER::MOLECULE) ("streptavidin" . SPARSER::PROTEIN)
    ("SFB" . SPARSER::PROTEIN) ("Spartan and Rad18" . SPARSER::COLLECTION)
    ("this putative gene SPRTN ( SprT -like domain at the N terminus) and its protein product Spartan"
     . SPARSER::COLLECTION)
    ("SPRTN" . SPARSER::PROTEIN)
    ("a previously uncharacterized protein" . SPARSER::PROTEIN)
    ("UBD" . SPARSER::PROTEIN) ("UBDs" . SPARSER::PROTEIN)
    ("FANCD2 and FANCI" . SPARSER::COLLECTION) ("FANCI" . SPARSER::PROTEIN)
    ("Pols" . SPARSER::PROTEIN) ("FEN-1 and p21" . SPARSER::COLLECTION)
    ("CNA" . SPARSER::PROTEIN) ("PRR and ICL" . SPARSER::COLLECTION)
    ("ICL" . SPARSER::PROTEIN) ("unique types" . TYPE)
    ("ICLs" . SPARSER::PROTEIN)
    ("a homotrimeric protein complex" . SPARSER::BIO-COMPLEX)
    ("PIP" . SPARSER::PROTEIN) ("Spartan" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Orc2" . SPARSER::PROTEIN) ("H2AX" . SPARSER::PROTEIN)
    ("RNF168" . SPARSER::PROTEIN) ("RNF8" . SPARSER::PROTEIN)
    ("Rap80" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SLX4" . SPARSER::PROTEIN)
    ("FAN1" . SPARSER::PROTEIN) ("K63" . SPARSER::PROTEIN)
    ("SprT -like domain at the N terminus" . SPARSER::PROTEIN)
    ("C1orf124" . SPARSER::PROTEIN) ("two domains" . SPARSER::PROTEIN)
    ("FANCD2" . SPARSER::PROTEIN) ("SNM1A" . SPARSER::PROTEIN)
    ("REV1" . SPARSER::PROTEIN) ("FEN-1" . SPARSER::PROTEIN)
    ("Rad18" . SPARSER::PROTEIN) ("YY" . SPARSER::MOLECULE)
    ("TX" . SPARSER::PROTEIN) ("iodine" . SPARSER::MOLECULE)
    ("aggressive subtypes" . SPARSER::PROTEIN)
    ("the Micro variant" . SPARSER::VARIANT) ("etc" . SPARSER::PROTEIN)
    ("multiple PTC and solitary PTC" . SPARSER::COLLECTION)
    ("certain histologic subtypes" . SPARSER::PROTEIN)
    ("multiple additional smaller foci" . SPARSER::PROTEIN)
    ("multiple noncontiguous tumor foci" . SPARSER::PROTEIN)
    ("Thyroid" . SPARSER::PROTEIN) ("376 solitary PTCs" . SPARSER::PROTEIN)
    ("PTCs" . SPARSER::PROTEIN) ("solitary PTC" . SPARSER::PROTEIN)
    ("aggressive PTC" . SPARSER::PROTEIN) ("PTC" . SPARSER::PROTEIN)
    ("recombinant thyroid-stimulating hormone" . SPARSER::DRUG)
    ("L-T" . SPARSER::PROTEIN) ("XLalphas" . SPARSER::PROTEIN)
    ("severe pre-" . SPARSER::PROTEIN) ("pre-" . SPARSER::PROTEIN)
    ("Exon" . SPARSER::PROTEIN) ("Broader" . SPARSER::PROTEIN)
    ("IGF2 and 25 CpGs" . SPARSER::COLLECTION)
    ("XLalphaS and Gsalpha" . SPARSER::COLLECTION)
    ("PPHP or POH" . SPARSER::COLLECTION) ("exon/intron" . SPARSER::COLLECTION)
    ("Iloprost" . SPARSER::DRUG) ("prostacyclin" . SPARSER::MOLECULE)
    ("prostaglandin" . SPARSER::PROTEIN) ("-ICR1" . SPARSER::COLLECTION)
    ("SNRPN" . SPARSER::PROTEIN) ("Zac" . SPARSER::PROTEIN)
    ("PTH and TSH" . SPARSER::COLLECTION) ("TSH" . SPARSER::PROTEIN)
    ("a complex and broad phenotype mostly characterized"
     . SPARSER::COLLECTION)
    ("SNURF and GRB10" . SPARSER::COLLECTION) ("SNURF" . SPARSER::PROTEIN)
    ("NESP" . SPARSER::DRUG) ("platelets" . SPARSER::PROTEIN)
    ("XLalphaS" . SPARSER::PROTEIN) ("POH" . SPARSER::DRUG)
    ("PPHP" . SPARSER::DRUG) ("Ia" . SPARSER::MOLECULE)
    ("PTH" . SPARSER::PROTEIN) ("Parathormone" . SPARSER::PROTEIN)
    ("Ib" . SPARSER::DRUG) ("GNAS" . SPARSER::PROTEIN)
    ("PHP" . SPARSER::PROTEIN) ("−2" . SPARSER::PROTEIN)
    ("CAP1" . SPARSER::PROTEIN) ("CAP-1" . SPARSER::PROTEIN)
    ("NESP55" . SPARSER::PROTEIN) ("STX16" . SPARSER::PROTEIN)
    ("PGE 1" . SPARSER::DRUG) ("E 1" . SPARSER::MOLECULE)
    ("mental retardation" . SPARSER::PROTEIN) ("ICR1" . SPARSER::PROTEIN)
    ("PLAGL1" . SPARSER::PROTEIN) ("GRB10" . SPARSER::PROTEIN)
    ("IGF2" . SPARSER::PROTEIN) ("casein" . SPARSER::PROTEIN)
    ("myogenic" . SPARSER::PROTEIN) ("PAX3/FOXO1" . SPARSER::COLLECTION)
    ("LRP6 instead of β-catenin" . SPARSER::COLLECTION)
    ("even lower PAX3" . SPARSER::PROTEIN)
    ("NF-κB, Bcl-2 and XIAP" . SPARSER::COLLECTION)
    ("SB216763 and GSK-3" . SPARSER::COLLECTION)
    ("DMSO or SB216763" . SPARSER::COLLECTION)
    ("exogenous PAX3" . SPARSER::PROTEIN)
    ("PAX3 or siScramble" . SPARSER::COLLECTION)
    ("exogenous GSK-3" . SPARSER::PROTEIN)
    ("amino acids and amino acids" . SPARSER::COLLECTION)
    ("site1, and pGex2T-PAX3PD" . SPARSER::COLLECTION)
    ("GST-PAX3" . SPARSER::COLLECTION)
    ("GSK-3β and PAX3" . SPARSER::COLLECTION)
    ("neither PAX3 nor HA-tagged GSK-3β" . SPARSER::COLLECTION)
    ("β-catenin and glycogen synthase" . SPARSER::COLLECTION)
    ("GSK-3 α or GSK-3 β" . SPARSER::COLLECTION)
    ("GSK-3 α or si" . SPARSER::COLLECTION)
    ("GSK-3 β and both GSK-3 α and GSK-3 β" . SPARSER::COLLECTION)
    ("si GSK-3 α and both si GSK-3 α and si GSK-3 β" . SPARSER::COLLECTION)
    ("GSK-3 α and si" . SPARSER::COLLECTION)
    ("only one GSK-3 isoform" . SPARSER::ISOFORM)
    ("DMSO or the highly specific GSK-3 small molecule inhibitor SB216763 ( xref )"
     . SPARSER::COLLECTION)
    ("GSK-3 and PAX3" . SPARSER::COLLECTION)
    ("GSK-3α or GSK-3β" . SPARSER::COLLECTION)
    ("GSK-3 α and GSK-3 β" . SPARSER::COLLECTION)
    ("GSK-3α and GSK-3β" . SPARSER::COLLECTION) ("CK2" . SPARSER::PROTEIN)
    ("LRP6" . SPARSER::PROTEIN) ("Hath1" . SPARSER::PROTEIN)
    ("site1" . SPARSER::PROTEIN) ("G 2 /M" . SPARSER::PROTEIN)
    ("P 32" . SPARSER::PROTEIN) ("S21" . SPARSER::PROTEIN)
    ("Gsk-3 β" . SPARSER::PROTEIN) ("GSK-3 β" . SPARSER::PROTEIN)
    ("GSK-3 α" . SPARSER::PROTEIN) ("SB216763" . SPARSER::DRUG)
    ("GSK-3" . SPARSER::PROTEIN)
    ("Glycogen Synthase Kinase-3" . SPARSER::PROTEIN)
    ("both PI3K and/or mTORC1 and p53" . SPARSER::COLLECTION)
    ("mTORC1 and p53" . SPARSER::COLLECTION)
    ("PTEN , PIK3CA and TP53" . SPARSER::COLLECTION)
    ("PTEN or PIK3CA" . SPARSER::COLLECTION)
    ("an aggressive tumour type" . TYPE)
    ("a relatively low-risk group" . SPARSER::MOLECULE)
    ("endometrial carcinoma subtype" . SPARSER::PROTEIN)
    ("the largest patient cohort" . SPARSER::MOLECULE)
    ("PIK3CA , PIK3R1 and PIK3R2" . SPARSER::COLLECTION)
    ("all endometrial carcinoma subtypes" . SPARSER::PROTEIN)
    ("components of the PI3K and/or mTORC1 signalling cascade"
     . SPARSER::COLLECTION)
    ("these highly aggressive cancer subtypes" . SPARSER::PROTEIN)
    ("rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("subtype or p53" . SPARSER::COLLECTION)
    ("strong nuclear p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("namely histological subtype" . SPARSER::PROTEIN)
    ("p110α, P-AKT, ErbB2 and p53" . SPARSER::COLLECTION)
    ("histological tumour subtype" . SPARSER::PROTEIN)
    ("a high-risk group and a low-risk group" . SPARSER::COLLECTION)
    ("p110α, P-S6, ErbB2 and p53" . SPARSER::COLLECTION)
    ("PI3K-mTORC1" . SPARSER::COLLECTION)
    ("histological subtype" . SPARSER::PROTEIN)
    ("PAX8 and IMP3" . SPARSER::COLLECTION) ("Examples" . SPARSER::EXAMPLE)
    ("TSC1, TSC2, P-S6K and P-4E-BP1" . SPARSER::COLLECTION)
    ("PAX8, IMP3 and p16" . SPARSER::COLLECTION)
    ("P-S6 ( xref ) and P-4E-BP1 ( xref )" . SPARSER::COLLECTION)
    ("P-S6 and P-4E-BP1" . SPARSER::COLLECTION) ("subtype" . SPARSER::PROTEIN)
    ("AKT-mTOR" . SPARSER::COLLECTION) ("SAPK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phospho-Ser240/244-ribosomal S6 protein (P-S6) and phospho-Thr37/46-4E-BP1 (P-4E-BP1)"
     . SPARSER::COLLECTION)
    ("AKT-mTORC1" . SPARSER::COLLECTION) ("BP" . SPARSER::PROTEIN)
    ("ErbB2" . SPARSER::PROTEIN) ("example" . SPARSER::EXAMPLE)
    ("coarse chromatin" . SPARSER::PROTEIN)
    ("three different histological subtypes" . SPARSER::PROTEIN)
    ("the glandular component" . SPARSER::COMPONENT)
    ("Cohorts" . SPARSER::MOLECULE) ("lox" . SPARSER::PROTEIN)
    ("type I and type II" . SPARSER::COLLECTION)
    ("PTEN or KRAS and microsatellite" . SPARSER::COLLECTION)
    ("KRAS and microsatellite" . SPARSER::COLLECTION)
    ("type I or type II" . SPARSER::COLLECTION) ("Prat" . SPARSER::PROTEIN)
    ("Lax" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTEN , PIK3CA , PIK3R1 , PIK3R2 , LKB1 , TSC2 and KRAS"
     . SPARSER::COLLECTION)
    ("PI3K-AKT-mTORC1" . SPARSER::COLLECTION)
    ("histologically diverse subtypes" . SPARSER::PROTEIN)
    ("the different endometrial cancer subtypes" . SPARSER::PROTEIN)
    ("type I as well as type II endometrial carcinoma subtypes"
     . SPARSER::COLLECTION)
    ("type II endometrial carcinoma subtypes" . SPARSER::PROTEIN)
    ("PI3K-mTOR" . SPARSER::PROTEIN) ("IMP3" . SPARSER::PROTEIN)
    ("PAX8" . SPARSER::PROTEIN) ("TSC1" . SPARSER::PROTEIN)
    ("BP1" . SPARSER::PROTEIN) ("P-4" . SPARSER::PROTEIN)
    ("4E-BP1" . SPARSER::PROTEIN) ("P-S6K" . SPARSER::PROTEIN)
    ("p70 S6" . SPARSER::PROTEIN) ("ERBB2" . SPARSER::PROTEIN)
    ("CTNNB1" . SPARSER::PROTEIN) ("TSC2" . SPARSER::PROTEIN)
    ("Type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mitochondria" . SPARSER::PROTEIN)
    ("DNA2, FANCJ and RTEL1" . SPARSER::COLLECTION)
    ("functional TFIIH" . SPARSER::PROTEIN)
    ("MMS19, FAM96B, IOP1, or ISCU" . SPARSER::COLLECTION)
    ("TFIIH" . SPARSER::PROTEIN) ("ISCU" . SPARSER::PROTEIN)
    ("Mms19 or other Fe/S protein assembly components" . SPARSER::COLLECTION)
    ("ISC or CIA" . SPARSER::COLLECTION) ("Cfd1-Nbp35" . SPARSER::COLLECTION)
    ("MMS19, CIAO1, and FAM96B" . SPARSER::COLLECTION)
    ("FANCJ" . SPARSER::PROTEIN)
    ("CIAO1, IOP1, and FAM96B" . SPARSER::COLLECTION)
    ("MMS19-associated protein" . SPARSER::PROTEIN)
    ("DPYD and POLD1" . SPARSER::COLLECTION)
    ("mitochondrial aconitase (mtAco) and succinate dehydrogenase (SDH)"
     . SPARSER::COLLECTION)
    ("dehydrogenase (SDH)" . SPARSER::PROTEIN) ("SDH" . SPARSER::PROTEIN)
    ("dehydrogenase" . SPARSER::PROTEIN)
    ("Nfs1, frataxin, and Nbp35" . SPARSER::COLLECTION)
    ("apoprotein" . SPARSER::MOLECULE)
    ("Nfs1 and frataxin" . SPARSER::COLLECTION) ("Nfs1" . SPARSER::PROTEIN)
    ("frataxin" . SPARSER::PROTEIN) ("IRP1 and GPAT" . SPARSER::COLLECTION)
    ("-thymine" . SPARSER::MOLECULE) ("thymine" . SPARSER::MOLECULE)
    ("DPYD" . SPARSER::PROTEIN)
    ("cytosolic aconitase IRP1 (iron regulatory protein 1) and GPAT"
     . SPARSER::COLLECTION)
    ("two well-studied Fe/S proteins, cytosolic aconitase IRP1 (iron regulatory protein 1) and GPAT"
     . SPARSER::COLLECTION)
    ("phosphoribosylpyrophosphate" . SPARSER::MOLECULE)
    ("glutamine" . SPARSER::AMINO-ACID) ("GPAT" . SPARSER::PROTEIN)
    ("aconitase" . SPARSER::PROTEIN) ("A – B" . SPARSER::PROTEIN)
    ("Efficient MMS19" . SPARSER::PROTEIN)
    ("CIAO1 and FAM96B" . SPARSER::COLLECTION)
    ("Rli1 and the DNA glycosylase Ntg2" . SPARSER::COLLECTION)
    ("helicase/nuclease" . SPARSER::COLLECTION) ("nuclease" . SPARSER::PROTEIN)
    ("Cfd1 and Nbp35" . SPARSER::COLLECTION) ("Cfd1" . SPARSER::PROTEIN)
    ("mms19" . SPARSER::PROTEIN) ("Nbp35 and Cia1" . SPARSER::COLLECTION)
    ("Rli1, and Ntg2" . SPARSER::COLLECTION) ("Ntg2" . SPARSER::PROTEIN)
    ("GAL" . SPARSER::PROTEIN) ("Cia1 and Cia2" . SPARSER::COLLECTION)
    ("various DNA metabolism-associated Fe/S proteins" . SPARSER::PROTEIN)
    ("Mms19" . SPARSER::PROTEIN) ("eukaryotic MMS19" . SPARSER::PROTEIN)
    ("Cia1" . SPARSER::PROTEIN) ("CFD1-NBP35" . SPARSER::COLLECTION)
    ("ISC and CIA" . SPARSER::COLLECTION) ("ISC" . SPARSER::MOLECULE)
    ("inorganic cofactors" . SPARSER::PROTEIN) ("cofactors" . SPARSER::PROTEIN)
    ("apoproteins" . SPARSER::MOLECULE) ("CIA" . SPARSER::PROTEIN)
    ("DNA2" . SPARSER::PROTEIN) ("apo-XPD" . SPARSER::PROTEIN)
    ("A 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Rad53" . SPARSER::PROTEIN)
    ("RTEL1" . SPARSER::PROTEIN) ("mitochondrial aconitase" . SPARSER::PROTEIN)
    ("Pol3" . SPARSER::PROTEIN) ("POLD1" . SPARSER::PROTEIN)
    ("dihydropyrimidine dehydrogenase" . SPARSER::PROTEIN)
    ("Fe-S" . SPARSER::PROTEIN) ("A – C" . SPARSER::PROTEIN)
    ("IRP1" . SPARSER::PROTEIN) ("FAM96B" . SPARSER::PROTEIN)
    ("DNA glycosylase" . SPARSER::PROTEIN) ("Dna2" . SPARSER::PROTEIN)
    ("S3A" . SPARSER::PROTEIN) ("Nbp35" . SPARSER::PROTEIN)
    ("alcohol dehydrogenase" . SPARSER::PROTEIN) ("Rli1" . SPARSER::PROTEIN)
    ("putative)" . SPARSER::PROTEIN) ("yeast)" . SPARSER::PROTEIN)
    ("MET18" . SPARSER::PROTEIN) ("IOP1" . SPARSER::PROTEIN)
    ("Nar1" . SPARSER::PROTEIN) ("CIAO1" . SPARSER::PROTEIN)
    ("NBP35" . SPARSER::PROTEIN) ("CFD1" . SPARSER::PROTEIN)
    ("iron-sulfur cluster" . SPARSER::MOLECULE)
    ("iron-sulfur" . SPARSER::MOLECULE) ("MMS19" . SPARSER::PROTEIN)
    ("vaccine-induced anti-HER2 antibodies" . SPARSER::ANTIBODY)
    ("bovine serum albumin" . SPARSER::PROTEIN)
    ("antibodies, and antibodies" . SPARSER::COLLECTION)
    ("trastuzumab and geldanamycin" . SPARSER::COLLECTION)
    ("trastuzumab or geldanamycin" . SPARSER::COLLECTION)
    ("geldanamycin" . SPARSER::DRUG) ("antibiotic" . SPARSER::DRUG)
    ("antibodies and small-molecule tyrosine kinase inhibitor"
     . SPARSER::COLLECTION)
    ("one mAb or multiple mAbs" . SPARSER::COLLECTION)
    ("crude serum antibodies" . SPARSER::ANTIBODY)
    ("AKT and ERK" . SPARSER::COLLECTION)
    ("a 1,255-amino-acid protein" . SPARSER::PROTEIN)
    ("exogenous Myc-tagged ubiquitin" . SPARSER::PROTEIN)
    ("HER2-ubiquitin-Myc" . SPARSER::COLLECTION)
    ("proteasomes" . SPARSER::PROTEIN)
    ("isoproterenol and HER2-VIA" . SPARSER::COLLECTION)
    ("receptor-RFP" . SPARSER::COLLECTION)
    ("-adrenergic" . SPARSER::COLLECTION) ("transferrin" . SPARSER::PROTEIN)
    ("adrenergic" . SPARSER::PROTEIN) ("HER1-GFP" . SPARSER::COLLECTION)
    ("EGFR (EGFR-GFP) and RFP protein" . SPARSER::COLLECTION)
    ("HER2-RFP" . SPARSER::COLLECTION) ("EGFR-GFP" . SPARSER::COLLECTION)
    ("RFP" . SPARSER::PROTEIN) ("HER2-YFP" . SPARSER::COLLECTION)
    ("YFP" . SPARSER::PROTEIN)
    ("overexpressed HER2 or endogenous HER2 protein" . SPARSER::COLLECTION)
    ("clathrin and clathrin-associated adaptor proteins" . SPARSER::COLLECTION)
    ("clathrin-associated adaptor proteins" . SPARSER::PROTEIN)
    ("Akt and signal transducer" . SPARSER::COLLECTION)
    ("PTB" . SPARSER::PROTEIN) ("tyrosines" . SPARSER::AMINO-ACID)
    ("the HER1 ligand epidermal growth factor (EGF) and the HER3 ligand neuregulin"
     . SPARSER::COLLECTION)
    ("epidermal growth factor (EGF)" . SPARSER::PROTEIN)
    ("HER1 and HER3" . SPARSER::COLLECTION)
    ("homodimers or heterodimers" . SPARSER::COLLECTION)
    ("neuregulin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("-Akt" . SPARSER::COLLECTION)
    ("The HER2 receptor forms homodimers as well as heterodimer"
     . SPARSER::COLLECTION)
    ("HER1, HER3, or HER4" . SPARSER::COLLECTION)
    ("HER3, and HER4" . SPARSER::COLLECTION)
    ("HER2 and HER3" . SPARSER::COLLECTION)
    ("mAbs or tyrosine kinase" . SPARSER::COLLECTION)
    ("trastuzumab and lapatinib" . SPARSER::COLLECTION)
    ("the dual epidermal growth factor receptor (EGFR) and HER2 receptor tyrosine kinase inhibitor lapatinib (Tykerb)"
     . SPARSER::COLLECTION)
    ("the dual epidermal growth factor receptor (EGFR)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mAbs and tyrosine kinase" . SPARSER::COLLECTION) ("mAbs" . SPARSER::DRUG)
    ("yellow fluorescent protein" . SPARSER::PROTEIN)
    ("tumor antigen" . SPARSER::DRUG) ("G-protein" . SPARSER::PROTEIN)
    ("β 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("lamin B" . SPARSER::PROTEIN-FAMILY) ("QS21" . SPARSER::DRUG)
    ("NP40" . SPARSER::MOLECULE) ("sulfo-NHS" . SPARSER::DRUG)
    ("erbB-2" . SPARSER::PROTEIN) ("17β-estradiol" . SPARSER::PROTEIN)
    ("N -ethylmaleimide" . SPARSER::MOLECULE) ("Sulfo-NHS" . SPARSER::DRUG)
    ("Lamin B1" . SPARSER::PROTEIN)
    ("phospholipase C gamma" . SPARSER::PROTEIN-FAMILY)
    ("HER4" . SPARSER::PROTEIN) ("PI3K, Akt and c-Src" . SPARSER::COLLECTION)
    ("receptor, PI3K, Akt, c-Src, c-Jun, and AP-1" . SPARSER::COLLECTION)
    ("Jun homodimers or Jun-Fos heterodimers" . SPARSER::COLLECTION)
    ("Jun-Fos" . SPARSER::COLLECTION) ("homodimers" . SPARSER::HOMODIMER)
    ("Jun and Fos" . SPARSER::COLLECTION)
    ("Fos" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Jun" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NF-κB, Sp-1, and AP-1" . SPARSER::COLLECTION)
    ("Akt inhibitor and Akt mutant" . SPARSER::COLLECTION)
    ("the dominant-negative mutant" . SPARSER::MUTANT)
    ("HGF and OPN" . SPARSER::COLLECTION)
    ("family and OPN" . SPARSER::COLLECTION)
    ("c-Met, PI3K, Akt, c-Src, c-Jun, and AP-1" . SPARSER::COLLECTION)
    ("PP2 or c-Met and c-Jun" . SPARSER::COLLECTION)
    ("c-Met and c-Jun" . SPARSER::COLLECTION)
    ("siRNA or p85, Akt, and c-Src" . SPARSER::COLLECTION)
    ("p85, Akt, and c-Src" . SPARSER::COLLECTION)
    ("PP2 or c-Met and Akt" . SPARSER::COLLECTION)
    ("receptor, PI3K, Akt, and c-Src" . SPARSER::COLLECTION)
    ("Ly294002, and Akt" . SPARSER::COLLECTION)
    ("c-Met and Akt" . SPARSER::COLLECTION)
    ("PI3K and Akt" . SPARSER::COLLECTION)
    ("receptor, PI3K, Akt, c-Src, and AP-1" . SPARSER::COLLECTION)
    ("a heterodimeric molecule" . SPARSER::MOLECULE)
    ("RGDS" . SPARSER::PROTEIN)
    ("bone morphogenetic proteins and osteopontin (OPN)" . SPARSER::COLLECTION)
    ("proteins and osteopontin" . SPARSER::COLLECTION)
    ("calcitonin" . SPARSER::PROTEIN) ("osteoclasts" . SPARSER::PROTEIN)
    ("HGF and c-Met" . SPARSER::COLLECTION)
    ("PI3K, Akt, c-Src, c-Jun, and AP-1" . SPARSER::COLLECTION)
    ("AP-1-luciferase" . SPARSER::COLLECTION)
    ("PI3K, Akt, and c-Src" . SPARSER::COLLECTION) ("curcumin" . SPARSER::DRUG)
    ("OPN" . SPARSER::PROTEIN) ("Osteopontin" . SPARSER::PROTEIN)
    ("Sp-1" . SPARSER::PROTEIN)
    ("catalytic subunit of PI3K" . SPARSER::PROTEIN)
    ("vitamin D 3" . SPARSER::MOLECULE) ("c-Src kinase" . SPARSER::COLLECTION)
    ("Kinase activity" . SPARSER::PROTEIN) ("c-Src Kinase" . SPARSER::PROTEIN)
    ("Kinase Activity" . SPARSER::PROTEIN) ("penicillin G" . SPARSER::MOLECULE)
    ("vitamin D" . SPARSER::MOLECULE)
    ("parathyroid hormone" . SPARSER::PROTEIN) ("Ly294002" . SPARSER::MOLECULE)
    ("c-Met" . SPARSER::PROTEIN)
    ("Hepatocyte growth factor" . SPARSER::PROTEIN)
    ("liver cancer histological type" . TYPE)
    ("the mutated DNA" . SPARSER::DNA)
    ("cirrhosis and CC" . SPARSER::COLLECTION) ("HBsAg-" . SPARSER::DRUG)
    ("alpha-fetoprotein (AFP)" . SPARSER::PROTEIN) ("AFP" . SPARSER::PROTEIN)
    ("Male" . SPARSER::MOLECULE) ("HCC/cirrhosis" . SPARSER::COLLECTION)
    ("CLD" . SPARSER::PROTEIN) ("CFDNA" . SPARSER::DNA)
    ("DNA (CFDNA)" . SPARSER::DNA) ("albumin-adduct" . SPARSER::PROTEIN-PAIR)
    ("HBsAg" . SPARSER::DRUG) ("Arginine" . SPARSER::AMINO-ACID)
    ("AGT" . SPARSER::PROTEIN) ("AGG" . SPARSER::MOLECULE)
    ("Guanine" . SPARSER::PROTEIN) ("epoxide" . SPARSER::MOLECULE)
    ("toxin" . SPARSER::MOLECULE) ("fungi" . SPARSER::PROTEIN)
    ("fungal toxins" . SPARSER::MOLECULE) ("toxins" . SPARSER::MOLECULE)
    ("Aflatoxins" . SPARSER::MOLECULE) ("Aflatoxin" . SPARSER::MOLECULE)
    ("HCC and CC" . SPARSER::COLLECTION) ("HCCs" . SPARSER::PROTEIN)
    ("HCC and cirrhosis" . SPARSER::COLLECTION)
    ("cirrhosis" . SPARSER::PROTEIN) ("SOMA" . SPARSER::DRUG)
    ("Oligonucleotide" . SPARSER::MOLECULE) ("aflatoxin" . SPARSER::MOLECULE)
    ("HCC" . SPARSER::PROTEIN) ("PLC" . SPARSER::PROTEIN)
    ("Alpha-fetoprotein" . SPARSER::PROTEIN) ("plasma)" . SPARSER::PROTEIN)
    ("P450" . SPARSER::PROTEIN-FAMILY) ("PI3K/AKT/mTOR" . SPARSER::COLLECTION)
    ("BRAF or MEK" . SPARSER::COLLECTION) ("NCT" . SPARSER::PROTEIN)
    ("PI3K/Akt/mTOR Inhibitors or MAP Kinase Pathway Inhibitors"
     . SPARSER::COLLECTION)
    ("PIK3CA and KRAS" . SPARSER::COLLECTION)
    ("cetuximab or panitumumab" . SPARSER::COLLECTION)
    ("PIK3CA and BRAF" . SPARSER::COLLECTION)
    ("KRAS , BRAF and PIK3CA" . SPARSER::COLLECTION)
    ("Subtypes" . SPARSER::PROTEIN) ("mitogen" . SPARSER::MITOGEN)
    ("CR/PR" . SPARSER::COLLECTION) ("PI3K/Akt/mTOR" . SPARSER::COLLECTION)
    ("CR" . SPARSER::PROTEIN) ("KRAS and PIK3CA" . SPARSER::COLLECTION)
    ("KRAS , PIK3CA and BRAF" . SPARSER::COLLECTION)
    ("mCRC" . SPARSER::PROTEIN) ("MAP Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("OR 2" . SPARSER::MOLECULE) ("HR 1" . SPARSER::PROTEIN-FAMILY)
    ("activating protein" . SPARSER::PROTEIN)
    ("Dnmt1 and DNA" . SPARSER::COLLECTION)
    ("Systemic Lupus Erythematosus" . SPARSER::PROTEIN)
    ("Mekk2 and Mekk3" . SPARSER::COLLECTION) ("Mekk3" . SPARSER::PROTEIN)
    ("Mekk2" . SPARSER::PROTEIN) ("Dnmt1 or Dnmt3b" . SPARSER::COLLECTION)
    ("Tbx21 and Gata3" . SPARSER::COLLECTION) ("Egr-2" . SPARSER::COLLECTION)
    ("Bcl2a1" . SPARSER::PROTEIN) ("paralogs" . SPARSER::PROTEIN)
    ("the highly apoptogenic Bim" . SPARSER::PROTEIN)
    ("H-ras and K-ras" . SPARSER::COLLECTION)
    ("cytokines and co-stimulation" . SPARSER::COLLECTION)
    ("the prosurvival genes" . SPARSER::GENE)
    ("Proapoptotic Bim" . SPARSER::PROTEIN)
    ("IL12rb1 (IL12 receptor) and Tbx21 (T-bet)" . SPARSER::COLLECTION)
    ("Cdkn1a ( p21  Cip1/Waf1 ), IL12rb1 (IL12 receptor) and Tbx21 (T-bet)"
     . SPARSER::COLLECTION)
    ("IL12rb1" . SPARSER::PROTEIN) ("Ccl3" . SPARSER::PROTEIN)
    ("Gata3 and Ccr8" . SPARSER::COLLECTION)
    ("the only cyclin-dependent kinase inhibitor" . SPARSER::INHIBITOR)
    ("p21  Cip1/Waf1" . SPARSER::COLLECTION) ("Cdkn1a" . SPARSER::PROTEIN)
    ("Tbx21 (T-bet) and Gata3" . SPARSER::COLLECTION)
    ("Rorc" . SPARSER::PROTEIN) ("Ror" . SPARSER::PROTEIN-FAMILY)
    ("Cux1 , Stat5 , and Zfhx3" . SPARSER::COLLECTION)
    ("Zfhx3" . SPARSER::PROTEIN) ("Cux1" . SPARSER::PROTEIN)
    ("Ccr6" . SPARSER::PROTEIN) ("Cux" . SPARSER::PROTEIN)
    ("heat-map" . SPARSER::PROTEIN) ("Foxp3 and Nrp1" . SPARSER::COLLECTION)
    ("Ccr8 , Ctsw , Dscr1l2 , Emp1 , and Edod1" . SPARSER::COLLECTION)
    ("Emp" . SPARSER::PROTEIN) ("Tnfrsf9" . SPARSER::PROTEIN)
    ("Tnfrsf1b" . SPARSER::PROTEIN) ("calcineurin" . SPARSER::PROTEIN)
    ("Cmtm7 and Glrx" . SPARSER::COLLECTION)
    ("Gpr83 , Ecm1 , Cmtm7 , Nkg7 , Socs2 and Glrx" . SPARSER::COLLECTION)
    ("Gpr83 and Nkg7" . SPARSER::COLLECTION) ("Cmtm7" . SPARSER::PROTEIN)
    ("Ecm1" . SPARSER::PROTEIN) ("Gpr83" . SPARSER::PROTEIN)
    ("Glrx" . SPARSER::PROTEIN) ("Nrp1" . SPARSER::PROTEIN)
    ("Dnmt1 and Dnmt3b" . SPARSER::COLLECTION) ("Klf2" . SPARSER::PROTEIN)
    ("oxysterol" . SPARSER::PROTEIN) ("Ebi" . SPARSER::PROTEIN)
    ("—an Erk dual-specific phosphatase" . SPARSER::PHOSPHATASE)
    ("Gpr68" . SPARSER::PROTEIN) ("Ccr8" . SPARSER::PROTEIN)
    ("Ccl1" . SPARSER::PROTEIN) ("Egr2" . SPARSER::PROTEIN)
    ("Dusp6" . SPARSER::PROTEIN) ("Mapk1" . SPARSER::PROTEIN)
    ("Gpr" . SPARSER::PROTEIN) ("Ccl" . SPARSER::DRUG)
    ("Dusp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mapk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Smad2 and Smad3" . SPARSER::COLLECTION) ("Dnmt" . SPARSER::PROTEIN)
    ("Cd" . SPARSER::PROTEIN) ("tetramers" . SPARSER::TETRAMER)
    ("Rag1" . SPARSER::PROTEIN) ("Rag" . SPARSER::PROTEIN)
    ("Erk1  −/− or Erk2  −/− mice" . SPARSER::COLLECTION)
    ("Gata-3" . SPARSER::PROTEIN) ("Gata" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("T-bet and phospho-Stat1" . SPARSER::COLLECTION)
    ("Stat1" . SPARSER::PROTEIN) ("Stat" . SPARSER::PROTEIN)
    ("IFNγ, IL-4 or IL-17" . SPARSER::COLLECTION)
    ("the pro-apoptotic protein Bim" . SPARSER::PROTEIN)
    ("Bim" . SPARSER::PROTEIN) ("Th2 or Th17" . SPARSER::COLLECTION)
    ("PMA and ionomycin" . SPARSER::COLLECTION) ("ionomycin" . SPARSER::DRUG)
    ("PMA" . SPARSER::PROTEIN) ("p21 Cip1/Waf1" . SPARSER::COLLECTION)
    ("CD25 and CD44" . SPARSER::COLLECTION)
    ("CD44 and CD62L" . SPARSER::COLLECTION)
    ("CD4 and CD8" . SPARSER::COLLECTION)
    ("a distal Lck promoter-Cre transgene" . SPARSER::PROTEIN)
    ("dLck-Cre" . SPARSER::COLLECTION) ("Lck" . SPARSER::PROTEIN)
    ("Erk1 or Erk2" . SPARSER::COLLECTION)
    ("Mek" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Erk1 and Erk2" . SPARSER::COLLECTION) ("chemotaxis" . SPARSER::PROTEIN)
    ("substrates and regulators" . SPARSER::COLLECTION)
    ("metazoan" . SPARSER::PROTEIN-FAMILY)
    ("Gata3 and Foxp3" . SPARSER::COLLECTION) ("Socs2" . SPARSER::PROTEIN)
    ("Tbx21" . SPARSER::PROTEIN) ("Tbx" . SPARSER::PROTEIN-FAMILY)
    ("T-bet and Gata3" . SPARSER::COLLECTION) ("Map" . SPARSER::PROTEIN)
    ("receptor, co-receptor, and cytokine" . SPARSER::COLLECTION)
    ("FOXP3" . SPARSER::PROTEIN) ("IL-2 receptor" . SPARSER::PROTEIN)
    ("Zinc finger homeobox 3" . SPARSER::PROTEIN) ("γ C" . SPARSER::PROTEIN)
    ("K-ras" . SPARSER::PROTEIN) ("H-ras" . SPARSER::PROTEIN)
    ("IL12" . SPARSER::PROTEIN-FAMILY) ("Nfatc1" . SPARSER::PROTEIN)
    ("p21  Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("chemokine receptor" . SPARSER::PROTEIN) ("4-1BB" . SPARSER::PROTEIN)
    ("calcineurin A" . SPARSER::PROTEIN) ("Rcan3" . SPARSER::PROTEIN)
    ("Faim3" . SPARSER::PROTEIN) ("cathepsin W" . SPARSER::PROTEIN)
    ("Nkg7" . SPARSER::PROTEIN) ("neuropilin-1" . SPARSER::PROTEIN)
    ("Dnmt3b" . SPARSER::PROTEIN) ("Foxo1" . SPARSER::PROTEIN)
    ("Smad3" . SPARSER::PROTEIN) ("Dnmt1" . SPARSER::PROTEIN)
    ("Waf1" . SPARSER::PROTEIN) ("p21 Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD28" . SPARSER::PROTEIN) ("cyclophilin A" . SPARSER::PROTEIN)
    ("Mnk1" . SPARSER::PROTEIN) ("CD45RB" . SPARSER::PROTEIN)
    ("gp61" . SPARSER::PROTEIN) ("gp66" . SPARSER::PROTEIN)
    ("CD62L" . SPARSER::PROTEIN) ("IL-12" . SPARSER::PROTEIN)
    ("anti-CD28" . SPARSER::PROTEIN) ("CD3" . SPARSER::PROTEIN)
    ("CD69" . SPARSER::PROTEIN) ("CD25" . SPARSER::PROTEIN)
    ("CD8" . SPARSER::PROTEIN) ("IL-2" . SPARSER::PROTEIN)
    ("Mpk1" . SPARSER::PROTEIN) ("Mpk3" . SPARSER::PROTEIN)
    ("Erk1" . SPARSER::PROTEIN) ("IL-17" . SPARSER::PROTEIN)
    ("IL-4" . SPARSER::PROTEIN) ("IFNγ" . SPARSER::PROTEIN)
    ("Stat5" . SPARSER::PROTEIN) ("Smad2" . SPARSER::PROTEIN)
    ("Foxp3" . SPARSER::PROTEIN) ("Th2" . SPARSER::PROTEIN)
    ("Gata3" . SPARSER::PROTEIN) ("T-bet" . SPARSER::PROTEIN)
    ("Erk2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("co-receptor" . SPARSER::PROTEIN)
    ("concurrent SAHA" . SPARSER::DRUG) ("discrete CpGs" . SPARSER::PROTEIN)
    ("Promoter" . SPARSER::PROMOTER)
    ("MSH2, MSH6, MLH1 and PMS2" . SPARSER::COLLECTION)
    ("mm3" . SPARSER::PROTEIN) ("SAHA or TMZ" . SPARSER::COLLECTION)
    ("Sp1, C-JUN, NF-KB and p300" . SPARSER::COLLECTION)
    ("histones" . SPARSER::PROTEIN) ("only 2 CpGs" . SPARSER::PROTEIN)
    ("CpGs" . SPARSER::PROTEIN) ("O6-BG" . SPARSER::COLLECTION)
    ("BG" . SPARSER::PROTEIN) ("the 3 parental MGMT" . SPARSER::PROTEIN)
    ("‘TMZ’" . SPARSER::DRUG) ("methylguanine" . SPARSER::MOLECULE)
    ("Temozolomide" . SPARSER::DRUG)
    ("TMZ and the HDAC inhibitor suberoylanilide hydroxamic acid (SAHA)"
     . SPARSER::COLLECTION)
    ("suberoylanilide hydroxamic acid (SAHA)" . SPARSER::DRUG)
    ("SAHA" . SPARSER::DRUG)
    ("SP1, C-JUN, NF-kB and p300" . SPARSER::COLLECTION)
    ("SP1" . SPARSER::PROTEIN) ("HDAC" . SPARSER::PROTEIN)
    ("temozolomide (TMZ)" . SPARSER::DRUG) ("NF-KB" . SPARSER::PROTEIN)
    ("O6-benzylguanine" . SPARSER::DRUG) ("O6" . SPARSER::PROTEIN)
    ("DNA repair protein" . SPARSER::PROTEIN)
    ("suberoylanilide hydroxamic acid" . SPARSER::DRUG)
    ("p300" . SPARSER::PROTEIN) ("C-JUN" . SPARSER::PROTEIN)
    ("postoperative prechemotherapy PSA" . SPARSER::PROTEIN)
    ("MYC and E2F" . SPARSER::COLLECTION)
    ("p53, p-Akt," . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53, p-Akt, or ERG" . SPARSER::COLLECTION)
    ("PTEN, Ki67, and MYC" . SPARSER::COLLECTION)
    ("PTEN and/or Ki67" . SPARSER::COLLECTION)
    ("intact PTEN" . SPARSER::PROTEIN) ("PTEN and p53" . SPARSER::COLLECTION)
    ("the tumor suppressor protein TP53 and the proliferation marker antigen KI-67 (Ki67)"
     . SPARSER::COLLECTION)
    ("p-mTOR" . SPARSER::COLLECTION) ("p-Akt" . SPARSER::COLLECTION)
    ("phosphatase and protein phosphatase" . SPARSER::COLLECTION)
    ("PTEN, MYC, and Ki67" . SPARSER::COLLECTION) ("PSA" . SPARSER::PROTEIN)
    ("ERG" . SPARSER::PROTEIN) ("docetaxel" . SPARSER::DRUG)
    ("ID1" . SPARSER::PROTEIN) ("ID-1" . SPARSER::PROTEIN)
    ("DNA-binding protein" . SPARSER::PROTEIN)
    ("MYC protein" . SPARSER::PROTEIN)
    ("enhancer of zeste homolog 2" . SPARSER::PROTEIN)
    ("TMPRSS2" . SPARSER::PROTEIN)
    ("transmembrane protease, serine 2" . SPARSER::PROTEIN)
    ("p-S6" . SPARSER::PROTEIN) ("PIP2" . SPARSER::PIP2)
    ("PIP3" . SPARSER::PIP3) ("protein 3" . SPARSER::PROTEIN)
    ("protein phosphatase" . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("prostate-specific antigen" . SPARSER::PROTEIN)
    ("tumor protein p53" . SPARSER::PROTEIN)
    ("Grb10 and pAkt" . SPARSER::COLLECTION)
    ("a maternally-imprinted allele" . SPARSER::ALLELE)
    ("insulin-like growth factor receptors or other regulators"
     . SPARSER::COLLECTION)
    ("which increases Grb10’s" . SPARSER::PROTEIN)
    ("which increases Grb10" . SPARSER::PROTEIN)
    ("HK-2 and LLC-PK 1" . SPARSER::COLLECTION)
    ("alternate polyadenylation variants" . SPARSER::VARIANT)
    ("pAkt and Grb10" . SPARSER::COLLECTION)
    ("the exogenous mouse Grb10 mRNA and protein" . SPARSER::COLLECTION)
    ("full-length mouse Grb10 or a mutant" . SPARSER::COLLECTION)
    ("exogenous HuR" . SPARSER::PROTEIN)
    ("HuR-associated Grb10" . SPARSER::PROTEIN)
    ("porcine forms" . SPARSER::FORM) ("active (CA)" . SPARSER::ACTIVE)
    ("Akt and NF-κB" . SPARSER::COLLECTION)
    ("Both Western blot" . SPARSER::PROTEIN)
    ("BAY11-7082, and HuR" . SPARSER::COLLECTION)
    ("LY-294002 and HuR" . SPARSER::COLLECTION)
    ("pAkt" . SPARSER::PROTEIN-FAMILY)
    ("the porcine proximal tubule line LLC-PK 1" . SPARSER::PROTEIN)
    ("LLC-PK 1" . SPARSER::PROTEIN) ("Grb7 and Grb14" . SPARSER::COLLECTION)
    ("caspases and caspase" . SPARSER::COLLECTION)
    ("FoxO" . SPARSER::PROTEIN-FAMILY) ("cisplatin" . SPARSER::DRUG)
    ("Bcl-2, Mcl-1, prothymosin-α, and XIAP" . SPARSER::COLLECTION)
    ("XIAP" . SPARSER::PROTEIN) ("prothymosin" . SPARSER::PROTEIN)
    ("two alternate HuR mRNAs" . SPARSER::PROTEIN)
    ("mature mRNAs" . SPARSER::PROTEIN)
    ("uridine- or adenine" . SPARSER::COLLECTION)
    ("uridine-" . SPARSER::PROTEIN) ("uridine" . SPARSER::PROTEIN)
    ("PI3-kinase/Akt" . SPARSER::COLLECTION) ("HuR" . SPARSER::PROTEIN)
    ("FoxO3a" . SPARSER::PROTEIN)
    ("insulin-like growth factor-1 receptor" . SPARSER::PROTEIN)
    ("growth factor receptor-bound protein 10" . SPARSER::PROTEIN)
    ("Glo 3" . SPARSER::PROTEIN) ("BAY11-7082" . SPARSER::DRUG)
    ("LY-294002" . SPARSER::PROTEIN) ("sodium bicarbonate" . SPARSER::DRUG)
    ("HK-2" . SPARSER::PROTEIN) ("growth hormone receptor" . SPARSER::PROTEIN)
    ("Grb14" . SPARSER::PROTEIN) ("Grb7" . SPARSER::PROTEIN)
    ("I/R" . SPARSER::PROTEIN) ("Mcl-1" . SPARSER::PROTEIN)
    ("pre-mRNA" . SPARSER::RNA) ("adaptor protein" . SPARSER::PROTEIN)
    ("Grb10" . SPARSER::PROTEIN) ("PI3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("each respective arm" . SPARSER::PROTEIN)
    ("KRAS/BRAF" . SPARSER::COLLECTION)
    ("fluorouracil and oxaliplatin" . SPARSER::COLLECTION)
    ("irinotecan" . SPARSER::DRUG) ("TAL" . SPARSER::MOLECULE)
    ("Cetuximab" . SPARSER::DRUG) ("PETACC-3" . SPARSER::COLLECTION)
    ("Adjuvant" . SPARSER::DRUG) ("vs" . SPARSER::PROTEIN)
    ("KRAS , NRAS , and BRAF" . SPARSER::COLLECTION)
    ("the mutant KRAS and WT KRAS" . SPARSER::COLLECTION)
    ("fluorouracil or capecitabine" . SPARSER::COLLECTION)
    ("Fluorouracil, Oxaliplatin, and Irinotecan" . SPARSER::COLLECTION)
    ("Fluorouracil" . SPARSER::DRUG) ("MRC" . SPARSER::PROTEIN)
    ("the control arm or the experimental arm" . SPARSER::COLLECTION)
    ("the experimental arm" . SPARSER::PROTEIN)
    ("Capecitabine, Irinotecan, and Oxaliplatin" . SPARSER::COLLECTION)
    ("capecitabine, oxaliplatin, and bevacizumab" . SPARSER::COLLECTION)
    ("oxaliplatin" . SPARSER::DRUG) ("Oxaliplatin" . SPARSER::DRUG)
    ("Irinotecan" . SPARSER::DRUG) ("Capecitabine" . SPARSER::DRUG)
    ("Panitumumab" . SPARSER::DRUG)
    ("the phase 3 Australian Gastrointestinal Trials Group (AGITG)"
     . SPARSER::MOLECULE)
    ("Group (AGITG)" . SPARSER::MOLECULE)
    ("KRAS and v-raf" . SPARSER::COLLECTION) ("v-raf" . SPARSER::PROTEIN-PAIR)
    ("bevacizumab" . SPARSER::DRUG) ("capecitabine" . SPARSER::DRUG)
    ("raf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MAX" . SPARSER::PROTEIN)
    ("Group" . SPARSER::MOLECULE)
    ("the WT KRAS group and the mutant KRAS group" . SPARSER::COLLECTION)
    ("metachronous WT KRAS" . SPARSER::PROTEIN)
    ("synchronous WT KRAS" . SPARSER::PROTEIN)
    ("KRAS and mutant" . SPARSER::COLLECTION) ("-mutant" . SPARSER::MUTANT)
    ("panitumumab and cetuximab" . SPARSER::COLLECTION)
    ("cetuximab" . SPARSER::DRUG) ("panitumumab" . SPARSER::DRUG)
    ("Ligands" . SPARSER::LIGAND) ("GDP" . SPARSER::NUCLEOTIDE)
    ("HRAS" . SPARSER::PROTEIN) ("Group B" . SPARSER::PROTEIN)
    ("anti-EGFR" . SPARSER::PROTEIN)
    ("protein kinase B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("small G-protein" . SPARSER::PROTEIN) ("RAS family" . SPARSER::PROTEIN)
    ("Ha-ras" . SPARSER::PROTEIN) ("Ki-ras" . SPARSER::PROTEIN)
    ("new potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("mPTP" . SPARSER::PROTEIN) ("ANT and cyclophilin-D" . SPARSER::COLLECTION)
    ("ANT" . SPARSER::HUMAN-PROTEIN-FAMILY) ("adenine" . SPARSER::NUCLEOBASE)
    ("ADP" . SPARSER::PROTEIN) ("mitochondria" . SPARSER::PROTEIN)
    ("ovarian cancer spheroids use integrin-" . SPARSER::PROTEIN)
    ("integrin-" . SPARSER::PROTEIN) ("talin" . SPARSER::PROTEIN)
    ("an essential regulator" . SPARSER::REGULATOR)
    ("E-cadherin and p-Src" . SPARSER::COLLECTION)
    ("new potential therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("SIRT3-shRNA" . SPARSER::COLLECTION)
    ("caspase-3 and DNA" . SPARSER::COLLECTION)
    ("a potential upstream regulator" . SPARSER::REGULATOR)
    ("HSC-3 and UM-SCC-14A" . SPARSER::COLLECTION)
    ("RIP or SIRT3" . SPARSER::COLLECTION) ("HSC-3" . SPARSER::PROTEIN)
    ("TMAs" . SPARSER::MOLECULE) ("SIRT3 and RIP" . SPARSER::COLLECTION)
    ("sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("Sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("FAK and RIP" . SPARSER::COLLECTION) ("CD95/Fas" . SPARSER::COLLECTION)
    ("alcohol" . SPARSER::DRUG) ("Anoikis" . SPARSER::PROTEIN)
    ("RIP and SIRT3" . SPARSER::COLLECTION)
    ("Fas/RIP/integrin/FAK" . SPARSER::COLLECTION) ("NAD" . SPARSER::MOLECULE)
    ("protein (RIP)" . SPARSER::PROTEIN) ("RIP" . SPARSER::PROTEIN)
    ("cyclophilin-D" . SPARSER::PROTEIN) ("p-Src" . SPARSER::PROTEIN)
    ("anti-β" . SPARSER::PROTEIN) ("myc-tagged" . SPARSER::PROTEIN)
    ("Sir2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SIRT1" . SPARSER::PROTEIN)
    ("SIRT3" . SPARSER::PROTEIN) ("CD95" . SPARSER::PROTEIN)
    ("RhoC/FMNL2" . SPARSER::COLLECTION) ("RhoGDI" . SPARSER::PROTEIN)
    ("RhoA or RhoC" . SPARSER::COLLECTION)
    ("RhoB and RhoC" . SPARSER::COLLECTION)
    ("Rac and RhoA" . SPARSER::COLLECTION)
    ("valine or isoleucine" . SPARSER::COLLECTION)
    ("XPLN, Dbl and Dbs" . SPARSER::COLLECTION)
    ("Rac" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("XPLN, GEFT, Dbs and Dbl" . SPARSER::COLLECTION)
    ("RhoA and RhoC" . SPARSER::COLLECTION) ("Glu" . SPARSER::AMINO-ACID)
    ("RhoGEFs" . SPARSER::PROTEIN)
    ("a basic Lys or Arg of the participatory GEF" . SPARSER::GEF)
    ("the participatory GEF" . SPARSER::GEF)
    ("a basic Lys or Arg" . SPARSER::COLLECTION)
    ("a small polar threonine" . SPARSER::AMINO-ACID)
    ("Lys or Arg" . SPARSER::COLLECTION) ("RhoC and GST" . SPARSER::COLLECTION)
    ("GEFs and RhoC" . SPARSER::COLLECTION) ("van" . SPARSER::PROTEIN)
    ("GFP-RhoA" . SPARSER::COLLECTION) ("GFP-RhoC" . SPARSER::COLLECTION)
    ("Transiently-expressed wild-type Myc- or GFP-tagged RhoC"
     . SPARSER::COLLECTION)
    ("Transiently-expressed wild-type Myc-" . SPARSER::PROTEIN)
    ("Myc-RhoC" . SPARSER::COLLECTION) ("Myc-" . SPARSER::PROTEIN)
    ("a significantly better substrate" . SPARSER::SUBSTRATE)
    ("XPLN, GEFT and Dbl" . SPARSER::COLLECTION)
    ("GST-RhoB" . SPARSER::COLLECTION)
    ("an isoleucine (RhoA and RhoB) or a valine (RhoC)" . SPARSER::COLLECTION)
    ("RhoA and RhoB" . SPARSER::COLLECTION) ("RhoA/B/C" . SPARSER::PROTEIN)
    ("Vav2, Dbl and Dbs" . SPARSER::COLLECTION)
    ("GEF and a labeled (mant) guanine nucleotide" . SPARSER::COLLECTION)
    ("Vav2, XPLN, GEFT, Dbs and Dbl" . SPARSER::COLLECTION)
    ("RhoA and GST" . SPARSER::COLLECTION) ("GST-Rho" . SPARSER::COLLECTION)
    ("guanine" . SPARSER::MOLECULE) ("Myc-RhoA" . SPARSER::COLLECTION)
    ("RhoA" . SPARSER::PROTEIN)
    ("properly-folded mutant GTPases" . SPARSER::GTPASE)
    ("GST-RhoC" . SPARSER::COLLECTION) ("GST-RhoA" . SPARSER::COLLECTION)
    ("statistically equivalent EDTA-stimulated nucleotide"
     . SPARSER::NUCLEOTIDE)
    ("GST-RhoA/B/C" . SPARSER::COLLECTION)
    ("Rhotekin and Citron" . SPARSER::COLLECTION) ("Citron" . SPARSER::PROTEIN)
    ("Rhotekin" . SPARSER::PROTEIN) ("Peptide" . SPARSER::PEPTIDE)
    ("Ile" . SPARSER::AMINO-ACID)
    ("Vav2, XPLN, GEFT, Dbl and Dbs" . SPARSER::COLLECTION)
    ("Dbl" . SPARSER::PROTEIN) ("GEFT" . SPARSER::PROTEIN)
    ("XPLN" . SPARSER::PROTEIN) ("GEF" . SPARSER::GEF)
    ("GEFs" . SPARSER::PROTEIN) ("RhoC" . SPARSER::PROTEIN)
    ("Filamentous actin" . SPARSER::BIO-COMPLEX)
    ("guanine nucleotide exchange factor" . SPARSER::GEF)
    ("T-1" . SPARSER::PROTEIN) ("Polyvinylidene fluoride" . SPARSER::DRUG)
    ("Monoclonal antibody" . SPARSER::DRUG)
    ("exchange factor" . SPARSER::EXCHANGE-FACTOR)
    ("Rho GTPase" . SPARSER::PROTEIN) ("FMNL2" . SPARSER::PROTEIN)
    ("ROCK2" . SPARSER::PROTEIN) ("ROCK1" . SPARSER::PROTEIN)
    ("FMNL3" . SPARSER::PROTEIN) ("Vav2" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors" . SPARSER::GEF)
    ("FGFR1-LRIT3" . SPARSER::COLLECTION) ("LRIT3s" . SPARSER::PROTEIN)
    ("FNIII and TM" . SPARSER::COLLECTION) ("LRIT3" . SPARSER::PROTEIN)
    ("ERK1/2 or AKT" . SPARSER::COLLECTION) ("TM" . SPARSER::PROTEIN)
    ("RTK-" . SPARSER::PROTEIN) ("syndromic CS" . SPARSER::PROTEIN)
    ("FGFR1 and LRIT3" . SPARSER::COLLECTION) ("bFGF" . SPARSER::PROTEIN)
    ("PNGase" . SPARSER::PROTEIN) ("Endo" . SPARSER::PROTEIN)
    ("the new exon (a forward primer) and the previously known exon1 (a reverse primer)"
     . SPARSER::COLLECTION)
    ("this new exon" . SPARSER::PROTEIN)
    ("the subsequent exon" . SPARSER::PROTEIN)
    ("AG and GT" . SPARSER::COLLECTION) ("GT" . SPARSER::PROTEIN)
    ("acceptor" . SPARSER::MOLECULE) ("the previous exon" . SPARSER::PROTEIN)
    ("the new exon" . SPARSER::PROTEIN)
    ("FGFRs and other growth factor receptors" . SPARSER::COLLECTION)
    ("FNIII, LRR, and IG" . SPARSER::COLLECTION)
    ("fibronectin-leucine-rich transmembrane protein 3" . SPARSER::PROTEIN)
    ("SEF" . SPARSER::PROTEIN) ("TK" . SPARSER::PROTEIN)
    ("Heparin or heparan sulfate" . SPARSER::COLLECTION)
    ("Heparin" . SPARSER::PROTEIN) ("FGFs" . SPARSER::PROTEIN)
    ("FNIII" . SPARSER::PROTEIN)
    ("leucine-rich repeat (LRR) and/or immunoglobulin (IG)"
     . SPARSER::COLLECTION)
    ("LRR" . SPARSER::PROTEIN) ("N-glycans" . SPARSER::MOLECULE)
    ("Exonuclease I" . SPARSER::PROTEIN)
    ("Alkaline Phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("non-syndromic" . SPARSER::PROTEIN) ("beta-tubulin" . SPARSER::PROTEIN)
    ("MKP3" . SPARSER::PROTEIN) ("MAP kinase phosphatase 3" . SPARSER::PROTEIN)
    ("heparan sulfate" . SPARSER::MOLECULE)
    ("fibronectin type III" . SPARSER::PROTEIN) ("FLRT3" . SPARSER::PROTEIN)
    ("transmembrane protein 3" . SPARSER::PROTEIN)
    ("leucine-rich repeat" . SPARSER::PROTEIN)
    ("Fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("p53 is" . SPARSER::PROTEIN)
    ("TLR agonists or antagonists" . SPARSER::COLLECTION)
    ("p53 and DNA" . SPARSER::COLLECTION) ("bacterial DNA" . SPARSER::DNA)
    ("functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TLR1 and TLR7" . SPARSER::COLLECTION)
    ("TLR4 and TLR5" . SPARSER::COLLECTION)
    ("TLR5, TLR9 and TLR10" . SPARSER::COLLECTION) ("A138V" . SPARSER::PROTEIN)
    ("B2M and p21" . SPARSER::COLLECTION)
    ("Seven cancer-associated p53 mutants" . SPARSER::MUTANT)
    ("almost all p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TLR 2" . SPARSER::PROTEIN)
    ("Nutlin-3 and doxorubicin" . SPARSER::COLLECTION)
    ("MCF7-p53i" . SPARSER::PROTEIN-PAIR)
    ("IL-6 and IL-8" . SPARSER::COLLECTION) ("flagellin" . SPARSER::PROTEIN)
    ("Doxorubicin" . SPARSER::PROTEIN)
    ("p53 and p21 protein" . SPARSER::COLLECTION)
    ("TLR2 and TLR6" . SPARSER::COLLECTION)
    ("doxorubicin and 5-fluoruracil-induced" . SPARSER::COLLECTION)
    ("p21 or PUMA" . SPARSER::COLLECTION)
    ("TLR2, TLR5 and TLR6" . SPARSER::COLLECTION)
    ("ethidium" . SPARSER::MOLECULE)
    ("Nutlin-3 or doxorubicin" . SPARSER::COLLECTION)
    ("AIP" . SPARSER::PROTEIN) ("almost all human TLR genes" . SPARSER::GENE)
    ("p53 and TLR" . SPARSER::COLLECTION)
    ("TLR2 and TLR5" . SPARSER::COLLECTION) ("TLR2" . SPARSER::PROTEIN)
    ("Nutlin" . SPARSER::DRUG) ("p53 and p21 proteins" . SPARSER::COLLECTION)
    ("pifithrin" . SPARSER::DRUG) ("Nutlin-3 or p53" . SPARSER::COLLECTION)
    ("nearly all TLR genes" . SPARSER::GENE)
    ("cancer-associated p53 mutants" . SPARSER::MUTANT)
    ("tumor-derived proteins or immunogenic peptides" . SPARSER::COLLECTION)
    ("immunogenic peptides" . SPARSER::PEPTIDE) ("APCs" . SPARSER::PROTEIN)
    ("Imiquimod" . SPARSER::DRUG) ("TNFalpha" . SPARSER::PROTEIN)
    ("TLR7 and TLR9" . SPARSER::COLLECTION)
    ("systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("DAMPs" . SPARSER::DAMP) ("inflammatory cytokines" . SPARSER::PROTEIN)
    ("MyD88, TIRAP, TRIF and TRAM" . SPARSER::COLLECTION)
    ("TRAM" . SPARSER::PROTEIN) ("TRIF" . SPARSER::PROTEIN)
    ("TIRAP" . SPARSER::PROTEIN) ("tetramer" . SPARSER::TETRAMER)
    ("TLRs" . SPARSER::PROTEIN-FAMILY)
    ("several p53 cancer-associated mutants" . SPARSER::MUTANT)
    ("adjuvants" . SPARSER::DRUG) ("PAMPs" . SPARSER::PROTEIN)
    ("TLR" . SPARSER::PROTEIN-FAMILY) ("tissue type" . SPARSER::PROTEIN)
    ("TLR10" . SPARSER::PROTEIN) ("B2M" . SPARSER::PROTEIN)
    ("response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("TLR1" . SPARSER::PROTEIN) ("TLR8" . SPARSER::PROTEIN)
    ("TLR6" . SPARSER::PROTEIN) ("p21 proteins" . SPARSER::PROTEIN)
    ("lamin B1" . SPARSER::PROTEIN) ("β-tubulin" . SPARSER::PROTEIN)
    ("C-11" . SPARSER::PROTEIN) ("TLR5" . SPARSER::PROTEIN)
    ("Forkhead Box P3" . SPARSER::PROTEIN) ("TLR4" . SPARSER::PROTEIN)
    ("TLR7" . SPARSER::PROTEIN) ("TLR 1" . SPARSER::PROTEIN)
    ("MAP kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NF-kappaB" . SPARSER::PROTEIN) ("MyD88" . SPARSER::PROTEIN)
    ("TLR9" . SPARSER::PROTEIN) ("TLR3" . SPARSER::PROTEIN)
    ("RUNX1 and p53" . SPARSER::COLLECTION) ("AP1" . SPARSER::PROTEIN)
    ("repressor and activator" . SPARSER::COLLECTION)
    ("TAp63 and p73" . SPARSER::COLLECTION)
    ("LOR and TGM1" . SPARSER::COLLECTION)
    ("RUNX1 and/or its cofactor CBF β" . SPARSER::COLLECTION)
    ("cofactor" . SPARSER::MOLECULE) ("KRT1 and LOR" . SPARSER::COLLECTION)
    ("TGM1 and LOR" . SPARSER::COLLECTION)
    ("transglutaminase1 and loricrin" . SPARSER::COLLECTION)
    ("LOR" . SPARSER::PROTEIN)
    ("RUNX1 and its regulator ΔNp63" . SPARSER::COLLECTION)
    ("the parts of RUNX1 exon 1 or intron" . SPARSER::COLLECTION)
    ("a mutated form" . SPARSER::FORM) ("p53 and ΔNp63" . SPARSER::COLLECTION)
    ("the long p63 isoform, TAp63, as well as the p53" . SPARSER::COLLECTION)
    ("TAp63 or p73" . SPARSER::COLLECTION)
    ("human interfollicular keratinocytes" . SPARSER::PROTEIN)
    ("HPK" . SPARSER::PROTEIN) ("intron" . SPARSER::PROTEIN)
    ("involucrin ( xref ) and loricrin ( xref )" . SPARSER::COLLECTION)
    ("keratin1 ( xref ), keratin10 ( xref ), involucrin ( xref ) and loricrin ( xref )"
     . SPARSER::COLLECTION)
    ("normal human interfollicular keratinocytes" . SPARSER::PROTEIN)
    ("loricrin" . SPARSER::PROTEIN) ("involucrin" . SPARSER::PROTEIN)
    ("eukaryotic genes" . SPARSER::GENE) ("p53/p63/p73" . SPARSER::COLLECTION)
    ("pGL4" . SPARSER::PROTEIN) ("RNAse A" . SPARSER::PROTEIN)
    ("NaHCO 3" . SPARSER::DRUG)
    ("reverse-transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KLF4" . SPARSER::PROTEIN) ("Krueppel-like factor 4" . SPARSER::PROTEIN)
    ("transglutaminase1" . SPARSER::PROTEIN) ("TGM1" . SPARSER::PROTEIN)
    ("Runx1" . SPARSER::PROTEIN) ("keratin10" . SPARSER::PROTEIN)
    ("keratin1" . SPARSER::PROTEIN) ("CBF β" . SPARSER::PROTEIN)
    ("core-binding factor beta" . SPARSER::PROTEIN)
    ("ΔNp63 α" . SPARSER::PROTEIN) ("TAp63" . SPARSER::PROTEIN)
    ("p63" . SPARSER::PROTEIN) ("KRT1" . SPARSER::PROTEIN)
    ("RUNX1" . SPARSER::PROTEIN)
    ("Runt-related transcription factor 1" . SPARSER::PROTEIN)
    ("KS" . SPARSER::PROTEIN) ("CD81 and CASP8" . SPARSER::COLLECTION)
    ("DR4 , MGMT and GATA6" . SPARSER::COLLECTION) ("MSP" . SPARSER::PROTEIN)
    ("DS, PV, and VA" . SPARSER::COLLECTION) ("VA" . SPARSER::MOLECULE)
    ("DS" . SPARSER::PROTEIN)
    ("GATA6 [ xref ] and CASP8 [ xref ]" . SPARSER::COLLECTION)
    ("CASP8 and GATA6" . SPARSER::COLLECTION)
    ("GATA6 , and CASP8" . SPARSER::COLLECTION)
    ("CD81 and DR4" . SPARSER::COLLECTION)
    ("DR4 and CASP8" . SPARSER::COLLECTION) ("TRAIL" . SPARSER::PROTEIN)
    ("tetraspanin" . SPARSER::PROTEIN-FAMILY) ("GATA" . SPARSER::PROTEIN)
    ("the most frequently methylated gene" . SPARSER::GENE)
    ("GATA6 , CD81 , DR4 , and CASP8" . SPARSER::COLLECTION)
    ("MGMT , GATA6 , and CASP8" . SPARSER::COLLECTION)
    ("MGMT (HR: 0.15, 95% CI: 0.05-0.42; P = 0.001) and GATA6 (HR: 2.78, 95% CI: 1.01-7.65; P = 0.047)"
     . SPARSER::COLLECTION)
    ("the methylated GATA6 and CASP8 promoters" . SPARSER::PROMOTER)
    ("The methylated MGMT promoter" . SPARSER::PROMOTER)
    ("MGMT , CASP8 , and GATA6" . SPARSER::COLLECTION)
    ("MGMT and CASP8" . SPARSER::COLLECTION)
    ("MGMT and CASP8, MGMT and GATA6" . SPARSER::COLLECTION)
    ("CASP8, MGMT and GATA6" . SPARSER::COLLECTION)
    ("the methylated CASP8 promoter" . SPARSER::PROMOTER)
    ("the methylated GATA6 promoter" . SPARSER::PROMOTER)
    ("GATA6 , CD81 , and DR4" . SPARSER::COLLECTION)
    ("GATA6 and CASP8" . SPARSER::COLLECTION)
    ("CASP8 and DR4" . SPARSER::COLLECTION) ("TMZ" . SPARSER::DRUG)
    ("temozolomide" . SPARSER::DRUG) ("log-rank" . SPARSER::PROTEIN)
    ("DR4 , and CASP8" . SPARSER::COLLECTION)
    ("DR4 (death receptor 4, TRAIL receptor 1) and GATA6 (GATA binding protein 6)"
     . SPARSER::COLLECTION)
    ("CD81 (CD81 antigen), DR4 (death receptor 4, TRAIL receptor 1) and GATA6 (GATA binding protein 6)"
     . SPARSER::COLLECTION)
    ("DNA silencing and transcriptional repression that can modulate"
     . SPARSER::COLLECTION)
    ("CpG" . SPARSER::PROTEIN) ("Cytosine" . SPARSER::NUCLEOBASE)
    ("MGMT and GATA6" . SPARSER::COLLECTION)
    ("MGMT , GATA6 and CASP8" . SPARSER::COLLECTION)
    ("bisulfite" . SPARSER::MOLECULE)
    ("MGMT , CD81 , GATA6 , DR4 , and CASP8" . SPARSER::COLLECTION)
    ("DNA repair enzyme" . SPARSER::PROTEIN)
    ("GATA binding protein 6" . SPARSER::PROTEIN)
    ("TRAIL receptor 1" . SPARSER::PROTEIN)
    ("death receptor 4" . SPARSER::PROTEIN) ("CD81 antigen" . SPARSER::PROTEIN)
    ("O 6 -methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("CASP8" . SPARSER::PROTEIN) ("DR4" . SPARSER::PROTEIN)
    ("GATA6" . SPARSER::PROTEIN) ("CD81" . SPARSER::PROTEIN)
    ("WSC" . SPARSER::PROTEIN-FAMILY) ("GSR" . SPARSER::PROTEIN)
    ("GK" . SPARSER::PROTEIN) ("YL" . SPARSER::PROTEIN)
    ("Pcolce" . SPARSER::PROTEIN) ("Sucrose" . SPARSER::MOLECULE)
    ("an anxious state" . SPARSER::BIO-STATE)
    ("MeA or BLA" . SPARSER::COLLECTION)
    ("CeA" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("corticosterone" . SPARSER::MOLECULE) ("BLA" . SPARSER::PROTEIN)
    ("MeA" . SPARSER::DRUG)
    ("Fibromodulin and osteoglycin" . SPARSER::COLLECTION)
    ("Proteoglycans and collagens" . SPARSER::COLLECTION)
    ("Proteoglycans" . SPARSER::PROTEIN)
    ("chronic stress-responsive genes" . SPARSER::GENE)
    ("transthyretin" . SPARSER::PROTEIN)
    ("monoaminergic transmission-related genes" . SPARSER::GENE)
    ("LI" . SPARSER::PROTEIN) ("STR-LI" . SPARSER::PROTEIN-PAIR)
    ("CTL and STR" . SPARSER::COLLECTION) ("STR and CTL" . SPARSER::COLLECTION)
    ("CTL" . SPARSER::PROTEIN)
    ("proteins, Igfbp2 and Igfbp4" . SPARSER::COLLECTION)
    ("sucrose" . SPARSER::MOLECULE) ("food" . SPARSER::MOLECULE)
    ("SPT and FST" . SPARSER::COLLECTION) ("FST" . SPARSER::PROTEIN)
    ("SPT" . SPARSER::PROTEIN)
    ("the trophic factor family" . SPARSER::PROTEIN-FAMILY)
    ("protein, and procollagen" . SPARSER::COLLECTION)
    ("Igfbp2, and Igfbp4" . SPARSER::COLLECTION) ("Igfbp4" . SPARSER::PROTEIN)
    ("Gdf10" . SPARSER::PROTEIN) ("proteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("thrombomodulin" . SPARSER::PROTEIN) ("Fibromodulin" . SPARSER::PROTEIN)
    ("Igf2 and Igfbp2" . SPARSER::COLLECTION)
    ("osteoglycin and fibromodulin" . SPARSER::COLLECTION)
    ("Igfbp2" . SPARSER::PROTEIN) ("fibromodulin" . SPARSER::PROTEIN)
    ("osteoglycin" . SPARSER::PROTEIN) ("CIS" . SPARSER::PROTEIN)
    ("Procollagen C-proteinase" . SPARSER::PROTEIN)
    ("Insulin-like growth factor binding protein 2" . SPARSER::PROTEIN)
    ("Insulin-like growth factor II" . SPARSER::PROTEIN)
    ("insulin-like growth factor binding protein 2" . SPARSER::PROTEIN)
    ("Igf2" . SPARSER::PROTEIN)
    ("insulin-like growth factor" . SPARSER::PROTEIN) ("PN" . SPARSER::PROTEIN)
    ("Nick" . SPARSER::PROTEIN) ("Interferon" . SPARSER::PROTEIN)
    ("Heme" . SPARSER::PROTEIN)
    ("human monocyte-derived macrophages" . SPARSER::PROTEIN)
    ("caspase 3 and PARP" . SPARSER::COLLECTION)
    ("inflammatory macrophages" . SPARSER::PROTEIN)
    ("murine primary apoptotic macrophages" . SPARSER::PROTEIN)
    ("fragmentation and condensation in attached cells"
     . SPARSER::PROTEIN-FAMILY)
    ("condensation" . SPARSER::PROTEIN-FAMILY)
    ("Nrf2/antioxidant" . SPARSER::COLLECTION)
    ("IL-8 and IL-29" . SPARSER::COLLECTION)
    ("antiviral genes RIG-1" . SPARSER::PROTEIN)
    ("Nrf2 and downstream HO-1" . SPARSER::COLLECTION)
    ("Cigarette" . SPARSER::DRUG) ("siRNA or AdNrf2" . SPARSER::COLLECTION)
    ("oxidants" . SPARSER::MOLECULE) ("interferon" . SPARSER::PROTEIN)
    ("HNE" . SPARSER::PROTEIN) ("Nrf2 and HO-1" . SPARSER::COLLECTION)
    ("24 hpi and 48 hpi" . SPARSER::COLLECTION)
    ("caspase 1 and caspase 3" . SPARSER::COLLECTION)
    ("hpi" . SPARSER::PROTEIN) ("cytokeratin" . SPARSER::PROTEIN-FAMILY)
    ("pulmonary surfactant" . SPARSER::PROTEIN)
    ("surfactant" . SPARSER::PROTEIN) ("Cho" . SPARSER::PROTEIN)
    ("antioxidant and defense genes" . SPARSER::COLLECTION)
    ("antiviral drugs" . SPARSER::DRUG) ("IFN" . SPARSER::DRUG)
    ("adenovirus Nrf2 (AdNrf2) or Nrf2 siRNA" . SPARSER::COLLECTION)
    ("Nrf2, HO-1 and caspase 1" . SPARSER::COLLECTION)
    ("antiviral genes" . SPARSER::GENE) ("ATI" . SPARSER::PROTEIN)
    ("anti-viral" . SPARSER::DRUG) ("RNA binding protein" . SPARSER::PROTEIN)
    ("IFN-β" . SPARSER::PROTEIN) ("RIG-1" . SPARSER::PROTEIN)
    ("interferon-induced" . SPARSER::PROTEIN)
    ("Hydrogen Peroxide" . SPARSER::MOLECULE)
    ("Green Fluorescent" . SPARSER::PROTEIN) ("PKH26" . SPARSER::DRUG)
    ("acridine orange" . SPARSER::MOLECULE)
    ("keratinocyte growth factor" . SPARSER::PROTEIN)
    ("CD14" . SPARSER::PROTEIN) ("epigallocatechin gallate" . SPARSER::DRUG)
    ("IL-29" . SPARSER::PROTEIN) ("OAS1" . SPARSER::PROTEIN)
    ("caspase 1" . SPARSER::PROTEIN) ("erythroid 2" . SPARSER::PROTEIN)
    ("Pre" . SPARSER::PROTEIN)
    ("all the pathologic subtypes" . SPARSER::PROTEIN)
    ("the mRNA and/or iii" . SPARSER::COLLECTION)
    ("EMBL-EBI" . SPARSER::COLLECTION) ("KIT/KITLG" . SPARSER::COLLECTION)
    ("EBI" . SPARSER::PROTEIN) ("GSI" . SPARSER::PROTEIN)
    ("KIT and Zonulin" . SPARSER::COLLECTION) ("Zonulin" . SPARSER::PROTEIN)
    ("DAKO" . SPARSER::PROTEIN)
    ("other commercial antibodies" . SPARSER::ANTIBODY)
    ("antibody (DAKO)" . SPARSER::ANTIBODY) ("MBL" . SPARSER::PROTEIN)
    ("the normal allelic nucleotide" . SPARSER::NUCLEOTIDE)
    ("Leu" . SPARSER::AMINO-ACID) ("Met " . SPARSER::AMINO-ACID)
    ("the one discussed here showed normal KIT" . SPARSER::PROTEIN)
    ("the gene’s" . SPARSER::GENE) ("RQ" . SPARSER::MOLECULE)
    ("The western blot" . SPARSER::PROTEIN)
    ("a promisingly strong KIT" . SPARSER::PROTEIN)
    ("the benign forms" . SPARSER::FORM)
    ("PDGFR (alpha- and beta-platelet-derived growth factor receptors) and KIT"
     . SPARSER::COLLECTION)
    ("alpha- and beta-platelet-derived growth factor" . SPARSER::COLLECTION)
    ("Gleevec" . SPARSER::DRUG) ("Imatinib" . SPARSER::DRUG)
    ("Hypoxia" . SPARSER::PROTEIN)
    ("one such transmembrane RTK" . SPARSER::PROTEIN)
    ("SCFR" . SPARSER::PROTEIN) ("p " . SPARSER::PROTEIN)
    ("KIT and KITLG" . SPARSER::COLLECTION) ("KITLG" . SPARSER::PROTEIN)
    ("TKI" . SPARSER::PROTEIN) ("its receptor" . SPARSER::PROTEIN)
    ("CEP4" . SPARSER::PROTEIN) ("A2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RP11" . SPARSER::PROTEIN) ("s 100" . SPARSER::PROTEIN)
    ("Beta Tubulin" . SPARSER::PROTEIN) ("a 20 " . SPARSER::PROTEIN)
    ("alpha-" . SPARSER::PROTEIN) ("STI-571" . SPARSER::DRUG)
    ("KIT Ligand" . SPARSER::PROTEIN)
    ("Receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PY" . SPARSER::MOLECULE) ("DY" . SPARSER::MOLECULE)
    ("ERK1/2 and DcR3" . SPARSER::COLLECTION)
    ("mRNA and DcR3 and ERK1/2" . SPARSER::COLLECTION)
    ("histological types" . TYPE) ("PD98059 and APDC" . SPARSER::COLLECTION)
    ("DcR3 and P-ERK" . SPARSER::COLLECTION)
    ("shRNA, ERK1/2 and P-ERK1/2" . SPARSER::COLLECTION)
    ("ERK1 and ERK2" . SPARSER::COLLECTION)
    ("DcR3, ERK1 and ERK2" . SPARSER::COLLECTION)
    ("JNK and p38" . SPARSER::COLLECTION)
    ("ERK1/2, JNK and p38" . SPARSER::COLLECTION)
    ("DcR3/ERK1/2" . SPARSER::COLLECTION) ("ERK and p38" . SPARSER::COLLECTION)
    ("ERK1/2 and JNK" . SPARSER::COLLECTION) ("kinase (JNK)" . SPARSER::KINASE)
    ("Wang" . SPARSER::PROTEIN) ("MAPK/ERK" . SPARSER::COLLECTION)
    ("TNF" . SPARSER::PROTEIN) ("LIGHT and TL1A" . SPARSER::COLLECTION)
    ("LIGHT" . SPARSER::PROTEIN) ("FasL" . SPARSER::PROTEIN)
    ("DcR3 and ERK1/2" . SPARSER::COLLECTION)
    ("MAPK/MEK/ERK" . SPARSER::COLLECTION)
    ("receptor (TNFR)" . SPARSER::RECEPTOR) ("TNFR" . SPARSER::PROTEIN)
    ("P-ERK" . SPARSER::PROTEIN) ("PD98059" . SPARSER::MOLECULE)
    ("anti-ERK" . SPARSER::PROTEIN) ("ERK2" . SPARSER::PROTEIN)
    ("NH2" . SPARSER::MOLECULE)
    ("extracellular signal-regulated kinase 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pN2" . SPARSER::PROTEIN) ("TR6" . SPARSER::PROTEIN)
    ("TL1A" . SPARSER::PROTEIN) ("Fas ligand" . SPARSER::PROTEIN)
    ("decoy receptor" . SPARSER::PROTEIN)
    ("signal regulated kinase" . SPARSER::PROTEIN) ("DcR3" . SPARSER::PROTEIN)
    ("Decoy receptor" . SPARSER::PROTEIN)
    ("estrogen and EGF" . SPARSER::COLLECTION)
    ("cell-cycle–independent kinase" . SPARSER::KINASE)
    ("TFIID" . SPARSER::PROTEIN) ("Ser-Pro" . SPARSER::COLLECTION)
    ("ligand or growth factor" . SPARSER::COLLECTION)
    ("antisera" . SPARSER::PROTEIN)
    ("the fully agonistic E2 ligand" . SPARSER::MOLECULE)
    ("a partially agonistic ligand" . SPARSER::LIGAND)
    ("ligands or growth factors" . SPARSER::COLLECTION)
    ("Pro-Ser-Pro" . SPARSER::COLLECTION) ("EGF and E2" . SPARSER::COLLECTION)
    ("E2 and EGF" . SPARSER::COLLECTION) ("forskolin" . SPARSER::PROTEIN)
    ("growth factors and E2" . SPARSER::COLLECTION)
    ("the Ser294 peptide and 16" . SPARSER::COLLECTION)
    ("SID-MRM" . SPARSER::PROTEIN-PAIR) ("spiked" . SPARSER::PROTEIN)
    ("SID" . SPARSER::PROTEIN-FAMILY) ("LOQs" . SPARSER::PROTEIN)
    ("charcoal-stripped media" . SPARSER::PROTEIN) ("AREG" . SPARSER::PROTEIN)
    ("amphiregulin" . SPARSER::PROTEIN) ("exogenous ERα" . SPARSER::PROTEIN)
    ("cell-cycle–independent kinases" . SPARSER::KINASE)
    ("pSer" . SPARSER::PROTEIN) ("E2 or tamoxifen" . SPARSER::COLLECTION)
    ("Only 60 amino acids" . SPARSER::AMINO-ACID)
    ("LBD/AF-2" . SPARSER::COLLECTION)
    ("serine, threonine, or tyrosine" . SPARSER::COLLECTION)
    ("antiestrogen" . SPARSER::DRUG)
    ("ligand-targeted antiestrogenic therapeutics" . SPARSER::THERAPEUTICS)
    ("an endogenous estrogenic ligand" . SPARSER::LIGAND)
    ("a complex and diverse role" . SPARSER::COLLECTION)
    ("recombinant ERα and specific cyclin–CDK complexes" . SPARSER::COLLECTION)
    ("cell-cycle–independent kinase CDK7" . SPARSER::PROTEIN)
    ("cyclin–CDK" . SPARSER::COLLECTION)
    ("roscovitine or SNS-032" . SPARSER::COLLECTION)
    ("roscovitine" . SPARSER::DRUG) ("EGF and ligand" . SPARSER::COLLECTION)
    ("ligand and growth factor" . SPARSER::COLLECTION)
    ("estradiol and tamoxifen" . SPARSER::COLLECTION)
    ("CDK 2" . SPARSER::PROTEIN) ("early growth response" . SPARSER::PROTEIN)
    ("CDK9" . SPARSER::PROTEIN) ("MNAT1" . SPARSER::PROTEIN)
    ("cyclinD1" . SPARSER::PROTEIN) ("cyclinA2" . SPARSER::PROTEIN)
    ("cyclinA1" . SPARSER::PROTEIN) ("CDK1" . SPARSER::PROTEIN)
    ("Amino acid" . SPARSER::AMINO-ACID) ("HCO 3" . SPARSER::MOLECULE)
    ("EGR3" . SPARSER::PROTEIN)
    ("glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("pSG5" . SPARSER::PROTEIN) ("F-10" . SPARSER::PROTEIN)
    ("AF-2" . SPARSER::PROTEIN)
    ("receptor protein" . SPARSER::RECEPTOR-PROTEIN)
    ("β-estradiol" . SPARSER::MOLECULE) ("CDK7" . SPARSER::PROTEIN)
    ("SNS-032" . SPARSER::DRUG) ("AF-1" . SPARSER::PROTEIN)
    ("the largest cohorts" . SPARSER::MOLECULE) ("agonists" . SPARSER::AGONIST)
    ("peroxynitrite" . SPARSER::MOLECULE) ("vasculature" . SPARSER::PROTEIN)
    ("proinflammatory cytokines" . SPARSER::PROTEIN)
    ("Bradykinin" . SPARSER::BRADYKININ)
    ("nitroprusside, and hydrogen peroxide" . SPARSER::COLLECTION)
    ("Vasodilator" . SPARSER::PROTEIN)
    ("resting FBF ( P =0.445 and 0.123) and FVR ( P =0.340 and 0.196)"
     . SPARSER::COLLECTION)
    ("FBF or FVR" . SPARSER::COLLECTION)
    ("basal FBF (3.6±1.1 vs. 4.0±1.1ml/100ml tissue/min; P =0.184) and FVR (22.7±1.1 vs. 20.8±1.1 mmHg/ml/100 ml tissue/min; P =0.084)"
     . SPARSER::COLLECTION)
    ("basal FBF" . SPARSER::PROTEIN)
    ("both FBF ( xref , P <0.001, q =0.010) and FVR ( xref , P =0.003, q =0.020)"
     . SPARSER::COLLECTION)
    ("cigarette" . SPARSER::DRUG)
    ("bradykinin and sodium" . SPARSER::COLLECTION)
    ("chemoattractant protein-1 and vascular cell adhesion molecule-1"
     . SPARSER::COLLECTION)
    ("transporters" . SPARSER::PROTEIN) ("bZip" . SPARSER::PROTEIN-FAMILY)
    ("bradykinin or sodium" . SPARSER::COLLECTION)
    ("nitroprusside" . SPARSER::DRUG) ("bradykinin" . SPARSER::BRADYKININ)
    ("gauge" . SPARSER::PROTEIN-FAMILY) ("FBF" . SPARSER::PROTEIN)
    ("vasodilator" . SPARSER::PROTEIN) ("Dual-Luciferase" . SPARSER::PROTEIN)
    ("pGL3" . SPARSER::PROTEIN)
    ("angiotensin-converting enzyme" . SPARSER::PROTEIN)
    ("vascular cell adhesion molecule-1" . SPARSER::PROTEIN)
    ("chemoattractant protein-1" . SPARSER::PROTEIN)
    ("NFE2L2" . SPARSER::PROTEIN) ("NRF2" . SPARSER::PROTEIN)
    ("non-adenocarcinoma histological subtypes" . SPARSER::PROTEIN)
    ("other histological subtypes" . SPARSER::PROTEIN)
    ("Cysteine" . SPARSER::AMINO-ACID)
    ("erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("The EGFR and its ligands" . SPARSER::COLLECTION)
    ("the non-adenocarcinoma histological subtypes" . SPARSER::PROTEIN)
    ("GAT" . SPARSER::PROTEIN) ("GGT" . SPARSER::PROTEIN)
    ("TGT" . SPARSER::PROTEIN) ("GGC" . SPARSER::PROTEIN)
    ("Types and Frequencies" . SPARSER::COLLECTION) ("Types" . TYPE)
    ("EGFR and KRAS" . SPARSER::COLLECTION)
    ("gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("erlotinib" . SPARSER::DRUG) ("Cytotoxic" . SPARSER::PROTEIN)
    ("three histological subtypes" . SPARSER::PROTEIN)
    ("non-adenocarcinoma histological types" . TYPE)
    ("epidermal growth factor receptor or KRAS" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor and KRAS" . SPARSER::COLLECTION)
    ("mTOR and/or Stat3" . SPARSER::COLLECTION)
    ("Stat3 and mTOR" . SPARSER::COLLECTION)
    ("PI3K-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGFβ and p53" . SPARSER::COLLECTION) ("RNAs" . SPARSER::RNA)
    ("miR-21 and EMT" . SPARSER::COLLECTION)
    ("PTEN and Spry1/2" . SPARSER::COLLECTION)
    ("Akt and MAPK" . SPARSER::COLLECTION)
    ("a potential regulator" . SPARSER::REGULATOR)
    ("EMT and p53" . SPARSER::COLLECTION)
    ("Zeb1 , Zeb2 and FoxC2" . SPARSER::COLLECTION) ("Zeb2" . SPARSER::PROTEIN)
    ("display broader" . SPARSER::PROTEIN)
    ("the chemotherapeutic drug" . SPARSER::DRUG)
    ("miR-21 and TP53" . SPARSER::COLLECTION)
    ("mTOR or Stat3" . SPARSER::COLLECTION)
    ("ribosomal protein, and active" . SPARSER::COLLECTION)
    ("miR-ZIPVec or miR-ZIP-21" . SPARSER::COLLECTION)
    ("miR-ZIPVec" . SPARSER::PROTEIN-PAIR)
    ("Erk and Akt" . SPARSER::COLLECTION) ("ZIP" . SPARSER::PROTEIN)
    ("miR-21 or Snail" . SPARSER::COLLECTION)
    ("Akt and ERK" . SPARSER::COLLECTION)
    ("Snail, miR-21 and Snail, or miR-21" . SPARSER::COLLECTION)
    ("Snail, or miR-21" . SPARSER::COLLECTION)
    ("Snail or Snail and miR-21" . SPARSER::COLLECTION)
    ("Foxc2" . SPARSER::PROTEIN) ("K5 and E-cadherin" . SPARSER::COLLECTION)
    ("miR-21 and Snail" . SPARSER::COLLECTION)
    ("Snail and both Snail and miR-21" . SPARSER::COLLECTION)
    ("Snail and miR-21" . SPARSER::COLLECTION)
    ("SCCs, SpCCs and tumours" . SPARSER::COLLECTION)
    ("Akt and Erk" . SPARSER::COLLECTION) ("Erk/MAPK" . SPARSER::COLLECTION)
    ("miR" . SPARSER::PROTEIN) ("possible miRNAs" . SPARSER::PROTEIN)
    ("Dicer, Dgcr8 or Drosha" . SPARSER::COLLECTION)
    ("Dgcr8" . SPARSER::PROTEIN) ("Drosha" . SPARSER::PROTEIN)
    ("Dicer" . SPARSER::PROTEIN) ("Zeb1" . SPARSER::PROTEIN)
    ("Zeb" . SPARSER::PROTEIN) ("Snail and FoxC2" . SPARSER::COLLECTION)
    ("SCCs and SpCCs" . SPARSER::COLLECTION) ("SCCs" . SPARSER::PROTEIN)
    ("Rb1 or Trp53 genes" . SPARSER::COLLECTION)
    ("pRb and p53" . SPARSER::COLLECTION) ("pRb" . SPARSER::PROTEIN)
    ("Rb1" . SPARSER::PROTEIN) ("MicroRNAs" . SPARSER::RNA)
    ("integrin and TGFβ" . SPARSER::COLLECTION) ("integrin" . SPARSER::PROTEIN)
    ("mTOR and Stat3" . SPARSER::COLLECTION)
    ("genome-wide mRNA and miRNA" . SPARSER::COLLECTION)
    ("mRNA and miRNA" . SPARSER::COLLECTION) ("U6" . SPARSER::PROTEIN)
    ("housekeeping gene" . SPARSER::PROTEIN)
    ("β - glucuronidase" . SPARSER::PROTEIN) ("DGCR8" . SPARSER::PROTEIN)
    ("Stat 3" . SPARSER::PROTEIN) ("Sprouty 2" . SPARSER::PROTEIN)
    ("P-S6" . SPARSER::PROTEIN) ("P-Erk" . SPARSER::PROTEIN)
    ("Na 3 VO 4" . SPARSER::MOLECULE) ("Fc receptor" . SPARSER::PROTEIN)
    ("Spry1" . SPARSER::PROTEIN) ("Sprouty2" . SPARSER::PROTEIN)
    ("miR-29" . SPARSER::PROTEIN) ("Snai1" . SPARSER::PROTEIN)
    ("E-Cadherin" . SPARSER::PROTEIN) ("FoxC2" . SPARSER::PROTEIN)
    ("K5" . SPARSER::PROTEIN) ("p107" . SPARSER::PROTEIN)
    ("p53 family" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Stat3" . SPARSER::PROTEIN)
    ("miR-21" . SPARSER::PROTEIN)
    ("Larger patient cohorts" . SPARSER::MOLECULE)
    ("BRCA1 or BRCA2" . SPARSER::COLLECTION)
    ("BRCA1 and c" . SPARSER::COLLECTION) ("Methionine" . SPARSER::AMINO-ACID)
    ("previously published deleterious variants" . SPARSER::VARIANT)
    ("methionine" . SPARSER::AMINO-ACID) ("insC" . SPARSER::PROTEIN)
    ("exon-intron" . SPARSER::PROTEIN-PAIR)
    ("BRCA1 and the large exons" . SPARSER::COLLECTION)
    ("a Canadian TNBC cohort" . SPARSER::MOLECULE)
    ("estrogen and progesterone receptors (ER/PR) and receptor"
     . SPARSER::COLLECTION)
    ("estrogen and progesterone" . SPARSER::COLLECTION)
    ("ER/PR" . SPARSER::COLLECTION) ("F11" . SPARSER::PROTEIN)
    ("IgG 1" . SPARSER::BIO-COMPLEX) ("BrCa1 name" . SPARSER::PROTEIN)
    ("enzymes and lipid" . SPARSER::COLLECTION)
    ("FASN and ACC" . SPARSER::COLLECTION)
    ("BrCa1 and ACC" . SPARSER::COLLECTION)
    ("ACC and FASN" . SPARSER::COLLECTION)
    ("key transcription factor" . SPARSER::PROTEIN)
    ("monocyte chemotactic protein-1, IL-6, and tumor necrosis factor-α"
     . SPARSER::COLLECTION)
    ("pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("protein-1, IL-6, and tumor necrosis factor-α" . SPARSER::COLLECTION)
    ("LPS" . SPARSER::PROTEIN) ("THP-1" . SPARSER::PROTEIN)
    ("MCM" . SPARSER::PROTEIN)
    ("mature adipocytes and SVCs" . SPARSER::COLLECTION)
    ("adipocytes and SVCs" . SPARSER::COLLECTION)
    ("P-ACC/ACC" . SPARSER::COLLECTION)
    ("isolated mature adipocytes" . SPARSER::PROTEIN)
    ("HOMA-IR" . SPARSER::COLLECTION) ("LDL" . SPARSER::PROTEIN)
    ("OM and SC fat" . SPARSER::COLLECTION)
    ("SREBP-1c , FASN and ACC" . SPARSER::COLLECTION)
    ("BrCa1 and phosphorylated-BrCa1" . SPARSER::COLLECTION)
    ("KDa" . SPARSER::PROTEIN) ("FAS and ACC" . SPARSER::COLLECTION)
    ("SREBP" . SPARSER::PROTEIN-FAMILY) ("sterol" . SPARSER::PROTEIN)
    ("glucose and lipid" . SPARSER::COLLECTION)
    ("the hyperplasic component" . SPARSER::COMPONENT)
    ("an essential substrate for FASN and the chain elongation systems xref"
     . SPARSER::COLLECTION)
    ("an essential substrate" . SPARSER::SUBSTRATE) ("CoA" . SPARSER::MOLECULE)
    ("malonyl" . SPARSER::PROTEIN) ("FASN" . SPARSER::PROTEIN)
    ("lipids" . SPARSER::PROTEIN)
    ("BrCa1 and lipogenic enzymes" . SPARSER::COLLECTION)
    ("lipogenic enzymes" . SPARSER::ENZYME) ("lipogenic genes" . SPARSER::GENE)
    ("mature adipocytes" . SPARSER::PROTEIN)
    ("both BrCa1 mRNA (3.5-fold, p<0.0001) and protein (1.2-fold, p = 0.001)"
     . SPARSER::COLLECTION)
    ("pre-adipocytes" . SPARSER::COLLECTION) ("OM" . SPARSER::PROTEIN)
    ("total and phosphorylated (P-) BrCa1, and ACC" . SPARSER::COLLECTION)
    ("BrCa1, and ACC" . SPARSER::COLLECTION) ("adipocytes" . SPARSER::PROTEIN)
    ("ACC" . SPARSER::PROTEIN) ("the main lipogenic enzymes" . SPARSER::ENZYME)
    ("Serine residue" . SPARSER::MOLECULE) ("Beta-Actin" . SPARSER::PROTEIN)
    ("Nonidet P-40" . SPARSER::DRUG) ("Cyclophilin A" . SPARSER::PROTEIN)
    ("fatty acid synthase" . SPARSER::PROTEIN) ("SREBF1" . SPARSER::PROTEIN)
    ("sterol regulatory element binding transcription factor 1"
     . SPARSER::PROTEIN)
    ("PPARγ" . SPARSER::PROTEIN) ("CO2" . SPARSER::PROTEIN)
    ("F-1" . SPARSER::PROTEIN) ("PBS 2" . SPARSER::PROTEIN)
    ("Type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cholesterol esterase" . SPARSER::PROTEIN)
    ("glucose oxidase" . SPARSER::PROTEIN)
    ("transaminase activity" . SPARSER::PROTEIN)
    ("Cancer-1" . SPARSER::PROTEIN) ("SREBP-1" . SPARSER::PROTEIN)
    ("tumor necrosis factor" . SPARSER::PROTEIN) ("SREBP1" . SPARSER::PROTEIN)
    ("SREBP-1c" . SPARSER::PROTEIN) ("HbA1" . SPARSER::PROTEIN)
    ("element binding protein" . SPARSER::PROTEIN)
    ("Fatty acid synthase" . SPARSER::PROTEIN) ("P-ACC" . SPARSER::PROTEIN)
    ("fatty acid" . SPARSER::MOLECULE) ("acetyl-CoA" . SPARSER::MOLECULE)
    ("BrCa1" . SPARSER::PROTEIN) ("Cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("strabismus" . SPARSER::PROTEIN) ("Proline" . SPARSER::AMINO-ACID)
    ("GCG" . SPARSER::PROTEIN) ("Alanine" . SPARSER::AMINO-ACID)
    ("retinas" . SPARSER::DRUG) ("retina" . SPARSER::DRUG)
    ("NLP" . SPARSER::PROTEIN) ("Ig" . SPARSER::MOLECULE)
    ("CS" . SPARSER::PROTEIN) ("and −1" . SPARSER::PROTEIN)
    ("I-2" . SPARSER::PROTEIN) ("FGFR 2" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("all the promigratory target genes" . SPARSER::GENE)
    ("FGFR1, GRINA and EBI3" . SPARSER::COLLECTION)
    ("FGFR1, KRTAP5-6 , SFN , and PRSS27" . SPARSER::COLLECTION)
    ("a larger complex" . SPARSER::BIO-COMPLEX)
    ("EBI3 ( xref ) and GRINA ( xref )" . SPARSER::COLLECTION)
    ("FGFR1, EBI3 ( xref ) and GRINA ( xref )" . SPARSER::COLLECTION)
    ("hyperproliferative keratinocytes" . SPARSER::PROTEIN)
    ("granzyme" . SPARSER::PROTEIN-FAMILY) ("exogenous GrB" . SPARSER::PROTEIN)
    ("known ligand" . SPARSER::LIGAND)
    ("PI3K, PLC-γ, and MAPK" . SPARSER::COLLECTION)
    ("FGFR1 and FGFR2" . SPARSER::COLLECTION)
    ("the target genes up-regulated by FGFR1 ( KRTAP5-6 , SFN , and PRSS27 )"
     . SPARSER::GENE)
    ("GRINA and EBI3" . SPARSER::COLLECTION)
    ("EBI3 and GRINA" . SPARSER::COLLECTION) ("Stratifin" . SPARSER::PROTEIN)
    ("GRINA" . SPARSER::PROTEIN) ("FGFR1 and IgG" . SPARSER::COLLECTION)
    ("GAPDH" . SPARSER::PROTEIN)
    ("Eight potential FGFR1 target genes" . SPARSER::GENE)
    ("the neonatal voltage-gated sodium channel (NESO) antibody"
     . SPARSER::ANTIBODY)
    ("OCs" . SPARSER::PROTEIN)
    ("Hematoxylin and eosin staining revealed invading particles (group of cells)"
     . SPARSER::COLLECTION)
    ("Hematoxylin" . SPARSER::MOLECULE)
    ("collagen/Matrigel" . SPARSER::COLLECTION)
    ("FGFR1 or IC-FGFR1-MYC" . SPARSER::COLLECTION)
    ("fragment (IC)" . SPARSER::FRAGMENT) ("VSAN" . SPARSER::PROTEIN)
    ("FGFR1b (VSAD)" . SPARSER::PROTEIN) ("FGFR1b" . SPARSER::PROTEIN)
    ("FGFR1b (VSAN)" . SPARSER::PROTEIN)
    ("both full-length and nuclear FGFR1" . SPARSER::COLLECTION)
    ("DCI" . SPARSER::PROTEIN) ("a chromogenic substrate" . SPARSER::SUBSTRATE)
    ("pERK" . SPARSER::PROTEIN) ("BIP" . SPARSER::PROTEIN)
    ("FGFR1 and full-length" . SPARSER::COLLECTION)
    ("FGF-10/heparin" . SPARSER::COLLECTION)
    ("PLC-γ and PI3K" . SPARSER::COLLECTION)
    ("AKT, and PLC-γ" . SPARSER::COLLECTION) ("heparin" . SPARSER::PROTEIN)
    ("ErbB4" . SPARSER::PROTEIN) ("ADAM" . SPARSER::PROTEIN)
    ("undergoes" . SPARSER::PROTEIN)
    ("Importin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FGFRs, and FGFR1" . SPARSER::COLLECTION)
    ("PLC-γ, and STATs" . SPARSER::COLLECTION)
    ("CyclinD1 and PEA3" . SPARSER::COLLECTION) ("STATs" . SPARSER::PROTEIN)
    ("GrB" . SPARSER::PROTEIN)
    ("FGF-10 and its receptors, FGFR1 and FGFR2" . SPARSER::COLLECTION)
    ("receptors, FGFR1 and FGFR2" . SPARSER::COLLECTION)
    ("opted" . SPARSER::HUMAN-PROTEIN-FAMILY) ("c-MYC" . SPARSER::PROTEIN)
    ("Full-length" . SPARSER::PROTEIN) ("1–2" . SPARSER::PROTEIN)
    ("Caspase-8" . SPARSER::PROTEIN) ("HSC70" . SPARSER::PROTEIN)
    ("PLC-γ1" . SPARSER::PROTEIN) ("MAPK1" . SPARSER::PROTEIN)
    ("Lamin A/C" . SPARSER::PROTEIN) ("HSC-70" . SPARSER::PROTEIN)
    ("D-6" . SPARSER::PROTEIN) ("GRP78" . SPARSER::PROTEIN)
    ("Akt1" . SPARSER::PROTEIN) ("Bis-Tris" . SPARSER::MOLECULE)
    ("POU2" . SPARSER::PROTEIN) ("L -glutamine" . SPARSER::MOLECULE)
    ("Keratin 6" . SPARSER::PROTEIN) ("Caspase 8" . SPARSER::PROTEIN)
    ("serine protease inhibitor" . SPARSER::PROTEIN)
    ("PRSS27" . SPARSER::PROTEIN) ("EBI3" . SPARSER::PROTEIN)
    ("POU2F2" . SPARSER::PROTEIN)
    ("hypoxanthine-guanine phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("STAC3" . SPARSER::PROTEIN) ("MARK3" . SPARSER::PROTEIN)
    ("RNA polymerase II" . SPARSER::PROTEIN)
    ("sodium channel" . SPARSER::PROTEIN) ("voltage-gated" . SPARSER::PROTEIN)
    ("Cathepsin C" . SPARSER::PROTEIN) ("60 kD" . SPARSER::PROTEIN)
    ("120 kD" . SPARSER::PROTEIN) ("1 D" . SPARSER::PROTEIN)
    ("1 C" . SPARSER::PROTEIN) ("1 B" . SPARSER::PROTEIN)
    ("1 A" . SPARSER::PROTEIN)
    ("extracellular signal–regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FRS2" . SPARSER::PROTEIN) ("γ-secretase" . SPARSER::PROTEIN)
    ("PEA3" . SPARSER::PROTEIN) ("CyclinD1" . SPARSER::PROTEIN)
    ("PLC-γ" . SPARSER::PROTEIN-FAMILY) ("FGFR2" . SPARSER::PROTEIN)
    ("FGF-10" . SPARSER::PROTEIN) ("Granzyme B" . SPARSER::PROTEIN)
    ("microvascular EDR" . SPARSER::PROTEIN)
    ("Nox-2 and Nox-4" . SPARSER::COLLECTION) ("Nox-2" . SPARSER::PROTEIN)
    ("AG" . SPARSER::PROTEIN) ("type 1, and PAI-1" . SPARSER::COLLECTION)
    ("type 1 and PAI-1" . SPARSER::COLLECTION)
    ("Tunicamycin" . SPARSER::MOLECULE) ("ester" . SPARSER::MOLECULE)
    ("Tudca or insulin (61.3% and 84.3%, respectively; xref )"
     . SPARSER::COLLECTION)
    ("eIF2α and mRNA" . SPARSER::COLLECTION) ("eIF2α" . SPARSER::PROTEIN)
    ("cGMP" . SPARSER::PROTEIN) ("eNOS" . SPARSER::PROTEIN)
    ("synthase" . SPARSER::PROTEIN) ("EDR" . SPARSER::PROTEIN)
    ("MRA" . SPARSER::DRUG) ("MRAs" . SPARSER::DRUG)
    ("PAI-1 and collagen" . SPARSER::COLLECTION)
    ("CHOP, ATF4, and ATF6" . SPARSER::COLLECTION)
    ("inhibitor (PAI)" . SPARSER::INHIBITOR)
    ("protein kinase-like ER eukaryotic initiation factor 2α kinase"
     . SPARSER::KINASE)
    ("glycoprotein" . SPARSER::PROTEIN) ("Nox2 and Nox4" . SPARSER::COLLECTION)
    ("Nox2" . SPARSER::PROTEIN)
    ("type I, and plasminogen activator inhibitor 1" . SPARSER::COLLECTION)
    ("CHOP, ATF4, ATF6, and phosphorylated-eIF2α" . SPARSER::COLLECTION)
    ("eIF" . SPARSER::PROTEIN) ("CHOP" . SPARSER::PROTEIN)
    ("Tudca" . SPARSER::DRUG) ("Nox-4" . SPARSER::PROTEIN)
    ("kinase–like" . SPARSER::PROTEIN-FAMILY)
    ("l -arginine" . SPARSER::MOLECULE) ("6.3" . SPARSER::PROTEIN)
    ("PAI-1" . SPARSER::PROTEIN) ("plasminogen activator" . SPARSER::PROTEIN)
    ("β-cell" . SPARSER::PROTEIN)
    ("activating transcription factor 6" . SPARSER::PROTEIN)
    ("protein-1" . SPARSER::PROTEIN) ("kinase-like" . SPARSER::PROTEIN-FAMILY)
    ("Nox4" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor 1" . SPARSER::PROTEIN)
    ("ATF6" . SPARSER::PROTEIN) ("ATF4" . SPARSER::PROTEIN)
    ("AG1478" . SPARSER::DRUG) ("REST-USP37-p27" . SPARSER::COLLECTION)
    ("cyclinE-CDK2" . SPARSER::COLLECTION)
    ("cyclinD-CDK4" . SPARSER::COLLECTION)
    ("cyclinE" . SPARSER::PROTEIN-FAMILY)
    ("the inner EGL and IGL" . SPARSER::COLLECTION)
    ("the cerebellar EGL" . SPARSER::PROTEIN)
    ("EGL and IGL" . SPARSER::COLLECTION)
    ("Syn1, BDNF and SCG10" . SPARSER::COLLECTION) ("BDNF" . SPARSER::PROTEIN)
    ("maleimide" . SPARSER::DRUG)
    ("purified epitope tagged proteins" . SPARSER::PROTEIN)
    ("anti-p27 antibodies or control IgG" . SPARSER::COLLECTION)
    ("Transgene" . SPARSER::PROTEIN) ("IGL" . SPARSER::PROTEIN)
    ("EGL" . SPARSER::PROTEIN) ("p27 and USP37" . SPARSER::COLLECTION)
    ("REST-antibody" . SPARSER::COLLECTION) ("DUBs" . SPARSER::PROTEIN)
    ("deubiquitylases" . SPARSER::DEUBIQUITYLASE)
    ("KPC1/KPC2" . SPARSER::COLLECTION) ("IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ub" . SPARSER::PROTEIN) ("siRNA or scr" . SPARSER::COLLECTION)
    ("scr" . SPARSER::PROTEIN) ("CHX" . SPARSER::PROTEIN)
    ("the pro-proliferative marker N-Myc" . SPARSER::PROTEIN)
    ("REST and Ki-67" . SPARSER::COLLECTION) ("IFA" . SPARSER::PROTEIN)
    ("scr-siRNA" . SPARSER::PROTEIN-PAIR)
    ("neuronal differentiation genes" . SPARSER::GENE)
    ("p27, REST and USP37" . SPARSER::COLLECTION)
    ("deubiquitylase (DUB)" . SPARSER::DEUBIQUITYLASE)
    ("DUB" . SPARSER::PROTEIN) ("Shh" . SPARSER::PROTEIN)
    ("CPC" . SPARSER::PROTEIN) ("p27/Kip1" . SPARSER::COLLECTION)
    ("CPCs" . SPARSER::PROTEIN) ("CDKI" . SPARSER::DRUG)
    ("MR" . SPARSER::PROTEIN) ("mSin3a and HDAC1/2" . SPARSER::COLLECTION)
    ("demethylase, and HDAC1/2" . SPARSER::COLLECTION)
    ("Brg1" . SPARSER::PROTEIN) ("mSin3a" . SPARSER::PROTEIN)
    ("demethylase" . SPARSER::PROTEIN) ("methyltransferase" . SPARSER::PROTEIN)
    ("carboxy" . SPARSER::MOLECULE)
    ("RE1 silencing transcription factor (REST)" . SPARSER::PROTEIN)
    ("USP37 and p27" . SPARSER::COLLECTION) ("cysteine" . SPARSER::AMINO-ACID)
    ("REST-target neuronal differentiation genes" . SPARSER::GENE)
    ("REST and USP37" . SPARSER::COLLECTION) ("peptidase" . SPARSER::PROTEIN)
    ("deubiquitylase" . SPARSER::DEUBIQUITYLASE)
    ("REST and p27" . SPARSER::COLLECTION)
    ("a cyclin-dependent kinase inhibitor and a brake" . SPARSER::COLLECTION)
    ("CDKNIB/p27" . SPARSER::COLLECTION)
    ("RE1 Silencing Transcription Factor (REST)" . SPARSER::PROTEIN)
    ("REST" . SPARSER::PROTEIN) ("De-" . SPARSER::MOLECULE)
    ("beta tubulin" . SPARSER::PROTEIN) ("TSC-2" . SPARSER::PROTEIN)
    ("tuberous sclerosis 2" . SPARSER::PROTEIN) ("SCG10" . SPARSER::PROTEIN)
    ("USP1" . SPARSER::PROTEIN) ("KPC2" . SPARSER::PROTEIN)
    ("KPC1" . SPARSER::PROTEIN) ("FBXW7" . SPARSER::PROTEIN)
    ("de-" . SPARSER::MOLECULE) ("N-Myc" . SPARSER::PROTEIN)
    ("Syn1" . SPARSER::PROTEIN) ("sonic hedgehog" . SPARSER::PROTEIN)
    ("Kip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("v-Myc" . SPARSER::PROTEIN)
    ("V-Myc" . SPARSER::PROTEIN) ("LSD1" . SPARSER::PROTEIN)
    ("G9a" . SPARSER::PROTEIN) ("HDAC1" . SPARSER::PROTEIN)
    ("RE1 silencing transcription factor" . SPARSER::PROTEIN)
    ("USP37" . SPARSER::PROTEIN)
    ("RE1 Silencing Transcription Factor" . SPARSER::PROTEIN)
    ("inhibitors and activators" . SPARSER::COLLECTION)
    ("chemicals" . SPARSER::MOLECULE)
    ("at least two proteins" . SPARSER::PROTEIN) ("Mitf" . SPARSER::PROTEIN)
    ("a β-catenin target and an inhibitor" . SPARSER::COLLECTION)
    ("β-catenin and MITF-M" . SPARSER::COLLECTION)
    ("pro-" . SPARSER::AMINO-ACID) ("our homogeneous NRAS" . SPARSER::PROTEIN)
    ("Nras-bcat" . SPARSER::COLLECTION) ("Nras and Nras" . SPARSER::COLLECTION)
    ("CSK, NF1 and ADAM9" . SPARSER::COLLECTION)
    ("CSK, SHC1, and NF1" . SPARSER::COLLECTION)
    ("BCL2, SHC1, NF1, CSK, ADAM9 and NRG2" . SPARSER::COLLECTION)
    ("Functional IPA" . SPARSER::MOLECULE)
    ("potential β-catenin" . SPARSER::PROTEIN)
    ("MITF-M protein" . SPARSER::COLLECTION)
    ("mRNAs and proteins" . SPARSER::COLLECTION)
    ("mutant and WT littermate neonates" . SPARSER::COLLECTION)
    ("the dorsal tip" . SPARSER::PROTEIN) ("*-LacZ" . SPARSER::COLLECTION)
    ("Dct::LacZ" . SPARSER::BIO-COMPLEX) ("LacZ" . SPARSER::PROTEIN)
    ("Dct" . SPARSER::PROTEIN) ("tyrosinase" . SPARSER::PROTEIN)
    ("the most ventral part" . SPARSER::COMPONENT)
    ("CK1/GSK-3β" . SPARSER::COLLECTION) ("NaCl-" . SPARSER::PROTEIN)
    ("bcat" . SPARSER::PROTEIN) ("BRAF-PTEN" . SPARSER::COLLECTION)
    ("β-catenin/LEF1" . SPARSER::COLLECTION) ("LiCl" . SPARSER::DRUG)
    ("mDia1 and Rho-GTPases" . SPARSER::COLLECTION)
    ("mDia1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("collagenase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("mDia" . SPARSER::PROTEIN)
    ("β-catenin-LEF/TCF" . SPARSER::COLLECTION)
    ("cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TCF/LEF" . SPARSER::COLLECTION) ("Nras" . SPARSER::PROTEIN)
    ("a key transcription factor" . SPARSER::PROTEIN)
    ("CSK" . SPARSER::PROTEIN) ("MITF" . SPARSER::PROTEIN)
    ("β-catenin/LEF" . SPARSER::COLLECTION) ("NRG2" . SPARSER::PROTEIN)
    ("ADAM9" . SPARSER::PROTEIN) ("NF1" . SPARSER::PROTEIN)
    ("SHC1" . SPARSER::PROTEIN) ("sodium chloride" . SPARSER::DRUG)
    ("LEF1" . SPARSER::PROTEIN) ("MMP14" . SPARSER::PROTEIN)
    ("MT1-MMP" . SPARSER::PROTEIN) ("Beta-catenin" . SPARSER::PROTEIN)
    ("ribosomal and nucleolar proteins" . SPARSER::PROTEIN)
    ("our previously describedp53 −/− ARF −/− MEFs" . SPARSER::PROTEIN)
    ("c-Myc and NPM" . SPARSER::COLLECTION) ("/ARF" . SPARSER::COLLECTION)
    ("c-Myc and exogenous NPM" . SPARSER::COLLECTION)
    ("andc-myc" . SPARSER::COLLECTION) ("NPM and c-Myc" . SPARSER::COLLECTION)
    ("other nucleolar ubiquitin ligases" . SPARSER::LIGASE)
    ("Fbw7" . SPARSER::PROTEIN) ("cycloheximide" . SPARSER::PROTEIN)
    ("exogenous NPM" . SPARSER::PROTEIN)
    ("ARF, Mdm2 or p53" . SPARSER::COLLECTION)
    ("NPM or c-Myc" . SPARSER::COLLECTION)
    ("inp53 −/− or TKO MEFs" . SPARSER::COLLECTION)
    ("exogenous c-Myc ( xref , Panels D–F) and endogenous c-Myc ( xref , Panels D–F)"
     . SPARSER::COLLECTION)
    ("nucleoplasmic inNPM −/− /p53 −/− MEFs" . SPARSER::PROTEIN)
    ("exogenous and endogenous c-Myc" . SPARSER::PROTEIN)
    ("ARF, Mdm2 and p53" . SPARSER::COLLECTION) ("inp53" . SPARSER::PROTEIN)
    ("p53/ARF/Mdm2 triple knockout (TKO) MEFs" . SPARSER::PROTEIN)
    ("p53/ARF/Mdm2" . SPARSER::COLLECTION) ("TKO" . SPARSER::PROTEIN)
    ("exogenous c-Myc" . SPARSER::PROTEIN)
    ("c-Myc and nucleolin" . SPARSER::COLLECTION) ("Inp53" . SPARSER::PROTEIN)
    ("nucleolin" . SPARSER::PROTEIN)
    ("both NPM and the tumor suppressor ARF ( xref ; xref ; xref ) and NPM"
     . SPARSER::COLLECTION)
    ("the tumor suppressor ARF ( xref ; xref ; xref ) and NPM"
     . SPARSER::COLLECTION)
    ("NPM or ARF" . SPARSER::COLLECTION) ("ARF and p53" . SPARSER::COLLECTION)
    ("myc/ras" . SPARSER::COLLECTION) ("ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a major nucleolar protein" . SPARSER::PROTEIN) ("pre" . SPARSER::PROTEIN)
    ("nucleolar c-Myc" . SPARSER::PROTEIN)
    ("5S rRNA as well as various tRNAs ( xref )" . SPARSER::COLLECTION)
    ("proteins and Pol" . SPARSER::COLLECTION) ("tRNAs" . SPARSER::PROTEIN)
    ("Pol" . SPARSER::PROTEIN) ("ribosomal proteins" . SPARSER::PROTEIN)
    ("the mature rRNAs" . SPARSER::RNA) ("pre-rRNA" . SPARSER::COLLECTION)
    ("rRNAs" . SPARSER::RNA) ("rDNA" . SPARSER::PROTEIN)
    ("p53, Mdm2 and ARF" . SPARSER::COLLECTION) ("ARF" . SPARSER::PROTEIN)
    ("NPM" . SPARSER::PROTEIN)
    ("a predominantly nucleolar protein" . SPARSER::PROTEIN)
    ("Nucleophosmin" . SPARSER::PROTEIN) ("ribosomal DNA" . SPARSER::DNA)
    ("rRNA" . SPARSER::PROTEIN) ("pol" . SPARSER::PROTEIN)
    ("polymerases" . SPARSER::PROTEIN) ("D–F" . SPARSER::PROTEIN)
    ("A–C" . SPARSER::PROTEIN) ("Mdm2" . SPARSER::PROTEIN)
    ("S100A4" . SPARSER::PROTEIN) ("autoantibodies" . SPARSER::PROTEIN)
    ("TPI or MDH1" . SPARSER::COLLECTION)
    ("MTUS1 and DNA" . SPARSER::COLLECTION)
    ("S100A8 and S100A9" . SPARSER::COLLECTION) ("ophthalmic" . SPARSER::DRUG)
    ("potential biomarkers" . SPARSER::MOLECULE)
    ("albumin and immunoglobulins" . SPARSER::COLLECTION)
    ("immunoglobulins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteins and their subunits ( xref , xref , xref )"
     . SPARSER::COLLECTION)
    ("simultaneous protein" . SPARSER::PROTEIN) ("s100a9" . SPARSER::PROTEIN)
    ("ddb1" . SPARSER::PROTEIN) ("tpi1" . SPARSER::PROTEIN)
    ("prkag3" . SPARSER::PROTEIN) ("ddb" . SPARSER::DRUG)
    ("proteins or complement" . SPARSER::COLLECTION)
    ("Representative fractions" . SPARSER::COMPONENT)
    ("many highly-abundant proteins" . SPARSER::PROTEIN)
    ("healthy sera" . SPARSER::PROTEIN) ("ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SELDI-TOF" . SPARSER::COLLECTION) ("refs" . SPARSER::PROTEIN)
    ("sera" . SPARSER::PROTEIN) ("new biomarkers" . SPARSER::MOLECULE)
    ("CEA" . SPARSER::PROTEIN) ("TPI" . SPARSER::PROTEIN)
    ("CTRL" . SPARSER::PROTEIN) ("TOF" . SPARSER::PROTEIN)
    ("Noninvasive biomarkers" . SPARSER::MOLECULE) ("C5a" . SPARSER::PROTEIN)
    ("TPI1" . SPARSER::PROTEIN) ("MDH1" . SPARSER::PROTEIN)
    ("DDB1" . SPARSER::PROTEIN) ("MTUS1" . SPARSER::PROTEIN)
    ("S100A9" . SPARSER::PROTEIN) ("diras2" . SPARSER::PROTEIN)
    ("Ras2" . SPARSER::PROTEIN) ("s100" . SPARSER::PROTEIN)
    ("Protein S100-A9" . SPARSER::PROTEIN)
    ("DNA damage-binding protein 1" . SPARSER::PROTEIN)
    ("lipocalin 1" . SPARSER::PROTEIN)
    ("Transferrin receptor protein 1" . SPARSER::PROTEIN)
    ("mtus1" . SPARSER::PROTEIN)
    ("Microtubule-associated tumor suppressor 1" . SPARSER::PROTEIN)
    ("Triosephosphate isomerase" . SPARSER::PROTEIN)
    ("cst2" . SPARSER::PROTEIN) ("Cystatin SA" . SPARSER::PROTEIN)
    ("Extracellular sulfatase Sulf-1" . SPARSER::PROTEIN)
    ("1D" . SPARSER::PROTEIN) ("ALDH3" . SPARSER::PROTEIN)
    ("S100A8" . SPARSER::PROTEIN)
    ("had uninformative BRCA" . SPARSER::PROTEIN-FAMILY)
    ("uninformative BRCA" . SPARSER::PROTEIN-FAMILY)
    ("miRNA" . SPARSER::PROTEIN) ("-variant and time" . SPARSER::COLLECTION)
    ("p " . SPARSER::PROTEIN) ("the entire cohort" . SPARSER::MOLECULE)
    ("uninformative HBOC families" . SPARSER::PROTEIN-FAMILY)
    ("clinically well-annotated cohorts" . SPARSER::MOLECULE)
    ("Families" . SPARSER::PROTEIN-FAMILY) ("-variant" . SPARSER::VARIANT)
    ("KRAS-" . SPARSER::PROTEIN) ("microRNA" . SPARSER::RNA)
    ("the EMT-associated genes Snail, Slug and vimentin" . SPARSER::COLLECTION)
    ("Snail, Slug and vimentin" . SPARSER::COLLECTION)
    ("Raf/MAPK" . SPARSER::COLLECTION)
    ("the pro-apoptotic proteins Bad and Bid" . SPARSER::COLLECTION)
    ("Bad and Bid" . SPARSER::COLLECTION) ("Bid" . SPARSER::PROTEIN)
    ("Bcl-2 and Bcl-X" . SPARSER::COLLECTION)
    ("VacA" . SPARSER::PROTEIN-FAMILY)
    ("cytochrome c, and caspase-3" . SPARSER::COLLECTION)
    ("vacA" . SPARSER::PROTEIN-FAMILY)
    ("strain-specific virulence factors" . SPARSER::PROTEIN-FAMILY)
    ("FAS and its ligand (FASL)" . SPARSER::COLLECTION)
    ("ligand (FASL)" . SPARSER::MOLECULE) ("FAS" . SPARSER::PROTEIN)
    ("cytometry and DNA" . SPARSER::COLLECTION) ("PARP" . SPARSER::PROTEIN)
    ("Snail and RKIP" . SPARSER::COLLECTION)
    ("protein or mRNA" . SPARSER::COLLECTION)
    ("proteasomal" . SPARSER::PROTEIN)
    ("the entire cag PAI or the oipA gene" . SPARSER::COLLECTION)
    ("isogenic mutants" . SPARSER::MUTANT)
    ("subcellular AGS cells fractions" . SPARSER::COMPONENT)
    ("either IL-6 (50 ng/ml) or co-cultured" . SPARSER::COLLECTION)
    ("Macrophages" . SPARSER::PROTEIN) ("Bis" . SPARSER::PROTEIN)
    ("bisindolylmaleimide" . SPARSER::DRUG) ("Jak/STAT" . SPARSER::COLLECTION)
    ("Jak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RKIP and STAT3" . SPARSER::COLLECTION)
    ("the phosphatidylethanolamine-binding protein family and a negative regulator"
     . SPARSER::COLLECTION)
    ("GRK" . SPARSER::PROTEIN) ("phosphatidylethanolamine" . SPARSER::MOLECULE)
    ("CagA" . SPARSER::PROTEIN) ("cagA" . SPARSER::PROTEIN)
    ("PAI" . SPARSER::PROTEIN)
    ("H. pylori simultaneously targets non-phosphorylated RKIP"
     . SPARSER::PROTEIN)
    ("blot and luciferase" . SPARSER::COLLECTION)
    ("Raf-kinase inhibitor protein (RKIP)" . SPARSER::PROTEIN)
    ("RKIP" . SPARSER::PROTEIN) ("interleukin 6" . SPARSER::PROTEIN)
    ("MMP-7" . SPARSER::PROTEIN) ("caspase-8" . SPARSER::PROTEIN)
    ("Bcl-X" . SPARSER::PROTEIN) ("Bcl-2" . SPARSER::PROTEIN)
    ("caspase-3" . SPARSER::PROTEIN) ("cytochrome c" . SPARSER::PROTEIN)
    ("IRF-1" . SPARSER::PROTEIN) ("18 h" . SPARSER::PROTEIN)
    ("IRF1" . SPARSER::PROTEIN) ("beta-actin" . SPARSER::PROTEIN)
    ("Green Fluorescent Protein" . SPARSER::PROTEIN)
    ("IL-6" . SPARSER::PROTEIN) ("Interleukin-6" . SPARSER::PROTEIN)
    ("histone deacetylase" . SPARSER::PROTEIN)
    ("G Protein-Coupled Receptor Kinase" . SPARSER::PROTEIN)
    ("Extracellular Signal-Regulated Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NF-kB" . SPARSER::PROTEIN) ("zinc-finger protein" . SPARSER::PROTEIN)
    ("epithelial cadherin" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("tumor suppressor protein" . SPARSER::PROTEIN)
    ("Raf-kinase inhibitor protein" . SPARSER::PROTEIN)
    ("directly inhibiting CDKs and indirectly regulating genes"
     . SPARSER::COLLECTION)
    ("E2F's" . SPARSER::PROTEIN-FAMILY) ("at least four genes" . SPARSER::GENE)
    ("the mitotic control gene PLK1" . SPARSER::PROTEIN)
    ("p21 repressed genes" . SPARSER::GENE)
    ("a conditional transgene" . SPARSER::PROTEIN) ("DHFR" . SPARSER::PROTEIN)
    ("CDH" . SPARSER::PROTEIN)
    ("transcription factor or co-factor" . SPARSER::COLLECTION)
    ("AURKB , BIRC5 , CDC25C , CCNE2 and WEE1" . SPARSER::COLLECTION)
    ("AURKB" . SPARSER::PROTEIN)
    ("CCNE2 proximal promoter" . SPARSER::PROMOTER)
    ("cyclin-CDK" . SPARSER::COLLECTION)
    ("CDK2 , KIF4A , PLK1 and WEE1" . SPARSER::COLLECTION)
    ("human CCNE2 and other p21-repressed genes" . SPARSER::COLLECTION)
    ("chromatin and nucleoplasmic fractions" . SPARSER::COLLECTION)
    ("nucleoplasmic fractions" . SPARSER::COMPONENT)
    ("at least part" . SPARSER::COMPONENT)
    ("CCNE2 , WEE1 and KIF4A" . SPARSER::COLLECTION)
    ("p21-GFP" . SPARSER::COLLECTION) ("CDK-cyclin" . SPARSER::COLLECTION)
    ("only 8 genes" . SPARSER::GENE)
    ("only 180 genes (with an expression change ≥2.3 fold after 12 h of p27 induction) and none"
     . SPARSER::COLLECTION)
    ("only 180 genes" . SPARSER::GENE)
    ("acetylated-histone" . SPARSER::PROTEIN)
    ("BIRC5 , CCNB1 and CDK2" . SPARSER::COLLECTION)
    ("mitotic genes" . SPARSER::GENE) ("CBP" . SPARSER::PROTEIN)
    ("inducer" . SPARSER::PROTEIN)
    ("a regulatory cyclin and a catalytic CDK subunit" . SPARSER::COLLECTION)
    ("a regulatory cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p27 KIP1 and p57 KIP2" . SPARSER::COLLECTION)
    ("human CCNE2 and other p21-repressed genes gene" . SPARSER::COLLECTION)
    ("Chromatin" . SPARSER::PROTEIN)
    ("CCNE2 and other genes" . SPARSER::COLLECTION) ("E2F4" . SPARSER::PROTEIN)
    ("WNT4" . SPARSER::PROTEIN) ("cyclin E" . SPARSER::PROTEIN)
    ("CDC25" . SPARSER::PROTEIN) ("CDC25A" . SPARSER::PROTEIN)
    ("polo-like kinase 1" . SPARSER::PROTEIN) ("BUB1" . SPARSER::PROTEIN)
    ("CCNB2" . SPARSER::PROTEIN) ("co-factor" . SPARSER::MOLECULE)
    ("CDC25C" . SPARSER::PROTEIN) ("p21 protein" . SPARSER::PROTEIN)
    ("WEE1" . SPARSER::PROTEIN) ("KIF4A" . SPARSER::PROTEIN)
    ("CCNB1" . SPARSER::PROTEIN) ("BIRC5" . SPARSER::PROTEIN)
    ("CCNE1" . SPARSER::PROTEIN) ("RPS14" . SPARSER::PROTEIN)
    ("ribosomal protein S14" . SPARSER::PROTEIN) ("p16" . SPARSER::PROTEIN)
    ("Zn 2+" . SPARSER::MOLECULE) ("E2F" . SPARSER::PROTEIN-FAMILY)
    ("E2Fs" . SPARSER::PROTEIN-FAMILY) ("C/EBPα" . SPARSER::PROTEIN)
    ("p57 KIP2" . SPARSER::PROTEIN)
    ("p21 CIP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin E2" . SPARSER::PROTEIN) ("CCNE2" . SPARSER::PROTEIN)
    ("the apical protein podocalyxin" . SPARSER::PROTEIN)
    ("α-actinin-4 and β-actin" . SPARSER::COLLECTION)
    ("IQGAP1, IQGAP2 and IQGAP3" . SPARSER::COLLECTION)
    ("nephrin, podocin, PLCε1, CD2AP, α-actinin-4, or NCK"
     . SPARSER::COLLECTION)
    ("IQGAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("APC, ARP 2/3, N-WASP or CLIP170" . SPARSER::COLLECTION)
    ("proteins and IQGAP1" . SPARSER::COLLECTION)
    ("catenins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-catenin and MAGI-1" . SPARSER::COLLECTION)
    ("podocin and nephrin" . SPARSER::COLLECTION)
    ("nephrin and IQGAP1" . SPARSER::COLLECTION)
    ("70 kDa FITC-dextran" . SPARSER::MOLECULE)
    ("kDa FITC-dextran" . SPARSER::MOLECULE)
    ("FITC-dextran" . SPARSER::MOLECULE) ("FAK" . SPARSER::PROTEIN)
    ("annexin V and propidium" . SPARSER::COLLECTION)
    ("Fluor" . SPARSER::MOLECULE)
    ("IQGAP1 and the apical transmembrane protein podocalyxin ( xref )"
     . SPARSER::COLLECTION)
    ("the apical transmembrane protein podocalyxin" . SPARSER::PROTEIN)
    ("IQGAP1 and proteins" . SPARSER::COLLECTION)
    ("nephrin, MAGI-1, CD2AP, podocin and NCK1/2" . SPARSER::COLLECTION)
    ("Luciferase" . SPARSER::PROTEIN) ("UT" . SPARSER::PROTEIN-FAMILY)
    ("IQGAP1 and Nephrin, MAGI-1, CD2AP, Podocin, NCK and Podocalyxin"
     . SPARSER::COLLECTION)
    ("Nephrin, MAGI-1, CD2AP, Podocin, NCK and Podocalyxin"
     . SPARSER::COLLECTION)
    ("NCK" . SPARSER::PROTEIN)
    ("an apical transmembrane protein" . SPARSER::PROTEIN)
    ("IQGAP1 and podocalyxin" . SPARSER::COLLECTION)
    ("α-actinin-4 and β-catenin" . SPARSER::COLLECTION)
    ("IQGAP1 and podocin or NCK1/2" . SPARSER::COLLECTION)
    ("podocin or NCK1/2" . SPARSER::COLLECTION)
    ("MAGI-1 and CD2AP" . SPARSER::COLLECTION)
    ("IQGAP1 and nephrin" . SPARSER::COLLECTION)
    ("IQGAP1 and Nephrin" . SPARSER::COLLECTION)
    ("Podocalyxin" . SPARSER::PROTEIN) ("Podocin" . SPARSER::PROTEIN)
    ("IQGAP1 and F-actin" . SPARSER::COLLECTION)
    ("CD2AP and podocin" . SPARSER::COLLECTION) ("Proteins" . SPARSER::PROTEIN)
    ("nephrin, podocin, and podocalyxin" . SPARSER::COLLECTION)
    ("the junctional complexes" . SPARSER::BIO-COMPLEX)
    ("migrating junctional complexes" . SPARSER::BIO-COMPLEX)
    ("APC and CLIP170" . SPARSER::COLLECTION)
    ("actin and the Rho GTPases Cdc42 and Rac1" . SPARSER::COLLECTION)
    ("Cdc42 and Rac1" . SPARSER::COLLECTION)
    ("which binds filamentous (F)-actin" . SPARSER::COLLECTION)
    ("GTPases, Cdc42 and Rac1" . SPARSER::COLLECTION)
    ("-actin" . SPARSER::COLLECTION) ("GRD" . SPARSER::PROTEIN)
    ("calmodulin" . SPARSER::PROTEIN) ("calponin" . SPARSER::PROTEIN)
    ("Nephrin" . SPARSER::PROTEIN)
    ("SD and cytoskeletal proteins" . SPARSER::COLLECTION)
    ("podocalyxin" . SPARSER::PROTEIN) ("podocin" . SPARSER::PROTEIN)
    ("Western blot (WB)" . SPARSER::PROTEIN)
    ("cytoskeletal proteins" . SPARSER::PROTEIN)
    ("IQGAP1 and SD" . SPARSER::COLLECTION) ("IsPL" . SPARSER::PROTEIN)
    ("the glomerular slit diaphragm (SD) complex" . SPARSER::BIO-COMPLEX)
    ("nephrin" . SPARSER::PROTEIN)
    ("the intercellular adhesion complex" . SPARSER::BIO-COMPLEX)
    ("Sulforhodamine B" . SPARSER::MOLECULE)
    ("3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("protein-G" . SPARSER::PROTEIN) ("Serum Albumin" . SPARSER::PROTEIN)
    ("T antigen" . SPARSER::MOLECULE) ("IQGAP3" . SPARSER::PROTEIN)
    ("PLCε1" . SPARSER::PROTEIN) ("IQGAP2" . SPARSER::PROTEIN)
    ("N-WASP" . SPARSER::PROTEIN) ("ARP 2" . SPARSER::PROTEIN)
    ("P-cadherin" . SPARSER::PROTEIN) ("annexin V" . SPARSER::PROTEIN)
    ("filamentous actin" . SPARSER::BIO-COMPLEX) ("1-4" . SPARSER::PROTEIN)
    ("NCK1" . SPARSER::PROTEIN) ("VE-cadherin" . SPARSER::PROTEIN)
    ("CLIP170" . SPARSER::PROTEIN) ("MEK1" . SPARSER::PROTEIN)
    ("CLIC5" . SPARSER::PROTEIN) ("phospholipase C" . SPARSER::PROTEIN)
    ("α-actinin-4" . SPARSER::PROTEIN) ("NCK 1" . SPARSER::PROTEIN)
    ("CD2AP" . SPARSER::PROTEIN) ("MAGI-1" . SPARSER::PROTEIN)
    ("IQGAP1" . SPARSER::PROTEIN)
    ("germline EGFR variants and somatic EGFR mutations" . SPARSER::COLLECTION)
    ("gender-specific significant variants" . SPARSER::VARIANT)
    ("epidermal growth factor receptor ( EGFR )"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("glial" . SPARSER::PROTEIN) ("p  " . SPARSER::PROTEIN)
    ("alpha-fetoprotein" . SPARSER::PROTEIN)
    ("GSK3β, β-catenin and MnSOD" . SPARSER::COLLECTION)
    ("EGFR and PI3KCA" . SPARSER::COLLECTION)
    ("EGFR and WNT" . SPARSER::COLLECTION)
    ("suppressors" . SPARSER::SUPPRESSOR)
    ("EGFR or PI3K" . SPARSER::COLLECTION)
    ("a functional AMPK" . SPARSER::PROTEIN)
    ("PIK3CA and thedelE746" . SPARSER::COLLECTION)
    ("not-transformed mammary epithelial cells GD" . SPARSER::PROTEIN)
    ("Oncogenes" . SPARSER::ONCOGENE) ("EGFR-" . SPARSER::PROTEIN)
    ("G6PDH and glutathione peroxidase" . SPARSER::COLLECTION)
    ("β-catenin-" . SPARSER::PROTEIN) ("EGFR/PI3K/GSK3β" . SPARSER::COLLECTION)
    ("GSK3β and β-catenin" . SPARSER::COLLECTION)
    ("GSK3β/FOXO4/MnSOD" . SPARSER::COLLECTION)
    ("FOXO4 and β-catenin" . SPARSER::COLLECTION)
    ("the delE746-A750 EGFR and the E545K PIK3CA proteins"
     . SPARSER::COLLECTION)
    ("EGFR and PI3K" . SPARSER::COLLECTION)
    ("β -catenin and FOXO4" . SPARSER::COLLECTION)
    ("FOXOs, FOXO4 and β-catenin" . SPARSER::COLLECTION)
    ("FOXOs" . SPARSER::PROTEIN-FAMILY) ("Forkhead" . SPARSER::PROTEIN)
    ("Catalase and MnSOD" . SPARSER::COLLECTION)
    ("Catalase" . SPARSER::PROTEIN)
    ("Manganese Superoxide dismutase ( MnSOD ) and catalase mRNAs"
     . SPARSER::COLLECTION)
    ("relevant antioxidant genes" . SPARSER::GENE)
    ("phosphorylase" . SPARSER::PROTEIN)
    ("LKB1 and phospho-LKB1" . SPARSER::COLLECTION)
    ("LKB1/AMPK" . SPARSER::COLLECTION) ("AMP/ATP" . SPARSER::PROTEIN-PAIR)
    ("AICAR" . SPARSER::PROTEIN) ("the major AMPK" . SPARSER::PROTEIN)
    ("cellular superoxide" . SPARSER::MOLECULE) ("AMP" . SPARSER::AMP)
    ("kinase (AMPK)" . SPARSER::KINASE) ("AMPK" . SPARSER::PROTEIN)
    ("pyruvate" . SPARSER::PROTEIN)
    ("the most important cellular antioxidant" . SPARSER::PROTEIN)
    ("glutathione (GSH)" . SPARSER::DRUG) ("cellular NADPH" . SPARSER::PROTEIN)
    ("GSSG" . SPARSER::DRUG) ("GSH" . SPARSER::DRUG)
    ("the isogenic derivatives" . SPARSER::DERIVATIVE)
    ("EGFR or PIK3CA" . SPARSER::COLLECTION)
    ("derivatives" . SPARSER::DERIVATIVE)
    ("the E545K PIK3CA or the delE746-A750 EGFR" . SPARSER::COLLECTION)
    ("β-catenin and FOXO4" . SPARSER::COLLECTION)
    ("MEK/ERK" . SPARSER::COLLECTION)
    ("phosphatidylinositols" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor Receptor (EGFR) and the phosphatidylinositol 3-kinase (PI3K)"
     . SPARSER::COLLECTION)
    ("an energetic barrier" . SPARSER::PROTEIN)
    ("glucose and oxygen" . SPARSER::COLLECTION)
    ("ischemia" . SPARSER::PROTEIN) ("glutathione" . SPARSER::DRUG)
    ("pentose" . SPARSER::MOLECULE) ("NADH" . SPARSER::MOLECULE)
    ("EGFR and PIK3CA" . SPARSER::COLLECTION)
    ("WNT/β-catenin" . SPARSER::COLLECTION)
    ("WNT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MnSOD and catalase" . SPARSER::COLLECTION) ("MnSOD" . SPARSER::PROTEIN)
    ("delE" . SPARSER::PROTEIN) ("GD" . SPARSER::PROTEIN)
    ("Glucose" . SPARSER::PROTEIN) ("oxidized Glutathione" . SPARSER::MOLECULE)
    ("pMT2" . SPARSER::PROTEIN) ("D-glucose" . SPARSER::MOLECULE)
    ("NADPH oxidase" . SPARSER::PROTEIN) ("lithium chloride" . SPARSER::DRUG)
    ("β -catenin" . SPARSER::PROTEIN)
    ("Manganese Superoxide dismutase" . SPARSER::PROTEIN)
    ("LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("G6PDH" . SPARSER::PROTEIN)
    ("AMP-activated" . SPARSER::PROTEIN) ("AMPKα" . SPARSER::PROTEIN-FAMILY)
    ("N-Acetyl-L-Cysteine" . SPARSER::MOLECULE)
    ("oxidized glutathione" . SPARSER::DRUG)
    ("Epidermal Growth Factor Receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anti-oxidant" . SPARSER::DRUG) ("PIK3" . SPARSER::PROTEIN)
    ("aging associated biomarker" . SPARSER::MOLECULE)
    ("multi" . SPARSER::PROTEIN) ("immunogens" . SPARSER::MOLECULE)
    ("the telomerase genes, expected to reduce telomerase levels by half"
     . SPARSER::GENE)
    ("TERT" . SPARSER::PROTEIN) ("hTERT and hTERC" . SPARSER::COLLECTION)
    ("tel" . SPARSER::PROTEIN) ("hTERT or hTERC" . SPARSER::COLLECTION)
    ("1–18 yrs and 19 yr" . SPARSER::COLLECTION) ("yrs" . SPARSER::PROTEIN)
    ("best-fit" . SPARSER::PROTEIN-FAMILY)
    ("hTERC or hTERT" . SPARSER::COLLECTION)
    ("the telomerase RNA gene ( hTERC ) or the telomerase reverse transcriptase gene ( hTERT )"
     . SPARSER::COLLECTION)
    ("myeloid and lymphoid" . SPARSER::COLLECTION)
    ("nucleotides" . SPARSER::NUCLEOTIDE)
    ("the telomerase reverse transcriptase ( hTERT ) or the telomerase RNA template ( hTERC ) gene"
     . SPARSER::COLLECTION)
    ("hTERC" . SPARSER::RNA) ("Y chromosome" . SPARSER::PROTEIN)
    ("CD57" . SPARSER::PROTEIN) ("CD20" . SPARSER::PROTEIN)
    ("CD45RA" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("Telomerase activity" . SPARSER::PROTEIN)
    ("trypsin-2 and MMP-9" . SPARSER::COLLECTION) ("70kDa" . SPARSER::PROTEIN)
    ("SRC-1 and SRC-2" . SPARSER::COLLECTION) ("estrogen-" . SPARSER::MOLECULE)
    ("TNF-α/MMP9" . SPARSER::COLLECTION)
    ("N-cadherin, Vimentin, Slug, Snail, β-catenin and TCF8"
     . SPARSER::COLLECTION)
    ("Snail" . SPARSER::PROTEIN) ("Slug" . SPARSER::PROTEIN)
    ("Vimentin" . SPARSER::PROTEIN) ("tBid" . SPARSER::PROTEIN)
    ("the endometriotic SRC-1 C-terminal isoform" . SPARSER::ISOFORM)
    ("full-length SRC-1 or the SRC-1 isoform" . SPARSER::COLLECTION)
    ("ER-α, ER-β and Progesterone Receptor(PR)" . SPARSER::COLLECTION)
    ("ER-α, ER-β and Progesterone Receptor" . SPARSER::COLLECTION)
    ("ER-β-" . SPARSER::PROTEIN) ("ER-α-" . SPARSER::PROTEIN)
    ("mutant and IHESCs" . SPARSER::COLLECTION)
    ("an MMP9 cleavage-defective SRC-1 (P790A) mutant" . SPARSER::MUTANT)
    ("dipeptide" . SPARSER::MOLECULE)
    ("F-SRC-1-M protein" . SPARSER::COLLECTION)
    ("the endometriotic 70-kDa SRC-1 C-terminal isoform" . SPARSER::ISOFORM)
    ("MMP2/MMP9" . SPARSER::COLLECTION) ("TNF-α/MMP-9" . SPARSER::COLLECTION)
    ("a posttranslational proteolytic C-terminal isoform" . SPARSER::ISOFORM)
    ("Flag or MYC" . SPARSER::COLLECTION)
    ("ER-β, VEGFR2 and COX-2" . SPARSER::COLLECTION)
    ("vimentin (an endometrial stromal cell biomarker) and cytokeratin 18 (an endometrial epithelial cell biomarker)"
     . SPARSER::COLLECTION)
    ("Flag and MYC" . SPARSER::COLLECTION)
    ("the exogenous F-SRC-1-M gene" . SPARSER::GENE)
    ("phospho-histone" . SPARSER::PROTEIN)
    ("COX-2 and the vascular endothelial growth factor receptor (VEGFR)"
     . SPARSER::COLLECTION)
    ("receptor (VEGFR)" . SPARSER::RECEPTOR)
    ("SRC-1  −/− endometrial fragments" . SPARSER::FRAGMENT)
    ("COX-2 and VEGFR" . SPARSER::COLLECTION)
    ("SRC-1  −/− uterine fragments" . SPARSER::FRAGMENT)
    (":GFP" . SPARSER::BIO-COMPLEX)
    ("the endometriotic SRC-1 isoform" . SPARSER::ISOFORM)
    ("SRC2 −/− and SRC-3 −/− ectopic lesions" . SPARSER::COLLECTION)
    ("SRC-2 (110 kDa) and SRC-3 (85 kDa)" . SPARSER::COLLECTION)
    ("SRC-2 and SRC-3" . SPARSER::COLLECTION)
    ("endometriotic SRC-1 isoform" . SPARSER::ISOFORM)
    ("estrogen, progesterone" . SPARSER::MOLECULE)
    ("estrogen, progesterone or their combination" . SPARSER::COLLECTION)
    ("external hormone" . SPARSER::MOLECULE)
    ("an intact SRC-1" . SPARSER::PROTEIN)
    ("intact SRC-1 nor the 70-kDa fragment ( xref )" . SPARSER::COLLECTION)
    ("intact SRC-1" . SPARSER::PROTEIN)
    ("an endometrial fragment" . SPARSER::FRAGMENT)
    ("estradiol" . SPARSER::PROTEIN) ("sham" . SPARSER::DRUG)
    ("SRCs and NRs" . SPARSER::COLLECTION) ("NRs" . SPARSER::PROTEIN)
    ("NR" . SPARSER::PROTEIN) ("MMP" . SPARSER::PROTEIN)
    ("Nonsteroidal anti-inflammatory drugs" . SPARSER::DRUG)
    ("ERB" . SPARSER::PROTEIN) ("analogs" . SPARSER::ANALOG)
    ("gonadotropin" . SPARSER::PROTEIN)
    ("the key modulators" . SPARSER::PROTEIN) ("modulators" . SPARSER::PROTEIN)
    ("Estrogen" . SPARSER::MOLECULE) ("TNF-α/MMP9/SRC-1" . SPARSER::COLLECTION)
    ("the endometriotic 70-kDa SRC-1 C-terminal fragment" . SPARSER::FRAGMENT)
    ("Mmp9" . SPARSER::PROTEIN) ("Tnf" . SPARSER::PROTEIN)
    ("SRCs" . SPARSER::PROTEIN) ("coactivators" . SPARSER::PROTEIN)
    ("a 37" . SPARSER::PROTEIN) ("EF-1" . SPARSER::PROTEIN)
    ("histone 3" . SPARSER::PROTEIN) ("mL −1" . SPARSER::PROTEIN)
    ("F-12" . SPARSER::PROTEIN) ("β estradiol" . SPARSER::MOLECULE)
    ("trypsin-2" . SPARSER::PROTEIN) ("steroid hormone" . SPARSER::MOLECULE)
    ("TCF8" . SPARSER::PROTEIN) ("Progesterone Receptor" . SPARSER::PROTEIN)
    ("M protein" . SPARSER::PROTEIN) ("MMP2" . SPARSER::PROTEIN)
    ("cytokeratin 18" . SPARSER::PROTEIN) ("F-SRC-1" . SPARSER::PROTEIN)
    ("SRC2" . SPARSER::PROTEIN) ("SRC-3" . SPARSER::PROTEIN)
    ("SRC-2" . SPARSER::PROTEIN) ("ER-α" . SPARSER::PROTEIN)
    ("cyclooxygenase-2" . SPARSER::PROTEIN) ("p160" . SPARSER::PROTEIN)
    ("c5N" . SPARSER::MOLECULE) ("ER-β" . SPARSER::PROTEIN)
    ("Estrogen Receptor" . SPARSER::PROTEIN) ("MMP9" . SPARSER::PROTEIN)
    ("SRC-1" . SPARSER::PROTEIN) ("exactly ATM" . SPARSER::PROTEIN)
    ("even specific inhibitors" . SPARSER::INHIBITOR)
    ("wortmannin and caffeine" . SPARSER::COLLECTION)
    ("wortmannin" . SPARSER::PROTEIN) ("serines" . SPARSER::AMINO-ACID)
    ("RITA" . SPARSER::PROTEIN)
    ("traditional cancer therapeutics" . SPARSER::THERAPEUTICS)
    ("ATM and 53BP1" . SPARSER::COLLECTION)
    ("radiation-induced foci" . SPARSER::PROTEIN)
    ("p21, PUMA or MDM2" . SPARSER::COLLECTION)
    ("caspase 8 and BID" . SPARSER::COLLECTION) ("BID" . SPARSER::PROTEIN)
    ("tBID" . SPARSER::PROTEIN)
    ("p21, 14-3-3σ, PUMA, BAX and BCL2" . SPARSER::COLLECTION)
    ("p21 and 14-3-3σ" . SPARSER::COLLECTION)
    ("mRNA or protein" . SPARSER::COLLECTION)
    ("Nutlin-3 or 5FU" . SPARSER::COLLECTION)
    ("Nutlin-3 and 5FU" . SPARSER::COLLECTION)
    ("p53 and PUMA" . SPARSER::COLLECTION) ("metabolite" . SPARSER::MOLECULE)
    ("the traditional genotoxic agent 5FU" . SPARSER::DRUG)
    ("Crizotinib and SU11274" . SPARSER::COLLECTION)
    ("MET-p53" . SPARSER::COLLECTION) ("V5-tagged MET" . SPARSER::PROTEIN)
    ("hairpins" . SPARSER::PROTEIN-FAMILY)
    ("MET and Nutlin-3-activated p53" . SPARSER::COLLECTION)
    ("the downstream MAPK cascade MEK4 (MAP2K4) and JNK2 (MAPK9)"
     . SPARSER::COLLECTION)
    ("hepatocyte growth factor receptor (HGFR)" . SPARSER::PROTEIN)
    ("HGFR" . SPARSER::PROTEIN) ("Matrigel" . SPARSER::PROTEIN)
    ("hypoxia" . SPARSER::PROTEIN) ("caspase-" . SPARSER::PROTEIN)
    ("caspase" . SPARSER::PROTEIN)
    ("neither Nutlin-3 nor ATMi" . SPARSER::COLLECTION)
    ("caspase 3 or trigger" . SPARSER::COLLECTION)
    ("the chemotherapeutic agent 5FU" . SPARSER::DRUG)
    ("PUMA and other BH3-only proteins ( xref )" . SPARSER::COLLECTION)
    ("interactors" . SPARSER::PROTEIN)
    ("MAPK9, MAPK12, and MAP2K4" . SPARSER::COLLECTION)
    ("SAPKs" . SPARSER::PROTEIN) ("/MET" . SPARSER::COLLECTION)
    ("Interleukin" . SPARSER::PROTEIN) ("Gastrin" . SPARSER::PROTEIN)
    ("Cholecystokinin" . SPARSER::PROTEIN) ("IPA" . SPARSER::MOLECULE)
    ("TRC" . SPARSER::PROTEIN) ("DMSO and Nutlin-3" . SPARSER::COLLECTION)
    ("DMSO-" . SPARSER::MOLECULE) ("ext" . SPARSER::PROTEIN)
    ("essential genes" . SPARSER::GENE) ("puromycin" . SPARSER::DRUG)
    ("p53-PUMA" . SPARSER::COLLECTION) ("fluorouracil" . SPARSER::DRUG)
    ("MET and p53" . SPARSER::COLLECTION) ("agonist" . SPARSER::AGONIST)
    ("p21, 14-3-3σ, PUMA or BAX" . SPARSER::COLLECTION)
    ("BAX" . SPARSER::PROTEIN)
    ("specific shRNAs and small molecules targeting" . SPARSER::COLLECTION)
    ("PUMA" . SPARSER::PROTEIN) ("SFN" . SPARSER::PROTEIN)
    ("p53 and MDM2" . SPARSER::COLLECTION)
    ("mimics three hydrophobic amino acids of p53"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a competitive inhibitor" . SPARSER::INHIBITOR)
    ("p53-MDM2" . SPARSER::COLLECTION) ("repressors" . SPARSER::REPRESSOR)
    ("genotoxic drugs" . SPARSER::DRUG) ("repressor" . SPARSER::REPRESSOR)
    ("ATM or MET" . SPARSER::COLLECTION) ("ATM and MET" . SPARSER::COLLECTION)
    ("nV5" . SPARSER::PROTEIN) ("sulforhodamine B" . SPARSER::MOLECULE)
    ("CAV1" . SPARSER::PROTEIN) ("MACF1" . SPARSER::PROTEIN)
    ("MADCAM1" . SPARSER::PROTEIN) ("SRPK1" . SPARSER::PROTEIN)
    ("MON1B" . SPARSER::PROTEIN) ("MED21" . SPARSER::PROTEIN)
    ("Val-Ala" . SPARSER::MOLECULE) ("KU55933" . SPARSER::DRUG)
    ("s 5A" . SPARSER::PROTEIN) ("insulin-receptor" . SPARSER::PROTEIN)
    ("anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("H2A" . SPARSER::PROTEIN) ("Nutlin-3 as" . SPARSER::DRUG)
    ("PRIMA-1" . SPARSER::PROTEIN) ("truncated BID" . SPARSER::PROTEIN)
    ("caspase 8" . SPARSER::PROTEIN) ("SU11274" . SPARSER::DRUG)
    ("JNK2" . SPARSER::PROTEIN) ("MEK4" . SPARSER::PROTEIN)
    ("PTPN11" . SPARSER::PROTEIN) ("SHP2" . SPARSER::PROTEIN)
    ("Z-VAD-FMK" . SPARSER::DRUG) ("KU-55933" . SPARSER::DRUG)
    ("BCL2" . SPARSER::PROTEIN) ("MAP2K4" . SPARSER::PROTEIN)
    ("MAPK12" . SPARSER::PROTEIN) ("MAPK9" . SPARSER::PROTEIN)
    ("IL8" . SPARSER::PROTEIN) ("Growth Factor" . SPARSER::GROWTH-FACTOR)
    ("BH3-only protein" . SPARSER::PROTEIN) ("BBC3" . SPARSER::PROTEIN)
    ("14-3-3" . SPARSER::PROTEIN)
    ("transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("Nutlin-3" . SPARSER::DRUG) ("Jurkat" . SPARSER::PROTEIN)
    ("Tyrosine" . SPARSER::AMINO-ACID) ("phospholipid" . SPARSER::PHOSPHOLIPID)
    ("E-Syt2 and E-Syt3" . SPARSER::COLLECTION)
    ("E-Syt1-3" . SPARSER::COLLECTION) ("COOH" . SPARSER::MOLECULE)
    ("Syt" . SPARSER::PROTEIN)
    ("MAPK, STAT-3 and mTORC1" . SPARSER::COLLECTION)
    ("the ALK inhibitor tool compound NVP-TAE684 and the clinically available ALK/MET inhibitor Crizotinib"
     . SPARSER::COLLECTION)
    ("the clinically available ALK/MET inhibitor Crizotinib" . SPARSER::DRUG)
    ("ALK/MET" . SPARSER::COLLECTION) ("ALK and ROS" . SPARSER::COLLECTION)
    ("SHP-2, STAT-3 and MAPK" . SPARSER::COLLECTION)
    ("a recurrent translocation t" . SPARSER::PROTEIN)
    ("MAPK, mTORC1 and STAT-3" . SPARSER::COLLECTION) ("pY" . SPARSER::PROTEIN)
    ("Quantitative phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("extraperitoneal fat" . SPARSER::PROTEIN)
    ("the clinically available drug Crizotinib" . SPARSER::DRUG)
    ("the tool compound ALK inhibitor NVP-TAE684 ( xref ) and the clinical compound Crizotinib (PF-02341066)"
     . SPARSER::COLLECTION)
    ("MAPK, SHP-2, STAT-3, Akt and mTORC1" . SPARSER::COLLECTION)
    ("SHP-1 and SHP-2, ERK1/2, IRS-1, PI3K, AKT and STAT3"
     . SPARSER::COLLECTION)
    ("SHP-2, ERK1/2, IRS-1, PI3K, AKT and STAT3" . SPARSER::COLLECTION)
    ("a Golgi apparatus-associated oncoprotein" . SPARSER::PROTEIN)
    ("CD74 and SLC34A2" . SPARSER::COLLECTION) ("Foci" . SPARSER::PROTEIN)
    ("SLC34A2-ROS" . SPARSER::COLLECTION) ("FIG-ROS" . SPARSER::COLLECTION)
    ("FIG" . SPARSER::PROTEIN)
    ("TPM3, SDC4, SLC34A2, LRIG3, CD74 and EZR" . SPARSER::COLLECTION)
    ("EZR" . SPARSER::PROTEIN) ("the invasive component" . SPARSER::COMPONENT)
    ("c-ROS" . SPARSER::PROTEIN) ("synaptotagmin" . SPARSER::PROTEIN)
    ("CD74-ROS" . SPARSER::COLLECTION) ("Flt3" . SPARSER::PROTEIN)
    ("SU-11274" . SPARSER::DRUG) ("PYK2" . SPARSER::PROTEIN)
    ("CSF-1R" . SPARSER::PROTEIN) ("Syt3" . SPARSER::PROTEIN)
    ("E-Syt2" . SPARSER::PROTEIN) ("NH 2" . SPARSER::MOLECULE)
    ("PF-02341066" . SPARSER::DRUG) ("NVP-TAE684" . SPARSER::DRUG)
    ("STAT-3" . SPARSER::PROTEIN) ("IRS-1" . SPARSER::PROTEIN)
    ("SHP-2" . SPARSER::PROTEIN) ("SHP-1" . SPARSER::PROTEIN)
    ("LRIG3" . SPARSER::PROTEIN) ("SLC34A2" . SPARSER::PROTEIN)
    ("SDC4" . SPARSER::PROTEIN) ("TPM3" . SPARSER::PROTEIN)
    ("orphan receptor" . SPARSER::PROTEIN) ("E-Syt1" . SPARSER::PROTEIN)
    ("CD74" . SPARSER::PROTEIN) ("-axin" . SPARSER::COLLECTION)
    ("axin" . SPARSER::PROTEIN) ("anchor" . SPARSER::ANCHOR)
    ("growth factor ( VEGF )" . SPARSER::GROWTH-FACTOR)
    ("metallopeptidase" . SPARSER::PROTEIN)
    ("snap" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Student t" . SPARSER::PROTEIN)
    ("80 phosphospecific and total protein antibodies" . SPARSER::ANTIBODY)
    ("Mapping" . SPARSER::PROTEIN) ("rank" . SPARSER::PROTEIN)
    ("-AKT" . SPARSER::COLLECTION) ("CHK2 and β-catenin" . SPARSER::COLLECTION)
    ("PDK1 and glycogen synthase" . SPARSER::COLLECTION)
    ("GSK" . SPARSER::PROTEIN) ("LCM" . SPARSER::PROTEIN-FAMILY)
    ("RPMA" . SPARSER::PROTEIN) ("Frat-1" . SPARSER::PROTEIN)
    ("β-TrCP" . SPARSER::PROTEIN) ("GSK-3β" . SPARSER::PROTEIN)
    ("α-catenin" . SPARSER::PROTEIN)
    ("epidermal growth factor" . SPARSER::PROTEIN) ("COX-2" . SPARSER::PROTEIN)
    ("vascular endothelial" . SPARSER::PROTEIN)
    ("cyclin D1" . SPARSER::PROTEIN) ("c-myc" . SPARSER::PROTEIN)
    ("group B" . SPARSER::PROTEIN) ("group A" . SPARSER::PROTEIN)
    ("endothelial growth factor" . SPARSER::PROTEIN)
    ("5-FU" . SPARSER::PROTEIN) ("N2" . SPARSER::PROTEIN)
    ("PI3K-AKT" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GSK-3α" . SPARSER::PROTEIN)
    ("glycogen synthase" . SPARSER::PROTEIN-FAMILY) ("PDK1" . SPARSER::PROTEIN)
    ("CHK2" . SPARSER::PROTEIN) ("ER, PR and HER2" . SPARSER::COLLECTION)
    ("currently available total HER2" . SPARSER::PROTEIN)
    ("a better predictive biomarker" . SPARSER::MOLECULE)
    ("Neu" . SPARSER::PROTEIN) ("a special type" . TYPE)
    ("estrogen, progesterone and HER2" . SPARSER::COLLECTION)
    ("progesterone" . SPARSER::PROTEIN)
    ("4-hydroxytamoxifen and ICI 182,780" . SPARSER::COLLECTION)
    ("c-Src and HER2" . SPARSER::COLLECTION)
    ("a dual tyrosine kinase inhibitor" . SPARSER::INHIBITOR)
    ("MAPK and Akt" . SPARSER::COLLECTION)
    ("basal estrogen" . SPARSER::MOLECULE) ("basal E 2" . SPARSER::MOLECULE)
    ("ER, PR, HER2, and EGFR" . SPARSER::COLLECTION)
    ("ER, HER2, EGFR, and c-Src" . SPARSER::COLLECTION)
    ("ER and growth factor" . SPARSER::COLLECTION)
    ("HR and HER2" . SPARSER::COLLECTION)
    ("receptors (HR)" . SPARSER::RECEPTOR)
    ("ER, HER2, and c-Src" . SPARSER::COLLECTION)
    ("the epidermal growth factor receptor (EGFR) and HER2"
     . SPARSER::COLLECTION)
    ("ER and receptor tyrosine kinases" . SPARSER::COLLECTION)
    ("relevant target molecules" . SPARSER::MOLECULE)
    ("The ER positive and HER2over-" . SPARSER::COLLECTION)
    ("two important predictive biomarkers" . SPARSER::MOLECULE)
    ("endocrine" . SPARSER::PROTEIN) ("ER, PR, and HER2" . SPARSER::COLLECTION)
    ("PI3K/Akt" . SPARSER::COLLECTION) ("ER and HER2" . SPARSER::COLLECTION)
    ("estrogen receptor (ER) and human epidermal growth factor receptor"
     . SPARSER::COLLECTION)
    ("K-RAS" . SPARSER::PROTEIN) ("ICI 182,780" . SPARSER::DRUG)
    ("PUM1" . SPARSER::PROTEIN) ("phenol red" . SPARSER::DRUG)
    ("E 2" . SPARSER::MOLECULE) ("ERα" . SPARSER::PROTEIN)
    ("phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("4-hydroxytamoxifen" . SPARSER::DRUG) ("PP2" . SPARSER::DRUG)
    ("MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("the case group (98.27–100%) and control group (99.50–100%; xref )"
     . SPARSER::COLLECTION)
    ("metal-dependent enzymes" . SPARSER::ENZYME) ("MMPs" . SPARSER::PROTEIN)
    ("metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("attractive biomarkers" . SPARSER::MOLECULE)
    ("a large northern Chinese case-controlled cohort" . SPARSER::MOLECULE)
    ("MMP-2" . SPARSER::PROTEIN) ("MMP-1" . SPARSER::PROTEIN)
    ("matrix metalloproteinase" . SPARSER::PROTEIN)
    ("a rational molecular target" . SPARSER::TARGET-PROTEIN)
    ("Daam1 and Dvl2" . SPARSER::COLLECTION)
    ("Dvl1 and Dvl3" . SPARSER::COLLECTION) ("Dvl3" . SPARSER::PROTEIN)
    ("Dvl1" . SPARSER::PROTEIN) ("Dvl2/Daam1" . SPARSER::COLLECTION)
    ("PKC and calcium" . SPARSER::COLLECTION)
    ("RNA and protein" . SPARSER::COLLECTION) ("LEF/TCF" . SPARSER::COLLECTION)
    ("Wnt/β-catenin" . SPARSER::COLLECTION) ("lymphoid" . SPARSER::PROTEIN)
    ("LEF" . SPARSER::PROTEIN) ("MCF-10A" . SPARSER::PROTEIN)
    ("developmental suppressor" . SPARSER::SUPPRESSOR)
    ("tumor-associated macrophages" . SPARSER::PROTEIN)
    ("CamK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("calcium" . SPARSER::CALCIUM)
    ("RhoB and Rab4" . SPARSER::COLLECTION) ("chemokine" . SPARSER::PROTEIN)
    ("RhoB" . SPARSER::PROTEIN) ("fluorescent phalloidin" . SPARSER::MOLECULE)
    ("Daam1 and RhoA" . SPARSER::COLLECTION)
    ("filaments" . SPARSER::PROTEIN-FAMILY) ("Formin" . SPARSER::PROTEIN)
    ("ΔDAD-Daam1" . SPARSER::COLLECTION) ("DAD" . SPARSER::PROTEIN)
    ("Wnt5a/Dvl2" . SPARSER::COLLECTION)
    ("Dvl and the small GTPase Rho" . SPARSER::COLLECTION)
    ("GTPase" . SPARSER::GTPASE) ("Dvl2 or mutants" . SPARSER::COLLECTION)
    ("EGFP" . SPARSER::PROTEIN) ("puncta" . SPARSER::PROTEIN)
    ("DIX" . SPARSER::PROTEIN-FAMILY)
    ("a more highly phosphorylated form" . SPARSER::FORM)
    ("Wnts" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Dishevelled 2 (Dvl2) and Dishevelled-associated activator"
     . SPARSER::COLLECTION)
    ("Wnt5a/PCP" . SPARSER::COLLECTION) ("macrophage" . SPARSER::PROTEIN)
    ("macrophages" . SPARSER::PROTEIN) ("PCP" . SPARSER::PROTEIN)
    ("Wnt/TCF" . SPARSER::COLLECTION) ("TCF" . SPARSER::PROTEIN)
    ("-Daam1" . SPARSER::COLLECTION)
    ("Dvl2, Daam1 and RhoA" . SPARSER::COLLECTION)
    ("Dishevelled-associated activator" . SPARSER::ACTIVATOR)
    ("Wnt5a" . SPARSER::PROTEIN) ("Daam1" . SPARSER::PROTEIN)
    ("Dvl" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CK1" . SPARSER::PROTEIN)
    ("beta-catenin" . SPARSER::PROTEIN) ("ROR2" . SPARSER::PROTEIN)
    ("CXCL12" . SPARSER::PROTEIN)
    ("enhanced green fluorescent protein" . SPARSER::PROTEIN)
    ("SFRP2" . SPARSER::PROTEIN)
    ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("F-actin" . SPARSER::BIO-COMPLEX) ("GTPγS" . SPARSER::PROTEIN)
    ("N1" . SPARSER::PROTEIN) ("Dishevelled 2" . SPARSER::PROTEIN)
    ("β-catenin" . SPARSER::PROTEIN) ("sFRP2" . SPARSER::PROTEIN)
    ("Secreted Frizzled-related protein 2" . SPARSER::PROTEIN)
    ("Dvl2" . SPARSER::PROTEIN) ("Wnt5" . SPARSER::PROTEIN)
    ("morphogenesis 1" . SPARSER::PROTEIN)
    ("PALB2 , CHEK2 and RAD51C" . SPARSER::COLLECTION)
    ("homopolymeric tract variants" . SPARSER::VARIANT)
    ("Intronic variants" . SPARSER::VARIANT)
    ("no pathogenic variants" . SPARSER::VARIANT)
    ("the last nucleotide" . SPARSER::NUCLEOTIDE) ("melting" . SPARSER::DRUG)
    ("PTT" . SPARSER::MOLECULE) ("BRCA" . SPARSER::PROTEIN-FAMILY)
    ("BRCA1 and BRCA2" . SPARSER::COLLECTION) ("RAD51C" . SPARSER::PROTEIN)
    ("CHEK2" . SPARSER::PROTEIN) ("PALB2" . SPARSER::PROTEIN)
    ("ADP–ribose" . SPARSER::MOLECULE)
    ("virtually any protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("active site ligands" . SPARSER::LIGAND) ("lysozyme" . SPARSER::PROTEIN)
    ("SPR" . SPARSER::PROTEIN) ("fits" . SPARSER::PROTEIN-FAMILY)
    ("Asp" . SPARSER::AMINO-ACID)
    ("strong binding molecules" . SPARSER::MOLECULE)
    ("the Fynomer and the target protein" . SPARSER::COLLECTION)
    ("Arg-Trp-Thr" . SPARSER::COLLECTION) ("Fynomers" . SPARSER::PROTEIN)
    ("the pharmaceutically relevant drug target chymase" . SPARSER::PROTEIN)
    ("water" . SPARSER::MOLECULE) ("Fynomer" . SPARSER::PROTEIN)
    ("chymase-Fynomer" . SPARSER::COLLECTION)
    ("tryptophan" . SPARSER::AMINO-ACID)
    ("neutrophil elastase and trypsin" . SPARSER::COLLECTION)
    ("KLK-1" . SPARSER::COLLECTION) ("trypsin" . SPARSER::PROTEIN)
    ("the active chymase and the inactive zymogen" . SPARSER::COLLECTION)
    ("runs" . SPARSER::PROTEIN-FAMILY) ("SDS" . SPARSER::PROTEIN)
    ("a myc- and a hexahistidine" . SPARSER::COLLECTION)
    ("myc-" . SPARSER::PROTEIN) ("myc" . SPARSER::PROTEIN)
    ("src" . SPARSER::PROTEIN) ("excellent inhibitors" . SPARSER::INHIBITOR)
    ("excellent molecules" . SPARSER::MOLECULE)
    ("Antibodies and antibody" . SPARSER::COLLECTION)
    ("disulfide" . SPARSER::MOLECULE) ("TGF-β and MMP-9" . SPARSER::COLLECTION)
    ("target, and chymase" . SPARSER::COLLECTION) ("smoke" . SPARSER::MOLECULE)
    ("tobacco" . SPARSER::DRUG) ("allergen" . SPARSER::MOLECULE)
    ("ovalbumin" . SPARSER::PROTEIN) ("COPD" . SPARSER::PROTEIN)
    ("elastin" . SPARSER::PROTEIN) ("proteoglycans" . SPARSER::PROTEIN)
    ("cytokines, chemokines, proteases, leukotrienes, and bio-active"
     . SPARSER::COLLECTION)
    ("polyamines" . SPARSER::MOLECULE) ("leukotrienes" . SPARSER::PROTEIN)
    ("proteases" . SPARSER::PROTEIN) ("−1" . SPARSER::PROTEIN)
    ("chymase" . SPARSER::PROTEIN) ("CCP4" . SPARSER::PROTEIN)
    ("factor 2" . SPARSER::PROTEIN) ("N -hydroxysuccinimide" . SPARSER::DRUG)
    ("P20" . SPARSER::PROTEIN) ("AT -3" . SPARSER::PROTEIN)
    ("N-terminally" . SPARSER::PROTEIN) ("AC -3" . SPARSER::PROTEIN)
    ("T/D" . SPARSER::PROTEIN) ("of 45" . SPARSER::PROTEIN)
    ("neutrophil elastase" . SPARSER::PROTEIN)
    ("kallikrein-1" . SPARSER::PROTEIN) ("DPP-4" . SPARSER::PROTEIN)
    ("cathepsin G" . SPARSER::PROTEIN) ("C-G" . SPARSER::PROTEIN)
    ("C-H" . SPARSER::PROTEIN) ("C-D" . SPARSER::PROTEIN)
    ("C-B" . SPARSER::PROTEIN) ("C-E" . SPARSER::PROTEIN)
    ("ankyrin repeat" . SPARSER::PROTEIN) ("Kunitz type" . SPARSER::PROTEIN)
    ("cytochrome C" . SPARSER::PROTEIN) ("MMP-9" . SPARSER::PROTEIN)
    ("chymotrypsin-like" . SPARSER::PROTEIN)
    ("LSK, LLB, SJD, RLW and ML" . SPARSER::COLLECTION)
    ("ternary complex" . SPARSER::BIO-COMPLEX) ("lysine" . SPARSER::AMINO-ACID)
    ("at least two different SH3 domain proteins" . SPARSER::PROTEIN)
    ("the protein’s" . SPARSER::PROTEIN)
    ("Hck and at least one additional SH3 domain protein"
     . SPARSER::COLLECTION)
    ("at least one additional SH3 domain protein" . SPARSER::PROTEIN)
    ("cofilin and CXCR4" . SPARSER::COLLECTION)
    ("cofilin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BLT" . SPARSER::PROTEIN)
    ("Hck, Lyn and Src" . SPARSER::COLLECTION) ("Lyn" . SPARSER::PROTEIN)
    ("clamp" . SPARSER::PROTEIN-FAMILY) ("lysines" . SPARSER::AMINO-ACID)
    ("Pred" . SPARSER::DRUG)
    ("P 78 and D 123 Nef mutants" . SPARSER::COLLECTION)
    ("mortalin" . SPARSER::PROTEIN) ("SMR" . SPARSER::PROTEIN)
    ("protein–protein" . SPARSER::COLLECTION) ("fit" . SPARSER::PROTEIN-FAMILY)
    ("the ternary complex" . SPARSER::BIO-COMPLEX)
    ("EVI and CD4" . SPARSER::COLLECTION) ("Gold" . SPARSER::MOLECULE)
    ("protein or a different protein" . SPARSER::COLLECTION)
    ("EVI and Nef/activated" . SPARSER::COLLECTION)
    ("multi-protein" . SPARSER::COLLECTION) ("glycine" . SPARSER::AMINO-ACID)
    ("P 72 and P 75" . SPARSER::COLLECTION) ("alanines" . SPARSER::AMINO-ACID)
    ("at least two cellular SH3 domain proteins" . SPARSER::PROTEIN)
    ("both prolines and the arginine" . SPARSER::COLLECTION)
    ("the prolines and the arginine" . SPARSER::COLLECTION)
    ("the tripartite complex" . SPARSER::BIO-COMPLEX)
    ("Hck and other Src family kinases" . SPARSER::COLLECTION)
    ("ZAP70/PI3K" . SPARSER::COLLECTION)
    ("relevant host cell target proteins" . SPARSER::PROTEIN)
    ("p21-activated protein kinase" . SPARSER::COLLECTION)
    ("AP-1" . SPARSER::PROTEIN) ("MHCI" . SPARSER::PROTEIN)
    ("the prolines or the arginine" . SPARSER::COLLECTION)
    ("EVI" . SPARSER::PROTEIN) ("prolines or arginine" . SPARSER::COLLECTION)
    ("a multifunctional protein" . SPARSER::PROTEIN) ("p24" . SPARSER::PROTEIN)
    ("B18)" . SPARSER::PROTEIN)
    ("fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("A11" . SPARSER::PROTEIN) ("Protein A" . SPARSER::PROTEIN)
    ("B18" . SPARSER::PROTEIN) ("L-glutamine" . SPARSER::MOLECULE)
    ("CXCR4" . SPARSER::PROTEIN) ("SF2" . SPARSER::PROTEIN)
    ("myelin basic protein" . SPARSER::PROTEIN) ("P78" . SPARSER::PROTEIN)
    ("P 75" . SPARSER::HUMAN-PROTEIN-FAMILY) ("P 72" . SPARSER::PROTEIN)
    ("P75" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ZAP70" . SPARSER::PROTEIN)
    ("activated protein kinase" . SPARSER::PROTEIN) ("CD4" . SPARSER::PROTEIN)
    ("major histocompatibility complex" . SPARSER::PROTEIN)
    ("PAK2" . SPARSER::PROTEIN) ("P 78" . SPARSER::PROTEIN)
    ("FY" . SPARSER::PROTEIN) ("SL" . SPARSER::PROTEIN)
    ("p21 and p27Kip1" . SPARSER::COLLECTION)
    ("p21 and p27Kip1and" . SPARSER::COLLECTION)
    ("kinase-cyclin" . SPARSER::COLLECTION)
    ("a potent tumor suppressor gene and an inhibitor" . SPARSER::COLLECTION)
    ("p27 Kip1 and p21" . SPARSER::COLLECTION) ("CD133-" . SPARSER::PROTEIN)
    ("p21, p27Kip1 and Skp2" . SPARSER::COLLECTION)
    ("Cdk2 and p53" . SPARSER::COLLECTION) ("rAAV" . SPARSER::PROTEIN)
    ("p21 and p27" . SPARSER::COLLECTION)
    ("p21, p27Kip1, Skp2 and p53" . SPARSER::COLLECTION)
    ("p21, p27Kip1, Skp2, Cdk2, Cdk4 and p53" . SPARSER::COLLECTION)
    ("p21, p27, and Cdk2" . SPARSER::COLLECTION) ("Skp2" . SPARSER::PROTEIN)
    ("Skp2, p21, p27Kip1, Cdk2, Cdk4 and p53" . SPARSER::COLLECTION)
    ("Skp" . SPARSER::PROTEIN) ("Nestin" . SPARSER::PROTEIN)
    ("GFAP" . SPARSER::PROTEIN) ("rAAV-BMPR-IB" . SPARSER::COLLECTION)
    ("si-BMPR-IB" . SPARSER::COLLECTION) ("si" . SPARSER::PROTEIN)
    ("an anti-phospho-smad1/5/8-specific antibody" . SPARSER::PROTEIN)
    ("AAV-BMPR-IB" . SPARSER::COLLECTION)
    ("U87 and U251" . SPARSER::COLLECTION)
    ("normal astrocytes" . SPARSER::PROTEIN) ("astrocytes" . SPARSER::PROTEIN)
    ("Smad" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BMPR" . SPARSER::PROTEIN)
    ("type I (BMP-RIA and BMP-RIB) and type II (BMP-RII) serine/threonine kinase receptors"
     . SPARSER::COLLECTION)
    ("RIB" . SPARSER::DRUG) ("gradient morphogens" . SPARSER::PROTEIN)
    ("morphogens" . SPARSER::PROTEIN) ("BMPs" . SPARSER::PROTEIN)
    ("BMP" . SPARSER::PROTEIN) ("PTEN, EGFR and VEGF" . SPARSER::COLLECTION)
    ("VEGF" . SPARSER::PROTEIN)
    ("a new potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("p21 and p27kip1" . SPARSER::COLLECTION) ("P27Kip1" . SPARSER::PROTEIN)
    ("p27 Kip1" . SPARSER::PROTEIN) ("BMPR1B" . SPARSER::PROTEIN)
    ("BMPR1A" . SPARSER::PROTEIN) ("S 2" . SPARSER::MOLECULE)
    ("CD133" . SPARSER::PROTEIN) ("BMP4" . SPARSER::PROTEIN)
    ("S 4" . SPARSER::PROTEIN-FAMILY) ("p27Kip1" . SPARSER::PROTEIN)
    ("BMPR-IA" . SPARSER::PROTEIN) ("BMP2" . SPARSER::PROTEIN)
    ("Cdk4" . SPARSER::PROTEIN) ("p27 KIP1" . SPARSER::PROTEIN)
    ("CDK2" . SPARSER::PROTEIN) ("p27" . SPARSER::PROTEIN)
    ("Smad4" . SPARSER::PROTEIN) ("BMPR-II" . SPARSER::PROTEIN)
    ("type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type I" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p27kip1" . SPARSER::PROTEIN)
    ("smad1" . SPARSER::PROTEIN) ("U87" . SPARSER::PROTEIN)
    ("BMPR-IB" . SPARSER::PROTEIN)
    ("bone morphogenetic protein" . SPARSER::PROTEIN)
    ("Smad1" . SPARSER::PROTEIN) ("enteric" . SPARSER::PROTEIN)
    ("gap" . SPARSER::HUMAN-PROTEIN-FAMILY) ("nNOS" . SPARSER::PROTEIN)
    ("the circular smooth muscle" . SPARSER::PROTEIN)
    ("longitudinal smooth muscle" . SPARSER::PROTEIN)
    ("PGP9.5-ir" . SPARSER::COLLECTION)
    ("both PDGFRα-( xref ) and SK3-ir ( xref )" . SPARSER::COLLECTION)
    ("PDGFRα-" . SPARSER::PROTEIN) ("circular muscle)" . SPARSER::PROTEIN)
    ("PDGFRα and SK3" . SPARSER::COLLECTION) ("IG" . SPARSER::MOLECULE)
    ("human gastric smooth muscle" . SPARSER::PROTEIN)
    ("smooth muscle" . SPARSER::PROTEIN) ("SK3-ir" . SPARSER::COLLECTION)
    ("ir" . SPARSER::PROTEIN) ("PDGFRα-ir" . SPARSER::COLLECTION)
    ("SK3 and PDGFRα" . SPARSER::COLLECTION) ("Cajal" . SPARSER::PROTEIN)
    ("caveolin-1" . SPARSER::PROTEIN)
    ("soluble guanylate cyclase" . SPARSER::PROTEIN) ("2-4" . SPARSER::PROTEIN)
    ("PGP9.5" . SPARSER::PROTEIN) ("type 3" . SPARSER::PROTEIN)
    ("PDGFRβ" . SPARSER::PROTEIN) ("SK3" . SPARSER::PROTEIN)
    ("K +" . SPARSER::MOLECULE) ("Ca 2+" . SPARSER::CALCIUM-ION)
    ("a horseradish peroxidase-conjugated secondary antibody (Bio-Rad Laboratories) and ECL reagent (Amersham Biosciences)"
     . SPARSER::COLLECTION)
    ("a horseradish peroxidase-conjugated secondary antibody"
     . SPARSER::PROTEIN)
    ("reagent" . SPARSER::MOLECULE) ("nitrocellulose" . SPARSER::MOLECULE)
    ("polyacrylamide" . SPARSER::DRUG) ("sulfate" . SPARSER::MOLECULE)
    ("dodecyl" . SPARSER::MOLECULE) ("vanadate" . SPARSER::MOLECULE)
    ("aprotinin" . SPARSER::DRUG) ("leupeptin" . SPARSER::DRUG)
    ("glycerol" . SPARSER::PROTEIN) ("NaCl" . SPARSER::PROTEIN)
    ("Tris" . SPARSER::MOLECULE) ("sepharose" . SPARSER::MOLECULE)
    ("both Western blot" . SPARSER::PROTEIN)
    ("-GTAGGAGTACTCAGGAAAACACACCATGTGAATATCCTACTCT-3" . SPARSER::COLLECTION)
    ("BRAF and Y472C/R509H" . SPARSER::COLLECTION) ("Dr" . SPARSER::MOLECULE)
    ("c-Src and CRAF" . SPARSER::COLLECTION) ("RPMI" . SPARSER::PROTEIN)
    ("Solution" . SPARSER::MOLECULE)
    ("fluorescein and 7-AAD" . SPARSER::COLLECTION)
    ("fluorescein" . SPARSER::MOLECULE)
    ("antibody and 7-Aminoactinomycin" . SPARSER::COLLECTION)
    ("AAD" . SPARSER::MOLECULE) ("FITC" . SPARSER::MOLECULE)
    ("trypsinized" . SPARSER::PROTEIN) ("BRDU" . SPARSER::DRUG)
    ("APO" . SPARSER::PROTEIN) ("solution" . SPARSER::MOLECULE)
    ("residual media" . SPARSER::PROTEIN)
    ("Senescence-Associated β-Galactosidase" . SPARSER::PROTEIN)
    ("a 3-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Dasatinib, PLX4032 and sorafenib" . SPARSER::COLLECTION)
    ("Chemicals" . SPARSER::MOLECULE) ("fluor" . SPARSER::MOLECULE)
    ("Anti" . SPARSER::PROTEIN) ("Flag and β-actin" . SPARSER::COLLECTION)
    ("p-c-Kit" . SPARSER::COLLECTION) ("EphA2" . SPARSER::PROTEIN)
    ("Chemical" . SPARSER::MOLECULE) ("Sigma" . SPARSER::PROTEIN-FAMILY)
    ("cip" . SPARSER::PROTEIN) ("Antibodies" . SPARSER::ANTIBODY)
    ("HCK, DDR1, EPHA3, or ARG" . SPARSER::COLLECTION)
    ("complement" . SPARSER::PROTEIN)
    ("c-Src, STAT3, c-Myc, FOXO4, Chk2, and c-Jun-N-terminal-kinase"
     . SPARSER::COLLECTION)
    ("/p53" . SPARSER::COLLECTION) ("RAS and RAF" . SPARSER::COLLECTION)
    ("Oncogene" . SPARSER::ONCOGENE) ("Active" . SPARSER::ACTIVE)
    ("active and important" . SPARSER::COLLECTION)
    ("RAS, BRAF, and CRAF" . SPARSER::COLLECTION)
    ("homodimer" . SPARSER::HOMODIMER) ("heterodimers" . SPARSER::HETERODIMER)
    ("the only RAF substrate" . SPARSER::SUBSTRATE)
    ("BRAF and CRAF" . SPARSER::COLLECTION)
    ("CRAF and BRAF" . SPARSER::COLLECTION)
    ("previously characterized kinase" . SPARSER::KINASE)
    ("no credible direct CRAF inhibitors" . SPARSER::INHIBITOR)
    ("CRAF and pan-RAF" . SPARSER::COLLECTION)
    ("sorafenib or dasatinib" . SPARSER::COLLECTION)
    ("vemurafenib" . SPARSER::DRUG) ("S11 and S13" . SPARSER::COLLECTION)
    ("BAD or JNK" . SPARSER::COLLECTION) ("BAD" . SPARSER::PROTEIN)
    ("Nilotinib" . SPARSER::DRUG) ("Y472C BRAF’s" . SPARSER::PROTEIN)
    ("BRAF/CRAF" . SPARSER::COLLECTION) ("net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("dimers" . SPARSER::DIMER)
    ("Only cells expressing kinase-deficient BRAF" . SPARSER::PROTEIN)
    ("active or inactive" . SPARSER::COLLECTION)
    ("CRAF or BRAF" . SPARSER::COLLECTION) ("BRAF or wt" . SPARSER::COLLECTION)
    ("β-galactosidase and HPI-gamma" . SPARSER::COLLECTION)
    ("HPI" . SPARSER::PROTEIN)
    ("previously characterized BRAF proteins" . SPARSER::PROTEIN)
    ("RAS/RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("BRAF-CRAF" . SPARSER::COLLECTION)
    ("G466V BRAF or Y472C BRAF" . SPARSER::COLLECTION)
    ("wt BRAF or V600E BRAF ( xref )" . SPARSER::COLLECTION)
    ("Y472C  BRAF and G466V  BRAF both activated MEK and ERK"
     . SPARSER::COLLECTION)
    ("ERK and MEK" . SPARSER::COLLECTION)
    ("MEK, ERK, and CRAF" . SPARSER::COLLECTION)
    ("Y472C  BRAF , G466V  BRAF (kinase-impaired), and V600E  BRAF (constitutively active)"
     . SPARSER::COLLECTION)
    ("Flag" . SPARSER::PROTEIN-FAMILY) ("PDGFR" . SPARSER::PROTEIN)
    ("KIT" . SPARSER::PROTEIN) ("SRC" . SPARSER::PROTEIN)
    ("FYN" . SPARSER::PROTEIN) ("FGR" . SPARSER::PROTEIN)
    ("LYN" . SPARSER::PROTEIN)
    ("HCK, DDR1, EPHA3, and ARG" . SPARSER::COLLECTION)
    ("ARG" . SPARSER::PROTEIN) ("HCK" . SPARSER::PROTEIN)
    ("total and phosphorylated EphA2, c-Kit, and PDGFRα" . SPARSER::COLLECTION)
    ("EphA2, c-Kit, and PDGFRα" . SPARSER::COLLECTION)
    ("EphA" . SPARSER::PROTEIN-FAMILY) ("EGFR or KRAS" . SPARSER::COLLECTION)
    ("SUV" . SPARSER::PROTEIN) ("paraspinal muscle)" . SPARSER::PROTEIN)
    ("MEK and ERK" . SPARSER::COLLECTION)
    ("extracellular signal-regulated kinase (ERK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAFs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("EML4-ALK" . SPARSER::COLLECTION)
    ("ALK" . SPARSER::PROTEIN) ("dasatinib and BRAF" . SPARSER::COLLECTION)
    ("BRAF and a dasatinib target" . SPARSER::COLLECTION)
    ("Dasatinib" . SPARSER::DRUG) ("previously known kinase" . SPARSER::KINASE)
    ("CRAF, MEK, and ERK" . SPARSER::COLLECTION) ("CRAF" . SPARSER::PROTEIN)
    ("dasatinib" . SPARSER::DRUG) ("egtazic acid" . SPARSER::MOLECULE)
    ("U24" . SPARSER::PROTEIN) ("MEK-1" . SPARSER::PROTEIN)
    ("Mg 2+" . SPARSER::MOLECULE) ("protein expressed in" . SPARSER::PROTEIN)
    ("X-gal" . SPARSER::MOLECULE) ("dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("HP1" . SPARSER::PROTEIN)
    ("derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pERK 1/2" . SPARSER::PROTEIN) ("c-Jun" . SPARSER::PROTEIN)
    ("Chk2" . SPARSER::PROTEIN) ("FOXO4" . SPARSER::PROTEIN)
    ("p14 ARF" . SPARSER::PROTEIN) ("p16 INK4A" . SPARSER::PROTEIN)
    ("S14" . SPARSER::PROTEIN) ("PLX4032" . SPARSER::DRUG)
    ("S13" . SPARSER::PROTEIN) ("AZD0530" . SPARSER::DRUG)
    ("S12" . SPARSER::PROTEIN) ("S11" . SPARSER::PROTEIN)
    ("S10" . SPARSER::PROTEIN) ("PTK6" . SPARSER::PROTEIN)
    ("TNK2" . SPARSER::PROTEIN) ("EPHA4" . SPARSER::PROTEIN)
    ("EPHA2" . SPARSER::PROTEIN) ("EPHA1" . SPARSER::PROTEIN)
    ("EPHB3" . SPARSER::PROTEIN) ("EPHB2" . SPARSER::PROTEIN)
    ("EPHB1" . SPARSER::PROTEIN) ("ABL2" . SPARSER::PROTEIN)
    ("EPHA3" . SPARSER::PROTEIN) ("DDR1" . SPARSER::PROTEIN)
    ("PDGFRα" . SPARSER::PROTEIN) ("DDR2" . SPARSER::PROTEIN)
    ("c-Src" . SPARSER::COLLECTION) ("K-Ras" . SPARSER::PROTEIN)
    ("S1B" . SPARSER::PROTEIN) ("muscle)" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitogen-activated protein kinase kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-galactosidase" . SPARSER::PROTEIN) ("EML4" . SPARSER::PROTEIN)
    ("RTKs and their downstream effectors" . SPARSER::COLLECTION)
    ("Cre" . SPARSER::PROTEIN) ("SPRY2, ErbB and PTEN" . SPARSER::COLLECTION)
    ("cytotoxic" . SPARSER::PROTEIN)
    ("The stress-inducible kinase p38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTEN, and HER2" . SPARSER::COLLECTION)
    ("driving EGFR" . SPARSER::PROTEIN)
    ("EGFR, SPRY2, and PTEN" . SPARSER::COLLECTION)
    ("p-ERK1/2" . SPARSER::PROTEIN) ("Prostatic" . SPARSER::PROTEIN)
    ("Pten and Spry2" . SPARSER::COLLECTION)
    ("Spry2 and Pten" . SPARSER::COLLECTION)
    ("aggressive PC" . SPARSER::PROTEIN)
    ("SPRY2 and PTEN" . SPARSER::COLLECTION)
    ("PI3K and its downstream effector p38" . SPARSER::COLLECTION)
    ("p38 and EGFR" . SPARSER::COLLECTION)
    ("p38 and PI3K" . SPARSER::COLLECTION) ("EGFRs" . SPARSER::PROTEIN)
    ("a cell permeable inhibitor" . SPARSER::INHIBITOR)
    ("dynamin" . SPARSER::PROTEIN) ("dynasore" . SPARSER::MOLECULE)
    ("SPRY2 or PTEN" . SPARSER::COLLECTION)
    ("both MEK1/2 and the downstream ERK1/2" . SPARSER::COLLECTION)
    ("Slack" . SPARSER::PROTEIN) ("PTEN-" . SPARSER::PROTEIN)
    ("p-PTEN" . SPARSER::COLLECTION) ("KD and Nsi" . SPARSER::COLLECTION)
    ("Nsi and SPRY2" . SPARSER::COLLECTION) ("NHS" . SPARSER::PROTEIN)
    ("Heregulin" . SPARSER::PROTEIN) ("p-AKT" . SPARSER::COLLECTION)
    ("HER2, EGFR and HER3" . SPARSER::COLLECTION)
    ("heregulin and EGF" . SPARSER::COLLECTION)
    ("heregulin" . SPARSER::PROTEIN) ("HER2 and EGFR" . SPARSER::COLLECTION)
    ("Nsi" . SPARSER::PROTEIN) ("EGFR and HER2" . SPARSER::COLLECTION)
    ("simultaneous high HER2" . SPARSER::PROTEIN)
    ("two-independent PC cohorts" . SPARSER::MOLECULE)
    ("cohorts" . SPARSER::MOLECULE) ("SPRY2 and HER2" . SPARSER::COLLECTION)
    ("PTEN and SPRY2" . SPARSER::COLLECTION) ("CRE" . SPARSER::PROTEIN)
    ("PI3K/p-AKT" . SPARSER::COLLECTION) ("Pten" . SPARSER::PROTEIN)
    ("PIN" . SPARSER::PROTEIN) ("EGFR/HER" . SPARSER::COLLECTION)
    ("ERK/MAPK" . SPARSER::COLLECTION) ("RAS/RAF/MEK" . SPARSER::COLLECTION)
    ("RAF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PP2A, Grb2, Braf, Shp2, c-Cbl and GAP1" . SPARSER::COLLECTION)
    ("GAP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Braf" . SPARSER::PROTEIN)
    ("primary PC" . SPARSER::PROTEIN) ("Sprouty" . SPARSER::PROTEIN-FAMILY)
    ("antagonist" . SPARSER::MOLECULE) ("SPRY" . SPARSER::PROTEIN)
    ("AKT and MAPK" . SPARSER::COLLECTION) ("RTKs" . SPARSER::PROTEIN)
    ("Ras/Raf/MEK" . SPARSER::COLLECTION) ("/AKT" . SPARSER::COLLECTION)
    ("Raf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SPRY2-" . SPARSER::PROTEIN)
    ("clathrin" . SPARSER::PROTEIN) ("EGFR/HER2" . SPARSER::COLLECTION)
    ("PI3K/AKT" . SPARSER::COLLECTION) ("ErbB-PI3K/AKT" . SPARSER::COLLECTION)
    ("Nkx 3.1" . SPARSER::PROTEIN) ("reducing agent" . SPARSER::MOLECULE)
    ("EGFR antibody" . SPARSER::PROTEIN) ("p-p38" . SPARSER::PROTEIN)
    ("chemo-attractant" . SPARSER::PROTEIN) ("sprouty2" . SPARSER::PROTEIN)
    ("p-ERK1" . SPARSER::PROTEIN) ("PI103" . SPARSER::DRUG)
    ("p-ERK2" . SPARSER::PROTEIN) ("ATF2" . SPARSER::PROTEIN)
    ("P38" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PD098059" . SPARSER::DRUG)
    ("LY294002" . SPARSER::MOLECULE) ("phospho-kinases" . SPARSER::PROTEIN)
    ("Phospho-Kinase" . SPARSER::PROTEIN) ("S-S" . SPARSER::PROTEIN)
    ("EEA1" . SPARSER::PROTEIN) ("HER3" . SPARSER::PROTEIN)
    ("HER1" . SPARSER::PROTEIN) ("Spry2" . SPARSER::PROTEIN)
    ("negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("c-Cbl" . SPARSER::PROTEIN) ("Shp2" . SPARSER::PROTEIN)
    ("Grb2" . SPARSER::PROTEIN) ("SPRY 1" . SPARSER::PROTEIN)
    ("fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Epidermal growth factor" . SPARSER::PROTEIN) ("HER-1" . SPARSER::PROTEIN)
    ("androgen receptor" . SPARSER::PROTEIN) ("SPRY2" . SPARSER::PROTEIN)
    ("mTOR and MAPK" . SPARSER::COLLECTION) ("sorafenib" . SPARSER::DRUG)
    ("VEGFR" . SPARSER::PROTEIN) ("antagonists" . SPARSER::MOLECULE)
    ("polyproline" . SPARSER::PROTEIN) ("BRAF or NRAS" . SPARSER::COLLECTION)
    ("p44/ERK" . SPARSER::COLLECTION) ("NRAS and BRAF" . SPARSER::COLLECTION)
    ("NRAS" . SPARSER::PROTEIN)
    ("the p-S6K and/or p-4eBP1 immunohistochemistry" . SPARSER::COLLECTION)
    ("PIK3CA transcript undergoes" . SPARSER::PROTEIN)
    ("available RNA" . SPARSER::RNA)
    ("-AGATTTTCTATGGACCACAGG-3" . SPARSER::COLLECTION)
    ("-CAGTTACTATTCTGTGACTGGTGT-3" . SPARSER::COLLECTION)
    ("Rev" . SPARSER::PROTEIN-FAMILY) ("hot" . SPARSER::PROTEIN)
    ("p44/p-ERK" . SPARSER::COLLECTION) ("P14 and HDM2" . SPARSER::COLLECTION)
    ("P14 or MDM2" . SPARSER::COLLECTION)
    ("p14 and MDM2" . SPARSER::COLLECTION) ("p" . SPARSER::PROTEIN)
    ("KDR" . SPARSER::PROTEIN)
    ("CGH and immunohistochemistry" . SPARSER::COLLECTION)
    ("TP53 or PTEN" . SPARSER::COLLECTION) ("genesis" . SPARSER::PROTEIN)
    ("loco" . SPARSER::PROTEIN) ("Radical" . SPARSER::MOLECULE)
    ("STS" . SPARSER::PROTEIN) ("p-4eBP1" . SPARSER::COLLECTION)
    ("PIK3CA/AKT/mTOR" . SPARSER::COLLECTION) ("P72" . SPARSER::PROTEIN)
    ("PI3" . SPARSER::PROTEIN) ("ribosomal protein" . SPARSER::PROTEIN)
    ("mTORC1" . SPARSER::PROTEIN) ("4E-binding protein 1" . SPARSER::PROTEIN)
    ("P53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("A 20" . SPARSER::PROTEIN)
    ("p-ERK" . SPARSER::PROTEIN) ("p44" . SPARSER::PROTEIN)
    ("p-S6K" . SPARSER::PROTEIN) ("PAPSS2" . SPARSER::PROTEIN)
    ("PTEN1" . SPARSER::PROTEIN) ("CDKN2A" . SPARSER::PROTEIN)
    ("P14" . SPARSER::PROTEIN) ("ADM2" . SPARSER::PROTEIN)
    ("4eBP1" . SPARSER::PROTEIN) ("pS6K" . SPARSER::PROTEIN)
    ("HDM2" . SPARSER::PROTEIN) ("p14" . SPARSER::PROTEIN)
    ("a rational drig target" . SPARSER::TARGET-PROTEIN)
    ("these histologic subtypes" . SPARSER::PROTEIN)
    ("FGFRs" . SPARSER::PROTEIN)
    ("FGFR4 ( xref ) and its cognate ligand FGF19 ( xref )"
     . SPARSER::COLLECTION)
    ("neutralizing monoclonal antibodies" . SPARSER::ANTIBODY)
    ("further supports FGFR4" . SPARSER::PROTEIN)
    ("FGFR4 and BCL2L1" . SPARSER::COLLECTION) ("anoikis" . SPARSER::PROTEIN)
    ("similarly co-opting PAX3" . SPARSER::PROTEIN)
    ("alternate RMS-specific proteins" . SPARSER::PROTEIN)
    ("PI/Annexin V" . SPARSER::COLLECTION)
    ("a pharmacologic inhibitor" . SPARSER::INHIBITOR)
    ("a commercially available small molecule inhibitor" . SPARSER::INHIBITOR)
    ("iodide and Annexin V" . SPARSER::COLLECTION)
    ("iodide" . SPARSER::PROTEIN) ("propidium" . SPARSER::MOLECULE)
    ("reagents" . SPARSER::MOLECULE)
    ("Ki67, TUNEL and CD31" . SPARSER::COLLECTION)
    ("SMS-CTR" . SPARSER::COLLECTION) ("CTR" . SPARSER::PROTEIN)
    ("SMS" . SPARSER::PROTEIN) ("trypan" . SPARSER::DRUG)
    ("MTT" . SPARSER::MOLECULE) ("shRNA" . SPARSER::PROTEIN)
    ("sh" . SPARSER::PROTEIN-FAMILY)
    ("the eRMS and aRMS subtypes" . SPARSER::COLLECTION)
    ("a larger cohort" . SPARSER::MOLECULE) ("STR" . SPARSER::PROTEIN)
    ("step-wise converted normal human skeletal muscle myoblasts"
     . SPARSER::PROTEIN)
    ("a desirable drug target" . SPARSER::TARGET-PROTEIN)
    ("The alveolar variant" . SPARSER::VARIANT)
    ("PAX3-FKHR" . SPARSER::COLLECTION) ("FKHR" . SPARSER::PROTEIN)
    ("The embryonal variant" . SPARSER::VARIANT)
    ("RMS histologic variants" . SPARSER::VARIANT)
    ("PAX3-FOXO1" . SPARSER::COLLECTION) ("myoblasts" . SPARSER::PROTEIN)
    ("FGFR" . SPARSER::PROTEIN) ("eRMS" . SPARSER::PROTEIN)
    ("skeletal muscle" . SPARSER::PROTEIN) ("N 2" . SPARSER::PROTEIN)
    ("phospho-tyrosine" . SPARSER::MOLECULE) ("G10" . SPARSER::PROTEIN)
    ("ERK1" . SPARSER::PROTEIN) ("FOXO1A" . SPARSER::PROTEIN)
    ("C-16" . SPARSER::PROTEIN) ("FGF19" . SPARSER::PROTEIN)
    ("Pax3" . SPARSER::PROTEIN) ("FGFR1" . SPARSER::PROTEIN)
    ("sensitive to apoptosis" . SPARSER::PROTEIN) ("BCL-X" . SPARSER::PROTEIN)
    ("caspase 3" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor 4" . SPARSER::PROTEIN)
    ("FOXO1" . SPARSER::PROTEIN) ("PAX3" . SPARSER::PROTEIN)
    ("BCL2L1" . SPARSER::PROTEIN) ("PD173074" . SPARSER::DRUG)
    ("FGFR4" . SPARSER::PROTEIN)
    ("PLK1 and other molecules" . SPARSER::COLLECTION)
    ("actin and microtubules" . SPARSER::COLLECTION)
    ("microtubules" . SPARSER::PROTEIN)
    ("the NC group and Mock group" . SPARSER::COLLECTION)
    ("RR" . SPARSER::MOLECULE)
    ("a cycle-associated protein" . SPARSER::PROTEIN)
    ("cyclinD and cyclin-dependent kinases" . SPARSER::COLLECTION)
    ("cyclinD" . SPARSER::PROTEIN)
    ("an indispensable protein" . SPARSER::PROTEIN)
    ("cdc2-cyclinB" . SPARSER::COLLECTION) ("cyclinB" . SPARSER::PROTEIN)
    ("NC group and Mock group" . SPARSER::COLLECTION)
    ("the NC group and the Mock group ( P <0.01, xref )" . SPARSER::COLLECTION)
    ("SD" . SPARSER::PROTEIN)
    ("the NC group (scrambled siRNA-treated group) and the Mock group (Lipofectamine 2000™-treated group)"
     . SPARSER::COLLECTION)
    ("NC" . SPARSER::PROTEIN) ("oligonucleotides" . SPARSER::MOLECULE)
    ("PLK1 and PCNA" . SPARSER::COLLECTION)
    ("a diagnostic biomarker" . SPARSER::MOLECULE)
    ("a highly conservative serine/threonine kinase" . SPARSER::KINASE)
    ("Drosophila) and CDC5" . SPARSER::COLLECTION)
    ("supernumerary centrosomes" . SPARSER::PROTEIN)
    ("cdc5" . SPARSER::PROTEIN) ("loss of heterozygosity" . SPARSER::PROTEIN)
    ("Reverse Transcriptase" . SPARSER::PROTEIN) ("DLD-1" . SPARSER::PROTEIN)
    ("CDC5" . SPARSER::PROTEIN) ("Drosophila)" . SPARSER::PROTEIN)
    ("Annexin-V" . SPARSER::PROTEIN) ("CCK-8" . SPARSER::PROTEIN)
    ("Polo-like kinase" . SPARSER::PROTEIN)
    ("Hsp 27-ERK1/2" . SPARSER::COLLECTION) ("NES" . SPARSER::PROTEIN)
    ("cdc2–cyclin" . SPARSER::COLLECTION)
    ("Bcl2 and Bcl-xL" . SPARSER::COLLECTION)
    ("BrdU and MTS" . SPARSER::COLLECTION)
    ("Hsp27 and promoter" . SPARSER::COLLECTION)
    ("a stress-induced molecular chaperone" . SPARSER::PROTEIN)
    ("chaperone" . SPARSER::PROTEIN)
    ("a crucial transcription factor" . SPARSER::PROTEIN)
    ("ERK1/2/Akt" . SPARSER::COLLECTION) ("Akt/ERK" . SPARSER::COLLECTION)
    ("both ERK1/2 ( xref , right panel; lanes 2 and 3) and Akt ( xref , right panel; lanes 2 and 3) proteins"
     . SPARSER::COLLECTION)
    ("Hsp27-ERK/Akt" . SPARSER::COLLECTION)
    ("ERK and Akt" . SPARSER::COLLECTION) ("pCMV-Hsp27" . SPARSER::COLLECTION)
    ("pEGFP" . SPARSER::PROTEIN) ("ERK/Akt" . SPARSER::COLLECTION)
    ("survival molecules Bcl2 ( xref , lane 2) and Bcl-xL ( xref , lane 2) and caspase 9"
     . SPARSER::COLLECTION)
    ("Bcl-xL ( xref , lane 2) and caspase 9" . SPARSER::COLLECTION)
    ("molecular weight ∼47 kDa (procaspase 9) and ∼35 kDa (cleaved caspase-9)"
     . SPARSER::COLLECTION)
    ("nick" . SPARSER::PROTEIN) ("dUTP" . SPARSER::MOLECULE)
    ("TdT" . SPARSER::PROTEIN)
    ("G2-regulatory kinase cyclin B1" . SPARSER::PROTEIN)
    ("Si-LEDGF-DU145" . SPARSER::COLLECTION)
    ("Sp1 or Prdx6 or β -actin" . SPARSER::COLLECTION)
    ("Prdx6 or β -actin" . SPARSER::COLLECTION) ("Si" . SPARSER::PROTEIN)
    ("Sp1, Prdx6 and β -actin" . SPARSER::COLLECTION)
    ("Prdx6" . SPARSER::PROTEIN) ("Prdx" . SPARSER::PROTEIN-FAMILY)
    ("LEDGF mRNA ( xref ) and protein ( xref )" . SPARSER::COLLECTION)
    ("transfectants" . SPARSER::PROTEIN) ("Si-LEDGF" . SPARSER::COLLECTION)
    ("further supports LEDGF" . SPARSER::PROTEIN)
    ("LEDGF mRNA ( xref , black bars) and Hsp 27 ( xref , gray bars)"
     . SPARSER::COLLECTION)
    ("pEGFP-LEDGF" . SPARSER::COLLECTION)
    ("LEDGF and Hsp27" . SPARSER::COLLECTION)
    ("PC-3 and LNCaP" . SPARSER::COLLECTION)
    ("protein and mRNA" . SPARSER::COLLECTION)
    ("western blot" . SPARSER::PROTEIN) ("androgen" . SPARSER::PROTEIN)
    ("A multi-domain flexible nuclear protein" . SPARSER::PROTEIN)
    ("crystallin and Hsp27" . SPARSER::COLLECTION)
    ("crystallin" . SPARSER::PROTEIN) ("transposase" . SPARSER::PROTEIN)
    ("menin" . SPARSER::PROTEIN) ("LEDGF or Hsp27" . SPARSER::COLLECTION)
    ("ERK1/2 and Akt" . SPARSER::COLLECTION) ("Bax" . SPARSER::PROTEIN)
    ("DU145, PC-3 and LNCaP" . SPARSER::COLLECTION) ("PCs" . SPARSER::PROTEIN)
    ("PC-3" . SPARSER::PROTEIN) ("PC" . SPARSER::PROTEIN)
    ("LEDGF" . SPARSER::PROTEIN) ("1–2 " . SPARSER::PROTEIN)
    ("pERK1/2" . SPARSER::PROTEIN) ("cdc2" . SPARSER::PROTEIN)
    ("caspase-9" . SPARSER::PROTEIN) ("Bcl-xL" . SPARSER::PROTEIN)
    ("serine residue" . SPARSER::MOLECULE) ("β -actin" . SPARSER::PROTEIN)
    ("Sp1" . SPARSER::PROTEIN) ("Hsp 27" . SPARSER::PROTEIN)
    ("response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Cdc7" . SPARSER::PROTEIN) ("zinc finger" . SPARSER::PROTEIN)
    ("JPO2" . SPARSER::PROTEIN)
    ("lens epithelium-derived growth factor" . SPARSER::PROTEIN)
    ("Bcl- XL" . SPARSER::PROTEIN) ("Bcl2" . SPARSER::PROTEIN)
    ("caspase 9" . SPARSER::PROTEIN) ("cyclin B1" . SPARSER::PROTEIN)
    ("Hsp27" . SPARSER::PROTEIN) ("heat-shock protein 27" . SPARSER::PROTEIN)
    ("Lens epithelium-derived growth factor" . SPARSER::PROTEIN)
    ("SS" . SPARSER::PROTEIN) ("PB" . SPARSER::PROTEIN)
    ("BK, HN, CB, and TMG" . SPARSER::COLLECTION) ("CB" . SPARSER::PROTEIN)
    ("BK" . SPARSER::PROTEIN) ("TMG" . SPARSER::PROTEIN)
    ("United States Food and Drug Administration" . SPARSER::COLLECTION)
    ("PPA" . SPARSER::PROTEIN) ("OPA" . SPARSER::MOLECULE)
    ("Formalin" . SPARSER::MOLECULE) ("Digoxigenin" . SPARSER::MOLECULE)
    ("EGFR and met" . SPARSER::COLLECTION) ("met" . SPARSER::AMINO-ACID)
    ("protein, HER2 , and CEN17" . SPARSER::COLLECTION)
    ("another aromatic molecule" . SPARSER::MOLECULE)
    ("benzidine" . SPARSER::MOLECULE)
    ("DAB and the DNP hapten" . SPARSER::COLLECTION)
    ("chromogen and hydrogen peroxide" . SPARSER::COLLECTION)
    ("chromogen" . SPARSER::MOLECULE) ("hematoxylin" . SPARSER::MOLECULE)
    ("co-visualize HER2 protein and the HER2 gene" . SPARSER::COLLECTION)
    ("lapatinib" . SPARSER::DRUG) ("ANA" . SPARSER::PROTEIN)
    ("the HER2 IHC part" . SPARSER::COMPONENT)
    ("kappa" . SPARSER::PROTEIN-FAMILY) ("protein (IHC)" . SPARSER::PROTEIN)
    ("HER2 and CEN17" . SPARSER::COLLECTION) ("hapten" . SPARSER::MOLECULE)
    ("DNP" . SPARSER::DRUG) ("gene and CEN17" . SPARSER::COLLECTION)
    ("DAB" . SPARSER::MOLECULE) ("peroxidase (HRP)" . SPARSER::PROTEIN)
    ("alkaline phosphatase (AP)" . SPARSER::PROTEIN-FAMILY)
    ("HRP" . SPARSER::PROTEIN) ("CISH" . SPARSER::PROTEIN)
    ("pertuzumab, neratinib, and afatinib" . SPARSER::COLLECTION)
    ("afatinib" . SPARSER::DRUG) ("neratinib" . SPARSER::DRUG)
    ("pertuzumab" . SPARSER::DRUG)
    ("protein, estrogen receptor, and progesterone receptor"
     . SPARSER::COLLECTION)
    ("Tykerb" . SPARSER::DRUG) ("Lapatinib" . SPARSER::DRUG)
    ("a humanized monoclonal anti-HER2 antibody" . SPARSER::ANTIBODY)
    ("protein and HER2" . SPARSER::COLLECTION)
    ("gene, and CEN17" . SPARSER::COLLECTION) ("naphthol" . SPARSER::MOLECULE)
    ("2,4-dinitrophenyl-labeled HER2 and digoxigenin-labeled CEN17"
     . SPARSER::COLLECTION)
    ("2,4-dinitrophenyl-labeled HER2" . SPARSER::PROTEIN)
    ("digoxigenin" . SPARSER::MOLECULE) ("dinitrophenyl" . SPARSER::DRUG)
    ("peroxidase" . SPARSER::PROTEIN)
    ("a rabbit monoclonal anti-HER2 antibody" . SPARSER::ANTIBODY)
    ("formalin" . SPARSER::MOLECULE) ("MCF7" . SPARSER::PROTEIN)
    ("FDA" . SPARSER::PROTEIN) ("Drug" . SPARSER::DRUG)
    ("Food" . SPARSER::MOLECULE)
    ("Epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Chromosome 17" . SPARSER::PROTEIN)
    ("Alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("CC1" . SPARSER::PROTEIN) ("progesterone receptor" . SPARSER::PROTEIN)
    ("chromosome 17" . SPARSER::PROTEIN) ("LG" . SPARSER::MOLECULE)
    ("CG" . SPARSER::PROTEIN) ("EM" . SPARSER::PROTEIN)
    ("the BRCA1 variants M1775R and A1789T" . SPARSER::COLLECTION)
    ("OBFC2A , upregulated by M1775R, and OBFC2B" . SPARSER::COLLECTION)
    ("a telomere-associated protein" . SPARSER::PROTEIN)
    ("nucleoprotein" . SPARSER::PROTEIN) ("Complex" . SPARSER::BIO-COMPLEX)
    ("arm" . SPARSER::PROTEIN) ("iron" . SPARSER::MOLECULE)
    ("ATP-dependent and X-ray repair complementing defective repair in Chinese hamster cells 4"
     . SPARSER::COLLECTION)
    ("LIG4-XRCC4" . SPARSER::COLLECTION) ("AHNAK" . SPARSER::PROTEIN)
    ("PPP1R1A/PPP1R15A/PP1" . SPARSER::COLLECTION) ("ATM-" . SPARSER::PROTEIN)
    ("a macromolecular tRNA synthetase complex" . SPARSER::BIO-COMPLEX)
    ("tRNA" . SPARSER::PROTEIN)
    ("a recently discovered lysosome-associated protein" . SPARSER::PROTEIN)
    ("caspases" . SPARSER::PROTEIN) ("Fas" . SPARSER::PROTEIN)
    ("FADD" . SPARSER::PROTEIN)
    ("a pleiotropic transcription factor" . SPARSER::PROTEIN)
    ("ZWILCH" . SPARSER::PROTEIN) ("DUSPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAPKs" . SPARSER::PROTEIN) ("FOS" . SPARSER::PROTEIN)
    ("TP53 and MRE11A" . SPARSER::COLLECTION) ("helicase" . SPARSER::PROTEIN)
    ("TXNIP and RASSF1" . SPARSER::COLLECTION) ("TXNIP" . SPARSER::PROTEIN)
    ("CCND1-CDK4" . SPARSER::COLLECTION) ("indole" . SPARSER::DRUG)
    ("CEBPA" . SPARSER::PROTEIN)
    ("GPR56, MRE11A, PML and NFKB1" . SPARSER::COLLECTION)
    ("Mut" . SPARSER::PROTEIN)
    ("two missense variants, M1775R and A1789T" . SPARSER::COLLECTION)
    ("phosphoprotein" . SPARSER::PROTEIN) ("aa" . SPARSER::MOLECULE)
    ("SQ" . SPARSER::MOLECULE)
    ("RBBP8 (retinoblastoma binding protein 8) and MRN (MRE11A/RAD50/NBN: meiotic recombination 11 homolog A (S. cerevisiae), RAD50 homolog (S. cerevisiae), nibrin)"
     . SPARSER::COLLECTION)
    ("nibrin" . SPARSER::PROTEIN) ("meiotic" . SPARSER::DRUG)
    ("NBN" . SPARSER::PROTEIN) ("Ser/Thr" . SPARSER::COLLECTION)
    ("BRCA1-ATR" . SPARSER::COLLECTION) ("BRCA1-ATM" . SPARSER::COLLECTION)
    ("ataxia telangiectasia mutated and ataxia" . SPARSER::COLLECTION)
    ("ATM/ATR" . SPARSER::COLLECTION) ("OBFC2B" . SPARSER::PROTEIN)
    ("OBFC2A" . SPARSER::PROTEIN) ("TERF1" . SPARSER::PROTEIN)
    ("Brca1" . SPARSER::PROTEIN)
    ("manganese superoxide dismutase" . SPARSER::PROTEIN)
    ("SOD2" . SPARSER::PROTEIN)
    ("X-ray repair complementing defective repair in Chinese hamster cells 4"
     . SPARSER::PROTEIN)
    ("ligase IV" . SPARSER::PROTEIN) ("XRCC4" . SPARSER::PROTEIN)
    ("LIG4" . SPARSER::PROTEIN) ("PPP1R15A" . SPARSER::PROTEIN)
    ("PPP1R1A" . SPARSER::PROTEIN) ("gamma isoform" . SPARSER::PROTEIN)
    ("PPP1CC" . SPARSER::PROTEIN) ("SMC1A" . SPARSER::PROTEIN)
    ("EEF1E1" . SPARSER::PROTEIN) ("PLEKHF1" . SPARSER::PROTEIN)
    ("DYRK2" . SPARSER::PROTEIN) ("TNFRSF6" . SPARSER::PROTEIN)
    ("member 10" . SPARSER::PROTEIN)
    ("tumor necrosis factor (ligand) superfamily" . SPARSER::PROTEIN)
    ("TNFSF10" . SPARSER::PROTEIN) ("TNFRSF10B" . SPARSER::PROTEIN)
    ("G protein-coupled receptor" . SPARSER::PROTEIN)
    ("SKP1" . SPARSER::PROTEIN) ("EDN1" . SPARSER::PROTEIN)
    ("Mitogen-Activated Protein Kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DUSP2" . SPARSER::PROTEIN) ("DUSP1" . SPARSER::PROTEIN)
    ("ATP-dependent" . SPARSER::PROTEIN) ("RASSF1" . SPARSER::PROTEIN)
    ("RUVBL1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 4" . SPARSER::PROTEIN)
    ("CDK4" . SPARSER::PROTEIN) ("CCND1" . SPARSER::PROTEIN)
    ("TGF-beta" . SPARSER::PROTEIN) ("IgG2b" . SPARSER::BIO-COMPLEX)
    ("NFKB1" . SPARSER::PROTEIN) ("GPR56" . SPARSER::PROTEIN)
    ("BRCA1 associated RING domain 1" . SPARSER::PROTEIN)
    ("BARD1" . SPARSER::PROTEIN)
    ("RAD50 homolog (S. cerevisiae)" . SPARSER::PROTEIN)
    ("homolog A (S. cerevisiae)" . SPARSER::PROTEIN)
    ("RAD50" . SPARSER::PROTEIN) ("MRE11A" . SPARSER::PROTEIN)
    ("retinoblastoma binding protein 8" . SPARSER::PROTEIN)
    ("RBBP8" . SPARSER::PROTEIN) ("tumor suppressor gene" . SPARSER::PROTEIN)
    ("cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rac1 and STAT3" . SPARSER::COLLECTION)
    ("the cryptococcal Plb1" . SPARSER::PROTEIN)
    ("Rac1 and GTP-Rac1" . SPARSER::COLLECTION)
    ("its Δplb1 mutant or its reconstituted PLB1 strain" . SPARSER::COLLECTION)
    ("cryptococcal Plb1" . SPARSER::PROTEIN) ("Plb1" . SPARSER::PROTEIN)
    ("Δplb1 mutant or the mutant" . SPARSER::COLLECTION)
    ("the cryptococcal Δplb1 mutant" . SPARSER::MUTANT)
    ("cryptococcal PLB1" . SPARSER::PROTEIN)
    ("cryptococcal Rac1" . SPARSER::PROTEIN)
    ("NSC23766 or PBS" . SPARSER::COLLECTION)
    ("the Rac1 inhibitor (NSC27366) or vehicle (PBS)" . SPARSER::COLLECTION)
    ("monolayers" . SPARSER::PROTEIN) ("Blot" . SPARSER::PROTEIN)
    ("Rac1, and STAT3" . SPARSER::COLLECTION) ("GTP" . SPARSER::NUCLEOTIDE)
    ("γ-glutamyl" . SPARSER::MOLECULE)
    ("low-density lipoprotein" . SPARSER::PROTEIN) ("cPLA2" . SPARSER::PROTEIN)
    ("exchange factors" . SPARSER::EXCHANGE-FACTOR)
    ("phospholipase A2" . SPARSER::PROTEIN)
    ("virulence factors" . SPARSER::PROTEIN-FAMILY)
    ("transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("PLB1" . SPARSER::PROTEIN) ("rac1" . SPARSER::PROTEIN)
    ("RAC1" . SPARSER::PROTEIN) ("NSC23766" . SPARSER::DRUG)
    ("PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PAK-1" . SPARSER::PROTEIN)
    ("membrane-bound" . SPARSER::PROTEIN)
    ("phospholipase B1" . SPARSER::PROTEIN) ("Rac1" . SPARSER::PROTEIN)
    ("Rho family" . SPARSER::PROTEIN) ("HER2-" . SPARSER::PROTEIN)
    ("biologic" . SPARSER::DRUG) ("Trastuzumab" . SPARSER::DRUG)
    ("Herceptin" . SPARSER::DRUG)
    ("anti-HER2/ neu antibody and the proposed HER2/ neu"
     . SPARSER::COLLECTION)
    ("plentiful TORC1 and TORC2" . SPARSER::COLLECTION)
    ("Cut1 or Cut2" . SPARSER::COLLECTION)
    ("bipolar cell elongation" . SPARSER::PROTEIN) ("sharp" . SPARSER::PROTEIN)
    ("stress-responsive MAPK Sty1/Spc1" . SPARSER::COLLECTION)
    ("Sty1/Spc1" . SPARSER::COLLECTION) ("KCl" . SPARSER::MOLECULE)
    ("salt" . SPARSER::MOLECULE) ("sorbitol" . SPARSER::PROTEIN)
    ("conformation" . SPARSER::BIO-CONFORMATION)
    ("cut2 and separase/" . SPARSER::COLLECTION) ("FKBP" . SPARSER::PROTEIN)
    ("TORC2 and cdc25 or wee1" . SPARSER::COLLECTION)
    ("cdc25 or wee1" . SPARSER::COLLECTION)
    ("Tor1 (TORC2) and Tor2 (TORC1)" . SPARSER::COLLECTION)
    ("Cdc25 and Wee1" . SPARSER::COLLECTION)
    ("kinases, TORC1 and TORC2" . SPARSER::COLLECTION)
    ("cdc25 and wee1" . SPARSER::COLLECTION)
    ("Ksg1 and Gad8" . SPARSER::COLLECTION)
    ("the genomic TOR" . SPARSER::PROTEIN)
    ("Mip1 or Ste20" . SPARSER::COLLECTION)
    ("Cut1 and/or Cut2" . SPARSER::COLLECTION) ("−drug" . SPARSER::DRUG)
    ("Cut1 and Cut2" . SPARSER::COLLECTION) ("Cut1–GFP" . SPARSER::COLLECTION)
    ("cut1-206-GFP" . SPARSER::PROTEIN-PAIR) ("nmt1" . SPARSER::PROTEIN)
    ("Cut1" . SPARSER::PROTEIN) ("Securin–separase" . SPARSER::COLLECTION)
    ("Securin" . SPARSER::PROTEIN) ("cut2 and cut1" . SPARSER::COLLECTION)
    ("Cut1–Cut2" . SPARSER::COLLECTION) ("tor2" . SPARSER::PROTEIN)
    ("cut1" . SPARSER::PROTEIN) ("tor2 cut1" . SPARSER::PROTEIN)
    ("Separase and securin" . SPARSER::COLLECTION)
    ("Separase" . SPARSER::PROTEIN) ("Cut2" . SPARSER::PROTEIN)
    ("cut2" . SPARSER::PROTEIN) ("cut2-EA2" . SPARSER::COLLECTION)
    ("cut1-206" . SPARSER::PROTEIN) ("mitotic Cdc2 kinase" . SPARSER::KINASE)
    ("mitogen-activated protein kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the inactive Cdc2 as well as abundant Rum1" . SPARSER::COLLECTION)
    ("Cdc2 (PSTAIR)" . SPARSER::PROTEIN) ("PSTAIR" . SPARSER::PROTEIN)
    ("myosin" . SPARSER::PROTEIN-FAMILY) ("Myo" . SPARSER::PROTEIN)
    ("excessively polymerized actin" . SPARSER::PROTEIN)
    ("strain cut1-206" . SPARSER::PROTEIN) ("Clp1/Flp1" . SPARSER::COLLECTION)
    ("highly bright actin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tip" . SPARSER::PROTEIN) ("DAPI and actin" . SPARSER::COLLECTION)
    ("phalloidin" . SPARSER::MOLECULE) ("tubulin" . SPARSER::PROTEIN)
    ("aberrantly bright actin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("bright" . SPARSER::PROTEIN) ("CK" . SPARSER::PROTEIN)
    ("DAPI" . SPARSER::DRUG) ("phenylindole" . SPARSER::MOLECULE)
    ("YPD" . SPARSER::MOLECULE) ("low-glucose" . SPARSER::PROTEIN)
    ("Mutants" . SPARSER::MUTANT)
    ("α -tubulin (TAT1) and Cdc2 (PSTAIR)" . SPARSER::COLLECTION)
    ("TAT1" . SPARSER::PROTEIN) ("tor2-S and tor1-D" . SPARSER::COLLECTION)
    ("substrate (PAS)" . SPARSER::SUBSTRATE)
    ("Akt" . SPARSER::HUMAN-PROTEIN-FAMILY) ("labile" . SPARSER::PROTEIN)
    ("SMC" . SPARSER::PROTEIN) ("condensin" . SPARSER::PROTEIN-FAMILY)
    ("PIK and PIKK" . SPARSER::COLLECTION) ("Wortmannin" . SPARSER::PROTEIN)
    ("the authentic human substrate" . SPARSER::SUBSTRATE)
    ("Mutant" . SPARSER::MUTANT) ("DMSO" . SPARSER::MOLECULE)
    ("sulphoxide" . SPARSER::DRUG) ("leucine" . SPARSER::AMINO-ACID)
    ("tor2-S" . SPARSER::PROTEIN)
    ("a conditional tor1 substitution mutant" . SPARSER::MUTANT)
    ("Tco89–GFP" . SPARSER::COLLECTION) ("Mip1–GFP" . SPARSER::COLLECTION)
    ("Ste20, Sin1 or Bit61" . SPARSER::COLLECTION)
    ("Tor2–FLAG" . SPARSER::COLLECTION) ("Mip1 or Tco89" . SPARSER::COLLECTION)
    ("Tor1–FLAG" . SPARSER::COLLECTION) ("EMM" . SPARSER::PROTEIN)
    ("All the GFP- and FLAG-tagged genes" . SPARSER::COLLECTION)
    ("GFP-" . SPARSER::PROTEIN) ("sterile" . SPARSER::PROTEIN-FAMILY)
    ("Ste20, Sin1 and Bit61" . SPARSER::COLLECTION)
    ("/cyclosome" . SPARSER::COLLECTION)
    ("a conditional tor1 mutant" . SPARSER::MUTANT)
    ("Mip1 and Tco89" . SPARSER::COLLECTION)
    ("minimal (synthetic) media" . SPARSER::PROTEIN)
    ("Mip1, Pop3, Toc1 and Tco89" . SPARSER::COLLECTION)
    ("Pop3, Bit61 and Ste20" . SPARSER::COLLECTION) ("Toc1" . SPARSER::PROTEIN)
    ("FLAG–Tor2" . SPARSER::COLLECTION) ("FLAG–Tor1" . SPARSER::COLLECTION)
    ("Mip1 and Ste20" . SPARSER::COLLECTION) ("Mip1" . SPARSER::PROTEIN)
    ("Raptor" . SPARSER::PROTEIN) ("homologues" . SPARSER::PROTEIN)
    ("GTPases" . SPARSER::GTPASE) ("Tor2 and Tor1" . SPARSER::COLLECTION)
    ("Avo1, Avo2, Tsc11, Lst8, Bit61 and Slm2" . SPARSER::COLLECTION)
    ("Slm2" . SPARSER::PROTEIN) ("Tsc11" . SPARSER::PROTEIN)
    ("Avo2" . SPARSER::PROTEIN) ("Tor1 or Tor2" . SPARSER::COLLECTION)
    ("Kog1, Lst8 and Tco89" . SPARSER::COLLECTION)
    ("Tor1 and Tor2 form two functionally distinct TOR" . SPARSER::PROTEIN)
    ("PIKK" . SPARSER::KINASE) ("ribosome" . SPARSER::BIO-COMPLEX)
    ("Tor1 and Tor2" . SPARSER::COLLECTION) ("Frp1" . SPARSER::PROTEIN)
    ("kinases, Tor1 and Tor2" . SPARSER::COLLECTION)
    ("Saccharomyces" . SPARSER::PROTEIN)
    ("complex (TORC)" . SPARSER::BIO-COMPLEX)
    ("TORC" . SPARSER::PROTEIN-FAMILY) ("FK" . SPARSER::MOLECULE)
    ("immunosuppressant" . SPARSER::DRUG) ("Rapamycin" . SPARSER::DRUG)
    ("kinase (CDK)" . SPARSER::KINASE) ("TOR" . SPARSER::PROTEIN)
    ("Wee1 and Cdc25" . SPARSER::COLLECTION)
    ("TORC1 and TORC2" . SPARSER::COLLECTION)
    ("tor1-L2045D" . SPARSER::PROTEIN)
    ("the previously isolated TORC1 mutant tor2-L2048S" . SPARSER::PROTEIN)
    ("tor2-L2048S" . SPARSER::PROTEIN) ("PIK" . SPARSER::BIO-COMPLEX)
    ("securin–separase" . SPARSER::COLLECTION) ("separase" . SPARSER::PROTEIN)
    ("securin" . SPARSER::PROTEIN) ("phosphatidyl" . SPARSER::MOLECULE)
    ("nutrient" . SPARSER::MOLECULE) ("TORCs" . SPARSER::PROTEIN-FAMILY)
    ("rapamycin" . SPARSER::DRUG) ("Target" . SPARSER::TARGET-PROTEIN)
    ("sin1" . SPARSER::PROTEIN) ("tco89" . SPARSER::PROTEIN-FAMILY)
    ("Anti-" . SPARSER::ANTIBODY) ("NH 4 Cl" . SPARSER::MOLECULE)
    ("Spc1" . SPARSER::PROTEIN) ("regulator of cell cycle" . SPARSER::PROTEIN)
    ("Gad8" . SPARSER::PROTEIN) ("Ksg1" . SPARSER::PROTEIN)
    ("Rad21" . SPARSER::PROTEIN) ("ste20" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S5" . SPARSER::MOLECULE) ("S4" . SPARSER::PROTEIN-FAMILY)
    ("EA2" . SPARSER::PROTEIN) ("S–M" . SPARSER::PROTEIN)
    ("Sty1" . SPARSER::PROTEIN) ("Cdc13" . SPARSER::PROTEIN)
    ("heavy chain" . SPARSER::PROTEIN) ("clp1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Flp1" . SPARSER::PROTEIN) ("latrunculin A" . SPARSER::DRUG)
    ("ssp1" . SPARSER::PROTEIN) ("cdc25" . SPARSER::PROTEIN)
    ("wee1" . SPARSER::PROTEIN) ("d-glucose" . SPARSER::MOLECULE)
    ("α -tubulin" . SPARSER::PROTEIN)
    ("ribosomal protein S6" . SPARSER::PROTEIN) ("p70S6" . SPARSER::PROTEIN)
    ("PI3 kinase" . SPARSER::PROTEIN)
    ("green fluorescent protein" . SPARSER::PROTEIN)
    ("Sin1" . SPARSER::PROTEIN) ("Pop3" . SPARSER::PROTEIN)
    ("Ste20" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ryh1" . SPARSER::PROTEIN)
    ("Rheb1" . SPARSER::PROTEIN) ("S. cerevisiae" . SPARSER::PROTEIN)
    ("Bit61" . SPARSER::PROTEIN) ("Avo1" . SPARSER::PROTEIN)
    ("Tco89" . SPARSER::PROTEIN-FAMILY) ("Lst8" . SPARSER::PROTEIN)
    ("Kog1" . SPARSER::PROTEIN) ("Tor2" . SPARSER::PROTEIN)
    ("Tor1" . SPARSER::PROTEIN)
    ("peptidyl-prolyl cis-trans isomerase" . SPARSER::PROTEIN)
    ("FKBP12" . SPARSER::PROTEIN) ("1-L" . SPARSER::PROTEIN)
    ("2-L" . SPARSER::PROTEIN) ("Cdc2" . SPARSER::PROTEIN)
    ("TORC2" . SPARSER::PROTEIN) ("TORC1" . SPARSER::PROTEIN)
    ("Nrf2 and/or its downstream protective components" . SPARSER::COLLECTION)
    ("apocynin" . SPARSER::MOLECULE) ("renal superoxide" . SPARSER::MOLECULE)
    ("oxidase (NOX)" . SPARSER::PROTEIN) ("superoxide" . SPARSER::MOLECULE)
    ("NOX" . SPARSER::PROTEIN) ("oxidase" . SPARSER::PROTEIN)
    ("telmisartan" . SPARSER::DRUG) ("PETN" . SPARSER::PROTEIN-FAMILY)
    ("AGE-modified bovine albumin" . SPARSER::PROTEIN)
    ("HO-1 and NQO1" . SPARSER::COLLECTION)
    ("glutathione peroxidase-1" . SPARSER::COLLECTION)
    ("albumin" . SPARSER::PROTEIN)
    ("Nrf2 and its downstream target genes" . SPARSER::COLLECTION)
    ("SNF-" . SPARSER::PROTEIN-FAMILY)
    ("Nrf2 and its downstream targets NQO1 and γ -GCS" . SPARSER::COLLECTION)
    ("its downstream targets NQO1 and γ -GCS" . SPARSER::COLLECTION)
    ("CDDO-Me or RTA" . SPARSER::COLLECTION) ("RTA" . SPARSER::PROTEIN)
    ("aka" . SPARSER::PROTEIN) ("cardiac Nrf2" . SPARSER::PROTEIN)
    ("Keap1-Cul3-Rbx1" . SPARSER::COLLECTION) ("amide" . SPARSER::MOLECULE)
    ("triterpenoid" . SPARSER::MOLECULE)
    ("triterpenoids, CDDO, and CDDO-imidazolide" . SPARSER::COLLECTION)
    ("CDDO-imidazolide" . SPARSER::DRUG)
    ("ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("inducers" . SPARSER::MOLECULE) ("imidazolide" . SPARSER::MOLECULE)
    ("CDDO" . SPARSER::DRUG) ("triterpenoids" . SPARSER::MOLECULE)
    ("catalase, and glutathione peroxidase" . SPARSER::COLLECTION)
    ("GPx" . SPARSER::PROTEIN) ("catalase" . SPARSER::PROTEIN)
    ("Nrf2 and downstream antioxidants" . SPARSER::COLLECTION)
    ("malondialdehyde" . SPARSER::MOLECULE) ("antioxidants" . SPARSER::DRUG)
    ("resveratrol" . SPARSER::PROTEIN)
    ("a red wine antioxidant and a natural phytoalexin" . SPARSER::COLLECTION)
    ("a natural phytoalexin" . SPARSER::MOLECULE)
    ("phytoalexin" . SPARSER::MOLECULE) ("wine" . SPARSER::MOLECULE)
    ("Resveratrol" . SPARSER::PROTEIN) ("IV, and p21" . SPARSER::COLLECTION)
    ("collagen" . SPARSER::PROTEIN)
    ("TGF- β 1 and its downstream effectors" . SPARSER::COLLECTION)
    ("Nrf2 activators, tert -Butylhydroquinone ( t BHQ), SNF, or cinnamic aldehyde (CA)"
     . SPARSER::COLLECTION)
    ("cinnamic aldehyde (CA)" . SPARSER::MOLECULE)
    ("aldehyde" . SPARSER::MOLECULE) ("LAB" . SPARSER::PROTEIN)
    ("hexosamine and PKC" . SPARSER::COLLECTION)
    ("hexosamine" . SPARSER::MOLECULE)
    ("transketolase and glutathione reductase" . SPARSER::COLLECTION)
    ("transketolase" . SPARSER::PROTEIN) ("SNF" . SPARSER::PROTEIN-FAMILY)
    ("sulforaphane" . SPARSER::PROTEIN) ("parts" . SPARSER::COMPONENT)
    ("fat" . SPARSER::PROTEIN) ("isoproterenol" . SPARSER::PROTEIN)
    ("several fibrotic mediators" . SPARSER::PROTEIN)
    ("glycogen" . SPARSER::PROTEIN) ("metabolites" . SPARSER::MOLECULE)
    ("proteinuria" . SPARSER::PROTEIN) ("NQO1 and HO1" . SPARSER::COLLECTION)
    ("STZ" . SPARSER::DRUG) ("streptozotocin" . SPARSER::DRUG)
    ("Nrf2 and/or its downstream antioxidant genes" . SPARSER::COLLECTION)
    ("HG or hyperglycemia" . SPARSER::COLLECTION)
    ("Nrf2 and NQO1" . SPARSER::COLLECTION)
    ("N-acetylcysteine (NAC)" . SPARSER::DRUG) ("NAC" . SPARSER::PROTEIN)
    ("NQO1, HO-1, and GST" . SPARSER::COLLECTION)
    ("Nrf2 and HO1" . SPARSER::COLLECTION) ("HG-" . SPARSER::MOLECULE)
    ("glucose-" . SPARSER::PROTEIN) ("HG" . SPARSER::MOLECULE)
    ("synthetase" . SPARSER::PROTEIN) ("oxygenase" . SPARSER::PROTEIN)
    ("heme" . SPARSER::PROTEIN) ("NADPH" . SPARSER::PROTEIN)
    ("AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("its inhibitor kelch-like ECH-associated protein 1"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("antioxidant" . SPARSER::PROTEIN)
    ("oxygen or nitrogen" . SPARSER::COLLECTION)
    ("nitrogen" . SPARSER::MOLECULE) ("glucose" . SPARSER::PROTEIN)
    ("activators" . SPARSER::ACTIVATOR) ("redox" . SPARSER::PROTEIN)
    ("hyperglycemia" . SPARSER::PROTEIN) ("NAD(P)H" . SPARSER::MOLECULE)
    ("angiotensin II" . SPARSER::PROTEIN) ("type 2" . SPARSER::PROTEIN)
    ("CDDO-Me" . SPARSER::DRUG) ("Bardoxolone methyl" . SPARSER::DRUG)
    ("Rbx1" . SPARSER::PROTEIN) ("Cul3" . SPARSER::PROTEIN)
    ("NF- κ B" . SPARSER::PROTEIN)
    ("glutathione peroxidase" . SPARSER::PROTEIN) ("SOD1" . SPARSER::PROTEIN)
    ("superoxide dismutase 1" . SPARSER::PROTEIN) ("Keap1" . SPARSER::PROTEIN)
    ("tert -Butylhydroquinone" . SPARSER::DRUG)
    ("glutathione reductase" . SPARSER::PROTEIN)
    ("free-radical" . SPARSER::MOLECULE) ("TGF- β 1" . SPARSER::PROTEIN)
    ("nitric oxide" . SPARSER::MOLECULE) ("type 1" . SPARSER::PROTEIN)
    ("N-acetylcysteine" . SPARSER::DRUG) ("HO-1" . SPARSER::PROTEIN)
    ("HO1" . SPARSER::PROTEIN) ("glutathione S-transferase" . SPARSER::PROTEIN)
    ("NQO1" . SPARSER::PROTEIN) ("quinone oxidoreductase" . SPARSER::PROTEIN)
    ("KEAP1" . SPARSER::PROTEIN) ("protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Nrf2" . SPARSER::PROTEIN) ("NFE2-related factor 2" . SPARSER::PROTEIN)
    ("Transcription factor" . SPARSER::PROTEIN) ("the intestinal type" . TYPE)
    ("the histological type" . TYPE) ("anti-HER-2/neu" . SPARSER::COLLECTION)
    ("HER-2/neu" . SPARSER::COLLECTION)
    ("classification type or gastric cancer" . SPARSER::COLLECTION)
    ("nodal" . SPARSER::PROTEIN) ("trastuzumab" . SPARSER::DRUG)
    ("a transmembrane tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("IRS" . SPARSER::PROTEIN) ("Chi 2" . SPARSER::PROTEIN)
    ("H 2 O 2" . SPARSER::DRUG)
    ("epidermal growth factor receptors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("IRS 4" . SPARSER::PROTEIN) ("Southern blot" . SPARSER::PROTEIN)
    ("both intestinal type" . TYPE)
    ("a large gastric cancer cohort" . SPARSER::MOLECULE)
    ("RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a large archival gastric cancer cohort" . SPARSER::MOLECULE)
    ("residual tumour, and Lauren histologic subtypes" . SPARSER::PROTEIN)
    ("versa" . SPARSER::PROTEIN)
    ("the Lauren histological subtypes" . SPARSER::PROTEIN)
    ("subtypes" . SPARSER::PROTEIN)
    ("tyrosine kinase inhibitors and therapeutic monoclonal antibodies"
     . SPARSER::COLLECTION)
    ("therapeutic monoclonal antibodies" . SPARSER::ANTIBODY)
    ("consecutively accrued gastric cancer cohort" . SPARSER::MOLECULE)
    ("as 2" . SPARSER::PROTEIN) ("mitomycin C" . SPARSER::DRUG)
    ("5FU" . SPARSER::DRUG) ("PHA-665752" . SPARSER::DRUG)
    ("hepatocyte growth factor receptor" . SPARSER::PROTEIN)
    ("PKM-" . SPARSER::PROTEIN) ("PKM" . SPARSER::PROTEIN)
    ("Variant" . SPARSER::VARIANT)
    ("homoeostatic regulators and mechanisms" . SPARSER::COLLECTION)
    ("regulators and mechanisms" . SPARSER::COLLECTION)
    ("atypical PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DISP" . SPARSER::PROTEIN)
    ("classic tumour suppressor genes" . SPARSER::GENE)
    ("families" . SPARSER::PROTEIN-FAMILY)
    ("atypical PRKC–ι enzymes" . SPARSER::ENZYME)
    ("a potential protein 985 amino acids" . SPARSER::AMINO-ACID)
    ("Alu-Sb1" . SPARSER::COLLECTION) ("Sq" . SPARSER::MOLECULE)
    ("subsequent oligonucleotide" . SPARSER::MOLECULE)
    ("Alu" . SPARSER::PROTEIN) ("Nucleotide" . SPARSER::NUCLEOTIDE)
    ("the hypothetical protein" . SPARSER::PROTEIN)
    ("PRKC–" . SPARSER::PROTEIN-FAMILY) ("antiserum" . SPARSER::PROTEIN)
    ("COR" . SPARSER::PROTEIN-FAMILY)
    ("Conformation" . SPARSER::BIO-CONFORMATION)
    ("monoclonal antibodies" . SPARSER::ANTIBODY)
    ("stop" . SPARSER::HUMAN-PROTEIN-FAMILY) ("run" . SPARSER::PROTEIN-FAMILY)
    ("radical" . SPARSER::MOLECULE) ("derivative" . SPARSER::DERIVATIVE)
    ("PRKC" . SPARSER::PROTEIN-FAMILY) ("LNCaP" . SPARSER::PROTEIN)
    ("TSP" . SPARSER::PROTEIN) ("TSP1–TSP3" . SPARSER::COLLECTION)
    ("a 20-mer" . SPARSER::COLLECTION) ("mer" . SPARSER::PROTEIN)
    ("serine–threonine" . SPARSER::COLLECTION) ("va" . SPARSER::MOLECULE)
    ("-zeta ( PRKCZ )" . SPARSER::COLLECTION) ("prostatic" . SPARSER::PROTEIN)
    ("PKC-" . SPARSER::PROTEIN) ("-zeta ( PRKCZ)" . SPARSER::COLLECTION)
    ("-zeta" . SPARSER::COLLECTION) ("PRKCZ" . SPARSER::PROTEIN)
    ("zeta" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tight junction" . SPARSER::PROTEIN)
    ("ion channels" . SPARSER::PROTEIN-FAMILY) ("TNFR2" . SPARSER::PROTEIN)
    ("TERE1" . SPARSER::PROTEIN) ("Sb1" . SPARSER::PROTEIN)
    ("C1orf86" . SPARSER::PROTEIN) ("a 20" . SPARSER::PROTEIN)
    ("NS1" . SPARSER::PROTEIN) ("Rev-2" . SPARSER::PROTEIN)
    ("m–u" . SPARSER::PROTEIN) ("TSP2" . SPARSER::PROTEIN)
    ("TSP9" . SPARSER::PROTEIN-FAMILY) ("TSP4" . SPARSER::PROTEIN)
    ("TSP3" . SPARSER::PROTEIN) ("TSP1" . SPARSER::PROTEIN)
    ("DNase I" . SPARSER::PROTEIN) ("l −1" . SPARSER::PROTEIN)
    ("si-RNA" . SPARSER::RNA) ("DU145" . SPARSER::PROTEIN)
    ("p36" . SPARSER::PROTEIN) ("ligand, or EGFR" . SPARSER::COLLECTION)
    ("leukocytes" . SPARSER::PROTEIN)
    ("matrix metalloprotease(s) or Src proteins" . SPARSER::COLLECTION)
    ("matrix" . SPARSER::PROTEIN-FAMILY)
    ("EGFR and ERBB4" . SPARSER::COLLECTION) ("EGF" . SPARSER::PROTEIN)
    ("BRAF and KRAS" . SPARSER::COLLECTION) ("Chen" . SPARSER::PROTEIN)
    ("HPP and SSA/P" . SPARSER::COLLECTION)
    ("EGFR-antibody" . SPARSER::COLLECTION)
    ("EGFR or its ligands" . SPARSER::COLLECTION)
    ("a submicromolar small-molecule specific EGFR inhibitor"
     . SPARSER::INHIBITOR)
    ("Gefitinib" . SPARSER::DRUG) ("gefitinib" . SPARSER::DRUG)
    ("Soluble HB-EGF" . SPARSER::PROTEIN)
    ("EGFR, ERBB4, NRDc, and heparan sulfate proteoglycan"
     . SPARSER::COLLECTION)
    ("NRDc" . SPARSER::PROTEIN)
    ("the growth factor and a remnant C-terminal peptide"
     . SPARSER::COLLECTION)
    ("a soluble form" . SPARSER::FORM) ("EGFR and MEK" . SPARSER::COLLECTION)
    ("Erbb4" . SPARSER::PROTEIN) ("Egfr" . SPARSER::PROTEIN)
    ("HPP or TSA" . SPARSER::COLLECTION) ("MGMT" . SPARSER::PROTEIN)
    ("Mgmt" . SPARSER::PROTEIN)
    ("contained dysplastic foci" . SPARSER::PROTEIN)
    ("produced basophilic mucin" . SPARSER::PROTEIN)
    ("US28 and HB-EGF" . SPARSER::COLLECTION)
    ("soluble HB-EGF" . SPARSER::PROTEIN)
    ("metalloprotease-" . SPARSER::PROTEIN)
    ("metalloprotease" . SPARSER::PROTEIN)
    ("GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("mucin" . SPARSER::PROTEIN)
    ("BrdU" . SPARSER::DRUG) ("EDTA" . SPARSER::MOLECULE)
    ("HB-EGF and GFP" . SPARSER::COLLECTION)
    ("HB-EGF/GFP" . SPARSER::COLLECTION)
    ("HPP, SSA/P, and TSA" . SPARSER::COLLECTION)
    ("GPCR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR and its ligands" . SPARSER::COLLECTION)
    ("ligands" . SPARSER::LIGAND)
    ("a transmembrane receptor tyrosine kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HER" . SPARSER::PROTEIN) ("ERBB" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ink4a/Arf" . SPARSER::COLLECTION) ("Arf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KRAS and BRAF" . SPARSER::COLLECTION) ("TSA" . SPARSER::PROTEIN)
    ("SSA" . SPARSER::PROTEIN) ("Serrated" . SPARSER::PROTEIN)
    ("Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("EGFR or MAP kinase" . SPARSER::COLLECTION)
    ("HB-EGF and US28" . SPARSER::COLLECTION)
    ("EGFR and ERK1/2" . SPARSER::COLLECTION)
    ("KRAS or BRAF" . SPARSER::COLLECTION) ("HPP" . SPARSER::PROTEIN)
    ("EGFR and the extracellular-regulated kinases (ERK)1/2"
     . SPARSER::COLLECTION)
    ("HPPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRAF or KRAS" . SPARSER::COLLECTION) ("serrated" . SPARSER::PROTEIN)
    ("BRAF, KRAS, or epidermal growth factor receptor" . SPARSER::COLLECTION)
    ("EGFR" . SPARSER::PROTEIN) ("KRAS" . SPARSER::PROTEIN)
    ("BRAF" . SPARSER::PROTEIN) ("Aims" . SPARSER::PROTEIN)
    ("PD0325901" . SPARSER::DRUG) ("MEK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("heparan sulfate proteoglycan" . SPARSER::PROTEIN)
    ("ERBB4" . SPARSER::PROTEIN) ("Msh6" . SPARSER::PROTEIN)
    ("Msh2" . SPARSER::PROTEIN) ("Ki67" . SPARSER::PROTEIN)
    ("– 3" . SPARSER::PROTEIN) ("INK4a" . SPARSER::PROTEIN)
    ("transmembrane protein" . SPARSER::PROTEIN)
    ("P-ERK1/2" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ink4a" . SPARSER::PROTEIN) ("p16 INK4a" . SPARSER::PROTEIN)
    ("MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("G-protein–coupled receptor" . SPARSER::PROTEIN)
    ("US28" . SPARSER::PROTEIN) ("ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HB-EGF" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Commercially available JAK2 inhibitors" . SPARSER::INHIBITOR)
    ("light" . SPARSER::PROTEIN) ("JAK2, MPL and SH2B3" . SPARSER::COLLECTION)
    ("regulators" . SPARSER::REGULATOR) ("JAK2 or MPL" . SPARSER::COLLECTION)
    ("TET2 or genes" . SPARSER::COLLECTION)
    ("HR or gene" . SPARSER::COLLECTION) ("Leukemia" . SPARSER::PROTEIN)
    ("examples" . SPARSER::EXAMPLE) ("IDS" . SPARSER::PROTEIN)
    ("respectively carry co-incident JAK2 exon" . SPARSER::PROTEIN)
    ("those rare PV" . SPARSER::PROTEIN) ("JAK2 and MPL" . SPARSER::COLLECTION)
    ("prone" . SPARSER::PROTEIN-FAMILY)
    ("these MPN-associated mutant proteins" . SPARSER::PROTEIN)
    ("BCR/ABL" . SPARSER::COLLECTION) ("JAK2 or ABL" . SPARSER::COLLECTION)
    ("imatinib" . SPARSER::DRUG) ("ABL" . SPARSER::PROTEIN)
    ("BCR" . SPARSER::PROTEIN) ("ion" . SPARSER::MOLECULE)
    ("asparagine" . SPARSER::AMINO-ACID) ("Targets" . SPARSER::TARGET-PROTEIN)
    ("heterochromatin" . SPARSER::PROTEIN)
    ("LMO2, NANOG and MYC" . SPARSER::COLLECTION) ("NANOG" . SPARSER::PROTEIN)
    ("promoters" . SPARSER::PROMOTER) ("tyrosine" . SPARSER::AMINO-ACID)
    ("histone" . SPARSER::PROTEIN) ("otherwise silenced genes" . SPARSER::GENE)
    ("Hp1" . SPARSER::PROTEIN) ("Hop" . SPARSER::PROTEIN)
    ("modifiers" . SPARSER::MOLECULE) ("ROS" . SPARSER::PROTEIN)
    ("oxygen" . SPARSER::MOLECULE) ("LSK" . SPARSER::PROTEIN)
    ("ASXL1, TET2, EZH2 or DNMT3A" . SPARSER::COLLECTION)
    ("homozygous JAK2 exon" . SPARSER::PROTEIN) ("LV" . SPARSER::MOLECULE)
    ("transgene" . SPARSER::PROTEIN)
    ("the Ph chromosome-negative MPNs" . SPARSER::PROTEIN)
    ("TET2 or DNMT3A" . SPARSER::COLLECTION) ("HSCs" . SPARSER::PROTEIN)
    ("DNMT3A or TET2" . SPARSER::COLLECTION)
    ("TET2, ASXL1, DNMT3A and EZH2" . SPARSER::COLLECTION)
    ("chronic myelomonocytic leukemia (CMML)" . SPARSER::PROTEIN)
    ("MDS" . SPARSER::PROTEIN)
    ("TET2, ASXL1, DNMT3A or EZH2" . SPARSER::COLLECTION)
    ("JAK1, JAK3, TYK2, STAT5A or STAT5B" . SPARSER::COLLECTION)
    ("JAK/STAT" . SPARSER::COLLECTION) ("ATP-competitive" . SPARSER::ATP)
    ("JAK" . SPARSER::PROTEIN) ("ATP" . SPARSER::ATP)
    ("JAK2, MPL or SH2B3" . SPARSER::COLLECTION) ("LNK" . SPARSER::PROTEIN)
    ("trans" . SPARSER::PROTEIN-FAMILY)
    ("thrombopoietin (TPO)" . SPARSER::PROTEIN) ("TPO" . SPARSER::PROTEIN)
    ("thrombopoietin" . SPARSER::PROTEIN) ("MPL" . SPARSER::PROTEIN)
    ("STAT, AKT and ERK" . SPARSER::COLLECTION) ("STAT" . SPARSER::PROTEIN)
    ("cytokine" . SPARSER::PROTEIN) ("erythropoietin (EPO)" . SPARSER::PROTEIN)
    ("erythroid" . SPARSER::PROTEIN) ("EPO" . SPARSER::PROTEIN)
    ("erythropoietin" . SPARSER::PROTEIN) ("JH" . SPARSER::PROTEIN)
    ("phenylalanine" . SPARSER::AMINO-ACID) ("valine" . SPARSER::AMINO-ACID)
    ("polypeptides" . SPARSER::PEPTIDE)
    ("the Philadelphia chromosome (Ph)-negative MPNs" . SPARSER::PROTEIN)
    ("methylcellulose" . SPARSER::DRUG)
    ("chronic neutrophilic leukemia" . SPARSER::PROTEIN)
    ("PV" . SPARSER::PROTEIN)
    ("acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("MPNs" . SPARSER::PROTEIN) ("STAT3" . SPARSER::PROTEIN)
    ("Na + /H +" . SPARSER::PROTEIN) ("NHE-1" . SPARSER::PROTEIN)
    ("Bcl-x" . SPARSER::PROTEIN) ("BCR-ABL" . SPARSER::PROTEIN)
    ("γH2AX" . SPARSER::PROTEIN) ("L3MBTL1" . SPARSER::PROTEIN)
    ("LMO2" . SPARSER::PROTEIN) ("HP1α" . SPARSER::PROTEIN)
    ("heterochromatin protein-1" . SPARSER::PROTEIN)
    ("γ-H2AX" . SPARSER::PROTEIN) ("pro-B" . SPARSER::DRUG)
    ("Tet2" . SPARSER::PROTEIN) ("Dnmt3a" . SPARSER::PROTEIN)
    ("EZH2" . SPARSER::PROTEIN) ("DNMT3A" . SPARSER::PROTEIN)
    ("ASXL1" . SPARSER::PROTEIN) ("TET2" . SPARSER::PROTEIN)
    ("STAT5B" . SPARSER::PROTEIN) ("STAT5A" . SPARSER::PROTEIN)
    ("TYK2" . SPARSER::PROTEIN) ("JAK3" . SPARSER::PROTEIN)
    ("JAK1" . SPARSER::PROTEIN) ("SH2B3" . SPARSER::PROTEIN)
    ("G6PD" . SPARSER::PROTEIN)
    ("glucose-6-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("JAK2" . SPARSER::PROTEIN) ("Janus kinase 2" . SPARSER::PROTEIN)
    ("myotonic dystrophy protein kinase" . SPARSER::KINASE)
    ("myotonic dystrophy kinase-related Cdc42-binding kinase"
     . SPARSER::KINASE)
    ("Rho-associated kinase" . SPARSER::KINASE)
    ("Rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LATS1 and Gwl" . SPARSER::COLLECTION)
    ("PKA, PKG, and PKC" . SPARSER::COLLECTION) ("PKC" . SPARSER::PROTEIN)
    ("PKG" . SPARSER::PROTEIN) ("PKA" . SPARSER::PROTEIN)
    ("MASTL" . SPARSER::PROTEIN)
    ("closely related heat-stable proteins" . SPARSER::PROTEIN)
    ("endosulfine" . SPARSER::PROTEIN-FAMILY) ("Gwl" . SPARSER::PROTEIN)
    ("Greatwall" . SPARSER::PROTEIN)
    ("kinases and phosphatases" . SPARSER::COLLECTION)
    ("Cdc14B and Cdh1" . SPARSER::COLLECTION)
    ("LATS1, Cdc14B, and Cdh1" . SPARSER::COLLECTION)
    ("LATS1–MYPT1–PP1C" . SPARSER::COLLECTION)
    ("YAP1–p73" . SPARSER::COLLECTION)
    ("Wee1, or Claspin" . SPARSER::COLLECTION) ("ataxia" . SPARSER::PROTEIN)
    ("which targets PLK1" . SPARSER::PROTEIN)
    ("anaphase-promoting complex/cyclosome" . SPARSER::COLLECTION)
    ("cyclosome" . SPARSER::PROTEIN) ("Cdc14B" . SPARSER::PROTEIN)
    ("homologue" . SPARSER::PROTEIN) ("PLK1 and MYPT1" . SPARSER::COLLECTION)
    ("MYPT1 and PLK1" . SPARSER::COLLECTION) ("CD" . SPARSER::PROTEIN)
    ("a smaller subunit" . SPARSER::FRAGMENT) ("holoenzyme" . SPARSER::PROTEIN)
    ("Phosphoproteomic screening identified MYPT1" . SPARSER::PROTEIN)
    ("Claspin and Wee1" . SPARSER::COLLECTION) ("Claspin" . SPARSER::PROTEIN)
    ("LATS1-" . SPARSER::PROTEIN) ("doxorubicin (DRB)" . SPARSER::PROTEIN)
    ("DRB" . SPARSER::PROTEIN) ("double-thymidine" . SPARSER::PROTEIN)
    ("thymidine" . SPARSER::PROTEIN)
    ("an MYPT1 phospho-S445–specific antibody" . SPARSER::PROTEIN)
    ("IR" . SPARSER::PROTEIN) ("a mitotic kinase" . SPARSER::KINASE)
    ("LATS1–MYPT1" . SPARSER::COLLECTION) ("GST-fused" . SPARSER::COLLECTION)
    ("GST-PP1C" . SPARSER::COLLECTION)
    ("phosphomimic mutant" . SPARSER::MUTANT)
    ("MEFs, and PLK1" . SPARSER::COLLECTION)
    ("Homozygous KO (LATS1 −/− ) MEFs" . SPARSER::PROTEIN)
    ("Eg5" . SPARSER::PROTEIN) ("Noc" . SPARSER::PROTEIN)
    ("nocodazole" . SPARSER::DRUG) ("LATS1 and PLK1" . SPARSER::COLLECTION)
    ("MYPT1–PP1C" . SPARSER::COLLECTION)
    ("His-x-Arg/His/Lys-x-x-Ser/Thr" . SPARSER::COLLECTION)
    ("mixture" . SPARSER::MOLECULE) ("Cdk1–Cyclin" . SPARSER::COLLECTION)
    ("oligonucleotide" . SPARSER::MOLECULE) ("Threonine" . SPARSER::AMINO-ACID)
    ("Serine" . SPARSER::AMINO-ACID)
    ("both exogenous and endogenous LATS1" . SPARSER::PROTEIN)
    ("MYPT1-CD" . SPARSER::PROTEIN-PAIR) ("ANK" . SPARSER::PROTEIN)
    ("ankyrin" . SPARSER::PROTEIN)
    ("MYPT1, PP1C and PLK1" . SPARSER::COLLECTION)
    ("antibody, and MYPT1" . SPARSER::COLLECTION)
    ("a mature form" . SPARSER::FORM) ("Omi/HtrA2" . SPARSER::COLLECTION)
    ("protease" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Omi" . SPARSER::PROTEIN)
    ("Myc-MYPT1" . SPARSER::COLLECTION) ("Myc" . SPARSER::PROTEIN)
    ("LATS1 and MYPT1" . SPARSER::COLLECTION) ("–1" . SPARSER::PROTEIN)
    ("the exogenous kinase" . SPARSER::KINASE) ("spiking" . SPARSER::PROTEIN)
    ("RB" . SPARSER::PROTEIN) ("MYPT1 and SAPS3" . SPARSER::COLLECTION)
    ("thermosensitive alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("previously unknown targets" . SPARSER::TARGET-PROTEIN)
    ("MP" . SPARSER::PROTEIN) ("phosphatases" . SPARSER::PHOSPHATASE)
    ("kinase and Cdc14" . SPARSER::COLLECTION)
    ("ezrin, radixin, and moesin" . SPARSER::COLLECTION)
    ("cues" . SPARSER::PROTEIN-FAMILY) ("moesin" . SPARSER::PROTEIN)
    ("radixin" . SPARSER::PROTEIN) ("ezrin" . SPARSER::PROTEIN)
    ("Merlin" . SPARSER::PROTEIN) ("LATS" . SPARSER::PROTEIN)
    ("Hpo" . SPARSER::PROTEIN) ("Cdc15 and Dbf2" . SPARSER::COLLECTION)
    ("a mitotic Cdk-counteracting phosphatase" . SPARSER::PHOSPHATASE)
    ("Cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the many known mitotic kinases" . SPARSER::KINASE)
    ("mitotic kinases" . SPARSER::KINASE) ("Dbf2" . SPARSER::PROTEIN)
    ("phosphatase" . SPARSER::PHOSPHATASE)
    ("Histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-mercaptoethanol" . SPARSER::MOLECULE) ("MnCl 2" . SPARSER::DRUG)
    ("SP5" . SPARSER::PROTEIN) ("γ-tubulin" . SPARSER::PROTEIN)
    ("S2" . SPARSER::MOLECULE) ("Cdc25A" . SPARSER::PROTEIN)
    ("B-5" . SPARSER::PROTEIN) ("α-tubulin" . SPARSER::PROTEIN)
    ("c-Myc" . SPARSER::PROTEIN) ("Tween 20" . SPARSER::MOLECULE)
    ("GL2" . SPARSER::DRUG) ("F12" . SPARSER::PROTEIN)
    ("S6 E" . SPARSER::PROTEIN-FAMILY) ("lactic acid" . SPARSER::MOLECULE)
    ("Lys-C" . SPARSER::PROTEIN) ("NP-40" . SPARSER::DRUG)
    ("Cdc42" . SPARSER::PROTEIN)
    ("cAMP-regulated phosphoprotein" . SPARSER::PROTEIN)
    ("ARPP-19" . SPARSER::PROTEIN) ("p73" . SPARSER::PROTEIN)
    ("anaphase-promoting complex" . SPARSER::PROTEIN)
    ("Clp1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("3 D" . SPARSER::PROTEIN-FAMILY)
    ("S19" . SPARSER::PROTEIN) ("myosin light chain" . SPARSER::PROTEIN)
    ("20 kD" . SPARSER::PROTEIN) ("checkpoint kinase 1" . SPARSER::PROTEIN)
    ("NUAK1" . SPARSER::PROTEIN) ("PHAS-I" . SPARSER::PROTEIN)
    ("1–4" . SPARSER::PROTEIN) ("2–4" . SPARSER::PROTEIN)
    ("Wee1" . SPARSER::PROTEIN) ("Cdc25" . SPARSER::PROTEIN)
    ("full-length" . SPARSER::PROTEIN)
    ("cGMP-dependent protein kinase I" . SPARSER::PROTEIN)
    ("HtrA2" . SPARSER::PROTEIN) ("Myc-tagged" . SPARSER::PROTEIN)
    ("B/Cdk1" . SPARSER::PROTEIN) ("PP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SAPS3" . SPARSER::PROTEIN)
    ("Yes-associated protein 1" . SPARSER::PROTEIN) ("YAP1" . SPARSER::PROTEIN)
    ("alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("PP1C" . SPARSER::PROTEIN) ("subunit 1" . SPARSER::PROTEIN)
    ("myosin phosphatase" . SPARSER::PROTEIN) ("family 1" . SPARSER::PROTEIN)
    ("RASSF1A" . SPARSER::PROTEIN)
    ("ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("protein phosphatase 2" . SPARSER::PROTEIN) ("PP2A" . SPARSER::PROTEIN)
    ("Cdc15" . SPARSER::PROTEIN) ("Tem1" . SPARSER::PROTEIN)
    ("Ras-like GTPase" . SPARSER::PROTEIN)
    ("myosin phosphatase–targeting subunit 1" . SPARSER::PROTEIN)
    ("Cdc14" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PLK1" . SPARSER::PROTEIN)
    ("MYPT1" . SPARSER::PROTEIN) ("LATS1" . SPARSER::PROTEIN)
    ("APB and TIF" . SPARSER::COLLECTION) ("PML-VI" . SPARSER::PROTEIN-PAIR)
    ("promoting APB or reducing TIF" . SPARSER::COLLECTION)
    ("PML-IV–tethered proteins" . SPARSER::PROTEIN)
    ("trigger" . SPARSER::PROTEIN) ("elongation" . SPARSER::PROTEIN)
    ("the nucleoplasmic mutant" . SPARSER::MUTANT)
    ("RAD51 (FLAG) and TRF1-So (HA)" . SPARSER::COLLECTION)
    ("RAD51 and TRF1-So" . SPARSER::COLLECTION)
    ("RAD51 and TRF1-So or PML-IV" . SPARSER::COLLECTION)
    ("nontelomeric RAD51 foci" . SPARSER::PROTEIN)
    ("NS knockdown increases nontelomeric RAD51 foci" . SPARSER::PROTEIN)
    ("telomere-associated RAD51 foci" . SPARSER::PROTEIN)
    ("TRF1-GFP" . SPARSER::COLLECTION) ("Quantitative FISH" . SPARSER::PROTEIN)
    ("PML-KD" . SPARSER::COLLECTION) ("Tel-FISH" . SPARSER::COLLECTION)
    ("FISH" . SPARSER::PROTEIN) ("Tel" . SPARSER::PROTEIN)
    ("TRF1 and PML" . SPARSER::COLLECTION)
    ("a topoisomerase II inhibitor" . SPARSER::INHIBITOR)
    ("topoisomerase" . SPARSER::PROTEIN) ("etoposide" . SPARSER::PROTEIN)
    ("TRF1 and TRF1-So" . SPARSER::COLLECTION)
    ("A PML-IV-specific siRNA" . SPARSER::PROTEIN)
    ("TRF1 and PML-IV" . SPARSER::COLLECTION)
    ("APB- and TIF-regulatory" . SPARSER::COLLECTION)
    ("APB-" . SPARSER::PROTEIN) ("APB/PML" . SPARSER::COLLECTION)
    ("states" . SPARSER::BIO-STATE) ("Lys" . SPARSER::AMINO-ACID)
    ("SUMO" . SPARSER::PROTEIN) ("SUMO1-fused" . SPARSER::COLLECTION)
    ("fused" . SPARSER::PROTEIN) ("TRF1 and MMS21" . SPARSER::COLLECTION)
    ("ligase" . SPARSER::LIGASE) ("foci, or TRF1-gfp" . SPARSER::COLLECTION)
    ("TRF1-gfp" . SPARSER::PROTEIN-PAIR)
    ("a nucleoplasmic mutant" . SPARSER::MUTANT) ("APBs" . SPARSER::PROTEIN)
    ("an essential component" . SPARSER::COMPONENT)
    ("nontelomeric (IDF, interstitial damage foci) damage foci"
     . SPARSER::PROTEIN)
    ("TIF" . SPARSER::PROTEIN)
    ("the telomeric proteins, telomeric repeat-binding factor 1 (TRF1; xref , xref ; xref )"
     . SPARSER::PROTEIN)
    ("paralogue" . SPARSER::PROTEIN)
    ("a nucleolar GTP-binding protein" . SPARSER::PROTEIN)
    ("A potential molecule" . SPARSER::MOLECULE)
    ("molecule" . SPARSER::MOLECULE)
    ("several PML-associated proteins" . SPARSER::PROTEIN)
    ("TRF1 and TRF2" . SPARSER::COLLECTION)
    ("RAD52, and RPA" . SPARSER::COLLECTION) ("RPA" . SPARSER::PROTEIN)
    ("HR" . SPARSER::PROTEIN) ("DNAs" . SPARSER::DNA)
    ("APB" . SPARSER::PROTEIN) ("TA" . SPARSER::PROTEIN)
    ("PML" . SPARSER::PROTEIN) ("nucleostemin" . SPARSER::PROTEIN)
    ("Rad51" . SPARSER::PROTEIN) ("PG-M" . SPARSER::PROTEIN)
    ("GNL3" . SPARSER::PROTEIN) ("core protein" . SPARSER::PROTEIN)
    ("anti–" . SPARSER::ANTIBODY) ("SUMO-1" . SPARSER::PROTEIN)
    ("SUMO1" . SPARSER::PROTEIN) ("MMS21" . SPARSER::PROTEIN)
    ("E2" . SPARSER::MOLECULE) ("E1" . SPARSER::MOLECULE)
    ("aa 1" . SPARSER::PROTEIN) ("E3" . SPARSER::MOLECULE)
    ("siRNA-mediated" . SPARSER::PROTEIN)
    ("factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GNL3L" . SPARSER::PROTEIN)
    ("guanine nucleotide-binding protein-like 3" . SPARSER::PROTEIN)
    ("GTP-binding protein" . SPARSER::PROTEIN) ("RAD52" . SPARSER::PROTEIN)
    ("telomerase activity" . SPARSER::PROTEIN) ("TRF2" . SPARSER::PROTEIN)
    ("TRF1" . SPARSER::PROTEIN) ("RAD51" . SPARSER::PROTEIN)
    ("a potential drug target" . SPARSER::TARGET-PROTEIN)
    ("JNK, Erk and p38" . SPARSER::COLLECTION) ("MAPKKK" . SPARSER::PROTEIN)
    ("Erk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("JNK" . SPARSER::PROTEIN)
    ("activator" . SPARSER::ACTIVATOR) ("hepatocytes" . SPARSER::PROTEIN)
    ("TAK1 and IKK" . SPARSER::COLLECTION) ("GO" . SPARSER::PROTEIN)
    ("myeloid" . SPARSER::PROTEIN) ("Hook" . SPARSER::PROTEIN-FAMILY)
    ("triterpene" . SPARSER::MOLECULE) ("quinone" . SPARSER::PROTEIN)
    ("TNFα, or IL-1" . SPARSER::COLLECTION)
    ("TβRII and TAK1" . SPARSER::COLLECTION)
    ("TβRII or SMAD4" . SPARSER::COLLECTION)
    ("TGFβ and TAK1" . SPARSER::COLLECTION)
    ("TβRII-SMAD" . SPARSER::COLLECTION)
    ("TAK1 and SMAD7" . SPARSER::COLLECTION)
    ("SMAD or NF-κB" . SPARSER::COLLECTION) ("fraction" . SPARSER::COMPONENT)
    ("p65-NF-κB" . SPARSER::COLLECTION)
    ("phospho-p65 and/or signal SMADs" . SPARSER::COLLECTION)
    ("TAK1-p65-NF-κB" . SPARSER::COLLECTION)
    ("strong (++) p-p65" . SPARSER::COLLECTION)
    ("SMAD7 and the phosphorylated/activated NF-κB subunit p65"
     . SPARSER::COLLECTION)
    ("SMAD7 and NF-κB" . SPARSER::COLLECTION) ("RI" . SPARSER::MOLECULE)
    ("celastrol" . SPARSER::MOLECULE) ("TAK1 and p65" . SPARSER::COLLECTION)
    ("matrigel" . SPARSER::PROTEIN) ("FBS" . SPARSER::PROTEIN)
    ("partial" . SPARSER::PROTEIN) ("TAK1 and SMAD2" . SPARSER::COLLECTION)
    ("10% serum -/+ supplemental TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SMAD and TAK1" . SPARSER::COLLECTION) ("siRNAs" . SPARSER::PROTEIN)
    ("TGF-β and TAK1" . SPARSER::COLLECTION)
    ("TGF-β and TNF-α" . SPARSER::COLLECTION)
    ("IκB-luciferase" . SPARSER::COLLECTION)
    ("TNFα and TGF-β" . SPARSER::COLLECTION) ("p—p65" . SPARSER::COLLECTION)
    ("ser" . SPARSER::AMINO-ACID) ("NF-κB-luciferase" . SPARSER::COLLECTION)
    ("TAK1-IKK-NF-κB" . SPARSER::COLLECTION) ("TNFα-" . SPARSER::PROTEIN)
    ("IKK-NF-κB" . SPARSER::COLLECTION) ("p-IκBα" . SPARSER::COLLECTION)
    ("p-IKK" . SPARSER::COLLECTION) ("p-p65" . SPARSER::COLLECTION)
    ("p-TAK1" . SPARSER::COLLECTION) ("weaker" . SPARSER::PROTEIN)
    ("TAK1 and phospho-p65" . SPARSER::COLLECTION)
    ("TAK1-NF-κB" . SPARSER::COLLECTION) ("RELA/p65" . SPARSER::COLLECTION)
    ("the TGFβR2" . SPARSER::PROTEIN) ("SMAD3 and SMAD7" . SPARSER::COLLECTION)
    ("Western blot" . SPARSER::PROTEIN)
    ("TβRII and SMADs" . SPARSER::COLLECTION) ("HOK" . SPARSER::PROTEIN)
    ("keratinocytes" . SPARSER::PROTEIN)
    ("immediate downstream canonical signaling substrates"
     . SPARSER::SUBSTRATE)
    ("p-SMAD3" . SPARSER::COLLECTION) ("p-SMAD2" . SPARSER::COLLECTION)
    ("strong (++) TβRII" . SPARSER::PROTEIN)
    ("TGF-β-SMAD" . SPARSER::COLLECTION) ("Receptor" . SPARSER::RECEPTOR)
    ("NF-κB and SMAD7" . SPARSER::COLLECTION)
    ("NF-κB and TGF-β" . SPARSER::COLLECTION)
    ("TAK1 siRNA and a known TAK1 inhibitor" . SPARSER::COLLECTION)
    ("TNFα or IL-1" . SPARSER::COLLECTION)
    ("IKKα and IKKβ" . SPARSER::COLLECTION)
    ("SMAD and TGF-β" . SPARSER::COLLECTION) ("NEMO" . SPARSER::PROTEIN)
    ("linkers" . SPARSER::LINKER) ("Kinase" . SPARSER::KINASE)
    ("KappaB" . SPARSER::PROTEIN) ("Inhibitor" . SPARSER::INHIBITOR)
    ("IL-1α and TNF-α" . SPARSER::COLLECTION)
    ("NF-κB/RELA" . SPARSER::COLLECTION)
    ("a heterodimeric complex" . SPARSER::BIO-COMPLEX)
    ("SMAD2 and SMAD3" . SPARSER::COLLECTION)
    ("TGF-β-NF-κB" . SPARSER::COLLECTION)
    ("TAK1 and NF-κB" . SPARSER::COLLECTION)
    ("SMAD and NF-κB" . SPARSER::COLLECTION)
    ("SMAD" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGF-β and RELA" . SPARSER::COLLECTION)
    ("traditional Chinese medicine" . SPARSER::DRUG)
    ("TAK1 and RELA" . SPARSER::COLLECTION) ("TGF-β1-" . SPARSER::PROTEIN)
    ("Celastrol" . SPARSER::MOLECULE)
    ("IKK, IκB, and RELA" . SPARSER::COLLECTION)
    ("TAK1, IKK, IκBα, and RELA" . SPARSER::COLLECTION)
    ("IKK" . SPARSER::PROTEIN) ("RELA" . SPARSER::PROTEIN)
    ("TGF-β and NF-κB" . SPARSER::COLLECTION)
    ("Transcription Factor" . SPARSER::PROTEIN)
    ("p3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitogen-activated protein kinase kinase kinase" . SPARSER::PROTEIN)
    ("MAPK kinase" . SPARSER::PROTEIN)
    ("TGF-βs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TGF-β2" . SPARSER::PROTEIN)
    ("R-SMAD" . SPARSER::PROTEIN-FAMILY) ("IκB-α" . SPARSER::PROTEIN)
    ("p-65" . SPARSER::PROTEIN) ("1-2" . SPARSER::PROTEIN)
    ("TP53" . SPARSER::PROTEIN) ("IL-8" . SPARSER::PROTEIN)
    ("PAI1" . SPARSER::PROTEIN) ("SMAD 2" . SPARSER::PROTEIN)
    ("TGFβR" . SPARSER::PROTEIN) ("SMADs 2" . SPARSER::PROTEIN)
    ("IKKγ" . SPARSER::PROTEIN) ("IKKβ" . SPARSER::PROTEIN)
    ("IKKα" . SPARSER::PROTEIN) ("IL-1" . SPARSER::PROTEIN)
    ("IL-1α" . SPARSER::PROTEIN) ("TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SMAD4" . SPARSER::PROTEIN) ("SMAD3" . SPARSER::PROTEIN)
    ("SMAD2" . SPARSER::PROTEIN) ("TβRI" . SPARSER::PROTEIN)
    ("TβRII" . SPARSER::PROTEIN) ("SMAD7" . SPARSER::PROTEIN)
    ("Annexin V" . SPARSER::PROTEIN) ("TNFα" . SPARSER::PROTEIN)
    ("NF–κB" . SPARSER::PROTEIN) ("IκB" . SPARSER::PROTEIN)
    ("IκBα" . SPARSER::PROTEIN) ("TGF-β1" . SPARSER::PROTEIN)
    ("p65" . SPARSER::PROTEIN) ("TAK1" . SPARSER::PROTEIN)
    ("NF-κB" . SPARSER::PROTEIN) ("Factor-κB" . SPARSER::PROTEIN)
    ("TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("prolines" . SPARSER::AMINO-ACID) ("PI and Fyn" . SPARSER::COLLECTION)
    ("chemical" . SPARSER::MOLECULE) ("PI or ALIX" . SPARSER::COLLECTION)
    ("PI" . SPARSER::PROTEIN) ("apo-ALIX" . SPARSER::COLLECTION)
    ("apo" . SPARSER::PROTEIN) ("PRR and part" . SPARSER::COLLECTION)
    ("GST" . SPARSER::PROTEIN) ("uracil" . SPARSER::DRUG)
    ("arginine" . SPARSER::AMINO-ACID) ("Fyn" . SPARSER::PROTEIN)
    ("isoleucine" . SPARSER::AMINO-ACID) ("PPII" . SPARSER::PROTEIN)
    ("ALIX" . SPARSER::PROTEIN) ("Isoleucine" . SPARSER::AMINO-ACID)
    ("the viral Nef protein" . SPARSER::PROTEIN) ("actin" . SPARSER::PROTEIN)
    ("Kinases" . SPARSER::KINASE)
    ("TSG101 and Src-homology" . SPARSER::COLLECTION)
    ("proline" . SPARSER::AMINO-ACID) ("PRR" . SPARSER::PROTEIN)
    ("various viral and cellular proteins" . SPARSER::PROTEIN)
    ("Alix-Hck" . SPARSER::COLLECTION) ("Hck" . SPARSER::PROTEIN)
    ("Alix" . SPARSER::PROTEIN) ("protein-protein" . SPARSER::COLLECTION)
    ("SH" . SPARSER::PROTEIN-FAMILY) ("Homology" . SPARSER::PROTEIN)
    ("Src" . SPARSER::PROTEIN) ("3D" . SPARSER::PROTEIN-FAMILY)
    ("SAM68" . SPARSER::PROTEIN) ("β-Galactosidase" . SPARSER::PROTEIN)
    ("ID 1" . SPARSER::PROTEIN) ("H- 15" . SPARSER::PROTEIN)
    ("SH3 protein" . SPARSER::PROTEIN) ("HS3" . SPARSER::PROTEIN)
    ("protein Nef" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Hematopoietic cell kinase" . SPARSER::PROTEIN)
    ("three domains" . SPARSER::PROTEIN) ("gene 2" . SPARSER::PROTEIN)
    ("ALG-2" . SPARSER::PROTEIN) ("a 3D" . SPARSER::PROTEIN)
    ("Gene 2" . SPARSER::PROTEIN) ("underwent EMT" . SPARSER::PROTEIN)
    ("ED-A or ED-B" . SPARSER::COLLECTION)
    ("two different complete type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("gold" . SPARSER::MOLECULE) ("Ncad and vimentin" . SPARSER::COLLECTION)
    ("BSA" . SPARSER::PROTEIN) ("agarose" . SPARSER::MOLECULE)
    ("whose Thr" . SPARSER::AMINO-ACID)
    ("Val-Thr-His-Pro-Gly-Tyr" . SPARSER::COLLECTION)
    ("-acetylgalactosaminyltransferase" . SPARSER::COLLECTION)
    ("acetylgalactosaminyltransferase" . SPARSER::PROTEIN)
    ("polypeptide" . SPARSER::PROTEIN) ("Tyr" . SPARSER::AMINO-ACID)
    ("Gly" . SPARSER::AMINO-ACID) ("Val" . SPARSER::AMINO-ACID)
    ("Gal" . SPARSER::PROTEIN) ("mAb FDC6" . SPARSER::PROTEIN)
    ("immunogen" . SPARSER::MOLECULE) ("FDC" . SPARSER::PROTEIN)
    ("mAb" . SPARSER::DRUG) ("Ncad" . SPARSER::PROTEIN)
    ("vimentin" . SPARSER::PROTEIN) ("Ecad" . SPARSER::PROTEIN)
    ("carbohydrate" . SPARSER::MOLECULE) ("glycoproteins" . SPARSER::PROTEIN)
    ("GSLs" . SPARSER::PROTEIN) ("glycosphingolipids" . SPARSER::MOLECULE)
    ("TGF" . SPARSER::DRUG) ("oncofetal FN" . SPARSER::PROTEIN)
    ("FN" . SPARSER::PROTEIN) ("fibronectin" . SPARSER::PROTEIN)
    ("EMT" . SPARSER::PROTEIN) ("ED-B" . SPARSER::PROTEIN)
    ("ED-A" . SPARSER::PROTEIN) ("g protein" . SPARSER::PROTEIN)
    ("protein A" . SPARSER::PROTEIN) ("SP2" . SPARSER::PROTEIN)
    ("serum albumin" . SPARSER::PROTEIN) ("IgG1" . SPARSER::BIO-COMPLEX)
    ("CO 2" . SPARSER::PROTEIN) ("UDP-" . SPARSER::PROTEIN)
    ("TGFβ1" . SPARSER::PROTEIN) ("type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GalNAcα" . SPARSER::MOLECULE) ("O-glycan" . SPARSER::MOLECULE)
    ("N-cadherin" . SPARSER::PROTEIN) ("E-cadherin" . SPARSER::PROTEIN)
    ("transforming growth factor" . SPARSER::PROTEIN)
    ("monoclonal antibody" . SPARSER::DRUG)
    ("mRNA and gene" . SPARSER::COLLECTION) ("biomarker" . SPARSER::MOLECULE)
    ("anti-HER2/neu" . SPARSER::COLLECTION) ("anti" . SPARSER::PROTEIN)
    ("neu" . SPARSER::PROTEIN) ("Tamoxifen" . SPARSER::MOLECULE)
    ("intestinal type" . TYPE) ("TMA" . SPARSER::MOLECULE)
    ("blot" . SPARSER::PROTEIN) ("thyroid" . SPARSER::PROTEIN)
    ("pT1 and pT2" . SPARSER::COLLECTION) ("TNM" . SPARSER::MOLECULE)
    ("potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("c-kit" . SPARSER::PROTEIN) ("C-MET" . SPARSER::PROTEIN)
    ("–2" . SPARSER::PROTEIN) ("c- MET" . SPARSER::PROTEIN)
    ("hydrogen peroxide" . SPARSER::MOLECULE) ("beta chain" . SPARSER::PROTEIN)
    ("Hepatocyte Growth Factor" . SPARSER::PROTEIN)
    ("tyrosine kinase" . SPARSER::PROTEIN) ("pT1" . SPARSER::PROTEIN)
    ("a 2 " . SPARSER::HUMAN-PROTEIN-FAMILY) ("c-MET" . SPARSER::PROTEIN)
    ("rational therapeutics" . SPARSER::THERAPEUTICS) ("drug" . SPARSER::DRUG)
    ("PTEN, and AKT" . SPARSER::COLLECTION)
    ("BKM120, BEZ235, and XL147" . SPARSER::COLLECTION)
    ("pan-PI3K inhibitors, PI3Kα inhibitors, and dual PI3K/mTOR inhibitors"
     . SPARSER::COLLECTION)
    ("dual PI3K/mTOR inhibitors" . SPARSER::INHIBITOR)
    ("PI3K/mTOR" . SPARSER::COLLECTION) ("Inhibitors" . SPARSER::INHIBITOR)
    ("tamoxifen or aromatase" . SPARSER::COLLECTION)
    ("aromatase" . SPARSER::PROTEIN) ("PI3K and ER" . SPARSER::COLLECTION)
    ("tamoxifen" . SPARSER::MOLECULE) ("x-ray" . SPARSER::COLLECTION)
    ("ray" . SPARSER::PROTEIN) ("estrogen" . SPARSER::MOLECULE)
    ("barrier" . SPARSER::PROTEIN) ("GEM" . SPARSER::PROTEIN)
    ("HER-2-" . SPARSER::PROTEIN) ("hormone" . SPARSER::MOLECULE)
    ("ER" . SPARSER::PROTEIN) ("pik" . SPARSER::BIO-COMPLEX)
    ("PTEN" . SPARSER::PROTEIN) ("the HD and the KD" . SPARSER::COLLECTION)
    ("KD" . SPARSER::PROTEIN) ("HD" . SPARSER::PROTEIN)
    ("PIK3CA , PIK3CB , and PIK3CD" . SPARSER::COLLECTION)
    ("two shorter isoforms" . SPARSER::ISOFORM)
    ("PIK3R1 , PIK3R2 , and PIK3R3" . SPARSER::COLLECTION)
    ("isoforms" . SPARSER::ISOFORM) ("FOXO" . SPARSER::PROTEIN-FAMILY)
    ("Bad" . SPARSER::PROTEIN) ("serine/threonine" . SPARSER::COLLECTION)
    ("AKT" . SPARSER::HUMAN-PROTEIN-FAMILY) ("threonine" . SPARSER::AMINO-ACID)
    ("serine" . SPARSER::AMINO-ACID)
    ("phosphatidylinositol" . SPARSER::PROTEIN)
    ("receptors" . SPARSER::PROTEIN) ("RTK" . SPARSER::PROTEIN)
    ("ligand" . SPARSER::LIGAND) ("IB" . SPARSER::DRUG)
    ("IA" . SPARSER::MOLECULE) ("class" . CLASS)
    ("heterodimer" . SPARSER::HETERODIMER)
    ("homology and substrate" . SPARSER::COLLECTION)
    ("homology" . SPARSER::PROTEIN) ("classes" . CLASS)
    ("phospholipids" . SPARSER::PHOSPHOLIPID) ("inositol" . SPARSER::PROTEIN)
    ("lipid" . SPARSER::LIPID) ("kinases" . SPARSER::PROTEIN)
    ("therapeutics" . SPARSER::THERAPEUTICS) ("XL147" . SPARSER::DRUG)
    ("BEZ235" . SPARSER::DRUG) ("BKM120" . SPARSER::DRUG)
    ("PI3Kα" . SPARSER::PROTEIN) ("a 15" . SPARSER::PROTEIN)
    ("HER-2" . SPARSER::PROTEIN) ("HER2" . SPARSER::PROTEIN)
    ("AKT1" . SPARSER::PROTEIN) ("kinase activity" . SPARSER::PROTEIN)
    ("Ras-binding" . SPARSER::PROTEIN) ("PIK3CD" . SPARSER::PROTEIN)
    ("PIK3CB" . SPARSER::PROTEIN) ("Src-homology" . SPARSER::PROTEIN)
    ("PIK3R3" . SPARSER::PROTEIN) ("PIK3R2" . SPARSER::PROTEIN)
    ("PIK3R1" . SPARSER::PROTEIN) ("p110" . SPARSER::PROTEIN)
    ("p85" . SPARSER::PROTEIN)
    ("mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("P27" . SPARSER::PROTEIN) ("MDM2" . SPARSER::PROTEIN)
    ("GSK3β" . SPARSER::PROTEIN) ("Cyclin D1" . SPARSER::PROTEIN)
    ("PIP 3" . SPARSER::PIP3) ("PIP 2" . SPARSER::PIP2)
    ("G protein-coupled" . SPARSER::PROTEIN)
    ("receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Class I" . SPARSER::PROTEIN) ("PI3Ks" . SPARSER::PROTEIN)
    ("Phosphatidylinositol-3" . SPARSER::PROTEIN)
    ("estrogen receptor" . SPARSER::PROTEIN)
    ("catalytic subunit" . SPARSER::PROTEIN) ("p110α" . SPARSER::PROTEIN)
    ("PIK3CA" . SPARSER::PROTEIN) ("PI3K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatidylinositol-3" . SPARSER::PROTEIN)
    ("biomarkers" . SPARSER::MOLECULE) ("Trp " . SPARSER::AMINO-ACID)
    ("XRCC1 and EPD" . SPARSER::COLLECTION) ("invasive EPD" . SPARSER::PROTEIN)
    ("PIG7/LITAF" . SPARSER::COLLECTION) ("cycline" . SPARSER::PROTEIN-FAMILY)
    ("LITAF" . SPARSER::PROTEIN) ("AK and BD" . SPARSER::COLLECTION)
    ("AK" . SPARSER::PROTEIN) ("Han" . SPARSER::PROTEIN)
    ("EPD" . SPARSER::PROTEIN) ("his" . SPARSER::AMINO-ACID)
    ("SSB" . SPARSER::PROTEIN) ("BRCA1, BRCA2 and XRCC3" . SPARSER::COLLECTION)
    ("MLH1, MSH2, PMS2 and MSH6" . SPARSER::COLLECTION)
    ("XPC" . SPARSER::PROTEIN) ("Enzymes" . SPARSER::ENZYME)
    ("MLH1" . SPARSER::PROTEIN) ("NER" . SPARSER::PROTEIN)
    ("mutagens" . SPARSER::MOLECULE)
    ("tumor suppressor genes and DNA repair genes" . SPARSER::COLLECTION)
    ("oncogenes" . SPARSER::ONCOGENE) ("fragments" . SPARSER::FRAGMENT)
    ("His" . SPARSER::AMINO-ACID) ("Trp" . SPARSER::AMINO-ACID)
    ("Gln" . SPARSER::AMINO-ACID) ("Arg" . SPARSER::AMINO-ACID)
    ("cross-complementing" . SPARSER::PROTEIN)
    ("complementing" . SPARSER::PROTEIN) ("IL-10" . SPARSER::PROTEIN)
    ("interleukin 10" . SPARSER::PROTEIN) ("PIG7" . SPARSER::PROTEIN)
    ("c-erb" . SPARSER::PROTEIN) ("–3" . SPARSER::PROTEIN)
    ("MSH6" . SPARSER::PROTEIN) ("PMS2" . SPARSER::PROTEIN)
    ("MSH2" . SPARSER::PROTEIN) ("XRCC3" . SPARSER::PROTEIN)
    ("BRCA2" . SPARSER::PROTEIN) ("BRCA1" . SPARSER::PROTEIN)
    ("ERCC1" . SPARSER::PROTEIN) ("XRCC1" . SPARSER::PROTEIN)
    ("X-ray repair" . SPARSER::PROTEIN) ("medicine" . SPARSER::DRUG)
    ("MMR proteins and/or the age group" . SPARSER::COLLECTION)
    ("the most common gynecological type" . TYPE)
    ("hMSH2, hMSH6, and hMLH1" . SPARSER::COLLECTION)
    ("States" . SPARSER::BIO-STATE) ("PR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type" . TYPE) ("hMLH1 , hMSH2 , and hMSH6" . SPARSER::COLLECTION)
    ("at least one MMR protein" . SPARSER::PROTEIN)
    ("Pr" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MLE" . SPARSER::PROTEIN)
    ("hMLH1, hMSH2, and hMSH6" . SPARSER::COLLECTION)
    ("San" . SPARSER::PROTEIN) ("FHC" . SPARSER::PROTEIN)
    ("aims" . SPARSER::PROTEIN) ("EC" . SPARSER::PROTEIN)
    ("MMR" . SPARSER::PROTEIN) ("Type 1" . SPARSER::PROTEIN)
    ("−3" . SPARSER::PROTEIN) ("m 2" . SPARSER::MOLECULE)
    ("hMSH6" . SPARSER::PROTEIN) ("hMSH2" . SPARSER::PROTEIN)
    ("hMLH1" . SPARSER::PROTEIN) ("oncoproteins" . SPARSER::PROTEIN)
    ("TYRP2 and MET" . SPARSER::COLLECTION)
    ("a potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("a regulator of protein trafficking and melanoma proliferation xref"
     . SPARSER::COLLECTION)
    ("regulator" . SPARSER::REGULATOR) ("types" . TYPE)
    ("oncogene" . SPARSER::ONCOGENE)
    ("pro-inflammatory molecules" . SPARSER::MOLECULE)
    ("proteins and chemokines" . SPARSER::COLLECTION)
    ("proteins and miRNAs" . SPARSER::COLLECTION) ("miRNAs" . SPARSER::PROTEIN)
    ("osteopontin" . SPARSER::PROTEIN)
    ("RAB27A , RAB5B and RAB7" . SPARSER::COLLECTION)
    ("RAB1A , RAB5A , RAB5B , RAB7 , RAB27A , and RAB27B"
     . SPARSER::COLLECTION)
    ("RAB" . SPARSER::PROTEIN) ("MET and phospho-MET" . SPARSER::COLLECTION)
    ("Crizotinib" . SPARSER::DRUG) ("ERK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HGF/MET" . SPARSER::COLLECTION) ("MAPK" . SPARSER::PROTEIN)
    ("mTOR" . SPARSER::PROTEIN) ("HGF" . SPARSER::PROTEIN)
    ("shRNAs" . SPARSER::RNA) ("Cd44" . SPARSER::PROTEIN)
    ("group" . SPARSER::MOLECULE) ("Met and phospho-Met" . SPARSER::COLLECTION)
    ("oncoprotein, CD44, Hsp70 and annexin A6" . SPARSER::COLLECTION)
    ("exosomal Met" . SPARSER::AMINO-ACID)
    ("growth factors and chemokines" . SPARSER::COLLECTION)
    ("chemokines" . SPARSER::PROTEIN) ("PBS" . SPARSER::PROTEIN)
    ("luciferase" . SPARSER::PROTEIN) ("mCherry" . SPARSER::PROTEIN)
    ("proteins, S100a8 and S100a9" . SPARSER::COLLECTION)
    ("S100a9" . SPARSER::PROTEIN) ("S100a8" . SPARSER::PROTEIN)
    ("effectors" . SPARSER::EFFECTOR) ("ECM" . SPARSER::PROTEIN)
    ("differentially" . SPARSER::PROTEIN) ("media" . SPARSER::PROTEIN)
    ("dextran" . SPARSER::DEXTRAN) ("exosomal proteins" . SPARSER::PROTEIN)
    ("SK" . SPARSER::PROTEIN) ("a retrospective cohort" . SPARSER::MOLECULE)
    ("cohort" . SPARSER::MOLECULE) ("VLA-4 and HSP70" . SPARSER::COLLECTION)
    ("CD63, CD9 and MHC-I" . SPARSER::COLLECTION) ("MHC" . SPARSER::PROTEIN)
    ("electron" . SPARSER::MOLECULE) ("Exosomal proteins" . SPARSER::PROTEIN)
    ("exosomal TYRP2" . SPARSER::PROTEIN) ("IV" . SPARSER::PROTEIN)
    ("Rab" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cytokines and growth factors" . SPARSER::COLLECTION)
    ("mRNAs, microRNAs and proteins" . SPARSER::COLLECTION)
    ("microRNAs" . SPARSER::RNA) ("mRNAs" . SPARSER::PROTEIN)
    ("molecules" . SPARSER::MOLECULE) ("cytokines" . SPARSER::PROTEIN)
    ("luminal" . SPARSER::DRUG)
    ("an HSP90 isoform and the MET oncoprotein" . SPARSER::COLLECTION)
    ("oncoprotein" . SPARSER::PROTEIN) ("isoform" . SPARSER::ISOFORM)
    ("RAB1a , RAB5b , RAB7 , and RAB27a" . SPARSER::COLLECTION)
    ("RAB27a" . SPARSER::PROTEIN) ("RAB5b" . SPARSER::PROTEIN)
    ("RAB1a" . SPARSER::PROTEIN) ("pro" . SPARSER::AMINO-ACID)
    ("Met" . SPARSER::AMINO-ACID) ("receptor" . SPARSER::RECEPTOR)
    ("MET" . SPARSER::PROTEIN) ("mediators" . SPARSER::PROTEIN)
    ("S6 kinase" . SPARSER::PROTEIN-FAMILY) ("TSG101" . SPARSER::PROTEIN)
    ("PS2" . SPARSER::PROTEIN) ("VLA4" . SPARSER::PROTEIN)
    ("TYRP-2" . SPARSER::PROTEIN) ("Rab4" . SPARSER::PROTEIN)
    ("Hsc70" . SPARSER::PROTEIN) ("Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Annexin A6" . SPARSER::PROTEIN) ("Annexin A2" . SPARSER::PROTEIN)
    ("min −1" . SPARSER::PROTEIN) ("L −1" . SPARSER::PROTEIN)
    ("AS2" . SPARSER::PROTEIN) ("β-actin" . SPARSER::PROTEIN)
    ("Ly6G" . SPARSER::PROTEIN) ("CD19" . SPARSER::PROTEIN)
    ("CD5" . SPARSER::PROTEIN) ("VCAM-1" . SPARSER::PROTEIN)
    ("CD31" . SPARSER::PROTEIN) ("Texas Red" . SPARSER::DRUG)
    ("SW480" . SPARSER::PROTEIN) ("CD202B" . SPARSER::PROTEIN)
    ("CD34" . SPARSER::PROTEIN) ("CD117" . SPARSER::PROTEIN)
    ("CD105" . SPARSER::PROTEIN) ("CD29" . SPARSER::PROTEIN)
    ("B8)" . SPARSER::PROTEIN) ("CD11B" . SPARSER::PROTEIN)
    ("CD3ε" . SPARSER::PROTEIN) ("VEGFR2" . SPARSER::PROTEIN)
    ("CD32" . SPARSER::PROTEIN) ("CD16" . SPARSER::PROTEIN)
    ("growth factor" . SPARSER::GROWTH-FACTOR) ("or 2" . SPARSER::MOLECULE)
    ("F10" . SPARSER::PROTEIN) ("6 B" . SPARSER::PROTEIN)
    ("derived growth factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PDGF-AA" . SPARSER::PROTEIN) ("RAb27a" . SPARSER::PROTEIN)
    ("RAB27B" . SPARSER::PROTEIN) ("RAB27A" . SPARSER::PROTEIN)
    ("RAB5B" . SPARSER::PROTEIN) ("RAB5A" . SPARSER::PROTEIN)
    ("RAB1A" . SPARSER::PROTEIN) ("phospho-ERK" . SPARSER::PROTEIN)
    ("proto-oncogene" . SPARSER::PROTEIN) ("annexin A6" . SPARSER::PROTEIN)
    ("Hsp70" . SPARSER::PROTEIN) ("CD44" . SPARSER::PROTEIN)
    ("VEGFR1" . SPARSER::PROTEIN) ("Gr1" . SPARSER::PROTEIN)
    ("CD11b" . SPARSER::PROTEIN) ("a 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("brain)" . SPARSER::PROTEIN) ("TNF-α" . SPARSER::PROTEIN)
    ("S100" . SPARSER::PROTEIN) ("colon cancer" . SPARSER::PROTEIN)
    ("ml −1" . SPARSER::PROTEIN) ("CD9" . SPARSER::PROTEIN)
    ("CD63" . SPARSER::PROTEIN) ("heat shock protein 70" . SPARSER::PROTEIN)
    ("tyrosinase-related protein-2" . SPARSER::PROTEIN)
    ("growth factors" . SPARSER::GROWTH-FACTOR)
    ("cell membrane" . SPARSER::PROTEIN)
    ("HSP90" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HSP70" . SPARSER::PROTEIN)
    ("VLA-4" . SPARSER::PROTEIN) ("TYRP2" . SPARSER::PROTEIN)
    ("Rab27a" . SPARSER::PROTEIN) ("RAB27" . SPARSER::PROTEIN)
    ("RAB7" . SPARSER::PROTEIN) ("RAB5" . SPARSER::PROTEIN)
    ("RAB1" . SPARSER::PROTEIN) ("TIE2" . SPARSER::PROTEIN)
    ("C-KIT" . SPARSER::PROTEIN) ("CD45" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tie2" . SPARSER::PROTEIN) ("c-Kit" . SPARSER::PROTEIN)
    ("GENe" . SPARSER::GENE) ("Matrix" . SPARSER::PROTEIN-FAMILY)
    ("SNAP" . SPARSER::PROTEIN)
    ("MYC and other genes (including SMADs and other TGF -β pathway genes)"
     . SPARSER::COLLECTION)
    ("SMADs" . SPARSER::PROTEIN) ("components" . SPARSER::COMPONENT)
    ("male" . SPARSER::MOLECULE)
    ("POLD3, CDKN1A, GPR143 or SHROOM2" . SPARSER::COLLECTION)
    ("RNA" . SPARSER::RNA) ("cis" . SPARSER::PROTEIN)
    ("FAP" . SPARSER::PROTEIN) ("GPR143 and SHROOM2" . SPARSER::COLLECTION)
    ("promoter" . SPARSER::PROMOTER) ("APX" . SPARSER::PROTEIN)
    ("map" . SPARSER::PROTEIN) ("sporadic CRC" . SPARSER::PROTEIN)
    ("MSI" . SPARSER::PROTEIN)
    ("dysplastic aberrant crypt foci" . SPARSER::PROTEIN)
    ("foci" . SPARSER::PROTEIN) ("PCNA and DNA" . SPARSER::COLLECTION)
    ("PCNA–p21" . SPARSER::COLLECTION) ("MYC" . SPARSER::PROTEIN)
    ("suppressor" . SPARSER::SUPPRESSOR) ("effector" . SPARSER::EFFECTOR)
    ("Cip" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen (PCNA)" . SPARSER::PROTEIN)
    ("MIM" . SPARSER::PROTEIN) ("polymerase" . SPARSER::PROTEIN)
    ("maps" . SPARSER::PROTEIN) ("het" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Family" . SPARSER::PROTEIN-FAMILY) ("mapping" . SPARSER::PROTEIN)
    ("component" . SPARSER::COMPONENT) ("cryptic" . SPARSER::PROTEIN)
    ("Cohort" . SPARSER::MOLECULE) ("Duo" . SPARSER::PROTEIN)
    ("adjuvant" . SPARSER::DRUG) ("Gene" . SPARSER::GENE)
    ("UK" . SPARSER::PROTEIN) ("part" . SPARSER::COMPONENT)
    ("mismatch" . SPARSER::PROTEIN) ("CRCs" . SPARSER::PROTEIN)
    ("CRC" . SPARSER::PROTEIN) ("2/3" . SPARSER::PROTEIN)
    ("32 P" . SPARSER::|32P|) ("amino acid" . SPARSER::AMINO-ACID)
    ("X chromosome" . SPARSER::PROTEIN)
    ("TGF -β" . SPARSER::HUMAN-PROTEIN-FAMILY) ("X-linked" . SPARSER::PROTEIN)
    ("T-cell" . SPARSER::PROTEIN) ("transcription factor" . SPARSER::PROTEIN)
    ("homolog of" . SPARSER::PROTEIN)
    ("shroom family member 2" . SPARSER::PROTEIN)
    ("G protein-coupled receptor 143" . SPARSER::PROTEIN)
    ("GPR143" . SPARSER::PROTEIN) ("WAF1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor 1" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("delta 3" . SPARSER::PROTEIN) ("Colon Cancer" . SPARSER::PROTEIN)
    ("SHROOM2" . SPARSER::PROTEIN) ("POLD3" . SPARSER::PROTEIN)
    ("CDKN1A" . SPARSER::PROTEIN) ("p21" . SPARSER::PROTEIN)
    ("identifying rare Mendelian disease genes" . SPARSER::GENE)
    ("tetra" . SPARSER::MOLECULE) ("kDa" . SPARSER::PROTEIN)
    ("Ubiquitin" . SPARSER::PROTEIN) ("alleles" . SPARSER::ALLELE)
    ("flag" . SPARSER::PROTEIN-FAMILY) ("GFP-CDKN1C" . SPARSER::COLLECTION)
    ("importin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mRNA and protein" . SPARSER::COLLECTION)
    ("the mutated allele" . SPARSER::ALLELE)
    ("the maternal allele" . SPARSER::ALLELE)
    ("the paternal allele" . SPARSER::ALLELE) ("allele" . SPARSER::ALLELE)
    ("variants" . SPARSER::VARIANT) ("GC" . SPARSER::PROTEIN)
    ("genes" . SPARSER::GENE) ("variant" . SPARSER::VARIANT)
    ("Family A, V-1 and V-6" . SPARSER::COLLECTION) ("II" . SPARSER::PROTEIN)
    ("-1" . SPARSER::PROTEIN) ("CGH" . SPARSER::PROTEIN)
    ("IBD" . SPARSER::PROTEIN) ("a causative gene" . SPARSER::GENE)
    ("PCNA" . SPARSER::PROTEIN) ("Drosophila" . SPARSER::PROTEIN)
    ("a 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("1C" . SPARSER::PROTEIN)
    ("M2" . SPARSER::MOLECULE) ("ANTI-" . SPARSER::ANTIBODY)
    ("MG-132" . SPARSER::DRUG) ("anti-" . SPARSER::ANTIBODY)
    ("CYP11A1" . SPARSER::PROTEIN) ("m1" . SPARSER::MOLECULE)
    ("reverse transcriptase" . SPARSER::PROTEIN) ("P49918" . SPARSER::PROTEIN)
    ("Nsp1" . SPARSER::PROTEIN) ("-2" . SPARSER::PROTEIN)
    ("M1" . SPARSER::MOLECULE)
    ("cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GAL4" . SPARSER::PROTEIN) ("autosomal dominant" . SPARSER::PROTEIN)
    (NIL . SPARSER::PROTEIN) ("Family A" . SPARSER::PROTEIN)
    ("P57KIP2" . SPARSER::PROTEIN) ("CDKN1C" . SPARSER::PROTEIN)
    ("leukemia" . SPARSER::PROTEIN) ("drugs" . SPARSER::DRUG)
    ("cladribine" . SPARSER::PROTEIN) ("fludarabine" . SPARSER::DRUG)
    ("gemcitabine" . SPARSER::DRUG) ("HU" . SPARSER::DRUG)
    ("the cellular dNTP" . SPARSER::MOLECULE)
    ("RRM2B or p53R2" . SPARSER::COLLECTION) ("p53R2" . SPARSER::PROTEIN)
    ("complex" . SPARSER::BIO-COMPLEX) ("Chk1-" . SPARSER::PROTEIN)
    ("Cyclin F(M309A) or Cyclin F(LP/AA)" . SPARSER::COLLECTION)
    ("alkaline" . SPARSER::PROTEIN) ("inactive" . SPARSER::INACTIVE)
    ("doxycycline-repressible Cyclin F" . SPARSER::PROTEIN)
    ("forms" . SPARSER::FORM) ("doxycycline" . SPARSER::DRUG)
    ("fractions" . SPARSER::COMPONENT) ("chromatin" . SPARSER::BIO-COMPLEX)
    ("seven" . SPARSER::PROTEIN) ("GFP" . SPARSER::PROTEIN)
    ("fragment" . SPARSER::FRAGMENT) ("exogenous Cyclin F" . SPARSER::PROTEIN)
    ("mRNA" . SPARSER::PROTEIN) ("Ataxia" . SPARSER::PROTEIN)
    ("ATM and/or ATR" . SPARSER::COLLECTION) ("caffeine" . SPARSER::MOLECULE)
    ("ATM" . SPARSER::PROTEIN) ("CPT" . SPARSER::PROTEIN)
    ("doxorubicin" . SPARSER::PROTEIN) ("purines" . SPARSER::DRUG)
    ("exon" . SPARSER::PROTEIN) ("TG" . SPARSER::PROTEIN)
    ("t" . SPARSER::PROTEIN) ("hypoxanthine" . SPARSER::DRUG)
    ("gene" . SPARSER::GENE)
    ("RRM2(T33A) and RRM2(RxI/AxA)" . SPARSER::COLLECTION)
    ("deoxyribonucleosides" . SPARSER::MOLECULE)
    ("nucleotide" . SPARSER::NUCLEOTIDE) ("hydroxyurea" . SPARSER::DRUG)
    ("pyrimidine" . SPARSER::DRUG) ("purine" . SPARSER::DRUG)
    ("dATP and dGTP" . SPARSER::COLLECTION)
    ("dCTP and dTTP" . SPARSER::COLLECTION) ("dTTP" . SPARSER::MOLECULE)
    ("dCTP" . SPARSER::MOLECULE) ("dGTP" . SPARSER::DGTP)
    ("dATP" . SPARSER::DATP)
    ("RRM2(RxI/AxA) and RRM2(T33A)" . SPARSER::COLLECTION)
    ("hTert" . SPARSER::PROTEIN)
    ("parental Cyclin F  Flox/− MEFs" . SPARSER::PROTEIN)
    ("Flox" . SPARSER::PROTEIN) ("MEFs" . SPARSER::PROTEIN)
    ("hTERT" . SPARSER::PROTEIN) ("siRNA" . SPARSER::PROTEIN)
    ("active" . SPARSER::ACTIVE) ("alanine" . SPARSER::AMINO-ACID)
    ("AA" . SPARSER::MOLECULE)
    ("the first 30-40 amino acids of Cyclin F" . SPARSER::PROTEIN)
    ("state" . SPARSER::BIO-STATE) ("Cdk2-Cyclin A" . SPARSER::COLLECTION)
    ("Cdk1-Cyclin" . SPARSER::COLLECTION) ("CKII" . SPARSER::PROTEIN)
    ("MEK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Roscovitine" . SPARSER::DRUG)
    ("inhibitors" . SPARSER::INHIBITOR) ("kinase" . SPARSER::KINASE)
    ("Pro" . SPARSER::AMINO-ACID) ("Ser" . SPARSER::AMINO-ACID)
    ("Histone" . SPARSER::PROTEIN) ("Cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("form" . SPARSER::FORM) ("peptide" . SPARSER::PEPTIDE)
    ("antibody" . SPARSER::PROTEIN) ("Ala" . SPARSER::AMINO-ACID)
    ("AxA" . SPARSER::MOLECULE) ("Cyclin F and RRM2" . SPARSER::COLLECTION)
    ("mutants" . SPARSER::MUTANT)
    ("MG132 and the CRM1/exportin1 inhibitor Leptomycin B (LMB)"
     . SPARSER::COLLECTION)
    ("Leptomycin B (LMB)" . SPARSER::MOLECULE)
    ("CRM1/exportin1" . SPARSER::COLLECTION) ("LMB" . SPARSER::MOLECULE)
    ("antibodies" . SPARSER::ANTIBODY)
    ("centrosomes ( xref ) and RRM2" . SPARSER::COLLECTION)
    ("endogenous Cyclin F and endogenous RRM2" . SPARSER::COLLECTION)
    ("cytometry" . SPARSER::PROTEIN)
    ("the only F-box protein" . SPARSER::PROTEIN)
    ("inhibitor" . SPARSER::INHIBITOR)
    ("RRM2 and Cyclin F" . SPARSER::COLLECTION)
    ("five unique RRM2 peptides" . SPARSER::PEPTIDE)
    ("Skp1 and Cul1" . SPARSER::COLLECTION) ("subunit" . SPARSER::FRAGMENT)
    ("peptides" . SPARSER::PEPTIDE) ("Protein" . SPARSER::PROTEIN)
    ("FLAG" . SPARSER::PROTEIN-FAMILY) ("Cdh1" . SPARSER::PROTEIN)
    ("Cdh" . SPARSER::PROTEIN) ("APC" . SPARSER::PROTEIN)
    ("enzymes" . SPARSER::ENZYME)
    ("two identical large subunits (called RRM1, RNR1, RR1, or R1) and two identical small subunits (called RRM2, RNR2, RR2, or R2)"
     . SPARSER::COLLECTION)
    ("a well-studied enzyme" . SPARSER::ENZYME) ("enzyme" . SPARSER::ENZYME)
    ("centrosomal Cyclin F" . SPARSER::PROTEIN)
    ("targets" . SPARSER::TARGET-PROTEIN) ("centrosomes" . SPARSER::PROTEIN)
    ("typical cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDKs" . SPARSER::PROTEIN) ("cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("family" . SPARSER::PROTEIN-FAMILY) ("substrates" . SPARSER::SUBSTRATE)
    ("target" . SPARSER::TARGET-PROTEIN)
    ("ubiquitin conjugating enzyme (UBC)" . SPARSER::PROTEIN-FAMILY)
    ("UBC" . SPARSER::PROTEIN) ("scaffold" . SPARSER::SCAFFOLD)
    ("ligases" . SPARSER::LIGASE) ("variety" . SPARSER::VARIETY)
    ("ubiquitin" . SPARSER::PROTEIN) ("mutant" . SPARSER::MUTANT)
    ("ATR" . SPARSER::PROTEIN) ("dNTP" . SPARSER::MOLECULE)
    ("Thr" . SPARSER::AMINO-ACID) ("CDK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DNA" . SPARSER::DNA) ("dNTPs" . SPARSER::MOLECULE)
    ("deoxyribonucleotides" . SPARSER::MOLECULE)
    ("ribonucleotides" . SPARSER::MOLECULE) ("RNR" . SPARSER::PROTEIN)
    ("Ribonucleotide" . SPARSER::MOLECULE)
    ("ribonucleotide" . SPARSER::MOLECULE) ("complexes" . SPARSER::BIO-COMPLEX)
    ("protein" . SPARSER::PROTEIN) ("SCF" . SPARSER::PROTEIN)
    ("subunits" . SPARSER::PROTEIN) ("substrate" . SPARSER::SUBSTRATE)
    ("proteins" . SPARSER::PROTEIN) ("-3" . SPARSER::PROTEIN)
    ("DNA polymerase" . SPARSER::PROTEIN) ("G418" . SPARSER::MOLECULE)
    ("MgCl 2" . SPARSER::MOLECULE) ("Triton X-100" . SPARSER::MOLECULE)
    ("RRM2B" . SPARSER::PROTEIN) ("E2F1" . SPARSER::PROTEIN)
    ("p53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("53BP1" . SPARSER::PROTEIN)
    ("Chk1" . SPARSER::PROTEIN) ("CHK1" . SPARSER::PROTEIN)
    ("G2/M" . SPARSER::PROTEIN) ("Plk1" . SPARSER::PROTEIN)
    ("Cyclin A" . SPARSER::PROTEIN) ("Cdk2" . SPARSER::PROTEIN)
    ("Cdk1" . SPARSER::PROTEIN) ("DNA-PK" . SPARSER::PROTEIN)
    ("U0126" . SPARSER::DRUG) ("p38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SB203580" . SPARSER::DRUG) ("NU6102" . SPARSER::DRUG)
    ("amino acids" . SPARSER::AMINO-ACID) ("Leptomycin B" . SPARSER::MOLECULE)
    ("exportin1" . SPARSER::PROTEIN) ("CRM1" . SPARSER::PROTEIN)
    ("MG132" . SPARSER::PROTEIN)
    ("transcription factor E2F1" . SPARSER::PROTEIN) ("RR2" . SPARSER::PROTEIN)
    ("RNR2" . SPARSER::PROTEIN) ("RR1" . SPARSER::PROTEIN)
    ("RNR1" . SPARSER::PROTEIN) ("RRM1" . SPARSER::PROTEIN)
    ("NuSAP1" . SPARSER::PROTEIN) ("CP110" . SPARSER::PROTEIN)
    ("cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein can" . SPARSER::PROTEIN)
    ("ubiquitin conjugating enzyme" . SPARSER::PROTEIN-FAMILY)
    ("subunit E" . SPARSER::PROTEIN) ("Cyclin F" . SPARSER::PROTEIN)
    ("family member 2" . SPARSER::PROTEIN) ("RRM2" . SPARSER::PROTEIN)
    ("ubiquitin ligase" . SPARSER::PROTEIN) ("Cul1" . SPARSER::PROTEIN)
    ("Skp1" . SPARSER::PROTEIN)))